Citrus Sinensis ID: 037365
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 398 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZR08 | 852 | G-type lectin S-receptor- | yes | no | 0.791 | 0.369 | 0.505 | 2e-91 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.748 | 0.350 | 0.521 | 4e-90 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.771 | 0.364 | 0.515 | 4e-89 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.688 | 0.322 | 0.523 | 5e-89 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.771 | 0.362 | 0.509 | 5e-89 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.919 | 0.433 | 0.432 | 6e-89 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.778 | 0.378 | 0.505 | 7e-89 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.894 | 0.427 | 0.435 | 1e-87 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.751 | 0.355 | 0.489 | 4e-87 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.751 | 0.355 | 0.488 | 7e-86 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function desciption |
|---|
Score = 336 bits (861), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 181/358 (50%), Positives = 241/358 (67%), Gaps = 43/358 (12%)
Query: 82 NIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGN 141
+I+ + S K++ + +D P F ++ AT+ FS+ANKLG+GGFGPVYKG+
Sbjct: 497 HIKELIESGRFKQDDSQGID-VPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQ 555
Query: 142 EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF 201
EIAVKRLS SGQGL E KNE +IAK+QH+NLVRLLG C+ +EK+L+YEYMP+KSLDF
Sbjct: 556 EIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDF 615
Query: 202 FLFN--------------------------------------LKASNILLDKDMNPKISD 223
F+F+ LK SNILLD++MNPKISD
Sbjct: 616 FIFDRKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISD 675
Query: 224 FGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTG 283
FG+ARI GG+E ANT+R+VGTYGYMSPEYA+EG+FS K DVFSFGV+++E +SGK+NTG
Sbjct: 676 FGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTG 735
Query: 284 FYRTD-TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRP 342
F+ + +L+LLG+AWDLW++ R +EL D L+ E + L+ +N+ LLCVQE +DRP
Sbjct: 736 FHEPEKSLSLLGHAWDLWKAERGIELLDQALQ-ESCETEGFLKCLNVGLLCVQEDPNDRP 794
Query: 343 TTNDVVSMLTNEAAALLP-PKQPAFSYVR-NTVTSTSSTGKTEDCSINQVTISLLEAR 398
T ++VV ML + AA LP PKQPAF R + + SS+ K E CS N++TI+L + R
Sbjct: 795 TMSNVVFMLGSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 332 bits (850), Expect = 4e-90, Method: Compositional matrix adjust.
Identities = 178/341 (52%), Positives = 225/341 (65%), Gaps = 43/341 (12%)
Query: 101 DQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMK 160
++ +FSF SV+ AT+ FSDANKLGEGGFGPVYKG L G E+A+KRLS SGQGL E K
Sbjct: 510 NELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFK 569
Query: 161 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN--------------- 205
NEA +IAK+QH NLV+LLGCC++KDEK+LIYEYMPNKSLD+FLF+
Sbjct: 570 NEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRI 629
Query: 206 -----------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242
+KA NILLD+DMNPKISDFGMARI G E +ANT R+
Sbjct: 630 MEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRV 689
Query: 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD--TLNLLGYAWDLW 300
GT+GYMSPEY EG+FS K DVFSFGVL+LEI+ G+KN F+ LNL+ + W+L+
Sbjct: 690 AGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLF 749
Query: 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA-AALL 359
+ NR E+ D L D +LR V +ALLCVQ++ADDRP+ DVVSM+ + AL
Sbjct: 750 KENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALS 809
Query: 360 PPKQPAF--SYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 398
PK+PAF R++ + E+ S N+VTI+++EAR
Sbjct: 810 LPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (842), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 181/351 (51%), Positives = 229/351 (65%), Gaps = 44/351 (12%)
Query: 92 TKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR 151
T + KK E + PL +++TATN FS+ NKLG+GGFG VYKG L G EIAVKRLS
Sbjct: 493 TSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKM 552
Query: 152 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------ 205
S QG E NE +IAK+QH NLVRLLGCC+DK EK+LIYEY+ N SLD LF+
Sbjct: 553 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 612
Query: 206 --------------------------------LKASNILLDKDMNPKISDFGMARICGGN 233
LKASN+LLDK+M PKISDFGMARI G
Sbjct: 613 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 672
Query: 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-LNL 292
E +ANT R+VGTYGYMSPEYA++GIFS+K DVFSFGVLLLEI+SGK+N GFY ++ LNL
Sbjct: 673 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 732
Query: 293 LGYAWDLWRSNRTLELTDAILEDEYSSK---QVLLRYVNIALLCVQESADDRPTTNDVVS 349
LG+ W W+ LE+ D I D SSK +LR + I LLCVQE A+DRP + V+
Sbjct: 733 LGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 792
Query: 350 MLTNEAAALLPPKQPAFSYVRNTVT--STSSTGKTEDCSINQVTISLLEAR 398
ML +E A+ PK+P F R+ + S+SST + ++C++NQ+T+S+++AR
Sbjct: 793 MLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 5e-89, Method: Compositional matrix adjust.
Identities = 164/313 (52%), Positives = 211/313 (67%), Gaps = 39/313 (12%)
Query: 96 KKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQG 155
K + P+FS ++++ ATN F N+LG GGFGPVYKGVL G EIAVKRLSG+SGQG
Sbjct: 507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566
Query: 156 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN---------- 205
+ E KNE +IAK+QH+NLVRLLGCC + +EK+L+YEYMPNKSLDFFLF+
Sbjct: 567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626
Query: 206 ----------------------------LKASNILLDKDMNPKISDFGMARICGGNELQA 237
LK SN+LLD +MNPKISDFGMARI GGN+ +A
Sbjct: 627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686
Query: 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW 297
NT R+VGTYGYMSPEYA+EG+FS+K DV+SFGVLLLEIVSGK+NT ++ +L+GYAW
Sbjct: 687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAW 746
Query: 298 DLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357
L+ R+ EL D + S ++ LR +++A+LCVQ+SA +RP V+ ML ++ A
Sbjct: 747 YLYTHGRSEELVDPKIRVTCSKREA-LRCIHVAMLCVQDSAAERPNMASVLLMLESDTAT 805
Query: 358 LLPPKQPAFSYVR 370
L P+QP F+ R
Sbjct: 806 LAAPRQPTFTSTR 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 5e-89, Method: Compositional matrix adjust.
Identities = 179/351 (50%), Positives = 228/351 (64%), Gaps = 44/351 (12%)
Query: 92 TKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR 151
T + K + + PL + +++ ATN FS NKLG+GGFG VYKG+L G EIAVKRLS
Sbjct: 497 TSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKM 556
Query: 152 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------ 205
S QG E NE +IAK+QH NLVRLLGCC+DK EK+LIYEY+ N SLD LF+
Sbjct: 557 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 616
Query: 206 --------------------------------LKASNILLDKDMNPKISDFGMARICGGN 233
LKASN+LLDK+M PKISDFGMARI G
Sbjct: 617 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 676
Query: 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-LNL 292
E +ANT R+VGTYGYMSPEYA++GIFS+K DVFSFGVLLLEI+SGK+N GFY ++ LNL
Sbjct: 677 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 736
Query: 293 LGYAWDLWRSNRTLELTDAILEDEYSSK---QVLLRYVNIALLCVQESADDRPTTNDVVS 349
LG+ W W+ + LE+ D I D SS+ +LR + I LLCVQE A+DRP + V+
Sbjct: 737 LGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 796
Query: 350 MLTNEAAALLPPKQPAFSYVR--NTVTSTSSTGKTEDCSINQVTISLLEAR 398
ML +E A+ PK+P F R V S+SST + ++C++NQVT+S+++AR
Sbjct: 797 MLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 328 bits (840), Expect = 6e-89, Method: Compositional matrix adjust.
Identities = 179/414 (43%), Positives = 260/414 (62%), Gaps = 48/414 (11%)
Query: 30 GVDSASFFVLLSLSITLAAVATLGLNFYCFLHTSGEDLMMFDLDLNLKA-NNVNIELPVN 88
G VL+ +S+ +A V L ++F+C+L + L + + +L +
Sbjct: 435 GASGKKRLVLILISL-IAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDS 493
Query: 89 SKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRL 148
L + K + PLF S+++TATN F+ NKLG GGFGPVYKGVL+ G EIAVKRL
Sbjct: 494 FILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRL 553
Query: 149 SGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN--- 205
S SGQG+ E KNE +I+K+QH+NLVR+LGCC++ +EK+L+YEY+PNKSLD+F+F+
Sbjct: 554 SKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQ 613
Query: 206 -----------------------------------LKASNILLDKDMNPKISDFGMARIC 230
LKASN+LLD +M PKI+DFG+ARI
Sbjct: 614 RAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIF 673
Query: 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTL 290
GGN+++ +T+R+VGTYGYMSPEYA++G FSIK DV+SFGVL+LEI++GK+N+ FY ++L
Sbjct: 674 GGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFYE-ESL 732
Query: 291 NLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350
NL+ + WD W + +E+ D ++ +E + +++ ++I LLCVQE++ DRP + VV M
Sbjct: 733 NLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFM 792
Query: 351 LTNEAAALLPPKQPAFS--YVRNTVTSTSS----TGKTEDCSINQVTISLLEAR 398
L + A L PK PAF+ RNT T SS +G+T +IN VT++ ++ R
Sbjct: 793 LGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSS-TINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 7e-89, Method: Compositional matrix adjust.
Identities = 178/352 (50%), Positives = 227/352 (64%), Gaps = 42/352 (11%)
Query: 89 SKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRL 148
S + KRN++K ++ +FSF SV +AT+ FSD NKLGEGGFGPVYKG L G E+A+KRL
Sbjct: 467 SCIHKRNERKSNNELQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRL 526
Query: 149 SGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN--- 205
S SGQGL E KNEA +IAK+QH NLV++LGCCI+KDEK+LIYEYM NKSLD+FLF+
Sbjct: 527 SLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLR 586
Query: 206 -----------------------------------LKASNILLDKDMNPKISDFGMARIC 230
+KASNILLD+DMNPKISDFG+ARI
Sbjct: 587 KNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIF 646
Query: 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYR--TD 288
G E +ANT R+ GT+GYMSPEY EG+FS K DVFSFGVL+LEI+ G+KN F+
Sbjct: 647 GAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEG 706
Query: 289 TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVV 348
LNL+ + W+L++ N+ E+ D L D +LR V +ALLCVQE+A+DRP+ DVV
Sbjct: 707 PLNLIVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDVV 766
Query: 349 SMLTNEA-AALLPPKQPAF-SYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 398
SM+ E AL PK+PAF R + + + +TI++LEAR
Sbjct: 767 SMIYGEGNNALSLPKEPAFYDGPRRSFPEMKVEPQEPENVSASITITVLEAR 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 174/400 (43%), Positives = 241/400 (60%), Gaps = 44/400 (11%)
Query: 38 VLLSLSITLAAVATLGLNFYCFLHTSGEDLMMFDLDLNLKANNVNIELPVNSKLTKRNKK 97
VLL L +AAV L + +C + + + + AN + + K
Sbjct: 439 VLLILISLIAAVMLLTVILFCVVRERRKS----NRHRSSSANFAPVPFDFDESFRFEQDK 494
Query: 98 KEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLR 157
+ PLF +++ ATN FS NKLG GGFGPVYKGVL+ EIAVKRLS SGQG+
Sbjct: 495 ARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGME 554
Query: 158 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------ 205
E KNE +I+K+QH+NLVR+LGCC++ +EK+L+YEY+PNKSLD+F+F+
Sbjct: 555 EFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKR 614
Query: 206 --------------------------LKASNILLDKDMNPKISDFGMARICGGNELQANT 239
LKASNILLD +M PKISDFGMARI GGN+++ T
Sbjct: 615 MEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCT 674
Query: 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL 299
SR+VGT+GYM+PEYA+EG FSIK DV+SFGVL+LEI++GKKN+ F+ ++ NL+G+ WDL
Sbjct: 675 SRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHE-ESSNLVGHIWDL 733
Query: 300 WRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359
W + E+ D +++ E ++ +++ + I LLCVQE+A DR + VV ML + A L
Sbjct: 734 WENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLP 793
Query: 360 PPKQPAFSYVRNTVTSTSSTGKTE-DCSINQVTISLLEAR 398
PK PAF+ R + K + S+N VT S ++ R
Sbjct: 794 NPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 322 bits (824), Expect = 4e-87, Method: Compositional matrix adjust.
Identities = 166/339 (48%), Positives = 221/339 (65%), Gaps = 40/339 (11%)
Query: 99 EVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE 158
++ + PLF F ++T+T+ FS NKLG+GGFGPVYKG L +G EIAVKRLS +SGQGL E
Sbjct: 505 KLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEE 564
Query: 159 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------- 205
+ NE VI+K+QH+NLV+LLGCCI+ +E++L+YEYMP KSLD +LF+
Sbjct: 565 LMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRF 624
Query: 206 -------------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTS 240
LKASNILLD+++NPKISDFG+ARI NE +ANT
Sbjct: 625 NIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTR 684
Query: 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD-TLNLLGYAWDL 299
R+VGTYGYMSPEYA+EG FS K DVFS GV+ LEI+SG++N+ ++ + LNLL YAW L
Sbjct: 685 RVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKL 744
Query: 300 WRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359
W L D + D+ K++ + V+I LLCVQE A+DRP ++V+ MLT E +L
Sbjct: 745 WNDGEAASLADPAVFDKCFEKEI-EKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLA 803
Query: 360 PPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 398
PKQPAF R + SS ++ SIN V+++ + R
Sbjct: 804 DPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 7e-86, Method: Compositional matrix adjust.
Identities = 165/338 (48%), Positives = 214/338 (63%), Gaps = 39/338 (11%)
Query: 99 EVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE 158
+ P+FSF SV++AT F++ NKLG+GGFG VYKG +G EIAVKRLSG+S QGL E
Sbjct: 506 DTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEE 565
Query: 159 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------- 205
KNE +IAK+QH+NLVRLLGCCI+ +EK+L+YEYMPNKSLD FLF+
Sbjct: 566 FKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRW 625
Query: 206 -------------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTS 240
LKASNILLD +MNPKISDFGMARI + ANT
Sbjct: 626 EVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTI 685
Query: 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLW 300
R+VGTYGYM+PEYA+EGIFS K DV+SFGVL+LEIVSG+KN F TD +L+GYAW LW
Sbjct: 686 RVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLW 745
Query: 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLP 360
+T E+ D I++D + +R +++ +LC Q+S RP V+ ML ++ + L P
Sbjct: 746 SQGKTKEMIDPIVKDTRDVTEA-MRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPP 804
Query: 361 PKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 398
P+QP F N+ + + S+N VT + + R
Sbjct: 805 PRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 398 | ||||||
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.934 | 0.430 | 0.580 | 1e-118 | |
| 297742753 | 637 | unnamed protein product [Vitis vinifera] | 0.919 | 0.574 | 0.575 | 1e-118 | |
| 359493705 | 830 | PREDICTED: receptor-like serine/threonin | 0.939 | 0.450 | 0.548 | 1e-115 | |
| 302143120 | 674 | unnamed protein product [Vitis vinifera] | 0.891 | 0.526 | 0.56 | 1e-113 | |
| 296090091 | 674 | unnamed protein product [Vitis vinifera] | 0.942 | 0.556 | 0.548 | 1e-113 | |
| 356514857 | 834 | PREDICTED: G-type lectin S-receptor-like | 0.831 | 0.396 | 0.579 | 1e-113 | |
| 302143128 | 692 | unnamed protein product [Vitis vinifera] | 0.834 | 0.479 | 0.568 | 1e-110 | |
| 302143125 | 585 | unnamed protein product [Vitis vinifera] | 0.939 | 0.639 | 0.539 | 1e-110 | |
| 224138268 | 818 | predicted protein [Populus trichocarpa] | 0.846 | 0.411 | 0.549 | 1e-109 | |
| 224106539 | 846 | predicted protein [Populus trichocarpa] | 0.819 | 0.385 | 0.562 | 1e-109 |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1110), Expect = e-118, Method: Compositional matrix adjust.
Identities = 245/422 (58%), Positives = 290/422 (68%), Gaps = 50/422 (11%)
Query: 18 FLILAFISGLSKGVDSASFFVLLSLSITLAAVATLGLNFYCF---LHTSGEDLMMFDLDL 74
+L LA S LS V S+ + V L +TLA T + L GE+L++FDL
Sbjct: 453 YLKLA-ASELSGKVSSSKWKVWLI--VTLAISVTSAFVIWGIRRRLRRKGENLLLFDL-- 507
Query: 75 NLKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYK 134
+ + + N EL SKL +KKEVD P+FSF+SVS ATN FS NKLGEGGFGPVYK
Sbjct: 508 SNSSVDTNYELSETSKLWS-GEKKEVD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYK 565
Query: 135 GVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194
G +KG E+AVKRLS RSGQG E+KNE +IAK+QHKNLV+L G CI+KDEKILIYEYM
Sbjct: 566 GKSQKGYEVAVKRLSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYM 625
Query: 195 PNKSLDFFLFN--------------------------------------LKASNILLDKD 216
PNKSLDFFLF+ LKASNILLDKD
Sbjct: 626 PNKSLDFFLFDPTKHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKD 685
Query: 217 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIV 276
MNP+ISDFGMARI GGNE +A T+ IVGTYGYMSPEYA+EG+FS K DVFSFGVLLLEI+
Sbjct: 686 MNPQISDFGMARIFGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEIL 744
Query: 277 SGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQE 336
SGKKNTGFY+TD+LNLLGYAWDLW+ +R EL D LE+ + +LLRY+NI LLCVQE
Sbjct: 745 SGKKNTGFYQTDSLNLLGYAWDLWKDSRGQELMDPGLEETLPT-HILLRYINIGLLCVQE 803
Query: 337 SADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLE 396
SADDRPT +DVVSML NE+ L PKQPAFS +R+ V S K + CS+N VT+S++E
Sbjct: 804 SADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVME 863
Query: 397 AR 398
AR
Sbjct: 864 AR 865
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1107), Expect = e-118, Method: Compositional matrix adjust.
Identities = 240/417 (57%), Positives = 289/417 (69%), Gaps = 51/417 (12%)
Query: 24 ISGLSKGVDSASF----FVLLSLSITLAAVATLGLNFYCFLHTSGEDLMMFDLDLNLKAN 79
+SG + S+ + V L++S+T +A G+ L GE+L++FDL + +
Sbjct: 230 LSGKGNKISSSKWKVWLIVTLAISVT-SAFVIWGIRRR--LRRKGENLLLFDL--SNSSV 284
Query: 80 NVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK 139
+ N EL SKL +KKEVD P+FSF+SVS ATN FS NKLGEGGFGPVYKG +K
Sbjct: 285 DTNYELSETSKLWS-GEKKEVD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQK 342
Query: 140 GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199
G E+AVKRLS RSGQG E+KNE +IAK+QHKNLV+L G CI+KDEKILIYEYMPNKSL
Sbjct: 343 GYEVAVKRLSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSL 402
Query: 200 DFFLFN--------------------------------------LKASNILLDKDMNPKI 221
DFFLF+ LKASNILLDKDMNP+I
Sbjct: 403 DFFLFDPTKHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQI 462
Query: 222 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKN 281
SDFGMARI GGNE +A T+ IVGTYGYMSPEYA+EG+FS K DVFSFGVLLLEI+SGKKN
Sbjct: 463 SDFGMARIFGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKN 521
Query: 282 TGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDR 341
TGFY+TD+LNLLGYAWDLW+ +R EL D LE+ + +LLRY+NI LLCVQESADDR
Sbjct: 522 TGFYQTDSLNLLGYAWDLWKDSRGQELMDPGLEETLPT-HILLRYINIGLLCVQESADDR 580
Query: 342 PTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 398
PT +DVVSML NE+ L PKQPAFS +R+ V S K + CS+N VT+S++EAR
Sbjct: 581 PTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1079), Expect = e-115, Method: Compositional matrix adjust.
Identities = 231/421 (54%), Positives = 290/421 (68%), Gaps = 47/421 (11%)
Query: 18 FLILAFISGLSKGVDSASF--FVLLSLSITLAAVATLGLNFYCFLHTSGEDLMMFDLDLN 75
F I S L+K V S+ + +++++L+I+L + + + GEDL++FD
Sbjct: 417 FYIKLAASELNKRVSSSKWKVWLIITLAISLTSAFVI-YGIWGRFRRKGEDLLVFDF--G 473
Query: 76 LKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKG 135
+ + + EL ++L R +K+EVD P+FSF+SVS +TN FS NKLGEGGFG VYKG
Sbjct: 474 NSSEDTSYELDETNRLW-RGEKREVD-LPMFSFASVSASTNNFSIENKLGEGGFGSVYKG 531
Query: 136 VLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195
++ E+AVKRLS RS QG E+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM
Sbjct: 532 KSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMS 591
Query: 196 NKSLDFFLFN--------------------------------------LKASNILLDKDM 217
NKSLDFFLF+ LKASNILLDKDM
Sbjct: 592 NKSLDFFLFDPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDM 651
Query: 218 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
NPKISDFGMARI GGNE + T+ IVGTYGYMSPEYA+EG+FS K DVFSFGVLLLEI+S
Sbjct: 652 NPKISDFGMARIFGGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILS 710
Query: 278 GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQES 337
GKKNTGFY+TD+LNLLGYAWDLW+ +R LEL D LE+ + +LLRY+N+ LLCVQES
Sbjct: 711 GKKNTGFYQTDSLNLLGYAWDLWKDSRGLELMDPGLEETLPT-HILLRYINVGLLCVQES 769
Query: 338 ADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEA 397
ADDRPT +DVVSML NE+ L PKQPAFS +R+ V S + E CS+N VT+S++EA
Sbjct: 770 ADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEA 829
Query: 398 R 398
R
Sbjct: 830 R 830
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1069), Expect = e-113, Method: Compositional matrix adjust.
Identities = 224/400 (56%), Positives = 280/400 (70%), Gaps = 45/400 (11%)
Query: 37 FVLLSLSITLAAVATLGLNFYCFLHTSGEDLMMFDLDLNLKANNVNIELPVNSKLTKRNK 96
+++++L+I+L + + + GEDL++FD + + + EL ++L R +
Sbjct: 282 WLIITLAISLTSAFVI-YGIWGRFRRKGEDLLVFDF--GNSSEDTSYELDETNRLW-RGE 337
Query: 97 KKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGL 156
K+EVD P+FSF+SVS +TN FS NKLGEGGFG VYKG ++ E+AVKRLS RS QG
Sbjct: 338 KREVD-LPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGW 396
Query: 157 REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN----------- 205
E+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLF+
Sbjct: 397 EELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKT 456
Query: 206 ---------------------------LKASNILLDKDMNPKISDFGMARICGGNELQAN 238
LKASNILLDKDMNPKISDFGMARI GGNE +
Sbjct: 457 RVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKV- 515
Query: 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD 298
T+ IVGTYGYMSPEYA+EG+FS K DVFSFGVLLLEI+SGKKNTGFY+TD+LNLLGYAWD
Sbjct: 516 TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWD 575
Query: 299 LWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358
LW+ +R LEL D LE+ + +LLRY+N+ LLCVQESADDRPT +DVVSML NE+ L
Sbjct: 576 LWKDSRGLELMDPGLEETLPT-HILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRL 634
Query: 359 LPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 398
PKQPAFS +R+ V S + E CS+N VT+S++EAR
Sbjct: 635 PSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296090091|emb|CBI39910.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1067), Expect = e-113, Method: Compositional matrix adjust.
Identities = 231/421 (54%), Positives = 287/421 (68%), Gaps = 46/421 (10%)
Query: 18 FLILAFISGLSKGVDSASF--FVLLSLSITLAAVATLGLNFYCFLHTSGEDLMMFDLDLN 75
F I S L+K V S+ + +++++L+I+L + + + GEDL++FD N
Sbjct: 260 FYIKLAASELNKRVSSSEWKVWLIVTLAISLTSAFVI-YGIWGRFRRKGEDLLLFDFG-N 317
Query: 76 LKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKG 135
+ EL ++L R +KKEVD P+FSF+SVS +TN F + NKLGEGGFG VYKG
Sbjct: 318 SSEDTSCYELGETNRLW-RGEKKEVD-LPMFSFASVSASTNNFCNENKLGEGGFGSVYKG 375
Query: 136 VLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195
++ E+AVKRLS RS QG E+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM
Sbjct: 376 KSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMS 435
Query: 196 NKSLDFFLFN--------------------------------------LKASNILLDKDM 217
NKSLDFFLF+ LKASNILLDKDM
Sbjct: 436 NKSLDFFLFDPTKHGILNWKTWVHIIEGVAQGLLYLHQYSRMRIIHRDLKASNILLDKDM 495
Query: 218 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
NPKISDFGMARI GGNE +A T+ IVGTYGYMSPEYA+EG+FS K DVFSFGVLL+EI+S
Sbjct: 496 NPKISDFGMARIFGGNEPKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLMEILS 554
Query: 278 GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQES 337
GKKNTGFY+TD+LNLLGYAWDLW+ +R EL D LE E S +LLRY+N+ LLCVQES
Sbjct: 555 GKKNTGFYQTDSLNLLGYAWDLWKDSRGQELMDPGLE-ETSPTHILLRYINVGLLCVQES 613
Query: 338 ADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEA 397
ADDRPT +DVVSML NE+ L PKQPAFS +R+ V S + S+N VT+S++EA
Sbjct: 614 ADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPGIYSLNGVTLSVMEA 673
Query: 398 R 398
R
Sbjct: 674 R 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514857|ref|XP_003526119.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1062), Expect = e-113, Method: Compositional matrix adjust.
Identities = 218/376 (57%), Positives = 260/376 (69%), Gaps = 45/376 (11%)
Query: 64 GEDLMMFDLDLNLKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANK 123
GEDL+ F + +++K + + + + KKKEV + PLFSF SV+ ATN FSDANK
Sbjct: 463 GEDLLRFHVSMSMKVEDSEL---AEAHRGAKVKKKEV-KLPLFSFVSVAAATNNFSDANK 518
Query: 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 183
LGEGGFGPVYKG+L G+E+AVKRLS RSGQG E++NEA +IAK+QH NLVRLLGCCID
Sbjct: 519 LGEGGFGPVYKGILLNGDEVAVKRLSRRSGQGWEELRNEALLIAKLQHNNLVRLLGCCID 578
Query: 184 KDEKILIYEYMPNKSLDFFLFN-------------------------------------- 205
+DEK+LIYE MPNKSLD FLF+
Sbjct: 579 RDEKMLIYELMPNKSLDVFLFDATKRRMLDWGTRVRIIDGIAQGILYLHQYSRFRIIHRD 638
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
LKASNILLD +MNPKISDFGMARI G NELQANT+RIVGTYGYMSPEYA+EG+FSIK DV
Sbjct: 639 LKASNILLDTNMNPKISDFGMARIFGDNELQANTNRIVGTYGYMSPEYAMEGLFSIKSDV 698
Query: 266 FSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE---YSSKQV 322
FSFGVLLLEI+SGKKNTGFY+T++ NLLGYAWDLW +N ++L D L+D SS
Sbjct: 699 FSFGVLLLEILSGKKNTGFYQTNSFNLLGYAWDLWTNNSGMDLMDPALDDSDTTSSSMHT 758
Query: 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKT 382
+ RYVNI LLCVQES DRPT +DVVSM+ N+ AL PK PAF VR S
Sbjct: 759 VPRYVNIGLLCVQESPADRPTMSDVVSMIGNDTVALPSPKPPAFLNVRGNQNSILPASMP 818
Query: 383 EDCSINQVTISLLEAR 398
E S+N +T +++EAR
Sbjct: 819 ESFSLNLITDTMVEAR 834
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1039), Expect = e-110, Method: Compositional matrix adjust.
Identities = 213/375 (56%), Positives = 264/375 (70%), Gaps = 43/375 (11%)
Query: 62 TSGEDLMMFDLDLNLKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDA 121
T+ +D+++++ + KA EL +++ K +K K+ PLFSF+SVS AT FS
Sbjct: 323 TTSQDILLYEFGMGSKA--TENELNEGNRVGK-DKNKDA-WLPLFSFASVSAATEHFSTE 378
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
NKLG+GGFGPVYKG L G EIAVKRLS SGQGL E+KNE ++A++QH+NLVRLLGCC
Sbjct: 379 NKLGQGGFGPVYKGELFNGQEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRLLGCC 438
Query: 182 IDKDEKILIYEYMPNKSLDFFLFN------------------------------------ 205
I++ EKILIYEYMPNKSLD FLF+
Sbjct: 439 IEQGEKILIYEYMPNKSLDSFLFDPNKRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIH 498
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
LKASNILLD DMNPKISDFGMAR+ GGNE ANT+RIVGTYGYMSPEYA+EG+FS K
Sbjct: 499 RDLKASNILLDNDMNPKISDFGMARMFGGNESYANTNRIVGTYGYMSPEYALEGLFSTKS 558
Query: 264 DVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323
DVFSFGVL+LEI+SGKKNTGFY +DTLNL+GYAW+LW+S+ + L D +LE + SS+ +L
Sbjct: 559 DVFSFGVLMLEILSGKKNTGFYNSDTLNLIGYAWELWKSDMAINLMDPMLEGQ-SSQYML 617
Query: 324 LRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTE 383
LRY+N+ LLCV+E A DRPT ++VVSMLTNE A L PK PAFS VR+ SS + E
Sbjct: 618 LRYINVGLLCVEEIAADRPTLSEVVSMLTNELAVLPSPKHPAFSTVRSMENPRSSMSRPE 677
Query: 384 DCSINQVTISLLEAR 398
S N ++IS++EAR
Sbjct: 678 IYSANGLSISVMEAR 692
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143125|emb|CBI20420.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1039), Expect = e-110, Method: Compositional matrix adjust.
Identities = 227/421 (53%), Positives = 282/421 (66%), Gaps = 47/421 (11%)
Query: 18 FLILAFISGLSKGVDSASF--FVLLSLSITLAAVATLGLNFYCFLHTSGEDLMMFDLDLN 75
F I S L+K V S+ + +++++L+I+L + + + GEDL++FD N
Sbjct: 172 FYIKLAASELNKRVSSSKWKVWLIITLAISLTSAFVI-YGIWGKFRRKGEDLLVFDFG-N 229
Query: 76 LKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKG 135
+ EL ++L R +KKEVD P+FSF SVS +TN F NKLGEGGFG VYKG
Sbjct: 230 SSEDTSCYELGETNRLW-RGEKKEVD-LPMFSFVSVSASTNNFCIENKLGEGGFGSVYKG 287
Query: 136 VLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195
++G E+AVKRLS RS QG E+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM
Sbjct: 288 KSQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMS 347
Query: 196 NKSLDFFLFN--------------------------------------LKASNILLDKDM 217
NKSLDFFLF+ LKASNILLDKDM
Sbjct: 348 NKSLDFFLFDPAKRGILNWETRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 407
Query: 218 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
NPKISDFGMARI GGNE +A T IVGTYGYMSPEY + G+FS K DVFSFGVLLLEI+S
Sbjct: 408 NPKISDFGMARIFGGNESKA-TKHIVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILS 466
Query: 278 GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQES 337
GKK T FY +D+LNLLGYAWDLW++NR EL D + +E SS+ +LLRY+N+ALLCVQE+
Sbjct: 467 GKKITEFYHSDSLNLLGYAWDLWKNNRGQELIDPV-PNEISSRHILLRYINVALLCVQEN 525
Query: 338 ADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEA 397
ADDRPT +DVVSML E L P +PAFSY+R V +S + E CS+N VT+S + A
Sbjct: 526 ADDRPTMSDVVSMLGRENVLLSSPNEPAFSYLRG-VKPHASQERPEICSLNDVTLSSMGA 584
Query: 398 R 398
R
Sbjct: 585 R 585
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138268|ref|XP_002326560.1| predicted protein [Populus trichocarpa] gi|222833882|gb|EEE72359.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1032), Expect = e-109, Method: Compositional matrix adjust.
Identities = 218/397 (54%), Positives = 263/397 (66%), Gaps = 60/397 (15%)
Query: 51 TLGLNFYCF------LHTSGED-----LMMFDLDLNLKANNVNIELPVNSKLTKRNKKKE 99
T GL YC LH GE+ L+ FD D + N N+ V+ N++K
Sbjct: 433 TFGLFIYCCYLRKSKLHHKGEEDTSENLLFFDFDTCPNSTN-NVPSSVD------NRRKN 485
Query: 100 VDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREM 159
V + PLFS+ SVS T +FS +KLGEGGFGPVYKG L G E+AVKRLS RSGQGL E
Sbjct: 486 V-ELPLFSYESVSAVTEQFS--HKLGEGGFGPVYKGKLSNGVEVAVKRLSKRSGQGLEEF 542
Query: 160 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------- 205
+NE VIA++QH+NLVRLLGCCI++DEKILIYEYMPNKSLDFFLF+
Sbjct: 543 RNETMVIARLQHRNLVRLLGCCIERDEKILIYEYMPNKSLDFFLFDANKRQILDWGSRVR 602
Query: 206 ------------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241
LK SNILLD +MNPKISDFGMARI G +E +ANT +
Sbjct: 603 IIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIFGDSETEANTKK 662
Query: 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR 301
I GTYGYMSPEYA++G+FSIK DVFSFGVLLLEIVSG+KNTGFY D+LNLLG+AW W
Sbjct: 663 IAGTYGYMSPEYAMDGLFSIKSDVFSFGVLLLEIVSGRKNTGFYHRDSLNLLGHAWKSWN 722
Query: 302 SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPP 361
S+R L+L D +L D S VLLR++NI LLCVQES DRPT +DV SM+ NE A L P
Sbjct: 723 SSRALDLMDPVLGDP-PSTSVLLRHINIGLLCVQESPADRPTMSDVFSMIVNEHAPLPAP 781
Query: 362 KQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 398
KQPAF+ RN ++SST S+N VT+++++AR
Sbjct: 782 KQPAFATGRNMGDTSSSTSSAGFPSVNNVTVTMMDAR 818
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106539|ref|XP_002333669.1| predicted protein [Populus trichocarpa] gi|222837960|gb|EEE76325.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1030), Expect = e-109, Method: Compositional matrix adjust.
Identities = 212/377 (56%), Positives = 252/377 (66%), Gaps = 51/377 (13%)
Query: 63 SGEDLMMFDLDLNLKANNVNIELPVNSKLTKRNKKKEVD---QFPLFSFSSVSTATNRFS 119
+G +L+ FD D + + N + N+KK +FPLFS+ SVS AT +FS
Sbjct: 480 TGHNLLRFDFDADPNST-------TNESSSVDNRKKRWSKNIEFPLFSYESVSVATGQFS 532
Query: 120 DANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 179
D KLGEGGFGPVYKG L G EIAVKRLS RSGQGL E +NE ++IAK+QH+NLVRLLG
Sbjct: 533 D--KLGEGGFGPVYKGKLPTGLEIAVKRLSERSGQGLEEFRNETTLIAKLQHRNLVRLLG 590
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------- 205
CI++DEK+LIYEYMPNKSLDFFLF+
Sbjct: 591 SCIERDEKMLIYEYMPNKSLDFFLFDANRGQILDWGTRIRIIEGIAQGLLYLHRYSRLRI 650
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSI 261
LK SNILLD +MNPKISDFGMARI GGNE QA+T+RIVGTYGYMSPEYA+EG+FSI
Sbjct: 651 IHRDLKPSNILLDSEMNPKISDFGMARIFGGNETQAHTNRIVGTYGYMSPEYAMEGLFSI 710
Query: 262 KFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321
K DVFSFGVL+LEIVSGKKNT FY +DTL+LLG+AW LW SN+ L+L D IL D S
Sbjct: 711 KSDVFSFGVLVLEIVSGKKNTSFYHSDTLHLLGHAWKLWNSNKALDLMDPILGDP-PSTA 769
Query: 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGK 381
LLRY+NI LLCVQES DRPT +DV+SM+ NE AL PKQPAF RN
Sbjct: 770 TLLRYINIGLLCVQESPADRPTMSDVISMIANEHVALPEPKQPAFVACRNMAEQGPLMSS 829
Query: 382 TEDCSINQVTISLLEAR 398
+ S+N +TI+ ++ R
Sbjct: 830 SGVPSVNNMTITAIDGR 846
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 398 | ||||||
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.487 | 0.230 | 0.56 | 1e-88 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.487 | 0.229 | 0.565 | 5.7e-88 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.487 | 0.228 | 0.517 | 1.8e-86 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.487 | 0.228 | 0.545 | 1.2e-84 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.484 | 0.227 | 0.497 | 1.9e-84 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.484 | 0.227 | 0.507 | 1.9e-84 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.462 | 0.275 | 0.525 | 3.6e-82 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.452 | 0.266 | 0.529 | 1.3e-81 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.520 | 0.245 | 0.469 | 8e-81 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.484 | 0.246 | 0.507 | 6.9e-80 |
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 1.0e-88, Sum P(2) = 1.0e-88
Identities = 112/200 (56%), Positives = 148/200 (74%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LKASN+LLDK+M PKISDFGMARI G E +ANT R+VGTYGYMSPEYA++GIFS+K D
Sbjct: 644 DLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSD 703
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTDT-LNLLGYAWDLWRSNRTLELTDAILEDEYSSK--- 320
VFSFGVLLLEI+SGK+N GFY ++ LNLLG+ W W+ LE+ D I D SSK
Sbjct: 704 VFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPT 763
Query: 321 QVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVT--STSS 378
+LR + I LLCVQE A+DRP + V+ ML +E A+ PK+P F R+ + S+SS
Sbjct: 764 HEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSS 823
Query: 379 TGKTEDCSINQVTISLLEAR 398
T + ++C++NQ+T+S+++AR
Sbjct: 824 TQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 5.7e-88, Sum P(2) = 5.7e-88
Identities = 113/200 (56%), Positives = 150/200 (75%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LKASN+LLDK+M PKISDFGMARI G E +ANT R+VGTYGYMSPEYA++GIFS+K D
Sbjct: 648 DLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSD 707
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTDT-LNLLGYAWDLWRSNRTLELTDAILEDEYSSK--- 320
VFSFGVLLLEI+SGK+N GFY ++ LNLLG+ W W+ + LE+ D I D SS+
Sbjct: 708 VFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPT 767
Query: 321 QVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNT--VTSTSS 378
+LR + I LLCVQE A+DRP + V+ ML +E A+ PK+P F R++ V S+SS
Sbjct: 768 HEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSS 827
Query: 379 TGKTEDCSINQVTISLLEAR 398
T + ++C++NQVT+S+++AR
Sbjct: 828 TQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 487 (176.5 bits), Expect = 1.8e-86, Sum P(2) = 1.8e-86
Identities = 103/199 (51%), Positives = 136/199 (68%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
++KA NILLD+DMNPKISDFGMARI G E +ANT R+ GT+GYMSPEY EG+FS K D
Sbjct: 652 DIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSD 711
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTDT--LNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322
VFSFGVL+LEI+ G+KN F+ LNL+ + W+L++ NR E+ D L D
Sbjct: 712 VFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQ 771
Query: 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA-ALLPPKQPAF--SYVRNTVTSTSST 379
+LR V +ALLCVQ++ADDRP+ DVVSM+ + AL PK+PAF R++
Sbjct: 772 VLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEP 831
Query: 380 GKTEDCSINQVTISLLEAR 398
+ E+ S N+VTI+++EAR
Sbjct: 832 PEMENVSANRVTITVMEAR 850
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 1.2e-84, Sum P(2) = 1.2e-84
Identities = 109/200 (54%), Positives = 145/200 (72%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LKASNILLDK M PKISDFGMARI G +E +ANT ++VGTYGYMSPEYA++GIFS+K D
Sbjct: 651 DLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSD 710
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTDT-LNLLGYAWDLWRSNRTLELTDAILEDEYSS--KQ 321
VFSFGVLLLEI+S K+N GFY +D LNLLG W W+ + LE+ D I+ D S+ +
Sbjct: 711 VFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQH 770
Query: 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGK 381
+LR + I LLCVQE A+DRPT + V+ ML +E+ + PK P + R+ + + SS+ K
Sbjct: 771 EILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSK 830
Query: 382 TED---CSINQVTISLLEAR 398
D ++NQ+T+S+L+AR
Sbjct: 831 QRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 1.9e-84, Sum P(2) = 1.9e-84
Identities = 98/197 (49%), Positives = 139/197 (70%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LK SN+LLD +MNPKISDFGMARI GGN+ +ANT R+VGTYGYMSPEYA+EG+FS+K D
Sbjct: 654 DLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSD 713
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324
V+SFGVLLLEIVSGK+NT ++ +L+GYAW L+ R+ EL D + S ++ L
Sbjct: 714 VYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREAL- 772
Query: 325 RYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVR-NTVTSTSSTGKTE 383
R +++A+LCVQ+SA +RP V+ ML ++ A L P+QP F+ R N++ + ++
Sbjct: 773 RCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQ 832
Query: 384 D--CSINQVTISLLEAR 398
S N++T +++ R
Sbjct: 833 QYIVSSNEITSTVVLGR 849
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.9e-84, Sum P(2) = 1.9e-84
Identities = 99/195 (50%), Positives = 136/195 (69%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LKASNILLD DM PKISDFGMAR+ GG++ Q NT+R+VGT+GYMSPEYA+EGIFS+K D
Sbjct: 655 DLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSD 714
Query: 265 VFSFGVLLLEIVSGKKNTGFY-RTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323
V+ FGVL+LEI++GK+ F+ D+LN+ GYAW W + EL D ++ S +QVL
Sbjct: 715 VYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVL 774
Query: 324 LRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTE 383
R ++IALLCVQ+ AD+RP V+ ML+N++++L P+ P + S+ S+ K
Sbjct: 775 -RCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLMLRGREIESSKSSEKDR 833
Query: 384 DCSINQVTISLLEAR 398
SI VT++ L R
Sbjct: 834 SHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 3.6e-82, Sum P(3) = 3.6e-82
Identities = 103/196 (52%), Positives = 134/196 (68%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LKASNILLD DMNPKI+DFGMARI G ++ + NTSRIVGTYGYMSPEYA+ G +S+K D
Sbjct: 473 DLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSD 532
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTDTLN-LLGYAWDLWRSNRTLELTD-AILEDEYSSKQV 322
V+SFGVL+LEI+SGKKN+ FY+TD + L+ YAW LW + R LEL D AI+E+ +
Sbjct: 533 VYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVEN--CQRNE 590
Query: 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSY--------VRNTVT 374
++R V+I LLCVQE +RPT + +V MLT+ L P+QP + + T
Sbjct: 591 VVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTT 650
Query: 375 STSSTGKTEDCSINQV 390
S S G +D SI +
Sbjct: 651 SKSLLGSVDDASITDI 666
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 464 (168.4 bits), Expect = 1.3e-81, Sum P(3) = 1.3e-81
Identities = 99/187 (52%), Positives = 126/187 (67%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LKA NILL DMN KI+DFGMARI G ++ +ANT RIVGTYGYMSPEYA+ G FS+K D
Sbjct: 476 DLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSD 535
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTDTL---NLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321
V+SFGVL+LEI+SGKKN+ Y+ D NL+ Y W LW + LEL D D Y +
Sbjct: 536 VYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINE 595
Query: 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGK 381
V R ++IALLCVQE A+DRPT + +V MLT + AL P++P F + R++ G
Sbjct: 596 VS-RCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRPGF-FFRSS--KHEQVGL 651
Query: 382 TEDCSIN 388
+ SIN
Sbjct: 652 VDRLSIN 658
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 471 (170.9 bits), Expect = 8.0e-81, Sum P(2) = 8.0e-81
Identities = 99/211 (46%), Positives = 138/211 (65%)
Query: 189 LIYEYMPNKSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
L+Y + ++ L +LKASNILLD +MNPKISDFGMARI + ANT R+VGTYGY
Sbjct: 635 LLYLHRDSR-LKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGY 693
Query: 249 MSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308
M+PEYA+EGIFS K DV+SFGVL+LEIVSG+KN F TD +L+GYAW LW +T E+
Sbjct: 694 MAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEM 753
Query: 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAF-S 367
D I++D + + R +++ +LC Q+S RP V+ ML ++ + L PP+QP F S
Sbjct: 754 IDPIVKDTRDVTEAM-RCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHS 812
Query: 368 YVRNTVTSTSSTGKTEDCSINQVTISLLEAR 398
++ + + G + S+N VT + + R
Sbjct: 813 FLNSGDIELNFDGH-DVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 475 (172.3 bits), Expect = 6.9e-80, Sum P(2) = 6.9e-80
Identities = 99/195 (50%), Positives = 135/195 (69%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LKASN+LLD DMN KISDFG+AR GG+E +ANT+R+VGTYGYMSPEY I+G FS+K D
Sbjct: 590 DLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSD 649
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTD-TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323
VFSFGVL+LEIVSG++N GF + LNLLG+AW + ++ E+ D + + + +
Sbjct: 650 VFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEV 709
Query: 324 LRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTE 383
LR ++I LLCVQ+ DRP + VV ML++E LL P+QP F RN + S + + E
Sbjct: 710 LRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEML-LLDPRQPGFFNERNLLFSDTVSINLE 768
Query: 384 DCSINQVTISLLEAR 398
S N T+S+++ R
Sbjct: 769 IPSNNFQTMSVIDPR 783
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00003111001 | SubName- Full=Chromosome undetermined scaffold_139, whole genome shotgun sequence; (827 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 398 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-34 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.002 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.002 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.003 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.003 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.004 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.004 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.004 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 84/289 (29%), Positives = 122/289 (42%), Gaps = 85/289 (29%)
Query: 122 NKLGEGGFGPVYKGVLRKGN----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 176
KLGEG FG VYKG L+ + E+AVK L S + ++ EA V+ K+ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL----------------------F---------- 204
LLG C +++ L+ EYM L +L F
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 205 ---------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMS 250
+L A N L+ +D+ KISDFG++R ++ + T G +M+
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIRWMA 175
Query: 251 PEYAIEGIFSIKFDVFSFGVLLLEIVS-------GKKNTGFYRTDTLNLLGYAWDLWRSN 303
PE +GIF+ K DV+SFGVLL EI + G N + L L R
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEYL-------RKG 223
Query: 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352
L + ++ Y + L C Q +DRPT +++V L
Sbjct: 224 YRLPKPEYCPDELY----------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 8e-38
Identities = 64/194 (32%), Positives = 93/194 (47%), Gaps = 40/194 (20%)
Query: 123 KLGEGGFGPVYKGVLRKGN-----EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
KLGEG FG VYKG L+ E+AVK L S Q + E EA ++ K+ H N+V+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL--------------F------------------ 204
LLG C +++ ++ EYM L +L F
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIH 125
Query: 205 -NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
+L A N L+ +++ KISDFG++R ++ + +M+PE EG F+ K
Sbjct: 126 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGKFTSKS 184
Query: 264 DVFSFGVLLLEIVS 277
DV+SFGVLL EI +
Sbjct: 185 DVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 65/196 (33%), Positives = 97/196 (49%), Gaps = 43/196 (21%)
Query: 123 KLGEGGFGPVYKGVLRKGN-----EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
KLGEG FG VYKG L+ E+AVK L S Q + E EA ++ K+ H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL---------------F----------------- 204
LLG C +++ +++ EYMP L +L F
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFI 125
Query: 205 --NLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSI 261
+L A N L+ +++ KISDFG++R + + + ++ +M+PE EG F+
Sbjct: 126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKFTS 183
Query: 262 KFDVFSFGVLLLEIVS 277
K DV+SFGVLL EI +
Sbjct: 184 KSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 59/189 (31%), Positives = 89/189 (47%), Gaps = 39/189 (20%)
Query: 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREM-KNEASVIAKVQHKNLVRLLGCC 181
LGEGGFG VY +K G ++A+K + L E E ++ K+ H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 182 IDKDEKILIYEYMPNKSLDFFLF---------------------------------NLKA 208
D++ L+ EY SL L +LK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 209 SNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-EGIFSIKFDVF 266
NILLD D K++DFG++++ ++ T IVGT YM+PE + +G +S K D++
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 267 SFGVLLLEI 275
S GV+L E+
Sbjct: 179 SLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 67/196 (34%), Positives = 93/196 (47%), Gaps = 41/196 (20%)
Query: 123 KLGEGGFGPVYKGVLR-----KGNEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
KLGEG FG VYKG L+ ++AVK L G S + E EAS++ K+ H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL------FNLK----------------------- 207
LLG C + ++ EYMP L FL LK
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125
Query: 208 ----ASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
A N L+ +++ KISDFG++R I + + + +M+PE +G F+ K
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDGKFTSK 184
Query: 263 FDVFSFGVLLLEIVSG 278
DV+SFGVLL EI +
Sbjct: 185 SDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 38/193 (19%)
Query: 123 KLGEGGFGPVYKGVLRKGNEI-AVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 179
KLG G FG VYK + +I AVK L + + + E ++ ++ H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN--------------------------------LK 207
DKD L+ EY L +L LK
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLK 125
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI-FSIKFDVF 266
NILLD++ KI+DFG+A+ + ++ + VGT YM+PE + G + K DV+
Sbjct: 126 PENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183
Query: 267 SFGVLLLEIVSGK 279
S GV+L E+++GK
Sbjct: 184 SLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 37/196 (18%)
Query: 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLV 175
+ KLGEG FG VY +K G +A+K + + + RE + E ++ K++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFL-----FN------------------------- 205
RL D+D+ L+ EY L L +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
LK NILLD+D + K++DFG+AR E + VGT YM+PE + +
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 264 DVFSFGVLLLEIVSGK 279
D++S GV+L E+++GK
Sbjct: 178 DIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 37/195 (18%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
LG G FG VY + + G +AVK LSG S + L ++ E +++ +QH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 179 GCCIDKDEK-ILIY-EYMPNKSLDFFL-----FN-------------------------- 205
G D+++ + I+ EY+ SL L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+K +NIL+D D K++DFG A+ G E T + GT +M+PE + D
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD 185
Query: 265 VFSFGVLLLEIVSGK 279
++S G ++E+ +GK
Sbjct: 186 IWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 8e-24
Identities = 62/197 (31%), Positives = 90/197 (45%), Gaps = 52/197 (26%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMK-----NEASVIAKVQHKNLVRL 177
KLG G FG V+ G ++AVK L + G M EA ++ K++H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL--KPGT----MSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
C +++ ++ EYM SL FL +
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIH 126
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIEGIFS 260
L A NIL+ +++ KI+DFG+AR+ +E A I T +PE A G F+
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFT 182
Query: 261 IKFDVFSFGVLLLEIVS 277
IK DV+SFG+LL EIV+
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 37/196 (18%)
Query: 118 FSDANKLGEGGFGPVYKG-VLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
F K+G+GGFG VYK R G E+A+K + S + ++ NE ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL------FN------------------------- 205
G + KDE ++ E+ SL L
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
+KA+NILL D K+ DFG++ + NT +VGT +M+PE + K
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNT--MVGTPYWMAPEVINGKPYDYKA 178
Query: 264 DVFSFGVLLLEIVSGK 279
D++S G+ +E+ GK
Sbjct: 179 DIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-23
Identities = 59/190 (31%), Positives = 88/190 (46%), Gaps = 45/190 (23%)
Query: 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 183
+G+G FG V G R G ++AVK L + EASV+ ++H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 184 KDEKILIYEYMPNKSLDFFL---------------F-------------------NLKAS 209
+ ++ EYM SL +L F +L A
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131
Query: 210 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIEGIFSIKFDVFS 267
N+L+ +D+ K+SDFG+A+ +A+ + G + +PE E FS K DV+S
Sbjct: 132 NVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 268 FGVLLLEIVS 277
FG+LL EI S
Sbjct: 185 FGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-22
Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 177
F+ KLG G FG V++G+ + +A+K L ++ + E + +++HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
C + +I E M SL FL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
L A NIL+ +D+ K++DFG+AR+ + ++ +I Y + +PE A G FS K
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKS 185
Query: 264 DVFSFGVLLLEIVS 277
DV+SFG+LL E+ +
Sbjct: 186 DVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 57/216 (26%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRKGNE------IAVKRLSGRSGQGLR-EMKNEASVIAKV 169
RF + LGEG FG VYKG L NE +A+K L + ++ E + EA +++ +
Sbjct: 8 RFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 170 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF------------------------- 204
QH N+V LLG C + +++EY+ + L FL
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 205 -----------------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241
+L A N L+ + + KISDFG++R + S+
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+ +M PE + G F+ + D++SFGV+L EI S
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 9e-21
Identities = 78/275 (28%), Positives = 111/275 (40%), Gaps = 64/275 (23%)
Query: 122 NKLGEGGFGPVYKGVLR--KGNEI--AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVR 176
+LG G FG V KGV G E+ AVK L G +E EASV+A++ H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------- 205
L+G C + +L+ E P L +L
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 206 -LKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTY--GYMSPEYAIEGIFS 260
L A N+LL KISDFGM+R G + +A T+ G + + +PE G FS
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAPECINYGKFS 176
Query: 261 IKFDVFSFGVLLLEIVS--GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318
K DV+S+GV L E S K + + +L S L + ++ YS
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-------ESGERLPRPEECPQEIYS 229
Query: 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
I L C + +DRPT +++ S
Sbjct: 230 ----------IMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 53/199 (26%), Positives = 82/199 (41%), Gaps = 44/199 (22%)
Query: 122 NKLGEGGFGPVYKGVL-----RKGNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLV 175
+LGEG FG V G ++AVK L+ Q + + E ++ + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 176 RLLGCCIDKDEKI--LIYEYMPNKSLDFFL--------------F--------------- 204
+ G C + LI EY+P+ SL +L F
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 205 ----NLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEYAIEGI 258
+L A NIL++ + KISDFG+A++ + + Y +PE
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSK 188
Query: 259 FSIKFDVFSFGVLLLEIVS 277
FS DV+SFGV L E+ +
Sbjct: 189 FSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-20
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 41/200 (20%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNE--IAVKR--LSGRSGQGLREMKNEASVIAKVQHKN 173
F NK+G+G FG V+K V+RK ++ A+K+ LS + + E +EA V+AK+
Sbjct: 2 FEILNKIGKGSFGVVFK-VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSL------------------DFFL------------ 203
++R +DK + ++ EY N L FF+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 204 ----FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
++K+ N+ LD N KI D G+A++ N ANT IVGT Y+SPE + +
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPY 178
Query: 260 SIKFDVFSFGVLLLEIVSGK 279
+ K DV++ GV+L E +GK
Sbjct: 179 NEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-20
Identities = 55/190 (28%), Positives = 84/190 (44%), Gaps = 34/190 (17%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 181
K+G+G FG VYKGVL+ E+AVK L+ EA ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 182 IDKDEKILIYEYMPNKSLDFFL---------------------------------FNLKA 208
+ K ++ E +P SL FL +L A
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSF 268
N L+ ++ KISDFGM+R G + + +PE G ++ + DV+S+
Sbjct: 122 RNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSY 181
Query: 269 GVLLLEIVSG 278
G+LL E S
Sbjct: 182 GILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 58/215 (26%), Positives = 89/215 (41%), Gaps = 62/215 (28%)
Query: 124 LGEGGFGPVYKGVLRKGNE------IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVR 176
LGEG FG V+ G +AVK L + R+ + EA ++ QH+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL--------------------------------- 203
G C + D I+++EYM + L+ FL
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 204 ----------F---NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT----Y 246
F +L N L+ D+ KI DFGM+R + + R+ G
Sbjct: 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTMLPI 188
Query: 247 GYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKK 280
+M PE + F+ + DV+SFGV+L EI + GK+
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-19
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 42/192 (21%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182
KLG G FG V++G+ +AVK L + ++ EA ++ K++H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 183 DKDEKILIYEYMPNKSLDFFLFN----------------------------------LKA 208
++ ++ E M SL +L L A
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAA 131
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIKFDV 265
N+L+ ++ K++DFG+AR+ + +A G + +PE A+ FSIK DV
Sbjct: 132 RNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 266 FSFGVLLLEIVS 277
+SFG+LL EIV+
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 41/200 (20%)
Query: 117 RFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLS--GRSGQGLREMKNEASVIAKVQHKN 173
+ + +G G FG VYKG+ L G+ +A+K++S + L+ + E ++ ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSL-----DFFLFN----------------------- 205
+V+ +G D +I EY N SL F F
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE--GIF 259
+KA+NIL KD K++DFG+A + +VGT +M+PE IE G
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPE-VIEMSGA- 176
Query: 260 SIKFDVFSFGVLLLEIVSGK 279
S D++S G ++E+++G
Sbjct: 177 STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 3e-19
Identities = 60/270 (22%), Positives = 108/270 (40%), Gaps = 61/270 (22%)
Query: 122 NKLGEGGFGPVYKGVLRK--GNEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNLVRL 177
++G+G FG VY V RK G +K LS S + + NE ++ K+ H N+++
Sbjct: 6 KQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
+K + ++ EY L +
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI-FS 260
+K NI L + K+ DFG++++ A T +VGT Y+SPE + ++
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE-LCQNKPYN 181
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320
K D++S G +L E+ + K F + L L + L+ + +YSS+
Sbjct: 182 YKSDIWSLGCVLYELCTLKH--PFEGENLLELA---------LKILKGQYPPIPSQYSSE 230
Query: 321 QVLLRYVNIALLCVQESADDRPTTNDVVSM 350
LR N+ +Q+ ++RP+ ++
Sbjct: 231 ---LR--NLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 75/283 (26%), Positives = 111/283 (39%), Gaps = 70/283 (24%)
Query: 122 NKLGEGGFGPVYKGVLRKGN------EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 174
LG G FG VY+G+ R + ++AVK L S Q + EA +++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFL------------------------------- 203
VRL+G ++ + ++ E M L FL
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 204 -----F---NLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 252
F ++ A N LL KI+DFGMAR R + +M PE
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191
Query: 253 YAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR-TLELT-- 309
++GIF+ K DV+SFGVLL EI S LGY R+N+ +E
Sbjct: 192 AFLDGIFTSKTDVWSFGVLLWEIFS---------------LGYMPYPGRTNQEVMEFVTG 236
Query: 310 DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352
L+ + R I C Q + +DRP ++ +
Sbjct: 237 GGRLDPPKGCPGPVYR---IMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-19
Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 37/191 (19%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
+KLG G +G VY+GV +K +AVK L + E EA+V+ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 181 CIDKDEKILIYEYMPNKSL----------------------------------DFFLFNL 206
C + +I E+M +L +F +L
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
A N L+ ++ K++DFG++R+ G+ A+ + +PE FSIK DV+
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVW 189
Query: 267 SFGVLLLEIVS 277
+FGVLL EI +
Sbjct: 190 AFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 41/197 (20%)
Query: 124 LGEGGFGPVYKGVLRKGNE-----IAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 177
LG G FG VYKGV E +A+K L + + +E+ +EA V+A V H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
LG C+ + LI + MP L ++ N
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
L A N+L+ + KI+DFG+A++ +E + + +M+ E + I++ K D
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSD 193
Query: 265 VFSFGVLLLEIVS-GKK 280
V+S+GV + E+++ G K
Sbjct: 194 VWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 7e-19
Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 39/193 (20%)
Query: 123 KLGEGGFGPVYKGVLRKGNEI-AVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
LG+G G VYK + +I A+K++ + +++ E + + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 181 CIDKDEKILIYEYMPNKSLDFFL-----FN----------------------------LK 207
+ E ++ EYM SL L +K
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIK 127
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVF 266
SN+L++ KI+DFG++++ Q NT VGT YMSPE I+G +S D++
Sbjct: 128 PSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPE-RIQGESYSYAADIW 184
Query: 267 SFGVLLLEIVSGK 279
S G+ LLE GK
Sbjct: 185 SLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 8e-19
Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 59/213 (27%)
Query: 124 LGEGGFGPVYKGVLRKGN-EIAVKRLSGRSGQGLREMK-----NEASVIAKV-QHKNLVR 176
+GEG F V ++ N E A+K L R Q ++E K E V+ ++ H +++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 177 LLGCCIDKDEKILIYEYMPN----------KSLDF---------------FLFN------ 205
L D++ + EY PN SLD +L +
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHR 126
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNEL------------------QANTSRIVGTY 246
LK NILLDKDM+ KI+DFG A++ N + + VGT
Sbjct: 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTA 186
Query: 247 GYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
Y+SPE E D+++ G ++ ++++GK
Sbjct: 187 EYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 71/275 (25%)
Query: 124 LGEGGFGPVYKGVLRKGNE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+G G FG V +G L+ + +A+K L +G S + + EAS++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLFN--------------------------------- 205
G ++I EYM N SLD FL
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRD 131
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTS--RIVGTYGYMSPEYAIEGIFSIKF 263
L A NIL++ ++ K+SDFG++R +E T +I + +PE F+
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRKFTSAS 189
Query: 264 DVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY----- 317
DV+SFG+++ E++S G++ Y WD+ SN+ ++ A+ ED Y
Sbjct: 190 DVWSFGIVMWEVMSYGERP---Y-----------WDM--SNQ--DVIKAV-EDGYRLPPP 230
Query: 318 -SSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
L + + L C Q+ ++RPT + +VS L
Sbjct: 231 MDCPSALYQ---LMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 61/192 (31%), Positives = 90/192 (46%), Gaps = 43/192 (22%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMK---NEASVIAKVQHKNLVRLLG 179
KLG G FG V+ G ++A+K L QG + EA+++ ++QH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 180 CCIDKDEKILIYEYMPNKSLDFFL----------------------------------FN 205
+ ++ +I EYM N SL FL +
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRD 127
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
L+A+NIL+ + + KI+DFG+AR+ NE A + +PE G F+IK DV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDV 186
Query: 266 FSFGVLLLEIVS 277
+SFG+LL EIV+
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 37/195 (18%)
Query: 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
+ + K+GEG G VYK R G E+A+K++ R Q + NE ++ +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79
Query: 177 LLGCCIDKDEKILIYEYMPNKSL----DFFLF---------------------------- 204
+ DE ++ EYM SL
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIH 139
Query: 205 -NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
++K+ NILL KD + K++DFG A + + N+ +VGT +M+PE + K
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKV 197
Query: 264 DVFSFGVLLLEIVSG 278
D++S G++ +E+ G
Sbjct: 198 DIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 4e-18
Identities = 79/267 (29%), Positives = 119/267 (44%), Gaps = 59/267 (22%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182
KLG G FG V+ G ++AVK L + ++ EA+++ +QH LVRL +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV-V 70
Query: 183 DKDEKI-LIYEYMPNKSLDFFL----------------------------------FNLK 207
K+E I +I EYM SL FL +L+
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLR 130
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFS 267
A+N+L+ + + KI+DFG+AR+ NE A + +PE G F+IK DV+S
Sbjct: 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWS 189
Query: 268 FGVLLLEIVSGKK--NTGFYRTDTLNLLGYAWDLWR-SNRTLELTDAILEDEYSSKQVLL 324
FG+LL EIV+ K G +D ++ L + + R N EL D
Sbjct: 190 FGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD-------------- 235
Query: 325 RYVNIALLCVQESADDRPTTNDVVSML 351
I C +E A++RPT + + S+L
Sbjct: 236 ----IMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 38/191 (19%)
Query: 123 KLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
KLGEG +G VYK + ++ ++ A+K + + L+E+ E S++ + +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 182 IDKDEKILIYEY-----------MPNKSLD-----FFLFN-----------------LKA 208
+ ++ EY + NK+L L+ +KA
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKA 127
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSF 268
NILL+++ K++DFG++ + NT ++GT +M+PE E ++ K D++S
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKADIWSL 185
Query: 269 GVLLLEIVSGK 279
G+ +E+ GK
Sbjct: 186 GITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 72/267 (26%), Positives = 114/267 (42%), Gaps = 56/267 (20%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182
KLG G FG V+ K ++AVK + S + EA+V+ +QH LV+L +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 183 DKDEKILIYEYMPNKSLDFFL----------------------------------FNLKA 208
K+ +I E+M SL FL +L+A
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 130
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSF 268
+NIL+ + KI+DFG+AR+ NE A + +PE G F+IK DV+SF
Sbjct: 131 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSF 189
Query: 269 GVLLLEIVSGKKN--TGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326
G+LL+EIV+ + G + + L + + R + E+ Y
Sbjct: 190 GILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------PENCPEELY--------- 233
Query: 327 VNIALLCVQESADDRPTTNDVVSMLTN 353
NI + C + ++RPT + S+L +
Sbjct: 234 -NIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 63/208 (30%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVKRL---SGRSG---QGLREMKNEASVIAKVQHKNL 174
++GEG +G VYK +K E+ A+K++ + + G +RE+K ++ K++H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLRHPNI 60
Query: 175 VRLLGCCIDKDEK--ILIYEYMP--------NKSLDF------FLF-------------- 204
VRL K + +++EYM + + F
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 205 ----NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE-------- 252
++K SNIL++ D K++DFG+AR T+R++ T Y PE
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRY 179
Query: 253 -YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ D++S G +L E+ GK
Sbjct: 180 GPEV--------DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 49/203 (24%)
Query: 124 LGEGGFGPVYKGVLR---KGN---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVR 176
LG+G FG VY+G+ + KG +A+K ++ + R E NEASV+ + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 177 LLGCCIDKDEKILIYEYM-------------PNK-------------------------- 197
LLG +++ E M P
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 198 ---SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 254
+ F +L A N ++ +D+ KI DFGM R + + + +M+PE
Sbjct: 134 YLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193
Query: 255 IEGIFSIKFDVFSFGVLLLEIVS 277
+G+F+ K DV+SFGV+L E+ +
Sbjct: 194 KDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (191), Expect = 6e-16
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 58/203 (28%)
Query: 123 KLGEGGFGPVYKGVLRKGNEI-AVKRL------SGRSGQGLREMKNEASVIAKVQHKNLV 175
KLGEG +G VYK +K EI A+K++ G LRE+ S++ +++H N+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREI----SLLKELKHPNIV 61
Query: 176 RLLGCCIDKDEKILIYEYMPN------------------KSLDFFLFN------------ 205
+LL + + L++EY KS+ + L
Sbjct: 62 KLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE-------YAIE 256
LK NIL+++D K++DFG+AR G L+ T +V T Y +PE Y
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILLGSKHY--- 176
Query: 257 GIFSIKFDVFSFGVLLLEIVSGK 279
S D++S G + E+++GK
Sbjct: 177 ---STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 8e-16
Identities = 73/268 (27%), Positives = 107/268 (39%), Gaps = 62/268 (23%)
Query: 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCI 182
LG G FG V+ G R ++A+K + R G + EA V+ K+ H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI--REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 183 DKDEKILIYEYMPNKSLDFFL---------------------------------FNLKAS 209
+ ++ EYM N L +L +L A
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAAR 129
Query: 210 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIKFDVF 266
N L+ +D K+SDFG+AR ++ ++ GT + PE FS K DV+
Sbjct: 130 NCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 267 SFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE--YSSKQVLL 324
SFGVL+ E+ S K + R SN E+ +++ Y K
Sbjct: 186 SFGVLMWEVFSEGK-MPYER--------------FSN--SEVVESVSAGYRLYRPKLAPT 228
Query: 325 RYVNIALLCVQESADDRPTTNDVVSMLT 352
I C E +DRP ++S LT
Sbjct: 229 EVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 77.5 bits (189), Expect = 1e-15
Identities = 64/321 (19%), Positives = 113/321 (35%), Gaps = 53/321 (16%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQH-KNLVRLL 178
KLGEG FG VY RK +A+K L+ + + + E ++A + H N+V+L
Sbjct: 7 KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLFN--------------------------------- 205
D+ L+ EY+ SL+ L
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH 124
Query: 206 --LKASNILLDKDMN-PKISDFGMARICGGN----ELQANTSRIVGTYGYMSPEYAI--- 255
+K NILLD+D K+ DFG+A++ + A S VGT GYM+PE +
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315
S D++S G+ L E+++G F + + T L +
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTS 375
++ + + +R +++ +S L ++
Sbjct: 243 NPELISKAAS--DLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPL 300
Query: 376 TSSTGKTEDCSINQVTISLLE 396
S + + I+ + +
Sbjct: 301 RLSLPPSLEALISSLNSLAIS 321
|
Length = 384 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 54/207 (26%)
Query: 124 LGEGGFGPVYKG----VLRKGNE---IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 175
LG G FG VY+G +L G+ +AVK L G + Q +E EA +++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------------------------------- 203
+LLG C+ + + +I E M L +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 204 ----F---NLKASNILL-----DKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 250
F +L A N L+ D D KI DFG+AR I + + ++ +M+
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR-WMA 181
Query: 251 PEYAIEGIFSIKFDVFSFGVLLLEIVS 277
PE ++G F+ + DV+SFGVL+ EI++
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 39/190 (20%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 181
KLG+G FG V+ G +A+K L + G E EA V+ K++H+ LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 69
Query: 182 IDKDEKILIYEYMPNKSLDFFL----------------------------------FNLK 207
+ ++ ++ EYM SL FL +L+
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFS 267
A+NIL+ +++ K++DFG+AR+ NE A + +PE A+ G F+IK DV+S
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWS 188
Query: 268 FGVLLLEIVS 277
FG+LL E+ +
Sbjct: 189 FGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 59/190 (31%), Positives = 87/190 (45%), Gaps = 45/190 (23%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+GEG FG V +G G ++AVK + + Q E E +V+ K+ HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVI 68
Query: 182 IDKDEKILIYEYMPNKSLDFFL----------------------------------FNLK 207
+ I++ E M +L FL +L
Sbjct: 69 LHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA 127
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFS 267
A NIL+ +D K+SDFG+AR+ + + S++ + +PE FS K DV+S
Sbjct: 128 ARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWS 182
Query: 268 FGVLLLEIVS 277
+GVLL E+ S
Sbjct: 183 YGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 43/195 (22%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCC 181
++G G FG V+ G + ++A+K + R G + EA V+ K+ H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI--REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 182 IDKDEKILIYEYMPNKSLDFFL---------------------------------FNLKA 208
++ L++E+M + L +L +L A
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAA 128
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIKFDV 265
N L+ ++ K+SDFGM R ++ ++T GT + SPE +S K DV
Sbjct: 129 RNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 266 FSFGVLLLEIVSGKK 280
+SFGVL+ E+ S K
Sbjct: 185 WSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 59/192 (30%), Positives = 92/192 (47%), Gaps = 43/192 (22%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 181
KLG G FG V+ G ++AVK L + G E EA ++ K++H LV+L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV- 69
Query: 182 IDKDEKILIYEYMPNKSLDFFL----------------------------------FNLK 207
+ ++ ++ EYM SL FL +L+
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIEGIFSIKFDV 265
++NIL+ + KI+DFG+AR+ NE T+R + + +PE A+ G F+IK DV
Sbjct: 130 SANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 266 FSFGVLLLEIVS 277
+SFG+LL E+V+
Sbjct: 187 WSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 63/262 (24%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLS----GRSGQG-LREMKNEASVIAKVQHKNLVRL 177
LG G FG VY+G+ L G+ AVK +S G++GQ +++++ E ++++K+QH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 178 LGCCIDKDEKILIY-EYMPNKSL-----DFFLF--------------------------- 204
LG + ++ + I+ E +P SL + F
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY-AIEGIFSIKF 263
++K +NIL+D + K++DFGMA+ + G+ +M+PE A +G + +
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 264 DVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA--WDLWRSNRTLELTDAILEDEYSSKQ 321
D++S G +LE+ +GK L G A + + RS + D L DE
Sbjct: 184 DIWSLGCTVLEMATGKPPWS-------QLEGVAAVFKIGRSKELPPIPDH-LSDEAK--- 232
Query: 322 VLLRYVNIALLCVQESADDRPT 343
+ L C+Q RPT
Sbjct: 233 ------DFILKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 1e-14
Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 42/194 (21%)
Query: 124 LGEGGFGPVYKGVLRK--GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLL 178
LG+G FG V V +K G A+K L + + + E ++++++ H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 179 GCCIDKDEKI-LIYEYMPNKSLDFFL-----FN--------------------------- 205
+EK+ L+ EY P L L F+
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
LK NILLD D + K++DFG+A+ + NT GT Y++PE + + D
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 266 FSFGVLLLEIVSGK 279
+S GVLL E+++GK
Sbjct: 177 WSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 39/190 (20%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 181
KLG+G FG V+ G ++A+K L + G + E EA ++ K++H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV- 69
Query: 182 IDKDEKILIYEYMPNKSLDFFL----------------------------------FNLK 207
+ ++ ++ E+M SL FL +L+
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR 129
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFS 267
A+NIL+ ++ KI+DFG+AR+ NE A + +PE A+ G F+IK DV+S
Sbjct: 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWS 188
Query: 268 FGVLLLEIVS 277
FG+LL E+V+
Sbjct: 189 FGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 50/205 (24%)
Query: 122 NKLGEGGFGPVYKGVLRK--GNEIAVKRLS-GRSGQGLREM-KNEASVIAKVQHKNLVRL 177
+G+G FG V K V RK G + K + G + ++ +E +++ +++H N+VR
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 178 LGCCIDKD-EKILIY--------------------EYMP-NKSLDFFL------------ 203
ID+ + + I +Y+
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 204 ---------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 254
+LK +NI LD + N K+ DFG+A+I G + A T VGT YMSPE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQL 182
Query: 255 IEGIFSIKFDVFSFGVLLLEIVSGK 279
+ K D++S G L+ E+ +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 54/201 (26%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVK--RLSGRSG---QGLREMKNEASVIAKVQHKNLV 175
+LG G G V K + R +I AVK RL Q LRE+ ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD----ILHKCNSPYIV 62
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------------------------------- 203
G + + + EYM SLD L
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 204 --FNLKASNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGYMSPEYAIEGI 258
++K SNIL++ K+ DFG++ +L A T VGT YM+PE
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG-----QLVNSLAKTF--VGTSSYMAPERIQGND 175
Query: 259 FSIKFDVFSFGVLLLEIVSGK 279
+S+K D++S G+ L+E+ +G+
Sbjct: 176 YSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 124 LGEGGFGPVYKGVLRKGNE-----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRL 177
LGEG FG V N+ +AVK L GQ K E +++ + H+N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 178 LGCCIDKDEKI--LIYEYMPNKSL------------DFFLF------------------- 204
GCC ++ K LI EY+P SL LF
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHR 131
Query: 205 NLKASNILLDKDMNPKISDFGMAR-ICGGNE---LQANTSRIVGTYGYMSPEYAIEGIFS 260
+L A N+LLD D KI DFG+A+ + G+E ++ + V Y + E E FS
Sbjct: 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---AVECLKENKFS 188
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308
DV+SFGV L E+++ + ++G R +EL
Sbjct: 189 YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 49/198 (24%)
Query: 124 LGEGGFGPVYKGVL----RKGNEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+G G FG V++G+L RK +A+K L G + + ++ +EAS++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFL---------------------------------FN 205
G ++I EYM N +LD +L +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRD 132
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIEGIF 259
L A NIL++ ++ K+SDFG++R+ L+ + T G + +PE F
Sbjct: 133 LAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 260 SIKFDVFSFGVLLLEIVS 277
+ DV+SFG+++ E++S
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 43/189 (22%)
Query: 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI- 182
+G+G FG V G R GN++AVK + ++ + EASV+ +++H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 183 DKDEKILIYEYMPNKSL----------------------------------DFFLFNLKA 208
+K ++ EYM SL +F +L A
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSF 268
N+L+ +D K+SDFG+ + + +T ++ + +PE E FS K DV+SF
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSDVWSF 185
Query: 269 GVLLLEIVS 277
G+LL EI S
Sbjct: 186 GILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 67/227 (29%)
Query: 111 VSTATNRFSDANKLGEGGFGPVYKGVL------RKGNEIAVKRLSGRSGQGLRE-MKNEA 163
++ +T RF + +LGE FG VYKG L + +A+K L ++ LRE K+EA
Sbjct: 2 INLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 164 SVIAKVQHKNLVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLF------------------ 204
+ +++QH N+V LLG + K++ + +I+ Y + L FL
Sbjct: 60 MMRSRLQHPNIVCLLG-VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 205 ------------------------------NLKASNILLDKDMNPKISDFGMARICGGNE 234
+L N+L+ +N KISD G+ R
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR----EV 174
Query: 235 LQANTSRIVGT----YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
A+ +++G +MSPE + G FSI D++S+GV+L E+ S
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 51/200 (25%)
Query: 124 LGEGGFGPVYKGVL----RKGNEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+G G FG V +G L ++ +A+K L SG + + R+ +EAS++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFL---------------------------------FN 205
G ++I E+M N +LD FL +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRD 131
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--------YMSPEYAIEG 257
L A NIL++ ++ K+SDFG++R L+ +TS T + +PE
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRF-----LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 258 IFSIKFDVFSFGVLLLEIVS 277
F+ DV+S+G+++ E++S
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 60/265 (22%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182
+LG G FG V G R ++A+K + S E EA V+ K+ H+ LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 183 DKDEKILIYEYMPN---------------------------------KSLDFFLFNLKAS 209
+ ++ EYM N +S F +L A
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAAR 129
Query: 210 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIKFDVF 266
N L+D K+SDFG++R +E ++ VG+ + PE + FS K DV+
Sbjct: 130 NCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 267 SFGVLLLEIVS-GKKNTGFY-RTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324
+FGVL+ E+ S GK + ++T+ + L+R + E AI+ YS
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIM---YS------ 236
Query: 325 RYVNIALLCVQESADDRPTTNDVVS 349
C E A++RPT ++S
Sbjct: 237 --------CWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 57/216 (26%)
Query: 117 RFSDANKLGEGGFGPVYKGVL-----RKGNEIAVKRLSG-RSGQGLREMKNEASVIAKVQ 170
RF + +LGE FG +YKG L +A+K L + Q E + EAS++A++
Sbjct: 8 RFME--ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH 65
Query: 171 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-------------------------- 204
H N+V LLG + +++EY+ L FL
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 205 -----------------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241
+L A NIL+ + ++ KISD G++R + +
Sbjct: 126 FLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+ +M PE + G FS D++SFGV+L EI S
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 50/209 (23%)
Query: 117 RFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQG--LREMKNEASVIAKVQHKN 173
R+ NK+G G FG VY V L G +AVK + + ++E+ +E V+ ++H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN---------------------------- 205
LV+ G + +++ + EY +L+ L +
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-------VGTYGYMSPEYA 254
+K +NI LD + K+ DFG A L+ NT+ + GT YM+PE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVK-----LKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 255 IEGIFSIKF---DVFSFGVLLLEIVSGKK 280
G D++S G ++LE+ +GK+
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 46/202 (22%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKR--LSGRSGQG-------LREMKNEASVIAKVQHKN 173
+G G FG VY G+ G +AVK+ L S L + E +++ ++QH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN---------------------------- 205
+V+ LG +D D + EY+P S+ L N
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQA--NTSR--IVGTYGYMSPEYAIEG 257
+K +NIL+D KISDFG+++ N L N +R + G+ +M+PE +
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187
Query: 258 IFSIKFDVFSFGVLLLEIVSGK 279
++ K D++S G L++E+++GK
Sbjct: 188 SYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 53/220 (24%)
Query: 123 KLGEGGFGPVY----KGVLRKGNE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
+LGEG FG V+ +L + ++ +AVK L S ++ + EA ++ +QH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL--------------------------------- 203
G C + ++++EYM + L+ FL
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 204 --------------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 249
+L N L+ + + KI DFGM+R + R + +M
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191
Query: 250 SPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT 289
PE + F+ + D++SFGV+L EI + K + ++T
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 67/275 (24%), Positives = 101/275 (36%), Gaps = 67/275 (24%)
Query: 123 KLGEGGFGPVYKGVLRKGN----EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
KLG+G FG V +G +AVK L S + + + EA+++ + H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 178 LGCCIDKDEKILIYEYMPNKSL---------DFFLF------------------------ 204
G + ++ E P SL FL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120
Query: 205 -NLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAIEGIF 259
+L A NILL D KI DFG+ R NE ++ + V + + +PE F
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH--LKV-PFAWCAPESLRTRTF 177
Query: 260 SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLW---RSNRTLELTDAILEDE 316
S DV+ FGV L E+ + Y + W ++ L+ D E
Sbjct: 178 SHASDVWMFGVTLWEMFT-----------------YGEEPWAGLSGSQILKKIDKEGERL 220
Query: 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
+ N+ L C + DRPT + L
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 51/196 (26%), Positives = 78/196 (39%), Gaps = 45/196 (22%)
Query: 124 LGEGGFGPVY------KGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG+GGFG V G + ++ KRL R G+ + NE ++ KV + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQM--ALNEKKILEKVSSRFIVSL 58
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
KD+ L+ M L + ++N
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
LK N+LLD N +ISD G+A + R GT GYM+PE ++
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEVYDFSV 175
Query: 264 DVFSFGVLLLEIVSGK 279
D F+ G L E+++G+
Sbjct: 176 DWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 54/222 (24%)
Query: 123 KLGEGGFGPVYKGV---LRKGNE---IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
+LGEG FG V+ L + +AVK L + ++ + EA ++ +QH+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL--------------------------------- 203
G C D D I+++EYM + L+ FL
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 204 ---------------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
+L N L+ ++ KI DFGM+R + + +
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 191
Query: 249 MSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTL 290
M PE + F+ + DV+SFGV+L EI + K F ++T
Sbjct: 192 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 9e-13
Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 54/174 (31%)
Query: 123 KLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQG------LREMKNEASVIAKVQHKNLV 175
++GEG G V+K R+ E A+K+++ R +G LRE+K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 176 RLL-----GCCIDKDEKILIYEYMPN------------------KSLDFFLFN------- 205
+LL G +L+ EYMP+ KS L
Sbjct: 63 KLLDVFPHGSGF-----VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 206 -------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 252
LK +N+L+ D KI+DFG+AR+ E + + + V T Y +PE
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 36/208 (17%)
Query: 105 LFSFSSVSTATNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEA 163
L S SV +++ K+G+G G VY + + G E+A+K+++ + + NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 164 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN-------------------------KS 198
V+ + ++ N+V L + DE ++ EY+ ++
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 127
Query: 199 LDFFLFN------LKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSP 251
LDF N +K+ NILL D + K++DFG A+I Q+ S +VGT +M+P
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAP 184
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
E + K D++S G++ +E+V G+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 56/210 (26%)
Query: 124 LGEGGFGPVYKGVLR---KGNE---IAVKRLSG-RSGQGLREMKNEASVIAKV-QHKNLV 175
LGEG FG V K NE +AVK L + + L ++ +E ++ + +HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 176 RLLGCCIDKDEKILIYEY-------------------------------MPNKSLDFFLF 204
LLG C + ++ EY + K L F +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 205 -----------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247
+L A N+L+ +D KI+DFG+AR + T+
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK 199
Query: 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+M+PE + +++ + DV+SFGVLL EI +
Sbjct: 200 WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 39/190 (20%)
Query: 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGCCI 182
LG+G FG V+KG L+ +AVK Q L+ + +EA ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 183 DKDEKILIYEYMPNKSLDFFLF-----------------------------------NLK 207
+ ++ E +P DF F +L
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFS 267
A N L+ ++ KISDFGM+R ++ + + + +PE G +S + DV+S
Sbjct: 121 ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESDVWS 179
Query: 268 FGVLLLEIVS 277
+G+LL E S
Sbjct: 180 YGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 76/278 (27%)
Query: 124 LGEGGFGPVYKGVLR----KGNEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+G G FG V G L+ + +A+K L +G + + R+ +EAS++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFL---------------------------------FN 205
G +++ EYM N SLD FL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 131
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIEGIF 259
L A NIL++ ++ K+SDFG++R+ + A T+R G + +PE F
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAIAYRKF 186
Query: 260 SIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI--LEDE 316
+ DV+S+G+++ E++S G++ W++ SN+ D I +E+
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPY--------------WEM--SNQ-----DVIKAIEEG 225
Query: 317 Y---SSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
Y + + L C Q+ ++RP +VS+L
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 47/199 (23%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLS-GRSGQGLRE----MKNEASVIAKVQHKNLVRL 177
LG+G FG VY + G E+AVK++ ++ ++ E ++ +QH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 178 LGCCIDKDEKILIY-EYMPNKSLD-------------------------FFLF------- 204
GC D DE + I+ EYMP S+ +L
Sbjct: 70 YGCLRD-DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 205 NLKASNILLDKDMNPKISDFGMAR----ICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
++K +NIL D N K+ DFG ++ IC + GT +MSPE +
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSS---GTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 261 IKFDVFSFGVLLLEIVSGK 279
K DV+S G ++E+++ K
Sbjct: 186 RKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 46/197 (23%)
Query: 123 KLGEGGFGPVYKGV-LRKGNEIAVKRLS------GRSGQGLREMKNEASVIAKVQHKNLV 175
K+GEG +G VYK G +A+K++ G LRE+K ++ ++ H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 176 RLLGCCIDKDEKILIYEYM---------------PNKSLDFFLF---------------- 204
+LL K + L++E+M P + +L+
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILH 121
Query: 205 -NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-EGIFSIK 262
+LK N+L++ + K++DFG+AR G + V T Y +PE + + +S
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 263 FDVFSFGVLLLEIVSGK 279
D++S G + E++S +
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 38/209 (18%)
Query: 105 LFSFSSVSTATNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMK-NE 162
L + SV +++ K+G+G G VY + + G E+A+K+++ Q +E+ NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 163 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----------------------- 199
V+ + +H N+V L + DE ++ EY+ SL
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126
Query: 200 --DFFLFN------LKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMS 250
+F N +K+ NILL D + K++DFG A+I Q+ S +VGT +M+
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMA 183
Query: 251 PEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
PE + K D++S G++ +E+V G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 49/199 (24%)
Query: 124 LGEGGFGPV----YKGVL-RKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
LG+G FG V Y + G +AVK+L + + LR+ + E ++ +QH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 179 GCCID--KDEKILIYEYMPNKSLDFFLFN------------------------------- 205
G C + L+ EY+P SL +L
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSPEYAIEGI 258
L NIL++ + KI DFG+ ++ ++ + S I + +PE E
Sbjct: 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPESLTESK 187
Query: 259 FSIKFDVFSFGVLLLEIVS 277
FS+ DV+SFGV+L E+ +
Sbjct: 188 FSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 51/203 (25%), Positives = 74/203 (36%), Gaps = 51/203 (25%)
Query: 124 LGEGGFGPVYKGVLRKGNE-------IAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 175
LG G FG V+ KG E + VK L + E + E + K+ HKN+V
Sbjct: 13 LGRGEFGEVFLAKA-KGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 176 RLLGCCIDKDEKILIYEYMPNKSL-DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234
RLLG C + + +I EY L F L ++ K +I G +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 235 LQANTSRIV--------------------------GTYG--------------YMSPEYA 254
+N +R V Y +++PE
Sbjct: 132 HLSN-ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190
Query: 255 IEGIFSIKFDVFSFGVLLLEIVS 277
E FS K DV+SFGVL+ E+ +
Sbjct: 191 QEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 40/209 (19%)
Query: 109 SSVSTATNRFSD---ANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLR-EMKNEA 163
S +A S+ N++G G G VYK + R G A+K + G +R ++ E
Sbjct: 64 GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREI 123
Query: 164 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD-------FFLFNL---------- 206
++ V H N+V+ E ++ E+M SL+ FL ++
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAY 183
Query: 207 -----------KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 255
K SN+L++ N KI+DFG++RI N+S VGT YMSPE
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERIN 241
Query: 256 EGIFSIKF-----DVFSFGVLLLEIVSGK 279
+ + D++S GV +LE G+
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 63/268 (23%), Positives = 113/268 (42%), Gaps = 61/268 (22%)
Query: 124 LGEGGFGP--VYK----GVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG+G FG +Y+ L E+ + RLS + R+ NE +++ +QH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 178 LGCCIDKDEKILIYEY-----------------MPNKSLDFFLF---------------- 204
+D + ++ EY + + ++LF
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124
Query: 205 -NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
++K NI L K K+ DFG+++I G A T +VGT YMSPE ++ K
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKS 182
Query: 264 DVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323
D+++ G +L E+++ K+ D N L + + N T + YSS+ +
Sbjct: 183 DIWALGCVLYELLTLKRT-----FDATNPLNLVVKIVQGNYTPVV------SVYSSELIS 231
Query: 324 LRYVNIALLCVQESADDRPTTNDVVSML 351
L + +Q+ + RPT ++V+
Sbjct: 232 LVHS-----LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 5e-12
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 42/211 (19%)
Query: 124 LGEGGFGPVYKGVLRKGNE-----IAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 177
LG G FG VYKG+ E +A+K L+ +G + E +EA ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 178 LGCCIDKDEKILIYEYMPNKSL------------DFFLFN-------------------- 205
LG C+ + L+ + MP+ L L N
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
L A N+L+ + KI+DFG+AR+ G+E + N +M+ E F+ + D
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 193
Query: 265 VFSFGVLLLEIVS--GKKNTGFYRTDTLNLL 293
V+S+GV + E+++ GK G + +LL
Sbjct: 194 VWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 47/203 (23%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVK------RLSGRSGQGLREM----KNEASVIAKVQHK 172
+G+G +G VY + + G +AVK ++GR ++M ++E + + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 173 NLVRLLGCCIDKDEKILIY-EYMPNKSLDFFLFN-------------------------- 205
N+V+ LG +E + I+ EY+P S+ L
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 206 ------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE--YAIEG 257
LKA N+L+D D KISDFG+++ + G+ +M+PE ++
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ 187
Query: 258 IFSIKFDVFSFGVLLLEIVSGKK 280
+S K D++S G ++LE+ +G++
Sbjct: 188 GYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 51/208 (24%), Positives = 79/208 (37%), Gaps = 52/208 (25%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSG-----QGLREMKNEASVIAKV 169
+ + ++LGEG G V K L+ I A+K ++ Q LRE++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 170 QHKNLVRLLGCCID-KDEKILI-YEYMPNKSLDFFLFNLKA------------------- 208
+ +V+ G +D I I EY SLD +K
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 209 -----------------SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 251
SNILL + K+ DFG++ G + + GT YM+P
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAP 172
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
E +SI DV+S G+ LLE+ +
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 60/222 (27%)
Query: 116 NRFSDANKLGEGGFGPVY----KGVLR-----------KGNEIAVKRLSGRSGQGLR-EM 159
+ KLGEG FG V+ +G+ + +AVK L + R +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 160 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF--------------- 204
E +++++++ N++RLLG C+ D +I EYM N L+ FL
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 205 -----------------------------NLKASNILLDKDMNPKISDFGMARICGGNEL 235
+L N L+ KI+DFGM+R +
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
R V +M+ E + G F+ DV++FGV L E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 44/201 (21%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQH 171
F LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKS-LDF-----------FLFN-------------- 205
++ RLLG C+ + LI + MP LD+ +L N
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 206 -------LKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEYAIE 256
L A N+L+ + KI+DFG+A++ G +E A ++ +M+ E +
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALESILH 185
Query: 257 GIFSIKFDVFSFGVLLLEIVS 277
I++ + DV+S+GV + E+++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 52/210 (24%)
Query: 123 KLGEGGFGPVY----KGVLRKGNEI--AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
+LGEG FG V+ + + ++I AVK L S ++ EA ++ +QH+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL--------------------------------- 203
G C++ D I+++EYM + L+ FL
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 204 ------------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 251
+L N L+ +++ KI DFGM+R + + +M P
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVS-GKK 280
E + F+ + DV+S GV+L EI + GK+
Sbjct: 192 ESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 36/208 (17%)
Query: 105 LFSFSSVSTATNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEA 163
L S SV +++ K+G+G G VY + + G E+A+++++ + + NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 164 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN-------------------------KS 198
V+ + ++ N+V L + DE ++ EY+ ++
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 199 LDFFLFN------LKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSP 251
L+F N +K+ NILL D + K++DFG A+I Q+ S +VGT +M+P
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAP 185
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
E + K D++S G++ +E++ G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 46/195 (23%), Positives = 92/195 (47%), Gaps = 35/195 (17%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 175
F+ ++G+G FG VYKG+ + E+ A+K + + + +++ E +V+++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 176 RLLGCCIDKDEKILIYEYMPN-------------------------KSLDFFLF------ 204
R G + + +I EY+ K LD+
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
++KA+N+LL + + K++DFG+A +++ NT VGT +M+PE + + K D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDFKAD 183
Query: 265 VFSFGVLLLEIVSGK 279
++S G+ +E+ G+
Sbjct: 184 IWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 49/213 (23%)
Query: 114 ATNRFSDANKLGEGGFGPVY----KGVLRKGNE--IAVKRLSGRSGQGLR-EMKNEASVI 166
A + + + +LG+G FG VY KGV++ E +A+K ++ + R E NEASV+
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 167 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFNLK------------------- 207
+ ++VRLLG ++I E M L +L +L+
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 208 -----------------------ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244
A N ++ +D KI DFGM R + + +
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+MSPE +G+F+ DV+SFGV+L EI +
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 54/206 (26%)
Query: 124 LGEGGFGPVYKGVLRKGN----EIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LGEG FG V +G L + + ++AVK +L + + E +EA+ + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 178 LGCCIDKDEK------ILIYEYMPNKSLDFFLF--------------------------- 204
+G C + ++I +M + L FL
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 205 -----------NLKASNILLDKDMNPKISDFGMAR-ICGGNEL-QANTSRIVGTYGYMSP 251
+L A N +L +DM ++DFG+++ I G+ Q +++ +++
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKWIAI 184
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVS 277
E + +++ K DV++FGV + EI +
Sbjct: 185 ESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 73/307 (23%), Positives = 121/307 (39%), Gaps = 86/307 (28%)
Query: 116 NRFSDANKLGEGGFGPVY----KGVLR----------KGNE---IAVKRLSGRSGQGLR- 157
R + KLGEG FG V+ +G+ + GN+ +AVK L + + R
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 158 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN--------------------- 196
+ E ++++++ N++RLL CI D +I EYM N
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 197 ----------------------KSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234
SL+F +L N L+ K+ KI+DFGM+R +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYR-TDTLNLL 293
R V +MS E + G F+ DV++FGV L EI++ K + + +D
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD----- 239
Query: 294 GYAWDLWRSNRTLELTDAILEDEYSSKQVLL--------RYVNIALLCVQESADDRPTTN 345
+ +E T D+ +QV L + L C + +A +RP+
Sbjct: 240 ---------EQVIENTGEFFRDQ--GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288
Query: 346 DVVSMLT 352
++ + L
Sbjct: 289 EIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 49/204 (24%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQG-----LREMKNEASVIAKVQH 171
F KLGEG + VYKG R EI A+K + + +G +RE+ S++ +++H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI----SLMKELKH 57
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPN--------------------KSLDFFLF------- 204
+N+VRL +++ +L++EYM KS + L
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 205 -------NLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIE 256
+LK N+L++K K++DFG+AR G + NT S V T Y +P+ +
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPDVLLG 174
Query: 257 G-IFSIKFDVFSFGVLLLEIVSGK 279
+S D++S G ++ E+++G+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 40/198 (20%)
Query: 117 RFSDANKLGEGGFGPVYKG-VLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
+ K+GEG G V G ++AVK++ R Q + NE ++ QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 176 RLLGCCIDKDEKILIYEYMPNKSL-DF-----------------------FLFN------ 205
+ + DE ++ E++ +L D FL
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIEGIFSI 261
+K+ +ILL D K+SDFG C ++ R +VGT +M+PE +
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGF---CA--QVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194
Query: 262 KFDVFSFGVLLLEIVSGK 279
+ D++S G++++E+V G+
Sbjct: 195 EVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGL------REMKNEASVIAKVQHKNLV 175
LG+G +G VY G+ +G IAVK++ + L +++ E ++ ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------------------------------- 203
+ LG C+D + + E++P S+ L
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 204 FNLKASNILLDKDMNPKISDFGMA-RIC--GGNELQANTSRIV-GTYGYMSPEYAIEGIF 259
++K +N++L + K+ DFG A R+ G + +N + + GT +M+PE E +
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185
Query: 260 SIKFDVFSFGVLLLEIVSGK 279
K D++S G + E+ +GK
Sbjct: 186 GRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 62/267 (23%), Positives = 113/267 (42%), Gaps = 60/267 (22%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLS---GRSGQGLREMKNEASVIAKVQHKN 173
FSD ++G G FG VY + +E+ A+K++S +S + +++ E + K++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDF-------------------------FLFN--- 205
++ GC + + L+ EY + D +L +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI---EGI 258
+KA NILL + K+ DFG A I A + VGT +M+PE + EG
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQ 190
Query: 259 FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318
+ K DV+S G+ +E+ ++ + + ++ L + + L+ +
Sbjct: 191 YDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------IAQNESPALQSGHW 239
Query: 319 SKQVLLRYVNIALLCVQESADDRPTTN 345
S+ + N C+Q+ DRPT+
Sbjct: 240 SEY----FRNFVDSCLQKIPQDRPTSE 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 52/180 (28%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVK--RLSGRSGQG-------LREMKNEASVI 166
R+ KLGEG + VYK ++ G +A+K +L R LRE+K ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK----LL 56
Query: 167 AKVQHKNLVRLLGCCIDKDEKILIYEYMP--------NKSLDF----------------- 201
+++H N++ LL K L++E+M +KS+
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 202 FLFN-------LKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIVGTYGYMSPE 252
+L + LK +N+L+ D K++DFG+AR G ++ T ++V T Y +PE
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV-TRWYRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 63/270 (23%), Positives = 116/270 (42%), Gaps = 60/270 (22%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNE-IAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 173
F+D ++G G FG VY + NE +A+K++S +S + +++ E + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLF----------------------------- 204
+ GC + + L+ EY + D
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 205 ---NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI---EGI 258
++KA NILL + K++DFG A I AN+ VGT +M+PE + EG
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIAS----PANS--FVGTPYWMAPEVILAMDEGQ 200
Query: 259 FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318
+ K DV+S G+ +E+ ++ + + ++ L + + TL+ E+S
Sbjct: 201 YDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQ--NESPTLQSN------EWS 250
Query: 319 SKQVLLRYVNIALLCVQESADDRPTTNDVV 348
+ N C+Q+ DRPT+ +++
Sbjct: 251 D-----YFRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 45/202 (22%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRL--SGRSGQ-GLREMKNEASVIAKVQHK 172
F+D ++G G FG VY + NE+ A+K++ SG+ +++ E + +++H
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLDF-------------------------FLFNL- 206
N + GC + + L+ EY + D +L +
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE 135
Query: 207 ------KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI---EG 257
KA NILL + K++DFG A + AN+ VGT +M+PE + EG
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVILAMDEG 189
Query: 258 IFSIKFDVFSFGVLLLEIVSGK 279
+ K DV+S G+ +E+ K
Sbjct: 190 QYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 60/197 (30%)
Query: 112 STATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRL---SGRSG---QGLREMKNEAS 164
+ + KLGEG FG VYK K G +A+K++ + + G LRE+K
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK---- 59
Query: 165 VIAKVQHKNLVRLLGCCIDKDEKI--------LIYEYM----------PNKSLD------ 200
++ K++H N+V L+ +++ +K ++ YM P+ L
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC 119
Query: 201 ----------------FFLFNLKASNILLDKDMNPKISDFGMARI---------CGGNEL 235
++KA+NIL+D KI+DFG+AR GG
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 236 QANTSRIVGTYGYMSPE 252
+ +V T Y PE
Sbjct: 180 TRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 105 LFSFSSVSTATNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEA 163
L + S+ +++ K+G+G G V+ + + G E+A+K+++ + + NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 164 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN-------------------------KS 198
V+ ++++ N+V L + DE ++ EY+ ++
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA 127
Query: 199 LDFFLFN------LKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSP 251
L+F N +K+ N+LL D + K++DFG A+I Q+ S +VGT +M+P
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAP 184
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
E + K D++S G++ +E+V G+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 123 KLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGL---REMKNEASVIAKVQHKNLVRLL 178
++G+GG+G V+ + EI A+KR+ L R + E ++ + + LV+LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLFN--------------------------------L 206
D + L EY+P L N L
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
K N L+D + K++DFG+++ G AN+ +VG+ YM+PE + D +
Sbjct: 128 KPENFLIDASGHIKLTDFGLSK--GIVTY-ANS--VVGSPDYMAPEVLRGKGYDFTVDYW 182
Query: 267 SFGVLLLEIVSG 278
S G +L E + G
Sbjct: 183 SLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 48/196 (24%), Positives = 83/196 (42%), Gaps = 43/196 (21%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182
LG+G +G VY L IA+K + R + ++ + E ++ + ++H+N+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 183 DKDEKILIYEYMPNKSLDFFL-----------------------------------FNLK 207
+ + E +P SL L ++K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 208 ASNILLDKDMNP-KISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIEGI--FSIKF 263
N+L++ KISDFG + R+ G N T GT YM+PE +G +
Sbjct: 136 GDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGYGAPA 192
Query: 264 DVFSFGVLLLEIVSGK 279
D++S G ++E+ +GK
Sbjct: 193 DIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 63/266 (23%), Positives = 98/266 (36%), Gaps = 56/266 (21%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 181
+LG G FG V+ G R ++A+K + G E EA V+ K+ H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 182 IDKDEKILIYEYMPNKSL---------------------------------DFFLFNLKA 208
+ ++ E+M N L F +L A
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAA 128
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSF 268
N L+ K+SDFGM R +E ++S + PE +S K DV+SF
Sbjct: 129 RNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187
Query: 269 GVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE--YSSKQVLLRY 326
GVL+ E+ + K + E+ + I Y K +
Sbjct: 188 GVLMWEVFTEGKMP-----------------FEKKSNYEVVEMISRGFRLYRPKLASMTV 230
Query: 327 VNIALLCVQESADDRPTTNDVVSMLT 352
+ C E + RPT +++ +T
Sbjct: 231 YEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 47/198 (23%)
Query: 123 KLGEGGFGPVYKGVLRKGNEI-AVKRL------SGRSGQGLREMKNEASVIAKVQHKNLV 175
K+GEG +G VYK + EI A+K++ G +RE+ S++ ++ H N+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI----SLLKELNHPNIV 61
Query: 176 RLLGCCIDKDEKILIYEYM-----------PNKSLD-----FFLF--------------- 204
RLL +++ L++E++ P LD +L+
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 205 --NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG-IFSI 261
+LK N+L+D++ K++DFG+AR G ++ T +V T Y +PE + +S
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQYST 179
Query: 262 KFDVFSFGVLLLEIVSGK 279
D++S G + E+V+ +
Sbjct: 180 PVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 48/204 (23%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNEI-AVKRL------SGRSGQGLREMKNEASVIAKVQ 170
++ K+GEG +G VYKG +K +I A+K++ G +RE+ S++ ++Q
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKELQ 57
Query: 171 HKNLVRLLGCCIDKDEKILIYEYM------------PNKSLDFFLF-------------- 204
H N+V L + + LI+E++ + +D L
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 205 --------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE 256
+LK N+L+D K++DFG+AR G ++ T +V T Y +PE +
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLG 175
Query: 257 GI-FSIKFDVFSFGVLLLEIVSGK 279
+S D++S G + E+ + K
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 55/204 (26%), Positives = 85/204 (41%), Gaps = 49/204 (24%)
Query: 123 KLGEGGFGPVYKGVLR---KGN---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 175
+LG+G FG VY+G R KG +AVK ++ + R E NEASV+ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLFNLK---------------------------- 207
RLLG +++ E M + L +L +L+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 208 --------------ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 253
A N ++ D KI DFGM R + + + +M+PE
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192
Query: 254 AIEGIFSIKFDVFSFGVLLLEIVS 277
+G+F+ D++SFGV+L EI S
Sbjct: 193 LKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 55/220 (25%), Positives = 83/220 (37%), Gaps = 69/220 (31%)
Query: 123 KLGEGGFGPVY---------------KGVLRKGNE--IAVKRL-SGRSGQGLREMKNEAS 164
KLGEG FG V+ +AVK L S + E
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 165 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN---------------------------- 196
+++++ N+ RLLG C +I EYM N
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 197 ---------------KSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241
+SL+F +L N L+ K+ KI+DFGM+R N ++ R
Sbjct: 132 LLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSDYYR 187
Query: 242 IVGT----YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+ G +M+ E + G F+ K DV++FGV L EI++
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 63/228 (27%)
Query: 103 FPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGN---EIAVKRLSGRSGQG-LRE 158
+P+ ++ + +F D +GEG FG V K ++K + A+KR+ + + R+
Sbjct: 1 YPVLEWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 53
Query: 159 MKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------- 203
E V+ K+ H N++ LLG C + L EY P+ +L FL
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113
Query: 204 ----------------------------------FNLKASNILLDKDMNPKISDFGMARI 229
+L A NIL+ ++ KI+DFG++R
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR- 172
Query: 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
G E+ + +M+ E +++ DV+S+GVLL EIVS
Sbjct: 173 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 42/198 (21%)
Query: 123 KLGEGGFGPVYKGVLR---KGNEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLL 178
+LG G FG V KGV + K ++A+K L + + +R EM EA ++ ++ + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLF---------------------------------N 205
G C + + +L+ E L+ FL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIEGIFSIKF 263
L A N+LL KISDFG+++ G ++ +R G + + +PE FS +
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 264 DVFSFGVLLLEIVS-GKK 280
DV+S+G+ + E S G+K
Sbjct: 180 DVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 55/218 (25%)
Query: 112 STATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRL------SGRSGQGLREMKNEAS 164
++F ++GEG +G VYK + E+ A+K++ G +RE+K
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK---- 58
Query: 165 VIAKVQHKNLVRLLGCCIDKDEKI----------LIYEYMP------------------N 196
++ ++ H+N+V L DK + + L++EYM
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 197 KSL--------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242
KS +F ++K SNILL+ K++DFG+AR+ E + T+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 243 VGTYGYMSPEYAI-EGIFSIKFDVFSFGVLLLEIVSGK 279
+ T Y PE + E + DV+S G +L E+ + K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 51/198 (25%)
Query: 124 LGEGGFGPVYK-GVLRKGNEIAVKRLSGRS--GQGLREM-KNEASVIAKVQHKNLVRL-- 177
LG GGFG V V K A+K + R G +E +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 178 ---------------LGCCI----------DKDEK-------ILIYEYMPNKSL---DFF 202
LG + D+ +L +EY+ N+ + D
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD-- 118
Query: 203 LFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI-FSI 261
LK N+LLD + K+ DFG A+ + T GT Y++PE I +
Sbjct: 119 ---LKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPE-IILNKGYDF 171
Query: 262 KFDVFSFGVLLLEIVSGK 279
D +S G+LL E+++G+
Sbjct: 172 SVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 69/224 (30%)
Query: 123 KLGEGGFGPV---------------YKGVLRKGNE--IAVKRLSGRSGQGLR-EMKNEAS 164
KLGEG FG V + +RKG +AVK L + + R + E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 165 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN---------------------------- 196
++++++ N++RLLG C+D+D +I EYM N
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 197 -----------------------KSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233
SL+F +L N L+ +++ KI+DFGM+R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191
Query: 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+ R V +M+ E + G F+ DV++FGV L EI+
Sbjct: 192 DYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 53/203 (26%), Positives = 81/203 (39%), Gaps = 47/203 (23%)
Query: 118 FSDANKLGEGGFGPV------YKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQH 171
F LG+GGFG V G + + KR+ R G+ + NE ++ KV
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM--ALNEKQILEKVNS 59
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------- 205
+ +V L KD L+ M L F ++N
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 206 --------LKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIE 256
LK NILLD + +ISD G+A +I G ++ VGT GYM+PE
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNN 175
Query: 257 GIFSIKFDVFSFGVLLLEIVSGK 279
+++ D + G L+ E++ G+
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 44/200 (22%), Positives = 91/200 (45%), Gaps = 41/200 (20%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQG-LREMKNEASVIAKVQHKN 173
F+ +G+G FG VYK + ++ N++ A+K + + + +++ E +++ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKS-LDF-----------------------FLFN---- 205
+ + G + + +I EY S LD +L
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKI 120
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIEGIF 259
+KA+NILL ++ + K++DFG++ +L + S+ VGT +M+PE + +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 260 SIKFDVFSFGVLLLEIVSGK 279
K D++S G+ +E+ G+
Sbjct: 176 DEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 56/207 (27%)
Query: 124 LGEGGFGPVYKGVLRK-GNEI--AVKRLSGRSGQG-LREMKNEASVIAKV-QHKNLVRLL 178
+GEG FG V + +++K G ++ A+K L + + R+ E V+ K+ H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFL----------------------------------- 203
G C ++ + EY P +L FL
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 204 -------------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 250
+L A N+L+ +++ KI+DFG++R G E+ + +M+
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVRWMA 186
Query: 251 PEYAIEGIFSIKFDVFSFGVLLLEIVS 277
E +++ K DV+SFGVLL EIVS
Sbjct: 187 IESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 50/207 (24%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNE-IAVKRL------SGRSGQGLREMKNEASVIAK 168
+++ K+GEG +G VYK R NE IA+K++ G +RE+ S++ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREI----SLLKE 57
Query: 169 VQHKNLVRLLGCCIDKDEKI-LIYEYMP-------NKSLDF---------FLF------- 204
+QH N+VRL + ++++ L++EY+ + S DF +L+
Sbjct: 58 MQHGNIVRLQD-VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 205 ----------NLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEY 253
+LK N+L+D+ N K++DFG+AR G ++ T +V T Y +PE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV-TLWYRAPEI 174
Query: 254 AIEG-IFSIKFDVFSFGVLLLEIVSGK 279
+ +S D++S G + E+V+ K
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 44/195 (22%), Positives = 87/195 (44%), Gaps = 45/195 (23%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQG-LREMKNEASVIAKVQH---KNLVRLL 178
+G G +G VY+G + G +A+K ++ + + +++ E +++++++ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFL-------------------------------FNLK 207
G + +I EY S+ + ++K
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIK 128
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIEGI-FSIKF 263
A+NIL+ N K+ DFG+A L N+S+ VGT +M+PE EG + K
Sbjct: 129 AANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183
Query: 264 DVFSFGVLLLEIVSG 278
D++S G+ + E+ +G
Sbjct: 184 DIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 5e-10
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 50/201 (24%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVKRL---SGRSG---QGLREMKNEASVIAKVQHKNL 174
N++ EG +G VY+ +K EI A+K+L + G LRE+ +++ K+QH N+
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI----NILLKLQHPNI 66
Query: 175 VRL----LGCCIDK----------DEKILIYEYMPN-------KSLDFFLFN-------- 205
V + +G +DK D K L+ E M K L L +
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 206 ------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-EGI 258
LK SN+LL+ KI DFG+AR G L+ T +V T Y +PE +
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVV-TLWYRAPELLLGAKE 183
Query: 259 FSIKFDVFSFGVLLLEIVSGK 279
+S D++S G + E+++ K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 5e-10
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 69/205 (33%)
Query: 124 LGEGGFGPVYKGVLRKGNE--IAVKRLSG----RSGQGLREMKNEASVIAKVQHKNLVRL 177
LG G FG V V KG+ A+K LS + Q + + NE ++ ++H LV L
Sbjct: 9 LGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNL 66
Query: 178 LGCCIDKDEK------------------------------------ILIYEYMPNKSL-- 199
G +D+ +L EY+ + +
Sbjct: 67 YGS--FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVY 124
Query: 200 -DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI 258
D LK N+LLD D KI+DFG A+ ++ T + GT Y++PE I
Sbjct: 125 RD-----LKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPE-----I 169
Query: 259 FSIK-----FDVFSFGVLLLEIVSG 278
K D ++ G+L+ E+++G
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 54/207 (26%)
Query: 120 DANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKN---EASVIAKVQH-KNL 174
D ++G G FG V K + + G +AVKR+ RS +E K + V+ + +
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 175 VRLLG-------CCI---------DKDEKILIYE----YMPN-----------KSLDFFL 203
V+ G C I DK K +YE +P K+L++
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKY-VYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 204 FNL-------KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 252
L K SNILLD++ N K+ DFG I G +R G YM+PE
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDP 181
Query: 253 YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
A +G + ++ DV+S G+ L E+ +GK
Sbjct: 182 SARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 40/193 (20%)
Query: 124 LGEGGFGPVYKGV-LRKGNEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 177
LG G FG V+KG+ + +G+ I A+K + RSG Q +E+ + + + H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 178 LGCCIDKDEKILIYEYMPNKSL--------------------------DFFL-------F 204
LG C + L+ + P SL ++L
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHR 133
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
NL A NILL D +I+DFG+A + ++ + S +M+ E + G ++ + D
Sbjct: 134 NLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSD 193
Query: 265 VFSFGVLLLEIVS 277
V+S+GV + E++S
Sbjct: 194 VWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 57/197 (28%), Positives = 84/197 (42%), Gaps = 47/197 (23%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 176
LG+G FG V L+ +E+ AVK L + L++ E V+A +H L +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDF-------------------------FLF------- 204
L C KD + EY+ L F FL
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 205 NLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+LK N+LLD + + KI+DFGM + I GG TS GT Y++PE +
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAPEILSYQPYGPA 176
Query: 263 FDVFSFGVLLLEIVSGK 279
D ++ GVLL E+++G+
Sbjct: 177 VDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 47/202 (23%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE----MKNEASVIAKVQHK 172
F +++G G FG VY NE+ AVK++S SG+ E + E + +++H
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHP 81
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF---------------------------- 204
N + GC + + L+ EY + D
Sbjct: 82 NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 205 ----NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI---EG 257
++KA NILL + K++DFG A AN+ VGT +M+PE + EG
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS--FVGTPYWMAPEVILAMDEG 195
Query: 258 IFSIKFDVFSFGVLLLEIVSGK 279
+ K DV+S G+ +E+ K
Sbjct: 196 QYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 47/203 (23%)
Query: 118 FSDANKLGEGGFGPV------YKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQH 171
F LG+GGFG V G + ++ KR+ R G+ + NE ++ KV
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--ALNEKQILEKVNS 59
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF--------------------------- 204
+ +V L KD L+ M L F ++
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 205 -------NLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIE 256
+LK NILLD + +ISD G+A + G ++ VGT GYM+PE
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN 175
Query: 257 GIFSIKFDVFSFGVLLLEIVSGK 279
++ D ++ G LL E+++G+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 41/191 (21%)
Query: 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182
LG+G FG VYK ++ G A K + S + L + E ++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 183 DKDEKILIYEYMPNKSLD--------------------------FFLFN-------LKAS 209
+++ ++ E+ +LD FL + LKA
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 210 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS-----IKFD 264
NILL D + K++DFG++ + LQ + +GT +M+PE F K D
Sbjct: 133 NILLTLDGDVKLADFGVSAK-NKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYDYKAD 190
Query: 265 VFSFGVLLLEI 275
++S G+ L+E+
Sbjct: 191 IWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 46/206 (22%)
Query: 116 NRFSDANKLGEGGFGPVYK----GVLRKGN--EIAVKRLSGRSGQGLRE-MKNEASVIAK 168
N S LG G FG V + G+ + ++AVK L + RE + +E +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 169 V-QHKNLVRLLGCCI----------------------DKDEKILIYE------YMPNKSL 199
+ H+N+V LLG C K E L E Y K +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 200 DFFLF------NLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 251
F +L A N+LL KI DFG+AR + N + +R+ +M+P
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAP 212
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVS 277
E +++ + DV+S+G+LL EI S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 45/194 (23%)
Query: 124 LGEGGFGPVYKGVLRKGNE-IAVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 179
+G G FG V+ R A+K ++ L++ + NE V+ +V H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 180 CCIDKDEKIL--IYEYMPNKSLDFFLFN-------------------------------- 205
+ D++ L + EY+P L +L N
Sbjct: 68 -WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
LK NILLDK+ + K++DFG A+ +L+ T + GT Y++PE + D
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDW 181
Query: 266 FSFGVLLLEIVSGK 279
++ G+L+ E++ G
Sbjct: 182 WALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 40/198 (20%)
Query: 122 NKLGEGGFGPVYKGV-LRKGNEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 179
+G G VY + L ++A+KR+ + + E++ E +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 180 CCIDKDEKILIYEYM-------------PN----------------KSLDFFLFN----- 205
+ DE L+ Y+ P K L++ N
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR 126
Query: 206 -LKASNILLDKDMNPKISDFGM-ARICGGNELQANTSR-IVGTYGYMSPEYAIEGI-FSI 261
+KA NILL +D + KI+DFG+ A + G + + VGT +M+PE + +
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF 186
Query: 262 KFDVFSFGVLLLEIVSGK 279
K D++SFG+ +E+ +G
Sbjct: 187 KADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 51/190 (26%), Positives = 75/190 (39%), Gaps = 35/190 (18%)
Query: 123 KLGEGGFGPVYKGVLRKGNE-IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGC 180
++G G FG V+ G LR N +AVK L+ + EA ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFN---------------------------------LK 207
C K ++ E + FL L
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFS 267
A N L+ + KISDFGM+R + + +PE G +S + DV+S
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWS 181
Query: 268 FGVLLLEIVS 277
FG+LL E S
Sbjct: 182 FGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 47/190 (24%), Positives = 87/190 (45%), Gaps = 36/190 (18%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
K+GEG G V ++ G +AVK++ R Q + NE ++ QH+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 182 IDKDEKILIYEYMPNKSLDFFLF-------------------------------NLKASN 210
+ DE ++ E++ +L + ++K+ +
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 211 ILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFG 269
ILL D K+SDFG A++ E+ S +VGT +M+PE + + D++S G
Sbjct: 147 ILLTHDGRVKLSDFGFCAQV--SKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 270 VLLLEIVSGK 279
++++E+V G+
Sbjct: 204 IMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 45/198 (22%), Positives = 86/198 (43%), Gaps = 45/198 (22%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
++G G +G VYK E+ A+K + G ++ E S++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 181 CIDKDEKILIYEYMPNKSLD--------------------------FFLFN-------LK 207
+ +D+ ++ EY SL +L +K
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIK 128
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIE---GIFSI 261
+NILL +D + K++DFG++ +L A ++ +GT +M+PE A G +
Sbjct: 129 GANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDG 183
Query: 262 KFDVFSFGVLLLEIVSGK 279
K D+++ G+ +E+ +
Sbjct: 184 KCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 49/201 (24%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG+G FG VY + G E+A K++ S + + + ++ E ++ +QH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 178 LGCCIDKDEKIL--IYEYMPNKS--------------------------LDFFLFNL--- 206
GC D+ EK L EYMP S + + N+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 207 ---KASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMSPEYAIEGI 258
K +NIL D N K+ DFG ++ IC G +++ + GT +MSPE
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS----VTGTPYWMSPEVISGEG 185
Query: 259 FSIKFDVFSFGVLLLEIVSGK 279
+ K DV+S G ++E+++ K
Sbjct: 186 YGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 44/197 (22%)
Query: 124 LGEGGFGPVY------KGVLRKGNEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVR 176
LGEG FG V +G G ++AVK L G + ++K E ++ + H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 177 LLGCCI-DKDEKI-LIYEYMPNKSLDFFL------FNLK--------------------- 207
G C D I LI E++P+ SL +L NLK
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQY 130
Query: 208 ------ASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
A N+L++ + KI DFG+ + I E + + +PE I+ F
Sbjct: 131 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY 190
Query: 261 IKFDVFSFGVLLLEIVS 277
I DV+SFGV L E+++
Sbjct: 191 IASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 56/207 (27%)
Query: 124 LGEGGFGPVYKGVLRKGN---EIAVKRLSGRSGQG-LREMKNEASVIAKV-QHKNLVRLL 178
+GEG FG V K ++K + A+KR+ + + R+ E V+ K+ H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFL----------------------------------- 203
G C + L EY P+ +L FL
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 204 -------------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 250
+L A NIL+ ++ KI+DFG++R G E+ + +M+
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMA 179
Query: 251 PEYAIEGIFSIKFDVFSFGVLLLEIVS 277
E +++ DV+S+GVLL EIVS
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 36/95 (37%), Positives = 59/95 (62%), Gaps = 9/95 (9%)
Query: 186 EKILIYEYMPNKSLDFFLF-NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244
E IL E+M N+ F ++ +LK +NILLD+ + +ISD G+A C ++ + + S VG
Sbjct: 105 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VG 157
Query: 245 TYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSG 278
T+GYM+PE +G+ + D FS G +L +++ G
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 54/201 (26%), Positives = 79/201 (39%), Gaps = 52/201 (25%)
Query: 124 LGEGGFGPVY------KGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG+GGFG V G L ++ KRL R +G E ++AKV + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
K + L+ M L + ++N
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGYMSPEYAIEGI 258
LK N+LLD D N +ISD G+A EL Q+ T GT G+M+PE
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAV-----ELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 259 FSIKFDVFSFGVLLLEIVSGK 279
+ D F+ GV L E+++ +
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 44/195 (22%), Positives = 91/195 (46%), Gaps = 35/195 (17%)
Query: 118 FSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 175
F+ ++G+G FG V+KG+ R +A+K + + + +++ E +V+++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 176 RLLGCCIDKDEKILIYEYMPN-------------------------KSLDFFLF------ 204
+ G + + +I EY+ K LD+
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 125
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
++KA+N+LL + + K++DFG+A +++ NT VGT +M+PE + + K D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSKAD 183
Query: 265 VFSFGVLLLEIVSGK 279
++S G+ +E+ G+
Sbjct: 184 IWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 52/197 (26%), Positives = 80/197 (40%), Gaps = 47/197 (23%)
Query: 124 LGEGGFGPV------YKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG+GGFG V G + ++ KR+ R G+ + NE ++ KV + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKRILEKVNSRFVVSL 65
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
KD L+ M L F ++N
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 206 --LKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
LK NILLD + +ISD G+A +I G ++ VGT GYM+PE ++
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEKYTFS 181
Query: 263 FDVFSFGVLLLEIVSGK 279
D + G L+ E++ G+
Sbjct: 182 PDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 63/269 (23%), Positives = 111/269 (41%), Gaps = 67/269 (24%)
Query: 124 LGEGGFGPVY--------KGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
+G G FG V+ K V+ K +I V++++ +NE V+ + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIK--QIPVEQMTKDERLA---AQNECQVLKLLSHPNII 62
Query: 176 RLLGCCIDKDEKILIYEYMPNKS------------------LDFFL-------------- 203
++ +++ EY P + L FF+
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122
Query: 204 --FNLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
+LK NILLDK M KI DFG+++I ++ +VGT Y+SPE ++
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYN 179
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320
K D+++ G +L E+ S K+ F + NL + T A + D YS
Sbjct: 180 QKSDIWALGCVLYELASLKR--AF---EAANLPALVLKIMSG------TFAPISDRYSPD 228
Query: 321 QVLLRYVNIALLCVQESADDRPTTNDVVS 349
LR + +++L + RP + +++
Sbjct: 229 ---LRQLILSMLNLD--PSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 53/197 (26%), Positives = 79/197 (40%), Gaps = 47/197 (23%)
Query: 124 LGEGGFGPV------YKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG+GGFG V G + ++ KR+ R G+ + NE ++ KV + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQILEKVNSRFVVSL 65
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
KD L+ M L F ++N
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 206 --LKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
LK NILLD + +ISD G+A I G ++ VGT GYM+PE ++
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEVVKNERYTFS 181
Query: 263 FDVFSFGVLLLEIVSGK 279
D + G L+ E++ GK
Sbjct: 182 PDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 43/201 (21%), Positives = 84/201 (41%), Gaps = 48/201 (23%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLS------GRSGQGLREMKNEASVIAKVQHKNLVR 176
LG G F Y+ ++ G +AVK+++ + + ++ E ++A++ H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------- 205
+LG + L E+M S+ L
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 206 -LKASNILLDKD-MNPKISDFGMA-----RICGGNELQANTSRIVGTYGYMSPEYAIEGI 258
+K +N+L+D +I+DFG A + G E Q +++GT +M+PE
Sbjct: 128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMAPEVLRGEQ 184
Query: 259 FSIKFDVFSFGVLLLEIVSGK 279
+ DV+S G +++E+ + K
Sbjct: 185 YGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 56/202 (27%)
Query: 123 KLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVR 176
+LG+G FG VY ++ E+ A+K++ + LRE+K S+ +H N+V+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK---SLRKLNEHPNIVK 62
Query: 177 LLGCCIDKDEKILIYEYMPN---------------------------KSLD------FFL 203
L + DE ++EYM + L FF
Sbjct: 63 LKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122
Query: 204 FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-----IVGTYGYMSPEYAIE-G 257
+LK N+L+ KI+DFG+AR E++ SR V T Y +PE +
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR-----EIR---SRPPYTDYVSTRWYRAPEILLRST 174
Query: 258 IFSIKFDVFSFGVLLLEIVSGK 279
+S D+++ G ++ E+ + +
Sbjct: 175 SYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 59/184 (32%)
Query: 123 KLGEGGFGPVYKGVL---RKGNEIAVKRLSGRSGQG-------LREMKNEASVIAKVQHK 172
+G G +G VYK + G E A+K+ G Q RE+ +++ +++H+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREI----ALLRELKHE 62
Query: 173 NLVRLLGCCIDKDEKI--LIYEY-------------------MPN---KSLDFFLFN--- 205
N+V L+ ++ +K L+++Y +P KSL + + N
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 206 -----------LKASNILLDKDMNP----KISDFGMARICGGNELQ--ANTSRIVGTYGY 248
LK +NIL+ + KI D G+AR+ L+ A+ +V T Y
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVVTIWY 181
Query: 249 MSPE 252
+PE
Sbjct: 182 RAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 63/272 (23%)
Query: 124 LGEGGFGPVYKGVLRKGNEIAVKRL------SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG G G V K + K++ S Q LRE++ ++ + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68
Query: 178 LGCCIDKDEKILIYEYMPNKSLD-------------------------FFLFN------- 205
G ++++ + E+M SLD +L+N
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+K SNIL++ K+ DFG++ G + + VGT YMSPE G +++K D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY----SSK 320
V+S G+ ++E+ GK F D L+L I+++ SS
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDD-------PMGILDLLQQIVQEPPPRLPSSD 237
Query: 321 --QVLLRYVNIALLCVQESADDRPTTNDVVSM 350
+ L +V+ C+ + +RPT + +M
Sbjct: 238 FPEDLRDFVDA---CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 63/212 (29%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMK-------------NEA 163
F KLG+G +G VYK VKRLS L+E+ NE
Sbjct: 1 DFKVLKKLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEI 50
Query: 164 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------------------DFFL 203
++A V H N++ +D ++ ++ EY P L F+
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 204 ----------------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247
+LK++NILL + KI D G++++ N A T +GT
Sbjct: 111 QLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQ--IGTPH 166
Query: 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
YM+PE +S K D++S G LL E+ +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 59/273 (21%)
Query: 124 LGEGGFGPVYKGVLRKGNE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 178 LGCCIDKDEKILIYEYMPNKS-LDF-----------FLFN-------------------- 205
LG C+ + L+ + MP LD+ L N
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR 133
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
L A N+L+ + KI+DFG+AR+ +E + + +M+ E + F+ + D
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSD 193
Query: 265 VFSFGVLLLEIVS--GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322
V+S+GV + E+++ K G + +L LE + + + + V
Sbjct: 194 VWSYGVTVWELMTFGAKPYDGIPAREIPDL-------------LEKGERLPQPPICTIDV 240
Query: 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355
+ I + C ++ RP ++V + A
Sbjct: 241 YM----IMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 33/76 (43%), Positives = 45/76 (59%), Gaps = 4/76 (5%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYAIEGIFSIKF 263
+LK NILLD D + KI+DFGM C N L A T GT Y++PE + ++
Sbjct: 121 DLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177
Query: 264 DVFSFGVLLLEIVSGK 279
D +SFGVLL E++ G+
Sbjct: 178 DWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 48/198 (24%)
Query: 123 KLGEGGFGPVYKGVLRK--GNEIAVKRL---SGRSGQGLREMKNEASV--IAKVQHKNLV 175
++GEG +G V+K K G +A+KR+ +G G L ++ A + + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 176 RLLGCC----IDKDEKI-LIYEYMPN---------------------------KSLDFFL 203
RL C D++ K+ L++E++ + LDF
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 204 F------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
+LK NIL+ K++DFG+ARI Q + +V T Y +PE ++
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQS 184
Query: 258 IFSIKFDVFSFGVLLLEI 275
++ D++S G + E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 59/208 (28%)
Query: 118 FSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQG------LREMKNEASVIAKVQ 170
+ + ++GEG +G VYK L G +A+K++ + LRE+ +++ +++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI----ALLKQLE 56
Query: 171 ---HKNLVRLLGCC-----------------IDKD---------------EKI--LIYEY 193
H N+VRLL C +D+D E I L+ +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 194 MPNKSLDFFLFN------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247
+ + +DF + LK NIL+ D KI+DFG+ARI A TS +V T
Sbjct: 117 L--RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTS-VVVTLW 171
Query: 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEI 275
Y +PE ++ ++ D++S G + E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 7e-09
Identities = 47/196 (23%), Positives = 94/196 (47%), Gaps = 37/196 (18%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 175
F+ K+G+G FG V+KG+ + ++ A+K + + + +++ E +V+++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 176 RLLGCCIDKDEKI-LIYEYMPN-------------------------KSLDFFLF----- 204
+ G + KD K+ +I EY+ K LD+
Sbjct: 66 KYYGSYL-KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 205 -NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
++KA+N+LL + K++DFG+A +++ NT VGT +M+PE + + K
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKA 182
Query: 264 DVFSFGVLLLEIVSGK 279
D++S G+ +E+ G+
Sbjct: 183 DIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 36/128 (28%), Positives = 57/128 (44%), Gaps = 23/128 (17%)
Query: 124 LGEGGFGPVYK----GVL--RKGNEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
+G+G FG V++ G+L +AVK L S + + EA+++A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFNLKASNILLDKDMNPK-----ISDFGMARICG 231
LLG C L++EYM L+ FL + +P+ AR CG
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFL-----------RHRSPRAQCSLSHSTSSARKCG 121
Query: 232 GNELQANT 239
N L +
Sbjct: 122 LNPLPLSC 129
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 31/75 (41%), Positives = 46/75 (61%), Gaps = 2/75 (2%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LK N+LLDKD + KI+DFGM + E +A+T GT Y++PE ++ D
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQKYNESVD 178
Query: 265 VFSFGVLLLEIVSGK 279
+SFGVLL E++ G+
Sbjct: 179 WWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 44/199 (22%)
Query: 123 KLGEGGFGPVYKGVLR--KGNE-IAVKRLSGRSG-QGLR-EMKNEASVIAKVQHKNLVRL 177
+LG G FG V KG+ + K + +AVK L + L+ E+ EA+V+ ++ + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 178 LGCC---------------------------IDKDEKILIYEY-MPNKSLD---FFLFNL 206
+G C +K+ L+++ M K L+ F +L
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI----FSIK 262
A N+LL KISDFG+++ G +E N + + YA E + FS K
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 263 FDVFSFGVLLLEIVS-GKK 280
DV+SFGVL+ E S G+K
Sbjct: 179 SDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 41/192 (21%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+LG+G FG VYK ++ G A K + +S + L + E ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 182 IDKDEKILIYEYMPNKSLDFFLF---------------------------------NLKA 208
+ ++ E+ P ++D + +LKA
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----EGIFSIKF 263
N+LL D + K++DFG++ LQ S +GT +M+PE + + + K
Sbjct: 139 GNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS-FIGTPYWMAPEVVMCETMKDTPYDYKA 196
Query: 264 DVFSFGVLLLEI 275
D++S G+ L+E+
Sbjct: 197 DIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 58/222 (26%)
Query: 114 ATNRFSDANKLGEGGFGPVY--------KGVLRKGNEIAVKRL-SGRSGQGLREMKNEAS 164
+R LGEG FG V K + ++AVK L S + + L ++ +E
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 165 VIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FN------- 205
++ + +HKN++ LLG C +I EY +L +L +N
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 206 ------------------------------LKASNILLDKDMNPKISDFGMARICGGNEL 235
L A N+L+ +D KI+DFG+AR +
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 195
Query: 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
T+ +M+PE + I++ + DV+SFGVLL EI +
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 47/203 (23%)
Query: 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 170
F K+GEG +G VYK + G +A+K++ G +RE+ S++ ++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 57
Query: 171 HKNLVRLLGCCIDKDEKILIYEYMPN-------------------KSLDFFLFN------ 205
H N+V+LL +++ L++E++ KS F L
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 206 --------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-E 256
LK N+L++ + K++DFG+AR G ++ T +V T Y +PE +
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLGC 175
Query: 257 GIFSIKFDVFSFGVLLLEIVSGK 279
+S D++S G + E+V+ +
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 57/209 (27%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRKG---------NEIAVKRLSGRSGQGLREMKNEASVIA 167
++ K+GEG FG K +L K EI + ++S + + E + E +V++
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLS 54
Query: 168 KVQHKNLVRL------LGC-------C--------IDKDEKILIYEYMPNKSLDFFL--- 203
++H N+V+ G C I+ +L E ++ LD+F+
Sbjct: 55 NMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE---DQILDWFVQIC 111
Query: 204 -------------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 250
++K+ NI L KD K+ DFG+AR+ A T +GT Y+S
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--IGTPYYLS 169
Query: 251 PEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
PE ++ K D+++ G +L E+ + K
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 52/206 (25%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNEI-AVKRL------SGRSGQGLREMKNEASVIAKVQ 170
F N++GEG +G VY+ EI A+K++ G LRE+ +++ ++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI----TLLLNLR 64
Query: 171 HKNLVRLLGCCIDK--DEKILIYEY-----------MPN---------------KSLDF- 201
H N+V L + K D L+ EY MP + L +
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 202 ---FLF--NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY--- 253
F+ +LK SN+LL KI+DFG+AR G + T ++V T Y +PE
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPELLLG 182
Query: 254 AIEGIFSIKFDVFSFGVLLLEIVSGK 279
+I D+++ G +L E+++ K
Sbjct: 183 CTTYTTAI--DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 16/109 (14%)
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSL---DFFLFNLKASNILLDKDMNPKISDFGMARICG 231
V+ C I +L EY+ +K + D +K NILLD+ + I+DF +A
Sbjct: 102 VKFWICEI-----VLALEYLHSKGIIHRD-----IKPDNILLDEQGHVHITDFNIATKVT 151
Query: 232 GNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKK 280
+ L +TS GT GYM+PE +S+ D +S GV E + GK+
Sbjct: 152 PDTLTTSTS---GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 58/220 (26%)
Query: 116 NRFSDANKLGEGGFGPVY--------KGVLRKGNEIAVKRLSGR-SGQGLREMKNEASVI 166
R + LGEG FG V K K +AVK L + + L ++ +E ++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMM 71
Query: 167 AKV-QHKNLVRLLGCCIDKDEKILIYEY--------------------------MPNKSL 199
+ +HKN++ LLG C ++ EY +P + L
Sbjct: 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 200 DF---------------FLF-------NLKASNILLDKDMNPKISDFGMARICGGNELQA 237
F +L +L A N+L+ +D KI+DFG+AR +
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
T+ +M+PE + +++ + DV+SFGVLL EI +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 36/95 (37%), Positives = 58/95 (61%), Gaps = 9/95 (9%)
Query: 186 EKILIYEYMPNKSLDFFLF-NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244
E IL E+M N+ F ++ +LK +NILLD+ + +ISD G+A C ++ + + S VG
Sbjct: 105 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VG 157
Query: 245 TYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSG 278
T+GYM+PE +G + D FS G +L +++ G
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 53/205 (25%)
Query: 124 LGEGGFGPVYKGVLRKGNEI---AVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
LGEG FG V +G L + + I AVK +++ + + + +EA + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 179 GCCIDKDEK------ILIYEYMPNKSLDFFLF---------------------------- 204
G C+ E ++I +M + L FL
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 205 ----------NLKASNILLDKDMNPKISDFGMA-RICGGNEL-QANTSRIVGTYGYMSPE 252
+L A N +L+++MN ++DFG++ +I G+ Q +++ +++ E
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWIAIE 184
Query: 253 YAIEGIFSIKFDVFSFGVLLLEIVS 277
+ +++ K DV+SFGV + EI +
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 47/203 (23%), Positives = 79/203 (38%), Gaps = 45/203 (22%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQ------GLREMKNEASVIAK 168
N++ +GEG +G V K + EI A+K+ LRE+K V+ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK----VLRQ 56
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEYMPN------------------KSLDFFLFN----- 205
++H+N+V L K L++EY+ +S + L
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 206 ---------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE 256
+K NIL+ + K+ DFG AR T V T Y +PE +
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRAPELLVG 175
Query: 257 GI-FSIKFDVFSFGVLLLEIVSG 278
+ DV++ G ++ E++ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 50/212 (23%)
Query: 108 FSSVSTATNRFSDANKLGEGGFGPV--YKGVLRKGNEIAVKRL------SGRSGQGLREM 159
F +V TNR+ D +G G FG V + L G +A+K++ + + RE+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYREL 60
Query: 160 KNEASVIAKVQHKNLVRLLGCCIDKDEKI-LIYEYM-------------PNKSLDFFLF- 204
K ++ ++H+N++ L I E I + E + + + +FL+
Sbjct: 61 K----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ 116
Query: 205 ----------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
+LK SNIL++++ + KI DFG+ARI + V T Y
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYY 171
Query: 249 MSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGK 279
+PE + + ++ D++S G + E++ GK
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 55/187 (29%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKR-LSGRSGQG-----LREMKNEASVIAK 168
+++ K+G+G FG V+K +K +I A+K+ L +G LRE+K ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQL 67
Query: 169 VQHKNLVRLLGCCIDKDEK--------ILIYEY--------MPNKSLDFFL--------- 203
++H+N+V L+ C K L++E+ + NK++ F L
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 204 ---------FN------LKASNILLDKDMNPKISDFGMARICGGNELQAN---TSRIVGT 245
N +KA+NIL+ KD K++DFG+AR ++ T+R+V T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 246 YGYMSPE 252
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 49/201 (24%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG G FG VY G E+AVK++ S + + + ++ E ++ ++H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 178 LGCCIDKDEKIL--IYEYMPNKSLD-------------------------FFLF------ 204
GC D +EK L EYMP S+ +L
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 205 -NLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMSPEYAIEGI 258
++K +NIL D N K+ DFG ++ IC G +++ + GT +MSPE
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS----VTGTPYWMSPEVISGEG 185
Query: 259 FSIKFDVFSFGVLLLEIVSGK 279
+ K DV+S ++E+++ K
Sbjct: 186 YGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-08
Identities = 19/48 (39%), Positives = 30/48 (62%), Gaps = 2/48 (4%)
Query: 353 NEAAALLPPKQPAFSYVRNTV--TSTSSTGKTEDCSINQVTISLLEAR 398
+E + PKQP F R+ S+SST + E ++NQVT+S+++AR
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 41/197 (20%)
Query: 123 KLGEGGFGPVYKGVLRKGN----EIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRL 177
+GEG FG VY+GV +AVK + +RE EA ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 178 LGCCID--------------------------KDEKILIYEYMPNKSL------DFFLFN 205
+G + +++Y Y + +L F +
Sbjct: 73 IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRD 132
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+ A N+L+ K+ DFG++R +A+ ++ +M+PE F+ D
Sbjct: 133 IAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRRFTSASD 190
Query: 265 VFSFGVLLLEIVS-GKK 280
V+ FGV + EI+ G K
Sbjct: 191 VWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 49/201 (24%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG+G FG VY G E+AVK++ S + + + ++ E ++ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 178 LGCCIDKDEKIL--IYEYMPNKS-----------------------LDFFLF-------- 204
GC D E+ L E+MP S L+ +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 205 -NLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMSPEYAIEGI 258
++K +NIL D N K+ DFG ++ IC G +++ + GT +MSPE
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWMSPEVISGEG 185
Query: 259 FSIKFDVFSFGVLLLEIVSGK 279
+ K D++S G ++E+++ K
Sbjct: 186 YGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 58/212 (27%)
Query: 124 LGEGGFGPVYK----GVLRKGNE----IAVKRLSGR-SGQGLREMKNEASVIAKV-QHKN 173
LGEG FG V + G+ + + +AVK L + + L ++ +E ++ + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLF----------------------------- 204
++ LLG C + +I EY +L FL
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 205 -------------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245
+L A N+L+ +D KI+DFG+AR + TS
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199
Query: 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+M+PE + +++ + DV+SFG+L+ EI +
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 49/197 (24%), Positives = 80/197 (40%), Gaps = 47/197 (23%)
Query: 124 LGEGGFGPV------YKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG+GGFG V G + ++ KRL +SG+ + ++ E ++ KV +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKVNSPFIVNL 58
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
K L+ M L + ++N
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 206 --LKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+K N+LLD N ++SD G+A + G ++ GT GYM+PE E +S
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKEEPYSYP 174
Query: 263 FDVFSFGVLLLEIVSGK 279
D F+ G + E+V+G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 51/200 (25%)
Query: 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKN---EASVIAKVQH-KNLVRLL 178
+G G G VYK +K G+ +AVK++ R+G E K + V+ K +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR-RTGNK-EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 179 GC----------------CIDKDEKILIYEYMPN-----------KSLDFFLFN------ 205
G C+DK I +P K+L +
Sbjct: 81 GYFITDSDVFICMELMSTCLDK-LLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHR 139
Query: 206 -LKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY----AIEGIF 259
+K SNILLD N K+ DFG++ R+ + +A T R G YM+PE +
Sbjct: 140 DVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERIDPPDPNPKY 195
Query: 260 SIKFDVFSFGVLLLEIVSGK 279
I+ DV+S G+ L+E+ +G+
Sbjct: 196 DIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 37/201 (18%)
Query: 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLR-EMKNEASVIAKVQH 171
A + + KLGEG + VYKG+ R G +A+K +S ++ +G+ EAS++ ++H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNK---------------SLDFFLF------------ 204
N+V L K+ ++EYM ++ F+F
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 205 -----NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI- 258
+LK N+L+ K++DFG+AR Q +S +V T Y P+ +
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPDVLLGATD 180
Query: 259 FSIKFDVFSFGVLLLEIVSGK 279
+S D++ G + +E++ G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 47/190 (24%), Positives = 87/190 (45%), Gaps = 36/190 (18%)
Query: 123 KLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
K+GEG G V + G ++AVK++ R Q + NE ++ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 182 IDKDEKILIYEYMPNKSLD------------------------FFLFN-------LKASN 210
+ DE ++ E++ +L +L N +K+ +
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 211 ILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFG 269
ILL D K+SDFG A++ E+ S +VGT +M+PE + + D++S G
Sbjct: 149 ILLTSDGRIKLSDFGFCAQV--SKEVPKRKS-LVGTPYWMAPEVISRLPYGTEVDIWSLG 205
Query: 270 VLLLEIVSGK 279
++++E++ G+
Sbjct: 206 IMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 8e-08
Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 44/195 (22%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIA--KVQ-HKNLVRL 177
K+GEG F V K RK G A+K + + L ++ N + A ++ H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 178 LGCCIDKDEKIL----------IYEYMPN------------------KSLDF------FL 203
+ D+ L +YE + KSLD F
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123
Query: 204 FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-EGIFSIK 262
++K NIL+ D K++DFG R G T I T Y +PE + +G + K
Sbjct: 124 RDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLLTDGYYGPK 179
Query: 263 FDVFSFGVLLLEIVS 277
D+++ G + EI+S
Sbjct: 180 MDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 28/76 (36%), Positives = 43/76 (56%), Gaps = 6/76 (7%)
Query: 205 NLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+LK N+LLD + + K++DFGM + I G TS GT Y++PE E ++
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 263 FDVFSFGVLLLEIVSG 278
D ++ GVLL E++ G
Sbjct: 177 VDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 49/202 (24%), Positives = 93/202 (46%), Gaps = 46/202 (22%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLS------GRSGQGLREMKNEASVIAKV 169
++ K+GEG +G V+K R+ +EI A+KR+ G LRE+ ++ ++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKEL 56
Query: 170 QHKNLVRLLGCCIDKDEKILIYEY---------------MPNKSLDFFLF---------- 204
+HKN+VRL + L++EY + + + F+F
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 205 -------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
+LK N+L++K+ K++DFG+AR G ++ ++ +V T Y P+
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWYRPPDVLFGA 174
Query: 258 -IFSIKFDVFSFGVLLLEIVSG 278
++S D++S G + E+ +
Sbjct: 175 KLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 45/194 (23%), Positives = 76/194 (39%), Gaps = 42/194 (21%)
Query: 127 GGFGPVYKGVLRKGNEI-AVKRLSGRSGQG---LREMKNEASVIAKVQHKNLVRLLGCCI 182
G +G V+ + +I A+K + + ++ E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 183 DKDEKILIYEYMPNKSLDFFLFN--------------------------------LKASN 210
K L+ EY+P L L N LK N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 211 ILLDKDMNPKISDFG------MARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
IL+D + + K++DFG + R N+ + RIVGT Y++PE + S D
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVD 183
Query: 265 VFSFGVLLLEIVSG 278
+S G +L E + G
Sbjct: 184 WWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 19/149 (12%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+L A N+L+ + KISDFG++R + S+ +M+ E + I++ + D
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211
Query: 265 VFSFGVLLLEIVS--GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322
V+SFGVLL EIV+ G G NLL ++ +E + E+ Y
Sbjct: 212 VWSFGVLLWEIVTLGGNPYPGIAPERLFNLL-------KTGYRMERPENCSEEMY----- 259
Query: 323 LLRYVNIALLCVQESADDRPTTNDVVSML 351
N+ L C ++ D RPT D+ L
Sbjct: 260 -----NLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 55/204 (26%), Positives = 84/204 (41%), Gaps = 51/204 (25%)
Query: 117 RFSDANKLGEGGFGPVY-----KGV----LRKGNEIAVKRLSGRSGQGLREMKNEASVIA 167
R+ +LG+G FG VY K V L+ EI V L+ + EA +++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLS 57
Query: 168 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL------------------------ 203
K+ H +V+ +++D +I EY + LD L
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 204 ------------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 251
+LKA NI L ++ KI DFG++R+ G+ A T GT YMSP
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSP 174
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEI 275
E + K D++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 36/190 (18%)
Query: 123 KLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
K+GEG G V + G ++AVK + R Q + NE ++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 182 IDKDEKILIYEYMPNKSLDFFLF-------------------------------NLKASN 210
+ +E ++ E++ +L + ++K+ +
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 211 ILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFG 269
ILL D K+SDFG A+I ++ +VGT +M+PE + + D++S G
Sbjct: 148 ILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204
Query: 270 VLLLEIVSGK 279
++++E+V G+
Sbjct: 205 IMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 49/208 (23%), Positives = 92/208 (44%), Gaps = 49/208 (23%)
Query: 117 RFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRL---SGRSGQGLREMKNEASVIAKVQ-- 170
++ ++G G +G VYK G+ +A+K + + G L ++ E +++ +++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAF 59
Query: 171 -HKNLVRLLGCC----IDKDEKI-LIYEYMPN---------------------------K 197
H N+VRL+ C D++ K+ L++E++ +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 198 SLDFFLFN------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 251
LDF N LK NIL+ K++DFG+ARI Q + +V T Y +P
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAP 176
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
E ++ ++ D++S G + E+ K
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 55/202 (27%)
Query: 124 LGEGGFGPVYKGVL--RKGNEI--AVKRLS-----GRSGQGLRE---MKNEASVIAKVQH 171
+G+G FG VY G L G +I AVK L+ Q L+E MK+ H
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKD-------FSH 55
Query: 172 KNLVRLLGCCIDKD-EKILIYEYMPNKSLDFFLFN------------------------- 205
N++ LLG C+ + +++ YM + L F+ +
Sbjct: 56 PNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115
Query: 206 --------LKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYAI 255
L A N +LD+ K++DFG+AR E + N + +M+ E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 256 EGIFSIKFDVFSFGVLLLEIVS 277
F+ K DV+SFGVLL E+++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 63/237 (26%)
Query: 99 EVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVY--------KGVLRKGNEIAVKRLSG 150
E+ + P + FS ++ + LGEG FG V K ++ +AVK L
Sbjct: 3 ELPEDPRWEFSR-----DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57
Query: 151 RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEY--------------- 193
+ + L ++ +E ++ + +HKN++ LLG C +I EY
Sbjct: 58 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117
Query: 194 -----------MPNKSLDF---------------FLF-------NLKASNILLDKDMNPK 220
+P++ + F +L +L A N+L+ ++ K
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMK 177
Query: 221 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
I+DFG+AR + T+ +M+PE + +++ + DV+SFGVL+ EI +
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 30/76 (39%), Positives = 44/76 (57%), Gaps = 4/76 (5%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYAIEGIFSIKF 263
+LK N++LD+D + KI+DFGM C N N S GT Y++PE ++
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 264 DVFSFGVLLLEIVSGK 279
D +SFGVLL E++ G+
Sbjct: 178 DWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 48/206 (23%), Positives = 90/206 (43%), Gaps = 47/206 (22%)
Query: 117 RFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQ 170
R+ + + +GEG +G V G ++A+K++S Q LRE+K ++ + +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61
Query: 171 HKNLVRLLGCCIDKD-----EKILIYEYMP-------------NKSLDFFLF-------- 204
H+N++ +L + ++ E M N + +FL+
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 205 ---------NLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYA 254
+LK SN+LL+ + + KI DFG+ARI + V T Y +PE
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 255 IEG-IFSIKFDVFSFGVLLLEIVSGK 279
+ ++ D++S G +L E++S +
Sbjct: 182 LNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 61/215 (28%)
Query: 117 RFSDANKLGEGGFGPVYKGVLR-----KGNEIAVKRLS-GRSGQGLREMKNEASVIAKVQ 170
R + ++ L EG FG ++ G+L K E+ VK + S + + E+ ++ +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 171 HKNLVRLLGCCI-DKDEKILIYEYMPNKSLDFFLFN------------------------ 205
H+N++ +L CI D + ++Y YM +L FL
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 206 ----------------LKASNILLDKDMNPKISDFGMARI-------CGGNELQANTSRI 242
+ A N ++D+++ KI+D ++R C G+ N +R
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----NENRP 182
Query: 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
V +M+ E + +S DV+SFGVLL E+++
Sbjct: 183 VK---WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 7/93 (7%)
Query: 186 EKILIYEYMPNKSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245
E +L +EY+ +K D +LK N+LLD + K++DFG A+ ++ T + GT
Sbjct: 126 ELVLAFEYLHSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGT 178
Query: 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSG 278
Y++PE D ++ GVLL E ++G
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240
C + +LI+EY+ +SL+ +LK N+LLDKD K++DFG A++ + T
Sbjct: 134 CFYAAQIVLIFEYL--QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTY 186
Query: 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSG 278
+ GT Y++PE + D ++ G+ + EI+ G
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 61/281 (21%), Positives = 117/281 (41%), Gaps = 67/281 (23%)
Query: 115 TNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKN---------EAS 164
F K+G+G F VYK + L G +A+K++ + EM + E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEID 54
Query: 165 VIAKVQHKNLVRLLGCCIDKDEKILIYEY-------------------MPNKSL-DFFL- 203
++ ++ H N+++ L I+ +E ++ E +P +++ +F+
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 204 ---------------FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
++K +N+ + K+ D G+ R A++ +VGT Y
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 249 MSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308
MSPE E ++ K D++S G LL E+ + + + FY D +NL + L + +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFY-GDKMNL----YSLCKKIEKCDY 225
Query: 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349
+ D YS + LR ++ C+ + RP + V+
Sbjct: 226 P-PLPADHYSEE---LR--DLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 41/200 (20%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHK 172
+ + KLGEG + VYKG + G +A+K RL G ++ EAS++ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNK---------------SLDFFLF------------- 204
N+V L K+ L++EY+ ++ FLF
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 205 ----NLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIEGI- 258
+LK N+L+ K++DFG+AR + ++T S V T Y P+ +
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 259 FSIKFDVFSFGVLLLEIVSG 278
+S D++ G + +E++ G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 5e-07
Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 71/219 (32%)
Query: 117 RFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLS--------GRSGQGLREMKNEASVIA 167
R+ +G G +G V V R G ++A+K++S + + LRE+K ++
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK--RILREIK----LLR 54
Query: 168 KVQHKNLVRLLGCCIDKDEK-----ILIYEYMP---------NKSLD-----FFLFN--- 205
++H+N++ LL + ++ E M + L +FL+
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 206 --------------LKASNILLDKDMNPKISDFGMARICGGNELQAN--TSRIVGTYGYM 249
LK SNIL++ + + KI DFG+AR +E + T +V T Y
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYR 173
Query: 250 SPE---------YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+PE AI D++S G + E+++ K
Sbjct: 174 APELLLSSSRYTKAI--------DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 61/275 (22%), Positives = 112/275 (40%), Gaps = 59/275 (21%)
Query: 118 FSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 173
F K+G G F VY+ L G +A+K++ + + E ++ ++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 174 LVRLLGCCIDKDEKILIYEY-------------------MPNKSLDFFLFNLKA------ 208
+++ I+ +E ++ E +P K++ + L +
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 209 SNILLDKDMNP-----------KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
S ++ +D+ P K+ D G+ R A++ +VGT YMSPE E
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHEN 181
Query: 258 IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD--AILED 315
++ K D++S G LL E+ + + + FY D +NL + +E D + D
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQ--SPFY-GDKMNLYSLC-------KKIEQCDYPPLPSD 231
Query: 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350
YS + L + VN +C+ + RP V +
Sbjct: 232 HYS--EELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 46/192 (23%), Positives = 84/192 (43%), Gaps = 41/192 (21%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+LG+G FG VYK ++ +A K + +S + L + E ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 182 IDKDEKILIYEYMPNKSLDFFLF---------------------------------NLKA 208
++ ++ E+ ++D + +LKA
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----EGIFSIKF 263
NIL D + K++DFG++ +Q S +GT +M+PE + + + K
Sbjct: 132 GNILFTLDGDIKLADFGVSAK-NTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPYDYKA 189
Query: 264 DVFSFGVLLLEI 275
DV+S G+ L+E+
Sbjct: 190 DVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 11/87 (12%)
Query: 201 FFLFN-------LKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPE 252
FFL + LK N++LD + + KI+DFGM C N T+R GT Y++PE
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCGTPDYIAPE 171
Query: 253 YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ D ++FGVLL E+++G+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 48/211 (22%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
R+ D LG G G V+ V +AVK++ Q ++ E +I ++ H N+V
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 176 RLL------GCCIDKDEKIL-----IY---EYM-------------PNKSLDFFLF---- 204
++ G + +D L +Y EYM + F++
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 205 -------------NLKASNILLD-KDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYM 249
+LK +N+ ++ +D+ KI DFG+ARI + + S + T Y
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 250 SPEYAIE-GIFSIKFDVFSFGVLLLEIVSGK 279
SP + ++ D+++ G + E+++GK
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 40/201 (19%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKR---LSGRSGQGLREMKNEASVIAKVQHKN 173
R+ K+GEG FG +Y + +E V + L+ + K E ++AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 174 LVRLLGCCIDKDEKILIYEYM------------------PNKSLDFFL------------ 203
+V + ++ EY ++ L +F+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 204 ----FNLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI 258
++K+ NI L K+ M K+ DFG+AR + A T VGT Y+SPE
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPYYLSPEICQNRP 178
Query: 259 FSIKFDVFSFGVLLLEIVSGK 279
++ K D++S G +L E+ + K
Sbjct: 179 YNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 4/75 (5%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+L A NILL ++ KI DFG+AR + ++ +R+ +M+PE + +++ +
Sbjct: 198 DLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQ 255
Query: 263 FDVFSFGVLLLEIVS 277
DV+SFGVLL EI S
Sbjct: 256 SDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 53/199 (26%)
Query: 124 LGEGGFGPVYKGVL----RKGNEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
LG G FG + +G L ++ +A+ L +G S + R EA + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLF---------------------------------N 205
G + +++ EYM N +LD FL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKG 132
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYG------YMSPEYAIEGI 258
L A +L++ D+ KIS F LQ + S I T + +PE
Sbjct: 133 LAAHKVLVNSDLVCKISGFR--------RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 259 FSIKFDVFSFGVLLLEIVS 277
FS DV+SFG+++ E++S
Sbjct: 185 FSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 57/266 (21%), Positives = 108/266 (40%), Gaps = 45/266 (16%)
Query: 120 DANKLGEGGFGPVYKGVLRKGN-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+ N + G G YKG K + VK + + E + + K+QH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPSS--EIADMGKLQHPNIVKLI 749
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLFNL---------------------KASNILLDKDM 217
G C + LI+EY+ K+L L NL + S ++ ++
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809
Query: 218 NPK---ISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLL 273
+P+ I + L ++ + Y++PE + K D++ FG++L+
Sbjct: 810 SPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILI 869
Query: 274 EIVSGKKNTGFYRTDTLNLLGYA--------WDLWRSNRTLELTDAILEDEYSSKQVLLR 325
E+++GK +++ +A D+W + +I D ++ ++
Sbjct: 870 ELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW-------IDPSIRGDVSVNQNEIVE 922
Query: 326 YVNIALLCVQESADDRPTTNDVVSML 351
+N+AL C RP NDV+ L
Sbjct: 923 VMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 32/97 (32%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 198 SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
SL +LK NILLD++ + K++DFG+++ +E +A + GT YM+PE
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRR 173
Query: 258 IFSIKFDVFSFGVLLLEIVSGK-KNTGFYRTDTLNLL 293
+ D +SFGVL+ E+++G G R +T+ ++
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 57/207 (27%)
Query: 123 KLGEGGFGPVYKGV-LRKGNEIAVK--RLS----GRSGQGLREMKNEASVIAKVQHKN-L 174
K+GEG +G VYK G +A+K RL G LRE+ S++ + +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI----SLLQMLSESIYI 63
Query: 175 VRLLGC--CIDKDEKILIY---EY-------------------MPNKSLDFFLF------ 204
VRLL +K+ K +Y EY +P K++ F++
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 205 -----------NLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPE 252
+LK N+L+DK KI+D G+ R +++ T IV T Y +PE
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIV-TLWYRAPE 181
Query: 253 YAIEGI-FSIKFDVFSFGVLLLEIVSG 278
+ +S D++S G + E+
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 49/212 (23%)
Query: 110 SVSTATNRFSDANKLGEGGFGPV---YKGVLRKGNEIAVKRLSGRSGQGLREMKN---EA 163
S T R+ + +G G G V Y V G +A+K+LS R Q + K E
Sbjct: 10 STFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLS-RPFQNVTHAKRAYREL 66
Query: 164 SVIAKVQHKNLVRLLGCCI------DKDEKILIYEYMP------------NKSLDFFLF- 204
++ V HKN++ LL + + L+ E M ++ + + L+
Sbjct: 67 VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ 126
Query: 205 ----------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
+LK SNI++ D KI DFG+AR G + + T +V Y Y
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 183
Query: 249 MSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGK 279
+PE I G+ + D++S G ++ E++ G
Sbjct: 184 RAPE-VILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 61/210 (29%)
Query: 124 LGEGGFGPVYKGVLR---------KGNEIAVKR-LSGRSGQGLREMKNEASVIAKVQHKN 173
LG+G F +YKGVLR G E++V + G + AS+++++ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLF----------------------------- 204
LV+L G C+ +DE I++ EY+ LD FL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 205 ----NLKASNILLDK-DMNP------KISDFGMARICGGNELQANTSRIVGTYGYMSPEY 253
N+ NIL+ + +N K+SD G+ E + RI +++PE
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER--VERI----PWIAPEC 175
Query: 254 AIEGIFS---IKFDVFSFGVLLLEIVSGKK 280
I + I D +SFG LLEI S +
Sbjct: 176 -IRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 10/100 (10%)
Query: 186 EKILIYEYMPNKSLDFFLF------NLKASNILLDKDMNPKISDFGMARIC--GGNELQA 237
E ++ Y + K ++F +L A NILL ++ KI DFG+AR + ++
Sbjct: 179 EDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238
Query: 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+R+ +M+PE + +++I+ DV+SFGVLL EI S
Sbjct: 239 GDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 48/214 (22%), Positives = 79/214 (36%), Gaps = 50/214 (23%)
Query: 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHK 172
T F +GEG +G VYK +K ++ ++ E+K E +++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63
Query: 173 NLVRLLGCCIDKDEKI------LIYEY--------------MPNKSLD------------ 200
N+ G I K+ L+ E K L
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 201 ---FFLFN-------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 250
+L +K NILL K+ K+ DFG++ + NT +GT +M+
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGTPYWMA 181
Query: 251 PE-----YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
PE + + + DV+S G+ +E+ GK
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 6/77 (7%)
Query: 205 NLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+LK NILLD + + K++DFGM + I G T+ GT Y++PE E +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEILQELEYGPS 176
Query: 263 FDVFSFGVLLLEIVSGK 279
D ++ GVL+ E+++G+
Sbjct: 177 VDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 124 LGEGGFGPVYKGVLRK--------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
LG+G F ++KG+ R+ E+ +K L AS+++++ HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFL 203
G C+ DE I++ EY+ SLD +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL 90
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 49/218 (22%)
Query: 117 RFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKN---EASVIAKVQHK 172
R+ + + +G G +G V + G +AVK+LS R Q + K E ++ ++H+
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 173 NLVRLLGC-----------------------------C---IDKDEKILIYEYMPN---- 196
N++ LL C D + LIY+ +
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 136
Query: 197 KSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE 256
S D +LK SN+ +++D KI DFG+AR + V T Y +PE +
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLN 191
Query: 257 GI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL 293
+ ++ D++S G ++ E+++G+ T F TD ++ L
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 31/87 (35%), Positives = 44/87 (50%), Gaps = 7/87 (8%)
Query: 124 LGEGGFGPVYKGVL-----RKG-NEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
LGEG FG V K R G +AVK L S LR++ +E +++ +V H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL 203
L G C +LI EY SL FL
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFL 94
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 46/204 (22%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQ------GLREMKNEASVIAK 168
N+F +GEG +G V K ++ EI A+K+ LRE+K ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEY-----------MPN-------KSLDFFLF------ 204
++ +N+V L + + L++EY MPN +S + L
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 205 --------NLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAI 255
++K N+L+ + K+ DFG AR + G+ AN + V T Y SPE +
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLL 174
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGK 279
+ D++S G +L E+ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 63/282 (22%), Positives = 116/282 (41%), Gaps = 72/282 (25%)
Query: 124 LGEGGFGPVYKGVLRK----GNEIAVKRLSGRS---GQGLRE-------MKNEASVIAK- 168
LG G FG VYK +RK N +A+K ++ + G+ RE + +E ++I +
Sbjct: 8 LGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFF--------------LFN-------- 205
++H N+VR ++ D ++ + + L + F ++N
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 206 --------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 251
L +NI+L +D I+DFG+A+ + +VGT Y P
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCP 182
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311
E + K DV++FG +L ++ + FY T+ L+L + + +E
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNMLSL---------ATKIVEAVYE 231
Query: 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
L + S+ V + C+ A+ RP V +M+++
Sbjct: 232 PLPEGMYSEDVTD----VITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 16/103 (15%)
Query: 186 EKILIYEYMPNKSLDFFLF------NLKASNILLDKDMNPKISDFGMARICGGNELQANT 239
E +L + Y K + F +L A NILL KI DFG+AR +++ ++
Sbjct: 214 EDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDS 268
Query: 240 SRIVGTYG-----YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+ +V +M+PE +++ + DV+S+G+LL EI S
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 26/76 (34%), Positives = 45/76 (59%), Gaps = 4/76 (5%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYAIEGIFSIKF 263
+LK N++LD + + KI+DFGM C + + T+R GT Y++PE +
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGM---CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 264 DVFSFGVLLLEIVSGK 279
D +++GVLL E+++G+
Sbjct: 183 DWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 27/76 (35%), Positives = 44/76 (57%), Gaps = 4/76 (5%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYAIEGIFSIKF 263
+LK N++LD + + KI+DFGM C N T++ GT Y++PE +
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGM---CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 264 DVFSFGVLLLEIVSGK 279
D ++FGVLL E+++G+
Sbjct: 183 DWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 59/267 (22%), Positives = 109/267 (40%), Gaps = 59/267 (22%)
Query: 118 FSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 173
F K+G G F VY+ L +A+K++ + ++ E ++ ++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 174 LVRLLGCCIDKDEKILIYEY-------------------MPNKSLDFFLFNLKA------ 208
+++ L I+ +E ++ E +P +++ + L +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 209 SNILLDKDMNP-----------KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
S ++ +D+ P K+ D G+ R A++ +VGT YMSPE E
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHEN 181
Query: 258 IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD--AILED 315
++ K D++S G LL E+ + + FY D +NL + +E D + +
Sbjct: 182 GYNFKSDIWSLGCLLYEMAA--LQSPFY-GDKMNLFSLC-------QKIEQCDYPPLPTE 231
Query: 316 EYSSKQVLLRYVNIALLCVQESADDRP 342
YS K LR + +C+ D RP
Sbjct: 232 HYSEK---LR--ELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 10/100 (10%)
Query: 186 EKILIYEYMPNKSLDFFLF------NLKASNILLDKDMNPKISDFGMARIC--GGNELQA 237
E ++ Y + + ++F +L A NILL ++ KI DFG+AR + ++
Sbjct: 174 EDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 233
Query: 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
++R+ +M+PE + +++ + DV+SFGVLL EI S
Sbjct: 234 GSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 50/198 (25%), Positives = 72/198 (36%), Gaps = 50/198 (25%)
Query: 124 LGEGGFGPV----YKG--------VLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQH 171
LG G FG V YK L+KG+ IA + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV-----ESLMCEKRIFETANSERH 61
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNK-------------------------SLDFFLFN- 205
LV L C +D + EY L + N
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 206 -----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
LK N+LLD + KI+DFG+ + G TS GT +++PE E ++
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 261 IKFDVFSFGVLLLEIVSG 278
D + GVL+ E++ G
Sbjct: 180 RAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 46/212 (21%), Positives = 90/212 (42%), Gaps = 54/212 (25%)
Query: 118 FSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQH 171
F+ LG+G FG V + L+ ++AVK L S + E EA+ + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 172 KNLVRLLGCCIDKDEK------ILIYEYMPNKSLDFFLF--------------------- 204
N+++L+G + K ++I +M + L FL
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 205 -----------------NLKASNILLDKDMNPKISDFGMAR-ICGGNEL-QANTSRIVGT 245
+L A N +L+++M ++DFG+++ I G+ Q S++
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--P 178
Query: 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+++ E + +++ DV++FGV + EI++
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 47/210 (22%)
Query: 110 SVSTATNRFSDANKLGEGGFGPV---YKGVLRKGNEIAVKRLSGRSGQGLREMKN---EA 163
S T R+ +G G G V + VL G +AVK+LS R Q K E
Sbjct: 15 STFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-RPFQNQTHAKRAYREL 71
Query: 164 SVIAKVQHKNLVRLLGC------------------CIDKDEKILIYEYMPNKSLDFFLF- 204
++ V HKN++ LL +D + +I+ + ++ + + L+
Sbjct: 72 VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQ 131
Query: 205 ----------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
+LK SNI++ D KI DFG+AR N + T +V Y Y
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-Y 188
Query: 249 MSPEYAIEGIFSIKFDVFSFGVLLLEIVSG 278
+PE + + D++S G ++ E+V G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 41/195 (21%)
Query: 122 NKLGEGGFGPVYKGVLR-KGNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+KLGEG + VYKG + N +A+K RL G ++ E S++ ++H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 179 GCCIDKDEKILIYEYMPNK---------------SLDFFLF-----------------NL 206
+ L++EY+ ++ FLF +L
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIEGI-FSIKFD 264
K N+L+++ K++DFG+AR + T S V T Y P+ + +S + D
Sbjct: 131 KPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 265 VFSFGVLLLEIVSGK 279
++ G + E+ +G+
Sbjct: 188 MWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 25/75 (33%), Positives = 44/75 (58%), Gaps = 4/75 (5%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
++K SNIL++ K+ DFG++ G + + + VGT YMSPE +S++ D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 265 VFSFGVLLLEIVSGK 279
++S G+ L+E+ G+
Sbjct: 185 IWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 48/227 (21%)
Query: 95 NKKKEVDQFPLFSF-SSVSTATNRFSDANKLGEGGFGPV---YKGVLRKGNEIAVKRLSG 150
++ K + F S T R+ + +G G G V Y +L + +A+K+LS
Sbjct: 2 SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLS- 58
Query: 151 RSGQGLREMKN---EASVIAKVQHKNLVRLLGC------------------CIDKDEKIL 189
R Q K E ++ V HKN++ LL +D + +
Sbjct: 59 RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV 118
Query: 190 IYEYMPNKSLDFFLF-----------------NLKASNILLDKDMNPKISDFGMARICGG 232
I + ++ + + L+ +LK SNI++ D KI DFG+AR G
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
Query: 233 NELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ + T +V Y Y +PE + + D++S G ++ E++ G
Sbjct: 179 SFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 3/76 (3%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY--AIEGIFSIK 262
++K NILLD + + ++DFG+++ E + S GT YM+PE G
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKA 188
Query: 263 FDVFSFGVLLLEIVSG 278
D +S GVL E+++G
Sbjct: 189 VDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 25/75 (33%), Positives = 44/75 (58%), Gaps = 4/75 (5%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
++K SNIL++ K+ DFG++ G + + + VGT YMSPE +S++ D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 265 VFSFGVLLLEIVSGK 279
++S G+ L+E+ G+
Sbjct: 185 IWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 45/201 (22%), Positives = 81/201 (40%), Gaps = 48/201 (23%)
Query: 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 182
+G G +G VYKG K ++A ++ +G E+K E +++ K H+N+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 183 DK------DEKILIYEYMPNKSLDFFLFN------------------------------- 205
K D+ L+ E+ S+ + N
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----EG 257
+K N+LL ++ K+ DFG++ + NT +GT +M+PE +
Sbjct: 134 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDA 191
Query: 258 IFSIKFDVFSFGVLLLEIVSG 278
+ K D++S G+ +E+ G
Sbjct: 192 TYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 4/75 (5%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
++K SNIL++ K+ DFG++ G + + + VGT YMSPE ++++ D
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSD 180
Query: 265 VFSFGVLLLEIVSGK 279
++S G+ L+E+ G+
Sbjct: 181 IWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 25/75 (33%), Positives = 42/75 (56%), Gaps = 2/75 (2%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LK N+LLD D + K++D+GM + G TS GT Y++PE + D
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 265 VFSFGVLLLEIVSGK 279
++ GVL+ E+++G+
Sbjct: 179 WWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 58/262 (22%), Positives = 102/262 (38%), Gaps = 56/262 (21%)
Query: 124 LGEGGFGPVYKG-VLRKGNEIAVKRLSGRSGQGL-REMKNEASVIAKVQHKNLVRLLGCC 181
LG G G VYK L +AVK + L +++ +E ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 182 IDKDEKILIYEYMPNKSLDFF---------------------LFNLK-------ASNILL 213
++ + E+M SLD + L++LK SN+L+
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV 128
Query: 214 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLL 273
+ K+ DFG++ + + VGT YM+PE + I DV+S G+ +
Sbjct: 129 NTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 274 EIVSGK-------KNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326
E+ G+ KN G L LL D E + ++S K +
Sbjct: 185 ELALGRFPYPQIQKNQGSLM--PLQLLQCIVD--------EDPPVLPVGQFSEK-----F 229
Query: 327 VNIALLCVQESADDRPTTNDVV 348
V+ C+++ +RP +++
Sbjct: 230 VHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 47/211 (22%)
Query: 110 SVSTATNRFSDANKLGEGGFGPV---YKGVLRKGNEIAVKRLSGRSGQGLREMKN---EA 163
S T R+ + +G G G V Y VL + +A+K+LS R Q K E
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLS-RPFQNQTHAKRAYREL 67
Query: 164 SVIAKVQHKNLVRLLGCCIDK------DEKILIYEYMP------------NKSLDFFLF- 204
++ V HKN++ LL + + L+ E M ++ + + L+
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 127
Query: 205 ----------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
+LK SNI++ D KI DFG+AR G + + T +V Y Y
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184
Query: 249 MSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+PE + + D++S G ++ E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 44/200 (22%), Positives = 90/200 (45%), Gaps = 40/200 (20%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKR-LSGRSGQGLREMK-NEASVIAKVQHK 172
++ + +GEG +G V K ++ +I A+K+ L + ++++ E ++ +++H+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLD---------------FFLF------------- 204
NLV L+ K L++E++ + LD +LF
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 205 ----NLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIEGI- 258
++K NIL+ + K+ DFG AR + E+ + V T Y +PE +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLVGDTK 177
Query: 259 FSIKFDVFSFGVLLLEIVSG 278
+ D+++ G L+ E+++G
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 41/195 (21%)
Query: 122 NKLGEGGFGPVYKGVLR-KGNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
KLGEG + V+KG + N +A+K RL G ++ E S++ ++H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 179 GCCIDKDEKILIYEY---------------MPNKSLDFFLF-----------------NL 206
L++EY M ++ FL+ +L
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAI-EGIFSIKFD 264
K N+L+++ K++DFG+AR + T S V T Y P+ + +S + D
Sbjct: 131 KPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 265 VFSFGVLLLEIVSGK 279
++ G + E+ SG+
Sbjct: 188 MWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 70/213 (32%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVKRLSG------------RSGQGLREMKNEASVIAK 168
KLG+G +G V+K + R+ E+ A+K++ R L+E+ +
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65
Query: 169 VQHKNLVRLLGCC-IDKDEKI-LIYEYMPN----------------KSLDFFLFN----- 205
H N+V+LL + D+ I L++EYM + + + L
Sbjct: 66 --HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYI 123
Query: 206 ---------LKASNILLDKDMNPKISDFGMAR-ICGGNELQANT--SRIVGTYGYMSPE- 252
LK SNILL+ D K++DFG+AR + E N + V T Y +PE
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 253 ------YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
Y +G+ D++S G +L E++ GK
Sbjct: 184 LLGSTRYT-KGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 48/230 (20%), Positives = 92/230 (40%), Gaps = 70/230 (30%)
Query: 115 TNRFSDANK-LGEGGFGPVYKGV-LRKGNEIAVKRL------SGRSGQG----------- 155
+ R+ LGEG +G V K G +A+K++ + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 156 -LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN---KSLD----------- 200
LRE+K ++ +++H+N++ L+ ++ D L+ + M + K +D
Sbjct: 67 TLRELK----IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVK 122
Query: 201 ----------------FFLF-NLKASNILLDKDMNPKISDFGMARICGGNELQAN----- 238
+F+ +L +NI ++ KI+DFG+AR G
Sbjct: 123 CILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 239 --------TSRIVGTYGYMSPEYAI-EGIFSIKFDVFSFGVLLLEIVSGK 279
TS++V T Y +PE + + D++S G + E+++GK
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 41/195 (21%)
Query: 122 NKLGEGGFGPVYKGVLR-KGNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+KLGEG + V+KG + N +A+K RL G ++ E S++ ++H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 179 GCCIDKDEKILIYEYMPNK---------------SLDFFLF-----------------NL 206
+ L++EY+ + ++ F+F +L
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIEGI-FSIKFD 264
K N+L+++ K++DFG+AR + T S V T Y P+ + +S D
Sbjct: 130 KPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 265 VFSFGVLLLEIVSGK 279
++ G +L E+ +G+
Sbjct: 187 MWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 43/195 (22%), Positives = 84/195 (43%), Gaps = 40/195 (20%)
Query: 118 FSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
F ++G G +G VYK + G A+K + G+ ++ E ++ +H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 177 LLGCCIDKDEKILIYEYMPNKSLD-------------------------FFLFN------ 205
G + +D+ + E+ SL ++L +
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130
Query: 206 -LKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAI---EGIFS 260
+K +NILL + + K++DFG+ A+I A +GT +M+PE A +G ++
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 261 IKFDVFSFGVLLLEI 275
D+++ G+ +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 24/75 (32%), Positives = 42/75 (56%), Gaps = 2/75 (2%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LK N+LLD + + K++D+GM + G TS GT Y++PE + D
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 265 VFSFGVLLLEIVSGK 279
++ GVL+ E+++G+
Sbjct: 179 WWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 4/84 (4%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LK N++LDKD + KI+DFG+ + G + A GT Y++PE + + D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTD 288
+ GV++ E++ G+ FY D
Sbjct: 179 WWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 59/211 (27%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGL-------REMKNEASVIA 167
+R+ + + +G G +G V K G ++A+K+LS R Q RE++ ++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELR----LLK 69
Query: 168 KVQHKNLVRLLGCC-------------------------IDK-----DEKI--LIYE--- 192
+ H+N++ LL I K D+ I L+Y+
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 193 ---YMPNKSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 249
Y+ S +LK SNI +++D KI DFG+AR + V T Y
Sbjct: 130 GLKYI--HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYR 182
Query: 250 SPEYAIEGI-FSIKFDVFSFGVLLLEIVSGK 279
+PE + + ++ D++S G ++ E+++GK
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 192 EYMPNKSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 251
EY+ S D ++K N++LDKD + KI+DFG+ + G A GT Y++P
Sbjct: 109 EYL--HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 164
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD 288
E + + D + GV++ E++ G+ FY D
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LK N++LDKD + KI+DFG+ + G A GT Y++PE + + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTD 288
+ GV++ E++ G+ FY D
Sbjct: 178 WWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 24/75 (32%), Positives = 43/75 (57%), Gaps = 8/75 (10%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF- 263
++K N+L+D+ + K++DFG++R N+ + VGT Y++PE I G+ K
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDKMS 174
Query: 264 DVFSFGVLLLEIVSG 278
D +S G ++ E + G
Sbjct: 175 DWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 51/206 (24%)
Query: 117 RFSDANKLGEGGFGPV---YKGVLRKGNEIAVKRLSGRSGQGL---REMKNEASVIAKVQ 170
R+ + +G G +G V Y LR+ ++AVK+LS R Q L R E ++ ++
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKLS-RPFQSLIHARRTYRELRLLKHMK 72
Query: 171 HKNLVRLLG------------------------------CCIDKDEKI--LIYEYMPN-- 196
H+N++ LL C DE + LIY+ +
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132
Query: 197 --KSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 254
S +LK SN+ +++D +I DFG+AR + + V T Y +PE
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIM 187
Query: 255 IEGI-FSIKFDVFSFGVLLLEIVSGK 279
+ + ++ D++S G ++ E++ GK
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 205 NLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
++ A N+LL KI DFG+AR + N + +R+ +M+PE + +++++
Sbjct: 237 DVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQ 294
Query: 263 FDVFSFGVLLLEIVS-GKK-------NTGFYR 286
DV+S+G+LL EI S GK N+ FY+
Sbjct: 295 SDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 46/202 (22%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ------GLREMKNEASVIAKV 169
++ +K+GEG +G V+K R+ G +A+K+ LRE++ ++ ++
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQL 57
Query: 170 QHKNLVRLLGCCIDKDEKILIYEYM-----------PN---------------KSLDF-- 201
+H NLV L+ K + L++EY P ++++F
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 202 ----FLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-E 256
++K NIL+ K K+ DFG ARI G + + V T Y +PE + +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGD 175
Query: 257 GIFSIKFDVFSFGVLLLEIVSG 278
+ DV++ G + E+++G
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+LK N++LDKD + KI+DFG+ + G A GT Y++PE + + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTD 288
+ GV++ E++ G+ FY D
Sbjct: 178 WWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQAN--TSRIVGTYGYMSPEYAI-EGIFSI 261
+LK NILLD + + DFG+++ L N T+ GT Y++PE + E ++
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK----ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 262 KFDVFSFGVLLLEIVSGKKNTGFYRTDT 289
D +S GVL+ E+ G + FY DT
Sbjct: 177 HVDFWSLGVLVFEMCCGW--SPFYAEDT 202
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 2/81 (2%)
Query: 198 SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
+ +LK NILLD + + DFG+ ++ ++ + NT GT Y++PE +
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGH 168
Query: 258 IFSIKFDVFSFGVLLLEIVSG 278
++ D ++ GVLL E+++G
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 25/77 (32%), Positives = 44/77 (57%), Gaps = 6/77 (7%)
Query: 205 NLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+LK N+LLD + + K++D+GM + I G+ TS GT Y++PE +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 263 FDVFSFGVLLLEIVSGK 279
D ++ GVL+ E+++G+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 48/198 (24%)
Query: 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVR---- 176
+G+G +G V R G + +K+L+ R S + + + EA ++++++H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 177 ----------LLGCCIDKDEKILIY--------EYMP-NKSLDFFL-------------- 203
++G C D +Y + +P N+ +++F+
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 204 --FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSI 261
+LK N+ L + K+ D G+AR+ A+T ++GT YMSPE ++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 262 KFDVFSFGVLLLEIVSGK 279
K DV++ G + E+ + K
Sbjct: 182 KSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 26/74 (35%), Positives = 42/74 (56%), Gaps = 2/74 (2%)
Query: 205 NLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
+L A N+LL + KI DFG+AR I + + S + +M+PE + +++
Sbjct: 262 DLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV-KWMAPESIFDNLYTTLS 320
Query: 264 DVFSFGVLLLEIVS 277
DV+S+G+LL EI S
Sbjct: 321 DVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 12/79 (15%)
Query: 205 NLKASNILLDKDMNPKISDFGMAR------ICGGNELQANTSRIVGTYGYMSPEYAIEGI 258
+L N L+ ++M KI+DFG++R +E A R +M PE
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR------WMPPESIFYNR 208
Query: 259 FSIKFDVFSFGVLLLEIVS 277
++ + DV+++GV+L EI S
Sbjct: 209 YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 43/189 (22%), Positives = 79/189 (41%), Gaps = 38/189 (20%)
Query: 123 KLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
++G G +G VYK L G AVK + G ++ E ++ + +H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 182 IDKDEKILIYEYMPNKSL-DFFLF-------------------------------NLKAS 209
+ +++ + EY SL D + ++K +
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGA 135
Query: 210 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI---EGIFSIKFDVF 266
NILL + + K++DFG+A A +GT +M+PE A G ++ D++
Sbjct: 136 NILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIW 193
Query: 267 SFGVLLLEI 275
+ G+ +E+
Sbjct: 194 AVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 52/219 (23%)
Query: 117 RFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQG---LREMKNEASVIAKVQHK 172
R++ ++G G +G V + R G ++A+K+LS R Q + E +++ +QH+
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 173 NLVRLLGCCIDK-----------------------------DEKI--LIYEYMPNKSLDF 201
N++ LL ++K+ L+Y+ + L +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML--CGLKY 132
Query: 202 FLF------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 255
+LK N+ +++D KI DFG+AR A + V T Y +PE +
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVIL 187
Query: 256 EGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL 293
+ ++ D++S G ++ E+++GK T F D L+ L
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK--TLFKGKDYLDQL 224
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 52/279 (18%), Positives = 95/279 (34%), Gaps = 59/279 (21%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIA---VKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 177
+++G G FG V G +G A VK L + E ++ H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 178 LGCCIDKDEKILIYEYMPNKSL-------------------------------------D 200
LG CI+ +L+ E+ P L D
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 201 FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
F +L N L D++ KI D+G+A + +++PE
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180
Query: 261 IKF-------DVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313
+ +++S GV + E+ + + +L + ++L L
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWEL-FTAADQPYPDLSDEQVLKQV----VREQDIKLPKPQL 235
Query: 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352
+ +YS R+ + C + + RPT +V +LT
Sbjct: 236 DLKYSD-----RWYEVMQFCWLDP-ETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 49/224 (21%), Positives = 99/224 (44%), Gaps = 61/224 (27%)
Query: 117 RFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRL---------SGRSGQGLREMKNEASVI 166
R+ D ++G G +G V + R G ++A+K+L + R+ + LR +K+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH----- 70
Query: 167 AKVQHKNLVRLLGC-----CIDKDE--------------KILIYEYMPNKSLDFFLF--- 204
++H+N++ LL +D+ K++ +E + + F ++
Sbjct: 71 --MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 205 --------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 250
+LK N+ +++D KI DFG+AR + + + V T Y +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRA 183
Query: 251 PEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL 293
PE + + ++ D++S G ++ E+++GK F D L+ L
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK--PLFKGHDHLDQL 225
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 41/193 (21%)
Query: 123 KLGEGGFGPVYKGVLR-KGNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 179
KLGEG + VYKG + G +A+K RL G ++ EAS++ ++H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 180 CCIDKDEKILIYEYM-----------PN----KSLDFFLF-----------------NLK 207
K L++EY+ ++ FLF +LK
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLK 130
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIEGI-FSIKFDV 265
N+L+ + K++DFG+AR + + T S V T Y P+ + +S D+
Sbjct: 131 PQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDM 187
Query: 266 FSFGVLLLEIVSG 278
+ G + E+ +G
Sbjct: 188 WGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 50/199 (25%)
Query: 124 LGEGGFGPVYKGVLRK------GNEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKN 173
LG+GG+G V++ +RK G A+K L R+ + K E +++ V+H
Sbjct: 4 LGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSL---------------DFFLF-------------- 204
+V L+ + LI EY+ L F+L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 205 ---NLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
+LK NILLD + K++DFG+ + I G T GT YM+PE +
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEILMRSGH 177
Query: 260 SIKFDVFSFGVLLLEIVSG 278
D +S G L+ ++++G
Sbjct: 178 GKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 24/82 (29%), Positives = 46/82 (56%), Gaps = 13/82 (15%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV--GTYGYMSPEYAIEGI---- 258
++K SN+L++++ K+ DFG I G L + ++ + G YM+PE I
Sbjct: 129 DVKPSNVLINRNGQVKLCDFG---ISG--YLVDSVAKTIDAGCKPYMAPE-RINPELNQK 182
Query: 259 -FSIKFDVFSFGVLLLEIVSGK 279
+ +K DV+S G+ ++E+ +G+
Sbjct: 183 GYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 198 SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
SL+ +LK NILLD + ++DFG+ + G E + TS GT Y++PE +
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 258 IFSIKFDVFSFGVLLLEIVSG 278
+ D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 53/205 (25%), Positives = 82/205 (40%), Gaps = 50/205 (24%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 177
+G G FG V + ++ A+K LS RS E ++A + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIVQL 108
Query: 178 LGCCIDKDEKIL--IYEYMPN-------------------------------KSLDFFLF 204
+D+K L + EYMP S+ F
Sbjct: 109 --HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHR 166
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY----AIEGIFS 260
++K N+LLDK + K++DFG N + VGT Y+SPE +G +
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFY 285
+ D +S GV L E++ G +T FY
Sbjct: 226 RECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 24/76 (31%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI--EGIFSIK 262
++K NILLD + + ++DFG+++ +E++ S GT YM+P+ +G
Sbjct: 130 DIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRGGDGGHDKA 188
Query: 263 FDVFSFGVLLLEIVSG 278
D +S GVL+ E+++G
Sbjct: 189 VDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 31/87 (35%), Positives = 52/87 (59%), Gaps = 10/87 (11%)
Query: 205 NLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY--AIE---GI 258
++K N+LLDK+ + +++DFG R+ +Q+N + VGT Y+SPE A+E G
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYISPEILQAMEDGKGR 184
Query: 259 FSIKFDVFSFGVLLLEIVSGKKNTGFY 285
+ + D +S GV + E++ G+ T FY
Sbjct: 185 YGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 26/77 (33%), Positives = 45/77 (58%), Gaps = 2/77 (2%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYAIEGIFSIKF 263
++K++NILL + K+ DFG +++ + + R GT Y++PE +S K
Sbjct: 168 DIKSANILLCSNGLVKLGDFGFSKMYA-ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA 226
Query: 264 DVFSFGVLLLEIVSGKK 280
D+FS GVLL E+++ K+
Sbjct: 227 DMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 2/75 (2%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
++K+ NI L ++ K+ DFG AR+ A T VGT Y+ PE ++ K D
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSD 182
Query: 265 VFSFGVLLLEIVSGK 279
++S G +L E+ + K
Sbjct: 183 IWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 198 SLDFFLFNLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY--- 253
S+ F ++K N+LLDK + K++DFG ++ ++ +T+ VGT Y+SPE
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKS 217
Query: 254 -AIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFY 285
+G + + D +S GV L E++ G +T FY
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 4/92 (4%)
Query: 198 SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
SL+ +LK NILLD + ++DFG+ + G E TS GT Y++PE +
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 258 IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT 289
+ D + G +L E++ G FY DT
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP--FYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 7/79 (8%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY-AIEGIFSIKF 263
++K +NILL + K+ DFG++ L+ NTS VGT +M+PE A E + +
Sbjct: 153 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSY 210
Query: 264 ----DVFSFGVLLLEIVSG 278
DV+S G+ +E+ G
Sbjct: 211 DARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 198 SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYAIE 256
SL+ +LK NILLD + ++DFG+ C N E TS GT Y++PE +
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 257 GIFSIKFDVFSFGVLLLEIVSG-----KKNTGFYRTDTLN 291
+ D + G +L E++ G +NT + LN
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 43/201 (21%), Positives = 82/201 (40%), Gaps = 48/201 (23%)
Query: 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 182
+G G +G VYKG K ++A ++ + E+K E +++ K H+N+ G I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 183 DK------DEKILIYEYMPNKSL--------------DFFLF------------------ 204
K D+ L+ E+ S+ D+ +
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVI 143
Query: 205 --NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----EG 257
++K N+LL ++ K+ DFG++ + NT +GT +M+PE +
Sbjct: 144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDA 201
Query: 258 IFSIKFDVFSFGVLLLEIVSG 278
+ + D++S G+ +E+ G
Sbjct: 202 TYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 16/89 (17%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTS-----------RIVGTYGY 248
+LK NILL I D+G A E + + +IVGT Y
Sbjct: 138 DLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDY 197
Query: 249 MSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
M+PE + S D+++ GV+L ++++
Sbjct: 198 MAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 21/76 (27%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI-FSIKF 263
++K N+L++ + KI DFG+AR+ +E + T +V Y Y +PE + ++
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRHYTSAV 186
Query: 264 DVFSFGVLLLEIVSGK 279
D++S G + E++ +
Sbjct: 187 DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 57/229 (24%)
Query: 103 FPLFS----FSSVSTATNRFSDANKLGEGGFGPVYKGVLRK--GNEIAVKRLSGRSGQGL 156
FPL F S ++ + +G+G +G V+K VL K G++ AVK L
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID- 58
Query: 157 REMKNEASVI-AKVQHKNLVRLLGCCIDKDEKI-----LIYEY----------------- 193
E++ E +++ A H N+V+ G KD K L+ E
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118
Query: 194 --MPNKSLDFFLF-----------------NLKASNILLDKDMNPKISDFGMARICGGNE 234
M + + L ++K +NILL + K+ DFG++
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178
Query: 235 LQANTSRIVGTYGYMSPEY-----AIEGIFSIKFDVFSFGVLLLEIVSG 278
L+ NTS VGT +M+PE ++ + + DV+S G+ +E+ G
Sbjct: 179 LRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 3/78 (3%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGN--ELQANTSRIVGTYGYMSPEYAIE-GIFSI 261
+LK N+L++ D KI DFG+AR N E + V T Y +PE + ++
Sbjct: 130 DLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTK 189
Query: 262 KFDVFSFGVLLLEIVSGK 279
DV+S G +L E++ K
Sbjct: 190 AIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 186 EKILIYEYMPNKSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245
E IL E++ L ++K NILLD + + ++DFG+++ E + T GT
Sbjct: 113 EIILALEHL--HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGT 169
Query: 246 YGYMSPEYAI-EGIFSIKFDVFSFGVLLLEIVSG 278
YM+PE +G D +S G+L+ E+++G
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 46/207 (22%), Positives = 81/207 (39%), Gaps = 44/207 (21%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE----MKNEASVIAKVQH 171
F + +G G FG V + +I ++ +S +E + E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSL----------------DFFLFNL--------- 206
+ +L DKD L+ EY P L F+L L
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 207 --------KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY----- 253
K N+L+D+ + K++DFG A N+ N+ VGT Y++PE
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMN 179
Query: 254 -AIEGIFSIKFDVFSFGVLLLEIVSGK 279
+G + ++ D +S GV+ E++ G+
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 23/73 (31%), Positives = 38/73 (52%)
Query: 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+L A N+L+ + KI DFG+AR + + +M+PE +++ D
Sbjct: 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSD 323
Query: 265 VFSFGVLLLEIVS 277
V+SFG+LL EI +
Sbjct: 324 VWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 398 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.65 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.64 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.64 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.62 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.61 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.56 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.55 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.51 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.46 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.45 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.43 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.32 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.3 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.9 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.73 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.4 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.15 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.9 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.8 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.54 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.47 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.42 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.24 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.14 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.05 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.9 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.83 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.56 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.55 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.25 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 96.24 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.17 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.15 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.06 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 95.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.03 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 94.88 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.37 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.24 | |
| PLN02236 | 344 | choline kinase | 93.97 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.83 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 93.62 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 93.36 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 93.28 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 93.08 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 92.95 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.87 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 91.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 91.67 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 90.75 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.45 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 90.14 | |
| KOG3021 | 313 | consensus Predicted kinase [General function predi | 89.65 | |
| PF15050 | 133 | SCIMP: SCIMP protein | 89.47 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 88.57 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 88.5 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 88.39 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 87.92 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 87.77 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=370.78 Aligned_cols=252 Identities=43% Similarity=0.771 Sum_probs=218.4
Q ss_pred CCCccchhhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEE
Q 037365 102 QFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181 (398)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 181 (398)
....|++.++..+|++|...+.||+|+||.||+|...+|..||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46779999999999999999999999999999999999999999998766433145699999999999999999999999
Q ss_pred EeCC-eeEEEEeccCCCChh-------------------------------------HHhhcCCCCCceecCCCCeEEcc
Q 037365 182 IDKD-EKILIYEYMPNKSLD-------------------------------------FFLFNLKASNILLDKDMNPKISD 223 (398)
Q Consensus 182 ~~~~-~~~lV~e~~~~g~L~-------------------------------------~~~~dlkp~NILl~~~~~~kl~D 223 (398)
.+.+ +.+||+|||++|+|. ++||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999982 56789999999999999999999
Q ss_pred cccceecCCCCcccccccc-cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCC-CCccchhHHHHHhhh
Q 037365 224 FGMARICGGNELQANTSRI-VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYR-TDTLNLLGYAWDLWR 301 (398)
Q Consensus 224 FGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~-~~~~~~~~~~~~~~~ 301 (398)
||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+++||+||+++.+... .....+..|++..+.
T Consensus 221 FGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99997654311 111112 79999999999999999999999999999999999999877544 334568999999999
Q ss_pred cCCccccchhhhh-cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 302 SNRTLELTDAILE-DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 302 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
.....+++|+.+. +.+........+..++.+|++.+|.+||+|.||+++|+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999999999987 44433367788999999999999999999999999996654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=332.73 Aligned_cols=218 Identities=25% Similarity=0.382 Sum_probs=180.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-eeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e 192 (398)
++.+..+.||+|..|+||+++++. ++.+|+|++... ++...+++.+|++++++.+||+||++||.|.+++ ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 356677899999999999999976 778999999544 4566788999999999999999999999999999 5999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||++|+| +++||||||+|||++..|.+||||||.++.+.+. ..
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 9999998 4778999999999999999999999999887644 34
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC-
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS- 318 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 318 (398)
..++||..|||||.+.+..|+.++||||||++++|+.+|+.|+........+..+ +++.+..+...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-------------Ll~~Iv~~ppP~ 301 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-------------LLCAIVDEPPPR 301 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-------------HHHHHhcCCCCC
Confidence 5679999999999999999999999999999999999999998765232222222 22222221110
Q ss_pred -hH-HHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 319 -SK-QVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 319 -~~-~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+. .++.++..++..||++||.+|||++|+++.
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12 256679999999999999999999999863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=336.50 Aligned_cols=225 Identities=28% Similarity=0.457 Sum_probs=179.5
Q ss_pred CCCccceecccCceEEEEEEEcCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-eeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e~ 193 (398)
.+...+.+|+|+||+||+|.++....||||++.... ....+.|.+|+.+|.+++|||||+++|+|.++. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344456699999999999999744449999997653 222568999999999999999999999999988 79999999
Q ss_pred cCCCCh----------------------------------h-HHhhcCCCCCceecCCC-CeEEcccccceecCCCCccc
Q 037365 194 MPNKSL----------------------------------D-FFLFNLKASNILLDKDM-NPKISDFGMARICGGNELQA 237 (398)
Q Consensus 194 ~~~g~L----------------------------------~-~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 237 (398)
|++|+| . ++||||||+|||++.++ ++||+|||+++...... .
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 999998 4 68999999999999997 99999999998765432 2
Q ss_pred ccccccccccccChhhhc--cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 238 NTSRIVGTYGYMSPEYAI--EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
..+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ...+...........+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~~Rp~~------- 267 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGGLRPPI------- 267 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCCCCCC-------
Confidence 233368999999999999 56899999999999999999999999865433 1111122222222221
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
+..++..+..++.+||+.||..||++.+++..|+.+....
T Consensus 268 ---p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 268 ---PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ---CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 1124556889999999999999999999999999765533
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=331.44 Aligned_cols=216 Identities=26% Similarity=0.446 Sum_probs=176.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh-------hhHHHHHHHHHHHHhcCCCcccceeeEEEeCC
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG-------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 185 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 185 (398)
..+.|.+.+.||+|+||.|-+|..+. |+.||||.+.+... .....+.+|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567888999999999999999765 99999999965421 12234579999999999999999999999999
Q ss_pred eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCC---CCeEEcccccceec
Q 037365 186 EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKD---MNPKISDFGMARIC 230 (398)
Q Consensus 186 ~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~---~~~kl~DFGla~~~ 230 (398)
..|+||||++||+| ++.||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999988 57889999999999765 78999999999987
Q ss_pred CCCCcccccccccccccccChhhhccCCC---CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGIF---SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE 307 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+.. ..+.+.+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||.....+. .
T Consensus 330 g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----------------s 389 (475)
T KOG0615|consen 330 GEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----------------S 389 (475)
T ss_pred ccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----------------c
Confidence 643 23556899999999999987653 458899999999999999999986443321 1
Q ss_pred cchhhhhcccC-----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 308 LTDAILEDEYS-----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 308 ~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+.+.+..+.+. .....++..+|+.+||..||++|||++|+++
T Consensus 390 l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 22333333322 4456678999999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=326.05 Aligned_cols=167 Identities=31% Similarity=0.521 Sum_probs=150.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
..+|...+.||+|+||+||+|++++ +..||||.+.+. .....+.+..|+.+|+.++|||||.+++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4678888999999999999999876 889999999766 5666778899999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCC------CCeEEcccccceecCCC
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKD------MNPKISDFGMARICGGN 233 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~------~~~kl~DFGla~~~~~~ 233 (398)
|||.||+| +++||||||+|||++.. -.+||+|||+|+.+...
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 99999998 57889999999999764 45899999999998754
Q ss_pred CcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCC
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGF 284 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~ 284 (398)
. ...+.+|++.|||||++..++|+.|+|+||.|+++|+|++|+.||..
T Consensus 169 ~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 169 S---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred h---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 3 34557999999999999999999999999999999999999999763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=340.59 Aligned_cols=214 Identities=23% Similarity=0.400 Sum_probs=183.4
Q ss_pred CCCCccceecccCceEEEEEEE-cCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVL-RKGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.+|...+.||+|||+.||.+++ ..|+.||+|++.+. .....+.+.+|+++.++|+|||||+++++|++.++.|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 66999999999764 3455678899999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+|++|+| +++|||||..|++++++.++||+|||||..+..... ..
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc--cc
Confidence 99999988 578899999999999999999999999998875432 23
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC-
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS- 318 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 318 (398)
.+.+|||.|.|||++....++..+||||+||++|.|+.|++||.. ....+..+.+...++.
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet------------------k~vkety~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET------------------KTVKETYNKIKLNEYSM 237 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc------------------chHHHHHHHHHhcCccc
Confidence 457999999999999999999999999999999999999999753 2233333444333332
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+........+||.++|++||.+|||+++|+.
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2334466889999999999999999999995
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=354.84 Aligned_cols=229 Identities=29% Similarity=0.451 Sum_probs=191.1
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKD 185 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 185 (398)
....+.+..+.||+|+||+||+|+... ...||||.++..... ..++|++|++++..++|||||+++|+|..++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 344556667889999999999998643 456999999877555 7789999999999999999999999999999
Q ss_pred eeEEEEeccCCCCh----------------------------------------------hHHhhcCCCCCceecCCCCe
Q 037365 186 EKILIYEYMPNKSL----------------------------------------------DFFLFNLKASNILLDKDMNP 219 (398)
Q Consensus 186 ~~~lV~e~~~~g~L----------------------------------------------~~~~~dlkp~NILl~~~~~~ 219 (398)
..++|+|||..|+| .++||||..+|+|+.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 99999999999998 36678999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHH
Q 037365 220 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWD 298 (398)
Q Consensus 220 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 298 (398)
||+|||+++..-..+++.......-..+|||||.+..++||.+||||||||+|||+++ |+.|+.....+ .+..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------EVIe 716 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------EVIE 716 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------HHHH
Confidence 9999999998877777665545556789999999999999999999999999999998 88886543322 2223
Q ss_pred hhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 299 LWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
..+.++..+. +..++.++.+||..||+.+|++||+++||-..|+.....
T Consensus 717 ~i~~g~lL~~----------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 717 CIRAGQLLSC----------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHcCCcccC----------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 3333333222 455677899999999999999999999999999987543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=318.12 Aligned_cols=219 Identities=25% Similarity=0.399 Sum_probs=178.6
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceee-EEEeCCe-eEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG-CCIDKDE-KIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~l 189 (398)
...|++.+.||+|.||+||++.+. +|..+|.|.+.-. +....+....|+.+|++++|||||++++ .+.++.+ .+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 456888999999999999999854 5899999998633 4556678899999999999999999999 4555555 899
Q ss_pred EEeccCCCCh----------------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 190 IYEYMPNKSL----------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 190 V~e~~~~g~L----------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
|||||.+|+| .++||||||.||+++.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999998 167899999999999999999999999999
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+...... ....+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.. ++..++.
T Consensus 178 l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g------------------~n~~~L~ 237 (375)
T KOG0591|consen 178 LSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG------------------DNLLSLC 237 (375)
T ss_pred hcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc------------------ccHHHHH
Confidence 8755432 3457999999999999999999999999999999999999999642 2233333
Q ss_pred hhhhhcccC---hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 310 DAILEDEYS---SKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 310 ~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.++-.+++. ....+..+..|+..|+..||+.||+...++..+..
T Consensus 238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 333333332 24456778899999999999999996655555544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.82 Aligned_cols=225 Identities=30% Similarity=0.441 Sum_probs=181.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..+.+...+.||+|-||.||.|.++....||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..++..+|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 334456678899999999999999877799999997753 3447788999999999999999999999998899999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+.|+| +++||||.++|||++++..+||+|||||+...++.+...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~- 361 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS- 361 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec-
Confidence 999998 578899999999999999999999999996655544332
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....-+..|.|||.+..+.++.|||||||||+||||+| |+.||..... .+.+.. ...+... +.
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----~ev~~~-le~GyRl----------p~ 425 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----EEVLEL-LERGYRL----------PR 425 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----HHHHHH-HhccCcC----------CC
Confidence 23344678999999999999999999999999999999 7777543211 111111 1111111 11
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+..++..+.++|..||..+|++|||++.+...|+....
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 44566778999999999999999999999999887653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=319.64 Aligned_cols=214 Identities=23% Similarity=0.381 Sum_probs=176.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|++.+.||+|+||+||+++.++ ++.+|+|++++. .....+...+|..+|.+++||+||+++..|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4689999999999999999999876 888999999765 233457788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
+||+.||.| +++||||||+|||+|.+|+++|+|||+|+..-... ..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~ 181 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DA 181 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--Cc
Confidence 999999988 57779999999999999999999999998543322 23
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc-c
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE-Y 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 317 (398)
+.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||... +.....+.++.+. .
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~------------------~~~~~~~~I~~~k~~ 243 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE------------------DVKKMYDKILKGKLP 243 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc------------------cHHHHHHHHhcCcCC
Confidence 45589999999999999999999999999999999999999997532 2222333333322 1
Q ss_pred ChHH-HHHHHHHHHHHchhcCCCCCC----CHHHHH
Q 037365 318 SSKQ-VLLRYVNIALLCVQESADDRP----TTNDVV 348 (398)
Q Consensus 318 ~~~~-~~~~~~~li~~cl~~dP~~RP----t~~evl 348 (398)
..+. ......+++.+.|+.||++|. .+.+|-
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 1222 345678999999999999995 455543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=303.02 Aligned_cols=229 Identities=22% Similarity=0.353 Sum_probs=176.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
+.|+...++|+|+||.||+|+.++ |+.||||++... ++...+-..+|+.+|++++|+|+|.++.+|..+..++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888999999999999999887 999999999655 33444567899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
||+..-| +.+||||||+|||++.+|.+||||||+|+.+.... ...+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YT 159 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYT 159 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--chhh
Confidence 9987644 47889999999999999999999999999886422 2234
Q ss_pred cccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhH----------HHHHhhhcCCcc---
Q 037365 241 RIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLG----------YAWDLWRSNRTL--- 306 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~----------~~~~~~~~~~~~--- 306 (398)
..+.|.+|+|||.+.+ .+|++.+||||.||++.||++|.+-|...+. ..++.. .-...|......
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD-iDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD-IDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch-HHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 4578999999999998 6799999999999999999999987654322 111111 112222221111
Q ss_pred ---ccchh-hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ---ELTDA-ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ---~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+..+. .++.. .+....-+.+++..||+.||.+|++-+|++.
T Consensus 239 ~lP~~~~~epLe~k--~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERK--YPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhh--cccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11000 01111 1233346789999999999999999999884
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=315.02 Aligned_cols=221 Identities=20% Similarity=0.319 Sum_probs=174.0
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
...++|+.++.||+|+||.||+|+-++ |..+|+|++++.. ....+.+..|-.+|....+|+||+++..|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 356789999999999999999999776 8999999998763 345567889999999999999999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC---
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN--- 233 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~--- 233 (398)
|||||++||++ +++||||||+|+|||..|++||+|||||.-+...
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999986 6889999999999999999999999998533110
Q ss_pred -------------------Ccc-----cc------------------cccccccccccChhhhccCCCCcccccHHHHHH
Q 037365 234 -------------------ELQ-----AN------------------TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVL 271 (398)
Q Consensus 234 -------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 271 (398)
+.. .. ....+|||.|||||++.+..|+..+|+||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 000 00 013679999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCc--cchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCC---HHH
Q 037365 272 LLEIVSGKKNTGFYRTDT--LNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPT---TND 346 (398)
Q Consensus 272 l~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~e 346 (398)
+|||+.|-+||....... ..+..|...+-. . .......+..+||.+|+. ||++|.- ++|
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-------P--------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKF-------P--------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-------C--------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 999999999986543321 112222111000 0 011223567899999999 9999975 666
Q ss_pred HHH
Q 037365 347 VVS 349 (398)
Q Consensus 347 vl~ 349 (398)
|.+
T Consensus 442 IK~ 444 (550)
T KOG0605|consen 442 IKK 444 (550)
T ss_pred Hhc
Confidence 654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=315.78 Aligned_cols=221 Identities=26% Similarity=0.387 Sum_probs=183.2
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCe
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 186 (398)
....++|..++.||+|+|++|++|+..+ ++.+|||++.+. .....+.+..|-.+|.+| .||.|++|+..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3445689999999999999999999766 899999999755 233445678899999999 79999999999999999
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
+|+|+||+++|+| +++||||||+|||+|+||++||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999988 68899999999999999999999999999886432
Q ss_pred cc---------ccc--ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 235 LQ---------ANT--SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 235 ~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
.. ... ..++||..|.+||++..+..++.+|+|+|||++|.|+.|++||.. .
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra------------------~ 290 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA------------------A 290 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc------------------c
Confidence 21 111 458999999999999999999999999999999999999999642 2
Q ss_pred CccccchhhhhcccC-hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 304 RTLELTDAILEDEYS-SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+..-++..++.-++. ++.+++.+.+|+.+.|..||.+|+|.++|.+.
T Consensus 291 NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 291 NEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred cHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 222333344333332 33445678899999999999999999998864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=303.59 Aligned_cols=229 Identities=22% Similarity=0.364 Sum_probs=180.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
..+.|+..+.||.|..++||+|++.. +..||||++... .....+.+.+|+..++.++||||++++..|..++.+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 35789999999999999999999754 889999999654 2334688999999999999999999999999999999999
Q ss_pred eccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 192 EYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 192 e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
.||.+|++ +.+|||||+.|||++++|.+||+|||.+-.+.+.....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 99999987 46789999999999999999999999876654433211
Q ss_pred -cc-ccccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 238 -NT-SRIVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 238 -~~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.. ..+.||++|||||++.. ..|+.|+||||||++..||.+|..||..+..-..-+.. +.+. .....-..+
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lqn~-pp~~~t~~~ 257 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQND-PPTLLTSGL 257 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcCC-CCCcccccC
Confidence 12 56789999999999654 45999999999999999999999998766543322221 1111 111111111
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..+ ........+.+++..||+.||++|||++++++
T Consensus 258 ~~d-~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 258 DKD-EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ChH-HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111 13344567999999999999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=311.30 Aligned_cols=232 Identities=25% Similarity=0.409 Sum_probs=190.4
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
+.+...+.++||+|-||.|.+|....+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++.+++++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34456678899999999999999987899999999877544 45889999999999999999999999999999999999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
||++|+| +++|||+.++|+|+|.++++||+|||+++-+-..+++..
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999988 578899999999999999999999999998777777777
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHc--CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS--GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
....+-..+|||||.+.-++++.++|||+||+++||+++ ...||.....+ +.++-....++........
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~~~~~l------- 766 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQGRQVVL------- 766 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCCcceec-------
Confidence 777778899999999999999999999999999999875 56676533222 2222222223322211111
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
..+..++..+.+++.+||..|-++|||++++...|++.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11444566788999999999999999999999988764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=317.09 Aligned_cols=220 Identities=25% Similarity=0.395 Sum_probs=182.2
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
...|....+||+|+.|.||.|+... ++.||||++........+-+.+|+.+|+..+|+|||++++.|..++++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4468888999999999999998654 889999999877666667789999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
|+||+| +++|||||.+|||++.+|.+||+|||+|..+..... .....
T Consensus 352 m~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~Tm 429 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTM 429 (550)
T ss_pred cCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccc
Confidence 999998 578899999999999999999999999988765543 45567
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
+||++|||||+.....|++|.||||||++++||+-|.+||-.... ....+.....+. .++- .....
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrAlyLIa~ng~-P~lk--------~~~kl 495 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGT-PKLK--------NPEKL 495 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHHHHHHhhcCC-CCcC--------Ccccc
Confidence 999999999999999999999999999999999999999754111 111111111111 1111 13344
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...+.+++.+||+.|+++|+|+.|+|+.
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 5678999999999999999999999963
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=338.96 Aligned_cols=228 Identities=32% Similarity=0.493 Sum_probs=184.2
Q ss_pred CCCCccceecccCceEEEEEEEcC--CC----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK--GN----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
++.+..+.||+|.||.||.|...+ +. .||+|.+... +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667889999999999999765 43 3899999766 4566778999999999999999999999999999999
Q ss_pred EEEeccCCCCh---------------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 189 LIYEYMPNKSL---------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
+++|||++|+| ..+||||..+|+|++....+||+|||+|+.
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 99999999998 467889999999999999999999999997
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+...+++.......-...|||||.+..+.+|.|+|||||||++||++| |..||...... +.... ...+++
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~v~~~---~~~ggR---- 922 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--EVLLD---VLEGGR---- 922 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--HHHHH---HHhCCc----
Confidence 666665554444344568999999999999999999999999999998 77776532221 11111 112221
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
+. .+..++..+.++|.+||+.+|++||++..+++.+..+.....
T Consensus 923 ----L~---~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 923 ----LD---PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ----cC---CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 11 144566778899999999999999999999999988766544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=307.21 Aligned_cols=230 Identities=23% Similarity=0.318 Sum_probs=176.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--CeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 189 (398)
.+.|+.+++||+|.||.||+|+... |+.||+|++.... .....-..+|+.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568899999999999999999755 8999999986553 44556678999999999999999999999886 68999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|+|||++--. +++|||||.+|||||.+|.+||+|||||+++.......
T Consensus 196 VFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 196 VFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred EEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 9999987421 57889999999999999999999999999887655433
Q ss_pred ccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc--------
Q 037365 238 NTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL-------- 308 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 308 (398)
.+..+-|.+|+|||++.+. .|+.+.|+||.||||.||++|++.+... .+.+....+..+........+
T Consensus 276 -~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~--tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 276 -YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR--TEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred -cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc--cHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 3345669999999999985 5999999999999999999999886532 222222222222211111100
Q ss_pred --c------hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 309 --T------DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 309 --~------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+ ...+.+. ....+...++|+..+|..||.+|.|+.++++
T Consensus 353 ~~~kp~~~y~r~l~E~--~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRET--FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccchHHHH--hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 0111111 1223456789999999999999999999885
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.35 Aligned_cols=216 Identities=22% Similarity=0.388 Sum_probs=177.6
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..|...+.||+|.||.||+|.+.. ++.||+|++... .....+.+++|+.+|.+++|+||.++||.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 457777899999999999999866 788999999765 344567889999999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
|.||++ ..+|||||+.|||+..+|.+||+|||.+-.+...... ...
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~t 170 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKT 170 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc--ccc
Confidence 999976 4677899999999999999999999999887654432 356
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+........-. ..... ..+.+.+ .
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------lIpk~-----~PP~L~~-----~ 234 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------LIPKS-----APPRLDG-----D 234 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------eccCC-----CCCcccc-----c
Confidence 899999999999998899999999999999999999999975433210000 00111 1122222 3
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+...+.+++..||+.||+.|||+.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4456899999999999999999999985
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=321.30 Aligned_cols=226 Identities=25% Similarity=0.373 Sum_probs=182.6
Q ss_pred CCCCccceecccCceEEEEEEEcC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
+...+.++||.|.||.||+|+++. ...||||.++.. .+....+|+.|..||.++.||||++|.|+........+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 455677899999999999999864 356999999876 445677899999999999999999999999999999999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc-
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ- 236 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 236 (398)
.|||++|+| +++||||..+|||++.+..+|++|||+++.+.++...
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 999999998 4778899999999999999999999999988655421
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
..+..-.-..+|.|||.+...++|.+|||||||+++||.++ |.+||-.... .+..+.+.+.++ -
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--QdVIkaIe~gyR-------------L 853 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAIEQGYR-------------L 853 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--HHHHHHHHhccC-------------C
Confidence 12222233578999999999999999999999999999886 8889633221 111111111111 0
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
..+.+++..+.+|++.||+.|-.+||++.||+..|+++...
T Consensus 854 -PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 854 -PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 12556778899999999999999999999999999987543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=312.76 Aligned_cols=215 Identities=26% Similarity=0.427 Sum_probs=174.5
Q ss_pred CccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCC
Q 037365 119 SDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~ 198 (398)
..++.||+|+.|.||+|+++ ++.||||+++... ..+++-|++|+||||+.+.|+|....-+|||||||+.|.
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34578999999999999996 8899999985332 347888999999999999999999999999999999998
Q ss_pred h--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccc
Q 037365 199 L--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 246 (398)
Q Consensus 199 L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 246 (398)
| .++|||||+-||||..+..+||+|||.++...+.. ..-.++||.
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaGTV 275 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAGTV 275 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhhhH
Confidence 8 57889999999999999999999999998765432 233479999
Q ss_pred cccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHH
Q 037365 247 GYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326 (398)
Q Consensus 247 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (398)
.|||||++...+.+.|+||||||||||||+||..||..-... ..+|.. +.+...+ ..+..+++-+
T Consensus 276 aWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGV--GsNsL~L--------pvPstcP~Gf 340 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGV--GSNSLHL--------PVPSTCPDGF 340 (904)
T ss_pred hhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEec--cCCcccc--------cCcccCchHH
Confidence 999999999999999999999999999999999997432111 111111 1111111 1144556678
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 327 VNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 327 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
+-|+.+||+..|.+||++.+++..|+=..+++.
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 889999999999999999999999987665554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=301.65 Aligned_cols=224 Identities=24% Similarity=0.413 Sum_probs=174.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC--eeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~e 192 (398)
.++...+.||+|+||.||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778999999999999999876 8999999997664344677899999999999999999999855544 6899999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecC-CCCeEEcccccceecCC-CCccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDK-DMNPKISDFGMARICGG-NELQA 237 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~-~~~~kl~DFGla~~~~~-~~~~~ 237 (398)
|+++|+| +++|+||||+|||++. ++.+||+|||+++.... .....
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 9999988 4678899999999999 79999999999987664 11122
Q ss_pred ccccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
......||+.|||||++..+. ...++|||||||++.||+||++||... .....+............+
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~~P~i-------- 244 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDSLPEI-------- 244 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCCCCCC--------
Confidence 344578999999999999643 345999999999999999999997643 1112222222222211111
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
+...+....+++.+|++.||++|||++++++..--
T Consensus 245 --p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 245 --PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred --CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 22344567899999999999999999999986443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=308.83 Aligned_cols=238 Identities=24% Similarity=0.405 Sum_probs=186.7
Q ss_pred ccchhhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEE
Q 037365 105 LFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182 (398)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 182 (398)
..+..+++...+.+.+...||+|+||+||+|+|. ..||||++... ..+..+.|++|+..+++-+|.||+-+.|+|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 3445677788888889999999999999999995 56999999655 4567889999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 183 DKDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
.+.. .+|+.+|+|.+| +++|||||+.||++.+++.|||+|||++..
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 8877 999999999998 588999999999999999999999999864
Q ss_pred cCCCCcccccccccccccccChhhhcc---CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIE---GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
-..-..........|...|||||++.. .+|++.+||||||+++|||++|..||.....+ ++ + |..++-.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qI---i---fmVGrG~ 609 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QI---I---FMVGRGY 609 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--he---E---EEecccc
Confidence 321111122334567889999999974 56999999999999999999999997622111 11 1 1111111
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
-..|... ....+.+.+.+|+..||..++++||++.+|+..|+.+...
T Consensus 610 l~pd~s~----~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 LMPDLSK----IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCccchh----hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0111111 0234566799999999999999999999999999887654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=307.50 Aligned_cols=229 Identities=26% Similarity=0.388 Sum_probs=175.4
Q ss_pred hhcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 184 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 184 (398)
...++|++.+.||+|+||.||+|.+. .++.||+|++.... ......+.+|+.++.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34578999999999999999999752 25679999997543 33456788999999999 899999999998765
Q ss_pred C-eeEEEEeccCCCChh---------------------------------------------------------------
Q 037365 185 D-EKILIYEYMPNKSLD--------------------------------------------------------------- 200 (398)
Q Consensus 185 ~-~~~lV~e~~~~g~L~--------------------------------------------------------------- 200 (398)
+ ..+++|||+++|+|.
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 589999999998872
Q ss_pred -------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccccccc
Q 037365 201 -------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 249 (398)
Q Consensus 201 -------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 249 (398)
++||||||+|||++.++.+||+|||+++...............++..|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 4578999999999999999999999998654332222223345678899
Q ss_pred ChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHH
Q 037365 250 SPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVN 328 (398)
Q Consensus 250 aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (398)
|||++.+..++.++|||||||++|||++ |..||....... . .......+..... +...+..+.+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~----~~~~~~~~~~~~~----------~~~~~~~l~~ 308 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-E----FCQRLKDGTRMRA----------PENATPEIYR 308 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-H----HHHHHhcCCCCCC----------CCCCCHHHHH
Confidence 9999999999999999999999999997 998875432211 1 1111111111100 1122345789
Q ss_pred HHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 329 IALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 329 li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
++.+||+.||++|||+.|+++.|+....
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.05 Aligned_cols=230 Identities=27% Similarity=0.419 Sum_probs=173.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-----------------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-----------------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVR 176 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 176 (398)
.++|...+.||+|+||.||+|.+++ +..||+|.+.... ......+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678889999999999999998642 3369999987653 334567899999999999999999
Q ss_pred eeeEEEeCCeeEEEEeccCCCCh---------------------------------------------------hHHhhc
Q 037365 177 LLGCCIDKDEKILIYEYMPNKSL---------------------------------------------------DFFLFN 205 (398)
Q Consensus 177 l~~~~~~~~~~~lV~e~~~~g~L---------------------------------------------------~~~~~d 205 (398)
+++++.+.+..++||||+++|+| +++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 99999999999999999999865 245789
Q ss_pred CCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcC--CCCCC
Q 037365 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSG--KKNTG 283 (398)
Q Consensus 206 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg--~~P~~ 283 (398)
|||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||+++ ..||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 9999999999999999999999876544332223344567889999999988999999999999999999975 44544
Q ss_pred CCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 284 FYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.. ............+......... ..++.++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 244 ~~--~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 EL--TDEQVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cC--CHHHHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 32 2222222222212111100000 0012234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=279.37 Aligned_cols=230 Identities=22% Similarity=0.348 Sum_probs=174.7
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ--GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|...+.+|+|.||.||+|++.. |+.||||+++..+.. ......+|++.|+.++|+||+.++++|-+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 578888999999999999999765 999999999765322 23467899999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+.. | .++||||||.|+|++++|.+||+|||+|+.+.......
T Consensus 82 fm~td-Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-- 158 (318)
T KOG0659|consen 82 FMPTD-LEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-- 158 (318)
T ss_pred ecccc-HHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc--
Confidence 99842 2 47889999999999999999999999999987554322
Q ss_pred ccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc------chhh
Q 037365 240 SRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL------TDAI 312 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 312 (398)
...+-|.+|+|||.+.+. .|+...|+||.||++.||+-|.+-|. ...+- +....+...+.......+ .|..
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~sDi-dQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDSDI-DQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCchH-HHHHHHHHHcCCCCcccCccccccccHH
Confidence 223679999999999875 59999999999999999999986543 22222 222233333322222211 1111
Q ss_pred hhccc-------ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 313 LEDEY-------SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 313 ~~~~~-------~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.-..+ -.........+|+..+|..||.+|+|+.|++++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 10000 022334567899999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=306.33 Aligned_cols=217 Identities=24% Similarity=0.364 Sum_probs=175.5
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC----Ch-hhHHHHHHHHHHHHhcC-CCcccceeeEEEeCC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR----SG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD 185 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 185 (398)
...++|...+.||+|+||+|+.|.+.. +..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345789999999999999999998754 899999977553 11 23456778999999999 999999999999999
Q ss_pred eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCC-CCeEEcccccceecCC
Q 037365 186 EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKD-MNPKISDFGMARICGG 232 (398)
Q Consensus 186 ~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~-~~~kl~DFGla~~~~~ 232 (398)
..++||||+.+|+| +++||||||+|+|+|.+ +++||+|||++.....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 99999999999987 46889999999999999 9999999999988741
Q ss_pred CCcccccccccccccccChhhhccCC-CC-cccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIEGI-FS-IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||... + ...+..
T Consensus 174 --~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--~----------------~~~l~~ 233 (370)
T KOG0583|consen 174 --EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--N----------------VPNLYR 233 (370)
T ss_pred --CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--c----------------HHHHHH
Confidence 112345679999999999999977 85 8899999999999999999998651 1 111111
Q ss_pred hhhhcccChHH-H-HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AILEDEYSSKQ-V-LLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~~~~~~~~~~-~-~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+..+.+..+. . ...+..|+.+|+..||.+|+|+.++++
T Consensus 234 ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 234 KIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 12222222111 2 456889999999999999999999994
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=308.58 Aligned_cols=213 Identities=26% Similarity=0.409 Sum_probs=179.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|.+.+.||+|+||.||+|+.+. .+.||+|.+.+. .....+.+.+|++++++++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 567888999999999999999765 788999999654 44567789999999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|+.| +| .++|||+||.|||++.++.+|+||||+|+.+..+. ...+
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--eeee
Confidence 9987 65 46778999999999999999999999999876543 3455
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC-h
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS-S 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 319 (398)
...|||.|||||++.+++|+..+|.||+||++||+++|++||.. .....+...++.++.. +
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------------------~si~~Lv~~I~~d~v~~p 220 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------------------RSITQLVKSILKDPVKPP 220 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------------------HHHHHHHHHHhcCCCCCc
Confidence 67999999999999999999999999999999999999999642 2222233333333322 3
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......+.+++...|+.||..|.|-.+++.
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 345567899999999999999999999885
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=294.23 Aligned_cols=213 Identities=22% Similarity=0.330 Sum_probs=167.9
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhh---HHHHHHHHHHHHhcCCCcccceeeEEEe----CCeeEEEEecc
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQG---LREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIYEYM 194 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~e~~ 194 (398)
..||+|++|.||+|.+ +|+.||||++....... .+.+.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999999 58999999997653222 4677899999999999999999999977 34789999999
Q ss_pred CCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 195 PNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 195 ~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
++|+| ..+||||||+|||+++++.+||+|||+++...... ..
T Consensus 105 ~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~ 179 (283)
T PHA02988 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FK 179 (283)
T ss_pred CCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----cc
Confidence 99987 23478999999999999999999999998654322 23
Q ss_pred ccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 242 IVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+... .......... +
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~~~---i~~~~~~~~~----------~ 244 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIYDL---IINKNNSLKL----------P 244 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHHHH---HHhcCCCCCC----------C
Confidence 467899999999976 6799999999999999999999999864321 111111 1111110000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
...+..+.+++.+||+.||++|||++|+++.|+...
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 123456889999999999999999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=283.78 Aligned_cols=204 Identities=27% Similarity=0.403 Sum_probs=173.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|+..+.||.|+||+|.+++.+. |..+|+|+++... -.+.+...+|..+|+.+.||+++++.+.|.+.+..|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4678999999999999999999876 8889999997653 23445667899999999999999999999999999999
Q ss_pred EeccCCCChh--------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSLD--------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L~--------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||.+||.|- ++.|||||+|||+|.+|.+||+|||+|+.....
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-----
Confidence 9999999873 333699999999999999999999999987643
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
+.+.+|||.|+|||++....|+.++|.|||||++|||+.|.+||.. .+...+.++++.+...
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~------------------~~~~~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD------------------DNPIQIYEKILEGKVK 259 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC------------------CChHHHHHHHHhCccc
Confidence 4567999999999999999999999999999999999999999653 2334455566655544
Q ss_pred -hHHHHHHHHHHHHHchhcCCCCC
Q 037365 319 -SKQVLLRYVNIALLCVQESADDR 341 (398)
Q Consensus 319 -~~~~~~~~~~li~~cl~~dP~~R 341 (398)
+.-....+.+|+...++.|-.+|
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhh
Confidence 33344668899999999999999
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=308.90 Aligned_cols=213 Identities=25% Similarity=0.405 Sum_probs=181.6
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCe
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDE 186 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 186 (398)
....++|...++||+|.||+|+++..+. ++.+|||.+++. ..+..+....|..++...+ ||.+++++.+|+.+++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3455789999999999999999999876 788999999876 3456677888988888875 9999999999999999
Q ss_pred eEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 187 KILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 187 ~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.|+||||+.||++ ++++||||.+|||+|.+|.+||+|||+++..-...
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g- 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG- 522 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC-
Confidence 9999999999987 45668999999999999999999999998653222
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
..+++++||+.|||||++.+..|+.++|+|||||+||||+.|..||. ++...+++|.++.+
T Consensus 523 -~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~------------------gddEee~FdsI~~d 583 (694)
T KOG0694|consen 523 -DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP------------------GDDEEEVFDSIVND 583 (694)
T ss_pred -CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC------------------CCCHHHHHHHHhcC
Confidence 35677999999999999999999999999999999999999999954 34445566666665
Q ss_pred ccC-hHHHHHHHHHHHHHchhcCCCCCCCH
Q 037365 316 EYS-SKQVLLRYVNIALLCVQESADDRPTT 344 (398)
Q Consensus 316 ~~~-~~~~~~~~~~li~~cl~~dP~~RPt~ 344 (398)
++. +...+.+.++++.+++..+|++|.-+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 543 34455778999999999999999865
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=290.07 Aligned_cols=233 Identities=25% Similarity=0.326 Sum_probs=177.6
Q ss_pred CCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCcccceeeEEEeCC----eeEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCIDKD----EKILI 190 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lV 190 (398)
..+..+++|+|+||.||+|.+. ++.||||++.. ...+.|++|-+|++. ++|+||++++++-.... +++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4455678999999999999996 69999999964 344678888888776 57999999999987766 89999
Q ss_pred EeccCCCCh----------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceec
Q 037365 191 YEYMPNKSL----------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARIC 230 (398)
Q Consensus 191 ~e~~~~g~L----------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~ 230 (398)
+||.+.|+| .+.|||||++|||+.+|+++.|+|||+|..+
T Consensus 287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 999999999 3677899999999999999999999999988
Q ss_pred CCCCcccccccccccccccChhhhccCC-CC-----cccccHHHHHHHHHHHcCCCCCCCCCCC------------ccch
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGI-FS-----IKFDVFSFGVLLLEIVSGKKNTGFYRTD------------TLNL 292 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvvl~elltg~~P~~~~~~~------------~~~~ 292 (398)
............+||.+|||||++.+.. +. .+.||||+|.|||||+++..-......+ ...+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 7655555555689999999999998643 22 5689999999999999976544211111 1111
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
.+...-..+++....+.+..... .....+.+.+..||+.||+.|.|+.-+.+++.++....
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h-----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKH-----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcC-----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11111122333334444444432 23456889999999999999999999999998875433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=301.32 Aligned_cols=231 Identities=22% Similarity=0.332 Sum_probs=173.3
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHH--HHHHHHHHHhcC-CCcccceeeEEEeCC-eeE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLRE--MKNEASVIAKVQ-HKNLVRLLGCCIDKD-EKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~ 188 (398)
..++|...++||.|+||.||+|+... |..||||+++..-.. +++ =.+|+..|++++ ||||+++.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 35789999999999999999999655 889999999876432 333 368999999999 999999999999988 999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
+|||||+..-- +++|||+||+|||+..+..+||+|||+|+.+.....
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP- 165 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP- 165 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC-
Confidence 99999976421 578999999999999889999999999998765432
Q ss_pred cccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch-----
Q 037365 237 ANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD----- 310 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 310 (398)
.+..+.|.+|+|||++.. +.|+.+.|+||+||+++|+.+-++-|..... .+..-.+.+.+......++..
T Consensus 166 --YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 166 --YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred --cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccchhHHHHH
Confidence 344578999999999875 5689999999999999999999877643221 111111111111111111111
Q ss_pred hhhhcc------cC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 311 AILEDE------YS----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 311 ~~~~~~------~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+.-. .. .+.....+.+|+.+|+.+||.+|||++|+++.
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000000 00 12255678999999999999999999999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.86 Aligned_cols=215 Identities=24% Similarity=0.333 Sum_probs=180.2
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.+-|+.++.||.|+.|.|-+|++.. |+.+|||.+.+. .......+.+|+.+|+-+.|||+++++++++++.++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 3567888999999999999999765 999999999765 223345688999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
.||+++|.| +++||||||+|+|+|..+++||+|||+|..-..+. .
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---l 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---L 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc---c
Confidence 999999987 57789999999999999999999999998654333 2
Q ss_pred cccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
..+.||++.|.|||++.+.+| +.++||||.|||||.|+||+.||+. ++...++.+...+.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------------------dNir~LLlKV~~G~f 229 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------------------DNIRVLLLKVQRGVF 229 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------------------ccHHHHHHHHHcCcc
Confidence 345699999999999999998 6899999999999999999999762 233334444444444
Q ss_pred C-hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 318 S-SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 318 ~-~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. +...+.++.+|+.+|+..||+.|.|++||++.
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 3 23344668899999999999999999999985
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=292.60 Aligned_cols=230 Identities=22% Similarity=0.283 Sum_probs=174.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|+..+.||+|+||.||++++.. +..+|+|.+... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999875 788999998754 33445678999999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+++|+| .++|+||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~ 159 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----A 159 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----c
Confidence 9999987 25678999999999999999999999987654321 2
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHH-hhhcCC--------------
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD-LWRSNR-------------- 304 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~~~-------------- 304 (398)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...... ......
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCccccccc
Confidence 3357899999999999999999999999999999999999998543221 11110000 000000
Q ss_pred ---------------ccccchhhhhcc---cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 305 ---------------TLELTDAILEDE---YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 305 ---------------~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+..+...... .........+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 0011234568999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=327.07 Aligned_cols=231 Identities=23% Similarity=0.394 Sum_probs=182.8
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
...|...+.||+|+||.||+|+.. ++..||+|++...... ..+|++.+++++||||++++|+|.+++..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 345777889999999999999974 5899999998654322 23468899999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+++|+| .++||||||+||+++.++.+++. ||....... ...
T Consensus 765 ~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~ 837 (968)
T PLN00113 765 IEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTK 837 (968)
T ss_pred CCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCC
Confidence 999987 24568999999999999888876 665543221 112
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc-ChH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY-SSK 320 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 320 (398)
..||+.|+|||++.+..++.++|||||||++|||++|+.|++...........|+...+.........++.+.... ...
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 3678999999999999999999999999999999999999865555555666676655544444444555443321 133
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 321 QVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 321 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.....+.+++.+||+.||++||||+|++++|++...
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 455678899999999999999999999999998754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=296.73 Aligned_cols=214 Identities=23% Similarity=0.318 Sum_probs=170.2
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|++.+.||+|+||.||+|++.. ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3578889999999999999999865 889999998643 223345688999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++|+| +++|+||||+|||++.++.+||+|||+++......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----
Confidence 999999987 35678999999999999999999999998764322
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ... ...... ..
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~---~~~-i~~~~~-~~---------- 234 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRI---YEK-ILAGRL-KF---------- 234 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHH---HHH-HhcCCc-CC----------
Confidence 235789999999999999999999999999999999999999753211 111 111 111110 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPT-----TNDVVSM 350 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~ 350 (398)
+......+.+++.+||+.||.+||+ ++++++.
T Consensus 235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1112345789999999999999997 6877743
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.48 Aligned_cols=226 Identities=26% Similarity=0.361 Sum_probs=173.7
Q ss_pred hcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCC
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD 185 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 185 (398)
..++|+..+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|+.++..+ +||||++++++|...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 3467999999999999999999742 25689999996542 33456788999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChh-----------------------------------------------------------------
Q 037365 186 EKILIYEYMPNKSLD----------------------------------------------------------------- 200 (398)
Q Consensus 186 ~~~lV~e~~~~g~L~----------------------------------------------------------------- 200 (398)
..++||||+++|+|.
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999988761
Q ss_pred ------------------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 201 ------------------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 201 ------------------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
++|+||||+|||++.++.+||+|||+++..........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 35789999999999999999999999987654332222
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... ....+.....
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~----~~~~~~~~~~--------- 338 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYK----MIKEGYRMLS--------- 338 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHH----HHHhCccCCC---------
Confidence 223345678999999999999999999999999999998 77776533221 11111 1111110000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 339 -~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 -PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=297.90 Aligned_cols=216 Identities=22% Similarity=0.335 Sum_probs=180.6
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe-eEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-KILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lV 190 (398)
.++|..++.+|+|+||.++..+++. +..+++|++... .....+...+|+.++++++|||||.+.+.|..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 3678999999999999999998765 788999998644 33344577899999999999999999999999888 9999
Q ss_pred EeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 191 YEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 191 ~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
|+||+||++ .++|||||+.||+++.++.+||+|||+|+.+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 999999998 47889999999999999999999999999987554
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.......||+.||.||.+.+.+|+.|+|||||||++|||++-+++|.. .+...+...+....
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a------------------~~m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA------------------SNMSELILKINRGL 222 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc------------------cchHHHHHHHhhcc
Confidence 234557999999999999999999999999999999999999998643 22222223332222
Q ss_pred c--ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 317 Y--SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 317 ~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+ .+..+...+..++..|++.+|+.||++.+++..
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 134456678999999999999999999999975
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=291.03 Aligned_cols=213 Identities=23% Similarity=0.302 Sum_probs=169.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 468889999999999999999864 8899999986432 233456889999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++|+| +++|+||||+|||++.++.+||+|||+++..... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----c
Confidence 99999987 3567899999999999999999999999865432 2
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ...... ... .+ +
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~---~~~i~~-~~~-~~----------~ 218 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGI---YEKILA-GKL-EF----------P 218 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHHh-CCc-CC----------C
Confidence 235789999999999998999999999999999999999999753211 111 111111 100 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCC-----HHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPT-----TNDVVSM 350 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~ 350 (398)
......+.+++.+||+.||.+||+ ++|+++.
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 122345789999999999999995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=294.58 Aligned_cols=221 Identities=25% Similarity=0.370 Sum_probs=170.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|+..+.||+|+||.||+|++.. ++.||+|.+.... ......+.+|+++++.++|+||+++++++..++..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 3567788999999999999999764 8999999986543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCh----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 193 YMPNKSL----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 193 ~~~~g~L----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+++|+| +++||||||+|||+++++.+||+|||+++.+.... .......|
T Consensus 153 ~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 230 (353)
T PLN00034 153 FMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVG 230 (353)
T ss_pred cCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cccccccc
Confidence 9999987 46788999999999999999999999998764322 11234578
Q ss_pred cccccChhhhcc-----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 245 TYGYMSPEYAIE-----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 245 t~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
|..|+|||.+.. ...+.++|||||||++|||++|+.||...... +.......... ..... ..
T Consensus 231 t~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~-~~~~~----------~~ 297 (353)
T PLN00034 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICM-SQPPE----------AP 297 (353)
T ss_pred CccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhc-cCCCC----------CC
Confidence 999999998743 23457899999999999999999998632211 11111100000 00000 01
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
......+.+++.+||+.||++|||+.|+++.
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2234568899999999999999999999974
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=285.35 Aligned_cols=232 Identities=22% Similarity=0.293 Sum_probs=172.7
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|++.+.||+|+||.||+|+++. ++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 478899999999999999999875 7889999986542 2334667899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|++++.+ +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 159 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYT 159 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-cccc
Confidence 9998855 356789999999999999999999999987643221 1223
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH----------HHhhhcC-Cccccc
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA----------WDLWRSN-RTLELT 309 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~----------~~~~~~~-~~~~~~ 309 (398)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+.... +..+... ......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 3578999999999999899999999999999999999999986432211 000000 0000000 000000
Q ss_pred hhhhhccc-----ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 310 DAILEDEY-----SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 310 ~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+...... .....+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 01123456899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=283.65 Aligned_cols=222 Identities=30% Similarity=0.501 Sum_probs=175.0
Q ss_pred CCCCccceecccCceEEEEEEEcC-C-----CEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-G-----NEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
++|+..+.||+|+||.||+|.... + ..||+|.+.... ......+.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998654 2 579999987543 344567889999999999999999999999999999
Q ss_pred EEEeccCCCChh------------------------------------------------HHhhcCCCCCceecCCCCeE
Q 037365 189 LIYEYMPNKSLD------------------------------------------------FFLFNLKASNILLDKDMNPK 220 (398)
Q Consensus 189 lV~e~~~~g~L~------------------------------------------------~~~~dlkp~NILl~~~~~~k 220 (398)
++|||+++|+|. ++|+||||+||++++++.+|
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 999999998762 35579999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHh
Q 037365 221 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDL 299 (398)
Q Consensus 221 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 299 (398)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +... .
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~----~ 238 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE----M 238 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH----H
Confidence 999999986644333233344567889999999998899999999999999999998 98887532211 1111 1
Q ss_pred hhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 300 WRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
........ .+...+..+.+|+.+||+.||.+|||++||++.|++
T Consensus 239 i~~~~~~~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLLP----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcCC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 022345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.45 Aligned_cols=217 Identities=18% Similarity=0.201 Sum_probs=172.3
Q ss_pred CCCccceecccCceEEEEEEEcC--CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK--GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.|...+.||+|+||.||+|.... ++.||+|.+..........+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48888999999999999998654 5778999876665555567788999999999999999999999999999999999
Q ss_pred CCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 195 PNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 195 ~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
++|+| +++||||||+|||++.++.+||+|||+++..........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 99988 245679999999999999999999999987654332223
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .....
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~-~~~~~---------- 291 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYG-KYDPF---------- 291 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC-CCCCC----------
Confidence 3456799999999999999999999999999999999999999753211 1111111111 10000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+......+.+++.+||+.||++|||+++++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122345789999999999999999999874
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=288.28 Aligned_cols=232 Identities=21% Similarity=0.289 Sum_probs=168.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|++.+.||+|+||.||+|+... ++.||+|.+..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4789999999999999999999864 88999999865432 223457789999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|++++.+ +++||||||+|||+++++.+||+|||+++...... ....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~ 161 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYS 161 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCC
Confidence 9975422 46788999999999999999999999997653222 1123
Q ss_pred cccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc---------cc--
Q 037365 241 RIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL---------EL-- 308 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------~~-- 308 (398)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+. ............ ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE-RIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhCCCChhhccchhhcccccc
Confidence 3568999999999875 4578999999999999999999999864322111111 111111000000 00
Q ss_pred ------chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 309 ------TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 309 ------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+............+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000011245779999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=293.69 Aligned_cols=209 Identities=22% Similarity=0.317 Sum_probs=165.0
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
+.||+|+||.||+++... |+.||+|++... .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999764 889999998653 2233456788999999999999999999999999999999999999
Q ss_pred Ch--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccc
Q 037365 198 SL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245 (398)
Q Consensus 198 ~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 245 (398)
+| +++||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecC
Confidence 87 46778999999999999999999999987542221 123345799
Q ss_pred ccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHH
Q 037365 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLR 325 (398)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (398)
+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ... ... .. +......
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~---~~~-~~~-~~----------p~~~~~~ 221 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFEL---ILM-EEI-RF----------PRTLSPE 221 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHH---HHc-CCC-CC----------CCCCCHH
Confidence 999999999999999999999999999999999999753211 111111 010 000 00 1223455
Q ss_pred HHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 326 YVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 326 ~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 78999999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=301.16 Aligned_cols=234 Identities=27% Similarity=0.392 Sum_probs=179.3
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcCC----CE-EEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRKG----NE-IAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCC 181 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 181 (398)
.++-..++-...++||+|+||.||+|++..+ .. ||||..+.. ......++.+|.+++++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3444445666678999999999999997542 23 899999853 466778999999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 182 IDKDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 182 ~~~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
.....+++|||+|.||+| ..+||||..+|+|++.++.+||+|||+++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999998 35778999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLE 307 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
..... ........-...|+|||.+..+.|+.++|||||||++||+++ |..||..... .+...++ ...+....
T Consensus 311 ~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~kI---~~~~~r~~ 383 (474)
T KOG0194|consen 311 AGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKAKI---VKNGYRMP 383 (474)
T ss_pred CCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHHHH---HhcCccCC
Confidence 64311 111111234678999999999999999999999999999998 7878643211 1111111 01111111
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCC
Q 037365 308 LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLP 360 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 360 (398)
. +...+..+..++.+||..+|++||||.++.+.|+.......+
T Consensus 384 ~----------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 384 I----------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred C----------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1 112344577888899999999999999999999987655443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=283.34 Aligned_cols=223 Identities=27% Similarity=0.442 Sum_probs=174.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ..+.+.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998643 478999999765433 457889999999999999999999999999999
Q ss_pred EEEEeccCCCCh----------------------------------------------hHHhhcCCCCCceecCCCCeEE
Q 037365 188 ILIYEYMPNKSL----------------------------------------------DFFLFNLKASNILLDKDMNPKI 221 (398)
Q Consensus 188 ~lV~e~~~~g~L----------------------------------------------~~~~~dlkp~NILl~~~~~~kl 221 (398)
+++|||+++|+| +++|+||||+||+++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 999999998865 2456799999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhh
Q 037365 222 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLW 300 (398)
Q Consensus 222 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 300 (398)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||..... .......
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~~~~~~~---- 237 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EEVIECI---- 237 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----
Confidence 99999986543332222233456788999999999999999999999999999998 9988643221 1111111
Q ss_pred hcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
..+..... ....+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 238 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQGRLLQR----------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111100 11233568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=288.78 Aligned_cols=216 Identities=24% Similarity=0.393 Sum_probs=181.3
Q ss_pred cCCCCccceecccCceEEEEEEE-cCCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVL-RKGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +..+.-.+.+|++||+.++||||+.++.+|++.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999986 45999999999765 455666788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||..+|.| ..+|||||.+|||+|.++++||+|||++..+.+.. .
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---f 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---F 208 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc---H
Confidence 999999998 35678999999999999999999999998776543 2
Q ss_pred cccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
..+++|++-|.+||++.+.+| ++.+|-|||||+||.|+.|..||+.. ....++.++..+.|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~------------------Dhk~lvrQIs~GaY 270 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR------------------DHKRLVRQISRGAY 270 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc------------------hHHHHHHHhhcccc
Confidence 456899999999999999998 68899999999999999999997532 12223334444444
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 351 (398)
..+..+....-||++||..+|++|.|+.+|...-
T Consensus 271 rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 271 REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 4444444567899999999999999999998753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=283.48 Aligned_cols=217 Identities=26% Similarity=0.349 Sum_probs=169.1
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999975 48999999986432 2233457789999999999999999999999999999999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++|+| +++||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--- 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---
Confidence 9999987 356789999999999999999999999987643321
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... ............. .. +
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~-~~---------~- 224 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRVKEDQ-EE---------Y- 224 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHhhccc-cc---------C-
Confidence 223478999999999999999999999999999999999999986432211 0001111010000 00 0
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
.......+.+|+.+||+.||.+||| ++++++
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1223456789999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=292.04 Aligned_cols=221 Identities=21% Similarity=0.339 Sum_probs=172.8
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||.||+|++.+ ++.||+|++.... ......+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468889999999999999999875 8899999986442 234456888999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++|+| +++|+||||+|||++.++.+||+|||+++.... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999988 467789999999999999999999999976543 22
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ........ .+.... ..
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i---~~~~~~~~--~~~~~~--~~ 226 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENL---KYWKETLQ--RPVYDD--PR 226 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHH---Hhcccccc--CCCCCc--cc
Confidence 3457899999999999999999999999999999999999997543211 111100 00000000 000000 01
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
......+.+++.+||+.+|.+|||++++++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1234567899999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=296.92 Aligned_cols=228 Identities=24% Similarity=0.363 Sum_probs=174.8
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 184 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 184 (398)
...++|+..+.||+|+||.||+|++.. +..||+|++... .......+.+|+.+++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 345689999999999999999998532 357999999754 333456788999999999 899999999999999
Q ss_pred CeeEEEEeccCCCChh----------------------------------------------------------------
Q 037365 185 DEKILIYEYMPNKSLD---------------------------------------------------------------- 200 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L~---------------------------------------------------------------- 200 (398)
+..++||||+++|+|.
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999988752
Q ss_pred --------------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 201 --------------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 201 --------------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
++||||||+|||+++++.+||+|||+++..............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 357899999999999999999999999876443222222223
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
.++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... ........... +..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~----~~~~~~~~~~~----------~~~ 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFY----KMVKRGYQMSR----------PDF 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHH----HHHHcccCccC----------CCC
Confidence 45678999999999999999999999999999997 999975432211 111 11111100000 011
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
.+..+.+++.+||+.||++|||+.+++++|+++.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2345789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=288.20 Aligned_cols=226 Identities=24% Similarity=0.339 Sum_probs=178.5
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--------------hhHHHHHHHHHHHHhcCCCcc
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--------------QGLREMKNEASVIAKVQHKNL 174 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~nI 174 (398)
+-....++|++.+.||+|.||.|-+|+... ++.||+|++.+... ...+...+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 345566899999999999999999999754 89999999864311 123577899999999999999
Q ss_pred cceeeEEEeC--CeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeE
Q 037365 175 VRLLGCCIDK--DEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPK 220 (398)
Q Consensus 175 v~l~~~~~~~--~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~k 220 (398)
|+|+.+..+. +..|||+|||..|.+ +++||||||+|+|++++|++|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9999999874 589999999999865 578899999999999999999
Q ss_pred EcccccceecCCCC---cccccccccccccccChhhhccCC----CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchh
Q 037365 221 ISDFGMARICGGNE---LQANTSRIVGTYGYMSPEYAIEGI----FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL 293 (398)
Q Consensus 221 l~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~ 293 (398)
|+|||.+....... ........+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||..
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~--------- 321 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD--------- 321 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---------
Confidence 99999998763221 112234468999999999998743 36889999999999999999999642
Q ss_pred HHHHHhhhcCCccccchhhhhcccC---hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 294 GYAWDLWRSNRTLELTDAILEDEYS---SKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
....++.+++...... .++....+.+|+.++|+.||++|.+..+|.....-
T Consensus 322 ---------~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 322 ---------DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ---------chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 2223333444333322 22345678899999999999999999999876543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=290.09 Aligned_cols=207 Identities=20% Similarity=0.294 Sum_probs=162.5
Q ss_pred ecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
||+|+||.||+|+..+ ++.||+|.+... .......+.+|+.++.+++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999865 788999998643 233456678899999999999999999999999999999999999988
Q ss_pred --------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccccc
Q 037365 200 --------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247 (398)
Q Consensus 200 --------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 247 (398)
+++||||||+|||++.++.+||+|||+++...... .......||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcc
Confidence 46778999999999999999999999987543222 12334579999
Q ss_pred ccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHH
Q 037365 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYV 327 (398)
Q Consensus 248 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (398)
|+|||++.+..++.++|||||||++|||++|+.||..... ........... ... +......+.
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~--~~~----------~~~~~~~~~ 221 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEP--LRF----------PDGFDRDAK 221 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC--CCC----------CCcCCHHHH
Confidence 9999999999999999999999999999999999753211 11111111110 000 122335678
Q ss_pred HHHHHchhcCCCCCCC---HHHHHH
Q 037365 328 NIALLCVQESADDRPT---TNDVVS 349 (398)
Q Consensus 328 ~li~~cl~~dP~~RPt---~~evl~ 349 (398)
+++.+||+.||.+||+ +.|+++
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 9999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=280.31 Aligned_cols=223 Identities=23% Similarity=0.348 Sum_probs=172.2
Q ss_pred cCCCCccceecccCceEEEEEEEc----CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+..+.+++||||++++|++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999864 25689999997653 3334578899999999999999999999999999999
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++|+| +++|+||||+|||++.++.+|++|||.+.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 9999999987 3556799999999999999999999987654322111
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ..... ........
T Consensus 164 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~----~~~~~~~~-------- 228 (266)
T cd05064 164 -TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA----VEDGFRLP-------- 228 (266)
T ss_pred -cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH----HHCCCCCC--------
Confidence 1122345678999999999999999999999999999775 99987533211 11111 11111000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.+..++..+.+++.+||+.+|++|||++++++.|++.
T Consensus 229 --~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 --APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0222345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=281.32 Aligned_cols=225 Identities=27% Similarity=0.422 Sum_probs=173.1
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 185 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 185 (398)
..+++|+..+.||+|+||.||+|.+.. +..||+|++... .......+.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 456789999999999999999998642 467999998643 2234456889999999999999999999999999
Q ss_pred eeEEEEeccCCCCh------------------------------------------hHHhhcCCCCCceecCCCCeEEcc
Q 037365 186 EKILIYEYMPNKSL------------------------------------------DFFLFNLKASNILLDKDMNPKISD 223 (398)
Q Consensus 186 ~~~lV~e~~~~g~L------------------------------------------~~~~~dlkp~NILl~~~~~~kl~D 223 (398)
..++||||+++|+| +.+|+||||+||++++++.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 99999999999876 245679999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhc
Q 037365 224 FGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRS 302 (398)
Q Consensus 224 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 302 (398)
||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||..... ...... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~~----~~~ 236 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRF----VME 236 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHc
Confidence 999876544332222223355778999999998899999999999999999999 6777643211 111111 111
Q ss_pred CCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 303 NRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
...... ....+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 237 ~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 11123457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=277.10 Aligned_cols=219 Identities=28% Similarity=0.406 Sum_probs=171.0
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
++|+..+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577889999999999999999888889999986443 234678889999999999999999999999999999999999
Q ss_pred CCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 196 NKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 196 ~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+|+| +++|+||||+||++++++.+||+|||+++......... ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-~~~~ 161 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGA 161 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec-cCCC
Confidence 9977 35678999999999999999999999988654332211 1223
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ........ ...... . . +..
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i---~~~~~~-~--~--------~~~ 225 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMI---SRGFRL-Y--R--------PKL 225 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH---HCCCCC-C--C--------CCC
Confidence 45668999999998889999999999999999999 888864321 11111111 111110 0 0 111
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
....+.+++.+||+.+|++|||++++++.|.
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2345789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=297.11 Aligned_cols=228 Identities=29% Similarity=0.450 Sum_probs=184.0
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
.++-...+...-++||-|.||.||.|.|+. .-.||||.++... ...++|++|..+|+.++|||+|+++|+|.....+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 344444445556789999999999999987 7789999997653 56789999999999999999999999999999999
Q ss_pred EEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 189 LIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 189 lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
||+|||.+|+| .++||||..+|+|+.++..+|++|||+++++..+.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 99999999998 57888999999999999999999999999987665
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
+.... ...-...|.|||-+....++.|+|||+|||+|||+.| |..||.. .+ ...++.++..+-.++-
T Consensus 420 YTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-----id-lSqVY~LLEkgyRM~~----- 487 (1157)
T KOG4278|consen 420 YTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-----ID-LSQVYGLLEKGYRMDG----- 487 (1157)
T ss_pred eeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-----cc-HHHHHHHHhccccccC-----
Confidence 44432 2334678999999999999999999999999999998 6666531 11 1223333332221111
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
+..++..+.+||+.||+++|.+||++.|+-+.++.+.
T Consensus 488 -----PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 488 -----PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -----CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 4456778899999999999999999999998887653
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=304.87 Aligned_cols=223 Identities=22% Similarity=0.277 Sum_probs=173.6
Q ss_pred hhhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC---
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--- 185 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 185 (398)
....++|.+.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+..+..++|+|++++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344579999999999999999999865 4899999998654 3445567889999999999999999988776432
Q ss_pred -----eeEEEEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEccc
Q 037365 186 -----EKILIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDF 224 (398)
Q Consensus 186 -----~~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DF 224 (398)
..++||||+++|+| +++||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 36899999999987 2467899999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC
Q 037365 225 GMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR 304 (398)
Q Consensus 225 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
|+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......... ..
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~~-~~ 261 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTLA-GR 261 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhc-CC
Confidence 99987654332223345679999999999999999999999999999999999999975321 1111111111 11
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 305 TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...+ +...+..+.+++.+||+.||.+|||+.++++.
T Consensus 262 ~~~~----------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDPL----------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1000 12234568899999999999999999999863
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=292.77 Aligned_cols=214 Identities=21% Similarity=0.290 Sum_probs=169.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC--CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK--GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.++|+..+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4678899999999999999998654 368999998543 22344567889999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----
Confidence 9999999987 3567899999999999999999999999876432
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...... ... ..
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~---~~~i~~-~~~-~~--------- 247 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LI---YQKILE-GII-YF--------- 247 (340)
T ss_pred -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HH---HHHHhc-CCC-CC---------
Confidence 23457999999999999988999999999999999999999997532111 11 111111 100 00
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRP-----TTNDVVSM 350 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 350 (398)
+......+.+++.+||+.||++|+ |++++++.
T Consensus 248 -p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 -PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111234577999999999999995 89998864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.27 Aligned_cols=230 Identities=23% Similarity=0.338 Sum_probs=177.8
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCcccceeeEEE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCI 182 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~ 182 (398)
++...++|.+.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+++++++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 34456789999999999999999998632 3469999997543 334567899999999996 999999999999
Q ss_pred eCCeeEEEEeccCCCChh--------------------------------------------------------------
Q 037365 183 DKDEKILIYEYMPNKSLD-------------------------------------------------------------- 200 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L~-------------------------------------------------------------- 200 (398)
+.+..++|||||++|+|.
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999998762
Q ss_pred ------------------------------------------------------------------HHhhcCCCCCceec
Q 037365 201 ------------------------------------------------------------------FFLFNLKASNILLD 214 (398)
Q Consensus 201 ------------------------------------------------------------------~~~~dlkp~NILl~ 214 (398)
++|+||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 34789999999999
Q ss_pred CCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchh
Q 037365 215 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLL 293 (398)
Q Consensus 215 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 293 (398)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 999999999999987654332222333457788999999999999999999999999999997 888865322111
Q ss_pred HHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 294 GYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
............. .....+..+.+++.+||+.||++|||+.++.++|+...
T Consensus 348 -~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 -TFYNKIKSGYRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHHHHhcCCCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0111111111000 01223456889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=285.51 Aligned_cols=166 Identities=27% Similarity=0.357 Sum_probs=144.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|++.+.||+|+||.||++.+.. +..+|+|.+... .......+.+|++++++++||||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4789999999999999999999875 788999988654 33445678899999999999999999999999999999999
Q ss_pred ccCCCChh---------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSLD---------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L~---------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+++|+|. ++|+||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~ 159 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----A 159 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----c
Confidence 99999882 4567999999999999999999999987653221 2
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCC
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGF 284 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~ 284 (398)
....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 234689999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=281.57 Aligned_cols=225 Identities=27% Similarity=0.433 Sum_probs=175.9
Q ss_pred CCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999852 245689999977666666789999999999999999999999999999999
Q ss_pred EEeccCCCCh---------------------------------------------hHHhhcCCCCCceecCCCCeEEccc
Q 037365 190 IYEYMPNKSL---------------------------------------------DFFLFNLKASNILLDKDMNPKISDF 224 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------------------~~~~~dlkp~NILl~~~~~~kl~DF 224 (398)
+|||+++++| +++||||||+|||+++++.+||+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccC
Confidence 9999998876 2456799999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 225 GMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 225 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .. ......+
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~----~~~i~~~ 238 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EV----IECITQG 238 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcC
Confidence 99986643332222233446778999999998899999999999999999998 88886432211 11 1111111
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
..... ....+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 239 ~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 239 RVLQR----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CcCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11110 11123458899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=278.10 Aligned_cols=223 Identities=27% Similarity=0.433 Sum_probs=178.6
Q ss_pred hhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
...++|+..+.||+|+||.||+|.+.++..+|+|.+..........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 44567889999999999999999998899999999987766566788999999999999999999999999999999999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++|+| +++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-- 160 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-- 160 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--
Confidence 9999887 3456799999999999999999999999766433211
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ......... ......
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~----~~~~~~---------- 224 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQIT----AGYRMP---------- 224 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHH----hCCcCC----------
Confidence 123345778999999998899999999999999999998 788874322 111111111 100000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.+...+..+.+++.+||+.||++|||++++++.|++
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 012234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=288.90 Aligned_cols=209 Identities=22% Similarity=0.310 Sum_probs=164.2
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
+.||+|+||.||+++... |+.||+|.+... .......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 468999999999999764 899999998653 2234456778999999999999999999999999999999999999
Q ss_pred Ch--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccc
Q 037365 198 SL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245 (398)
Q Consensus 198 ~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 245 (398)
+| +++||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCC
Confidence 87 46678999999999999999999999987532221 112335789
Q ss_pred ccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHH
Q 037365 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLR 325 (398)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (398)
+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... .. . . +......
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~---~~~~~~-~~-~-----~-----p~~~~~~ 221 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLF---ELILME-EI-R-----F-----PRTLSPE 221 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHH---HHHhcC-CC-C-----C-----CCCCCHH
Confidence 9999999999999999999999999999999999997532211 111 011110 00 0 0 1122345
Q ss_pred HHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 326 YVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 326 ~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 78999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=288.94 Aligned_cols=210 Identities=21% Similarity=0.299 Sum_probs=165.3
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
+.||+|+||.||+++... ++.||+|++... .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999764 899999999654 2334567788999999999999999999999999999999999999
Q ss_pred Ch--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccc
Q 037365 198 SL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245 (398)
Q Consensus 198 ~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 245 (398)
+| +++||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCC
Confidence 87 35678999999999999999999999987543221 122345799
Q ss_pred ccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHH
Q 037365 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLR 325 (398)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (398)
+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....... .. . . +......
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~---~~~~~~~-~~-~-----~-----p~~~~~~ 221 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KL---FELILME-DI-K-----F-----PRTLSAD 221 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HH---HHHhccC-Cc-c-----C-----CCCCCHH
Confidence 9999999999999999999999999999999999997532111 11 1111100 00 0 0 1122345
Q ss_pred HHHHHHHchhcCCCCCC-----CHHHHHHH
Q 037365 326 YVNIALLCVQESADDRP-----TTNDVVSM 350 (398)
Q Consensus 326 ~~~li~~cl~~dP~~RP-----t~~evl~~ 350 (398)
+.+++.+||+.||++|| ++.|+++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 78999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=279.00 Aligned_cols=239 Identities=27% Similarity=0.358 Sum_probs=172.7
Q ss_pred CCC-CccceecccCceEEEEEEE-----cCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--Ce
Q 037365 116 NRF-SDANKLGEGGFGPVYKGVL-----RKGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DE 186 (398)
Q Consensus 116 ~~~-~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~ 186 (398)
++| +..+.||+|+||.||++.. .++..||+|.+.... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 7889999999999988753 247789999987553 23456788999999999999999999988763 46
Q ss_pred eEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 187 KILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 187 ~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.+++|||+++|+| +++|+||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 8999999999987 356789999999999999999999999987654322
Q ss_pred cc-ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QA-NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........................+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 11 11223456679999999988899999999999999999999999754332211111110000000000000000000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
.. .+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 243 ~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 243 LP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00 01223457899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=284.93 Aligned_cols=224 Identities=27% Similarity=0.448 Sum_probs=172.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-CC----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GN----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.+|+..+.||+|+||.||+|.+.. +. .||+|.+.... ....+.+.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 568999999999999999998643 33 38999987543 34556788999999999999999999999764 5789
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
++||+++|+| +++|+||||+|||+++++.+||+|||+++........
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 165 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence 9999999987 3567899999999999999999999999876543322
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .. ............
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~----~~~~~~~~~~~~------- 232 (316)
T cd05108 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EI----SSILEKGERLPQ------- 232 (316)
T ss_pred eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHhCCCCCCC-------
Confidence 22222345678999999999999999999999999999998 88887532111 11 111111110000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+..+...+.+++.+||+.+|.+|||+.+++..|.....
T Consensus 233 ---~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 233 ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11123457899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=280.77 Aligned_cols=230 Identities=25% Similarity=0.389 Sum_probs=171.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC---------------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCccccee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK---------------GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLL 178 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~ 178 (398)
.++|++.+.||+|+||.||+++..+ ...||+|.+... .......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999998642 234899998764 334456789999999999999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCh--------------------------------------------hHHhhcCCCCCceec
Q 037365 179 GCCIDKDEKILIYEYMPNKSL--------------------------------------------DFFLFNLKASNILLD 214 (398)
Q Consensus 179 ~~~~~~~~~~lV~e~~~~g~L--------------------------------------------~~~~~dlkp~NILl~ 214 (398)
+++...+..++||||+++++| +.+|+||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 999999999999999998865 234679999999999
Q ss_pred CCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcC--CCCCCCCCCCccch
Q 037365 215 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSG--KKNTGFYRTDTLNL 292 (398)
Q Consensus 215 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg--~~P~~~~~~~~~~~ 292 (398)
+++.+||+|||++................++..|+|||.+.++.++.++|||||||++|||+++ ..||... .....
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~--~~~~~ 241 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL--SDEQV 241 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc--ChHHH
Confidence 9999999999999765433322222334557789999999988999999999999999999984 4454322 11112
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.......+.......... ..+..+..+.+++.+||+.||++|||+++|++.|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111110000000 011123568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=279.98 Aligned_cols=229 Identities=20% Similarity=0.287 Sum_probs=168.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|+..+.||+|+||.||+|+... ++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 578999999999999999999764 8899999986542 22345677899999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++ +| +++||||||+|||++.++.+||+|||+++...... ....
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~ 161 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYS 161 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--cccc
Confidence 985 44 46788999999999999999999999997654322 1123
Q ss_pred cccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC---------ccc---
Q 037365 241 RIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR---------TLE--- 307 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---------~~~--- 307 (398)
...|++.|+|||++.+ ..++.++||||+||++|||++|+.||...... .............. ..+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 3468999999999875 56899999999999999999999997543221 11111111110000 000
Q ss_pred cchhhhhccc---ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 308 LTDAILEDEY---SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 308 ~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+...... ..........+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 00112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=275.68 Aligned_cols=221 Identities=30% Similarity=0.469 Sum_probs=174.9
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46788899999999999999998888899999986543 23567889999999999999999999999999999999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
++|+| +.+|+||||+||+++.++.+||+|||++.......... ..
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~ 162 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-RE 162 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec-cC
Confidence 99887 35667999999999999999999999998765432211 22
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...... ......... .
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~----~~~~~~~~~----------~ 226 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSA----LQRGYRMPR----------M 226 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHHH----HHcCCCCCC----------C
Confidence 2345678999999998889999999999999999998 8888753211 111111 111100000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
...+..+.+++.+||+.+|++|||++++.+.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=272.87 Aligned_cols=234 Identities=22% Similarity=0.300 Sum_probs=172.7
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCcccceeeEEEeC--Cee
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ--GLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 187 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 187 (398)
...+.|+..++|++|+||.||+|+++. ++.||+|+++..... .--...+|+.+|.+++|||||.+-.+.... +..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 344679999999999999999999876 788999999765321 122457899999999999999999888753 579
Q ss_pred EEEEeccCCCC--------------------------------hhHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKS--------------------------------LDFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~--------------------------------L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
|+|||||++.- ..++|||||++|+|+...|.+||+|||+|+.++...
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~- 231 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL- 231 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc-
Confidence 99999997631 147789999999999999999999999999987653
Q ss_pred ccccccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh--------cCCcc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR--------SNRTL 306 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--------~~~~~ 306 (398)
...+..+-|.+|+|||.+.+.+ |+++.|+||+|||+.||+++++-|..... .+..+.+...+. +-...
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHHHhCCCccccCCCcccc
Confidence 2344567799999999999865 89999999999999999999987643222 111112211111 10000
Q ss_pred c---------cchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 307 E---------LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 307 ~---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. .....+...+......+.-.+|+..++.+||.+|.|++|.++.
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 0111111222111133567799999999999999999998863
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=286.69 Aligned_cols=209 Identities=23% Similarity=0.350 Sum_probs=163.7
Q ss_pred ceecccCceEEEEEEEc----CCCEEEEEEccCC----ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 122 NKLGEGGFGPVYKGVLR----KGNEIAVKRLSGR----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+.||+|+||.||+++.. .++.||+|.+... .......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 4788999998643 222335677899999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+++|+| +++||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 159 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHT 159 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--Ccccc
Confidence 999987 46678999999999999999999999987543222 12233
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... . ..+ +..
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~-~-~~~----------~~~ 222 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKG-K-LNL----------PPY 222 (323)
T ss_pred cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcC-C-CCC----------CCC
Confidence 57999999999999988999999999999999999999997532211 111111111 0 000 112
Q ss_pred HHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
....+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 234578999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=273.15 Aligned_cols=224 Identities=20% Similarity=0.335 Sum_probs=176.4
Q ss_pred CCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999976 4899999987542 3344456889999999999999999999999999999999
Q ss_pred eccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 192 EYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 192 e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||+++|+| +++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999887 345679999999999999999999999987653321
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......|++.|+|||.+.+..++.++|+||||+++|||++|+.||.....+. ..+... ........
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~-~~~~~~~~-------- 227 (267)
T cd08228 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQK-IEQCDYPP-------- 227 (267)
T ss_pred --HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHH-HhcCCCCC--------
Confidence 1223468889999999998889999999999999999999999975332221 111111 11101000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 228 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 -LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00123345688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=286.94 Aligned_cols=213 Identities=24% Similarity=0.350 Sum_probs=163.1
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHH---HhcCCCcccceeeEEEeCCeeEEE
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVI---AKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
|++.+.||+|+||.||+|.+.. ++.||+|.++... ....+.+.+|..++ ++++||||+++++++.+++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5677899999999999999765 8899999996432 22344566666655 566799999999999999999999
Q ss_pred EeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 191 YEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 191 ~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|||+++|+| +++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--Ccc
Confidence 999999987 46678999999999999999999999987543221 123
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... . ....... .... .+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~---~~~~i~~-~~~~-----------~p 221 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--E---VFDSIVN-DEVR-----------YP 221 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--H---HHHHHHh-CCCC-----------CC
Confidence 3467999999999999999999999999999999999999997532111 1 1111111 0000 01
Q ss_pred HHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
...+..+.+++.+||+.||.+|| ++.++++
T Consensus 222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 12234578999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=264.91 Aligned_cols=214 Identities=24% Similarity=0.315 Sum_probs=176.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|++.+.||+|-||.||+|+.+. +..||+|++.+.. ....+++.+|+++-+.++||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4789999999999999999999765 7789999986542 23346788999999999999999999999999999999
Q ss_pred EeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 191 YEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 191 ~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
+||.++|.+ ..+||||||+|+|++..+..||+|||-+-....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~---- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC----
Confidence 999999987 578899999999999999999999999876432
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
......+||..|.+||...+..++..+|+|++|++.||++.|.+||...... +....+..-+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~------------------etYkrI~k~~ 238 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS------------------ETYKRIRKVD 238 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH------------------HHHHHHHHcc
Confidence 2345579999999999999999999999999999999999999997643311 1111111111
Q ss_pred c-ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 317 Y-SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 317 ~-~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. .+........+++.+|+..+|.+|.+..|++..
T Consensus 239 ~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 022334567899999999999999999998863
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=273.27 Aligned_cols=215 Identities=25% Similarity=0.382 Sum_probs=176.5
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
..+.|++.+.||+|.|+.||++.+.. |+.+|+|.+... .....+.+.+|+.|.+.++||||+++++...+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 35678888999999999999998765 888998887533 344678899999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceec---CCCCeEEcccccceecCCCCc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLD---KDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~---~~~~~kl~DFGla~~~~~~~~ 235 (398)
+|+|.||+| +++|||+||+|+|+. ...-+||+|||+|..+.+..
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~- 167 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE- 167 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc-
Confidence 999999988 578999999999994 34469999999999887332
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.....+|||+|||||++...+|+..+|||+.||+||-|+.|.+||.. .....+.+.+..+
T Consensus 168 --~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~------------------~~~~rlye~I~~g 227 (355)
T KOG0033|consen 168 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD------------------EDQHRLYEQIKAG 227 (355)
T ss_pred --ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC------------------ccHHHHHHHHhcc
Confidence 34457899999999999999999999999999999999999999642 1112222333333
Q ss_pred ccC-----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 316 EYS-----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 316 ~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+. .+...+...+|+++||..||.+|.|+.|.++
T Consensus 228 ~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 228 AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 222 2234467889999999999999999998875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=274.02 Aligned_cols=223 Identities=27% Similarity=0.402 Sum_probs=173.8
Q ss_pred CCCCccceecccCceEEEEEEEcC----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|+..+.||+|+||.||+|.+.. ...||+|.+.... ......+.+|+.++++++||||+++++.+...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999999753 3579999987543 33456788999999999999999999999999999999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+++++| +++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 999999987 35677999999999999999999999998775222211
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... .........
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~~~-------- 229 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKA----VEDGYRLPP-------- 229 (266)
T ss_pred eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHH----HHcCCCCCC--------
Confidence 2222345678999999998899999999999999999998 9888643221 111111 111100000
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
....+..+.+++.+||+.+|++|||++++++.|+++
T Consensus 230 --~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 --PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=274.74 Aligned_cols=221 Identities=24% Similarity=0.430 Sum_probs=169.9
Q ss_pred CCccceecccCceEEEEEEEcC----CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe-----
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----- 186 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 186 (398)
|.+.+.||+|+||.||+|.+.. +..||+|+++.. .......+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998753 367999998754 23445678999999999999999999999876554
Q ss_pred -eEEEEeccCCCCh--------------------------------------hHHhhcCCCCCceecCCCCeEEcccccc
Q 037365 187 -KILIYEYMPNKSL--------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMA 227 (398)
Q Consensus 187 -~~lV~e~~~~g~L--------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla 227 (398)
.+++|||+++|+| +++|+||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 7999999999887 2566799999999999999999999999
Q ss_pred eecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 228 RICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||.... .....+.. ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~~~~~~~----~~~~~~ 234 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHEIYDYL----RHGNRL 234 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCCC
Confidence 87654433222222345678999999988889999999999999999999 777764321 11111111 111111
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.. +......+.+++.+||+.||++|||+.|+++.|++.
T Consensus 235 ~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 KQ----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC----------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 122345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=274.30 Aligned_cols=222 Identities=28% Similarity=0.427 Sum_probs=174.2
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..++|+..+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 356788899999999999999998778889999987543 3346788999999999999999999999999999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+++++| +++|+||||+||++++++.+||+|||+++........ ..
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~ 161 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AR 161 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-cc
Confidence 999887 3556799999999999999999999999877533211 11
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||..... .... .......... .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~----~~~~~~~~~~----------~ 225 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVL----QQVDQGYRMP----------C 225 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHHcCCCCC----------C
Confidence 12233457999999998899999999999999999999 8888653211 1111 1111110000 0
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=279.34 Aligned_cols=216 Identities=33% Similarity=0.537 Sum_probs=161.4
Q ss_pred ccceecccCceEEEEEEEc-----CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 120 DANKLGEGGFGPVYKGVLR-----KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999987 2567999999654 334578899999999999999999999999988889999999
Q ss_pred cCCCChh----------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSLD----------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L~----------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+++|+|. ++|+||+++||++++++.+||+|||++............
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~ 162 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKND 162 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEES
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999883 445689999999999999999999999887433222223
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....+...|+|||.+.+..++.++||||||+++||+++ |+.|+... ..... .... ........
T Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~---~~~~-~~~~~~~~---------- 226 (259)
T PF07714_consen 163 SSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEI---IEKL-KQGQRLPI---------- 226 (259)
T ss_dssp TTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHH---HHHH-HTTEETTS----------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--ccccc---cccc-ccccccee----------
Confidence 33456788999999999999999999999999999999 67775432 11111 1111 11111111
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 351 (398)
+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112244578999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=287.10 Aligned_cols=227 Identities=16% Similarity=0.176 Sum_probs=167.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|++.+.||+|+||.||+|.+.. ++.||+|.... ..+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3679999999999999999999865 88999997532 3467899999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+.+ +| +++||||||+|||++.++.+||+|||+++...... ......
T Consensus 165 ~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 242 (391)
T PHA03212 165 YKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYG 242 (391)
T ss_pred CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccccc
Confidence 864 43 47889999999999999999999999997543221 112234
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc-----cchhHHHHHhhhcCC---c---cccch
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-----LNLLGYAWDLWRSNR---T---LELTD 310 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~-----~~~~~~~~~~~~~~~---~---~~~~~ 310 (398)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ............... . ....+
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 579999999999999999999999999999999999998864322110 001111111000000 0 00000
Q ss_pred hhh----h-------ccc---ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AIL----E-------DEY---SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~~----~-------~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
... . ... .....+..+.+++.+||+.||++|||++|+++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0 000 01123456889999999999999999999995
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=279.40 Aligned_cols=225 Identities=27% Similarity=0.416 Sum_probs=177.1
Q ss_pred CCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.+|...+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999853 245689999977666666788999999999999999999999999999999
Q ss_pred EEeccCCCChh------------------------------------------------HHhhcCCCCCceecCCCCeEE
Q 037365 190 IYEYMPNKSLD------------------------------------------------FFLFNLKASNILLDKDMNPKI 221 (398)
Q Consensus 190 V~e~~~~g~L~------------------------------------------------~~~~dlkp~NILl~~~~~~kl 221 (398)
||||+++++|. ++|+||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEE
Confidence 99999988652 346799999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhh
Q 037365 222 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLW 300 (398)
Q Consensus 222 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 300 (398)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .. ....
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~----~~~~ 238 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EV----IECI 238 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHH
Confidence 99999976544332222333456788999999999999999999999999999998 99886543221 11 1111
Q ss_pred hcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
........ ....+..+.+++.+||+.+|++|||+++++++|+++..
T Consensus 239 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 239 TQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred hCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111111 11223468899999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=293.04 Aligned_cols=213 Identities=27% Similarity=0.441 Sum_probs=173.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
..|+..+.||.|+||.||.|++.. .+.||||++.-. ..+.|+.+.+|+..|.+++|||++.+-|||......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 356777889999999999999765 778999999644 4566889999999999999999999999999999999999
Q ss_pred eccCCC--------------------------------ChhHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNK--------------------------------SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g--------------------------------~L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|||-|. ++..+|||||..|||+++.|.|||+|||.|.... ..
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PA 179 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PA 179 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------ch
Confidence 999775 2357889999999999999999999999987653 34
Q ss_pred ccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 240 SRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
..++|||+|||||++. .+.|+-|+||||||+++.||...++|.... +.+...+..-.... +.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-----NAMSALYHIAQNes------Pt---- 244 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNES------PT---- 244 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-----hHHHHHHHHHhcCC------CC----
Confidence 4579999999999986 578999999999999999999999995432 11111111111111 11
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...++....+.+++..||+.-|.+|||.+++++
T Consensus 245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 114566778999999999999999999998875
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=278.82 Aligned_cols=222 Identities=29% Similarity=0.424 Sum_probs=171.1
Q ss_pred CCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
.+|++.+.||+|+||.||+|.+.+ +..||+|++..... .....+.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357778899999999999998643 46799999975532 33456889999999999999999999999999999
Q ss_pred EEEeccCCCCh------------------------------------------------hHHhhcCCCCCceecCCCCeE
Q 037365 189 LIYEYMPNKSL------------------------------------------------DFFLFNLKASNILLDKDMNPK 220 (398)
Q Consensus 189 lV~e~~~~g~L------------------------------------------------~~~~~dlkp~NILl~~~~~~k 220 (398)
+++||+++++| +++|+||||+||++++++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999987764 246789999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHh
Q 037365 221 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDL 299 (398)
Q Consensus 221 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 299 (398)
|+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..|+..... ... . ..
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~---~-~~ 238 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDV---I-EM 238 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHH---H-HH
Confidence 999999886644332222333456789999999998899999999999999999998 7777643211 111 1 11
Q ss_pred hhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 300 WRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
......... ...++..+.+++.+||+.+|++|||+++|+..|+.
T Consensus 239 i~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQVLPC----------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCcCCC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111100 12234557899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=278.49 Aligned_cols=228 Identities=27% Similarity=0.422 Sum_probs=174.4
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 184 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 184 (398)
+...++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.++++++||||+++++++.++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3456889999999999999999997642 4579999986543 23345678899999999999999999999999
Q ss_pred CeeEEEEeccCCCChh------------------------------------------HHhhcCCCCCceecCCCCeEEc
Q 037365 185 DEKILIYEYMPNKSLD------------------------------------------FFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L~------------------------------------------~~~~dlkp~NILl~~~~~~kl~ 222 (398)
+..++||||+++|+|. ++|+||||+|||+++++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999988772 4567999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhh
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWR 301 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 301 (398)
|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||..... ...... ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~~~~~----~~ 235 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKF----VM 235 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HH
Confidence 9999986543332222222345678999999999999999999999999999998 6777643211 111111 11
Q ss_pred cCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 302 SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
....... ....+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 236 ~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGYLDQ----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1110000 1112356889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=276.50 Aligned_cols=230 Identities=26% Similarity=0.379 Sum_probs=174.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-----------------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-----------------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVR 176 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 176 (398)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4688999999999999999998653 2458999987553 345667889999999999999999
Q ss_pred eeeEEEeCCeeEEEEeccCCCCh-------------------------------------------hHHhhcCCCCCcee
Q 037365 177 LLGCCIDKDEKILIYEYMPNKSL-------------------------------------------DFFLFNLKASNILL 213 (398)
Q Consensus 177 l~~~~~~~~~~~lV~e~~~~g~L-------------------------------------------~~~~~dlkp~NILl 213 (398)
+++++..++..+++|||+++++| +++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 99999999999999999998855 34578999999999
Q ss_pred cCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc--CCCCCCCCCCCccc
Q 037365 214 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS--GKKNTGFYRTDTLN 291 (398)
Q Consensus 214 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~P~~~~~~~~~~ 291 (398)
++++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+... ....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~--~~~~ 241 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL--TDQQ 241 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc--ChHH
Confidence 9999999999999987654433333334456788999999998889999999999999999998 55665322 1112
Q ss_pred hhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 292 LLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
........+.......... .....+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 2222222211111111000 011223568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=286.42 Aligned_cols=229 Identities=27% Similarity=0.391 Sum_probs=174.3
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 184 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 184 (398)
...++|++.+.||+|+||.||+|...+ ++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 345689999999999999999997432 4789999987542 33345678899999999 899999999988754
Q ss_pred -CeeEEEEeccCCCChh---------------------------------------------------------------
Q 037365 185 -DEKILIYEYMPNKSLD--------------------------------------------------------------- 200 (398)
Q Consensus 185 -~~~~lV~e~~~~g~L~--------------------------------------------------------------- 200 (398)
...+++|||+++|+|.
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5688999999988662
Q ss_pred ------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccC
Q 037365 201 ------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 250 (398)
Q Consensus 201 ------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 250 (398)
++||||||+|||++.++.+||+|||+++.+.............++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 45789999999999999999999999987643332222333456778999
Q ss_pred hhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHH
Q 037365 251 PEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNI 329 (398)
Q Consensus 251 PE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 329 (398)
||++.+..++.++|||||||++|||++ |..||....... . ............. +......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~----~~~~~~~~~~~~~----------~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-E----FCRRLKEGTRMRA----------PEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-H----HHHHHhccCCCCC----------CccCCHHHHHH
Confidence 999999999999999999999999997 988875321111 1 1111111111000 11223458899
Q ss_pred HHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 330 ALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 330 i~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+.+||+.+|++|||+.|+++.|+.+.+
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=276.73 Aligned_cols=222 Identities=30% Similarity=0.453 Sum_probs=172.2
Q ss_pred CCCCccceecccCceEEEEEEEc-----CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-----KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|+..+.||+|+||.||+|.+. .+..+|+|.+... .......+.+|+.++++++||||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46778899999999999999852 3678999999754 33445678899999999999999999999999999999
Q ss_pred EEeccCCCCh-------------------------------------------------hHHhhcCCCCCceecCCCCeE
Q 037365 190 IYEYMPNKSL-------------------------------------------------DFFLFNLKASNILLDKDMNPK 220 (398)
Q Consensus 190 V~e~~~~g~L-------------------------------------------------~~~~~dlkp~NILl~~~~~~k 220 (398)
+|||+++|+| +++|+||||+|||+++++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 9999998865 245679999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHh
Q 037365 221 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDL 299 (398)
Q Consensus 221 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 299 (398)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ..... .
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~----~ 238 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIE----M 238 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----H
Confidence 999999987644332222333456778999999998889999999999999999998 8888643211 11111 1
Q ss_pred hhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 300 WRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
......... ....+..+.+++.+||+.||++||++.++++.|.+
T Consensus 239 ~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQLLPC----------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcCCC----------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111110 11223457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.51 Aligned_cols=226 Identities=25% Similarity=0.289 Sum_probs=180.2
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcCC-CEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEE-e---C-
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRKG-NEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCI-D---K- 184 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~-~---~- 184 (398)
.....++++.+.|.+|||+.||.|....+ ..+|+|++...+....+.+.+|+++|++|. |+|||.+++... . +
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456778889999999999999998875 999999998888889999999999999997 999999999432 1 1
Q ss_pred --CeeEEEEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEccccc
Q 037365 185 --DEKILIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 185 --~~~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
-+.+|.||||+||+| -++|||||-+||||+.+++.||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 257899999999877 378999999999999999999999999
Q ss_pred ceecCCCCccc-------ccccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH
Q 037365 227 ARICGGNELQA-------NTSRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA 296 (398)
Q Consensus 227 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 296 (398)
+...-...... ..-....|+.|+|||.+. +.+.++|+|||||||+||-|+....||+..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s----------- 261 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES----------- 261 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC-----------
Confidence 86432221100 011235699999999874 667899999999999999999999997532
Q ss_pred HHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 297 WDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....+++....-.. .+.....+.+||..||+.||.+||++-+|+..+..+..
T Consensus 262 -------g~laIlng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 262 -------GKLAILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -------cceeEEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 22233333222111 35677889999999999999999999999998877654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=290.94 Aligned_cols=221 Identities=23% Similarity=0.351 Sum_probs=166.4
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.|+..+.||+|+||.||+|+... ++.||+|++... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58888999999999999999765 789999999653 22345678899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc-----
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL----- 235 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~----- 235 (398)
|+++|+| +++||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999987 467789999999999999999999999764311000
Q ss_pred ----------------------------------------ccccccccccccccChhhhccCCCCcccccHHHHHHHHHH
Q 037365 236 ----------------------------------------QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEI 275 (398)
Q Consensus 236 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 275 (398)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 0001235799999999999998999999999999999999
Q ss_pred HcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHH--chhcCCCCCCCHHHHHHH
Q 037365 276 VSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALL--CVQESADDRPTTNDVVSM 350 (398)
Q Consensus 276 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP~~RPt~~evl~~ 350 (398)
++|+.||........ ............... .......+.+++.+ |+..+|..|||++++++.
T Consensus 242 ltG~~Pf~~~~~~~~-----~~~i~~~~~~~~~~~--------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 242 LVGQPPFLAPTPTET-----QLKVINWENTLHIPP--------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HhCCCCCcCCCHHHH-----HHHHHccccccCCCC--------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999864322110 001110000000000 01123456678877 556677779999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=274.13 Aligned_cols=222 Identities=21% Similarity=0.323 Sum_probs=172.2
Q ss_pred CCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|+..+.||+|+||.||+|.+. +++.||+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999875 4888999998654 334456788999999999999999999999999999999999
Q ss_pred cCCCCh----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccc
Q 037365 194 MPNKSL----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245 (398)
Q Consensus 194 ~~~g~L----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 245 (398)
+++++| +++|+||||+|||++.++.+||+|||++....... .....||
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~ 156 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGT 156 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCC
Confidence 999977 35678999999999999999999999997654322 2335789
Q ss_pred ccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhH-HHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLG-YAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
..|+|||++.+..++.++|+|||||++|+|++|+.||............ ............. . .......
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~----~~~~~~~ 227 (279)
T cd06619 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----L----PVGQFSE 227 (279)
T ss_pred hhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----C----CCCcCCH
Confidence 9999999999989999999999999999999999998643322111100 0000000000000 0 0111234
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 325 RYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.+.+++.+||+.+|++||+++|+++.
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 57899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=273.15 Aligned_cols=220 Identities=24% Similarity=0.427 Sum_probs=167.4
Q ss_pred CccceecccCceEEEEEEEcC-CC--EEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC------Cee
Q 037365 119 SDANKLGEGGFGPVYKGVLRK-GN--EIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DEK 187 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~ 187 (398)
.+.+.||+|+||.||+|.+.. +. .+|+|.++.. .....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999865 32 5899988654 344567788999999999999999999988542 256
Q ss_pred EEEEeccCCCCh--------------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 188 ILIYEYMPNKSL--------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
+++|||+++|+| +++|+||||+|||+++++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 899999999876 356789999999999999999999999987
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .... ............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~----~~~~~~~~~~~~ 235 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEI----YDYLRQGNRLKQ 235 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHH----HHHHHcCCCCCC
Confidence 654332222222345678999999999999999999999999999999 777764321 1111 111111111110
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
....+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 236 ----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=271.89 Aligned_cols=215 Identities=25% Similarity=0.355 Sum_probs=165.0
Q ss_pred ceecccCceEEEEEEEc-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 122 NKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
+.||+|+||.||+|.+. +++.+|+|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999976 4889999988654 334456789999999999999999999999999999999999999877
Q ss_pred ---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccc
Q 037365 200 ---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 246 (398)
Q Consensus 200 ---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 246 (398)
+++|+||||+||+++.++.+||+|||++................++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 35677999999999999999999999987654322111111122345
Q ss_pred cccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHH
Q 037365 247 GYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLR 325 (398)
Q Consensus 247 ~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (398)
.|+|||.+.++.++.++||||||+++|||++ |..|+...... . ............. ....+..
T Consensus 161 ~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~----~~~~~~~~~~~~~----------~~~~~~~ 224 (252)
T cd05084 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--Q----TREAIEQGVRLPC----------PELCPDA 224 (252)
T ss_pred eecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--H----HHHHHHcCCCCCC----------cccCCHH
Confidence 7999999999899999999999999999998 87776432111 0 1111111100000 1122456
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 326 YVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 326 ~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
+.+++.+||+.+|++|||+.+++++|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=283.91 Aligned_cols=210 Identities=24% Similarity=0.329 Sum_probs=163.5
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|+... ++.||+|.+... .......+..|..++..+ +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 368999999999999865 789999998653 223345677888888876 799999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccccccc
Confidence 987 45678999999999999999999999987643222 12234578
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... ... .......... .+.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~---~~~i~~~~~~------------~p~~~~~ 221 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--DDL---FESILHDDVL------------YPVWLSK 221 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--HHH---HHHHHcCCCC------------CCCCCCH
Confidence 9999999999999999999999999999999999999753321 111 1111111000 0111234
Q ss_pred HHHHHHHHchhcCCCCCC-------CHHHHHHH
Q 037365 325 RYVNIALLCVQESADDRP-------TTNDVVSM 350 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RP-------t~~evl~~ 350 (398)
.+.+++.+||+.||++|| +++++++.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 578999999999999999 88888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=289.99 Aligned_cols=220 Identities=22% Similarity=0.336 Sum_probs=168.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||+|+... ++.||||++... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 478899999999999999999865 889999999643 2234456788999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc--
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA-- 237 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 237 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++.+.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999987 35678999999999999999999999987653211000
Q ss_pred ----------------------------------ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCC
Q 037365 238 ----------------------------------NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTG 283 (398)
Q Consensus 238 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~ 283 (398)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112469999999999999999999999999999999999999985
Q ss_pred CCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCC---HHHHHH
Q 037365 284 FYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPT---TNDVVS 349 (398)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~ 349 (398)
..... .. ............... .......+.+++.+|+. +|.+|++ ++|+++
T Consensus 241 ~~~~~--~~---~~~i~~~~~~~~~~~--------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 241 SDNPQ--ET---YRKIINWKETLQFPD--------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCHH--HH---HHHHHcCCCccCCCC--------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 43211 11 111111110000000 00123457789999996 9999998 988886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=273.50 Aligned_cols=221 Identities=29% Similarity=0.463 Sum_probs=172.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.+|+..+.||+|+||.||+|.+.+ ++.||+|.+.... .....+.+|++++++++|+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457778899999999999999765 8889999987543 34567889999999999999999999999999999999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
++++| +++|+||||+||++++++.+||+|||++......... ...
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~ 163 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHA 163 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccC
Confidence 99987 3456799999999999999999999999876543221 112
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ... +.........+. +
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~----~~~~~~~~~~~~----------~ 227 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV----YELLEKGYRMER----------P 227 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHH----HHHHHCCCCCCC----------C
Confidence 2234668999999999999999999999999999998 8888643211 111 111111100000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
...+..+.+++.+||+.||++|||+.+++++|+..
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 22345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=282.49 Aligned_cols=215 Identities=20% Similarity=0.362 Sum_probs=164.3
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+++... ++.+|+|.+... .......+.+|..++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999765 788999999754 233445677899888877 799999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccC
Confidence 987 35678999999999999999999999987532211 12234578
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCC---ccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD---TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.......... .+ +..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~----------p~~ 227 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI----------PRS 227 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-CC----------CCC
Confidence 99999999999999999999999999999999999998532211 11112222222211111 00 122
Q ss_pred HHHHHHHHHHHchhcCCCCCCC------HHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRPT------TNDVVS 349 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt------~~evl~ 349 (398)
....+.+++.+||+.||++||| +.++++
T Consensus 228 ~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 228 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 2345789999999999999998 466654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=281.72 Aligned_cols=231 Identities=20% Similarity=0.318 Sum_probs=165.5
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-----eeE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI 188 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 188 (398)
+|++.+.||+|+||.||+|+... ++.||+|++... .......+.+|+.++++++||||+++++++...+ ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 57888999999999999999764 899999998643 2233456889999999999999999999886532 479
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc-
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL- 235 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 235 (398)
+||||+.+ +| +++||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 99999964 54 467889999999999999999999999976532221
Q ss_pred ccccccccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc-----------
Q 037365 236 QANTSRIVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS----------- 302 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~----------- 302 (398)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ............
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhhh
Confidence 111234578999999999876 67899999999999999999999997543211 111111111100
Q ss_pred CCccccchhhhhcccC-----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 303 NRTLELTDAILEDEYS-----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
................ .+.....+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000 01123457899999999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.19 Aligned_cols=221 Identities=23% Similarity=0.350 Sum_probs=172.1
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||.||+|+... ++.||+|++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 468889999999999999999864 8999999986432 234567888999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC-----
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE----- 234 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~----- 234 (398)
||+++|+| +++|+||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999987 35778999999999999999999999998664332
Q ss_pred ----------------------cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccch
Q 037365 235 ----------------------LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNL 292 (398)
Q Consensus 235 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~ 292 (398)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---- 236 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ---- 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH----
Confidence 001123457999999999999999999999999999999999999997643211
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCC-HHHHHHH
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPT-TNDVVSM 350 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~~ 350 (398)
................. ....+..+.+++.+|+. ||.+||+ ++++++.
T Consensus 237 -~~~~~i~~~~~~~~~p~--------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 -ETYNKIINWKESLRFPP--------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -HHHHHHhccCCcccCCC--------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111000000000 01124567899999997 9999999 9999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=285.87 Aligned_cols=210 Identities=21% Similarity=0.315 Sum_probs=163.9
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
+.||+|+||.||++.... ++.||+|.+... .......+.+|+.++..++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999754 889999998653 2233456778999999999999999999999999999999999999
Q ss_pred Ch---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 198 SL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 198 ~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccC
Confidence 77 35678999999999999999999999987543221 11233579
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ... .. ... +.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~---i~~-~~-~~~----------p~~~~~ 221 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL---ILM-EE-IRF----------PRTLSP 221 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHH---Hhc-CC-CCC----------CCCCCH
Confidence 99999999999999999999999999999999999997532211 11110 000 00 000 111234
Q ss_pred HHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 037365 325 RYVNIALLCVQESADDRP-----TTNDVVSM 350 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RP-----t~~evl~~ 350 (398)
.+.+++.+||+.||++|+ ++.++++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 578999999999999996 89998853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=283.64 Aligned_cols=204 Identities=25% Similarity=0.373 Sum_probs=159.2
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|+... ++.||+|.+... .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999865 889999998643 223445667888888876 699999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccccccc
Confidence 987 35678999999999999999999999987643221 12334579
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..... ... . . +.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~---~~i~~-~~~-~-----~-----~~~~~~ 221 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLF---EAILN-DEV-V-----Y-----PTWLSQ 221 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHH---HHHhc-CCC-C-----C-----CCCCCH
Confidence 99999999999999999999999999999999999997532211 111 11111 100 0 0 111234
Q ss_pred HHHHHHHHchhcCCCCCCCH
Q 037365 325 RYVNIALLCVQESADDRPTT 344 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~ 344 (398)
.+.+++.+||+.||++||++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 57899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=274.56 Aligned_cols=223 Identities=27% Similarity=0.446 Sum_probs=174.0
Q ss_pred cCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678889999999999999998753 3679999986543 34455788999999999999999999999999999
Q ss_pred EEEEeccCCCChh------------------------------------------HHhhcCCCCCceecCCCCeEEcccc
Q 037365 188 ILIYEYMPNKSLD------------------------------------------FFLFNLKASNILLDKDMNPKISDFG 225 (398)
Q Consensus 188 ~lV~e~~~~g~L~------------------------------------------~~~~dlkp~NILl~~~~~~kl~DFG 225 (398)
++||||+++|+|. ++|+||||+||+++.++.+||+|||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcc
Confidence 9999999988762 4567999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCC
Q 037365 226 MARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNR 304 (398)
Q Consensus 226 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
+++...............++..|+|||.+.++.++.++|||||||++||+++ |..||..... ...... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~----~~~~~ 238 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKF----VIDGG 238 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHH----HhcCC
Confidence 9986654433222333456789999999998889999999999999999998 8888643211 111111 11111
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 305 TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.... +...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 239 ~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 239 HLDL----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111 11124568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=274.53 Aligned_cols=222 Identities=27% Similarity=0.400 Sum_probs=172.5
Q ss_pred CCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.+|...+.||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999743 256799999887766667789999999999999999999999999999999
Q ss_pred EEeccCCCCh-----------------------------------------------hHHhhcCCCCCceecCCCCeEEc
Q 037365 190 IYEYMPNKSL-----------------------------------------------DFFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 190 V~e~~~~g~L-----------------------------------------------~~~~~dlkp~NILl~~~~~~kl~ 222 (398)
+|||+++|+| +++|+||||+|||+++++.+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEEC
Confidence 9999998765 24567999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhh
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWR 301 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 301 (398)
|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ... .. ..
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~---~~-~~ 238 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAI---EC-IT 238 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHH---HH-HH
Confidence 9999986643332222233345788999999999999999999999999999998 88886432111 111 00 10
Q ss_pred cCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 302 SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
....... +...+..+.+++.+||+.||.+||+++++++.|+.
T Consensus 239 ~~~~~~~----------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 QGRELER----------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCccCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1100000 11223457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=278.83 Aligned_cols=209 Identities=25% Similarity=0.348 Sum_probs=159.6
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|++.. ++.||+|.++.. .....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999865 788999998653 122334556677777654 899999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccC
Confidence 988 35678999999999999999999999998653322 22334579
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ...... .... . . +.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~---~~~~i~-~~~~-~-----~-----~~~~~~ 221 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DE---LFDSIL-NDRP-H-----F-----PRWISK 221 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HH---HHHHHH-cCCC-C-----C-----CCCCCH
Confidence 9999999999999999999999999999999999999753221 11 111111 1000 0 0 111234
Q ss_pred HHHHHHHHchhcCCCCCCCHH-HHHH
Q 037365 325 RYVNIALLCVQESADDRPTTN-DVVS 349 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~-evl~ 349 (398)
.+.+++.+||+.||++||++. ++++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 577899999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.53 Aligned_cols=228 Identities=22% Similarity=0.330 Sum_probs=163.5
Q ss_pred CCCCccceecccCceEEEEEEEc--CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhc---CCCcccceeeEEEe-----
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR--KGNEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCID----- 183 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~----- 183 (398)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47889999999999999999874 36789999986432 22234566777777766 69999999999863
Q ss_pred CCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 184 KDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
....++||||+++ +| +++|+||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 4568999999974 33 467789999999999999999999999987
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc--
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE-- 307 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 307 (398)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|++||...... +...............+
T Consensus 160 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 160 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhch
Confidence 6533 2233457899999999999889999999999999999999999997643221 11111111110000000
Q ss_pred ----cchhhhhc--ccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 308 ----LTDAILED--EYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 308 ----~~~~~~~~--~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
........ ... .+.....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000 000 1123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=275.58 Aligned_cols=230 Identities=27% Similarity=0.391 Sum_probs=171.6
Q ss_pred cCCCCccceecccCceEEEEEEEcC-----------------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-----------------GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 176 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~ 176 (398)
.++|++.+.||+|+||.||++.+.+ +..+|+|.+... .......+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3578999999999999999986432 346899999754 3344567899999999999999999
Q ss_pred eeeEEEeCCeeEEEEeccCCCCh-------------------------------------------hHHhhcCCCCCcee
Q 037365 177 LLGCCIDKDEKILIYEYMPNKSL-------------------------------------------DFFLFNLKASNILL 213 (398)
Q Consensus 177 l~~~~~~~~~~~lV~e~~~~g~L-------------------------------------------~~~~~dlkp~NILl 213 (398)
+++++..++..+++|||+++|+| +++|+||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 99999999999999999998876 24567999999999
Q ss_pred cCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc--CCCCCCCCCCCccc
Q 037365 214 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS--GKKNTGFYRTDTLN 291 (398)
Q Consensus 214 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~P~~~~~~~~~~ 291 (398)
+.++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..||..... ..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--~~ 241 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--EQ 241 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--HH
Confidence 9999999999999986543332222223345678999999988899999999999999999998 5666543211 11
Q ss_pred hhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 292 LLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
........+......... + ....++..+.+++.+||+.||.+|||+.++++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFRDQGRQVYL-P------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHhhccccccC-C------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111000000 0 011233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=277.10 Aligned_cols=228 Identities=27% Similarity=0.418 Sum_probs=175.4
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEe
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCID 183 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 183 (398)
....++|+..+.||+|+||.||++.... ...+|+|.+... .......+.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3445778899999999999999998753 357999998754 334446688999999999 79999999999999
Q ss_pred CCeeEEEEeccCCCCh------------------------------------------------hHHhhcCCCCCceecC
Q 037365 184 KDEKILIYEYMPNKSL------------------------------------------------DFFLFNLKASNILLDK 215 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L------------------------------------------------~~~~~dlkp~NILl~~ 215 (398)
++..+++|||+++|+| +++|+||||+||++++
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 9999999999998865 2456799999999999
Q ss_pred CCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhH
Q 037365 216 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLG 294 (398)
Q Consensus 216 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 294 (398)
++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~-- 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--EEL-- 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--HHH--
Confidence 99999999999987654432222233345678999999998899999999999999999998 8888643211 111
Q ss_pred HHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 295 YAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
............ +......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 244 --~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 --FKLLKEGYRMEK----------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHHHcCCcCCC----------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111110000 1122345889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=272.65 Aligned_cols=242 Identities=22% Similarity=0.320 Sum_probs=180.2
Q ss_pred cchhhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCcccceeeEEEe
Q 037365 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCID 183 (398)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~ 183 (398)
.++--..+...+....+.||+|.||.||+|.|+ |+.||||+|...++ ..+.+|.++++. ++|+||+.+++.-..
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 333344566678888999999999999999997 99999999976544 567788888876 599999999998765
Q ss_pred CC----eeEEEEeccCCCCh---------------------------------------hHHhhcCCCCCceecCCCCeE
Q 037365 184 KD----EKILIYEYMPNKSL---------------------------------------DFFLFNLKASNILLDKDMNPK 220 (398)
Q Consensus 184 ~~----~~~lV~e~~~~g~L---------------------------------------~~~~~dlkp~NILl~~~~~~k 220 (398)
++ ++|||++|-+.|+| .+.|||||+.|||+..++.+-
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 44 68999999999999 356789999999999999999
Q ss_pred EcccccceecCCC--CcccccccccccccccChhhhccCC----C--CcccccHHHHHHHHHHHcC----------CCCC
Q 037365 221 ISDFGMARICGGN--ELQANTSRIVGTYGYMSPEYAIEGI----F--SIKFDVFSFGVLLLEIVSG----------KKNT 282 (398)
Q Consensus 221 l~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwSlGvvl~elltg----------~~P~ 282 (398)
|+|+|+|-..... .........+||-+|||||++.... + -..+||||||.++||+..+ +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999765433 2233455679999999999997532 2 2459999999999999853 3454
Q ss_pred CCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 283 GFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
......+.+..+. .+.... +-..+.....+...+.+..+.+|+..||..+|..|-|+-.+-+.|.++..
T Consensus 437 yd~Vp~DPs~eeM-rkVVCv----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDPSFEEM-RKVVCV----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCCCHHHH-hcceee----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 4332222222111 111111 11222222233345667789999999999999999999999999988754
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=274.23 Aligned_cols=224 Identities=27% Similarity=0.397 Sum_probs=170.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CC----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GN----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|+..+.||+|+||.||+|.+.. ++ .+++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467888999999999999999753 43 47888875442 233466788888999999999999999875 456789
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
++||+++|+| +.+|+||||+|||+++++.+||+|||+++........
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 9999999988 3566799999999999999999999999876543322
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......++..|+|||.+.++.++.++|||||||++||+++ |+.||...... ... .....+.....
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~~~------- 232 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVP----DLLEKGERLAQ------- 232 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHCCCcCCC-------
Confidence 22334567788999999999999999999999999999998 98887533211 111 11111111110
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
...+...+.+++.+||..||++|||+.|+++.|.....
T Consensus 233 ---~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 ---PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 01122346789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=289.13 Aligned_cols=224 Identities=23% Similarity=0.301 Sum_probs=172.5
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
...++|+..+.||+|+||.||+++... ++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 345789999999999999999999865 889999998642 2233345778999999999999999999999999999
Q ss_pred EEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 189 LIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 189 lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
+||||+++|+| +++||||||+|||++.++.+||+|||++........ .
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-V 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-c
Confidence 99999999987 467789999999999999999999999987643321 1
Q ss_pred ccccccccccccChhhhccC----CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 238 NTSRIVGTYGYMSPEYAIEG----IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ................+
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~~~~~~~~--- 270 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMDHKNSLTFPD--- 270 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCCcCCCCC---
Confidence 22345799999999998753 3789999999999999999999997542211 11111111111111100
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADD--RPTTNDVVSM 350 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~ 350 (398)
....+..+.+++.+||+.+|.+ |+|++|+++.
T Consensus 271 -----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 -----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1123456789999999999987 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=281.50 Aligned_cols=215 Identities=20% Similarity=0.353 Sum_probs=165.1
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||++++.. ++.||+|.++.. .......+.+|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999865 889999999753 223345678899999998 699999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccC
Confidence 987 35678999999999999999999999987532111 12234579
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCC---ccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD---TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||...... .....++.......... .+ +..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----------p~~ 227 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-RI----------PRS 227 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-CC----------CCC
Confidence 99999999999999999999999999999999999998642211 11111222221211110 00 112
Q ss_pred HHHHHHHHHHHchhcCCCCCCC------HHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRPT------TNDVVS 349 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt------~~evl~ 349 (398)
....+.+++.+||+.||.+||| ++++++
T Consensus 228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 2345789999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=271.80 Aligned_cols=219 Identities=29% Similarity=0.422 Sum_probs=170.6
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
++|...+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999998777789999987543 234678899999999999999999999999999999999999
Q ss_pred CCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 196 NKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 196 ~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+|+| +++|+||||+||++++++.+||+|||.++........ .....
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~ 161 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGS 161 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCC
Confidence 9876 3566799999999999999999999999866443221 12223
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ......... ...
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~----~~~~~~~~~----------~~~ 225 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEK----VSQGLRLYR----------PHL 225 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH----HhcCCCCCC----------CCC
Confidence 45678999999998889999999999999999998 88886532211 11111 111110000 111
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
....+.+++.+||+.+|.+|||+.++++.|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2356889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=268.06 Aligned_cols=225 Identities=20% Similarity=0.346 Sum_probs=177.3
Q ss_pred CCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++..++..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999987 5899999988532 2334567889999999999999999999999999999999
Q ss_pred eccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 192 EYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 192 e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||+++|+| +++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999887 245679999999999999999999999876543321
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... ....... ........
T Consensus 162 --~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-~~~~~~~~-------- 227 (267)
T cd08224 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK-IEKCDYPP-------- 227 (267)
T ss_pred --ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhh-hhcCCCCC--------
Confidence 122346888999999999888999999999999999999999997533221 1111110 11111000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
.........+.+++.+||+.+|++|||+.+++++|+++.
T Consensus 228 -~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 -LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001233456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.08 Aligned_cols=206 Identities=23% Similarity=0.310 Sum_probs=160.4
Q ss_pred ceecccCceEEEEEEEc----CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 122 NKLGEGGFGPVYKGVLR----KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
+.||+|+||.||+++.. .|+.+|+|++.... ......+.+|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998752 47899999996532 2233456789999999999999999999999999999999999
Q ss_pred CCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccc
Q 037365 196 NKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243 (398)
Q Consensus 196 ~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 243 (398)
+|+| +++|+||||+|||+++++.+||+|||+++...... .......
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~ 159 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC 159 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cceeccc
Confidence 9987 36678999999999999999999999987654321 1223457
Q ss_pred ccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHH
Q 037365 244 GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323 (398)
Q Consensus 244 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ... ........ . .+ +....
T Consensus 160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~---~~~i~~~~-~-~~----------p~~~~ 222 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KET---MTMILKAK-L-GM----------PQFLS 222 (318)
T ss_pred CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--HHH---HHHHHcCC-C-CC----------CCCCC
Confidence 89999999999988899999999999999999999999753211 111 11111110 0 00 11223
Q ss_pred HHHHHHHHHchhcCCCCCCCHHH
Q 037365 324 LRYVNIALLCVQESADDRPTTND 346 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RPt~~e 346 (398)
..+.+++.+||+.||++|||+.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 45789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=284.34 Aligned_cols=219 Identities=21% Similarity=0.339 Sum_probs=169.7
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||+++... ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468889999999999999999764 8899999997542 234456788999999999999999999999999999999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
||+++|+| +++||||||+|||++.++.+||+|||++..+...... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-N 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-e
Confidence 99999987 3567899999999999999999999999876543322 2
Q ss_pred cccccccccccChhhhc------cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 239 TSRIVGTYGYMSPEYAI------EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...... ................+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~~~~-- 232 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQRFLKFPE-- 232 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCCCccCCCC--
Confidence 22347899999999987 456789999999999999999999997532211 11111111111111000
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.+++.+||+ +|.+|||++++++
T Consensus 233 ------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 233 ------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11223457889999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=271.12 Aligned_cols=223 Identities=22% Similarity=0.358 Sum_probs=171.2
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357999999999999999999975 4888999999765545556788999999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+++++| +++|+||||+||++++++.+||+|||++....... .....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~ 165 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKS 165 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCc
Confidence 999987 35677999999999999999999999998664322 11223
Q ss_pred ccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 242 IVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 242 ~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
..|+..|+|||.+. ...++.++|+|||||++|||++|+.|+........ ... ..... ...+....
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~-----~~~~~---~~~~~~~~--- 233 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFL-----MSKSN---FQPPKLKD--- 233 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-hee-----eecCC---CCCCCCcc---
Confidence 46889999999884 34578899999999999999999999743221100 000 00000 00000000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 351 (398)
....+..+.+++.+||+.+|++|||++++++.|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112345688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=280.03 Aligned_cols=220 Identities=20% Similarity=0.288 Sum_probs=167.0
Q ss_pred CCCccceecccCceEEEEEEEc----CCCEEEEEEccCC----ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCee
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGR----SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 187 (398)
+|++.+.||+|+||.||+++.. .++.||+|++... .....+.+.+|+.++..+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999863 4788999998643 223345678899999999 499999999999999999
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
++||||+++|+| +++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999999987 467789999999999999999999999976543221
Q ss_pred ccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ............ ...
T Consensus 161 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~-------~~~- 230 (332)
T cd05614 161 -ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKCD-------PPF- 230 (332)
T ss_pred -CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcCC-------CCC-
Confidence 122345799999999999865 478999999999999999999999864322111 111111111100 000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRP-----TTNDVVSM 350 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 350 (398)
+......+.+++.+||+.||++|| +++++++.
T Consensus 231 ----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 231 ----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 112234578999999999999999 77788753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=289.23 Aligned_cols=221 Identities=23% Similarity=0.325 Sum_probs=166.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||.||++.... ++.||+|++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 468889999999999999998764 889999998543 2234567788999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc---
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ--- 236 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 236 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999987 4677899999999999999999999998643210000
Q ss_pred ---------c---------------------------------ccccccccccccChhhhccCCCCcccccHHHHHHHHH
Q 037365 237 ---------A---------------------------------NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLE 274 (398)
Q Consensus 237 ---------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 274 (398)
. ......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 0012469999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCC---CCHHHHHHH
Q 037365 275 IVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDR---PTTNDVVSM 350 (398)
Q Consensus 275 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Pt~~evl~~ 350 (398)
|++|..||...... ... .............+ .......+.+++.+|+. +|.+| +|+.|+++.
T Consensus 241 lltG~~Pf~~~~~~--~~~---~~i~~~~~~~~~p~--------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 241 CLIGWPPFCSENSH--ETY---RKIINWRETLYFPD--------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCCCCCHH--HHH---HHHHccCCccCCCC--------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999998542211 111 11111000001000 01123457789999997 67765 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=273.73 Aligned_cols=216 Identities=24% Similarity=0.405 Sum_probs=177.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
+-|.++++||+|+||.||+|.++. |+.+|+|.+... .+.+++.+|+.++++...|++|++||.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 457788999999999999999876 999999999754 45688999999999999999999999999999999999999
Q ss_pred CCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 195 PNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 195 ~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
..|+. ..+|||||..|||++.+|.+||+|||.+-.+.+. ......
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNT 188 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNT 188 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCc
Confidence 99976 4678899999999999999999999999776532 234556
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh-cCCccccchhhhhcccChH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR-SNRTLELTDAILEDEYSSK 320 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 320 (398)
+.||+.|||||++..-.|+.++||||||++..||..|++||..-..-. ..|. ..++. +... .+.
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------AIFMIPT~PP----PTF~---KPE 253 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------AIFMIPTKPP----PTFK---KPE 253 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------eeEeccCCCC----CCCC---ChH
Confidence 799999999999999999999999999999999999999975321110 0000 00000 0011 144
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 321 QVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 321 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+..+-+++++||...|++|-|+-++++.
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 566789999999999999999999988763
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=285.93 Aligned_cols=169 Identities=24% Similarity=0.377 Sum_probs=143.8
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||+||++.... ++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999998765 8899999996532 233456788999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc---
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ--- 236 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 236 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999987 4677899999999999999999999998754321100
Q ss_pred ------------------------------cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCC
Q 037365 237 ------------------------------ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGF 284 (398)
Q Consensus 237 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~ 284 (398)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001235799999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=282.02 Aligned_cols=214 Identities=24% Similarity=0.309 Sum_probs=165.0
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCC-cccceeeEEEeCCeeEEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHK-NLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ 191 (398)
+|+..+.||+|+||.||+|+..+ ++.||+|++... .....+.+..|..++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999865 788999998643 223456678899999999765 6888999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--Cce
Confidence 99999988 35678999999999999999999999987532211 122
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... .... ... .. +
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~---~i~~-~~~-~~----------~ 221 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQ---SIME-HNV-SY----------P 221 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHH---HHHc-CCC-CC----------C
Confidence 345789999999999999999999999999999999999999753221 11111 1111 100 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCH-----HHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTT-----NDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~ 349 (398)
......+.+++.+||+.||.+|++. +++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1223457899999999999999986 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=273.77 Aligned_cols=223 Identities=30% Similarity=0.448 Sum_probs=170.5
Q ss_pred hcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
..++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678899999999999999999753 4678999886543 3344578899999999999999999999999999
Q ss_pred eEEEEeccCCCChh---------------------------------------HHhhcCCCCCceecCCC---CeEEccc
Q 037365 187 KILIYEYMPNKSLD---------------------------------------FFLFNLKASNILLDKDM---NPKISDF 224 (398)
Q Consensus 187 ~~lV~e~~~~g~L~---------------------------------------~~~~dlkp~NILl~~~~---~~kl~DF 224 (398)
.++||||+++++|. .+|+||||+||+++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 99999999998773 45679999999998654 5999999
Q ss_pred ccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 225 GMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 225 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ..... ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~----~~~~ 237 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEF----VTGG 237 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH----HHcC
Confidence 99987643322222222334568999999999999999999999999999997 88887532211 11111 1111
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
..... +...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 238 ~~~~~----------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDP----------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 10000 1122356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=281.31 Aligned_cols=209 Identities=24% Similarity=0.312 Sum_probs=162.2
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
+|+..+.||+|+||.||+|+... ++.||+|.+.... ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999999875 7889999986532 22334566788888777 5899999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--Ccc
Confidence 99999988 35678999999999999999999999997543221 122
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. .... ... .. +
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~---~i~~-~~~-~~----------p 221 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQ---SIME-HNV-AY----------P 221 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHH---HHHh-CCC-CC----------C
Confidence 345789999999999999999999999999999999999999753221 11111 1111 100 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTT 344 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~ 344 (398)
......+.+++.+|++.||++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1233457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=268.73 Aligned_cols=221 Identities=27% Similarity=0.434 Sum_probs=172.1
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|++++++++||||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 467999999999999999999987777899999975432 3357889999999999999999999874 45689999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
++|+| +++|+||||+||++++++.+||+|||.++........ ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~ 161 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQ 161 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-ccc
Confidence 99987 3567899999999999999999999999876543321 122
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...++..|+|||+..+..++.++||||||+++|||++ |..||...... ... ......... ...
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~~----~~~~~~~~~----------~~~ 225 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVL----DQVERGYRM----------PCP 225 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HHH----HHHhcCCCC----------CCc
Confidence 3346778999999988899999999999999999999 77776432111 111 111111000 002
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 23345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=273.18 Aligned_cols=224 Identities=29% Similarity=0.431 Sum_probs=172.8
Q ss_pred CCCccceecccCceEEEEEEEcC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
+|++.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999998632 3568999886543 3345678899999999999999999999999999999
Q ss_pred EEeccCCCChh--------------------------------------------------------HHhhcCCCCCcee
Q 037365 190 IYEYMPNKSLD--------------------------------------------------------FFLFNLKASNILL 213 (398)
Q Consensus 190 V~e~~~~g~L~--------------------------------------------------------~~~~dlkp~NILl 213 (398)
++||+++|+|. ++|+||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999988763 4567999999999
Q ss_pred cCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccch
Q 037365 214 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNL 292 (398)
Q Consensus 214 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 292 (398)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...+
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~ 238 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--PERL 238 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC--HHHH
Confidence 9999999999999976543332222233356778999999988889999999999999999998 888864321 1111
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+........... +......+.+++.+||+.+|++|||++++++.|+++..
T Consensus 239 ----~~~~~~~~~~~~----------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 239 ----FNLLKTGYRMER----------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ----HHHHhCCCCCCC----------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111110000 11223468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=280.35 Aligned_cols=209 Identities=25% Similarity=0.335 Sum_probs=163.3
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||++++.. ++.||+|.+... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999875 789999998753 223445677888999888 699999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++|+||||+|||+++++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccceec
Confidence 987 35678999999999999999999999987532221 12233578
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ... ...... . . +.....
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~---~~~-i~~~~~-~-----~-----~~~~~~ 221 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DEL---FQS-ILEDEV-R-----Y-----PRWLSK 221 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHH---HHH-HHcCCC-C-----C-----CCcCCH
Confidence 9999999999999999999999999999999999999753221 111 111 111110 0 0 112234
Q ss_pred HHHHHHHHchhcCCCCCCCH-----HHHHH
Q 037365 325 RYVNIALLCVQESADDRPTT-----NDVVS 349 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~-----~evl~ 349 (398)
.+.+++.+||+.||.+|||+ .++++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 57899999999999999999 88875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=271.39 Aligned_cols=235 Identities=20% Similarity=0.314 Sum_probs=172.9
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEcc--CCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe-----C
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLS--GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID-----K 184 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~ 184 (398)
....+|...+.||+|+||.|+.+.... |+.||+|++. -.+....+...+|+.+|+.++|+||+.+.+++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344567778999999999999999765 8999999997 3355567788999999999999999999999875 3
Q ss_pred CeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 185 DEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
+..|+|+|+|+. +| +++||||||+|+|++.+..+||+|||+|+....
T Consensus 99 ~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 478999999942 33 577899999999999999999999999998864
Q ss_pred CCcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc---c
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE---L 308 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 308 (398)
.......+..+.|.+|+|||++.. ..|+.+.||||.||++.||++|++-|..... .+....+........... +
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCCCCHHHHHHh
Confidence 422233456688999999998875 5699999999999999999999987653221 111112211111110000 0
Q ss_pred c----hhhhh-------cccC--hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 309 T----DAILE-------DEYS--SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 309 ~----~~~~~-------~~~~--~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. ...+. ..+. .+.......+|+.+||..||.+|+|++|.++.
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00000 0000 11233467899999999999999999999864
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=269.71 Aligned_cols=219 Identities=25% Similarity=0.410 Sum_probs=161.8
Q ss_pred ceecccCceEEEEEEEcC---CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 122 NKLGEGGFGPVYKGVLRK---GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
+.||+|+||.||+|.+.+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998654 4579999987653 233457888999999999999999999999999999999999999
Q ss_pred Chh-------------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 198 SLD-------------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 198 ~L~-------------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+|. ++|+||||+||+++.++.+||+|||+++............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 872 4567999999999999999999999987554333222223
Q ss_pred cccccccccChhhhccC-------CCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 241 RIVGTYGYMSPEYAIEG-------IFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
...++..|+|||++.+. .++.++||||||+++|||++ |+.||....... ..... .. .......++.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~---~~-~~~~~~~~~~ 234 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT---VR-EQQLKLPKPR 234 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH---hh-cccCCCCCCc
Confidence 34678889999998642 35789999999999999996 998975432211 11110 11 1111111111
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.. ......+.+++.+|| .+|++|||++||+..|+
T Consensus 235 ~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 112334778999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.83 Aligned_cols=230 Identities=23% Similarity=0.329 Sum_probs=176.0
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCcccceeeEEE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCI 182 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~ 182 (398)
++...++|.+.+.||+|+||.||+|+++. +..||+|++.... ....+.+.+|+.++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34455678888999999999999998642 4579999997543 233457889999999997 999999999999
Q ss_pred eCCeeEEEEeccCCCChh--------------------------------------------------------------
Q 037365 183 DKDEKILIYEYMPNKSLD-------------------------------------------------------------- 200 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L~-------------------------------------------------------------- 200 (398)
..+..++||||+++|+|.
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 999999999999998762
Q ss_pred --------------------------------------------------------------------HHhhcCCCCCce
Q 037365 201 --------------------------------------------------------------------FFLFNLKASNIL 212 (398)
Q Consensus 201 --------------------------------------------------------------------~~~~dlkp~NIL 212 (398)
++|+||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 347899999999
Q ss_pred ecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccc
Q 037365 213 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLN 291 (398)
Q Consensus 213 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~ 291 (398)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-- 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence 99999999999999986543222122223456788999999998889999999999999999998 888865332111
Q ss_pred hhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 292 LLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
........+..... +......+.+++.+||+.+|.+||+++||++.|+++.
T Consensus 350 ---~~~~~~~~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ---QFYNAIKRGYRMAK----------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHHHHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111100000 1122356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=260.42 Aligned_cols=229 Identities=23% Similarity=0.265 Sum_probs=178.4
Q ss_pred hhcCCCCccceecccCceEEEEEE-EcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-----Ce
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 186 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 186 (398)
...++|.+.+.||+|||+.||+++ ..+++.+|+|++.....++.+...+|++..++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 445889999999888878888999999999999999999999887644 35
Q ss_pred eEEEEeccCCCCh--------------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 187 KILIYEYMPNKSL--------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
.|++++|...|+| .+.||||||.|||+.+++.++|.|||.+.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 8999999999987 26778999999999999999999999987
Q ss_pred ecCCCCcc---c----ccccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHH
Q 037365 229 ICGGNELQ---A----NTSRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD 298 (398)
Q Consensus 229 ~~~~~~~~---~----~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 298 (398)
...-.-.. . .......|..|+|||.+. +...++++|||||||+||+|+.|..||......+.++.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence 54311000 0 011235789999999886 34578999999999999999999999864333222111
Q ss_pred hhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 299 LWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
..+....+.-. .....++.+.+++..|++.||.+||++.+++..++..
T Consensus 253 -------LAv~n~q~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 -------LAVQNAQISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------EeeeccccccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111111111 1222567789999999999999999999999998865
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=288.15 Aligned_cols=219 Identities=22% Similarity=0.347 Sum_probs=163.9
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
+|+..+.||+|+||.||+|+... ++.||+|++.... ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58889999999999999999765 7889999986532 2344578899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC------
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE------ 234 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~------ 234 (398)
|+++|+| +++||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999987 46788999999999999999999999975321000
Q ss_pred ---------------------------------------cccccccccccccccChhhhccCCCCcccccHHHHHHHHHH
Q 037365 235 ---------------------------------------LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEI 275 (398)
Q Consensus 235 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 275 (398)
.........||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 00001234799999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCC---HHHHHH
Q 037365 276 VSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPT---TNDVVS 349 (398)
Q Consensus 276 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~ 349 (398)
++|+.||....... ................ .........+++.+|+ .+|.+|++ ++++++
T Consensus 242 ltG~~Pf~~~~~~~-----~~~~i~~~~~~~~~p~--------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 242 LVGQPPFLAQTPLE-----TQMKVINWQTSLHIPP--------QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HhCCCCCCCCCHHH-----HHHHHHccCCCcCCCC--------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999986432110 0111111000000000 1112334667777765 49999997 888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=272.94 Aligned_cols=218 Identities=27% Similarity=0.341 Sum_probs=169.2
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
+|+..+.||+|+||.||++.... ++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 47788999999999999999754 8899999986532 1223456789999999999999999999999999999999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++|+| +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence 9999987 355679999999999999999999999987643321
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .............. ..+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~----------~~~- 224 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--VKREEVERRVKEDQ----------EEY- 224 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--hHHHHHHHHhhhcc----------ccc-
Confidence 22347899999999999889999999999999999999999998642211 11111111111000 000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRP-----TTNDVVSM 350 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 350 (398)
....+..+.+++.+||+.||++|| +++++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 122345678999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=268.61 Aligned_cols=219 Identities=31% Similarity=0.449 Sum_probs=169.7
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
.+|+..+.||+|+||.||++.++.+..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999998777789999986543 233567889999999999999999999999999999999999
Q ss_pred CCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 196 NKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 196 ~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++| +++|+||||+||++++++.+||+|||+++...+..... ....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~ 161 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGT 161 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc-cCCC
Confidence 9877 35678999999999999999999999998664332111 1122
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ....... ..+..
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~----~~~~~~~----------~~~~~ 225 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVES----VSAGYRL----------YRPKL 225 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHH----HHcCCcC----------CCCCC
Confidence 34567999999999999999999999999999999 78887532211 11111 1111000 00112
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 3456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=272.83 Aligned_cols=211 Identities=24% Similarity=0.354 Sum_probs=163.3
Q ss_pred ecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
||+|+||+||++.+.. ++.+|+|.+.... ....+.+..|+.++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999764 8899999986432 22335677899999999999999999999999999999999999987
Q ss_pred ------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccc
Q 037365 200 ------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243 (398)
Q Consensus 200 ------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 243 (398)
+++|+||||+||++++++.+||+|||++..+..... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccC
Confidence 356789999999999999999999999987654322 123457
Q ss_pred ccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHH
Q 037365 244 GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323 (398)
Q Consensus 244 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ........... . . .. +...+
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~--------~-~--~~-~~~~~ 225 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILND--------S-V--TY-PDKFS 225 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhccc--------C-C--CC-cccCC
Confidence 89999999999999999999999999999999999999864322110 00000000000 0 0 00 12234
Q ss_pred HHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 324 LRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
..+.+++.+||+.||++|| |++++++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 5678999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=281.71 Aligned_cols=233 Identities=22% Similarity=0.248 Sum_probs=170.7
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD---- 185 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 185 (398)
...++|+..+.||+|+||.||++.... |..||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 345789999999999999999999765 889999998643 3334567789999999999999999999987543
Q ss_pred --eeEEEEeccCCCCh-----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 186 --EKILIYEYMPNKSL-----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 186 --~~~lV~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
..|+||||++++.+ +++||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 47999999987532 46788999999999999999999999997643321
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhh--------------
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLW-------------- 300 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-------------- 300 (398)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 178 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 178 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI--DQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCcHHHHHHHHHH
Confidence 123357899999999999999999999999999999999999998643211 0000000000
Q ss_pred -----hcCCc------cccchhhhhcc--cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 301 -----RSNRT------LELTDAILEDE--YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 301 -----~~~~~------~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..... .+......... .........+.+++.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00000000000 0011123457899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=286.26 Aligned_cols=226 Identities=21% Similarity=0.284 Sum_probs=171.5
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
+....++|+..+.||+|+||.||+++... ++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 34456789999999999999999999875 788999998642 22334567889999999999999999999999999
Q ss_pred eEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 187 KILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 187 ~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.|+||||+++|+| +++||||||+|||+++++.+||+|||+++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999999999987 467789999999999999999999999987643321
Q ss_pred ccccccccccccccChhhhccCC----CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGI----FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ..................
T Consensus 198 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~p~- 270 (370)
T cd05621 198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMDHKNSLNFPE- 270 (370)
T ss_pred -eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCcccCCCC-
Confidence 1223457999999999997643 78999999999999999999999853221 111111111111111100
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADD--RPTTNDVVSM 350 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~ 350 (398)
.......+.+++.+|++.++.+ |+|+.|+++.
T Consensus 271 -------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 271 -------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1122345778999999855543 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=278.78 Aligned_cols=209 Identities=26% Similarity=0.363 Sum_probs=160.7
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|++.+ ++.||+|.++... .........|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999875 7889999986541 22345566788888764 899999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecC
Confidence 988 35678999999999999999999999987542221 12234578
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+... ...... .. +.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~----i~~~~~------~~-----~~~~~~ 221 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQS----IRMDNP------CY-----PRWLTR 221 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCCC------CC-----CccCCH
Confidence 9999999999999999999999999999999999999753221 111111 111000 00 111234
Q ss_pred HHHHHHHHchhcCCCCCCCHH-HHHH
Q 037365 325 RYVNIALLCVQESADDRPTTN-DVVS 349 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~-evl~ 349 (398)
.+.+++.+||+.||++||++. ++.+
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 578999999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=270.86 Aligned_cols=226 Identities=26% Similarity=0.393 Sum_probs=172.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CC----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GN----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
.++|+..+.||+|+||.||+|.+.. +. .||+|.+... .......+.+|..+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 3578888999999999999998643 44 4899998754 33445678899999999999999999999975 4578
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+++||+++|+| +++|+||||+|||+++++.+||+|||+++.......
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 99999999987 467789999999999999999999999987754332
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
........++..|+|||...+..++.++|||||||++|||++ |..||..... ..+..+ .........
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~~~------ 232 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDL----LEKGERLPQ------ 232 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHCCCcCCC------
Confidence 222222345678999999999899999999999999999998 8888653221 111111 111111110
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
....+..+.+++.+||+.||++|||+.++++.|+.....
T Consensus 233 ----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 233 ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 112234578999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=273.03 Aligned_cols=232 Identities=23% Similarity=0.386 Sum_probs=172.0
Q ss_pred CCCCccceecccCceEEEEEEEc-----CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--CCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-----KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 188 (398)
++|++.+.||+|+||.||++... ++..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888899999999999999853 378899999987766667788999999999999999999998764 34689
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+||||+++|+| +++|+||||+||++++++.+||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 99999999988 356679999999999999999999999987653322
Q ss_pred cc-ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc-cccch---
Q 037365 236 QA-NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT-LELTD--- 310 (398)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 310 (398)
.. ......++..|+|||.+.+..++.++|||||||++|||++|..++....... ......... .....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-------MRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-------hhhcccccccccchHHHH
Confidence 11 1111234456999999998899999999999999999999877643221110 000000000 00000
Q ss_pred hhhhcc---cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 311 AILEDE---YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 311 ~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
..+... ......+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000 00122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=273.02 Aligned_cols=224 Identities=26% Similarity=0.413 Sum_probs=172.4
Q ss_pred hcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
..++|+..+.||+|+||.||++.+. ++..||+|.+.... ......+.+|+.++++++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467899999999999999999864 36789999987553 3345678899999999999999999999999999
Q ss_pred eEEEEeccCCCCh------------------------------------------------------hHHhhcCCCCCce
Q 037365 187 KILIYEYMPNKSL------------------------------------------------------DFFLFNLKASNIL 212 (398)
Q Consensus 187 ~~lV~e~~~~g~L------------------------------------------------------~~~~~dlkp~NIL 212 (398)
.+++|||+++|+| +.+|+||||+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 9999999998865 2356799999999
Q ss_pred ecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccc
Q 037365 213 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLN 291 (398)
Q Consensus 213 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~ 291 (398)
+++++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~---- 238 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---- 238 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999876543322222222345678999999998999999999999999999997 7777642211
Q ss_pred hhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 292 LLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.+... .......... +...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 -~~~~~-~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -EEVIY-YVRDGNVLSC----------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHHH-HHhcCCCCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 1111111110 11234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=282.35 Aligned_cols=205 Identities=22% Similarity=0.312 Sum_probs=157.1
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHH-HHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|+... |+.||+|++.... ......+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999864 8999999986432 122334455554 56789999999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccC
Confidence 987 35678999999999999999999999987543221 12334579
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... . ... .+....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~-~-~~~----------~~~~~~ 221 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNK-P-LRL----------KPNISV 221 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcC-C-CCC----------CCCCCH
Confidence 9999999999999999999999999999999999999753211 1111111111 0 000 112245
Q ss_pred HHHHHHHHchhcCCCCCCCHH
Q 037365 325 RYVNIALLCVQESADDRPTTN 345 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~ 345 (398)
.+.+++.+||+.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 578999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=279.72 Aligned_cols=208 Identities=25% Similarity=0.337 Sum_probs=160.2
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|++.. |+.||+|.++... .........|..++... +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999875 8899999986531 22345567788888764 899999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCC
Confidence 987 46778999999999999999999999987532211 12334579
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ........ . . +.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~----~~~~~~~~-~-----~-----~~~~~~ 221 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELF----ESIRVDTP-H-----Y-----PRWITK 221 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHH----HHHHhCCC-C-----C-----CCCCCH
Confidence 9999999999999999999999999999999999999753221 1111 11111100 0 0 111234
Q ss_pred HHHHHHHHchhcCCCCCCCHH-HHH
Q 037365 325 RYVNIALLCVQESADDRPTTN-DVV 348 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~-evl 348 (398)
.+.+++.+||+.||++||++. +++
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 578999999999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=275.24 Aligned_cols=228 Identities=25% Similarity=0.376 Sum_probs=175.4
Q ss_pred hhcCCCCccceecccCceEEEEEEEc--------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR--------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 182 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 182 (398)
...++|.+.+.||+|+||.||+|++. ++..||+|.+... .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33567888899999999999999742 2457999998754 234456788999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCh------------------------------------------------hHHhhcCCCCCceec
Q 037365 183 DKDEKILIYEYMPNKSL------------------------------------------------DFFLFNLKASNILLD 214 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L------------------------------------------------~~~~~dlkp~NILl~ 214 (398)
..+..+++|||+++|+| +++|+||||+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 99999999999999865 245679999999999
Q ss_pred CCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchh
Q 037365 215 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLL 293 (398)
Q Consensus 215 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 293 (398)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.... ..
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~ 246 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----VE 246 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----HH
Confidence 999999999999987754333222333456778999999998889999999999999999998 677753221 11
Q ss_pred HHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 294 GYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+.. ........... ....+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 247 ~~~-~~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 ELF-KLLKEGHRMDK----------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHH-HHHHcCCcCCC----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111 11111111110 11234568899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=272.99 Aligned_cols=219 Identities=22% Similarity=0.396 Sum_probs=173.8
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468899999999999999999975 4889999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++++| +++|+||||+||+++.++.+||+|||++........ .....
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~ 176 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 176 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCcc
Confidence 999987 456789999999999999999999999876543221 12234
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .. ........ ... . .....
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~----~~~~~~~~-~~~-----~---~~~~~ 242 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-AL----YLIATNGT-PEL-----Q---NPEKL 242 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hH----HHHhcCCC-CCC-----C---Ccccc
Confidence 68899999999998889999999999999999999999975332111 00 00111110 000 0 01223
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+.+++.+||..+|++|||+.++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 355789999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=281.74 Aligned_cols=210 Identities=22% Similarity=0.294 Sum_probs=159.0
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHH-HHHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEA-SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|++.. ++.||+|.+.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999865 7789999986432 12223344444 456789999999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccC
Confidence 987 46778999999999999999999999987543221 12334579
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ...... . ... .+....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~---~~i~~~-~-~~~----------~~~~~~ 221 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMY---DNILNK-P-LQL----------KPNITN 221 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--HHHH---HHHHhC-C-cCC----------CCCCCH
Confidence 9999999999999999999999999999999999999753211 1111 111110 0 000 112334
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 325 RYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.+.+++.+||+.||.+||++.+.+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 57899999999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=264.82 Aligned_cols=216 Identities=27% Similarity=0.396 Sum_probs=171.5
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||+|++|.||+|.... ++.|++|.+... .......+.+|+.++++++|||++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 46777899999999999999864 889999998643 344566788999999999999999999999999999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+++++| +++|+||||+||+++.++.+||+|||+++........ .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--A 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--h
Confidence 999887 3556799999999999999999999999876543221 2
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....|++.|+|||++.+..++.++|+||||+++|||++|+.||..... .... .... ....... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~---~~~~-~~~~~~~----------~ 222 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALI---LKII-RGVFPPV----------S 222 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHH-cCCCCCC----------c
Confidence 234688899999999999999999999999999999999999754321 1111 1111 1111110 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
......+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=267.60 Aligned_cols=224 Identities=20% Similarity=0.332 Sum_probs=174.9
Q ss_pred CCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999965 5899999988643 2334467889999999999999999999999999999999
Q ss_pred eccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 192 EYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 192 e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||+++++| +++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999877 245679999999999999999999999876643321
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......|+..|+|||++.+..++.++|+||||+++|||++|..||.....+...... . ..... .+
T Consensus 162 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~-~~~~~-----~~---- 226 (267)
T cd08229 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---K-IEQCD-----YP---- 226 (267)
T ss_pred --ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---h-hhcCC-----CC----
Confidence 122346889999999999888999999999999999999999997532221111110 0 00000 00
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
..........+.+++.+||+.||++|||+.+|++.+++.
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 000122445688999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=280.35 Aligned_cols=208 Identities=20% Similarity=0.285 Sum_probs=158.2
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHH-HHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|+... |+.+|+|++... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999764 889999998643 2223344555554 46779999999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcccccC
Confidence 987 46778999999999999999999999987532221 12234579
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ........ .. . . .+....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~---~~~~~~~~-~~-~-----~-----~~~~~~ 221 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--AE---MYDNILHK-PL-V-----L-----RPGASL 221 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--HH---HHHHHHcC-Cc-c-----C-----CCCCCH
Confidence 9999999999999999999999999999999999999753211 11 11111110 00 0 0 111234
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHH
Q 037365 325 RYVNIALLCVQESADDRPTTNDVV 348 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~evl 348 (398)
.+.+++.+|++.+|.+||++.+.+
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCH
Confidence 577899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=266.19 Aligned_cols=216 Identities=21% Similarity=0.297 Sum_probs=170.9
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
+|++.+.||+|+||.||++.... ++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 47788999999999999999764 889999998643 3344567888999999999999999999999999999999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
++|+| +++|+||||+||++++++.++++|||++........ ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccc
Confidence 99876 356779999999999999999999999986643321 122
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChH
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (398)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ........ ....... +.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~-~~~~~~~----------~~ 222 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVC-QGSYKPL----------PS 222 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHh-cCCCCCC----------Cc
Confidence 35688999999999988899999999999999999999999753211 11111111 1111111 11
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 321 QVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 321 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.....+.+++.+||+.||++|||+.+++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 223457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=267.04 Aligned_cols=220 Identities=29% Similarity=0.466 Sum_probs=171.2
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 467889999999999999999988888899999976432 3467889999999999999999999875 56689999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
++++| +++|+||||+||++++++.+||+|||++.......... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~ 161 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQ 161 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-cc
Confidence 99877 35678999999999999999999999998765432211 12
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...++..|+|||.+.+..++.++||||||+++|||++ |..||.... ....... ......... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~----~~~~~~~~~----------~ 225 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQ----VERGYRMPC----------P 225 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHH----HHcCCCCCC----------C
Confidence 2345668999999988889999999999999999999 888864321 1111111 111100000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
...+..+.+++.+||+.+|++|||++++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=264.42 Aligned_cols=214 Identities=24% Similarity=0.360 Sum_probs=166.6
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh-
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL- 199 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L- 199 (398)
+.||+|+||.||+|...++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999987653 33345688999999999999999999999999999999999999987
Q ss_pred --------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccccc
Q 037365 200 --------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247 (398)
Q Consensus 200 --------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 247 (398)
+.+|+||||+||+++.++.+||+|||++......... ......++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~ 159 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIK 159 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCccc
Confidence 3567799999999999999999999998765432211 1112244667
Q ss_pred ccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHH
Q 037365 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326 (398)
Q Consensus 248 y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (398)
|+|||++.+..++.++||||||+++||+++ |..||...... .... .......... ....+..+
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~----~~~~~~~~~~----------~~~~~~~~ 223 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QARE----QVEKGYRMSC----------PQKCPDDV 223 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHH----HHHcCCCCCC----------CCCCCHHH
Confidence 999999998899999999999999999998 88887532111 1111 1111100000 11234568
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 327 VNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 327 ~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.+++.+||+.+|++|||+.|+++.|.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHhc
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=273.42 Aligned_cols=224 Identities=22% Similarity=0.315 Sum_probs=165.5
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-----eeEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKILI 190 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV 190 (398)
.|...+++|+|+||.||+|.... ++.||||++..... .-.+|+++|+++.|||||++..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667999999999999999876 68999999865542 2246999999999999999999887533 34589
Q ss_pred EeccCCCC-----------------------------------hhHHhhcCCCCCceecCC-CCeEEcccccceecCCCC
Q 037365 191 YEYMPNKS-----------------------------------LDFFLFNLKASNILLDKD-MNPKISDFGMARICGGNE 234 (398)
Q Consensus 191 ~e~~~~g~-----------------------------------L~~~~~dlkp~NILl~~~-~~~kl~DFGla~~~~~~~ 234 (398)
|||||..- .++.||||||.|+|+|.+ |.+||||||.|+.+..++
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 99998641 167889999999999976 899999999999887554
Q ss_pred cccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc-------
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL------- 306 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 306 (398)
.. .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|..... ..++... ...+......
T Consensus 181 pn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eI-ik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 181 PN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEI-IKVLGTPTREDIKSMNP 255 (364)
T ss_pred Cc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHH-HHHhCCCCHHHHhhcCc
Confidence 32 334668999999999985 599999999999999999999988754222 2222222 2222111111
Q ss_pred ---ccchhhhhccc----ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ---ELTDAILEDEY----SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ---~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+...+.+.... ..........+++.++++++|.+|.|+.|++.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111111 12334456889999999999999999999884
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.86 Aligned_cols=226 Identities=17% Similarity=0.267 Sum_probs=162.2
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--------
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-------- 184 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-------- 184 (398)
...+|+..+.||+|+||.||+|...+ ++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 45689999999999999999999864 8899999886432 2345799999999999999999887542
Q ss_pred CeeEEEEeccCCCCh-----------------------------------hHHhhcCCCCCceecCCC-CeEEcccccce
Q 037365 185 DEKILIYEYMPNKSL-----------------------------------DFFLFNLKASNILLDKDM-NPKISDFGMAR 228 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~ 228 (398)
...++||||++++.. +++||||||+|||++.++ .+||+|||+++
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 246799999986421 467889999999998665 69999999998
Q ss_pred ecCCCCcccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc--
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT-- 305 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 305 (398)
.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+.. ..........
T Consensus 220 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~-i~~~~~~p~~~~ 294 (440)
T PTZ00036 220 NLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVR-IIQVLGTPTEDQ 294 (440)
T ss_pred hccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH-HHHHhCCCCHHH
Confidence 764332 12235789999999998764 6899999999999999999999997543211 11111 1111100000
Q ss_pred -------------cccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 306 -------------LELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 306 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+...+ +...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~-p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVF-PKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHh-ccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000000000 1112356889999999999999999999984
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=274.89 Aligned_cols=226 Identities=27% Similarity=0.396 Sum_probs=173.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC--------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK--------GNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 184 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 184 (398)
.++|.+.+.||+|+||.||++++.. ...+|+|.+... .......+.+|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999998632 346999999754 234456788899999999 799999999999999
Q ss_pred CeeEEEEeccCCCCh------------------------------------------------hHHhhcCCCCCceecCC
Q 037365 185 DEKILIYEYMPNKSL------------------------------------------------DFFLFNLKASNILLDKD 216 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L------------------------------------------------~~~~~dlkp~NILl~~~ 216 (398)
+..++||||+++|+| +++|+||||+||+++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 999999999998755 24678999999999999
Q ss_pred CCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHH
Q 037365 217 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGY 295 (398)
Q Consensus 217 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 295 (398)
+.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~~--- 251 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL--- 251 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHH---
Confidence 9999999999876543222222222234568999999998889999999999999999998 7777642211 111
Q ss_pred HHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 296 AWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
..........+. +......+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 252 -~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 252 -FKLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred -HHHHHcCCCCCC----------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 111111111110 11233567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=270.32 Aligned_cols=213 Identities=24% Similarity=0.336 Sum_probs=162.6
Q ss_pred ecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
||+|+||.||+++... |+.+|+|.+.... ......+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999765 8999999986431 12234456799999999999999999999999999999999999987
Q ss_pred ----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccc
Q 037365 200 ----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245 (398)
Q Consensus 200 ----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 245 (398)
+++|+||||+||++++++.+||+|||++........ .....|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCC
Confidence 345679999999999999999999999987654321 2234689
Q ss_pred ccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHH
Q 037365 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLR 325 (398)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (398)
..|+|||++.+..++.++|||||||++|||++|+.||....... ............ ... .........
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~----------~~~~~~~~~ 225 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLED-EVK----------FEHQNFTEE 225 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhcc-ccc----------cccccCCHH
Confidence 99999999999889999999999999999999999975432211 111111111110 000 001123445
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHHH
Q 037365 326 YVNIALLCVQESADDRPTTNDVVSML 351 (398)
Q Consensus 326 ~~~li~~cl~~dP~~RPt~~evl~~L 351 (398)
+.+++.+||+.||++||++.|+++.+
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhhh
Confidence 78999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=278.06 Aligned_cols=205 Identities=21% Similarity=0.303 Sum_probs=156.6
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHH-HHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|+... ++.||+|.+.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 8899999986432 122334555554 67889999999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccC
Confidence 987 46678999999999999999999999987532221 12334578
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||.+.+..++.++|||||||++|||++|+.||..... .......... . ..+ +.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~-~-~~~----------~~~~~~ 221 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHK-P-LQL----------PGGKTV 221 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcC-C-CCC----------CCCCCH
Confidence 9999999999998999999999999999999999999753211 1111111110 0 000 112234
Q ss_pred HHHHHHHHchhcCCCCCCCHH
Q 037365 325 RYVNIALLCVQESADDRPTTN 345 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~ 345 (398)
.+.+++.+||+.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 578999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=273.54 Aligned_cols=225 Identities=25% Similarity=0.388 Sum_probs=173.4
Q ss_pred cCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 186 (398)
.++|...+.||+|+||.||++.+. .+..+|+|.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457889999999999999999752 24579999987553 34456788999999999 79999999999999999
Q ss_pred eEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 187 KILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 187 ~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
.+++|||+++|+| +++|+||||+|||++.++.+||+|||+++....
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 9999999999877 356779999999999999999999999986644
Q ss_pred CCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
...........++..|+|||.+.+..++.++|||||||++|||++ |..||....... ... ..........
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~~---- 264 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFY----KLIKEGYRMA---- 264 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHH----HHHHcCCcCC----
Confidence 322112223356778999999999999999999999999999998 888865322110 111 1111110000
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.....+..+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 265 ------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 ------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=266.08 Aligned_cols=222 Identities=29% Similarity=0.466 Sum_probs=174.4
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..++|.+.+.||+|+||.||+|...+++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++......+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457899999999999999999998878889999987543 3346788999999999999999999999998999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+++++| +++|+||||+||++++++.+||+|||+++........ ..
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~ 161 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AR 161 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh-hh
Confidence 999877 3566799999999999999999999999876532211 11
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....++..|+|||.+.+..++.++|+||||+++||+++ |+.||.... ........ ....... .
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~----~~~~~~~----------~ 225 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQV----ERGYRMP----------R 225 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCCCC----------C
Confidence 22334678999999998889999999999999999998 888874321 11111111 1000000 0
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
+...+..+.+++.+||+.+|++|||++++.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11123468899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=280.48 Aligned_cols=222 Identities=23% Similarity=0.322 Sum_probs=180.0
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh---hhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCee
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG---QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 187 (398)
.....|+..+.||+|.||.||+++.+. |+.+|+|.+.+... .....+.+|+++|+++. |||||.+++.+++.+..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678999999999999999999877 99999999976533 24468899999999998 99999999999999999
Q ss_pred EEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCC----CCeEEcccccceecCC
Q 037365 188 ILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKD----MNPKISDFGMARICGG 232 (398)
Q Consensus 188 ~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~----~~~kl~DFGla~~~~~ 232 (398)
++|||++.||.| +++||||||+|+|+... +.+|++|||++.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999987 57889999999999533 5799999999998765
Q ss_pred CCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
. ......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.......... .... +.. +
T Consensus 192 ~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~-~~~-~----- 256 (382)
T KOG0032|consen 192 G---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILR-GDF-D----- 256 (382)
T ss_pred C---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHc-CCC-C-----
Confidence 2 34556799999999999999999999999999999999999999975433221111 0111 111 0
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
....+ .+.....+.+++..|+..||.+|+|+.++++.
T Consensus 257 f~~~~-w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 FTSEP-WDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCC-ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 01111 33445678899999999999999999999983
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=266.33 Aligned_cols=214 Identities=29% Similarity=0.401 Sum_probs=164.2
Q ss_pred eecccCceEEEEEEEc---CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 123 KLGEGGFGPVYKGVLR---KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
.||+|+||.||+|.++ ++..+|+|+++... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 36789999986442 334567899999999999999999999885 45779999999999
Q ss_pred Ch--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc-ccccccc
Q 037365 198 SL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVG 244 (398)
Q Consensus 198 ~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~g 244 (398)
+| +++|+||||+||++++++.+||+|||+++......... ......+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 87 35678999999999999999999999998765433211 1122244
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
+..|+|||.+....++.++|+|||||++|||++ |+.||..... ...... ......... +...+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----i~~~~~~~~----------~~~~~ 224 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQM----IESGERMEC----------PQRCP 224 (257)
T ss_pred CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHCCCCCCC----------CCCCC
Confidence 678999999988889999999999999999998 8988753221 111111 111111111 11233
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 324 LRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
..+.+++.+||+.||++|||+++|.+.|++
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=270.38 Aligned_cols=227 Identities=23% Similarity=0.382 Sum_probs=175.4
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe-CCe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 186 (398)
..++|++.+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999999865 678999998754 33445678899999999999999999998876 567
Q ss_pred eEEEEeccCCCChh----------------------------------------HHhhcCCCCCceecCCCCeEEccccc
Q 037365 187 KILIYEYMPNKSLD----------------------------------------FFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 187 ~~lV~e~~~~g~L~----------------------------------------~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
.++++||+++|+|. ++|+||||+||++++++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999988762 35679999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCc
Q 037365 227 ARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRT 305 (398)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 305 (398)
++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||... +...+..+. .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~----~~~~~ 237 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYL----KDGYR 237 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHH----HcCCC
Confidence 986643332222223356778999999998889999999999999999999 99887532 111121111 11100
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 306 LELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.. . ....+..+.+++.+||+.||++|||+.++++.|+....
T Consensus 238 ~~--~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 238 LA--Q--------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC--C--------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 0 11123457899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=276.14 Aligned_cols=210 Identities=21% Similarity=0.370 Sum_probs=162.1
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+++... ++.+|+|++... .....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999765 788999999754 223445678899999888 699999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccC
Confidence 987 45678999999999999999999999987532211 12234579
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCC-ccchhHHHHHhhhcCCccccchhhhhcccChHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD-TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.......... .+ +...+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~----------p~~~~ 227 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-RI----------PRFLS 227 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-CC----------CCCCC
Confidence 99999999999999999999999999999999999998643222 11112222222211110 00 11223
Q ss_pred HHHHHHHHHchhcCCCCCCCH
Q 037365 324 LRYVNIALLCVQESADDRPTT 344 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RPt~ 344 (398)
..+.+++.+||+.||++|+++
T Consensus 228 ~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 228 VKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHHHhccCHHHcCCC
Confidence 457899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=287.36 Aligned_cols=221 Identities=22% Similarity=0.333 Sum_probs=166.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||.||+++... ++.||+|.+.... ......+.+|+.++.+++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 468899999999999999999765 8899999986432 223456788999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC-----
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE----- 234 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~----- 234 (398)
||+++|+| +++||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999987 36678999999999999999999999975321000
Q ss_pred ------------------------------------cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcC
Q 037365 235 ------------------------------------LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSG 278 (398)
Q Consensus 235 ------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg 278 (398)
.........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00001234799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCC---CHHHHHHH
Q 037365 279 KKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRP---TTNDVVSM 350 (398)
Q Consensus 279 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP---t~~evl~~ 350 (398)
+.||....... ................ .......+.+++.+|+ .+|.+|+ |+.++++.
T Consensus 241 ~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~--------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPAE-----TQLKVINWETTLHIPS--------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHH-----HHHHHhccCccccCCC--------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99986432211 1111110000000000 1112334667888866 5999999 89999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=279.85 Aligned_cols=233 Identities=22% Similarity=0.260 Sum_probs=170.8
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD---- 185 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 185 (398)
...++|+..+.||+|+||.||++.... ++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 345789999999999999999998754 889999999654 2334567788999999999999999999986543
Q ss_pred --eeEEEEeccCCCCh-----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 186 --EKILIYEYMPNKSL-----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 186 --~~~lV~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
..++||||++++.+ +++||||||+|||++.++.+||+|||+++......
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence 57999999987532 46788999999999999999999999998654322
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh-------------
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR------------- 301 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------- 301 (398)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+.
T Consensus 174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 174 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred ---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhhcHH
Confidence 123357899999999999999999999999999999999999998543211 11000000000
Q ss_pred -----cCC--cccc------chhhhhc-ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 302 -----SNR--TLEL------TDAILED-EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 302 -----~~~--~~~~------~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
... .... .+..... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0000 0000000 00011123467899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=275.57 Aligned_cols=228 Identities=26% Similarity=0.374 Sum_probs=174.2
Q ss_pred cCCCCccceecccCceEEEEEEEcC--------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK--------GNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 184 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 184 (398)
..+|.+.+.||+|+||.||++++.. +..||+|.+... .....+.+.+|+++++++ +||||++++++|..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3578889999999999999997532 236899988754 234456789999999999 799999999999999
Q ss_pred CeeEEEEeccCCCChh------------------------------------------------HHhhcCCCCCceecCC
Q 037365 185 DEKILIYEYMPNKSLD------------------------------------------------FFLFNLKASNILLDKD 216 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L~------------------------------------------------~~~~dlkp~NILl~~~ 216 (398)
+..+++|||+++|+|. ++|+||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 9999999999998652 4567999999999999
Q ss_pred CCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHH
Q 037365 217 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGY 295 (398)
Q Consensus 217 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 295 (398)
+.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+.
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~ 245 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VEEL 245 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HHHH
Confidence 9999999999987654332222222344568999999999999999999999999999998 777764321 1111
Q ss_pred HHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 296 AWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
.. .......... .......+.+++.+||+.+|++|||+.|+++.|++.....
T Consensus 246 ~~-~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 246 FK-LLKEGHRMDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HH-HHHcCCCCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 1111111110 1122346789999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=265.24 Aligned_cols=220 Identities=25% Similarity=0.377 Sum_probs=170.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|+..+.||+|++|.||++...+ ++.+|+|.+.... ......+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 568889999999999999999754 8999999886432 1234567889999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
++||+++++| +++|+||+|+||++++++.++|+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999987 35678999999999999999999999997654322111
Q ss_pred c-cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 N-TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ............... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-----~--- 228 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----MAAIFKIATQPTNPQ-----L--- 228 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----HHHHHHHhccCCCCC-----C---
Confidence 1 1234678899999999998899999999999999999999999753211 011111111111000 0
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+......+.+++.+||..+|.+|||+.++++.
T Consensus 229 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 --PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 12234457899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=283.72 Aligned_cols=228 Identities=21% Similarity=0.286 Sum_probs=172.3
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 184 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 184 (398)
.++....++|++.+.||+|+||.||++++.. ++.+|+|.+... .......+.+|..+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3445556899999999999999999999875 788999998542 223345677899999999999999999999999
Q ss_pred CeeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 185 DEKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
+..++||||+++|+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999999987 4667899999999999999999999999876533
Q ss_pred CcccccccccccccccChhhhccCC----CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGI----FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
.. .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .................
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~~ 269 (371)
T cd05622 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHKNSLTFP 269 (371)
T ss_pred Cc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCcccCC
Confidence 21 1223457999999999997543 78999999999999999999999753211 11111111111111111
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADD--RPTTNDVVSM 350 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~ 350 (398)
+ .......+.+++.+|+..++.+ |++++++++.
T Consensus 270 ~--------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 270 D--------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred C--------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 1123455788999999844433 7899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=270.86 Aligned_cols=219 Identities=23% Similarity=0.379 Sum_probs=173.8
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|+..+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 468999999999999999999975 4899999999766555556788999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++++| +++|+||||+|||++.++.+||+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 175 (297)
T cd06656 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 175 (297)
T ss_pred cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcc
Confidence 999987 356789999999999999999999999876543321 12234
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.......... ....... .. . ......
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~~~~-~~-----~---~~~~~~ 241 (297)
T cd06656 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT-PE-----L---QNPERL 241 (297)
T ss_pred cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eeccCCC-CC-----C---CCcccc
Confidence 68889999999999889999999999999999999999975322211000 0000000 00 0 001223
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+.+++.+||+.+|++|||++++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 345788999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=282.91 Aligned_cols=232 Identities=17% Similarity=0.224 Sum_probs=169.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcC---CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK---GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
...+|++.+.||+|+||.||++...+ +..||+|.+... ....+|+.++++++||||+++++++...+..+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 34579999999999999999997643 577999988653 2346899999999999999999999999999999
Q ss_pred EeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 191 YEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 191 ~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||++.+..+ +++||||||+|||++.++.+||+|||+++...........
T Consensus 165 ~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 165 MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred ehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence 999865321 5778999999999999999999999999876544333333
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc-cchhHHHHHhhhcCCcc-------ccch-
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-LNLLGYAWDLWRSNRTL-------ELTD- 310 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~-------~~~~- 310 (398)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+.......... .+..
T Consensus 245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 324 (392)
T PHA03207 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH 324 (392)
T ss_pred cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence 45679999999999999999999999999999999999999975433221 11111111111000000 0000
Q ss_pred -----hhhhcccCh------HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 311 -----AILEDEYSS------KQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 311 -----~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
......+.. ......+.+++.+||+.||++|||+.|++..
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 1123457789999999999999999999974
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=278.96 Aligned_cols=228 Identities=27% Similarity=0.381 Sum_probs=172.3
Q ss_pred hcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC-
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK- 184 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~- 184 (398)
..++|++.+.||+|+||.||+|.+. .++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3568999999999999999999742 36789999997543 33456788999999999 689999999988764
Q ss_pred CeeEEEEeccCCCChh----------------------------------------------------------------
Q 037365 185 DEKILIYEYMPNKSLD---------------------------------------------------------------- 200 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L~---------------------------------------------------------------- 200 (398)
...+++|||+++|+|.
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4678999999988762
Q ss_pred -----------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccc
Q 037365 201 -----------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245 (398)
Q Consensus 201 -----------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 245 (398)
++|+||||+|||++.++.+||+|||++................++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 357899999999999999999999999865433222222233456
Q ss_pred ccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
..|+|||.+.+..++.++||||||+++|||++ |..||....... .. ............ +.....
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~----~~~~~~~~~~~~----------~~~~~~ 309 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF----CRRLKEGTRMRA----------PDYTTP 309 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HH----HHHHhccCCCCC----------CCCCCH
Confidence 78999999999899999999999999999997 888865322111 11 111111111100 011123
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 325 RYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 57899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=265.93 Aligned_cols=221 Identities=30% Similarity=0.451 Sum_probs=172.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..++|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3467889999999999999999988899999999875432 3467889999999999999999999874 5678999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+++|+| +++|+||||+||++++++.++|+|||++......... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~ 160 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AR 160 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cc
Confidence 999987 3566799999999999999999999999876532221 12
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ...... .........
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~----~~~~~~~~~---------- 224 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQN----LERGYRMPR---------- 224 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHH----HHcCCCCCC----------
Confidence 23345678999999998889999999999999999999 9988753221 111111 111100000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
....+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=280.02 Aligned_cols=233 Identities=21% Similarity=0.266 Sum_probs=170.3
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-----
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK----- 184 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 184 (398)
...++|+..+.||+|+||.||++.... ++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 345789999999999999999999765 888999998653 233456778899999999999999999988643
Q ss_pred -CeeEEEEeccCCCCh-----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 185 -DEKILIYEYMPNKSL-----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 185 -~~~~lV~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
...|+||||++++.. +++||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 357999999987532 46788999999999999999999999998654322
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc------------
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS------------ 302 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------ 302 (398)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus 181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 181 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred ---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHHHHhhhHH
Confidence 123357899999999999999999999999999999999999998543211 111111100000
Q ss_pred ------CCc--cc-cchhhhhc-----c-cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 303 ------NRT--LE-LTDAILED-----E-YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 303 ------~~~--~~-~~~~~~~~-----~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
... .. ..+..... . .........+.+++.+||+.||.+|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00 00000000 0 0001123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=264.70 Aligned_cols=216 Identities=30% Similarity=0.422 Sum_probs=172.5
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.++|+..+.||+|+||.||+|... ++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999875 88999999976644 4577899999999999999999999999999999999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
++++| +++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-----
Confidence 99876 356789999999999999999999999987632221
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...++..|+|||.+.++.++.++||||||+++||+++ |..||...... .+... ......... .
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~----~~~~~~~~~----------~ 221 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPH----VEKGYRMEA----------P 221 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH----HhcCCCCCC----------c
Confidence 2234567999999998889999999999999999997 88886533111 11111 111100000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
...+..+.+++.+||..+|++|||+++++++|++
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1224568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=264.05 Aligned_cols=216 Identities=28% Similarity=0.421 Sum_probs=167.4
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh-
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL- 199 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L- 199 (398)
+.||+|+||.||++.+.+++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999998765433 556789999999999999999999999999999999999998877
Q ss_pred --------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccccc
Q 037365 200 --------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247 (398)
Q Consensus 200 --------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 247 (398)
+++|+||||+||+++.++.+||+|||++................++..
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 160 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceec
Confidence 356689999999999999999999999976543222111122234567
Q ss_pred ccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHH
Q 037365 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326 (398)
Q Consensus 248 y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (398)
|+|||.+.++.++.++|+||||+++|||++ |..||...... ..... ....... ..+...+..+
T Consensus 161 y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~----~~~~~~~----------~~~~~~~~~~ 224 (251)
T cd05041 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRER----IESGYRM----------PAPQLCPEEI 224 (251)
T ss_pred cCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHH----HhcCCCC----------CCCccCCHHH
Confidence 999999998899999999999999999999 77776432211 11111 1110000 0012234568
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 327 VNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 327 ~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.+++.+||+.+|++|||+.|+++.|+.
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=298.85 Aligned_cols=227 Identities=21% Similarity=0.277 Sum_probs=174.0
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578999999999999999999865 889999998653 2233467889999999999999999999999999999999
Q ss_pred eccCCCCh-------------------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 192 EYMPNKSL-------------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 192 e~~~~g~L-------------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999876 35678999999999999999999999998
Q ss_pred ecCCCCc----------------ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccch
Q 037365 229 ICGGNEL----------------QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNL 292 (398)
Q Consensus 229 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~ 292 (398)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k--i 239 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK--I 239 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--h
Confidence 7621110 001123569999999999999999999999999999999999999975422111 0
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHhhccc
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRP-TTNDVVSMLTNEAA 356 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~~~ 356 (398)
. .. ... ..+.... .....+..+.+++.+||+.||++|| +++++.+.|+....
T Consensus 240 ~---~~----~~i---~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 S---YR----DVI---LSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h---hh----hhc---cChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00 000 0000000 0112345578899999999999996 66777777776543
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=266.24 Aligned_cols=224 Identities=26% Similarity=0.438 Sum_probs=172.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-C---CEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-G---NEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.++|+..+.||+|+||.||+|.... + ..+|+|.+... .....+.+.+|++++++++|||++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999999753 3 36999998755 33445678899999999999999999999999999999
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++++| +++|+||||+||++++++.+||+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999999987 3566799999999999999999999999866432211
Q ss_pred cc-cccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 237 AN-TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 237 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.. ......+..|+|||++.+..++.++|||||||++|||++ |+.||..... .... .. ........
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~---~~-i~~~~~~~------- 230 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVM---KA-INDGFRLP------- 230 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHH---HH-HhcCCCCC-------
Confidence 11 111223457999999998889999999999999999997 9999743221 1111 11 11110000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 231 ---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=267.01 Aligned_cols=223 Identities=25% Similarity=0.404 Sum_probs=171.9
Q ss_pred CCCCccceecccCceEEEEEEEcC----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|++.+.||+|+||.||+|.+.. +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578888999999999999998742 3369999986542 34456789999999999999999999999999999999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+++++| +++|+||||+|||++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 999999987 35568999999999999999999999998765432211
Q ss_pred -ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 238 -NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......++..|+|||.+.+..++.++|+||||+++||+++ |..||...... ...... .......
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~----~~~~~~~-------- 229 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAI----EEGYRLP-------- 229 (267)
T ss_pred eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHH----hCCCcCC--------
Confidence 1122234568999999998899999999999999999886 99987533211 111111 1110000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.....+..+.+++.+||+.+|.+|||+.++++.|++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 --APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=269.25 Aligned_cols=219 Identities=22% Similarity=0.374 Sum_probs=171.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.+.|++.+.||+|+||.||+|+... +..+++|.+........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3678899999999999999999865 889999999877766778889999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++++| +++|+||||+||+++.++.+||+|||++....... ....
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 168 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRD 168 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cccc
Confidence 999987 35667999999999999999999999987543221 1122
Q ss_pred cccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 241 RIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
...++..|+|||++. ...++.++|||||||++|||++|..|+...... ......... .....
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~------- 235 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKS-EPPTL------- 235 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHHhcC-CCccC-------
Confidence 346788999999885 345788999999999999999999997532211 111111111 00000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.........+.+++.+||+.+|++||+++++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 -SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 001223345789999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=271.22 Aligned_cols=227 Identities=22% Similarity=0.305 Sum_probs=177.3
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|+..+.||+|.-|+||++++++ +..+|+|++.+.. .......+.|.+||+.++||.+..||+.++.+...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34568888999999999999999986 5889999997653 3344567789999999999999999999999999999
Q ss_pred EEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC--
Q 037365 190 IYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN-- 233 (398)
Q Consensus 190 V~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~-- 233 (398)
+||||+||+| +++.|||||+|||+.++|++.|+||.++..+.-.
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999999998 3444799999999999999999999987543110
Q ss_pred ------------------------------C-c---------------------ccccccccccccccChhhhccCCCCc
Q 037365 234 ------------------------------E-L---------------------QANTSRIVGTYGYMSPEYAIEGIFSI 261 (398)
Q Consensus 234 ------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 261 (398)
. . ......++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 00122467999999999999999999
Q ss_pred ccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC---hHHHHHHHHHHHHHchhcCC
Q 037365 262 KFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS---SKQVLLRYVNIALLCVQESA 338 (398)
Q Consensus 262 ~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP 338 (398)
++|+|+|||++|||+.|+.||... ...+.+..++..... .+..+..+.+||++.|..||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~------------------~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGS------------------NNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCC------------------CchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 999999999999999999996432 222222222222221 12344678999999999999
Q ss_pred CCCCC----HHHHHH--HHhhccccc
Q 037365 339 DDRPT----TNDVVS--MLTNEAAAL 358 (398)
Q Consensus 339 ~~RPt----~~evl~--~L~~~~~~~ 358 (398)
++|.- +.||-+ .+++...++
T Consensus 377 ~kRlg~~rGA~eIK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRHPFFEGVNWAL 402 (459)
T ss_pred hhhhccccchHHhhcCccccCCChhh
Confidence 99998 888775 345544443
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=268.31 Aligned_cols=220 Identities=25% Similarity=0.410 Sum_probs=168.5
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC-----
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK----- 184 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----- 184 (398)
+.+++.|+..+.||+|+||.||+|...+ ++.||+|.+.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 3567889999999999999999999765 7889999986543 3345778899999998 699999999998753
Q ss_pred -CeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 185 -DEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 185 -~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
+..+++|||+++|+| +++|+||||+||++++++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 468999999999877 356789999999999999999999999986
Q ss_pred cCCCCcccccccccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR 304 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
..... .......|+..|+|||++. +..++.++|||||||++|||++|+.||....... .. ..... ..
T Consensus 161 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~-~~~~~-~~ 232 (272)
T cd06637 161 LDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----AL-FLIPR-NP 232 (272)
T ss_pred ccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HH-HHHhc-CC
Confidence 54322 1223457899999999986 3458889999999999999999999975322110 00 00011 00
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 305 TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.... . ....+..+.+++.+||+.||.+|||+.++++
T Consensus 233 ~~~~----~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRL----K-----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC----C-----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 0 1122345789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=270.18 Aligned_cols=229 Identities=25% Similarity=0.380 Sum_probs=173.7
Q ss_pred CCCCccceecccCceEEEEEEEc-----CCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEe--CCee
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-----KGNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCID--KDEK 187 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 187 (398)
..|+..+.||+|+||.||++.+. .+..+|+|.+...... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999864 2678999999766443 46789999999999999999999999987 5578
Q ss_pred EEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 188 ILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 188 ~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
+++|||+++++| +++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 999999999987 35667999999999999999999999998765332
Q ss_pred cc-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccch---------hHHHHHhhhcCC
Q 037365 235 LQ-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNL---------LGYAWDLWRSNR 304 (398)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~---------~~~~~~~~~~~~ 304 (398)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 21 11112345567999999998899999999999999999999998865432221110 000000011000
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 305 TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.. .....++..+.+++.+||+.+|++|||+.|++++|+++
T Consensus 244 ~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 244 RL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00 00122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=261.42 Aligned_cols=215 Identities=25% Similarity=0.380 Sum_probs=173.0
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC----Ch----hhHHHHHHHHHHHHhc-CCCcccceeeEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR----SG----QGLREMKNEASVIAKV-QHKNLVRLLGCCID 183 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~----~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 183 (398)
.-+.|+..+.||.|..+.|.++.++. |++.|+|++... .. .-.+.-.+|+.+|+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34567778899999999999998765 888999988532 11 1233456799999998 59999999999999
Q ss_pred CCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 184 KDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
+...++|+|.|+.|.| +++||||||+|||+|++.++||+|||+++.+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999987 58899999999999999999999999999887
Q ss_pred CCCcccccccccccccccChhhhcc------CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIE------GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT 305 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 305 (398)
.+. .....+|||+|+|||.+.- ..|+...|+||+||++|.|+.|.+||-. . +.
T Consensus 175 ~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-----------------R-kQ 233 (411)
T KOG0599|consen 175 PGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-----------------R-KQ 233 (411)
T ss_pred Cch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-----------------H-HH
Confidence 654 3445799999999998862 3488999999999999999999999621 1 11
Q ss_pred cccchhhhhcccC-----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 306 LELTDAILEDEYS-----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 306 ~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.-++..+..+.+. ..+......+|+.+||+.||.+|.|++|+++
T Consensus 234 mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 234 MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1122233333322 3445567899999999999999999999985
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=271.24 Aligned_cols=228 Identities=24% Similarity=0.372 Sum_probs=171.2
Q ss_pred CCCccceecccCceEEEEEEEc-----CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--CeeE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-----KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI 188 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 188 (398)
.|++.+.||+|+||.||++.+. .+..||+|.+.... ......+.+|++++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4678899999999999999853 37789999987553 34456789999999999999999999999875 5689
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+||||+++++| +++|+||||+||+++.++.+||+|||+++.+.....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 99999999988 356679999999999999999999999987653322
Q ss_pred c-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCcc---------chhHHHHHhhhcCCc
Q 037365 236 Q-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTL---------NLLGYAWDLWRSNRT 305 (398)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~---------~~~~~~~~~~~~~~~ 305 (398)
. .......++..|+|||.+.+..++.++|||||||++|||++++.|......... ...............
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCcc
Confidence 1 112234567789999999988899999999999999999998876432111000 000000000110000
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 306 LELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.. .....+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 245 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 245 LP----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 0112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=267.45 Aligned_cols=223 Identities=24% Similarity=0.403 Sum_probs=170.7
Q ss_pred CCCCccceecccCceEEEEEEEcC-C---CEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-G---NEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|+..+.||+|+||.||+|.+.. + ..||+|.+... .......+..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457788999999999999999754 3 36999998755 344567899999999999999999999999999999999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+++|+| +++|+||||+||+++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 999999987 35567999999999999999999999987664332111
Q ss_pred cccc-c--cccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 238 NTSR-I--VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 238 ~~~~-~--~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.... . ..+..|+|||.+.+..++.++|||||||++||+++ |..||..... .....++...+ .. .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~---~~-~------ 231 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDY---RL-P------ 231 (269)
T ss_pred ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCC---cC-C------
Confidence 1111 1 12457999999999999999999999999999886 9888643211 11111111000 00 0
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
...+.+..+.+++.+||+.+|++||++++++..|++.
T Consensus 232 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112334578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=270.87 Aligned_cols=229 Identities=23% Similarity=0.303 Sum_probs=170.7
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|++.+.||+|+||.||++.+.. +..+|+|.+... .......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368889999999999999999765 778899988654 333456688999999999999999999999999999999999
Q ss_pred cCCCChh---------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSLD---------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L~---------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++++|. ++|+||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~ 156 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----AN 156 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----cc
Confidence 9999872 4567999999999999999999999987653221 23
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC----------------
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR---------------- 304 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---------------- 304 (398)
...|+..|+|||.+.+..++.++|+|||||++|||++|+.||...... ..............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCCCcc
Confidence 357889999999998888999999999999999999999997532211 11110000000000
Q ss_pred ----ccccchhhhhcc---cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 305 ----TLELTDAILEDE---YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 305 ----~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+..+...... .........+.+++.+||+.+|++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 0011134568899999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=273.47 Aligned_cols=226 Identities=27% Similarity=0.413 Sum_probs=172.4
Q ss_pred cCCCCccceecccCceEEEEEEEc--------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR--------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 184 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 184 (398)
.++|.+.+.||+|+||.||++... ....+|+|.+... .......+.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 467888999999999999999752 2456899998754 334456788999999999 699999999999999
Q ss_pred CeeEEEEeccCCCCh------------------------------------------------hHHhhcCCCCCceecCC
Q 037365 185 DEKILIYEYMPNKSL------------------------------------------------DFFLFNLKASNILLDKD 216 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L------------------------------------------------~~~~~dlkp~NILl~~~ 216 (398)
+..+++|||+++|+| +++|+||||+|||++++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 999999999998865 23567999999999999
Q ss_pred CCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHH
Q 037365 217 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGY 295 (398)
Q Consensus 217 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 295 (398)
+.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..||..... ....
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~-- 246 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--EELF-- 246 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--HHHH--
Confidence 9999999999986653322222222234567999999999899999999999999999999 7877642211 1111
Q ss_pred HHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 296 AWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.........+. ....+..+.+++.+||+.+|++|||+.++++.|++...
T Consensus 247 --~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 --KLLREGHRMDK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred --HHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111111110 11223457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=263.63 Aligned_cols=219 Identities=26% Similarity=0.401 Sum_probs=170.3
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
.+|+..+.||+|+||.||++.+.++..+|+|.+.... .....+.+|++++++++|||++++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677789999999999999998778899999987543 233568899999999999999999999999999999999999
Q ss_pred CCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 196 NKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 196 ~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++| +++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 161 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGT 161 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc-cCCC
Confidence 9877 35667999999999999999999999998664332211 1223
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
.++..|+|||.+.++.++.++||||||+++|||++ |+.||..... .. ........... .. +..
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~---~~~~~~~~~~~---~~--------~~~ 225 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SE---VVETINAGFRL---YK--------PRL 225 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HH---HHHHHhCCCCC---CC--------CCC
Confidence 35678999999998899999999999999999998 8888653221 11 11111110000 00 111
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=270.21 Aligned_cols=224 Identities=27% Similarity=0.403 Sum_probs=170.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-C--CEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-G--NEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999998765 3 34788888743 334456788999999999 799999999999999999999
Q ss_pred EeccCCCCh------------------------------------------------hHHhhcCCCCCceecCCCCeEEc
Q 037365 191 YEYMPNKSL------------------------------------------------DFFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 191 ~e~~~~g~L------------------------------------------------~~~~~dlkp~NILl~~~~~~kl~ 222 (398)
|||+++|+| +++|+||||+|||+++++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 999998876 34578999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhh
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWR 301 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 301 (398)
|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... +.. ....
T Consensus 162 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~----~~~~ 232 (297)
T cd05089 162 DFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELY----EKLP 232 (297)
T ss_pred CcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHh
Confidence 99998643211 11111233557999999998899999999999999999997 98887532211 111 1111
Q ss_pred cCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 302 SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
...... . ....+..+.+++.+||+.+|.+|||++++++.|+++....
T Consensus 233 ~~~~~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 233 QGYRME-----K-----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred cCCCCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 110000 0 1123345789999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=263.88 Aligned_cols=223 Identities=23% Similarity=0.379 Sum_probs=171.5
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++.+++.+.....||+|+||.||+|.+.+ +..||+|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34456667667899999999999999764 77899999987766667789999999999999999999999999999999
Q ss_pred EEeccCCCCh-----------------------------------hHHhhcCCCCCceecC-CCCeEEcccccceecCCC
Q 037365 190 IYEYMPNKSL-----------------------------------DFFLFNLKASNILLDK-DMNPKISDFGMARICGGN 233 (398)
Q Consensus 190 V~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~-~~~~kl~DFGla~~~~~~ 233 (398)
++||+++++| +++|+||||+||+++. ++.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999987 3455799999999976 678999999998765432
Q ss_pred CcccccccccccccccChhhhccCC--CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGI--FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
.. ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.|+.......... +...... ....
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~~~~--~~~~---- 232 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVGMFK--IHPE---- 232 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhhhhc--cCCC----
Confidence 21 122345789999999987654 7899999999999999999999975322111000 0000000 0000
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. +......+.+++.+||+.+|++|||+.|++.
T Consensus 233 -~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 233 -I-----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -C-----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 1223456789999999999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=271.90 Aligned_cols=230 Identities=20% Similarity=0.298 Sum_probs=167.8
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|...+.||+|+||.||+|+... ++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 578899999999999999999764 7889999986543 22334677899999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+++..+ +++||||||+|||++.++.+||+|||+++....... ....
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 163 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSN 163 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--cccc
Confidence 986321 467889999999999999999999999976543221 1223
Q ss_pred ccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc---------cccchh
Q 037365 242 IVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT---------LELTDA 311 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 311 (398)
..+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... +........+..... ....+.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 467899999999875 45899999999999999999999998543221 111111111100000 000000
Q ss_pred hhhcc-c-----ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ILEDE-Y-----SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~~~~~-~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..... . ..+.....+.+++.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 0 01123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=281.79 Aligned_cols=223 Identities=24% Similarity=0.391 Sum_probs=177.9
Q ss_pred CCCCccceecccCceEEEEEEEcC---CC--EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK---GN--EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
+.....+.||.|-||.||+|.+.+ |. .||||..+.. ..+..+.|..|..+|++++||||++++|+|.+ ...|+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344556789999999999999653 33 4899999875 45667889999999999999999999999975 57899
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
|||.++.|.| ..+||||..+|||+.....+||+|||+++.+.+..++
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 9999999977 4788999999999999999999999999999877665
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
... ...-...|||||.+.-.+++.+||||-|||.+||++. |..||..-...+.- .....+...
T Consensus 548 kaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------~~iEnGeRl--------- 611 (974)
T KOG4257|consen 548 KAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------GHIENGERL--------- 611 (974)
T ss_pred hcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------EEecCCCCC---------
Confidence 543 4455778999999999999999999999999999986 99997532221100 001111111
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
..++.++..+..|+.+||.+||.+||++.++...|+.+..
T Consensus 612 -P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 612 -PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1145566778899999999999999999999988866543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=261.84 Aligned_cols=221 Identities=22% Similarity=0.371 Sum_probs=173.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|+..+.||+|+||.||+|.... ++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4678889999999999999999764 788999999876655677899999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++++| +++|+||||+||++++++.+||+|||++....... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hccc
Confidence 999877 35677999999999999999999999987654321 1122
Q ss_pred cccccccccChhhhccC---CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 241 RIVGTYGYMSPEYAIEG---IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
...++..|+|||.+.+. .++.++|+||||+++|||++|+.|+....... ... .... ... ......
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-~~~----~~~~-~~~---~~~~~~--- 227 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-ALF----LISK-SNF---PPPKLK--- 227 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHH----HHHh-ccC---CCcccc---
Confidence 34678899999999876 78999999999999999999999975322111 000 0000 000 000000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 02234456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=266.31 Aligned_cols=221 Identities=22% Similarity=0.363 Sum_probs=170.2
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|+..+.||+|+||.||+|.... ++.||+|.++.........+.+|+.+++.++||||+++++.+..++..+++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 3578888999999999999998764 889999998766555556788999999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+++++| +++|+||||+||+++.++.+||+|||++....... .....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~ 165 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKS 165 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--ccccc
Confidence 999987 35678999999999999999999999987654321 12234
Q ss_pred ccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 242 IVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 242 ~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
..|+..|+|||++. ...++.++|+|||||++|||++|+.|+....... .. ......... ......
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~----~~~~~~~~~----~~~~~~--- 233 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-AL----FLMTKSNFQ----PPKLKD--- 233 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hH----HhhhccCCC----CCcccc---
Confidence 57899999999875 4568899999999999999999999974322111 00 000000000 000000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.+|++|||++++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0112345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=267.84 Aligned_cols=222 Identities=23% Similarity=0.355 Sum_probs=173.6
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|++.+.||+|+||.||++.... ++.+|+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 568888999999999999999765 8889999886542 34457788999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++++| +.+|+||||+||++++++.++|+|||++....... ..
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~ 160 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----AD 160 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cC
Confidence 999987 24667999999999999999999999986543221 22
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc------cchhHHHHHhhhcCCccccchhhhh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT------LNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
...|+..|+|||++.+..++.++|||||||++|++++|+.||....... .....+........ ..
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------- 231 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PP-------- 231 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CC--------
Confidence 3578999999999988899999999999999999999999986443221 11111111111110 00
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 351 (398)
.......+..+.+++.+||+.||++|||++|+++..
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 -RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000112345688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=267.75 Aligned_cols=228 Identities=23% Similarity=0.374 Sum_probs=172.5
Q ss_pred cchhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEE-
Q 037365 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI- 182 (398)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~- 182 (398)
+.++.+..+.++|++.+.||+|+||.||++.... ++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4556677788999999999999999999999765 7889999886533 2235678899999999 6999999999885
Q ss_pred ----eCCeeEEEEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEc
Q 037365 183 ----DKDEKILIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 183 ----~~~~~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~ 222 (398)
.++..++||||+++++| +++|+||||+||++++++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 34568999999999987 24567999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhcc-----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHH
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIE-----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW 297 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 297 (398)
|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+....... .. .
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~----~ 239 (286)
T cd06638 167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-AL----F 239 (286)
T ss_pred cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HH----h
Confidence 9999987643321 1223468999999998853 457899999999999999999999975432110 00 0
Q ss_pred HhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 298 DLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. ........... +......+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~-~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 K-IPRNPPPTLHQ--------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred h-ccccCCCcccC--------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 00000000000 11123457899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=263.27 Aligned_cols=220 Identities=28% Similarity=0.438 Sum_probs=170.6
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.++|++.+.||+|++|.||+|.+..+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688889999999999999998777789999886543 23466889999999999999999999875 46789999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
++|+| +++|+||||+||++++++.+||+|||+++........ ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~ 161 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQ 161 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccC
Confidence 99887 3566799999999999999999999999876443221 112
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...++..|+|||...+..++.++||||||+++|||++ |+.||..... .....+ ........ ..
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~~----------~~ 225 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQ----VERGYRMP----------CP 225 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCCCC----------CC
Confidence 2346678999999998899999999999999999999 8888653211 111111 11110000 01
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
...+..+.+++.+||+.||++|||++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=271.09 Aligned_cols=219 Identities=22% Similarity=0.400 Sum_probs=172.9
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..+|+..+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 357888999999999999999865 4889999999765555567788999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++++| +.+|+||||+||+++.++.+||+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~ 175 (296)
T cd06655 98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTM 175 (296)
T ss_pred cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCc
Confidence 999987 356789999999999999999999999876543321 12234
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... ......... .... . .....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----~~~~~~~~~-~~~~-----~---~~~~~ 241 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATNG-TPEL-----Q---NPEKL 241 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcC-Cccc-----C---CcccC
Confidence 68889999999998889999999999999999999999975422110 000111100 0000 0 01123
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 345788999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=280.01 Aligned_cols=231 Identities=20% Similarity=0.264 Sum_probs=167.7
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-----eeE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI 188 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 188 (398)
+|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 4899999998653 2334567889999999999999999999998876 789
Q ss_pred EEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 189 LIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 189 lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
+||||+.+..+ +++||||||+|||++.++.+||+|||+++....... .
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-K 159 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc-c
Confidence 99999975311 467889999999999999999999999986543321 1
Q ss_pred ccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc-------c
Q 037365 238 NTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL-------T 309 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 309 (398)
......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+...........+ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22334678999999999874 4799999999999999999999998543211 111111111110000000 0
Q ss_pred hhhhhccc----------ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 310 DAILEDEY----------SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 310 ~~~~~~~~----------~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
........ ........+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 011123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=274.61 Aligned_cols=209 Identities=23% Similarity=0.312 Sum_probs=161.4
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 191 (398)
+|+..+.||+|+||.||+|.... ++.||+|.+... .....+.+..|..++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36777899999999999999765 889999998643 2233456778888988886 577889999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccc
Confidence 99999987 45678999999999999999999999987543222 112
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..... ... .. +
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~---~~i~~-~~~-~~----------p 221 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELF---QSIME-HNV-SY----------P 221 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHH---HHHHh-CCC-CC----------C
Confidence 335689999999999999999999999999999999999999754321 1111 11111 000 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTT 344 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~ 344 (398)
......+.+++.+||+.+|.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1223457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=261.84 Aligned_cols=217 Identities=34% Similarity=0.474 Sum_probs=166.1
Q ss_pred ceecccCceEEEEEEEcC----CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK----GNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|.+.. +..+|+|.+..... ...+.+.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998643 26899999975543 34567889999999999999999999876 4568999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc-cccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA-NTSRIV 243 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~ 243 (398)
|+| +++|+||||+|||++.++.+||+|||+++......... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 987 35667999999999999999999999998764433211 111223
Q ss_pred ccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 244 GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 244 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....+.. ....... +...
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~----~~~~~~~----------~~~~ 223 (257)
T cd05060 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLE----SGERLPR----------PEEC 223 (257)
T ss_pred ccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH----cCCcCCC----------CCCC
Confidence 4567999999998899999999999999999998 8988754321 12222211 1111100 1123
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 356789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=261.18 Aligned_cols=217 Identities=23% Similarity=0.394 Sum_probs=172.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|+..+.||+|+||.||+|.+.+ ++.+++|.+..... .+.+.+|++++++++||||+++++++.++...|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999999876 78999999875532 57889999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++++| +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~ 157 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRN 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccc
Confidence 999877 356779999999999999999999999987654321 122
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChH
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (398)
...|+..|+|||.+.+..++.++||||||+++|+|++|+.|+.......... . ....... ... ...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~-~~~~~~~-----~~~---~~~ 223 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----M-IPNKPPP-----TLS---DPE 223 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----h-hccCCCC-----CCC---chh
Confidence 3457889999999998899999999999999999999999976432211000 0 0000000 000 022
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 321 QVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 321 ~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.....+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 23456889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=284.76 Aligned_cols=211 Identities=25% Similarity=0.418 Sum_probs=173.6
Q ss_pred eecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh--
Q 037365 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-- 199 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L-- 199 (398)
+||+|.||+||.|++.+ ...+|||.+...+....+-+.+|+.+-++++|.|||+++|.|..++..-+.||..+||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999876 456899999888777778889999999999999999999999999999999999999998
Q ss_pred ---------------------------------hHHhhcCCCCCceec-CCCCeEEcccccceecCCCCccccccccccc
Q 037365 200 ---------------------------------DFFLFNLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGT 245 (398)
Q Consensus 200 ---------------------------------~~~~~dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 245 (398)
.++|||||-+|||++ -.|.+||+|||.++.+..-. ..+.++.||
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFTGT 739 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFTGT 739 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccccccc
Confidence 477889999999995 57899999999998775322 335567899
Q ss_pred ccccChhhhccCC--CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHH
Q 037365 246 YGYMSPEYAIEGI--FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323 (398)
Q Consensus 246 ~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
..|||||++..++ |++++|||||||++.||.||++||-........+ |+-+- .......+.+..
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------FkVGm-------yKvHP~iPeels 805 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------FKVGM-------YKVHPPIPEELS 805 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------hhhcc-------eecCCCCcHHHH
Confidence 9999999998765 8999999999999999999999986543332111 11100 001111255667
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 324 LRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+...++.+|+.+||.+||++.+++.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 78899999999999999999999985
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=260.80 Aligned_cols=216 Identities=22% Similarity=0.350 Sum_probs=171.7
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||.|+||.||.++... ++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58888999999999999998755 888999998644 344556788999999999999999999999999999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+++|+| +.+|+||||+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cc
Confidence 999877 345779999999999999999999999987654331 22
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....|++.|+|||.+.+..++.++||||||+++|||++|..||..... ......... ...... .
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~-~~~~~~----------~ 222 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQ-GNYTPV----------V 222 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHc-CCCCCC----------c
Confidence 345689999999999888899999999999999999999998743211 111111111 111110 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...+..+.+++.+||+.+|++|||++++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 2234557899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=266.52 Aligned_cols=217 Identities=24% Similarity=0.375 Sum_probs=168.7
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
|++.+.||+|+||.||+|.+.. +..+++|.+........+.+.+|+++++.++|||++++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5677889999999999999875 778899998776666677889999999999999999999999999999999999999
Q ss_pred CCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccc
Q 037365 197 KSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243 (398)
Q Consensus 197 g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 243 (398)
|+| +++|+||||+||+++.++.+||+|||++....... .......
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 164 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFI 164 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc--ccccccc
Confidence 887 34567999999999999999999999987654321 1223356
Q ss_pred ccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 244 GTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 244 gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
|+..|+|||++. +..++.++|||||||++|||++|++||...... ........... .... .
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~--------~ 230 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEP-PTLA--------Q 230 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----HHHHHHhhcCC-CCCC--------C
Confidence 899999999984 345788999999999999999999997532211 11111111100 0000 0
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11234568899999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=261.96 Aligned_cols=215 Identities=30% Similarity=0.448 Sum_probs=167.3
Q ss_pred ceecccCceEEEEEEEcC--C--CEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK--G--NEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999754 2 3689999987655 566788999999999999999999999988 889999999998
Q ss_pred CCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc-ccccc
Q 037365 197 KSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ-ANTSR 241 (398)
Q Consensus 197 g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 241 (398)
|+| +.+|+||||+||+++.++.+||+|||+++.+...... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 877 3567899999999999999999999999876543211 11223
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (398)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +... .......... ...
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~---~~~~~~~~~~----------~~~ 224 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILK---KIDKEGERLE----------RPE 224 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHHhcCCcCC----------CCc
Confidence 457788999999998899999999999999999998 99997432111 1111 1111000000 011
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 321 QVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 321 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 23456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=262.55 Aligned_cols=218 Identities=28% Similarity=0.425 Sum_probs=162.9
Q ss_pred ceecccCceEEEEEEEcC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe-CCeeEEEEeccC
Q 037365 122 NKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEYMP 195 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~~~ 195 (398)
+.||+|+||.||+|.+.+ +..+|+|++... .....+.+.+|+.+++.++||||+++++++.. ++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 356999998643 33455678899999999999999999998764 556899999999
Q ss_pred CCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc--ccc
Q 037365 196 NKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA--NTS 240 (398)
Q Consensus 196 ~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~~ 240 (398)
+|+| +++|+||||+|||+++++.+||+|||+++......... ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 9987 35678999999999999999999999997654322111 112
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCC-CCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKN-TGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...++..|+|||.+.+..++.++|||||||++|||++|..| +... +....... ........ . .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~---~~~~~~~~-~----------~ 224 (262)
T cd05058 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVY---LLQGRRLL-Q----------P 224 (262)
T ss_pred cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHH---HhcCCCCC-C----------C
Confidence 33567789999999988999999999999999999996544 3321 11111111 11111000 0 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
...+..+.+++.+||+.+|++||++.++++.|++..
T Consensus 225 ~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 112345789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=265.56 Aligned_cols=224 Identities=28% Similarity=0.444 Sum_probs=172.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-CC----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GN----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.+|+..+.||+|+||.||+|.+.+ |. .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568888999999999999998754 33 58999887553 3445678899999999999999999999987 78999
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++|+| +++|+||||+||++++++.+||+|||+++........
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 9999999987 3457799999999999999999999999876533222
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......++..|+|||.+....++.++|+||||+++||+++ |+.||..... .++... .........
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~----~~~~~~~~~------- 232 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDL----LEKGERLPQ------- 232 (279)
T ss_pred eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHH----HhCCCCCCC-------
Confidence 22222234568999999988899999999999999999998 9999754321 111111 111110000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+......+.+++.+||..+|.+|||+.++++.|+....
T Consensus 233 ---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 ---PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11122357789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=263.58 Aligned_cols=218 Identities=22% Similarity=0.347 Sum_probs=158.9
Q ss_pred eecccCceEEEEEEEcC---CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCC
Q 037365 123 KLGEGGFGPVYKGVLRK---GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~ 198 (398)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+.+++.++||||+++++.+.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3568899876443 3344578899999999999999999999999999999999999988
Q ss_pred h-------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 199 L-------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 199 L-------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
| +++||||||+|||+++++.+||+|||++..............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCC
Confidence 7 346679999999999999999999999875433322222233
Q ss_pred ccccccccChhhhcc-------CCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 242 IVGTYGYMSPEYAIE-------GIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..++..|+|||++.. ..++.++|||||||++|||++ |..||..... ... ....... ....+..+..
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~---~~~~~~~-~~~~~~~~~~ 235 (269)
T cd05042 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQV---LKQVVRE-QDIKLPKPQL 235 (269)
T ss_pred CCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHH---HHHHhhc-cCccCCCCcc
Confidence 456778999998753 356889999999999999999 6777643211 111 1111111 1111111111
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.......+.+++..|| .||++|||+++|++.|.
T Consensus 236 -----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 236 -----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1123345677888999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=267.04 Aligned_cols=220 Identities=23% Similarity=0.384 Sum_probs=172.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|++.+.||+|+||.||++.+.. +..+|+|.+........+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 5679999999999999999999864 889999999877666667889999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++++| +++|+||||+||+++.++.++|+|||++....... ....
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~ 161 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRD 161 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--cccc
Confidence 999877 35667999999999999999999999886553322 1123
Q ss_pred cccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 241 RIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
...|+..|+|||.+. +..++.++|+||||+++|||++|+.||...... ........ ...... .
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~-----~- 229 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLKILK-SEPPTL-----D- 229 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHHHhc-CCCCCc-----C-
Confidence 356899999999985 345788999999999999999999997543211 11111111 100000 0
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.+......+.+++.+||+.+|++|||+.++++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 --QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011233457899999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=281.08 Aligned_cols=221 Identities=21% Similarity=0.317 Sum_probs=165.6
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||++.... ++.||+|.+... .......+.+|..++.+++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468888999999999999999865 889999998643 2234466788999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc---
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ--- 236 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 236 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999987 4677899999999999999999999998754321100
Q ss_pred ------------------------------cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCC
Q 037365 237 ------------------------------ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYR 286 (398)
Q Consensus 237 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 286 (398)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00123479999999999999999999999999999999999999975432
Q ss_pred CCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCC---HHHHHHH
Q 037365 287 TDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPT---TNDVVSM 350 (398)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~~ 350 (398)
.. .. ............... .......+.+++.+|+. ||.+|++ ++++++.
T Consensus 241 ~~--~~---~~~i~~~~~~~~~p~--------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQ--ET---YRKVMNWKETLVFPP--------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HH--HH---HHHHHcCCCceecCC--------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 21 11 111111000000000 00123456778888764 9999985 6666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=262.62 Aligned_cols=215 Identities=26% Similarity=0.393 Sum_probs=163.1
Q ss_pred eecccCceEEEEEEEc---CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCC
Q 037365 123 KLGEGGFGPVYKGVLR---KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~ 198 (398)
.||+|+||.||+|.+. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 25569999997653 334467889999999999999999999885 457899999999998
Q ss_pred h---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc-ccccccc
Q 037365 199 L---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVG 244 (398)
Q Consensus 199 L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~g 244 (398)
| +.+|+||||+|||++.++.+||+|||++.......... ......+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 8 34667999999999999999999999997654332211 1112234
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
+..|+|||.+.+..++.++|||||||++||+++ |..||...... .. ............ +....
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~----~~~~~~~~~~~~----------~~~~~ 224 (257)
T cd05115 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EV----MSFIEQGKRLDC----------PAECP 224 (257)
T ss_pred CcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HH----HHHHHCCCCCCC----------CCCCC
Confidence 578999999998889999999999999999996 99887532211 11 111111111110 11224
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 324 LRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
..+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 5678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=263.00 Aligned_cols=217 Identities=20% Similarity=0.392 Sum_probs=172.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..|+..+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 357778899999999999999765 8889999987543 34556788999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++|+| +.+|+||+|+||+++.++.++|+|||++........ .....
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 161 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTF 161 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccc
Confidence 999987 356679999999999999999999999977654321 12234
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.++..|+|||.+.+..++.++|+|||||++|||++|..|+....... . ... ....... ......
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~---~~~-~~~~~~~----------~~~~~~ 225 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--V---LFL-IPKNNPP----------TLTGEF 225 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--H---hhh-hhcCCCC----------CCchhh
Confidence 67889999999998889999999999999999999999975322110 0 000 0000000 012334
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+..+.+++.+||+.+|++|||++++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 5668899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=260.18 Aligned_cols=215 Identities=36% Similarity=0.543 Sum_probs=169.3
Q ss_pred ceecccCceEEEEEEEcC----CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK----GNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|.... +..+++|.+...... ..+.+.+|++.+..++|+|++++++++..+...+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999764 788999999765433 367889999999999999999999999999999999999987
Q ss_pred CCh-----------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 197 KSL-----------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 197 g~L-----------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
++| +++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 765 245679999999999999999999999987765432
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
........++..|+|||.+.+..++.++||||||+++|||++ |..||..... .... ...........
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~----~~~~~~~~~~~------ 228 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVL----EYLRKGYRLPK------ 228 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHHcCCCCCC------
Confidence 223344567889999999998899999999999999999999 5888754311 1111 11111110000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 229 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 ----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1222456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=263.97 Aligned_cols=217 Identities=20% Similarity=0.387 Sum_probs=172.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|+..+.||.|++|.||+|.+.. ++.+|+|.+.... ......+.+|++++++++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 468888999999999999999765 8899999986543 34456788999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++++| +.+|+||+|+||++++++.++|+|||+++...... ......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTF 158 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccc
Confidence 999987 35778999999999999999999999998775432 122335
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... . .... .......... ....
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~---~~~~-~~~~~~~~~~---------~~~~ 223 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--R---VLFL-IPKNNPPSLE---------GNKF 223 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--H---HHHH-hhhcCCCCCc---------cccc
Confidence 6888999999999888999999999999999999999997533211 1 0000 1111111110 0113
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+..+.+++.+||..+|++|||++++++
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 445789999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=270.37 Aligned_cols=223 Identities=28% Similarity=0.405 Sum_probs=168.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CC--EEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GN--EIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|++.+.||+|+||.||+|.+++ +. .+|+|.+... .......+.+|+.++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578888999999999999999754 43 4688887653 334456788999999999 899999999999999999999
Q ss_pred EeccCCCCh------------------------------------------------hHHhhcCCCCCceecCCCCeEEc
Q 037365 191 YEYMPNKSL------------------------------------------------DFFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 191 ~e~~~~g~L------------------------------------------------~~~~~dlkp~NILl~~~~~~kl~ 222 (398)
|||+++|+| +++|+||||+|||+++++.+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence 999998765 34568999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhh
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWR 301 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 301 (398)
|||+++..... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...... ..... ..
T Consensus 167 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~----~~ 237 (303)
T cd05088 167 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK----LP 237 (303)
T ss_pred ccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHH----Hh
Confidence 99998643211 11112234667999999988889999999999999999998 88887432111 11111 11
Q ss_pred cCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 302 SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
....... ....+..+.+++.+||+.+|++|||+++++..|+.+...
T Consensus 238 ~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 238 QGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred cCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1000000 111234578999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=281.04 Aligned_cols=220 Identities=23% Similarity=0.325 Sum_probs=171.4
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccC--CChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSG--RSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..|++.++||+||.+.||++...+.+.+|+|++.. .+......+.+|+..|.+++ |.+||++++|-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 35999999999999999999998888899988743 35666788999999999995 9999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|=+ .+| +++|.||||.|+|+- .|.+||+|||+|..+..+.+....
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~k 518 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVK 518 (677)
T ss_pred ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceee
Confidence 743 233 467779999999984 578999999999988776665556
Q ss_pred ccccccccccChhhhccCC-----------CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 240 SRIVGTYGYMSPEYAIEGI-----------FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
...+||+.||+||.+.... .+.++|||||||+||+|+.|+.||+..... |. +...+
T Consensus 519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--------~a-----Kl~aI 585 (677)
T KOG0596|consen 519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--------IA-----KLHAI 585 (677)
T ss_pred ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--------HH-----HHHhh
Confidence 6679999999999996332 568999999999999999999998643211 11 11122
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.++..+-.+..-.....+.+++..||.+||.+|||+.++|+.
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 222111111110111238899999999999999999999873
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=281.51 Aligned_cols=229 Identities=16% Similarity=0.186 Sum_probs=166.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..+|.+.+.||+|+||.||+|.+.. ++.||+|.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3479999999999999999999876 78899996432 3356899999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+.+ +| +++||||||+|||++.++.+||+|||+++............
T Consensus 242 ~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 242 YRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 864 44 46778999999999999999999999998765432222233
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCC-c-----cchhHHHHHhhh-cCCccc-----c
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD-T-----LNLLGYAWDLWR-SNRTLE-----L 308 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~-~-----~~~~~~~~~~~~-~~~~~~-----~ 308 (398)
...||..|+|||++.+..++.++|||||||++|||++|..|+...... . ..+...+...-. ...... +
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 457999999999999999999999999999999999988764332211 0 111111111000 000000 0
Q ss_pred chhhh-------hcccC---h---HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 309 TDAIL-------EDEYS---S---KQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 309 ~~~~~-------~~~~~---~---~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..... ..... . ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00000 0 0122357899999999999999999999974
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=267.94 Aligned_cols=217 Identities=25% Similarity=0.344 Sum_probs=167.5
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.|+..+.||+|+||.||++.+.. ++.+|+|.+.... ......+.+|+.++++++|+|++++++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 36777899999999999999865 8899999986542 2223456789999999999999999999999999999999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++|+| +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---
Confidence 9999988 245679999999999999999999999876543321
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ............. ...
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~~~~~------~~~----- 224 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVQ------EEY----- 224 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhhhhhh------hhc-----
Confidence 123478999999999999999999999999999999999999986432211 0000000000000 000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
.......+.+++.+||+.||++||| ++|+++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1122345789999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=260.89 Aligned_cols=222 Identities=29% Similarity=0.446 Sum_probs=173.5
Q ss_pred hhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
...++|+..+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3457889999999999999999998778889999887543 334678899999999999999999999887 77899999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++|+| +.+|+||||+||+++.++.+||+|||++......... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 159 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-A 159 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-c
Confidence 9999887 3566799999999999999999999999866433221 1
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....++..|+|||++....++.++|+|||||++|++++ |+.||..... ...... .........
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~----~~~~~~~~~--------- 224 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRA----LERGYRMPR--------- 224 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HhCCCCCCC---------
Confidence 222345678999999998889999999999999999999 8888653211 111111 111110000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 -PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=261.77 Aligned_cols=217 Identities=26% Similarity=0.448 Sum_probs=168.3
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh---------hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG---------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
+|.+.+.||+|++|.||+|.... ++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 46778899999999999999754 78999998864321 123567889999999999999999999999999
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
.+++|||+++++| +.+|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999877 35678999999999999999999999998765322
Q ss_pred ccc----ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 235 LQA----NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 235 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
... ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...... ........ .....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~--- 231 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFKIGE-NASPE--- 231 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHHHhc-cCCCc---
Confidence 111 112345788999999999888999999999999999999999997542111 00110000 00000
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. +...+..+.+++.+||+.||.+||++.++++
T Consensus 232 --~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 232 --I-----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --C-----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 1223456789999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=263.18 Aligned_cols=206 Identities=23% Similarity=0.326 Sum_probs=157.4
Q ss_pred ceecccCceEEEEEEEcC-------------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 122 NKLGEGGFGPVYKGVLRK-------------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
+.||+|+||.||+|.... ...|++|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998542 2358999887665555667888999999999999999999999999999
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCC-------eEEcccccce
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMN-------PKISDFGMAR 228 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~-------~kl~DFGla~ 228 (398)
++|||+++|+| +++|+||||+|||++.++. +|++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999876 3567899999999987664 8999999986
Q ss_pred ecCCCCcccccccccccccccChhhhc-cCCCCcccccHHHHHHHHHHH-cCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAI-EGIFSIKFDVFSFGVLLLEIV-SGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
..... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+....... . ..... ...
T Consensus 161 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~----~~~~~-~~~- 226 (262)
T cd05077 161 TVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--K----ERFYE-GQC- 226 (262)
T ss_pred cccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--H----HHHHh-cCc-
Confidence 54322 2245788899999887 466899999999999999998 5777754321110 0 00011 100
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 351 (398)
.. .......+.+++.+||+.||.+||++.++++.+
T Consensus 227 ~~----------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 ML----------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cC----------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 011124578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=261.86 Aligned_cols=220 Identities=27% Similarity=0.447 Sum_probs=167.9
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHH--HHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLR--EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
|+..+.||+|+||+||+++... ++.+|+|.+......... ...+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999999877 568999999877544332 3456999999999999999999999999999999999
Q ss_pred CCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 195 PNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 195 ~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
++++| +++|+||||+||++++++.++|+|||.+...... .......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEBSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc
Confidence 99887 3566799999999999999999999999864211 1223445
Q ss_pred cccccccChhhhc-cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 243 VGTYGYMSPEYAI-EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 243 ~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
.++..|+|||++. +..++.++||||+|+++|+|++|..|+...... +........... ...... .....
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~----~~~~~~----~~~~~ 228 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILKR----PLPSSS----QQSRE 228 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHHT----HHHHHT----TSHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhcccc----cccccc----cccch
Confidence 7899999999998 788999999999999999999999997643100 000000000000 000000 00001
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1256889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=263.65 Aligned_cols=216 Identities=29% Similarity=0.473 Sum_probs=166.0
Q ss_pred ceecccCceEEEEEEEcC-------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 122 NKLGEGGFGPVYKGVLRK-------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+++++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998753 2578999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------------hHHhhcCCCCCceecCCC-----CeEEccccccee
Q 037365 194 MPNKSL---------------------------------------DFFLFNLKASNILLDKDM-----NPKISDFGMARI 229 (398)
Q Consensus 194 ~~~g~L---------------------------------------~~~~~dlkp~NILl~~~~-----~~kl~DFGla~~ 229 (398)
+++|+| +.+|+||||+||+++.++ .+||+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 998877 245679999999999877 899999999976
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
..............++..|+|||.+.++.++.++|||||||++|||++ |+.||..... ...... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~----~~~~~~~~- 233 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQH----VTAGGRLQ- 233 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHH----HhcCCccC-
Confidence 644332222233355788999999999999999999999999999998 9988753211 111111 11100000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.....+..+.+++.+||+.+|++|||++++++.|++
T Consensus 234 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 234 ---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 022234568899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=263.17 Aligned_cols=223 Identities=22% Similarity=0.347 Sum_probs=171.8
Q ss_pred CCCCccceecccCceEEEEEEEcC----CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|...+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 467788999999999999998654 2468999987654 4556688999999999999999999999875 567899
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+++|+| +.+|+||||+||+++.++.+||+|||+++.........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 999999887 35667999999999999999999999998765442221
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.....++..|+|||.+....++.++||||||+++||+++ |..||...... ..... .........
T Consensus 165 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~----~~~~~~~~~-------- 229 (270)
T cd05056 165 -ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGR----IENGERLPM-------- 229 (270)
T ss_pred -cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH----HHcCCcCCC--------
Confidence 122344568999999988889999999999999999986 99997543221 11111 111110000
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....+..+.+++.+||..+|++|||+.++++.|++...
T Consensus 230 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 230 --PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 12234568899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=261.65 Aligned_cols=219 Identities=22% Similarity=0.405 Sum_probs=168.9
Q ss_pred CCCccceecccCceEEEEEEEcCCCEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477789999999999999998789999999886432 22335688899999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC----
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE---- 234 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~---- 234 (398)
+||+++++| +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 999999987 35677999999999999999999999987653211
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.........|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .. .......... +..
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~----~~~~~~~~~~----~~~- 230 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AM----FYIGAHRGLM----PRL- 230 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HH----HHhhhccCCC----CCC-
Confidence 1111223468899999999998889999999999999999999999975322110 00 0000000000 001
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.+++.+||+.+|++|||+.++++
T Consensus 231 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 ----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1123455789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=285.52 Aligned_cols=219 Identities=21% Similarity=0.374 Sum_probs=175.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.+.|+++..||.|+||.||+|..++ +-..|.|++.....+..+.+.-|++||....||+||++++.|...+.+|+..||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3567788899999999999999876 444578888888888889999999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|.||-. .++|||||..|||+.-+|.++|+|||.+..... ......
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRD 188 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRD 188 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhhhc
Confidence 999954 588999999999999999999999998754321 222345
Q ss_pred cccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 241 RIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|.... +.+......- ...+..+.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVllKia-KSePPTLl------ 256 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIA-KSEPPTLL------ 256 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHHHHh-hcCCCccc------
Confidence 679999999999875 568999999999999999999999984321 1111111111 11111111
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+..+...+.+++.+||..||..||++.++++
T Consensus 257 --qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 --QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 13445667899999999999999999999886
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=261.57 Aligned_cols=232 Identities=20% Similarity=0.274 Sum_probs=169.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCc-ccceeeEEEeCC-----
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKN-LVRLLGCCIDKD----- 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~----- 185 (398)
...|+..++||+|+||+||+|+... |+.||+|++..... .......+|+.+|++++|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3457777889999999999999765 88999999976533 23355689999999999999 999999999877
Q ss_pred -eeEEEEeccCCC---------------Ch--------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 186 -EKILIYEYMPNK---------------SL--------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 186 -~~~lV~e~~~~g---------------~L--------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
..++|+||++.- .. +++||||||+|||++++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 889999997421 10 578899999999999999999999999986
Q ss_pred cCCCCcccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
..-.. ...+...+|..|+|||++.+. .|+...||||+||++.||+++++-|..... .+....+...........+
T Consensus 170 ~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCccCC
Confidence 65222 223456889999999999987 689999999999999999998877654433 1111122222211110000
Q ss_pred ------chh--hhhccc---C----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 309 ------TDA--ILEDEY---S----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 309 ------~~~--~~~~~~---~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.+. ...... . .+.......+++.+|++.+|.+|.|++.++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 000000 0 01111367899999999999999999999875
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=261.03 Aligned_cols=214 Identities=29% Similarity=0.422 Sum_probs=167.0
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEE-eCCeeEEEEecc
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI-DKDEKILIYEYM 194 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~e~~ 194 (398)
.+|+..+.||+|+||.||++... +..+|+|.++... ..+.+.+|+.++++++|+|++++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999875 7889999986543 3467889999999999999999999765 456789999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
++|+| +++|+||||+||++++++.+||+|||+++...... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~ 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-----C
Confidence 99877 35667999999999999999999999987654321 1
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...++..|+|||++.+..++.++|||||||++|||++ |+.||.... ....... ......... .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~-~~~~~~~~~----------~ 221 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPR-VEKGYKMDA----------P 221 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH-HhcCCCCCC----------C
Confidence 2344668999999998889999999999999999997 888864321 1111111 111100000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=270.64 Aligned_cols=222 Identities=19% Similarity=0.262 Sum_probs=165.0
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||.||+++... ++.||+|.+... .....+.+.+|..++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999765 889999998642 2233456788999999999999999999999999999999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
||+++|+| +++||||||+|||++.++.+||+|||++......... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-Q 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-c
Confidence 99999987 3566799999999999999999999999765433221 1
Q ss_pred cccccccccccChhhhcc-----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 239 TSRIVGTYGYMSPEYAIE-----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+.............+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~~-- 232 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKEHFQFPPD-- 232 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCcccCCCc--
Confidence 223468999999999873 4578899999999999999999999753211 1111111111111111000
Q ss_pred hcccChHHHHHHHHHHHHHchhc--CCCCCCCHHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQE--SADDRPTTNDVVSM 350 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~--dP~~RPt~~evl~~ 350 (398)
....+..+.+++.+|+.. ++..||+++++++.
T Consensus 233 -----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 -----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111344577888887754 33348899999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.49 Aligned_cols=233 Identities=21% Similarity=0.209 Sum_probs=163.4
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCC------CcccceeeEE
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQH------KNLVRLLGCC 181 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~ 181 (398)
.++....++|++.+.||+|+||.||+|.+.. ++.||||+++... ........|++++.+++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3445567889999999999999999999765 7889999996532 223456678888887765 4588899988
Q ss_pred EeC-CeeEEEEeccCCCC--------------------------------hhHHhhcCCCCCceecCCC-----------
Q 037365 182 IDK-DEKILIYEYMPNKS--------------------------------LDFFLFNLKASNILLDKDM----------- 217 (398)
Q Consensus 182 ~~~-~~~~lV~e~~~~g~--------------------------------L~~~~~dlkp~NILl~~~~----------- 217 (398)
... .+.|+|||++.+.. .+++||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 201 QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 764 57899999874321 1478899999999998765
Q ss_pred -----CeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccch
Q 037365 218 -----NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNL 292 (398)
Q Consensus 218 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~ 292 (398)
.+||+|||.+..... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...... +.
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~ 353 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL--EH 353 (467)
T ss_pred CCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HH
Confidence 499999998754321 223468999999999999999999999999999999999999998643221 11
Q ss_pred hHHHHHh--------------------hhcC-Cccccchhh-----hhcc-cChHHHHHHHHHHHHHchhcCCCCCCCHH
Q 037365 293 LGYAWDL--------------------WRSN-RTLELTDAI-----LEDE-YSSKQVLLRYVNIALLCVQESADDRPTTN 345 (398)
Q Consensus 293 ~~~~~~~--------------------~~~~-~~~~~~~~~-----~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~ 345 (398)
....... +... ......++. .... .........+.+|+.+||+.||++|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 1111000 0000 000000000 0000 00001124577999999999999999999
Q ss_pred HHHH
Q 037365 346 DVVS 349 (398)
Q Consensus 346 evl~ 349 (398)
|+++
T Consensus 434 e~L~ 437 (467)
T PTZ00284 434 QMTT 437 (467)
T ss_pred HHhc
Confidence 9997
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=272.66 Aligned_cols=222 Identities=19% Similarity=0.262 Sum_probs=165.1
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||+++++. ++.+|+|.+... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999876 778999998542 1223345788999999999999999999999999999999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ce
Confidence 99999988 356789999999999999999999999976543221 12
Q ss_pred cccccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 239 TSRIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||.... ....................
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~p~~-- 232 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKERFQFPAQ-- 232 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCccccCCCc--
Confidence 23357999999999986 3468899999999999999999999975321 11111111111110000000
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCC--CCCCHHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESAD--DRPTTNDVVSM 350 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~--~RPt~~evl~~ 350 (398)
.......+.+++.+|+..++. .|++++|+++.
T Consensus 233 -----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 -----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 112345577889888865444 47899999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=265.34 Aligned_cols=217 Identities=22% Similarity=0.418 Sum_probs=169.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+.|+..+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 346677889999999999998764 7889999986442 34456788999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++++| +.+|+||+|+||++++++.+||+|||++..+..... .....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTF 161 (277)
T ss_pred cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcc
Confidence 999987 356679999999999999999999999976653321 12234
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.|+..|+|||.+.+..++.++|+|||||++|||++|+.|+....... . ... ...... +.. ....
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~---~~~-~~~~~~-----~~~-----~~~~ 225 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--V---LFL-IPKNSP-----PTL-----EGQY 225 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--H---Hhh-hhcCCC-----CCC-----Cccc
Confidence 67889999999998889999999999999999999999965322110 0 000 111100 001 1123
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+..+.+++.+||+.+|++|||+.++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4557899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=264.64 Aligned_cols=206 Identities=24% Similarity=0.326 Sum_probs=156.3
Q ss_pred eecccCceEEEEEEEcC-------------------------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccce
Q 037365 123 KLGEGGFGPVYKGVLRK-------------------------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 177 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 177 (398)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 23589999876555555678889999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCC-------
Q 037365 178 LGCCIDKDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDM------- 217 (398)
Q Consensus 178 ~~~~~~~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~------- 217 (398)
+++|.+++..++||||+++|+| +++|+||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999987 356789999999997644
Q ss_pred CeEEcccccceecCCCCcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHH-cCCCCCCCCCCCccchhHH
Q 037365 218 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIV-SGKKNTGFYRTDTLNLLGY 295 (398)
Q Consensus 218 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ell-tg~~P~~~~~~~~~~~~~~ 295 (398)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+....... ...
T Consensus 162 ~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~- 232 (274)
T cd05076 162 FIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KER- 232 (274)
T ss_pred eeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HHH-
Confidence 3799999987643221 12356788999998875 56899999999999999995 6888865322111 110
Q ss_pred HHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 296 AWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.+.... .. +......+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ---~~~~~~--~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 ---FYEKKH--RL----------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHhcc--CC----------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 011000 00 0111235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=260.11 Aligned_cols=215 Identities=22% Similarity=0.377 Sum_probs=170.1
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||+|+||.||++.... ++.+|+|++... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 57888999999999999999764 889999998643 234456788999999999999999999999999999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+++++| +.+|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hh
Confidence 999876 345679999999999999999999999986643321 12
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.|+.... ............ ... ..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~-~~~----------~~ 222 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRGS-YPP----------VS 222 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhcCC-CCC----------Cc
Confidence 23467889999999998889999999999999999999999975321 111111111111 100 01
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......+.+++.+||+.+|++||+++++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 223456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=265.57 Aligned_cols=227 Identities=21% Similarity=0.322 Sum_probs=161.8
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhc---CCCcccceeeEEEeC-----C
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCIDK-----D 185 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~-----~ 185 (398)
+|+..+.||+|+||.||+|+... ++.||+|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 57888999999999999999875 8899999986532 12223456677777665 699999999998652 4
Q ss_pred eeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 186 EKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 186 ~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
..+++|||+++ +| +++|+||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 57999999975 33 46778999999999999999999999998664
Q ss_pred CCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc----
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE---- 307 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---- 307 (398)
... ......||..|+|||++.+..++.++|||||||++|||++|++||...... .................
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 160 CQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred Ccc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHHHHHHhCCCChhhCccc
Confidence 322 123356899999999999999999999999999999999999987543221 11111111110000000
Q ss_pred --cchhhhhc-cc-----ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 308 --LTDAILED-EY-----SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 308 --~~~~~~~~-~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
........ .. ..+.....+.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00 01123456789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=266.34 Aligned_cols=163 Identities=23% Similarity=0.409 Sum_probs=131.0
Q ss_pred cceecccCceEEEEEEEcC---CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--CCeeEEEEeccC
Q 037365 121 ANKLGEGGFGPVYKGVLRK---GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMP 195 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~~ 195 (398)
.++||+|+||.||+|+..+ ++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 3689999999999999653 6789999986543 22456789999999999999999999865 456899999986
Q ss_pred CCC------------------h----------------------hHHhhcCCCCCcee----cCCCCeEEcccccceecC
Q 037365 196 NKS------------------L----------------------DFFLFNLKASNILL----DKDMNPKISDFGMARICG 231 (398)
Q Consensus 196 ~g~------------------L----------------------~~~~~dlkp~NILl----~~~~~~kl~DFGla~~~~ 231 (398)
+.. + +++||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 531 1 46778999999999 456789999999998765
Q ss_pred CCCcc-cccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCC
Q 037365 232 GNELQ-ANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFY 285 (398)
Q Consensus 232 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~ 285 (398)
..... .......||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 43211 123345789999999999874 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=261.46 Aligned_cols=218 Identities=23% Similarity=0.373 Sum_probs=168.7
Q ss_pred CCCccceecccCceEEEEEEEcC--CCEEEEEEccCC----------ChhhHHHHHHHHHHHHh-cCCCcccceeeEEEe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK--GNEIAVKRLSGR----------SGQGLREMKNEASVIAK-VQHKNLVRLLGCCID 183 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 183 (398)
+|+..+.||+|+||.||+|.+.. ++.+|+|.+... .......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999865 678999987532 22234557788888875 799999999999999
Q ss_pred CCeeEEEEeccCCCChh-------------------------------------HHhhcCCCCCceecCCCCeEEccccc
Q 037365 184 KDEKILIYEYMPNKSLD-------------------------------------FFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L~-------------------------------------~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
++..+++|||+++++|. .+|+||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999988762 45679999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 227 ARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
+....... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..... ...... .......
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~-~~~~~~~ 231 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATK-IVEAVYE 231 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHH-HhhccCC
Confidence 98765432 22345688999999999988899999999999999999999999743211 111111 1111110
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.. . .......+.+++.+||+.||++|||+.|+.++++
T Consensus 232 ~~----~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PL----P-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC----C-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 0 1122345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=266.03 Aligned_cols=229 Identities=20% Similarity=0.304 Sum_probs=166.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|+..+.||+|+||.||+|+... ++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 578889999999999999999764 7899999986442 23335677899999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++ +| +++|+||||+||++++++.+||+|||++........ ...
T Consensus 86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 162 (301)
T cd07873 86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYS 162 (301)
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--ccc
Confidence 974 44 356789999999999999999999999876432221 122
Q ss_pred cccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC---ccccch------
Q 037365 241 RIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR---TLELTD------ 310 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------ 310 (398)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .........+.... ...+..
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhccccccc
Confidence 34578899999998764 4789999999999999999999998643221 11111111110000 000000
Q ss_pred ---hhhhccc---ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 ---AILEDEY---SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ---~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+...... ........+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 01122345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=258.04 Aligned_cols=216 Identities=19% Similarity=0.319 Sum_probs=168.7
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe-CCeeEEEEe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYE 192 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e 192 (398)
+|++.+.||+|++|.||++.... ++.+|+|++... .....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47888999999999999999765 788999998643 23345678889999999999999999998764 446799999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++++| +++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--M 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--c
Confidence 9999877 356779999999999999999999999987643321 2
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||.... .......... +.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~-~~~~~~---------- 222 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIE-GKLPPM---------- 222 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHh-cCCCCC----------
Confidence 234568899999999999999999999999999999999999875321 1111111111 111000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.......+.+++.+||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=267.67 Aligned_cols=225 Identities=28% Similarity=0.443 Sum_probs=170.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CC----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GN----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
.++|+..+.||+|+||.||+|.+.. +. .+|+|.+.... ......+.+|+.++++++||||++++|+|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3567888999999999999998753 43 47899886543 23344688999999999999999999998754 467
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+++||+++|+| +++|+||||+||++++++.+||+|||+++.......
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 99999999876 457789999999999999999999999987654332
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .... ...........
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~----~~~~~~~~~~~------ 232 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIP----DLLEKGERLPQ------ 232 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH----HHHHCCCCCCC------
Confidence 222223445778999999998899999999999999999997 8888643211 1111 11111111000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.......+.+++.+||..+|++||+++++++.|+.+..
T Consensus 233 ----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 233 ----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11123457899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=263.13 Aligned_cols=217 Identities=21% Similarity=0.353 Sum_probs=168.4
Q ss_pred CCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|++.+.||+|+||.||++.+. .+..+|+|.+... .......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888899999999999999987 4899999988654 334456788999999999999999999999999999999999
Q ss_pred cCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 194 MPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 194 ~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
+++++| +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 998876 24567999999999999999999999987654322
Q ss_pred ccccccccccccChhhhccCC------CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 238 NTSRIVGTYGYMSPEYAIEGI------FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
.....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||...... .......... ......+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~-~~~~~~~--- 230 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAIV-DGDPPTL--- 230 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHHHh-hcCCCCC---
Confidence 22346788999999986543 588999999999999999999997542211 1111100000 1111110
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+......+.+++.+||+.+|++||++++++.
T Consensus 231 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 231 -------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -------CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 2234556789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=270.98 Aligned_cols=222 Identities=18% Similarity=0.241 Sum_probs=166.1
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||.||+++... ++.||+|.+... .......+.+|..++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478899999999999999999865 788999998642 2223445778999999999999999999999999999999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
||+++|+| +++||||||+|||++.++.+||+|||+++........ .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-Q 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-e
Confidence 99999987 3567899999999999999999999999876543221 1
Q ss_pred cccccccccccChhhhcc-----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 239 TSRIVGTYGYMSPEYAIE-----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.....||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... ................. ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~p-~~- 232 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHEERFQFP-SH- 232 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCCCcccCC-Cc-
Confidence 233579999999999875 5678999999999999999999999753211 11111111111000000 00
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADD--RPTTNDVVSM 350 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~ 350 (398)
....+..+.+++.+|+..++++ |++++++++.
T Consensus 233 -----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 -----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1122456788999998865544 5688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=263.11 Aligned_cols=229 Identities=23% Similarity=0.313 Sum_probs=164.8
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||+|++|.||+|+... +..||+|++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 47788999999999999999864 8899999986442 22346788899999999999999999999999999999999
Q ss_pred cCCCCh-----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 194 MPNKSL-----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 194 ~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
+++ +| +++|+||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (285)
T cd07861 81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RV 157 (285)
T ss_pred CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--cc
Confidence 974 33 35678999999999999999999999997654322 11
Q ss_pred cccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHH-------hhhcCCc-c---
Q 037365 239 TSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD-------LWRSNRT-L--- 306 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~-------~~~~~~~-~--- 306 (398)
.....+++.|+|||++.+. .++.++|||||||++|||++|+.||....... ........ .|..... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234578899999988754 47899999999999999999999875432110 00000000 0000000 0
Q ss_pred ccchhhhhccc--ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ELTDAILEDEY--SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
........... ........+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 01113456789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=259.75 Aligned_cols=220 Identities=23% Similarity=0.344 Sum_probs=172.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|+..+.||+|+||.||++.+.. ++.+|+|.+.... ......+.+|++++++++||||+++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 357788899999999999999874 8899999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+++++| +.+|+||||+||++++++.+||+|||.+....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----A 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----h
Confidence 998766 35667999999999999999999999987653221 1
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..................... ..... .
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~---------~ 226 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLP---------S 226 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCCCC---------h
Confidence 1256888999999999999999999999999999999999998654322222222221111111 00000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......+.+++.+||..||++|||+.+++.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 113456889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=264.17 Aligned_cols=207 Identities=26% Similarity=0.392 Sum_probs=157.6
Q ss_pred ceecccCceEEEEEEEcC--------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 122 NKLGEGGFGPVYKGVLRK--------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|..+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998743 234888888765555567788999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCC--------eEEcccccceecCC
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMN--------PKISDFGMARICGG 232 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~--------~kl~DFGla~~~~~ 232 (398)
+++|+| +++||||||+||+++.++. ++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 999987 3567899999999987765 69999998865432
Q ss_pred CCcccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCC-CCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGK-KNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
.....++..|+|||++.+. .++.++||||||+++|||++|. .|+...... . . ....... ...
T Consensus 161 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~---~-~~~~~~~--~~~-- 224 (258)
T cd05078 161 ------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--K---K-LQFYEDR--HQL-- 224 (258)
T ss_pred ------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--H---H-HHHHHcc--ccC--
Confidence 1234678899999999874 5799999999999999999995 443221110 0 0 0001100 000
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
+......+.+++.+||+.||++|||++++++.|.
T Consensus 225 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 --------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1112245789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=263.85 Aligned_cols=225 Identities=23% Similarity=0.399 Sum_probs=171.2
Q ss_pred chhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEe-
Q 037365 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID- 183 (398)
Q Consensus 107 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 183 (398)
++.++..+.+.|+..+.||+|+||.||+|.+.. ++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 445566677899999999999999999999855 7889999986543 3345678899999998 69999999999863
Q ss_pred -----CCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEccc
Q 037365 184 -----KDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDF 224 (398)
Q Consensus 184 -----~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DF 224 (398)
.+..+++|||+++|+| +++|+||||+||++++++.++|+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 4578999999999877 3567899999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHh
Q 037365 225 GMARICGGNELQANTSRIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL 299 (398)
Q Consensus 225 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 299 (398)
|++....... .......|+..|+|||.+. +..++.++|||||||++|||++|+.||....... .. ...
T Consensus 166 g~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-~~----~~~ 238 (282)
T cd06636 166 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-AL----FLI 238 (282)
T ss_pred cchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-hh----hhH
Confidence 9987653221 1223356899999999886 3457889999999999999999999975332110 00 000
Q ss_pred hhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 300 WRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.. ..... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~-~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 PR-NPPPK---------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hh-CCCCC---------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 00000 001123456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=260.81 Aligned_cols=215 Identities=29% Similarity=0.418 Sum_probs=162.7
Q ss_pred ceecccCceEEEEEEEcC-CC--EEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GN--EIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|.+.+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999865 33 4788988754 334456788999999999 799999999999999999999999998
Q ss_pred CCh------------------------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 197 KSL------------------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 197 g~L------------------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
|+| +++|+||||+|||+++++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 865 24567999999999999999999999986
Q ss_pred ecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLE 307 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
..... ........+..|+|||++....++.++|||||||++|||++ |..||..... ..... ........+
T Consensus 161 ~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~----~~~~~~~~~ 231 (270)
T cd05047 161 GQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYE----KLPQGYRLE 231 (270)
T ss_pred ccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHHHH----HHhCCCCCC
Confidence 32211 11111234567999999988889999999999999999997 8888743211 11111 111110000
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 308 LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
. .......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 232 ~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 232 K----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 1112345789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=272.79 Aligned_cols=208 Identities=21% Similarity=0.307 Sum_probs=155.6
Q ss_pred ecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhc---CCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKV---QHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
||+|+||.||+|+... ++.||+|++.... .........|..++.+. +||||+++++++.+++..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999765 8999999986431 12233455677777665 699999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|+| +++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccC
Confidence 987 36678999999999999999999999987543222 12234579
Q ss_pred cccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHH
Q 037365 245 TYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323 (398)
Q Consensus 245 t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
|+.|+|||++.+. .++.++|||||||++|||++|+.||..... ... ... ...... .+. .....
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--~~~---~~~-i~~~~~-~~~---------~~~~~ 222 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--QQM---YRN-IAFGKV-RFP---------KNVLS 222 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--HHH---HHH-HHcCCC-CCC---------CccCC
Confidence 9999999998765 489999999999999999999999753211 111 111 111100 000 11123
Q ss_pred HHHHHHHHHchhcCCCCCC----CHHHHHH
Q 037365 324 LRYVNIALLCVQESADDRP----TTNDVVS 349 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RP----t~~evl~ 349 (398)
..+.+++.+||+.||.+|| ++.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 4577899999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=280.44 Aligned_cols=164 Identities=25% Similarity=0.416 Sum_probs=138.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-C-----CcccceeeEEEeCCe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-H-----KNLVRLLGCCIDKDE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~ 186 (398)
...+|++.+.||+|+||.|-+|.+.. ++.||||++++.. ....+...|+.+|..++ | -|+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 34489999999999999999999876 8999999998764 34466678999999997 4 389999999999999
Q ss_pred eEEEEeccCCC---------------------------------ChhHHhhcCCCCCceecCC--CCeEEcccccceecC
Q 037365 187 KILIYEYMPNK---------------------------------SLDFFLFNLKASNILLDKD--MNPKISDFGMARICG 231 (398)
Q Consensus 187 ~~lV~e~~~~g---------------------------------~L~~~~~dlkp~NILl~~~--~~~kl~DFGla~~~~ 231 (398)
.|||+|.+... .++++|+||||+||||.+. ..+||+|||.|.+..
T Consensus 263 lciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 263 LCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 99999987542 1268889999999999643 369999999998765
Q ss_pred CCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCC
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTG 283 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~ 283 (398)
.... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.
T Consensus 343 q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 343 QRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred Ccce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 4432 3467889999999999999999999999999999999976554
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=262.43 Aligned_cols=231 Identities=23% Similarity=0.343 Sum_probs=169.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|+..+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+.++++++|||++++++++..++..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468888999999999999999875 8899999986432 2233567899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|++++.| +.+|+||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--ccc
Confidence 9998865 356789999999999999999999999987654321 122
Q ss_pred cccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHH----------HhhhcCCcc-cc
Q 037365 241 RIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW----------DLWRSNRTL-EL 308 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~----------~~~~~~~~~-~~ 308 (398)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+..... ..+...... ..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcccccccccc
Confidence 3457889999999876 457899999999999999999999986432211 1111000 000000000 00
Q ss_pred chhhhhcccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 309 TDAILEDEYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 309 ~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..+....... .+.....+.+++.+||+.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 1122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=263.45 Aligned_cols=216 Identities=26% Similarity=0.335 Sum_probs=166.1
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
|+..+.||+|+||+||++.+.. ++.+|+|.+.... ......+.+|++++++++|+|++++++++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 6677899999999999999764 8899999986542 22234577899999999999999999999999999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+++++| +++|+||||+||++++++.+||+|||++........ .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---I 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---c
Confidence 999987 356789999999999999999999999976543221 2
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....|+..|+|||++.+..++.++|+|||||++|||++|+.||....... ... .......... . .. .
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~-~~~~~~~~~~--~----~~-----~ 225 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KRE-EVDRRVLETE--E----VY-----S 225 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHHhhhccc--c----cc-----C
Confidence 23478999999999998899999999999999999999999975322110 000 0000000000 0 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
......+.+++.+||+.||++||| ++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 122345789999999999999999 667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=254.79 Aligned_cols=215 Identities=27% Similarity=0.453 Sum_probs=169.4
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++.+++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999987 58999999885432 23456788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
+||+++++| +++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999887 34678999999999999999999999988764332 1
Q ss_pred cccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....|+..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ....+...........
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~--------- 223 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGRSKELPPI--------- 223 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHHhcccCCCc---------
Confidence 23356889999999998776 89999999999999999999999754321 1111111110111110
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+......+.+++.+||+.+|++|||+++++.
T Consensus 224 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 -PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122355788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=260.95 Aligned_cols=221 Identities=22% Similarity=0.381 Sum_probs=167.9
Q ss_pred CCccceecccCceEEEEEEEc----CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC------
Q 037365 118 FSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 185 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 185 (398)
|.+.+.||+|+||.||+|.+. .++.||+|.+... .....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999864 2678999998654 3345567889999999999999999999887542
Q ss_pred eeEEEEeccCCCCh--------------------------------------hHHhhcCCCCCceecCCCCeEEcccccc
Q 037365 186 EKILIYEYMPNKSL--------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMA 227 (398)
Q Consensus 186 ~~~lV~e~~~~g~L--------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla 227 (398)
..++++||+++|+| +++|+||||+||++++++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 24788999998876 2456799999999999999999999999
Q ss_pred eecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 228 RICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
+...............+++.|++||.+.+..++.++|||||||++|||++ |+.|+..... .....+.. .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~----~~~~~ 234 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLI----KGNRL 234 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHH----cCCcC
Confidence 87644332222233455678999999998889999999999999999999 7777643211 11111111 11100
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.. ....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 235 ~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 KQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=258.83 Aligned_cols=218 Identities=21% Similarity=0.351 Sum_probs=157.7
Q ss_pred eecccCceEEEEEEEcCC---CEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCC
Q 037365 123 KLGEGGFGPVYKGVLRKG---NEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~ 198 (398)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999986443 346677766443 3345688999999999999999999999999999999999999998
Q ss_pred h------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 199 L------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 199 L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
| +++|+||||+|||++.++.+||+|||++...............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 161 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence 7 2456799999999999999999999998643222211222345
Q ss_pred cccccccChhhhcc-------CCCCcccccHHHHHHHHHHHcC-CCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 243 VGTYGYMSPEYAIE-------GIFSIKFDVFSFGVLLLEIVSG-KKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 243 ~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.++..|+|||++.. ..++.++|||||||++|||+++ ..||.... ... ........ ......++...
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~---~~~~~~~~-~~~~~~~~~~~ 235 (268)
T cd05086 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DRE---VLNHVIKD-QQVKLFKPQLE 235 (268)
T ss_pred cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHH---HHHHHHhh-cccccCCCccC
Confidence 67889999998753 2457899999999999999975 55653221 111 11111111 11122222221
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.. ....+.+++..|| .+|++|||++++++.|.
T Consensus 236 ~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11 2345778999999 67999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=270.84 Aligned_cols=160 Identities=18% Similarity=0.234 Sum_probs=134.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
...+|++.+.||+|+||.||+|.... ++.||+|...... ...|+.++++++||||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34579999999999999999999865 6789999754332 3568999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|+.+..+ +++||||||+|||++.++.+||+|||+++...... ...
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~ 214 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFL 214 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccc
Confidence 9865322 46788999999999999999999999987533221 123
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCC
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNT 282 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~ 282 (398)
...||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 457899999999999999999999999999999999876654
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=256.12 Aligned_cols=217 Identities=34% Similarity=0.556 Sum_probs=169.0
Q ss_pred CCccceecccCceEEEEEEEcC-----CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-----GNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
+++.+.||.|+||.||++.+.+ +..||+|.+...... ..+.+..|+..+.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3556889999999999999865 378999999765433 5678899999999999999999999999999999999
Q ss_pred eccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 192 EYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 192 e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||+++++| +++|+||||+||++++++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999877 34667999999999999999999999998776543222
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.. ...+++.|+|||.+.+..++.++||||||+++|||++ |..|+... ........ .........
T Consensus 161 ~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~----~~~~~~~~~-------- 225 (258)
T smart00219 161 KK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEY----LKKGYRLPK-------- 225 (258)
T ss_pred cc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHH----HhcCCCCCC--------
Confidence 21 2346789999999988889999999999999999998 67775431 11111111 111111100
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 351 (398)
....+..+.+++.+||..||++|||+.|+++.|
T Consensus 226 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 --PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111345688999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=257.61 Aligned_cols=223 Identities=24% Similarity=0.391 Sum_probs=172.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|+..+.||.|+||.||+|...+ +..+|+|++.... ......+.+|++.++.++|+|++++++.+..++..+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468889999999999999999754 7889999986542 33567789999999999999999999999999999999999
Q ss_pred cCCCCh-----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc-
Q 037365 194 MPNKSL-----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA- 237 (398)
Q Consensus 194 ~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 237 (398)
+++++| +++|+||||+||++++++.+||+|||++..+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 998876 34567999999999999999999999987665433221
Q ss_pred -ccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 238 -NTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......|+..|+|||.+... .++.++|+|||||++|||++|+.||....... ......... . .....
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~~~~~-~-----~~~~~ 229 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VLMLTLQND-P-----PSLET 229 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----hHHHHhcCC-C-----CCcCC
Confidence 22334688999999999877 78999999999999999999999975432211 111111110 0 00111
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+..+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001234466889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=265.08 Aligned_cols=230 Identities=21% Similarity=0.282 Sum_probs=165.8
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||+|+||.||+|++.. |+.+|+|++.... ......+.+|++++++++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 47888999999999999999864 8899999986432 22235677899999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
++++.+ +++|+||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 158 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSA 158 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCC
Confidence 975322 35678999999999999999999999997654322 11223
Q ss_pred ccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc------cccchh---
Q 037365 242 IVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT------LELTDA--- 311 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~--- 311 (398)
..++..|+|||.+.+.. ++.++|||||||++|||++|+.|+........ .............. ....+.
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 46788999999987654 78999999999999999999988643322111 11111110000000 000000
Q ss_pred -hhhcc----cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 -ILEDE----YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 -~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..... ...+.....+.+++.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 001123456789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=263.41 Aligned_cols=233 Identities=23% Similarity=0.295 Sum_probs=167.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++++|...+.||+|+||.||+|.... ++.||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 45789999999999999999998754 88999999865432 22345678999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+.++.+ +++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 160 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TY 160 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CC
Confidence 99964322 367789999999999999999999999876433221 12
Q ss_pred ccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC-------------c
Q 037365 240 SRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR-------------T 305 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-------------~ 305 (398)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ .....+..+.... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhhhccccc
Confidence 234578899999998764 478899999999999999999999864332111 1111111111000 0
Q ss_pred cccchh----hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 306 LELTDA----ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 306 ~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+.... ..............+.+++.+|++.||.+|||++|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 00000000011345779999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=263.93 Aligned_cols=162 Identities=23% Similarity=0.401 Sum_probs=130.8
Q ss_pred ceecccCceEEEEEEEcC---CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--CCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK---GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~~~ 196 (398)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999999754 5789999986543 22457789999999999999999999864 5578999999876
Q ss_pred CCh----------------------------------------hHHhhcCCCCCcee----cCCCCeEEcccccceecCC
Q 037365 197 KSL----------------------------------------DFFLFNLKASNILL----DKDMNPKISDFGMARICGG 232 (398)
Q Consensus 197 g~L----------------------------------------~~~~~dlkp~NILl----~~~~~~kl~DFGla~~~~~ 232 (398)
+.+ +++||||||+|||+ +.++.+||+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 411 36678999999999 5667899999999987654
Q ss_pred CCcc-cccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCC
Q 037365 233 NELQ-ANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFY 285 (398)
Q Consensus 233 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~ 285 (398)
.... .......||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 3221 122345789999999999764 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=280.58 Aligned_cols=217 Identities=30% Similarity=0.388 Sum_probs=172.2
Q ss_pred CCCccceecccCceEEEEEEEcC--CC--EEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK--GN--EIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.....++||+|.||.|++|.|.. |+ .||||.+...... ....|.+|+.+|.+|+|||+++|||+..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 44556789999999999999875 43 4899999766433 67899999999999999999999999987 6788999
Q ss_pred eccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 192 EYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 192 e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|+++.|+| ..+||||..+|+|+.....+||+|||+.+.++.++.+.
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999998 47889999999999999999999999999887654332
Q ss_pred -ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 238 -NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 238 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......-...|.|||.+....++.++|||+|||++|||+| |..||-.... -.+.+.+|.. +.
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------~qIL~~iD~~-er 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------IQILKNIDAG-ER 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------HHHHHhcccc-cc
Confidence 2333345678999999999999999999999999999998 6677432111 1111111100 00
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
-..++.+++.+.+++..||..+|++|||+..|.+.
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 01155677889999999999999999999999743
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=267.02 Aligned_cols=229 Identities=17% Similarity=0.218 Sum_probs=162.1
Q ss_pred ccceeccc--CceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 120 DANKLGEG--GFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 120 ~~~~lG~G--~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
+.++||+| +|++||++..+. |+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 789999998765 889999999754 2334456778999999999999999999999999999999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc----
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ---- 236 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~---- 236 (398)
++|+| +++|+||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 99877 3567899999999999999999999865433211100
Q ss_pred -cccccccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh------------
Q 037365 237 -ANTSRIVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR------------ 301 (398)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------ 301 (398)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccchhhhh
Confidence 01122356778999999976 4589999999999999999999999864322110 0000000000
Q ss_pred --cCCccccchhhh----------h---c---ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 302 --SNRTLELTDAIL----------E---D---EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 302 --~~~~~~~~~~~~----------~---~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
........+... . . ..........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000000000000 0 0 0001123456889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=263.63 Aligned_cols=231 Identities=21% Similarity=0.319 Sum_probs=172.0
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|+..+.||+|+||.||+|.+.+ ++.||+|++... .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 468889999999999999999875 789999998654 23345678899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|++++.+ +++|+||+|+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~ 159 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLT 159 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cccc
Confidence 9998765 356789999999999999999999999987654332 1223
Q ss_pred cccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHh-----------hhcC-----
Q 037365 241 RIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL-----------WRSN----- 303 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-----------~~~~----- 303 (398)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||...... +........ +...
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 35678899999999888 7899999999999999999999987533211 100000000 0000
Q ss_pred -CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 304 -RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 304 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......+............+..+.+++.+||+.+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000000001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=261.68 Aligned_cols=227 Identities=23% Similarity=0.354 Sum_probs=171.4
Q ss_pred cchhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEe
Q 037365 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID 183 (398)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 183 (398)
+...++..++++|+..+.||+|+||.||++...+ ++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4445666778999999999999999999999854 8899999986543 2235677899999999 79999999999875
Q ss_pred C-----CeeEEEEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEc
Q 037365 184 K-----DEKILIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 184 ~-----~~~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~ 222 (398)
. +..++||||+++|+| +.+|+||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 4 358999999999877 24567999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccC-----CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHH
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG-----IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW 297 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 297 (398)
|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.|+...... ..+ .
T Consensus 171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~----~ 243 (291)
T cd06639 171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTL----F 243 (291)
T ss_pred ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHH----H
Confidence 99998765432211 2234688899999998643 3689999999999999999999997532211 011 1
Q ss_pred HhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 298 DLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
... ......+.+ .......+.+++.+||+.+|++|||+.|+++
T Consensus 244 ~~~-~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIP-RNPPPTLLH--------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHh-cCCCCCCCc--------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 111111100 1122345889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=263.52 Aligned_cols=230 Identities=21% Similarity=0.334 Sum_probs=168.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|+..+.||+|+||.||+|.+++ ++.+|+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468888999999999999999865 8899999986442 2234567889999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|+++++| +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccC
Confidence 9998765 356779999999999999999999999987644321 122
Q ss_pred cccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc--CCc------cccch-
Q 037365 241 RIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS--NRT------LELTD- 310 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~------~~~~~- 310 (398)
...++..|+|||++.+ ..++.++||||||+++|||++|++||..... ............. ... ....+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 3467889999999875 4478899999999999999999988753221 1100000000000 000 00000
Q ss_pred ---hhhhccc----ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 ---AILEDEY----SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ---~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+...... ..+..+..+.+++.+||+.+|++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 01123456889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=269.63 Aligned_cols=228 Identities=21% Similarity=0.316 Sum_probs=165.0
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC------
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------ 184 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 184 (398)
..++|+..+.||+|+||.||+|.... ++.||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34789999999999999999999754 7899999986542 22345677899999999999999999988643
Q ss_pred CeeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 185 DEKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
...++++|++ +++| +++||||||+|||+++++.+||+|||+++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 3578999987 5554 4678899999999999999999999999875432
Q ss_pred CcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.......... ....+.....
T Consensus 172 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~-~~~~~~~~~~ 243 (343)
T cd07878 172 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVG-TPSPEVLKKI 243 (343)
T ss_pred -----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhC-CCCHHHHHhc
Confidence 233578999999999877 56899999999999999999999997532211 11111000000 0000000000
Q ss_pred --------hhc--ccC-------hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 313 --------LED--EYS-------SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 313 --------~~~--~~~-------~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
... ... .......+.+++.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000 00112346799999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=257.57 Aligned_cols=205 Identities=27% Similarity=0.411 Sum_probs=157.6
Q ss_pred ceecccCceEEEEEEEcCCC-----------EEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 122 NKLGEGGFGPVYKGVLRKGN-----------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999986533 4788887655433 5788899999999999999999999988 788999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCC-------CeEEcccccceec
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDM-------NPKISDFGMARIC 230 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~-------~~kl~DFGla~~~ 230 (398)
|||+++|+| +++|+||||+|||++.++ .+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 999999987 356789999999999887 7999999998765
Q ss_pred CCCCcccccccccccccccChhhhccC--CCCcccccHHHHHHHHHHHcC-CCCCCCCCCCccchhHHHHHhhhcCCccc
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEG--IFSIKFDVFSFGVLLLEIVSG-KKNTGFYRTDTLNLLGYAWDLWRSNRTLE 307 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
.. .....++..|+|||++.+. .++.++||||||+++|||++| ..|+...... .... .+.......
T Consensus 159 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~----~~~~~~~~~ 226 (259)
T cd05037 159 LS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKER----FYQDQHRLP 226 (259)
T ss_pred cc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHH----HHhcCCCCC
Confidence 43 1123567789999999876 789999999999999999995 6665432211 1000 011000000
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 308 LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
. .....+.+++.+||+.+|.+|||+.++++.|+
T Consensus 227 -------~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 227 -------M-----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------C-----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00146789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=257.68 Aligned_cols=222 Identities=23% Similarity=0.400 Sum_probs=166.8
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh----------hhHHHHHHHHHHHHhcCCCcccceeeEEEeCC
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG----------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 185 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 185 (398)
+|...+.||+|+||.||+|.... ++.+|+|.+..... ...+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 46777899999999999998754 88999998853211 12346778999999999999999999999999
Q ss_pred eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 186 EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 186 ~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
..++||||+++|+| +.+|+||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999987 3456799999999999999999999998765432
Q ss_pred CcccccccccccccccChhhhccCC--CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGI--FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
..........|+..|+|||.+.... ++.++|+||||+++||+++|..|+..... .................+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHHHhhccccCCcCCcc
Confidence 2111223346888999999987654 78999999999999999999999742211 1111111111111111110
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ....+..+.+++.+||+.+|++|||++++++
T Consensus 237 -~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 237 -V-----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -c-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0 1223456889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=264.69 Aligned_cols=224 Identities=15% Similarity=0.209 Sum_probs=169.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||++.... ++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999999865 7899999986543 233456788999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc----
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL---- 235 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 235 (398)
||+++++| +++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999987 356789999999999999999999999864211100
Q ss_pred ---------ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 236 ---------QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 236 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
........|+..|+|||.+.+..++.++|+|||||++|||++|..||..... .. ........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~~---~~~~~~~~-~~~ 234 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EE---LFGQVISD-DIE 234 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHHHhc-ccC
Confidence 0011124578899999999888899999999999999999999999752211 11 11111110 000
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.+.. ....+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 235 ---~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 235 ---WPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---CCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 11234457899999999999999997766666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=257.54 Aligned_cols=225 Identities=24% Similarity=0.316 Sum_probs=169.6
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--CeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 191 (398)
++|+..+.||.|++|.||++...+ ++.+|+|.+.... ......+.+|++++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 467888999999999999999865 7889999987543 23456788999999999999999999998653 4689999
Q ss_pred eccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 192 EYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 192 e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||+++++| +.+|+||+|+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999877 24567999999999999999999999987553221
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.|+...........+.... ........+.+.. ..
T Consensus 160 ---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~ 234 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDEP-GN 234 (287)
T ss_pred ---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccCC-CC
Confidence 123457889999999999999999999999999999999999986543211111111111 1111111111100 00
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 235 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 235 ---GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ---CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1123456889999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=265.19 Aligned_cols=219 Identities=23% Similarity=0.359 Sum_probs=170.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
+.|.....||+|+||.||++.... +..||+|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 344555779999999999999754 8899999987665556677889999999999999999999999999999999999
Q ss_pred CCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccc
Q 037365 195 PNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243 (398)
Q Consensus 195 ~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 243 (398)
++++| +++|+||||+||++++++.+||+|||++....... .......
T Consensus 102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 179 (292)
T cd06658 102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV 179 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence 99987 35578999999999999999999999987553322 1123346
Q ss_pred ccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHH
Q 037365 244 GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323 (398)
Q Consensus 244 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... . .... ....... .....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~---~-~~~~-----~~~~~~~---~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMR---R-IRDN-----LPPRVKD---SHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH---H-HHhc-----CCCcccc---ccccC
Confidence 88999999999888899999999999999999999999753211 11100 0 1000 0000000 11223
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 324 LRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+.+++.+||..||.+|||++++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 457889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=293.54 Aligned_cols=225 Identities=23% Similarity=0.335 Sum_probs=170.5
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--C
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--K 184 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~ 184 (398)
......++|++.+.||+|+||.||++.+.. +..+|+|.+... .......+..|+.++.+++||||++++++|.+ .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 344556789999999999999999999866 678899988643 33445678899999999999999999998865 3
Q ss_pred CeeEEEEeccCCCCh------------------------------------h-------HHhhcCCCCCceecC------
Q 037365 185 DEKILIYEYMPNKSL------------------------------------D-------FFLFNLKASNILLDK------ 215 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L------------------------------------~-------~~~~dlkp~NILl~~------ 215 (398)
...|+||||+++|+| . ++|+||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 568999999999877 1 688999999999964
Q ss_pred -----------CCCeEEcccccceecCCCCcccccccccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCC
Q 037365 216 -----------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNT 282 (398)
Q Consensus 216 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~ 282 (398)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 2358999999998764332 1234578999999999864 45899999999999999999999998
Q ss_pred CCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhh
Q 037365 283 GFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTN 353 (398)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~ 353 (398)
..... ..... ........ + .....+..+.+|+..||+.+|.+|||+.|++. .+..
T Consensus 244 ~~~~~----~~qli-~~lk~~p~--l---------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 244 HKANN----FSQLI-SELKRGPD--L---------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred CcCCc----HHHHH-HHHhcCCC--C---------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 53221 11111 11111100 0 01112345789999999999999999999984 4443
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=257.84 Aligned_cols=220 Identities=25% Similarity=0.398 Sum_probs=168.6
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCC-----
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD----- 185 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~----- 185 (398)
.++++|++.+.||+|++|.||+|.... ++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 457899999999999999999999864 78899999876543 346788999999999 6999999999997644
Q ss_pred -eeEEEEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 186 -EKILIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 186 -~~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
..++||||+++++| +.+|+||+|+||++++++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 48999999998866 34567999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccChhhhcc-----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIE-----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
...... .......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...... ... ..... .
T Consensus 162 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~----~~~~~-~ 233 (275)
T cd06608 162 QLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RAL----FKIPR-N 233 (275)
T ss_pred ecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHH----HHhhc-c
Confidence 654322 12233568899999998853 34678999999999999999999997532111 011 11111 0
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..... .........+.+++.+||..||++|||+.++++
T Consensus 234 ~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPPTL--------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCC--------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000 001224456889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=259.18 Aligned_cols=222 Identities=26% Similarity=0.378 Sum_probs=170.8
Q ss_pred CCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
++|+..+.||+|+||.||+|+... .+.+++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578888999999999999999642 467999988765433 4567899999999999999999999999999999
Q ss_pred EEEeccCCCCh-----------------------------------------hHHhhcCCCCCceecCCCCeEEcccccc
Q 037365 189 LIYEYMPNKSL-----------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMA 227 (398)
Q Consensus 189 lV~e~~~~g~L-----------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla 227 (398)
+||||+++|+| +++|+||||+||+++.++.++++|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 99999998877 3566799999999999999999999998
Q ss_pred eecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 228 RICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..... ........
T Consensus 165 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~----~~~~~~~~ 237 (275)
T cd05046 165 KDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLN----RLQAGKLE 237 (275)
T ss_pred cccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHH----HHHcCCcC
Confidence 75432221 12223456778999999988889999999999999999999 6777642211 11111 11111110
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.. . ....+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 238 ~~----~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 LP----V-----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CC----C-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00 0 11233468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=262.08 Aligned_cols=220 Identities=24% Similarity=0.395 Sum_probs=173.1
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|...+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468999999999999999999865 4788999998755545557788999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++++| +.+|+||||+||+++.++.+||+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 175 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 175 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccc
Confidence 999987 345679999999999999999999999876543322 12234
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.|++.|+|||.+.+..++.++|+||||+++|++++|+.||........ .. ........ . . ......
T Consensus 176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~----~~~~~~~~-~-----~---~~~~~~ 241 (293)
T cd06647 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY----LIATNGTP-E-----L---QNPEKL 241 (293)
T ss_pred cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-ee----ehhcCCCC-C-----C---CCcccc
Confidence 688899999999888899999999999999999999999854322110 00 00000000 0 0 001223
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...+.+++.+||+.+|++||++++++..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4467899999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=265.18 Aligned_cols=217 Identities=22% Similarity=0.339 Sum_probs=168.8
Q ss_pred CCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 118 FSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
|+....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..+++|||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444567999999999999975 4889999998765444556788999999999999999999999999999999999999
Q ss_pred CCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccc
Q 037365 197 KSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245 (398)
Q Consensus 197 g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 245 (398)
++| +++|+||||+||+++.++.+||+|||++........ ......|+
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~ 180 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGT 180 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecC
Confidence 887 356789999999999999999999999875543221 12235688
Q ss_pred ccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHH
Q 037365 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLR 325 (398)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (398)
..|+|||++.+..++.++|||||||++|||++|+.||...... ... .. ......... .. .......
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~---~~-~~~~~~~~~-----~~---~~~~~~~ 246 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAM---KR-LRDSPPPKL-----KN---AHKISPV 246 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---HH-HhccCCCCc-----cc---cCCCCHH
Confidence 9999999999889999999999999999999999997532211 111 10 111100000 00 1112345
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 326 YVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 326 ~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+.+++.+||+.+|++|||++++++.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 7889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=255.81 Aligned_cols=218 Identities=24% Similarity=0.385 Sum_probs=163.8
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCcccceeeEEEe--CCee
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEK 187 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 187 (398)
.+|+..+.||+|+||.||+|.... +..||+|++.... ......+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368889999999999999999765 8899999885431 2334568889999999999999999999876 3578
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
++++||+++++| +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 899999999877 356679999999999999999999999876542211
Q ss_pred -ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 -QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
........++..|+|||.+.+..++.++|||||||++|||++|+.||...... ........... .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~~~~~~~-----~~~~- 230 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFKIATQPT-----NPQL- 230 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHHHhcCCC-----CCCC-
Confidence 11122345888999999999888999999999999999999999997532111 11111110000 0000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+......+.+++ +||..+|++|||++|+++
T Consensus 231 ----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 231 ----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 122234456666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=256.46 Aligned_cols=213 Identities=28% Similarity=0.419 Sum_probs=166.1
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
++|++.+.||+|+||.||++.. .++.+|+|.+.... ....+.+|+.++++++|||++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688889999999999999976 57889999986543 235788999999999999999999998754 5799999999
Q ss_pred CCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 196 NKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 196 ~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+|+| +.+|+||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~ 156 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DN 156 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-----CC
Confidence 9887 35678999999999999999999999987643221 12
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (398)
...+..|+|||.+.++.++.++|+||||+++|||++ |+.||...... ... ........... ..
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~~~----------~~ 220 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVK----ECVEKGYRMEP----------PE 220 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHH----HHHhCCCCCCC----------CC
Confidence 234567999999998899999999999999999998 88886532211 111 11111110000 11
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 321 QVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 321 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
..+..+.+++.+||+.+|++|||++++++.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=257.37 Aligned_cols=216 Identities=22% Similarity=0.399 Sum_probs=168.5
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcC---CCcccceeeEEEeCCeeEEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.|+..+.||+|+||.||+|.+. +++.+|+|.+... .......+.+|+.++++++ |||++++++++..++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999975 4889999998654 3344567889999999997 999999999999999999999
Q ss_pred eccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 192 EYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 192 e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
||+++++| +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRS 159 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccc
Confidence 99999987 356779999999999999999999999987654431 223
Q ss_pred cccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...|+..|+|||.+.++ .++.++|+|||||++|+|++|+.||...... ..... ........ +. .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~-~~~~~~~~-----~~----~ 224 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML-IPKSKPPR-----LE----D 224 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc-cccCCCCC-----CC----c
Confidence 34688999999998754 4689999999999999999999997532211 11000 00000000 10 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 113456889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=266.34 Aligned_cols=214 Identities=22% Similarity=0.317 Sum_probs=177.3
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.+-|...+.||+|.|+.|-+|++- .|..||||++.+.. .-....+.+|+..|+-++|||||++|.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 456888899999999999999864 49999999997653 334457889999999999999999999999999999999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCcee-cCCCCeEEcccccceecCCCCccc
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILL-DKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl-~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|.-++|+| ..+||||||+||.+ ..-|-+||.|||++..+..++
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--- 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--- 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence 99999987 46778999999876 566889999999997765443
Q ss_pred ccccccccccccChhhhccCCCC-cccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFS-IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.....+|+..|-|||++.+..|+ +++|||||||+||-|++|+.||... +..+.+..++...
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA------------------NDSETLTmImDCK 235 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA------------------NDSETLTMIMDCK 235 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc------------------cchhhhhhhhccc
Confidence 34557999999999999999996 7799999999999999999997532 2233333444433
Q ss_pred cC-hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YS-SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~-~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
|. +.....++.+||..||..||.+|.|.++|..
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 33 4456678999999999999999999999985
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=261.40 Aligned_cols=212 Identities=26% Similarity=0.388 Sum_probs=168.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||++.+.. ++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468888999999999999999865 8899999986432 234466889999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++++| +++|+||+|+||+++.++.+||+|||+++..... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999987 3556799999999999999999999999876533 2
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... ......... . + +
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~----~~~~~~~~~-~-----~-----~ 218 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQI----YEKILEGKV-R-----F-----P 218 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHH----HHHHhcCCc-c-----C-----C
Confidence 334688999999999888899999999999999999999999753321 001 110111100 0 0 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
......+.+++.+||+.||.+|+ +++|+++
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11235678999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=257.21 Aligned_cols=216 Identities=21% Similarity=0.384 Sum_probs=169.2
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
-|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677789999999999999875 47899999886442 334467889999999999999999999999999999999999
Q ss_pred CCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccc
Q 037365 195 PNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243 (398)
Q Consensus 195 ~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 243 (398)
++++| +.+|+||||+||+++.++.++|+|||++........ ......
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 162 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFV 162 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhcccc
Confidence 99887 345679999999999999999999999877643321 122346
Q ss_pred ccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHH
Q 037365 244 GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323 (398)
Q Consensus 244 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
++..|+|||.+.+..++.++|+|||||++|+|++|..|+...... ..... ........ + ....+
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~~-----~-----~~~~~ 226 (277)
T cd06641 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL-IPKNNPPT-----L-----EGNYS 226 (277)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH-HhcCCCCC-----C-----CcccC
Confidence 788999999998888999999999999999999999997532211 11111 11111100 1 11233
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 324 LRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 457899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=254.23 Aligned_cols=214 Identities=23% Similarity=0.379 Sum_probs=167.8
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||+|+||.||++.... ++.+|+|.+... .....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 57888999999999999999754 888999998654 234456788999999999999999999999999999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCC-CCeEEcccccceecCCCCcccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKD-MNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~~~ 238 (398)
+++++| +++|+||||+||+++++ +.+||+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---c
Confidence 999876 35667999999999855 458999999998765432 1
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... .. ....... ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~---~~~~~~~-~~~~~---------- 221 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--AL---VLKIMSG-TFAPI---------- 221 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HH---HHHHHhc-CCCCC----------
Confidence 22346788999999999888999999999999999999999997532211 11 1111111 00111
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=256.46 Aligned_cols=222 Identities=23% Similarity=0.371 Sum_probs=170.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++.+....||.|+||+|++-.++. |+..|||++.... ....+++..|.+...+- +.||||+++|.+...+..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 455667889999999999999876 8999999997664 35567888888876655 68999999999999999999999
Q ss_pred ccCCC-------------------------------------ChhHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 193 YMPNK-------------------------------------SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 193 ~~~~g-------------------------------------~L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.|.-. .|.++|||+||+|||+|..|.+||||||++-.+.+.-
T Consensus 144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 98642 2378999999999999999999999999987664332
Q ss_pred ccccccccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..+..+|...|||||.+.. ..|+.+|||||||++|+|+.||+.|+..... ..+.......+... ++
T Consensus 223 --AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp------~l 290 (361)
T KOG1006|consen 223 --AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPP------IL 290 (361)
T ss_pred --HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCC------ee
Confidence 2334578999999999863 3589999999999999999999999754322 12222222222111 11
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+.........+.+++..|+..|-.+||..+++.+.
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111122345678999999999999999999998864
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=258.71 Aligned_cols=229 Identities=21% Similarity=0.285 Sum_probs=165.9
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChh-----hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
+|+..+.||+|+||.||+|.... ++.||+|++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 47778899999999999999764 889999999754322 234567899999999999999999999999999999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+ +|+| +++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-- 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--
Confidence 9999 7766 345779999999999999999999999987654321
Q ss_pred ccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcC---------Cccc
Q 037365 238 NTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSN---------RTLE 307 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 307 (398)
......++..|+|||.+.+ ..++.++|||||||++|||++|.+||..... ..........+... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhhhhhcccccc
Confidence 1222356788999998865 4578999999999999999999766543221 11111111100000 0000
Q ss_pred cchhhhhccc----ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 308 LTDAILEDEY----SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 308 ~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.......... ........+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 012234568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=260.57 Aligned_cols=216 Identities=25% Similarity=0.422 Sum_probs=167.2
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|+..+.||+|+||.||+|.... ++.||+|.+... .....+.+.+|+.+++.++||||++++++|.+++..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34678899999999999999999764 889999998643 23344678899999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||++++.+ +++|+||+|+||++++++.+||+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 9999975422 3567899999999999999999999998765422
Q ss_pred ccccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 238 NTSRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
....++..|+|||++. ...++.++||||||+++|||++|+.|+...... ......... ....
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~~-~~~~------- 233 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQN-DSPT------- 233 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhcC-CCCC-------
Confidence 2346788999999874 456889999999999999999999996432111 111111000 0000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.........+.+++.+||+.+|++|||+.+++..
T Consensus 234 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 --LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0022244568899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=252.30 Aligned_cols=221 Identities=21% Similarity=0.407 Sum_probs=169.5
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
+|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999874 48899999986432 1235678899999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCC-CeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDM-NPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++++| +++|+||||+||+++.++ .+||+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999987 356679999999998776 5999999998776543211
Q ss_pred c--ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 237 A--NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 237 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
. ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ................
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~-------- 230 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASATTAP-------- 230 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccCCCC--------
Confidence 1 122346788999999998888999999999999999999999997533221 1111111111100000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..+......+.+++.+||+.+|++|||+.++++
T Consensus 231 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 --SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 012234456889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=253.80 Aligned_cols=218 Identities=22% Similarity=0.331 Sum_probs=165.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--Cee
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 187 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 187 (398)
.+|++.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468888999999999999999765 889999987532 123346788899999999999999999998764 467
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+++|||+++++| +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999988 345679999999999999999999999876542211
Q ss_pred c-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 Q-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
. .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .. ......... .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~-~~~~~~~~~-----~---- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AA-IFKIATQPT-----N---- 227 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HH-HHHHhcCCC-----C----
Confidence 1 1122346888999999999888999999999999999999999997532111 00 011110000 0
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+......+.+++.+||. +|++|||++|+++
T Consensus 228 -~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 -PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00123344567889999995 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=257.33 Aligned_cols=217 Identities=24% Similarity=0.343 Sum_probs=169.0
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++..++..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999975 488999999876555555678899999999999999999999999999999999999
Q ss_pred CCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 196 NKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 196 ~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
+++| +++|+||+|+||+++.++.++|+|||++........ ......|
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~ 177 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVG 177 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccC
Confidence 9888 355789999999999999999999998875543211 1223468
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
+..|+|||.+.+..++.++||||||+++|||++|+.||..... . ..... ......... .. ......
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~---~~~~~-~~~~~~~~~-----~~---~~~~~~ 243 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--L---QAMKR-IRDNLPPKL-----KN---LHKVSP 243 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--H---HHHHH-HHhcCCCCC-----cc---cccCCH
Confidence 8999999999988899999999999999999999999753211 1 11111 111100000 00 111335
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 325 RYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+.+++.+||+.+|++|||+.++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 6889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=258.47 Aligned_cols=231 Identities=22% Similarity=0.306 Sum_probs=165.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|+..+.||+|++|.||+|.... ++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 3678899999999999999999864 88999999865422 223456789999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+++ +| +++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TY 160 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--cc
Confidence 9985 55 356789999999999999999999999875432211 11
Q ss_pred ccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc-----------
Q 037365 240 SRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE----------- 307 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 307 (398)
....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....... ......+..........
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 22346788999999876 458899999999999999999999975432111 11111111111000000
Q ss_pred ------cchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 308 ------LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 308 ------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.....+............+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000001145679999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=256.58 Aligned_cols=216 Identities=21% Similarity=0.357 Sum_probs=161.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHH-HHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASV-IAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|++.+.||+|+||.||++++.. |+.||+|+++... ......+..|..+ ++..+||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468888999999999999999864 8999999987542 2233455556665 566789999999999999999999999
Q ss_pred ccCCCCh-------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 193 YMPNKSL-------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 193 ~~~~g~L-------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
|+++ +| +.+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 9975 32 35678999999999999999999999988654321
Q ss_pred ccccccccccccccChhhhcc----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 236 QANTSRIVGTYGYMSPEYAIE----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||.........+ ...... .....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~--- 228 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL----KQVVEE-PSPQL--- 228 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH----HHHHhc-CCCCC---
Confidence 1122467889999998865 456899999999999999999999975322211111 111110 00000
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.....+..+.+++.+||..+|++|||++++++
T Consensus 229 ------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 ------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=258.46 Aligned_cols=221 Identities=23% Similarity=0.388 Sum_probs=166.7
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|+..+.||+|+||.||++.+.. ++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 356667889999999999999765 8899999986542 344567889999999996 9999999999999999999999
Q ss_pred ccCCC--------------C-----------------------hhHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 193 YMPNK--------------S-----------------------LDFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 193 ~~~~g--------------~-----------------------L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
|+... . .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 97642 0 1467789999999999999999999999976543221
Q ss_pred ccccccccccccccChhhhccC---CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEG---IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.....|+..|+|||.+.+. .++.++|||||||++|||++|+.||..... ........... ....
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~-~~~~----- 230 (288)
T cd06616 164 ---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKG-DPPI----- 230 (288)
T ss_pred ---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCC-CCCc-----
Confidence 1233678899999999876 689999999999999999999999754321 11111111111 1001
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+.... ....+..+.+++.+||+.||++|||++++++.
T Consensus 231 ~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11000 12234568899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=261.57 Aligned_cols=219 Identities=21% Similarity=0.310 Sum_probs=169.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|+..+.||+|+||.||+|...+ ++.+|+|.+..... ...+.+.+|++++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999875 89999999975432 24567889999999999999999999999999999999
Q ss_pred eccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc-
Q 037365 192 EYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ- 236 (398)
Q Consensus 192 e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 236 (398)
||+.+++| +.+|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999877 3457899999999999999999999998755322110
Q ss_pred --------------------------cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCcc
Q 037365 237 --------------------------ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTL 290 (398)
Q Consensus 237 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~ 290 (398)
.......||..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~- 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE- 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence 01123468889999999999889999999999999999999999975332210
Q ss_pred chhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCC----HHHHHH
Q 037365 291 NLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPT----TNDVVS 349 (398)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt----~~evl~ 349 (398)
.. ...... .. .. .. ....+..+.+++.+||+.||++||| ++++++
T Consensus 240 ~~----~~~~~~-~~-~~-----~~---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 TF----SNILKK-EV-TF-----PG---SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH----HHHhcC-Cc-cC-----CC---ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 00 011100 00 00 00 1113456889999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=260.60 Aligned_cols=233 Identities=19% Similarity=0.305 Sum_probs=167.2
Q ss_pred CCCccceecccCceEEEEEEEcC---CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--CeeE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK---GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI 188 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 188 (398)
+|++.+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999997632 33346678899999999999999999999988 7899
Q ss_pred EEEeccCCCCh------------------------------------hHHhhcCCCCCceecC----CCCeEEcccccce
Q 037365 189 LIYEYMPNKSL------------------------------------DFFLFNLKASNILLDK----DMNPKISDFGMAR 228 (398)
Q Consensus 189 lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~----~~~~kl~DFGla~ 228 (398)
+||||++++.+ +++|+||||+||+++. ++.+||+|||+++
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 99999975322 3457899999999999 8999999999998
Q ss_pred ecCCCCc-ccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccc-------hhHHHHHh
Q 037365 229 ICGGNEL-QANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLN-------LLGYAWDL 299 (398)
Q Consensus 229 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~-------~~~~~~~~ 299 (398)
....... ........++..|+|||.+.+. .++.++|||||||++|||++|++||......... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7654322 1123345678999999988764 5789999999999999999999998644332200 00000000
Q ss_pred hhcCC---------ccccch---hhhhcccC--------hH--HHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 300 WRSNR---------TLELTD---AILEDEYS--------SK--QVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 300 ~~~~~---------~~~~~~---~~~~~~~~--------~~--~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+.... ..+... ......+. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 000000 00000000 00 22346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=251.16 Aligned_cols=220 Identities=26% Similarity=0.445 Sum_probs=170.5
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|...+.||+|+||.||+|... +++.+++|.+..... ...+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999975 488999999876543 3667889999999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc--c
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN--T 239 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~ 239 (398)
+++++| +++|+||+|+||++++++.+||+|||++........... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 999987 356679999999999999999999999887654322111 1
Q ss_pred ccccccccccChhhhccCC---CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 240 SRIVGTYGYMSPEYAIEGI---FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
....++..|+|||++.+.. ++.++||||||+++||+++|+.||....... ........ ........
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~~-~~~~~~~~------ 229 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVGA-GHKPPIPD------ 229 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHhc-CCCCCCCc------
Confidence 2346788999999998766 8899999999999999999999985432111 01110000 10000000
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.+++.+||+.+|++|||+.+++.
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 --SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1112345779999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=275.66 Aligned_cols=223 Identities=28% Similarity=0.390 Sum_probs=178.1
Q ss_pred CccceecccCceEEEEEEEc-CC----CEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 119 SDANKLGEGGFGPVYKGVLR-KG----NEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
...++||+|+||+||+|.|- +| -+||+|++... ..+...++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 44588999999999999863 33 46899998655 3455678999999999999999999999998766 889999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+.|+| ..+||||..+|||+.+...+||.|||+++.+.........
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 9999998 4677899999999999999999999999988765544444
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....-.+.|||-|.+....|+.++|||||||++||++| |..|++....+ .+.++++.+.. +. +
T Consensus 858 ~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------eI~dlle~geR-------Ls---q 921 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------EIPDLLEKGER-------LS---Q 921 (1177)
T ss_pred cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------HhhHHHhcccc-------CC---C
Confidence 44455778999999999999999999999999999998 88886532221 12222222211 11 1
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
++.+...+..++.+||..|+..||+++++...+.+.+.++
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 4455667889999999999999999999999888765543
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=249.69 Aligned_cols=220 Identities=23% Similarity=0.359 Sum_probs=174.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|+..+.||+|++|.||+|.... ++.+++|++..... .....+.+|+..+.+++|+|++++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999999876 89999999876643 4457889999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++++| +.+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--cc
Confidence 998876 3567799999999999999999999999876543321 12
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChH
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (398)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ...+....... ...... ..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~-~~~~~~----------~~ 225 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICD-GPPPSL----------PA 225 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhc-CCCCCC----------Cc
Confidence 346788999999999888999999999999999999999997654321 11111111111 110000 11
Q ss_pred H-HHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 321 Q-VLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 321 ~-~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. .+..+.+++.+||+.+|++|||+.++++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 34568899999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=251.90 Aligned_cols=216 Identities=24% Similarity=0.386 Sum_probs=168.5
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--CCeeEEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIY 191 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 191 (398)
+|+..+.||.|+||.||++.... ++.+|+|.+... .....+.+.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47788999999999999998754 788999998643 33445678899999999999999999998864 45679999
Q ss_pred eccCCCCh---------------------------------h--------HHhhcCCCCCceecCCCCeEEcccccceec
Q 037365 192 EYMPNKSL---------------------------------D--------FFLFNLKASNILLDKDMNPKISDFGMARIC 230 (398)
Q Consensus 192 e~~~~g~L---------------------------------~--------~~~~dlkp~NILl~~~~~~kl~DFGla~~~ 230 (398)
||+++++| . ++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99998876 1 556799999999999999999999999876
Q ss_pred CCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ...+. ..........
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~----~~~~~~~~~~--- 229 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLA----SKIKEGKFRR--- 229 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHH----HHHhcCCCCC---
Confidence 543321 223468999999999998889999999999999999999999976432 11111 1111111110
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. .......+.+++.+||+.+|++|||+++|++.
T Consensus 230 --~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 --I-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --C-----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 22334568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=279.29 Aligned_cols=236 Identities=19% Similarity=0.216 Sum_probs=162.4
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC--CCEEEEE------------------EccCCChhhHHHHHHHHHHHHhcCC
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK--GNEIAVK------------------RLSGRSGQGLREMKNEASVIAKVQH 171 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H 171 (398)
....++|++.+.||+|+||+||+|.++. +...+.| .+. ........+.+|+.++++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 3445789999999999999999987643 2222222 111 112234567899999999999
Q ss_pred CcccceeeEEEeCCeeEEEEeccCCCCh------------------------------------hHHhhcCCCCCceecC
Q 037365 172 KNLVRLLGCCIDKDEKILIYEYMPNKSL------------------------------------DFFLFNLKASNILLDK 215 (398)
Q Consensus 172 ~nIv~l~~~~~~~~~~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~ 215 (398)
|||+++++++.+.+..|+++|++.+..+ +++||||||+|||++.
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 9999999999999999999998754311 4678999999999999
Q ss_pred CCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCC-CCCCCCc-cchh
Q 037365 216 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNT-GFYRTDT-LNLL 293 (398)
Q Consensus 216 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~-~~~~~~~-~~~~ 293 (398)
++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++ ....... ..+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999987654322 1223457999999999999999999999999999999999987543 2221111 1111
Q ss_pred HHHHHhhh--cCCcc----ccchhhhhcc-----------cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 294 GYAWDLWR--SNRTL----ELTDAILEDE-----------YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 294 ~~~~~~~~--~~~~~----~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.... ... ..... .+.+...... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 382 ~~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1110 000 00000 0000000000 0000122356788999999999999999999863
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=255.70 Aligned_cols=228 Identities=23% Similarity=0.328 Sum_probs=168.8
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999976 48899999987553 33456788999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+ +++| +.+|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYS 158 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cccc
Confidence 9 8877 346679999999999999999999999987654321 1123
Q ss_pred cccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc------cccch--h
Q 037365 241 RIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT------LELTD--A 311 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~--~ 311 (398)
...|+..|+|||.+.+. .++.++||||+|+++|||++|.+||..... ..........+..... .++.+ .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 34689999999998754 468999999999999999999776543221 1111111111110000 00000 0
Q ss_pred ---------hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 312 ---------ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 312 ---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..... .+.....+.+++.+||+.+|++|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEI--FPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHh--CCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 11234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-33 Score=289.12 Aligned_cols=227 Identities=22% Similarity=0.286 Sum_probs=177.8
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 184 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 184 (398)
.++..-.++|++.+.||+|+||.|..++++. ++.||+|++.+. .......|..|-.+|..-+.+-|++++..|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3555567899999999999999999999876 778899999763 233446788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 185 DEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
+++|+|||||+||+| +++||||||+|||+|.+|++||+|||.|-.+..
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999987 688999999999999999999999999977764
Q ss_pred CCcccccccccccccccChhhhc----c-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc
Q 037365 233 NELQANTSRIVGTYGYMSPEYAI----E-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE 307 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+.. ......+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||... +++...-..........
T Consensus 228 dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 228 DGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNHKESLS 301 (1317)
T ss_pred CCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhchhhhcC
Confidence 433 3345569999999999997 2 56999999999999999999999997521 12221111111111111
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCC---HHHHHHH
Q 037365 308 LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPT---TNDVVSM 350 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~~ 350 (398)
+.+ ....+....+||.+.+. +|+.|.. ++++-..
T Consensus 302 FP~--------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 302 FPD--------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CCc--------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 110 12245667888888765 6888887 8888753
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=257.64 Aligned_cols=226 Identities=20% Similarity=0.294 Sum_probs=164.3
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||.|++|.||+|+... ++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 47888999999999999999864 8899999986442 22345788999999999999999999999999999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+.+ +| +.+|+||+|+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (284)
T cd07860 81 LHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY 157 (284)
T ss_pred ccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--cc
Confidence 964 33 346789999999999999999999999876543221 12
Q ss_pred ccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC--------------
Q 037365 240 SRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR-------------- 304 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-------------- 304 (398)
....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...... ....... .......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIF-RTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHH-HHhCCCChhhhhhhhHHHHHH
Confidence 2335688999999887654 588999999999999999999997543211 1111100 0000000
Q ss_pred --ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 305 --TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 305 --~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
............ .+.....+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 0112345779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=252.45 Aligned_cols=216 Identities=23% Similarity=0.354 Sum_probs=168.1
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||+|+||.||++.... |..+|+|.+... .....+.+.+|+++++.++|+||+++++.+.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47788999999999999999865 888999998643 223445778999999999999999999999999999999999
Q ss_pred cCCCCh----------------------------------hHHhhcCCCCCceecCCC-CeEEcccccceecCCCCcccc
Q 037365 194 MPNKSL----------------------------------DFFLFNLKASNILLDKDM-NPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 194 ~~~g~L----------------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~ 238 (398)
+++++| +++|+||||+||++++++ .+||+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--L 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--c
Confidence 998876 356679999999998875 469999999876643321 1
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....|++.|+|||++.+..++.++|+||||+++|||++|..|+.... ........... .....
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~-~~~~~---------- 222 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQG-YFAPI---------- 222 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcc-cCCCC----------
Confidence 223468899999999988889999999999999999999999975321 11122211111 11000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.+.....+.+++.+||+.+|++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=268.24 Aligned_cols=217 Identities=22% Similarity=0.349 Sum_probs=182.0
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.-...|.+.+.||+|.|+.|.+|++.. +..||+|.+.+. +....+.+.+|+++|+.++|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345679999999999999999999765 899999999765 33444568899999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+.+|.+ .++|||||++|+||+.+.++||+|||++.++....
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~--- 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL--- 209 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc---
Confidence 9999999987 36778999999999999999999999999886432
Q ss_pred ccccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.....+|++.|.|||++.+..| ++++|+||+|+++|.|+.|..||+ +....++-+..+.+.
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD------------------G~~lk~Lr~rvl~gk 271 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD------------------GQNLKELRPRVLRGK 271 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC------------------Ccccccccchheeee
Confidence 3455799999999999999887 689999999999999999999964 344444445555544
Q ss_pred cChH-HHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 317 YSSK-QVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 317 ~~~~-~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+..+ -....+.+++++++..+|.+|++++++.+.
T Consensus 272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 4322 223457799999999999999999999863
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=257.90 Aligned_cols=229 Identities=16% Similarity=0.161 Sum_probs=157.4
Q ss_pred cCCCCccceecccCceEEEEEEEcCC----CEEEEEEccCCChhhH-----------HHHHHHHHHHHhcCCCcccceee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKG----NEIAVKRLSGRSGQGL-----------REMKNEASVIAKVQHKNLVRLLG 179 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~~ 179 (398)
.++|.+.+.||+|+||.||+|.+.++ ..+|+|.......... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999997653 4456665432221110 01122334455678999999999
Q ss_pred EEEeCC----eeEEEEeccCCCC-------------------------------hhHHhhcCCCCCceecCCCCeEEccc
Q 037365 180 CCIDKD----EKILIYEYMPNKS-------------------------------LDFFLFNLKASNILLDKDMNPKISDF 224 (398)
Q Consensus 180 ~~~~~~----~~~lV~e~~~~g~-------------------------------L~~~~~dlkp~NILl~~~~~~kl~DF 224 (398)
++.... ..++++|++.... .+++||||||+|||++.++.++|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 876543 3467788764321 14678999999999999999999999
Q ss_pred ccceecCCCCcc-----cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHh
Q 037365 225 GMARICGGNELQ-----ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL 299 (398)
Q Consensus 225 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 299 (398)
|+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||........ .......
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~~~~~- 248 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIHAAKC- 248 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHHHhHH-
Confidence 999876432211 112234699999999999999999999999999999999999999865422211 1111000
Q ss_pred hhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 300 WRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
+.......+.......+..+.+++..||+.+|++||++.++++.|+
T Consensus 249 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 249 -------DFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -------HHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0001111111111223456889999999999999999999998763
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=249.52 Aligned_cols=219 Identities=25% Similarity=0.378 Sum_probs=168.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 192 (398)
+..+.+..||+|+.|.|++++++. |...|||.+... +.+..+.++..+.++..-+ .|.||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345566789999999999999876 788999999655 5566677888888776665 8999999999999999999998
Q ss_pred ccCCC----------Ch-----------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNK----------SL-----------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g----------~L-----------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
.|... .. +++|||+||+|||+|+.|++|+||||++-.+.+... .
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---h 248 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---H 248 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc---c
Confidence 87431 00 578999999999999999999999999977755432 3
Q ss_pred ccccccccccChhhhcc---CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 240 SRIVGTYGYMSPEYAIE---GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
+...|.+.|||||.+.- ..|+..+||||||++++||.||+.||.....+...+. .+ .. ... +.+.+
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-kv---ln-~eP-----P~L~~- 317 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-KV---LN-EEP-----PLLPG- 317 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-HH---Hh-cCC-----CCCCc-
Confidence 34589999999999863 4589999999999999999999999764333321111 11 11 111 11211
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...++..+.+++..||+.|+.+||...++++.
T Consensus 318 --~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 --HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11245668899999999999999999998863
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-33 Score=262.24 Aligned_cols=211 Identities=29% Similarity=0.399 Sum_probs=169.0
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
+.|+.-++||+|+||.||-++.+. |+.+|.|++.+. .........+|-.+|.+++.+.||.+-..|++++.+|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 567888999999999999999776 899999988544 2233456688999999999999999999999999999999
Q ss_pred eccCCCChh----------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 192 EYMPNKSLD----------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 192 e~~~~g~L~----------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
..|.||+|. ++.|||||+|||+|+.|+++|+|.|+|..+...+..
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~- 343 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI- 343 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence 999999982 333699999999999999999999999988766532
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc--
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED-- 315 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 315 (398)
...+||.+|||||++.++.|+...|.|||||++|||+.|+.||....... ...++-...+..
T Consensus 344 --~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------k~eEvdrr~~~~~~ 407 (591)
T KOG0986|consen 344 --RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------KREEVDRRTLEDPE 407 (591)
T ss_pred --ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------------hHHHHHHHHhcchh
Confidence 23489999999999999999999999999999999999999975322211 011111111211
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTT 344 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~ 344 (398)
.+ +..+++...++....|+.||++|.--
T Consensus 408 ey-~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 408 EY-SDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hc-ccccCHHHHHHHHHHHccCHHHhccC
Confidence 12 34456778899999999999999643
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-34 Score=295.91 Aligned_cols=226 Identities=24% Similarity=0.370 Sum_probs=178.4
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
+...+-++.....||.|.||.||-|...+ |...|+|.+.-. .......+.+|..+|..++|||+|+++|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 44555678888999999999999999665 888899987544 233455678999999999999999999999999999
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+|.||||++|+| +++||||||.||+++.+|.+|++|||.|..+..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999998 578899999999999999999999999988765421
Q ss_pred c--cccccccccccccChhhhccCC---CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 236 Q--ANTSRIVGTYGYMSPEYAIEGI---FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 236 ~--~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
. .......||+.|||||++.+.. ...+.||||+|||+.||.||++||.....+-.-+ +.. ..+....+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM----y~V-~~gh~Pq~-- 1462 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM----YHV-AAGHKPQI-- 1462 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH----hHH-hccCCCCC--
Confidence 1 1234568999999999998644 5678999999999999999999986544331111 000 11111111
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 351 (398)
+......-.+++.+||+.||+.|.++.|+++.-
T Consensus 1463 --------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1463 --------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred --------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 223445567999999999999999999888753
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=262.38 Aligned_cols=232 Identities=22% Similarity=0.287 Sum_probs=169.0
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC------
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------ 184 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 184 (398)
..++|+..+.||+|+||.||+|.... ++.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45789999999999999999999764 899999998643 233445677899999999999999999998644
Q ss_pred CeeEEEEeccCCCCh-----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 185 DEKILIYEYMPNKSL-----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
...|+||||+.+..+ +++|+||||+||+++.++.+||+|||+++.......
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 173 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC
Confidence 357999999976311 356789999999999999999999999987643321
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh--------------
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR-------------- 301 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-------------- 301 (398)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ..........+.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 174 ---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred ---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 2234678899999999999999999999999999999999999754321 110000000000
Q ss_pred ----cCCc-------cccchhhhhccc---ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 302 ----SNRT-------LELTDAILEDEY---SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 302 ----~~~~-------~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.... ............ ........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000000000000 011234567899999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=245.21 Aligned_cols=219 Identities=25% Similarity=0.425 Sum_probs=173.4
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--CeeEEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIY 191 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 191 (398)
+|...+.||+|++|.||+|... +++.+++|++.... ....+.+.+|+..+++++||||+++++.+.+. +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999987 48899999986554 24567889999999999999999999999988 8999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++++| +.+|+||+|+||+++.++.++|+|||.+............
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99999887 3566799999999999999999999999877654321112
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....++..|+|||.+.+..++.++||||||+++|+|++|..||..... .....+..........+ +
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~----------~ 226 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGSSGEPPEI----------P 226 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhccccCCCcCC----------C
Confidence 335688899999999888899999999999999999999999765431 11111111111111111 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......+.+++.+||+.+|++|||+.+++.
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 222456889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=272.84 Aligned_cols=234 Identities=24% Similarity=0.321 Sum_probs=172.9
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC------eeE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------EKI 188 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~ 188 (398)
.+...+.||+|+||.||+|+.+. |+.||||.+... .....+..-+|+++|++++|+|||+++++-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34556889999999999999765 999999999764 3344566788999999999999999999876543 678
Q ss_pred EEEeccCCCCh-----------------------------------hHHhhcCCCCCceec--CCC--CeEEccccccee
Q 037365 189 LIYEYMPNKSL-----------------------------------DFFLFNLKASNILLD--KDM--NPKISDFGMARI 229 (398)
Q Consensus 189 lV~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~--~~~--~~kl~DFGla~~ 229 (398)
+|||||.+|+| +++||||||.||++- ++| ..||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999998 588999999999983 334 379999999999
Q ss_pred cCCCCcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc-
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE- 307 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 307 (398)
++++. .....+||..|++||.+.. +.|+..+|.|||||++||+.||..||-....+.. .....|.........-
T Consensus 174 l~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~-~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 174 LDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN-NKEIMWHIITKKPSGVA 249 (732)
T ss_pred CCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc-cchhhhhhhccCCCcee
Confidence 87765 3556799999999999994 8899999999999999999999999876544421 1122222222111110
Q ss_pred -cchhhhhcc------cC-----hHHHHHHHHHHHHHchhcCCCCCC--CHHHHHHHHhhc
Q 037365 308 -LTDAILEDE------YS-----SKQVLLRYVNIALLCVQESADDRP--TTNDVVSMLTNE 354 (398)
Q Consensus 308 -~~~~~~~~~------~~-----~~~~~~~~~~li~~cl~~dP~~RP--t~~evl~~L~~~ 354 (398)
.......+. .. .......+...+..++..+|++|- ...+....+..+
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 001111100 00 223345667888889999999998 666666655544
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=253.55 Aligned_cols=215 Identities=22% Similarity=0.292 Sum_probs=169.8
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
+|+..+.||.|+||.||+|.+.. ++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47888999999999999999864 8899999996542 2445788899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|+++++| +++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccc
Confidence 9999987 35667999999999999999999999987654332 122
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChH
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (398)
...|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ........... ... ..+.
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~~~----------~~~~ 223 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET-ADV----------LYPA 223 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc-ccc----------cCcc
Confidence 346788999999999888999999999999999999999997644332 11111111110 000 0012
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCH--HHHH
Q 037365 321 QVLLRYVNIALLCVQESADDRPTT--NDVV 348 (398)
Q Consensus 321 ~~~~~~~~li~~cl~~dP~~RPt~--~evl 348 (398)
..+..+.+++.+||+.||.+||++ +|++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 234568899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=252.67 Aligned_cols=220 Identities=25% Similarity=0.409 Sum_probs=172.7
Q ss_pred hhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
..++.|+..+.||+|++|.||++.+. ++..+++|++..... ....+.+|++.+++++|+|++++++++...+..++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888999999999999999987 488999999976544 4567889999999999999999999999999999999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
||+++++| +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--K 172 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--h
Confidence 99998887 345679999999999999999999998865543221 1
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ... .... ....... ..
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~---~~~~-~~~~~~~--------~~ 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RAL---FLIT-TKGIPPL--------KN 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHH---HHHH-hcCCCCC--------cc
Confidence 22345788999999999888999999999999999999999997532111 000 0000 0000000 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.+|.+|||+.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1123456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=255.58 Aligned_cols=218 Identities=25% Similarity=0.426 Sum_probs=166.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
..|+..+.||+|+||.||+++... +..+|+|.+... .......+.+|++++++++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 347778899999999999999764 889999998643 2234457888999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++..+ +++|+||+|+||+++.++.+||+|||++..... .
T Consensus 105 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~ 178 (317)
T cd06635 105 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------A 178 (317)
T ss_pred eCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------c
Confidence 99975321 357789999999999999999999999865432 2
Q ss_pred ccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 240 SRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
....|+..|+|||++. ++.++.++|||||||++|||++|+.||...... .............
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~---------- 243 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNESPT---------- 243 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHhccCCC----------
Confidence 2346788999999974 456899999999999999999999996532111 0001111110000
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.........+.+++.+||+.+|.+|||+.++++.+...
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 00122344578999999999999999999999865543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=261.40 Aligned_cols=238 Identities=20% Similarity=0.300 Sum_probs=169.9
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-----ee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~ 187 (398)
+++|++.+.||+|+||.||+|.+.. ++.||+|.+... .......+.+|+.++++++||||+++++++...+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5789999999999999999999754 889999998643 2234456788999999999999999999876543 57
Q ss_pred EEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 188 ILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 188 ~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
++++||+++ +| +++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 999999975 33 4677899999999999999999999999876433221
Q ss_pred c-ccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc---cchh
Q 037365 237 A-NTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE---LTDA 311 (398)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 311 (398)
. ......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .................. +...
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 1233568999999998765 4689999999999999999999999753211 111111111111100000 0000
Q ss_pred h----hh----ccc-----ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--Hhhcc
Q 037365 312 I----LE----DEY-----SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM--LTNEA 355 (398)
Q Consensus 312 ~----~~----~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 355 (398)
. .. ... ..+.....+.+++.+||+.||++|||+.|+++. ++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 00 000 011224568899999999999999999999975 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=245.24 Aligned_cols=216 Identities=27% Similarity=0.460 Sum_probs=171.4
Q ss_pred CCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
.|+..+.||+|++|.||++... ++..+++|++..........+.+|+..+++++|+|++++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999986 488999999977655566788999999999999999999999999999999999999
Q ss_pred CCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 196 NKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 196 ~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++| +.+|+||+|+||++++++.++|+|||.+........ ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~ 157 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTM 157 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccce
Confidence 8877 355679999999999999999999999877654321 2345
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... .... ........... ....
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~~~~~~--------~~~~ 223 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-----ALFK-IATNGPPGLRN--------PEKW 223 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHH-HHhcCCCCcCc--------cccc
Confidence 68889999999998889999999999999999999999975332110 0000 00011111100 1112
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 356889999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=253.27 Aligned_cols=229 Identities=22% Similarity=0.328 Sum_probs=167.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCcccceeeEEEeC--CeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 190 (398)
++|+..+.||+|+||.||+|.+.. ++.+|+|.++.... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 578888999999999999999875 88899999965432 2234567899999999999999999999887 899999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+++ +| +++|+||||+||+++.++.+||+|||++....... .
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--K 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--c
Confidence 999975 44 35678999999999999999999999998765432 1
Q ss_pred ccccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH-----------HHhhhc---
Q 037365 238 NTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA-----------WDLWRS--- 302 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~-----------~~~~~~--- 302 (398)
......+++.|+|||.+.+.. ++.++|+||||+++|||++|+.||...... ...... |..+..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--DQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchHHHHHhhccch
Confidence 122345788999999987654 689999999999999999999997643221 111110 110000
Q ss_pred ---CCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 303 ---NRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 303 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..........+...+........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000111111111112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=253.83 Aligned_cols=214 Identities=24% Similarity=0.353 Sum_probs=166.5
Q ss_pred ccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCC
Q 037365 120 DANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~ 198 (398)
....||+|+||.||++... +++.||+|++..........+.+|+.+++.++|+|++++++++..++..+++|||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3467999999999999875 488999999866555556678899999999999999999999999999999999999997
Q ss_pred h-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccccc
Q 037365 199 L-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247 (398)
Q Consensus 199 L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 247 (398)
| +++|+||+|+||++++++.++|+|||++........ ......|+..
T Consensus 104 L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~ 181 (292)
T cd06657 104 LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPY 181 (292)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCcc
Confidence 7 356789999999999999999999999876543221 1223468899
Q ss_pred ccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHH
Q 037365 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYV 327 (398)
Q Consensus 248 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (398)
|+|||.+.+..++.++|+||+|+++|||++|..||..... ...... ........ ... .......+.
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~----~~~~~~~~-----~~~---~~~~~~~l~ 247 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKM----IRDNLPPK-----LKN---LHKVSPSLK 247 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhhCCcc-----cCC---cccCCHHHH
Confidence 9999999888899999999999999999999999753211 111111 11000000 000 111234577
Q ss_pred HHHHHchhcCCCCCCCHHHHHH
Q 037365 328 NIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 328 ~li~~cl~~dP~~RPt~~evl~ 349 (398)
+++.+||+.+|.+||++.++++
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhc
Confidence 8999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=254.70 Aligned_cols=232 Identities=20% Similarity=0.285 Sum_probs=163.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 185 (398)
.++|+..+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4679999999999999999999864 8899999885432 222345678999999999999999999987654
Q ss_pred --eeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceec
Q 037365 186 --EKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARIC 230 (398)
Q Consensus 186 --~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~ 230 (398)
..++||||+.+ +| +++|+||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 45999999975 33 3567899999999999999999999999866
Q ss_pred CCCCcc--cccccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh------
Q 037365 231 GGNELQ--ANTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR------ 301 (398)
Q Consensus 231 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 301 (398)
...... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ...........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGSITPEV 247 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhh
Confidence 433211 1122345788999999887654 789999999999999999999887543221 11111111110
Q ss_pred --cCCccccch---------hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 302 --SNRTLELTD---------AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 302 --~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
........+ ...............+.+++.+||+.||.+|||++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000 000000000011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=258.37 Aligned_cols=234 Identities=24% Similarity=0.332 Sum_probs=167.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC--Cee
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK--DEK 187 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~--~~~ 187 (398)
..++|+..+.||+|+||.||+|.+.. ++.+|+|++... .......+.+|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45789999999999999999999864 788999988542 233445677899999999 999999999998754 368
Q ss_pred EEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 188 ILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 188 ~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
++||||+++ +| +++|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 85 YLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 999999974 44 3567899999999999999999999999866433221
Q ss_pred ---cccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhh-----------h
Q 037365 237 ---ANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLW-----------R 301 (398)
Q Consensus 237 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-----------~ 301 (398)
.......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......... .
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL--NQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHHH
Confidence 12233568999999998865 45789999999999999999999997532211 1111000000 0
Q ss_pred cCCccccchhhhhcccC-----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 302 SNRTLELTDAILEDEYS-----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
......+.+........ .+.....+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000001000000000 11134568899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=250.00 Aligned_cols=227 Identities=23% Similarity=0.332 Sum_probs=166.4
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--CeeEEEEe
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIYE 192 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e 192 (398)
|++.+.||+|+||.||+|...+ ++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999999875 8899999997652 33446688999999999999999999999988 89999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+++ +| +.+|+||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 158 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADY 158 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccc
Confidence 9975 43 345679999999999999999999999987654321 112
Q ss_pred ccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC--------------
Q 037365 240 SRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR-------------- 304 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-------------- 304 (398)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..............
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhccccccchhhh
Confidence 23456788999998765 45789999999999999999999997543321 11111111110000
Q ss_pred ---ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 305 ---TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 305 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
........+.... ...+...+.+++.+||+.+|++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHh-cccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000010000 0112456889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=252.07 Aligned_cols=231 Identities=23% Similarity=0.315 Sum_probs=165.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCcccceeeEEEeC--CeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 189 (398)
.++|+..+.||+|+||.||+|.+.. |+.||+|++..... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4689999999999999999999865 89999999864422 2223566899999999999999999998765 56899
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+.+ +| +++|+||||+||++++++.+||+|||++........
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 9999975 33 456789999999999999999999999987654321
Q ss_pred cccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc--------c
Q 037365 237 ANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL--------E 307 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 307 (398)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ................. .
T Consensus 164 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 164 -PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred -CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchhhhccc
Confidence 1222345788999999876 4578999999999999999999999753321 11111111111000000 0
Q ss_pred c-chhhhhc-ccC-----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 308 L-TDAILED-EYS-----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 308 ~-~~~~~~~-~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. ....... ... .......+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000000 000 01124567899999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=245.73 Aligned_cols=210 Identities=24% Similarity=0.401 Sum_probs=164.3
Q ss_pred ecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
||.|++|.||+++... ++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999865 8899999986542 23446788999999999999999999999999999999999999988
Q ss_pred --------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccccc
Q 037365 200 --------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247 (398)
Q Consensus 200 --------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 247 (398)
+.+|+||+|+||+++.++.+||+|||++....... ......|+..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 35667999999999999999999999998765432 1223467889
Q ss_pred ccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHH
Q 037365 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYV 327 (398)
Q Consensus 248 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (398)
|+|||.+.+..++.++|+||||+++|+|++|..||.....+..... ........... + +......+.
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~---------~-~~~~~~~~~ 224 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY---NDILKGNGKLE---------F-PNYIDKAAK 224 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH---HHHhccCCCCC---------C-CcccCHHHH
Confidence 9999999888899999999999999999999999865432211111 11111000000 0 111245688
Q ss_pred HHHHHchhcCCCCCCC-----HHHHHH
Q 037365 328 NIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 328 ~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
+++.+||+.+|++||| ++|+++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc
Confidence 9999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=249.54 Aligned_cols=214 Identities=21% Similarity=0.339 Sum_probs=164.0
Q ss_pred ecccCceEEEEEEEcC-CCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
||+|+||.||++++.. ++.+++|.+..... ...+.+.+|++++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999876 89999999865432 4456788999999999999999999999999999999999999877
Q ss_pred --------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc------cccccc
Q 037365 200 --------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL------QANTSR 241 (398)
Q Consensus 200 --------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~------~~~~~~ 241 (398)
+++|+||+|+||++++++.+||+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 356779999999999999999999999875433211 112233
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
..++..|+|||...+..++.++||||||+++||+++|..||...... ........ ... .... ...
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~-~~~~--------~~~ 225 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILN-GKI-EWPE--------DVE 225 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhc-CCc-CCCc--------ccc
Confidence 56788999999999888999999999999999999999997533211 11111110 000 0000 001
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 2456789999999999999999955555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=245.24 Aligned_cols=215 Identities=21% Similarity=0.377 Sum_probs=170.8
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||+|+||.||++.+.. +..+++|++.... ......+.+|++++++++|||++++++.+..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 47788999999999999999864 8899999997553 24566788999999999999999999999999999999999
Q ss_pred cCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 194 MPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 194 ~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
+++++| +.+|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--D 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--c
Confidence 999876 24566999999999999999999999998765432 1
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.|+..... ......... .....+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~~~~--------- 223 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILK-GQYPPI--------- 223 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhc-CCCCCC---------
Confidence 22334688899999999988899999999999999999999999753321 111111111 111111
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+......+.+++.+||..+|++|||+.++++
T Consensus 224 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 -PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=249.49 Aligned_cols=226 Identities=21% Similarity=0.286 Sum_probs=161.6
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCcccceeeEEEeC--CeeEEEEe
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDK--DEKILIYE 192 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~e 192 (398)
|+..+.||+|+||.||+|.... ++.+|+|++.... ........+|+..+.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5667899999999999999764 8899999986542 222234457889999885 99999999999987 88999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|++++.+ +++|+||||+||+++. +.+||+|||+++....... ..
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~ 156 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YT 156 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC---cC
Confidence 9975322 4677899999999999 9999999999987643321 12
Q ss_pred cccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh-----------cCCcccc
Q 037365 241 RIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR-----------SNRTLEL 308 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~ 308 (398)
...++..|+|||.+.+ +.++.++|||||||++|||++|..||..... .+.......... .......
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 2457889999997754 5578999999999999999999999754321 111111111110 0000000
Q ss_pred chhh-hhcc--cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 309 TDAI-LEDE--YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 309 ~~~~-~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..+. .... ......+..+.+++.+||+.+|++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000 0000 001233567899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=248.82 Aligned_cols=226 Identities=24% Similarity=0.367 Sum_probs=166.0
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
+|+..+.||.|++|.||+|+... |..||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47888999999999999999864 88999999875532 23456778999999999999999999999999999999999
Q ss_pred CCCCh-----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 195 PNKSL-----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 195 ~~g~L-----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
++ +| +.+|+||||+||++++++.+||+|||++....... ...
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--ccc
Confidence 86 33 35678999999999999999999999997654321 112
Q ss_pred ccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC---------ccc--
Q 037365 240 SRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR---------TLE-- 307 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---------~~~-- 307 (398)
....++..|++||++.+. .++.++|||||||++|+|++|+.||...... .............. ...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 234578899999998764 4689999999999999999999997543221 11111111100000 000
Q ss_pred -----cchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 308 -----LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 308 -----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..+... ... .+.....+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~-~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDL-QQL-FPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHH-HHH-hhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 000 1223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=245.47 Aligned_cols=213 Identities=25% Similarity=0.342 Sum_probs=169.3
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|++.+.||+|+||.||++.... ++.+|+|.+... .......+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47788999999999999998764 789999998654 233455778899999999999999999999999999999999
Q ss_pred cCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 194 MPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 194 ~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
+++++| +.+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--- 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--- 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC---
Confidence 999877 24567999999999999999999999998765431
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .+. . ..........
T Consensus 158 -~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~---~-~~~~~~~~~~--------- 221 (256)
T cd08530 158 -AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLR---Y-KVQRGKYPPI--------- 221 (256)
T ss_pred -cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---H-HHhcCCCCCC---------
Confidence 22245788999999999988999999999999999999999997533211 111 0 0111111111
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.+++.+||+.+|++|||+.++++
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 -PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1234456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=253.66 Aligned_cols=216 Identities=27% Similarity=0.413 Sum_probs=165.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
...|+..+.||+|+||.||+|+... +..+|+|.+... .......+.+|+++++.++|+|++++++++..++..++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 3457778899999999999999764 788999988642 233445778899999999999999999999999999999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+.+ ++ +.+|+||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 999975 43 4567899999999999999999999998765422
Q ss_pred ccccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 238 NTSRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
....|+..|+|||.+. ...++.++|||||||++|||++|+.|+...... ......... ....
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~-~~~~------- 233 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQN-ESPA------- 233 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HHHHHHhhc-CCCC-------
Confidence 2346788999999985 356789999999999999999999996432111 011110110 0000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.........+.+++.+||+.+|++|||+.++++...
T Consensus 234 --~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 --LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 001223456789999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=249.45 Aligned_cols=209 Identities=23% Similarity=0.319 Sum_probs=168.0
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|+..++||+|.||.|-+++-+. ++.+|+|++++. ..+....-..|-.+|+..+||.+..+...|+..+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 34679999999999999999999765 899999999766 23334455679999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+.||.| +++.||||.+|.|+|.+|++||+|||+++.-- ....
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~ 323 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGD 323 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc--cccc
Confidence 9999999987 23337999999999999999999999998532 2223
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.+..++|||.|+|||++....|+.++|.|.+||++|||++|+.||.....+ .+++-++.++.
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~------------------kLFeLIl~ed~ 385 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE------------------KLFELILMEDL 385 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh------------------HHHHHHHhhhc
Confidence 466789999999999999999999999999999999999999997532221 11122222211
Q ss_pred C-hHHHHHHHHHHHHHchhcCCCCCC
Q 037365 318 S-SKQVLLRYVNIALLCVQESADDRP 342 (398)
Q Consensus 318 ~-~~~~~~~~~~li~~cl~~dP~~RP 342 (398)
. +.....+...|+...|..||.+|.
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1 233345577899999999999996
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=243.14 Aligned_cols=215 Identities=26% Similarity=0.422 Sum_probs=170.7
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|+..+.||+|++|.||++.... ++.+++|.+..... .....+.+|++++.+++|+|++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47788999999999999998764 78999999976543 4567889999999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+++++| +++|+||||+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccc
Confidence 999877 3567899999999999999999999999876543321 233
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
..++..|+|||.+.+..++.++||||+|+++|+|++|+.|+..... ....+.... ...... ...
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~~~~----------~~~ 222 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRIVQ-DDHPPL----------PEG 222 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc-cCCCCC----------CCC
Confidence 4678899999999888889999999999999999999999753221 011111110 000000 112
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+.+++.+||+.+|++|||+.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2346789999999999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=249.84 Aligned_cols=306 Identities=22% Similarity=0.309 Sum_probs=212.7
Q ss_pred CccchhhHHHHHHHHHHHHHHHHHHHhhhhcCccccccchhhhhccCCc-cc--------------ccCCC-chhhcccc
Q 037365 33 SASFFVLLSLSITLAAVATLGLNFYCFLHTSGEDLMMFDLDLNLKANNV-NI--------------ELPVN-SKLTKRNK 96 (398)
Q Consensus 33 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~-~~--------------~~~~~-~~~~~~~~ 96 (398)
+....++++++++++++.+++++++|...+.+++.+..+.-.....+.. .. -.|.. ....+...
T Consensus 182 s~~~~f~V~v~va~a~v~lva~il~c~~~~s~Kr~~~~~~i~tSs~~~l~~~qps~~st~y~~P~t~tpi~sap~~r~~~ 261 (563)
T KOG1024|consen 182 SGLVTFIVGVIVALALVSLVALILYCAKGPSKKRSNGVHLIKTSSFQRLPTIQPSAHSTIYVTPSTITPIYSAPLTRSSP 261 (563)
T ss_pred cccEEEeeeHHHHHHHHHHHHHHHHHHhcccchhhccCcccchhhhhcCCcCCccccCCcccCCCccccccCCCcccCCC
Confidence 3444556777778888888888899988877666443221000000000 00 00000 00000000
Q ss_pred ccccCCCC---ccchhhhhhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCC-ChhhHHHHHHHHHHH
Q 037365 97 KKEVDQFP---LFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGR-SGQGLREMKNEASVI 166 (398)
Q Consensus 97 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l 166 (398)
.......+ .-..+++....++++...++-+|.||.||+|.|++ .+.|-+|.++.. ++-+...+..|.-.+
T Consensus 262 ns~~~~~p~e~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~ll 341 (563)
T KOG1024|consen 262 NSEYEHEPEEFNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLL 341 (563)
T ss_pred CccccCChHHHhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHH
Confidence 00000000 11234555566778888899999999999997654 345778888655 445567788999999
Q ss_pred HhcCCCcccceeeEEEeC-CeeEEEEeccCCCChh----------------------------------------HHhhc
Q 037365 167 AKVQHKNLVRLLGCCIDK-DEKILIYEYMPNKSLD----------------------------------------FFLFN 205 (398)
Q Consensus 167 ~~l~H~nIv~l~~~~~~~-~~~~lV~e~~~~g~L~----------------------------------------~~~~d 205 (398)
..+.|||+..+.+++..+ ...+.++.++.-|+|+ .+|.|
T Consensus 342 y~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkD 421 (563)
T KOG1024|consen 342 YGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKD 421 (563)
T ss_pred hcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccch
Confidence 999999999999998764 5778899999999883 45569
Q ss_pred CCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCC
Q 037365 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGF 284 (398)
Q Consensus 206 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~ 284 (398)
|..+|+++|+..++||+|=.+++.+-..+++.-......+..||+||.+....|+.++|||||||++|||+| |+.|+..
T Consensus 422 iAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 422 IAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred hhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 999999999999999999999998876666655555566789999999999999999999999999999998 8888643
Q ss_pred CCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 285 YRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
- +..++..+..+.++ +. ++.+++.++..++..||..+|++||+++|++..|.+-
T Consensus 502 I--DPfEm~~ylkdGyR-----------la---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 502 I--DPFEMEHYLKDGYR-----------LA---QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred c--CHHHHHHHHhccce-----------ec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 2 22222222222111 11 1445667789999999999999999999999998763
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=251.78 Aligned_cols=230 Identities=23% Similarity=0.303 Sum_probs=164.7
Q ss_pred CCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|+..+.||+|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999986 48899999986542 2234567889999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecC-CCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDK-DMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++..+ +++|+||||+||+++. ++.+||+|||++....... ..
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~ 159 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--RT 159 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--cc
Confidence 9965321 3567899999999985 5579999999997654321 11
Q ss_pred cccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc------cccchh
Q 037365 239 TSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT------LELTDA 311 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 311 (398)
.....+++.|+|||++.+. .++.++||||||+++|+|++|+.||...... +.............. ..+.+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhccccccchhh
Confidence 2234678899999988764 5789999999999999999999997543221 111000000000000 000000
Q ss_pred h------hhcc--cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 I------LEDE--YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~------~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. .... ...+.....+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000 001123355789999999999999999999986
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=247.82 Aligned_cols=210 Identities=24% Similarity=0.289 Sum_probs=155.1
Q ss_pred eecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHH---hcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIA---KVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
.||+|+||.||++...+ ++.+|+|.+.... ......+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999865 8899999886532 111223344444333 3479999999999999999999999999
Q ss_pred CCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccc
Q 037365 196 NKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243 (398)
Q Consensus 196 ~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 243 (398)
+|+| +++|+||||+|||+++++.+||+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcC
Confidence 9988 35678999999999999999999999987654322 22346
Q ss_pred ccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 244 GTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 244 gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
|+..|+|||.+.+ ..++.++|||||||++|||++|..||.......... ...... .. ...+ +...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~-~~-----~~~~-----~~~~ 222 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL-TV-----NVEL-----PDSF 222 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhh-cC-----CcCC-----cccc
Confidence 8999999999874 558999999999999999999999986432221111 000000 00 0000 2223
Q ss_pred HHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRP-----TTNDVVSM 350 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 350 (398)
+..+.+++.+||+.||++|| |++++++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 45688999999999999999 59988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=251.75 Aligned_cols=232 Identities=24% Similarity=0.347 Sum_probs=168.0
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD---- 185 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 185 (398)
...++|++.+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999865 8899999986542 223356778999999999999999999987655
Q ss_pred ------eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccc
Q 037365 186 ------EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMA 227 (398)
Q Consensus 186 ------~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla 227 (398)
..++|+||++++.+ +++|+||||+||++++++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999987321 4567899999999999999999999999
Q ss_pred eecCCCCcccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 228 RICGGNELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
........ .......++..|+|||.+.+. .++.++|||||||++|||++|++||..... .................
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELISRLCGSPCPA 240 (302)
T ss_pred ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChh
Confidence 87653321 111223567889999988654 578999999999999999999998753221 11111111111110000
Q ss_pred ---ccc--------h------hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ---ELT--------D------AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ---~~~--------~------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+. + ...... ....+..+.+++.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREE--FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hcccccccccccccccccccccchhhh--cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0 000000 1112456889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=249.15 Aligned_cols=228 Identities=21% Similarity=0.299 Sum_probs=163.4
Q ss_pred CCccceecccCceEEEEEEEc-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 118 FSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
|+..+.||.|++|.||+|.+. +|..||+|++.... ......+.+|++.+++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999976 48999999986543 223356788999999999999999999999999999999998
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+ ++| +.+|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccC
Confidence 5 344 346789999999999999999999999976543221 112
Q ss_pred cccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcC--------Cccccchh
Q 037365 241 RIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSN--------RTLELTDA 311 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 311 (398)
...++..|+|||++.+. .++.++||||||+++|||++|+.||...... ..+........... ...+....
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 23568899999988764 4789999999999999999999997543221 11111100000000 00000000
Q ss_pred hhhccc-----ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ILEDEY-----SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...... ..+.....+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 01122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=257.51 Aligned_cols=233 Identities=18% Similarity=0.295 Sum_probs=167.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEe----CCee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 187 (398)
.++|+..+.||+|+||.||+|.... ++.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3688999999999999999999765 8999999986542 2345667889999999999999999998763 3468
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
++||||+.+ +| +++|+||||+||++++++.+||+|||++........
T Consensus 84 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 999999964 44 467789999999999999999999999976643321
Q ss_pred cc--ccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh-----------
Q 037365 236 QA--NTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR----------- 301 (398)
Q Consensus 236 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~----------- 301 (398)
.. ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhhhhhc
Confidence 11 1223578899999999866 45899999999999999999999998543211 11111000000
Q ss_pred cCCccccchhhh-hcccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 302 SNRTLELTDAIL-EDEYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 302 ~~~~~~~~~~~~-~~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
........+... ..... .+..+..+.+++.+||+.+|++|||+++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000 00000 12234678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=249.53 Aligned_cols=229 Identities=21% Similarity=0.263 Sum_probs=163.0
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCe-----
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDE----- 186 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~----- 186 (398)
++|+..+.||+|+||.||+|.+.. ++.||+|.+.... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468889999999999999999864 8899999876442 223456788999999995 6999999999987665
Q ss_pred eEEEEeccCCCCh-------------------------------------hHHhhcCCCCCceecC-CCCeEEcccccce
Q 037365 187 KILIYEYMPNKSL-------------------------------------DFFLFNLKASNILLDK-DMNPKISDFGMAR 228 (398)
Q Consensus 187 ~~lV~e~~~~g~L-------------------------------------~~~~~dlkp~NILl~~-~~~~kl~DFGla~ 228 (398)
.|++|||+++ +| +++|+||||+||+++. ++.+||+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 33 3567899999999998 8899999999988
Q ss_pred ecCCCCcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc-
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL- 306 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 306 (398)
...... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||...... ...... ..........
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~~-~~~~~~~~~~~ 235 (295)
T cd07837 160 AFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLHI-FKLLGTPTEQV 235 (295)
T ss_pred ecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHH-HHHhCCCChhh
Confidence 654321 11122356888999998875 45799999999999999999999987542211 111100 0000000000
Q ss_pred -----ccchhhhhcc-------cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 -----ELTDAILEDE-------YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 -----~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+...... ...+.....+.+++.+||+.||.+|||++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 001223456889999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=253.78 Aligned_cols=227 Identities=20% Similarity=0.260 Sum_probs=160.0
Q ss_pred ceeccc--CceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEG--GFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
..||+| +||+||++.+. .|+.||+|.+... .....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999985 4899999998643 333456788999999999999999999999999999999999999
Q ss_pred CCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc-----c
Q 037365 197 KSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ-----A 237 (398)
Q Consensus 197 g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-----~ 237 (398)
|+| +++||||||+|||++.++.+|++||+.+......... .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 886 3567899999999999999999999865332211100 0
Q ss_pred ccccccccccccChhhhccC--CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHH---------------hh
Q 037365 238 NTSRIVGTYGYMSPEYAIEG--IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD---------------LW 300 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~---------------~~ 300 (398)
......++..|+|||++.+. .++.++|||||||++|||++|+.||................ .+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 01112356679999999764 47899999999999999999999986432211000000000 00
Q ss_pred hcC-----------C-----ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 301 RSN-----------R-----TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 301 ~~~-----------~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
... . ........+.. .....+...+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRT-PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccc-hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 0 00000000000 012335567899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=250.74 Aligned_cols=220 Identities=24% Similarity=0.388 Sum_probs=165.4
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 190 (398)
..++|+..+.||+|+||.||+|.+.+ ++.||||.+.... ......+..|+.++.+.. ||||+++++++.++...+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999876 8899999997543 233455677887777775 99999999999999999999
Q ss_pred EeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 191 YEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 191 ~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
|||+.+ ++ +++|+||+|+||++++++.+||+|||++..+.....
T Consensus 93 ~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 93 MELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred eeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 999864 21 356789999999999999999999999876543221
Q ss_pred cccccccccccccChhhhccCC----CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGI----FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... +......... ......
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~-~~~~~~-- 241 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----EVLTKILQEE-PPSLPP-- 241 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----HHHHHHhcCC-CCCCCC--
Confidence 12235788999999987554 7899999999999999999999975322111 1111111111 000000
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.......+.+++.+||+.||++|||++++++.
T Consensus 242 ------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 ------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01123468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=247.53 Aligned_cols=210 Identities=25% Similarity=0.381 Sum_probs=159.7
Q ss_pred ecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
||+|+||+||++.... |+.+|+|.+.... ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999998764 8899999986432 22344567899999999999999999999999999999999999877
Q ss_pred ----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccc
Q 037365 200 ----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245 (398)
Q Consensus 200 ----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 245 (398)
+++|+||+|+||++++++.+||+|||.+....... ......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCC
Confidence 35567999999999999999999999987654321 12234678
Q ss_pred ccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHH
Q 037365 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLR 325 (398)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (398)
..|+|||.+.+..++.++||||||+++|+|++|+.||........ .......... .... . .......
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~--~~~~-----~-----~~~~~~~ 224 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTLE--MAVE-----Y-----PDKFSPE 224 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhcccc--cccc-----C-----CccCCHH
Confidence 899999999888899999999999999999999999754322110 0000000000 0000 0 1223456
Q ss_pred HHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 326 YVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 326 ~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
+.+++.+||+.||++|| ++.++++
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 78999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=256.64 Aligned_cols=235 Identities=18% Similarity=0.289 Sum_probs=168.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-----Ce
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 186 (398)
.++|.+.+.||+|+||.||+|+... ++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4679999999999999999999764 889999998653 223345677899999999999999999988654 35
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
.++++||+.+ +| +++|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 7999999964 33 35678999999999999999999999998664332
Q ss_pred cccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc-----------
Q 037365 235 LQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS----------- 302 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~----------- 302 (398)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .............
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 163 --DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred --ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChHHhhhcCc
Confidence 11223467889999998875 4689999999999999999999999754321 1111111111100
Q ss_pred CCccccchhhhhc---c--cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--Hhhc
Q 037365 303 NRTLELTDAILED---E--YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM--LTNE 354 (398)
Q Consensus 303 ~~~~~~~~~~~~~---~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~~ 354 (398)
............. . ...+.....+.+++.+||+.+|++|||++++++. +...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000000000 0 0012234568899999999999999999999975 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=257.64 Aligned_cols=232 Identities=22% Similarity=0.342 Sum_probs=167.0
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 185 (398)
.++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999975 4899999998643 2223356789999999999999999999987543
Q ss_pred eeEEEEeccCCCCh------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 186 EKILIYEYMPNKSL------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 186 ~~~lV~e~~~~g~L------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
..++|+||+.. +| +++|+||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred eEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 46999999864 32 4678899999999999999999999998764321
Q ss_pred ccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh--
Q 037365 236 QANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI-- 312 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 312 (398)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .............. .....+..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (342)
T cd07879 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVP-GPEFVQKLED 244 (342)
T ss_pred ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCC-CHHHHHHhcc
Confidence 223467889999999876 4689999999999999999999999864221 11111111111000 00000000
Q ss_pred -------------hhccc--ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--Hhhcc
Q 037365 313 -------------LEDEY--SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM--LTNEA 355 (398)
Q Consensus 313 -------------~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 355 (398)
..... ..+.....+.+++.+||+.||++|||+++++.. ++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000 001123457899999999999999999999953 66554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=244.30 Aligned_cols=216 Identities=21% Similarity=0.304 Sum_probs=160.7
Q ss_pred hhhhhcCCCCcccee--cccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCC
Q 037365 110 SVSTATNRFSDANKL--GEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD 185 (398)
Q Consensus 110 ~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 185 (398)
+.....++|++.+.+ |+|+||.||++.... +..+|+|.+........ |......+ +||||+++++++..++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445677777776 999999999999764 78899999865422111 22222222 7999999999999999
Q ss_pred eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCC-CeEEcccccceecCC
Q 037365 186 EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDM-NPKISDFGMARICGG 232 (398)
Q Consensus 186 ~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~ 232 (398)
..++||||+++|+| +++|+||||+||+++.++ .++|+|||+++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 99999999999988 356679999999999988 999999999876543
Q ss_pred CCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.. ...|+..|+|||++.+..++.++||||||+++|||++|+.||............+.... ......
T Consensus 163 ~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~---- 229 (267)
T PHA03390 163 PS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPF---- 229 (267)
T ss_pred Cc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCc----
Confidence 21 23678899999999998999999999999999999999999864333222222221111 000000
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCC-HHHHHH
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPT-TNDVVS 349 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~ 349 (398)
.+.....+.+++.+||+.+|.+||+ ++++++
T Consensus 230 ------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 ------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1233456889999999999999996 688874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=249.16 Aligned_cols=217 Identities=24% Similarity=0.365 Sum_probs=169.3
Q ss_pred CCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 190 (398)
++|...+.||+|+||.||++... +++.||+|.+... .......+.+|.+++.+++ ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999986 4899999998653 2233467888999999998 99999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc--
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ-- 236 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 236 (398)
|||+++++| +.+|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999988 3556799999999999999999999998766433211
Q ss_pred ----------------cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhh
Q 037365 237 ----------------ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLW 300 (398)
Q Consensus 237 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 300 (398)
.......|+..|+|||...+..++.++|+||||+++|++++|+.|+...... . ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~~~ 235 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--L---TFQKIL 235 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--H---HHHHHH
Confidence 1223346788999999998888999999999999999999999997643210 0 001101
Q ss_pred hcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCH----HHHHH
Q 037365 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTT----NDVVS 349 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~----~evl~ 349 (398)
... .. . +...+..+.+++.+||+.+|++|||+ +++++
T Consensus 236 ~~~--~~---------~-~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 KLE--YS---------F-PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hcC--CC---------C-CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000 00 0 12224567899999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=252.12 Aligned_cols=232 Identities=23% Similarity=0.339 Sum_probs=168.3
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe-CCe
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDE 186 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 186 (398)
+...+++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|++++.+++||||+++++++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446789999999999999999999976 4899999988543 22344677889999999999999999999876 567
Q ss_pred eEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 187 KILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 187 ~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.++++||+. ++| +++|+||||+||++++++.+||+|||++......
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 899999984 444 4677899999999999999999999998754321
Q ss_pred ccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHh-----------hhcC
Q 037365 236 QANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL-----------WRSN 303 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-----------~~~~ 303 (398)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......... ....
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhccch
Confidence 123467889999998866 56899999999999999999999997543221 000000000 0000
Q ss_pred Cccccchhhhh-cccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 304 RTLELTDAILE-DEYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 304 ~~~~~~~~~~~-~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...+....... .... .+.....+.+++.+||+.+|++|||+++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0000 01123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=249.31 Aligned_cols=227 Identities=18% Similarity=0.198 Sum_probs=159.8
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++|+||+++++++.+++..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4445555555555544 4899999998654 345567889999999999999999999999999999999999999877
Q ss_pred ----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc-----ccccc
Q 037365 200 ----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL-----QANTS 240 (398)
Q Consensus 200 ----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-----~~~~~ 240 (398)
+++|+||||+||+++.++.+||+|||.+........ .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 356679999999999999999999998875532211 11122
Q ss_pred cccccccccChhhhccC--CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHh----hhcCC-------ccc
Q 037365 241 RIVGTYGYMSPEYAIEG--IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL----WRSNR-------TLE 307 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~----~~~~~-------~~~ 307 (398)
...++..|+|||++.+. .++.++|+|||||++|||++|+.||....... ......... +.... ...
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhhcCCcCc
Confidence 34577889999998763 58899999999999999999999986432211 111100000 00000 000
Q ss_pred ----cchhhhh---cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 308 ----LTDAILE---DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 308 ----~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+.... ...........+.+++.+||+.||++|||++++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 000122344678899999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=243.11 Aligned_cols=218 Identities=23% Similarity=0.332 Sum_probs=165.8
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--Cee
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 187 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 187 (398)
.+|++.+.||+|+||.||+|.... +..||+|.+... .......+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468889999999999999999765 889999987432 223456788999999999999999999998764 468
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
++++||+++++| +++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 899999999877 346679999999999999999999999986532111
Q ss_pred c-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 Q-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
. .......|+..|+|||.+.+..++.++|+|||||++|||++|+.||..... ...............
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~------- 229 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----MAAIFKIATQPTKPM------- 229 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----HHHHHHHHcCCCCCC-------
Confidence 1 112234688999999999988899999999999999999999999753211 111111111110000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+......+.+++.+||+ +|..|||+.+++.
T Consensus 230 ---~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 ---LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 022334568899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=244.87 Aligned_cols=212 Identities=21% Similarity=0.261 Sum_probs=157.1
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCCCh---hhHHHHHHHHHHH-HhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG---QGLREMKNEASVI-AKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|.... ++.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 568999999999999764 88999999865421 1223344555444 445899999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
++| +.+|+||+|+||++++++.+||+|||+++.... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 987 356779999999999999999999999876432 223467
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
+..|+|||.+.+..++.++||||||+++|||++|..||..... ... +......... . .. ......+.
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~----~~~~~~~~~~-~-~~-----~~~~~~~~ 222 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DAV----FDNILSRRIN-W-PE-----EVKEFCSP 222 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HHH----HHHHHhcccC-C-CC-----cccccCCH
Confidence 8899999999988899999999999999999999999753211 111 1111111000 0 00 00112345
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 325 RYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.+.+++.+||+.+|++|||+.++.+.|.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 6889999999999999998766555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=249.44 Aligned_cols=212 Identities=24% Similarity=0.438 Sum_probs=162.0
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
|...+.||+|+||.||+|+... +..|++|.+... .......+.+|++++++++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 6667789999999999999754 888999998643 223445678899999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+.+..+ +++|+||||+||+++.++.+||+|||++..... ...
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~ 176 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANS 176 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCC
Confidence 965321 456789999999999999999999998864321 223
Q ss_pred ccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 242 IVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 242 ~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
..|+..|+|||++. ...++.++|||||||++|||++|..|+..... ............ ....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~-~~~~--------- 241 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNDS-PTLQ--------- 241 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcCC-CCCC---------
Confidence 46889999999985 45688999999999999999999999643211 111111111110 0000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.......+.+++.+||+.+|.+|||+.+++..
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223457899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=246.46 Aligned_cols=227 Identities=21% Similarity=0.319 Sum_probs=167.3
Q ss_pred CCccceecccCceEEEEEEEc-CCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 118 FSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
|+..+.||+|++|.||+|... +++.+++|++..... .....+.+|++++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999976 488899999865432 24567888999999999999999999999999999999999
Q ss_pred CCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 195 PNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 195 ~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
++ +| +++|+||||+||+++.++.+||+|||.+....... .....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccC
Confidence 76 43 35667999999999999999999999998765433 11223
Q ss_pred ccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc---cccch-------
Q 037365 242 IVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT---LELTD------- 310 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------- 310 (398)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... .+.............. ....+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 4578899999999876 789999999999999999999988753321 1111111000000000 00000
Q ss_pred ----h-hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 ----A-ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ----~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ........+..+..+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00000002234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=270.99 Aligned_cols=230 Identities=28% Similarity=0.420 Sum_probs=177.8
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC--------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceee
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK--------GNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLG 179 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~ 179 (398)
.++...++..+.+.||+|.||.|++|.... ...||||.++.. .....+.+..|+++|+.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 345555666777799999999999998542 346999999755 335567889999999998 5999999999
Q ss_pred EEEeCCeeEEEEeccCCCCh------------------------------------------------hHHhhcCCCCCc
Q 037365 180 CCIDKDEKILIYEYMPNKSL------------------------------------------------DFFLFNLKASNI 211 (398)
Q Consensus 180 ~~~~~~~~~lV~e~~~~g~L------------------------------------------------~~~~~dlkp~NI 211 (398)
+|..++..++|+||+..|+| ..+||||..+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 99999999999999999865 247789999999
Q ss_pred eecCCCCeEEcccccceecCCCCccccccccc--ccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCC
Q 037365 212 LLDKDMNPKISDFGMARICGGNELQANTSRIV--GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTD 288 (398)
Q Consensus 212 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~ 288 (398)
|+.++..+||+|||+|+.......+.... .. -...|||||.+....|+.|+||||||++|||++| |..||..- ..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-~~ 527 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-PP 527 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-Cc
Confidence 99999999999999999766554443221 12 2456999999999999999999999999999998 67776431 11
Q ss_pred ccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 289 TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
..++ +...+.+...+. +..+..++.++++.||+.+|++||++.++.+.++...
T Consensus 528 ~~~l----~~~l~~G~r~~~----------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 528 TEEL----LEFLKEGNRMEQ----------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHH----HHHHhcCCCCCC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1111 222333322221 2233456789999999999999999999999999853
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=250.79 Aligned_cols=231 Identities=22% Similarity=0.302 Sum_probs=163.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCcccceeeEEEeCC------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 185 (398)
.++|++.+.||+|+||.||+|.+.. ++.+|+|++..... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5789999999999999999999764 88999998854321 22345678999999999999999999876533
Q ss_pred --eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 186 --EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 186 --~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
..++||||+.+..+ +++|+||||+||++++++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 46999999875321 45678999999999999999999999997654
Q ss_pred CCCcc---------cccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh
Q 037365 232 GNELQ---------ANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR 301 (398)
Q Consensus 232 ~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 301 (398)
..... .......+++.|+|||.+.+. .++.++|||||||++|||++|++||...... ......+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--~~~~~~~~~~~ 244 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--DQLHLIFKLCG 244 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence 32211 111234578889999988654 5789999999999999999999987532221 11111111111
Q ss_pred cCCc---------ccc--------chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 302 SNRT---------LEL--------TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 302 ~~~~---------~~~--------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.... ... ....+... .......+.+++.+||+.||++|||+.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEER--FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHH--cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 000 00000000 0112256789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=252.77 Aligned_cols=230 Identities=20% Similarity=0.305 Sum_probs=165.1
Q ss_pred cCCCCc-cceecccCceEEEEEEEcC-CCEEEEEEccCCChhh--------------HHHHHHHHHHHHhcCCCccccee
Q 037365 115 TNRFSD-ANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQG--------------LREMKNEASVIAKVQHKNLVRLL 178 (398)
Q Consensus 115 ~~~~~~-~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~ 178 (398)
.++|.. .+.||+|+||.||+|.... ++.||+|.+....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456764 4679999999999999764 8999999986442111 12467899999999999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEccccc
Q 037365 179 GCCIDKDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 179 ~~~~~~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
+++..++..+++|||+.+ +| +++|+||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999999999999975 44 467789999999999999999999999
Q ss_pred ceecCCCCc------------ccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchh
Q 037365 227 ARICGGNEL------------QANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL 293 (398)
Q Consensus 227 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~ 293 (398)
+........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~--~~~~ 243 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE--IDQL 243 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence 986652110 1111223568889999998764 468999999999999999999999754322 1111
Q ss_pred HHHHHhhhcCCccccc---------------hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 294 GYAWDLWRSNRTLELT---------------DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..+............. ....... .......+.+++.+||+.+|++|||++|++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI--FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh--CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111111000000 0000000 1122456789999999999999999999996
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=247.35 Aligned_cols=223 Identities=22% Similarity=0.285 Sum_probs=168.0
Q ss_pred CCCccceecccCceEEEEEEEc----CCCEEEEEEccCCC----hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCee
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 187 (398)
+|+..+.||+|++|.||+++.. ++..||+|.+.... ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999853 36789999986432 22345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
++||||+++|+| +.+|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 999999999877 356779999999999999999999999876543321
Q ss_pred ccccccccccccccChhhhccCC--CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGI--FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ..............
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~--------- 229 (288)
T cd05583 161 E-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKSKP--------- 229 (288)
T ss_pred c-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHccCC---------
Confidence 1 122346889999999987665 7889999999999999999999975322111 11111111111000
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
..+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 230 ---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 ---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0011223457899999999999999999888777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=254.29 Aligned_cols=232 Identities=22% Similarity=0.297 Sum_probs=164.9
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC---------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--------- 184 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------- 184 (398)
..+|+..+.||.|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4689999999999999999999865 889999999766656667888999999999999999999876653
Q ss_pred -----CeeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceec-CCCCeEEcccccc
Q 037365 185 -----DEKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLD-KDMNPKISDFGMA 227 (398)
Q Consensus 185 -----~~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~-~~~~~kl~DFGla 227 (398)
...++||||+++ +| +++|+||||+||+++ +++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 357899999975 44 467889999999997 4567899999999
Q ss_pred eecCCCCccc-ccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC-
Q 037365 228 RICGGNELQA-NTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR- 304 (398)
Q Consensus 228 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~- 304 (398)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 240 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILESVPVVRE 240 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCh
Confidence 8654321111 1122357889999998765 457899999999999999999999985332110 0000000000000
Q ss_pred --ccc----cchhhh----hcccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 305 --TLE----LTDAIL----EDEYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 305 --~~~----~~~~~~----~~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
... ...... ..... .+.....+.+++.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 000000 00000 0122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=244.01 Aligned_cols=225 Identities=21% Similarity=0.297 Sum_probs=162.7
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh-hhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEecc
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
|++.+.||+|++|.||+|...+ ++.|++|++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999865 78899999865422 22234467999999999 999999999999999999999999
Q ss_pred CCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 195 PNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 195 ~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+|+| +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 156 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YT 156 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cC
Confidence 6655 356779999999999999999999999987643321 12
Q ss_pred cccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc-------------CCcc
Q 037365 241 RIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS-------------NRTL 306 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-------------~~~~ 306 (398)
...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... ........+.. ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 3467889999998854 457899999999999999999998875432211 00000000000 0000
Q ss_pred ccchhhhh---cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ELTDAILE---DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
........ ... .+.....+.+++.+||+.||++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQL-IPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHH-cccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 000 0111356889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=245.66 Aligned_cols=219 Identities=21% Similarity=0.327 Sum_probs=165.1
Q ss_pred CCCccceecccCceEEEEEEEc----CCCEEEEEEccCCC----hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCee
Q 037365 117 RFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 187 (398)
+|+..+.||+|+||.||+++.. +|..||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4777899999999999999863 58899999986532 22345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
++||||+++++| +.+|+||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 999999999987 355789999999999999999999999987643321
Q ss_pred ccccccccccccccChhhhccC--CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEG--IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... ................
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~-------- 230 (290)
T cd05613 161 E-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSEPP-------- 230 (290)
T ss_pred c-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccCCC--------
Confidence 1 12235688999999998753 4688999999999999999999997532211 1111111111111100
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
+ +......+.+++.+||+.||++|| +++++++
T Consensus 231 ---~-~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 ---Y-PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---C-CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 112334578999999999999997 6677665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=241.51 Aligned_cols=226 Identities=21% Similarity=0.304 Sum_probs=162.6
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--hhHHHHHHHHHHHHhc---CCCcccceeeEEEeCCe-----
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--QGLREMKNEASVIAKV---QHKNLVRLLGCCIDKDE----- 186 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~----- 186 (398)
|++.+.||+|+||.||+|+++. ++.+|+|++..... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999875 89999999964322 2234566788777666 59999999999998776
Q ss_pred eEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 187 KILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 187 ~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
.+++|||+.+ +| +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999874 33 356789999999999999999999999987643
Q ss_pred CCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc-----
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE----- 307 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----- 307 (398)
... .....++..|+|||.+.+..++.++|+|||||++|||++|++||...... ..... ............
T Consensus 160 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 160 EMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDK-IFDVIGLPSEEEWPRNV 234 (287)
T ss_pred Ccc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHH-HHHHcCCCChHhcCCCc
Confidence 321 12335788999999999999999999999999999999998887543221 11111 111000000000
Q ss_pred -----cchhhhhccc--ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 308 -----LTDAILEDEY--SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 308 -----~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......... ..+.....+.+++.+||+.||++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 01233466789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=242.29 Aligned_cols=209 Identities=26% Similarity=0.323 Sum_probs=154.6
Q ss_pred eecccCceEEEEEEEcC-CCEEEEEEccCCCh---hhHHHHHHHH---HHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG---QGLREMKNEA---SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
.||+|+||.||++.... ++.||+|.+..... .....+..|. ..++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 88999999865321 1112233343 34445679999999999999999999999999
Q ss_pred CCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccc
Q 037365 196 NKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243 (398)
Q Consensus 196 ~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 243 (398)
+|+| +++|+||||+||+++.++.+||+|||++....... .....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcC
Confidence 9988 24567999999999999999999999987654322 22347
Q ss_pred ccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 244 GTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 244 gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........... ....... ... . +...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~-~~~-----~-----~~~~ 222 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTM-AVE-----L-----PDSF 222 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhhcc-CCC-----C-----CCcC
Confidence 89999999999754 589999999999999999999999754322111100 0000000 000 0 1122
Q ss_pred HHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
+..+.+++.+|+..+|.+|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 45688999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=250.10 Aligned_cols=236 Identities=19% Similarity=0.294 Sum_probs=172.8
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-----eeE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI 188 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 188 (398)
+|++.+.||+|+||.||+|.... ++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57888999999999999999865 8899999987643 344567889999999999999999999998775 789
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
++|||+++ +| +++|+||||+|||++.++.++|+|||++.........
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999985 33 3567899999999999999999999999876543210
Q ss_pred -cccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc-----------C
Q 037365 237 -ANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS-----------N 303 (398)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----------~ 303 (398)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ............ .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhhhcccc
Confidence 112334678899999999887 7899999999999999999999997543221 111111111100 0
Q ss_pred Cccccchhhhhcc-c----ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--Hhhcc
Q 037365 304 RTLELTDAILEDE-Y----SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM--LTNEA 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~-~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 355 (398)
............. . ..+.....+.+++.+||+.+|.+|||++++++. +++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000000000000 0 011234568899999999999999999999974 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=241.13 Aligned_cols=214 Identities=26% Similarity=0.359 Sum_probs=161.3
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
+|.+.+.||+|+||.||++.+.. +..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998764 444555555321 222334567899999999999999999999999999999
Q ss_pred EeccCCCChh------------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 191 YEYMPNKSLD------------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 191 ~e~~~~g~L~------------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
|||+++++|. .+|+||||+||++++ +.+||+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999998872 456799999999975 569999999998764332
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+.... .......... ..... .
T Consensus 160 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~-~~~~~-----~- 225 (260)
T cd08222 160 D--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVE-GPTPS-----L- 225 (260)
T ss_pred c--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHc-CCCCC-----C-
Confidence 1 1223467889999999988889999999999999999999999974211 1111111111 11000 0
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.+++.+||+.+|++||++.|+++
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 ----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 2233456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=239.40 Aligned_cols=225 Identities=24% Similarity=0.302 Sum_probs=171.9
Q ss_pred ceecccCceEEEEEE-EcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 122 NKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
+.||+|+|+.|--++ ..+|.++|||++.+........+.+|++++.+.+ |+||++++++|+++..+|||||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999987 4569999999998887777888999999999986 99999999999999999999999999987
Q ss_pred --------------------------------hHHhhcCCCCCceecCCC---CeEEcccccceecCCCC-----ccccc
Q 037365 200 --------------------------------DFFLFNLKASNILLDKDM---NPKISDFGMARICGGNE-----LQANT 239 (398)
Q Consensus 200 --------------------------------~~~~~dlkp~NILl~~~~---~~kl~DFGla~~~~~~~-----~~~~~ 239 (398)
++.||||||+|||..+.. -+||+||.+..-+..+. .....
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L 243 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL 243 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence 577899999999986544 37999998875432211 11123
Q ss_pred ccccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 240 SRIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
...+|+..|||||+.. ...|+.++|.|||||++|-|++|.+||....... ..|-.......-...+++.+.+
T Consensus 244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---CGWdrGe~Cr~CQ~~LFesIQE 320 (463)
T KOG0607|consen 244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---CGWDRGEVCRVCQNKLFESIQE 320 (463)
T ss_pred cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---CCccCCCccHHHHHHHHHHHhc
Confidence 3568999999999875 2348999999999999999999999986443321 1111000000011234444555
Q ss_pred cccCh-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 DEYSS-----KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~~~~~-----~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+.+.. ...+....+++...+..|+.+|.++.++++
T Consensus 321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 54442 234567789999999999999999999987
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=250.79 Aligned_cols=233 Identities=22% Similarity=0.311 Sum_probs=166.5
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK- 184 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~- 184 (398)
.++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 345567789999999999999999999865 48899999986542 22345678899999999999999999988643
Q ss_pred -----CeeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 185 -----DEKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 185 -----~~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
...+++++++ +++| +++|+||||+||++++++.+||+|||+++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3468888876 5554 35678999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE 307 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........... .....
T Consensus 169 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~-~~~~~ 240 (345)
T cd07877 169 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVG-TPGAE 240 (345)
T ss_pred ccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC-CCCHH
Confidence 64322 223467889999999876 56889999999999999999999997432211 11110000000 00000
Q ss_pred cchh-----------hhhc----ccC--hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 308 LTDA-----------ILED----EYS--SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 308 ~~~~-----------~~~~----~~~--~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.... .+.. .+. .......+.+++.+|++.||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 0000 000 00123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=250.92 Aligned_cols=235 Identities=21% Similarity=0.320 Sum_probs=167.0
Q ss_pred hhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD---- 185 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 185 (398)
...++|+..+.||+|+||.||++... ++..||+|++... .......+.+|+.++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999865 4889999998543 2233456789999999999999999999987654
Q ss_pred --eeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 186 --EKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 186 --~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
..++||||+ +++| +++|+||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 458999998 5555 456789999999999999999999999876543
Q ss_pred CCcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH----------HHhhh
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA----------WDLWR 301 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~----------~~~~~ 301 (398)
. .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||....... ...... ...+.
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhhc
Confidence 2 223467889999999876 458899999999999999999999976432110 000000 00000
Q ss_pred cCCccccchhh---hhccc--ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhhc
Q 037365 302 SNRTLELTDAI---LEDEY--SSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTNE 354 (398)
Q Consensus 302 ~~~~~~~~~~~---~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~~ 354 (398)
........... ..... ........+.+++.+|++.||++|||+.++++ .++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000000000 00000 00122345789999999999999999999994 34444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=239.59 Aligned_cols=227 Identities=23% Similarity=0.311 Sum_probs=166.1
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
|+..+.||+|++|.||+|...+ ++.+|+|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5566889999999999999875 8999999997652 333466788999999999999999999999999999999999
Q ss_pred CCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 195 PNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 195 ~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
++ +| +++|+||+|+||++++++.+||+|||+++....... ....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTH 157 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCc
Confidence 74 55 356789999999999999999999999976643321 1222
Q ss_pred ccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHh-----------hhcCC-cccc
Q 037365 242 IVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL-----------WRSNR-TLEL 308 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-----------~~~~~-~~~~ 308 (398)
..++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ......... +.... ....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 3557789999998876 7899999999999999999999887543211 111111110 00000 0000
Q ss_pred chhhhhccc--ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 309 TDAILEDEY--SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 309 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......... ..+.....+.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 01122456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=251.44 Aligned_cols=228 Identities=21% Similarity=0.347 Sum_probs=165.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe----
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE---- 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 186 (398)
..++|+..+.||+|++|.||+|++.. ++.||+|++... .....+.+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45789999999999999999999865 788999998653 23344567789999999999999999998876554
Q ss_pred --eEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 187 --KILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 187 --~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
.++|+||+ +++| +++|+||||+||++++++.+||+|||++......
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 89999998 4455 3567899999999999999999999999765432
Q ss_pred CcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc----------
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS---------- 302 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------- 302 (398)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 172 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred -----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCHHHHhhcc
Confidence 223467889999999865 3678999999999999999999999753221 1111111111000
Q ss_pred -CCccccchhhhh---cccC--hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 303 -NRTLELTDAILE---DEYS--SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 303 -~~~~~~~~~~~~---~~~~--~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
............ ..+. .......+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000 0000 0112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=246.07 Aligned_cols=209 Identities=27% Similarity=0.339 Sum_probs=164.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 188 (398)
...+|..+.+||+|+||.|.+|..+. .+.+|||++++. ..++.+.-..|-.+|.-. +-|.+++++.+|+.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34578889999999999999998765 667999999765 223334445566666655 4689999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
+||||+.||+| +++.||||.+|||+|.+|++||+|||+++.---..
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~-- 504 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG-- 504 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC--
Confidence 99999999998 34557999999999999999999999998532222
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
..+..++||+.|+|||++..++|+..+|+|||||+||||+.|++||+.... .+++..+....
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------------------~elF~aI~ehn 566 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------------------DELFQAIMEHN 566 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH------------------HHHHHHHHHcc
Confidence 235568999999999999999999999999999999999999999753222 22223333222
Q ss_pred cC-hHHHHHHHHHHHHHchhcCCCCCC
Q 037365 317 YS-SKQVLLRYVNIALLCVQESADDRP 342 (398)
Q Consensus 317 ~~-~~~~~~~~~~li~~cl~~dP~~RP 342 (398)
.. +...+.+...+....+...|.+|.
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 445566778889999999999985
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=270.99 Aligned_cols=223 Identities=25% Similarity=0.389 Sum_probs=160.7
Q ss_pred hhhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD---- 185 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 185 (398)
....++|+..+.||+||||.||+++.+ ||+.||||++... .......+.+|+..|.+|+|||||+++..+.+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456778999999999999999999975 5999999999765 3344567889999999999999999986543210
Q ss_pred --------------------------------------------------------------------------------
Q 037365 186 -------------------------------------------------------------------------------- 185 (398)
Q Consensus 186 -------------------------------------------------------------------------------- 185 (398)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------eeEEEEeccCCCCh-------------------------------
Q 037365 186 -----------------------------------EKILIYEYMPNKSL------------------------------- 199 (398)
Q Consensus 186 -----------------------------------~~~lV~e~~~~g~L------------------------------- 199 (398)
.+||-||||+...+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 12556666665443
Q ss_pred --hHHhhcCCCCCceecCCCCeEEcccccceecC----C------------CCcccccccccccccccChhhhccC---C
Q 037365 200 --DFFLFNLKASNILLDKDMNPKISDFGMARICG----G------------NELQANTSRIVGTYGYMSPEYAIEG---I 258 (398)
Q Consensus 200 --~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~---~ 258 (398)
+.+||||||.||++|++..+||+|||+|+... . .......+..+||.-|+|||++.+. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 46789999999999999999999999998721 0 0111123457899999999999865 4
Q ss_pred CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCC
Q 037365 259 FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESA 338 (398)
Q Consensus 259 ~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP 338 (398)
|+.|+|+||||+|++||+. ||+..... .. +...++.+....- ..+..+.. ..-..+++++++.||
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMER----a~-iL~~LR~g~iP~~------~~f~~~~~-~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMER----AS-ILTNLRKGSIPEP------ADFFDPEH-PEEASLIRWLLSHDP 859 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHH----HH-HHHhcccCCCCCC------cccccccc-hHHHHHHHHHhcCCC
Confidence 9999999999999999995 44332111 11 1122222222221 01111111 223579999999999
Q ss_pred CCCCCHHHHHH
Q 037365 339 DDRPTTNDVVS 349 (398)
Q Consensus 339 ~~RPt~~evl~ 349 (398)
.+|||+.|+++
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999986
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=235.52 Aligned_cols=204 Identities=25% Similarity=0.376 Sum_probs=160.0
Q ss_pred ecccCceEEEEEEEcC-CCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
||+|+||.||++...+ ++.+|+|.+..... .....+.+|+.++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999865 88999999865432 2455788999999999999999999999999999999999998877
Q ss_pred --------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccccccccc
Q 037365 200 --------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247 (398)
Q Consensus 200 --------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 247 (398)
+.+|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 35567999999999999999999999997764332 12234567889
Q ss_pred ccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHH
Q 037365 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYV 327 (398)
Q Consensus 248 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (398)
|+|||...+...+.++|+||||+++|++++|..||..... .... ..... .. .. . +...+..+.
T Consensus 159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~---~~~~~-~~-~~-----~-----~~~~~~~l~ 221 (250)
T cd05123 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIY---EKILK-DP-LR-----F-----PEFLSPEAR 221 (250)
T ss_pred ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHH---HHHhc-CC-CC-----C-----CCCCCHHHH
Confidence 9999999888889999999999999999999999753321 1111 11111 00 00 0 111235578
Q ss_pred HHHHHchhcCCCCCCCHHH
Q 037365 328 NIALLCVQESADDRPTTND 346 (398)
Q Consensus 328 ~li~~cl~~dP~~RPt~~e 346 (398)
+++.+||..||++|||+.+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 9999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=243.64 Aligned_cols=230 Identities=20% Similarity=0.247 Sum_probs=160.9
Q ss_pred CCCccceecccCceEEEEEEEcC---CCEEEEEEccCC--ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC----Ce
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK---GNEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK----DE 186 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~ 186 (398)
+|+..+.||+|+||.||+++... +..||+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47778899999999999999753 678999998643 222345678899999999 599999999976533 45
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
.++++||+.+ +| +++|+||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 7899999864 44 46788999999999999999999999998765332
Q ss_pred cc--cccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc---------
Q 037365 235 LQ--ANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS--------- 302 (398)
Q Consensus 235 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------- 302 (398)
.. .......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ............
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCCCHHHHHhh
Confidence 11 11233578999999998866 46899999999999999999999987542211 111110000000
Q ss_pred --CCccccchhhhhcc-cC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 303 --NRTLELTDAILEDE-YS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 303 --~~~~~~~~~~~~~~-~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..........-... .. .+.....+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 00 0112356889999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-31 Score=251.59 Aligned_cols=211 Identities=23% Similarity=0.368 Sum_probs=168.3
Q ss_pred cceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 121 ANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
.+.||+|-||+||-|.++. |+.||||++.+. ......++.+|++||+++.||.||.+...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4689999999999999876 999999999654 2344477889999999999999999999999999999999999765
Q ss_pred Ch---------------------------------hHHhhcCCCCCceecCC---CCeEEcccccceecCCCCccccccc
Q 037365 198 SL---------------------------------DFFLFNLKASNILLDKD---MNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 198 ~L---------------------------------~~~~~dlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
-| +++|.||||+|||+.+. -++||||||+|+.++.... ...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---Rrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---RRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh---hhh
Confidence 43 46778999999999543 4799999999999986543 334
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
.+||+.|+|||++..+.|+..-|+||.||++|.-++|..||.....-..++ ....... ......+
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI--------QNAaFMy-------Pp~PW~e 790 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI--------QNAAFMY-------PPNPWSE 790 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh--------hcccccc-------CCCchhh
Confidence 789999999999999999999999999999999999999986432211111 0000000 0011344
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.....++||...|+..-++|-|.++.+.
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 5566889999999999999999987764
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=254.38 Aligned_cols=214 Identities=21% Similarity=0.358 Sum_probs=163.9
Q ss_pred CCC-CccceecccCceEEEEEEEcC-CCEEEEEEcc----CCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe--e
Q 037365 116 NRF-SDANKLGEGGFGPVYKGVLRK-GNEIAVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--K 187 (398)
Q Consensus 116 ~~~-~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~ 187 (398)
++| +....||+|+|-+||+|.+.. |-+||--.++ ...+...+.|..|+.+|+.|+||||++++.++.+... .
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 444 334689999999999999865 7777754332 1245566889999999999999999999999998665 7
Q ss_pred EEEEeccCCCCh----------------------------------hHHhhcCCCCCceecC-CCCeEEcccccceecCC
Q 037365 188 ILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDK-DMNPKISDFGMARICGG 232 (398)
Q Consensus 188 ~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~-~~~~kl~DFGla~~~~~ 232 (398)
.+|+|.+..|+| -++|||||.+||+++. -|.|||+|+|+|.....
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 899999999999 3778999999999974 57899999999987654
Q ss_pred CCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.. .....|||.|||||.+. ..|+..+||||||+.++||.|+..||...... .++.. ....+.....+...
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-AQIYK----KV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-AQIYK----KVTSGIKPAALSKV 268 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-HHHHH----HHHcCCCHHHhhcc
Confidence 32 33479999999999887 78999999999999999999999997543221 11111 11111111111111
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...++.++|.+|+.. .++|||+.|+|+
T Consensus 269 ---------~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 ---------KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 123578999999999 999999999995
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=234.71 Aligned_cols=236 Identities=19% Similarity=0.300 Sum_probs=168.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-----CCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCcccceeeEEEe-CCe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-----GNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCID-KDE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 186 (398)
...|+..+.||+|.||.||+|.-.+ ...+|+|+++.... .......+|+.+++.++|||++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4578899999999999999996443 33689999976522 223456789999999999999999999987 778
Q ss_pred eEEEEeccCCCChh------------------------------------HHhhcCCCCCceecCC----CCeEEccccc
Q 037365 187 KILIYEYMPNKSLD------------------------------------FFLFNLKASNILLDKD----MNPKISDFGM 226 (398)
Q Consensus 187 ~~lV~e~~~~g~L~------------------------------------~~~~dlkp~NILl~~~----~~~kl~DFGl 226 (398)
.++++||++..-+. ++||||||.|||+..+ |.+||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999999875442 4567999999999777 8999999999
Q ss_pred ceecCCCCccc-ccccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCc-------cchhHHHH
Q 037365 227 ARICGGNELQA-NTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-------LNLLGYAW 297 (398)
Q Consensus 227 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~-------~~~~~~~~ 297 (398)
++.+.+.-... ....++-|.+|+|||.+.+.. ||++.||||.||++.||+|-.+-|.....+. .+..+-+.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 99886543222 345567899999999999865 8999999999999999999887765432221 11111111
Q ss_pred HhhhcCCccccch------------hhhhcccCh---HH-------HHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 298 DLWRSNRTLELTD------------AILEDEYSS---KQ-------VLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 298 ~~~~~~~~~~~~~------------~~~~~~~~~---~~-------~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+.......+.+ ......+.. .. -+....+|+.++|+.||.+|.|+++.++.
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1111111000000 000000000 00 11236789999999999999999998874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=215.93 Aligned_cols=231 Identities=21% Similarity=0.270 Sum_probs=168.0
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+|...++||+|.||+||+|+..+ ++.||+|++... ++.......+|+.+|+.++|.|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999766 788999998654 333345778999999999999999999999999999999999
Q ss_pred cCC----------CCh----------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPN----------KSL----------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~----------g~L----------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
|.. |.+ ..+|||+||.|.|++.+|..|++|||+++.++-... -.+.
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr--cysa 160 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSA 160 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--eeec
Confidence 964 332 467899999999999999999999999998764331 1223
Q ss_pred ccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh--cCCc---cccchhhhhc
Q 037365 242 IVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR--SNRT---LELTDAILED 315 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~ 315 (398)
.+-|..|++|.++.+.+ |+...|+||-||++.|+.....|......-..++....+.+-. +.+. ..+.|.....
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 46689999999999866 7999999999999999998655643322222233333222211 1111 1111111111
Q ss_pred ccC--------hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 316 EYS--------SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 316 ~~~--------~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+. .+.....-.+++++.+.-+|..|.++++.++
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111 1122233468999999999999999998765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=256.09 Aligned_cols=226 Identities=23% Similarity=0.390 Sum_probs=177.4
Q ss_pred chhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEe-
Q 037365 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID- 183 (398)
Q Consensus 107 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 183 (398)
.+..+...++.|++.+.||.|.+|.||+++..+ ++..|+|+..... +..+++..|.++|+.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344555667889999999999999999999655 8888999886654 3346778899999888 59999999999974
Q ss_pred ----CCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccc
Q 037365 184 ----KDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFG 225 (398)
Q Consensus 184 ----~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFG 225 (398)
++++|||||||.+|+. ..+|||+|-.|||++.++.+||.|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 5789999999999986 35678999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccChhhhcc-----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhh
Q 037365 226 MARICGGNELQANTSRIVGTYGYMSPEYAIE-----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLW 300 (398)
Q Consensus 226 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 300 (398)
.+..++... .......||+.|||||++.- ..|+..+|+||||++..||--|.+|+.....- ..+|
T Consensus 169 vSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF 238 (953)
T KOG0587|consen 169 VSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALF 238 (953)
T ss_pred eeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhc
Confidence 998876433 33455789999999999963 34788999999999999999999997643221 1111
Q ss_pred hcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.-.+ -..+.+. .+....+++.+++..||..|-++||++.++++
T Consensus 239 ~IpR---NPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 LIPR---NPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cCCC---CCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1100 0011111 14556788999999999999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=264.60 Aligned_cols=114 Identities=22% Similarity=0.382 Sum_probs=101.0
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|.+.+.||+|+||.||+|.+.. ++.||+|++... .......+.+|+.++..++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 3678899999999999999999874 889999998653 233346788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
|||+++++| +++||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999987 35678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=253.83 Aligned_cols=210 Identities=23% Similarity=0.273 Sum_probs=168.1
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.++.|+....+|.|+|+.|-.+.+.. ++..++|++.... .+-.+|+.++... +||||+++++.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46678888889999999999998765 8889999997652 2234567666555 6999999999999999999999
Q ss_pred eccCCCCh-------------------------------hHHhhcCCCCCcee-cCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL-------------------------------DFFLFNLKASNILL-DKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L-------------------------------~~~~~dlkp~NILl-~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|.+.+|.+ +++||||||+|||+ ++.++++|+|||.++..... .
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~ 470 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----C 470 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----h
Confidence 99999866 56789999999999 68999999999999876543 2
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...+-|..|.|||++....|++++||||||++||+|++|+.||.....+ . ++...+..+.+ .
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~----------------ei~~~i~~~~~-s 532 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-I----------------EIHTRIQMPKF-S 532 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-H----------------HHHHhhcCCcc-c
Confidence 2345688999999999999999999999999999999999997654333 1 11111111111 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...+...++|+.+||+.||.+||+++++...
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 3345668899999999999999999999863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-31 Score=234.23 Aligned_cols=234 Identities=20% Similarity=0.315 Sum_probs=165.6
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------- 184 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 184 (398)
.+.|+...+||+|.||.||+|+.++ |+.||+|++-.. ....-....+|+.+|..+.|+|++.++..|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4678888999999999999999876 778899876432 222234567899999999999999999988643
Q ss_pred -CeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 185 -DEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 185 -~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
..+|+||.+|+..-. .++|||+|++|+|++.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 358999999986311 57889999999999999999999999998765
Q ss_pred CCCcc--cccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHh--------h
Q 037365 232 GNELQ--ANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL--------W 300 (398)
Q Consensus 232 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~--------~ 300 (398)
..... ...+..+-|..|++||.+.+. .|+++.|||.-||++.||+||.+-+...... .....+..+ |
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQLHLISQLCGSITKEVW 253 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHHHHHHHHhccCCcccC
Confidence 43221 122344569999999999875 5899999999999999999998775432221 111111111 1
Q ss_pred hcCCccccchhh-----hhcccC-hHHH------HHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 301 RSNRTLELTDAI-----LEDEYS-SKQV------LLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 301 ~~~~~~~~~~~~-----~~~~~~-~~~~------~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.+-.-.++...+ ..+.+. .++. .....+|+..++..||.+|+++++++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111111111 111110 1111 1256799999999999999999998863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=229.41 Aligned_cols=215 Identities=19% Similarity=0.240 Sum_probs=165.6
Q ss_pred hcCCCCcc-ceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEe----CCe
Q 037365 114 ATNRFSDA-NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID----KDE 186 (398)
Q Consensus 114 ~~~~~~~~-~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~ 186 (398)
.+++|++. ++||-|-.|.|..+..+. ++.+|+|++... ....+|+++--.. .|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677654 579999999999999765 888999998644 3456788876555 59999999999875 345
Q ss_pred eEEEEeccCCCCh----------------------------------hHHhhcCCCCCceec---CCCCeEEccccccee
Q 037365 187 KILIYEYMPNKSL----------------------------------DFFLFNLKASNILLD---KDMNPKISDFGMARI 229 (398)
Q Consensus 187 ~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~---~~~~~kl~DFGla~~ 229 (398)
+.+|||.|+||.| ++.||||||+|+|.. .|..+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 7799999999987 578899999999995 455799999999987
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
-... ......+-|++|.|||++-..+|+..+|+||+||++|-|++|.+||....... +.. .+-
T Consensus 214 t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--isp------------gMk 276 (400)
T KOG0604|consen 214 TQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISP------------GMK 276 (400)
T ss_pred cCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CCh------------hHH
Confidence 5432 22344578999999999999999999999999999999999999976433321 100 011
Q ss_pred hhhhhcccC-----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 310 DAILEDEYS-----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 310 ~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..+..+.+. ....++...++++.+|..+|.+|.|+.++++.
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 112222221 33456778999999999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=245.40 Aligned_cols=173 Identities=25% Similarity=0.387 Sum_probs=144.5
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
+-|..++.||-|+||+|.+++..+ ...+|.|.+.+.+. .....++.|-+||....++-||+|+..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347778899999999999998655 66789999976532 33456788999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceec---CCCCcc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARIC---GGNELQ 236 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~---~~~~~~ 236 (398)
+|++||++ +++||||||+|||||.+|++||.|||||.-+ .+..++
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999987 6789999999999999999999999998532 111110
Q ss_pred c-------------------------------------ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCC
Q 037365 237 A-------------------------------------NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279 (398)
Q Consensus 237 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 279 (398)
. .....+||+.|+|||++....|+..+|+||.||+||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 0 001357999999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 037365 280 KNTGFYRTD 288 (398)
Q Consensus 280 ~P~~~~~~~ 288 (398)
.||-.....
T Consensus 869 ~pf~~~tp~ 877 (1034)
T KOG0608|consen 869 PPFLADTPG 877 (1034)
T ss_pred CCccCCCCC
Confidence 998654443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=240.56 Aligned_cols=225 Identities=28% Similarity=0.403 Sum_probs=166.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-------hhhHHHHHHHHHHHHhcCCCcccceeeEEE-eC
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-------GQGLREMKNEASVIAKVQHKNLVRLLGCCI-DK 184 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~ 184 (398)
..++|-.+.+||+|||+.||+|.+-. .+.||||+-..+. ....+...+|..|-+.+.||.||++|+++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34568888999999999999998544 7789999754321 112234568999999999999999999997 45
Q ss_pred CeeEEEEeccCCCChhH----------------------------------HhhcCCCCCceec---CCCCeEEcccccc
Q 037365 185 DEKILIYEYMPNKSLDF----------------------------------FLFNLKASNILLD---KDMNPKISDFGMA 227 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L~~----------------------------------~~~dlkp~NILl~---~~~~~kl~DFGla 227 (398)
+.+|-|+|||+|.+|++ +|.||||.|||+- ..|.+||.|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 68899999999999954 4459999999994 4577999999999
Q ss_pred eecCCCCccc-----ccccccccccccChhhhccC----CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHH
Q 037365 228 RICGGNELQA-----NTSRIVGTYGYMSPEYAIEG----IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD 298 (398)
Q Consensus 228 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 298 (398)
+.+++..+.. .++...||.+|++||++.-+ ..+.|+||||.||++|.++.|+.||+...... +
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--------d 692 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--------D 692 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--------H
Confidence 9987654432 24567899999999999754 36899999999999999999999987543321 1
Q ss_pred hhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 299 LWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+....+....+-.. ...+........+|++||++.-++|....++..
T Consensus 693 ILqeNTIlkAtEVqF---P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ILQENTILKATEVQF---PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHhhhchhcceeccC---CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111100000 012233456788999999999999988777653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=221.31 Aligned_cols=206 Identities=27% Similarity=0.381 Sum_probs=161.4
Q ss_pred CceEEEEEEEcC-CCEEEEEEccCCChhh-HHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh------
Q 037365 128 GFGPVYKGVLRK-GNEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL------ 199 (398)
Q Consensus 128 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L------ 199 (398)
+||.||+|...+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8999999997664443 67889999999999999999999999999999999999999877
Q ss_pred --------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhh
Q 037365 200 --------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 253 (398)
Q Consensus 200 --------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 253 (398)
+.+|+||+|+||++++++.++|+|||.+....... ......++..|++||.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEV 157 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHH
Confidence 34567999999999999999999999998765432 2234567889999999
Q ss_pred hccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHc
Q 037365 254 AIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLC 333 (398)
Q Consensus 254 ~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 333 (398)
+.+..++.++||||||+++|++++|..|+..... ..... ........... .. .......+.+++.+|
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-~~~~~----~~~~~~~~~~~-~~-------~~~~~~~~~~~i~~~ 224 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-LLELF----KKIGKPKPPFP-PP-------EWKISPEAKDLIRKL 224 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHH----HHHhccCCCCc-cc-------cccCCHHHHHHHHHH
Confidence 9988899999999999999999999998754211 11111 11111110000 00 000345688999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 037365 334 VQESADDRPTTNDVVS 349 (398)
Q Consensus 334 l~~dP~~RPt~~evl~ 349 (398)
|..+|++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=226.17 Aligned_cols=188 Identities=19% Similarity=0.177 Sum_probs=145.2
Q ss_pred cCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh------
Q 037365 127 GGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL------ 199 (398)
Q Consensus 127 G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L------ 199 (398)
|.+|.||++++.. ++.+|+|++.... .+.+|...+....||||+++++++.+.+..+++|||+++|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999865 8899999996543 233455555566799999999999999999999999999987
Q ss_pred --------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhh
Q 037365 200 --------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 253 (398)
Q Consensus 200 --------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 253 (398)
+++|+||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~ 153 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEV 153 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcc
Confidence 3566899999999999999999999987655432 122355778999999
Q ss_pred hccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHc
Q 037365 254 AIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLC 333 (398)
Q Consensus 254 ~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 333 (398)
+.+..++.++|+||+|+++|||++|+.|+....... ......+ . +......+.+++.+|
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~-----~-----~~~~~~~~~~li~~~ 212 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHTTLN-----I-----PEWVSEEARSLLQQL 212 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccccccC-----C-----cccCCHHHHHHHHHH
Confidence 988889999999999999999999998753221110 0000000 0 112234578999999
Q ss_pred hhcCCCCCCCHH
Q 037365 334 VQESADDRPTTN 345 (398)
Q Consensus 334 l~~dP~~RPt~~ 345 (398)
|+.||++|||+.
T Consensus 213 l~~dp~~R~~~~ 224 (237)
T cd05576 213 LQFNPTERLGAG 224 (237)
T ss_pred ccCCHHHhcCCC
Confidence 999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=225.85 Aligned_cols=216 Identities=21% Similarity=0.359 Sum_probs=169.4
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 188 (398)
..++|...+.||+|+|++|.++++.+ .+.+|+|++++. ..++....+.|-.++.+. +||.+|.++.+|+....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34679999999999999999999876 778999998754 344556677788888776 6999999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
+|.||.+||+| +++.||||.+|+|+|..|++||.|+|+++.--...
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-- 405 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-- 405 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC--
Confidence 99999999998 34447999999999999999999999998643222
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCC--ccchhHHHHHhhhcCCccccchhhhh
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD--TLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
..++.++||+.|.|||++.+..|+..+|+|+|||+++||+.|+.||+.-..+ ..+..++..+..-+.+..-
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri------- 478 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI------- 478 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc-------
Confidence 3466789999999999999999999999999999999999999998753332 2333333333322221110
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCC
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRP 342 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RP 342 (398)
+...+.+...++..-|+.||.+|.
T Consensus 479 ----prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 ----PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----cceeehhhHHHHHHhhcCCcHHhc
Confidence 222334456788888999999885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=248.60 Aligned_cols=212 Identities=28% Similarity=0.397 Sum_probs=163.1
Q ss_pred CCccceecccCce-EEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEeccC
Q 037365 118 FSDANKLGEGGFG-PVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 118 ~~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
|...+.+|.|+.| .||+|... |+.||||++-... ..-..+|++.|+.- +|||||++++.-.+....|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4455678999887 57999994 8999999986433 34567899999888 59999999999999999999999885
Q ss_pred CC-----------------------------------ChhHHhhcCCCCCceecC---C--CCeEEcccccceecCCCCc
Q 037365 196 NK-----------------------------------SLDFFLFNLKASNILLDK---D--MNPKISDFGMARICGGNEL 235 (398)
Q Consensus 196 ~g-----------------------------------~L~~~~~dlkp~NILl~~---~--~~~kl~DFGla~~~~~~~~ 235 (398)
.. +|+++||||||.||||+. + .+++|+|||+++.+..+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 42 237899999999999975 3 4689999999998865442
Q ss_pred -ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcC-CCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 236 -QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSG-KKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 236 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
........||-+|+|||++....-+.++||+|+||++|..++| ..||+.......++. .+......+.+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~~L~~-- 737 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLVHLEP-- 737 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCccceeeecc--
Confidence 2235667899999999999998888899999999999999986 889875433222221 11110000000
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..++ ...+||.+|++++|..||++.+|+.
T Consensus 738 -----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 738 -----LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 5789999999999999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-29 Score=233.52 Aligned_cols=240 Identities=21% Similarity=0.260 Sum_probs=172.6
Q ss_pred CCccchhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCC--C----ccc
Q 037365 103 FPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQH--K----NLV 175 (398)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----nIv 175 (398)
...+-+......+++|.+...+|+|.||.|-.+.++. +..||+|+++.-. ...+...-|+++|.++.+ | -+|
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 3445556666678999999999999999999999876 6889999997653 333556679999999943 2 378
Q ss_pred ceeeEEEeCCeeEEEEeccCCC---------------------------------ChhHHhhcCCCCCceecC-------
Q 037365 176 RLLGCCIDKDEKILIYEYMPNK---------------------------------SLDFFLFNLKASNILLDK------- 215 (398)
Q Consensus 176 ~l~~~~~~~~~~~lV~e~~~~g---------------------------------~L~~~~~dlkp~NILl~~------- 215 (398)
.+.++|.-.++.|+|+|.+.-. +++.+|-||||+|||+.+
T Consensus 155 ~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred eeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 8889999999999999987421 124566799999999831
Q ss_pred -------------CCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCC
Q 037365 216 -------------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNT 282 (398)
Q Consensus 216 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~ 282 (398)
+..+||+|||.|..-.... +..+.|..|+|||++.+-.++.++||||+||+|.|+++|..-|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 2358999999998754332 4567899999999999999999999999999999999999877
Q ss_pred CCCCCCc-cchhHHH--------------HHhhhcCCccccchhhhhc---------------ccChHHHHHHHHHHHHH
Q 037365 283 GFYRTDT-LNLLGYA--------------WDLWRSNRTLELTDAILED---------------EYSSKQVLLRYVNIALL 332 (398)
Q Consensus 283 ~~~~~~~-~~~~~~~--------------~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~ 332 (398)
......+ ..+++.+ ...+..+. .+..+....+ ......+...+.+|+.+
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~r-ldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGR-LDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhccc-ccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 6543211 1111111 11111111 1100100000 00122344578999999
Q ss_pred chhcCCCCCCCHHHHHH
Q 037365 333 CVQESADDRPTTNDVVS 349 (398)
Q Consensus 333 cl~~dP~~RPt~~evl~ 349 (398)
||..||.+|+|+.|++.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999885
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-29 Score=212.65 Aligned_cols=177 Identities=24% Similarity=0.339 Sum_probs=144.6
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCC
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD 185 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 185 (398)
+.++...+....+..||+|++|.|-+-++.. |...|+|++... +.+..+...+|+++..+. ..|.+|.++|......
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3455666777778899999999998888654 889999999755 344556778899887665 6999999999999999
Q ss_pred eeEEEEeccCCC------------------------------------ChhHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 186 EKILIYEYMPNK------------------------------------SLDFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 186 ~~~lV~e~~~~g------------------------------------~L~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
..|+.||.|.-. -|..+|||+||+|||++.+|++|+||||++-.
T Consensus 119 dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 119 DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 999999988542 13688999999999999999999999999987
Q ss_pred cCCCCcccccccccccccccChhhhcc----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCC
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIE----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD 288 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~ 288 (398)
+.+.-. .+-..|...|||||.+.. ..|+-|+||||||+++.||.+++.||+....+
T Consensus 199 L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 199 LVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred ehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 754321 222468889999998863 36999999999999999999999998765444
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=241.27 Aligned_cols=216 Identities=21% Similarity=0.330 Sum_probs=170.9
Q ss_pred CCCCccceecccCceEEEEEEEcCCC-EEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGN-EIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++++.+..||-|+||.|-+...+... .+|+|.+++. +....+.+..|-.+|.+.+.|.||++|-.|.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999876533 4788888654 4455677889999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|-|-||.| +++.|||||+|.++|.+|-+||.|||+|+.+..+. .+
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KT 576 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KT 576 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC---ce
Confidence 99999987 23346999999999999999999999999987654 45
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
.+++||+.|.|||++.+...+.++|.||||+++|||++|.+||... +.+.....+ +++-...++ +
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~--dpmktYn~I---LkGid~i~~----------P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV--DPMKTYNLI---LKGIDKIEF----------P 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC--chHHHHHHH---Hhhhhhhhc----------c
Confidence 6789999999999999999999999999999999999999997532 222111111 111111111 3
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
........+|+.+.+..+|.+|.- +.||-+
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 334456778999999999999975 566654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=249.03 Aligned_cols=226 Identities=19% Similarity=0.229 Sum_probs=142.2
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-----CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeE------EE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-----GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC------CI 182 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~ 182 (398)
..++|+..+.||+|+||.||+|++.+ +..||+|++...... +....| .+....+.++..+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999754 588999998643221 111111 1222223333333222 24
Q ss_pred eCCeeEEEEeccCCCCh----------------------------------------------------hHHhhcCCCCC
Q 037365 183 DKDEKILIYEYMPNKSL----------------------------------------------------DFFLFNLKASN 210 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L----------------------------------------------------~~~~~dlkp~N 210 (398)
.++..++||||+++++| +++||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 56689999999998865 25678999999
Q ss_pred ceecC-CCCeEEcccccceecCCCCcccccccccccccccChhhhccC----------------------CCCcccccHH
Q 037365 211 ILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG----------------------IFSIKFDVFS 267 (398)
Q Consensus 211 ILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDvwS 267 (398)
||++. ++.+||+|||+++.+...... ......+|+.|+|||.+... .++.++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99985 579999999999865433221 23346789999999976432 2345679999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc-ccc---chh----hhhcccC-hHHHHHHHHHHHHHchhcCC
Q 037365 268 FGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT-LEL---TDA----ILEDEYS-SKQVLLRYVNIALLCVQESA 338 (398)
Q Consensus 268 lGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~----~~~~~~~-~~~~~~~~~~li~~cl~~dP 338 (398)
|||++|||+++..+++.. +..........+.. ..+ ... .....+. .........+|+.+||+.||
T Consensus 365 lGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999876653211 11110000000000 000 000 0000000 00011235589999999999
Q ss_pred CCCCCHHHHHHH
Q 037365 339 DDRPTTNDVVSM 350 (398)
Q Consensus 339 ~~RPt~~evl~~ 350 (398)
++|||++|+++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999973
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=235.76 Aligned_cols=225 Identities=20% Similarity=0.298 Sum_probs=150.0
Q ss_pred cCCCCccceecccCceEEEEEEE-----------------cCCCEEEEEEccCCChhhHHHH--------------HHHH
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVL-----------------RKGNEIAVKRLSGRSGQGLREM--------------KNEA 163 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~ 163 (398)
.++|++.++||+|+||.||+|.+ .+++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999964 2356799999865433222333 3466
Q ss_pred HHHHhcCCCcc-----cceeeEEEe--------CCeeEEEEeccCCCCh-------------------------------
Q 037365 164 SVIAKVQHKNL-----VRLLGCCID--------KDEKILIYEYMPNKSL------------------------------- 199 (398)
Q Consensus 164 ~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~e~~~~g~L------------------------------- 199 (398)
..+.+++|.++ ++++++|.. .+..+|||||+++|+|
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 778888753 3568999999998766
Q ss_pred -------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhh
Q 037365 200 -------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 254 (398)
Q Consensus 200 -------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 254 (398)
+++||||||+|||++.++.+||+|||++......... ......+|+.|+|||.+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEEL 382 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhh
Confidence 2456799999999999999999999999765432211 11122457899999988
Q ss_pred ccCC--------------------C--CcccccHHHHHHHHHHHcCCC-CCCCCCCCccchh--HH---HHHhhhcCCcc
Q 037365 255 IEGI--------------------F--SIKFDVFSFGVLLLEIVSGKK-NTGFYRTDTLNLL--GY---AWDLWRSNRTL 306 (398)
Q Consensus 255 ~~~~--------------------~--~~~sDvwSlGvvl~elltg~~-P~~~~~~~~~~~~--~~---~~~~~~~~~~~ 306 (398)
.... + ..+.||||+||++++|++|.. |+........... .. .|..+.....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~- 461 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY- 461 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC-
Confidence 6432 1 134799999999999999875 4432111110000 00 1111111110
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCC---CCCCCHHHHHH
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESA---DDRPTTNDVVS 349 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~RPt~~evl~ 349 (398)
.. . .........++++.+++..+| .+|+|++|+++
T Consensus 462 ~~-~-------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 462 DF-S-------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred Cc-c-------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 0 011223567899999999766 68999999986
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=235.27 Aligned_cols=222 Identities=22% Similarity=0.346 Sum_probs=174.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|+...++|+|.||.||++++.. ++..|+|.++........-++.|+-+++..+||||+.++|.+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45789999999999999999999764 88899999988877777888899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
||.+|+| +.+|||||-.|||+++.|.+|++|||.+-.++..- ....
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~Krk 170 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRK 170 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--hhhh
Confidence 9999988 35789999999999999999999999987665332 3345
Q ss_pred cccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 241 RIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.+.||++|||||+.. .+.|..++|||++|+...|+-.-++|......- . +.-+....... .+.+++
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r-----~l~LmTkS~~q---pp~lkD-- 239 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-R-----ALFLMTKSGFQ---PPTLKD-- 239 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-H-----HHHHhhccCCC---CCcccC--
Confidence 679999999999875 566999999999999999998888773211110 0 00001111000 011111
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.++++.|+..+|++|||++.++.
T Consensus 240 -k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 -KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2223456889999999999999999987653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-27 Score=204.50 Aligned_cols=229 Identities=17% Similarity=0.315 Sum_probs=174.3
Q ss_pred cCCCCccceecccCceEEEEEEE-cCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCC--eeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVL-RKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD--EKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lV 190 (398)
.++|++.+++|+|.++.||.|.. .+.+.++||.+++.. .+.+.+|+.+|..++ ||||+++++...++. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 57899999999999999999984 457889999997653 367889999999997 999999999998754 56799
Q ss_pred EeccCCCCh-----------------------------hHHhhcCCCCCceecCC-CCeEEcccccceecCCCCcccccc
Q 037365 191 YEYMPNKSL-----------------------------DFFLFNLKASNILLDKD-MNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 191 ~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+||..+.+. +++|||+||.|+++|.. -.++|+|+|+|.++.....+..
T Consensus 114 FE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV-- 191 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-- 191 (338)
T ss_pred hhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeee--
Confidence 999988754 68899999999999854 4699999999998876543332
Q ss_pred cccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc--------CC--ccccc
Q 037365 241 RIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS--------NR--TLELT 309 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------~~--~~~~~ 309 (398)
.+.+..|.-||.+..- .|+..-|+|||||++..|+..+.||.....+..+++..+.-+-.. -. ...-.
T Consensus 192 -RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~ 270 (338)
T KOG0668|consen 192 -RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF 270 (338)
T ss_pred -eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence 3567788999999764 478899999999999999999999988777766666554221110 00 00111
Q ss_pred hhhhhcc-------cC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 310 DAILEDE-------YS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 310 ~~~~~~~-------~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+.++... +. ..-...+..+++.+.|..|-++|+|++|.+.
T Consensus 271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111100 00 0011256789999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-27 Score=223.40 Aligned_cols=230 Identities=19% Similarity=0.267 Sum_probs=168.7
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC------CCcccceeeEEEeC
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ------HKNLVRLLGCCIDK 184 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~~~~~~~ 184 (398)
+..-++|.+....|+|-|++|.+|.+.. |+.||||++..+... .+.=+.|+++|++|+ --|+++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3445678888899999999999999876 889999999876322 244568999999996 34899999999999
Q ss_pred CeeEEEEeccCCCCh-----------------------------------hHHhhcCCCCCceecCC-CCeEEcccccce
Q 037365 185 DEKILIYEYMPNKSL-----------------------------------DFFLFNLKASNILLDKD-MNPKISDFGMAR 228 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~~-~~~kl~DFGla~ 228 (398)
+++|||+|-+.- +| +++|.||||+|||+++. ..+||||||.|.
T Consensus 507 nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 507 NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 999999997643 22 57788999999999865 458999999998
Q ss_pred ecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHH--------hh
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD--------LW 300 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~--------~~ 300 (398)
....+.... ..-+..|.|||++.+.+|+...|+||.||+||||.||+..|.....+. +..+..+ .+
T Consensus 586 ~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~--MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 586 FASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ--MLRLFMELKGKFPNKML 659 (752)
T ss_pred ccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH--HHHHHHHhcCCCcHHHh
Confidence 877655322 234668999999999999999999999999999999998765433321 1111110 00
Q ss_pred hcCCc---------------------------cccchh------hhhcc--c--ChHHHHHHHHHHHHHchhcCCCCCCC
Q 037365 301 RSNRT---------------------------LELTDA------ILEDE--Y--SSKQVLLRYVNIALLCVQESADDRPT 343 (398)
Q Consensus 301 ~~~~~---------------------------~~~~~~------~~~~~--~--~~~~~~~~~~~li~~cl~~dP~~RPt 343 (398)
+.+.. ...+.+ .+.+. + ........+.+|+..|+..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 00000 000000 01110 1 12345567899999999999999999
Q ss_pred HHHHHH
Q 037365 344 TNDVVS 349 (398)
Q Consensus 344 ~~evl~ 349 (398)
..+.|+
T Consensus 740 ~nqAL~ 745 (752)
T KOG0670|consen 740 VNQALK 745 (752)
T ss_pred HHHHhc
Confidence 998875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=191.41 Aligned_cols=177 Identities=33% Similarity=0.576 Sum_probs=151.6
Q ss_pred ecccCceEEEEEEEcC-CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh--
Q 037365 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-- 199 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L-- 199 (398)
||+|.+|.||++...+ ++.+++|++...... ....+.+|++.++.++|++++++++++......++++||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999999766432 346789999999999999999999999999999999999998876
Q ss_pred -------------------------------hHHhhcCCCCCceecC-CCCeEEcccccceecCCCCccccccccccccc
Q 037365 200 -------------------------------DFFLFNLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYG 247 (398)
Q Consensus 200 -------------------------------~~~~~dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 247 (398)
+.+|+||+|.||+++. ++.++|+|||.+........ ......+...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCC
Confidence 3556799999999998 89999999999987654321 1223457788
Q ss_pred ccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHH
Q 037365 248 YMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326 (398)
Q Consensus 248 y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (398)
|++||..... .++.++|+|++|++++++ ..+
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~ 190 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PEL 190 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHH
Confidence 9999999877 788999999999999999 246
Q ss_pred HHHHHHchhcCCCCCCCHHHHHHH
Q 037365 327 VNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 327 ~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.+++..|++.+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 789999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=208.25 Aligned_cols=228 Identities=19% Similarity=0.287 Sum_probs=160.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----C---CcccceeeEEEe---
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----H---KNLVRLLGCCID--- 183 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~--- 183 (398)
.+|-..++||.|-|++||+|.+.. .+.||+|+.+... ...+....|+.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 689999999999999999999765 6789999986542 34466788999999984 3 379999999985
Q ss_pred -CCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCC------------
Q 037365 184 -KDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKD------------ 216 (398)
Q Consensus 184 -~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~------------ 216 (398)
+.+.|+|+|++...-| +++|-||||+|||+..+
T Consensus 157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~ 236 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAG 236 (590)
T ss_pred CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhc
Confidence 4589999999865433 34444666666666211
Q ss_pred --------------------------------------------------------------------------------
Q 037365 217 -------------------------------------------------------------------------------- 216 (398)
Q Consensus 217 -------------------------------------------------------------------------------- 216 (398)
T Consensus 237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v 316 (590)
T KOG1290|consen 237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV 316 (590)
T ss_pred cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence
Q ss_pred --------------------------------------------------------------------------CCeEEc
Q 037365 217 --------------------------------------------------------------------------MNPKIS 222 (398)
Q Consensus 217 --------------------------------------------------------------------------~~~kl~ 222 (398)
.++||+
T Consensus 317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa 396 (590)
T KOG1290|consen 317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA 396 (590)
T ss_pred hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence 125666
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCcc----chhHHHHH
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTL----NLLGYAWD 298 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~----~~~~~~~~ 298 (398)
|||-|.+... ..+.-..|..|+|||++.+..|++.+||||++|++|||.||...|.....+.. +....+.+
T Consensus 397 DlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E 471 (590)
T KOG1290|consen 397 DLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME 471 (590)
T ss_pred eccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence 6666655332 12233568899999999999999999999999999999999998876555422 11222211
Q ss_pred hh--------hcCC-ccccc-----------------hhhhhcccC-hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 299 LW--------RSNR-TLELT-----------------DAILEDEYS-SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 299 ~~--------~~~~-~~~~~-----------------~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
++ ..+. ..+++ ...+.+.|. ..+...++.+++.-||+.+|++|||+.+.++
T Consensus 472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 11 1111 11111 112222222 4455678999999999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-26 Score=205.86 Aligned_cols=231 Identities=19% Similarity=0.282 Sum_probs=161.0
Q ss_pred CccceecccCceEEEEEEEc-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-----eeEEE
Q 037365 119 SDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKILI 190 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV 190 (398)
+..+.||-|+||.||...+. +|+.||.|++..-- -...+.+.+|+++|..++|.|++..++...-.+ +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34478999999999999875 49999999986542 233467889999999999999999998876443 44566
Q ss_pred EeccCCC-------------------------------ChhHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 191 YEYMPNK-------------------------------SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 191 ~e~~~~g-------------------------------~L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
+|.|... +-+++||||||.|.|++.|..+||||||+++..+..+.. ..
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~-hM 214 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL-NM 214 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh-hh
Confidence 6665331 126889999999999999999999999999976544432 33
Q ss_pred ccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc-------chh
Q 037365 240 SRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL-------TDA 311 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 311 (398)
+..+-|.+|+|||++.+.+ |+.+.||||.||++.||+.++.-|.-... .+..+.+.+++.......+ -..
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 4456689999999999864 89999999999999999988776643222 1122222222211111100 000
Q ss_pred hhhcc------------cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 312 ILEDE------------YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 312 ~~~~~------------~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.+++. ..+.........+..+++..||++|.+..+.+..+.
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11110 001122234567888999999999999998886543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=196.54 Aligned_cols=222 Identities=18% Similarity=0.293 Sum_probs=161.3
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceee-EEEeCCeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLG-CCIDKDEKILI 190 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~-~~~~~~~~~lV 190 (398)
..+.|.+.+.+|+|.||.+-+++++. .+.+++|-+.... ....+|.+|..---.| .|.||+.-++ .|+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34679999999999999999999987 6678888876543 3457788888765556 4899998775 56677888999
Q ss_pred EeccCCCCh-------------------------------hHHhhcCCCCCceec--CCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL-------------------------------DFFLFNLKASNILLD--KDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L-------------------------------~~~~~dlkp~NILl~--~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
+||+|.|+| +.+|||||.+|||+- +..++||||||+++..+...
T Consensus 101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV--- 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV--- 177 (378)
T ss_pred eccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee---
Confidence 999999998 578999999999983 34579999999987654321
Q ss_pred ccccccccccccChhhhccC-----CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 238 NTSRIVGTYGYMSPEYAIEG-----IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
....-+..|.+||..... ...+.+|+|.||+++|.++||+.||.......... |-|..|..+......+.
T Consensus 178 --~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk~~~~P~~- 252 (378)
T KOG1345|consen 178 --KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRKNPALPKK- 252 (378)
T ss_pred --hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhcccCccCchh-
Confidence 112335569999987632 24688999999999999999999987443333333 33444554443332221
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.......+.++..+-+.++|++|=-..++.++
T Consensus 253 ------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 253 ------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 22334567788899999999999444444433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=202.71 Aligned_cols=228 Identities=23% Similarity=0.281 Sum_probs=164.0
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 185 (398)
..+|...+.+|.|.- .|..+.+. .++.||+|++... +...++...+|...+..++|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888888999988 56666543 3889999988543 3445677889999999999999999999987533
Q ss_pred eeEEEEeccCCCC-----------------------------hhHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 186 EKILIYEYMPNKS-----------------------------LDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 186 ~~~lV~e~~~~g~-----------------------------L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
..|+|||||.... .+++||||||+||++..+..+||.|||+|+.....
T Consensus 95 e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--- 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--- 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc---
Confidence 6799999997641 15788999999999999999999999999864432
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHH--hhh-------------
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD--LWR------------- 301 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~--~~~------------- 301 (398)
...+..+.|..|.|||++.+..|.+.+||||.||++.||++|+--|... + .+.+|..- ...
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~--d--~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK--D--HIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc--h--HHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 2345567899999999999988999999999999999999998766421 1 11111100 000
Q ss_pred -----cCCcc-------cc-chhhhhcccC-hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 302 -----SNRTL-------EL-TDAILEDEYS-SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 302 -----~~~~~-------~~-~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..... +. .|........ .+.......+++.+||..||++|.|++++++.
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000 00 0000000000 11123456799999999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=215.44 Aligned_cols=163 Identities=25% Similarity=0.373 Sum_probs=137.2
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--------hhHHHHHHHHHHHHhcC---CCcccceeeEEEeC
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--------QGLREMKNEASVIAKVQ---HKNLVRLLGCCIDK 184 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~ 184 (398)
.|...+.+|+|+||.|+.|.++. ...|++|.+.+..- ...-.+-.|++||..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 58889999999999999999876 66799998865521 11123456999999998 99999999999999
Q ss_pred CeeEEEEeccCCC-Ch--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 185 DEKILIYEYMPNK-SL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 185 ~~~~lV~e~~~~g-~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
+.+||+||--..| +| +++|||||-+|+.++.+|.+||+|||.+....
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc
Confidence 9999999965444 22 68999999999999999999999999987655
Q ss_pred CCCcccccccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCC
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTG 283 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~ 283 (398)
.+. ...++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 722 sgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 432 445799999999999999887 677999999999999999888863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=189.42 Aligned_cols=165 Identities=32% Similarity=0.467 Sum_probs=140.8
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999876 889999999766544 56788999999999999999999999999999999999999
Q ss_pred CCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 196 NKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 196 ~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+++| +.+|+|++|.||+++.++.++|+|||.+........ ......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 159 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTV 159 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccce
Confidence 9776 245679999999999999999999999987654321 112334
Q ss_pred cccccccChhhh-ccCCCCcccccHHHHHHHHHHHcCCCCCC
Q 037365 243 VGTYGYMSPEYA-IEGIFSIKFDVFSFGVLLLEIVSGKKNTG 283 (398)
Q Consensus 243 ~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~P~~ 283 (398)
.++..|++||.+ ....++.++|+||||++++||++|+.||.
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 678889999998 66678889999999999999999999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=204.45 Aligned_cols=237 Identities=23% Similarity=0.376 Sum_probs=172.2
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcC----CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCC
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD 185 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 185 (398)
.....+.|...++||+|.|+.||++.+.. .+.||+|.+..... ...+.+|++.|..+. |.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34455678999999999999999998543 67899999965532 356889999999995 999999999999999
Q ss_pred eeEEEEeccCCCCh-----------------------------hHHhhcCCCCCceecCC-CCeEEcccccceecCCCC-
Q 037365 186 EKILIYEYMPNKSL-----------------------------DFFLFNLKASNILLDKD-MNPKISDFGMARICGGNE- 234 (398)
Q Consensus 186 ~~~lV~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~-~~~kl~DFGla~~~~~~~- 234 (398)
+.++|+||+++-.. +++||||||+|+|.+.. +.-.|.|||+|.......
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 99999999988643 68999999999999754 567899999997221000
Q ss_pred ------------cc---------------------c--------ccccccccccccChhhhccCC-CCcccccHHHHHHH
Q 037365 235 ------------LQ---------------------A--------NTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLL 272 (398)
Q Consensus 235 ------------~~---------------------~--------~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl 272 (398)
.. . ......||++|+|||++...+ .++++||||.||++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00 0 011357999999999998654 68999999999999
Q ss_pred HHHHcCCCCCCCCCCCccchhHHHHH-----------------hhhcCCccc----------c-chhhhhccc------C
Q 037365 273 LEIVSGKKNTGFYRTDTLNLLGYAWD-----------------LWRSNRTLE----------L-TDAILEDEY------S 318 (398)
Q Consensus 273 ~elltg~~P~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~----------~-~~~~~~~~~------~ 318 (398)
+.+++++.||.....+...+.+.+.- .|...+... + ......... .
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 99999999998766654444433211 011011000 0 011111000 0
Q ss_pred -hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 -SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 -~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+|+..||.+|.|+++.|+
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 1112236789999999999999999999886
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=171.92 Aligned_cols=137 Identities=18% Similarity=0.132 Sum_probs=97.7
Q ss_pred hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCC
Q 037365 200 DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279 (398)
Q Consensus 200 ~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 279 (398)
..+|..-||+|||++.++.+|+ ||+++...... ..||+.|||||++.+..++.++|||||||++|||++|+
T Consensus 31 ~~lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 101 (176)
T smart00750 31 RELHRQAKSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYE 101 (176)
T ss_pred HHHHhcCCcccEeEcCccceee--ccceEeecccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCC
Confidence 4555555999999999999999 99998764321 26889999999999999999999999999999999999
Q ss_pred CCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH--HHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 280 KNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL--RYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 280 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.||.........+...... .... ... .......... .+.+++.+||+.||.+|||+.|+++.+...
T Consensus 102 ~p~~~~~~~~~~~~~~~~~-~~~~---~~~-----~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 102 LPYNEERELSAILEILLNG-MPAD---DPR-----DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred CCccccchhcHHHHHHHHH-hccC---Ccc-----ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 9975432211111111111 0000 000 0000122222 589999999999999999999999988764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=185.96 Aligned_cols=153 Identities=17% Similarity=0.198 Sum_probs=117.1
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEc--CCCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLR--KGNEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCID 183 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 183 (398)
.....++|...+.||+|+||+||+|.+. +++.+|||++... .....+.+.+|+++|++++|+|++..+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3345678999999999999999999875 3677899987533 22335668999999999999999853322
Q ss_pred CCeeEEEEeccCCCCh-------------------------hHHhhcC-CCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 184 KDEKILIYEYMPNKSL-------------------------DFFLFNL-KASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L-------------------------~~~~~dl-kp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
.+..++||||+++++| +++|||| ||+|||++.++.+||+|||+|+.+.......
T Consensus 90 ~~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~ 169 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALY 169 (365)
T ss_pred cCCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchh
Confidence 2468999999999877 4677899 9999999999999999999999775432111
Q ss_pred c------cccccccccccChhhhccCC------CCcccccH
Q 037365 238 N------TSRIVGTYGYMSPEYAIEGI------FSIKFDVF 266 (398)
Q Consensus 238 ~------~~~~~gt~~y~aPE~~~~~~------~~~~sDvw 266 (398)
. .....+++.|+|||.+.... .+..+|-|
T Consensus 170 ~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 170 RIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred hhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 1 13467888999999987432 33457776
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-22 Score=213.48 Aligned_cols=163 Identities=18% Similarity=0.203 Sum_probs=105.4
Q ss_pred hcCC-CcccceeeEE-------EeCCeeEEEEeccCCCCh---------------------------------hHHhhcC
Q 037365 168 KVQH-KNLVRLLGCC-------IDKDEKILIYEYMPNKSL---------------------------------DFFLFNL 206 (398)
Q Consensus 168 ~l~H-~nIv~l~~~~-------~~~~~~~lV~e~~~~g~L---------------------------------~~~~~dl 206 (398)
.++| +||++++++| ...+..+.++||++ ++| +++||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5777888877 22345677788763 344 5778999
Q ss_pred CCCCceecC-------------------CCCeEEcccccceecCCCCc--------------ccccccccccccccChhh
Q 037365 207 KASNILLDK-------------------DMNPKISDFGMARICGGNEL--------------QANTSRIVGTYGYMSPEY 253 (398)
Q Consensus 207 kp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aPE~ 253 (398)
||+|||++. ++.+|++|||+++....... ........||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 44566777777654221000 000112458899999999
Q ss_pred hccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHc
Q 037365 254 AIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLC 333 (398)
Q Consensus 254 ~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 333 (398)
+.+..|+.++|||||||+||||++|.+|+.... .. ... .... ...+. .........+++.+|
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~---~~~-~~~~----~~~~~------~~~~~~~~~~~~~~~ 248 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RT---MSS-LRHR----VLPPQ------ILLNWPKEASFCLWL 248 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HH---HHH-HHHh----hcChh------hhhcCHHHHHHHHHh
Confidence 999999999999999999999999887743110 00 000 0000 00000 001122356788899
Q ss_pred hhcCCCCCCCHHHHHH
Q 037365 334 VQESADDRPTTNDVVS 349 (398)
Q Consensus 334 l~~dP~~RPt~~evl~ 349 (398)
|+.+|.+|||+.|+++
T Consensus 249 L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 249 LHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCChhhCcChHHHhh
Confidence 9999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-21 Score=171.31 Aligned_cols=210 Identities=23% Similarity=0.334 Sum_probs=156.5
Q ss_pred ccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 120 DANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
...+|.+...|..|+|+|+ |..+++|++... .....+.|..|.-.|+-+.||||..++|.|..+.+..++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456788899999999996 667777877533 3334467889999999999999999999999999999999999999
Q ss_pred ChhHHhh------------------------------------cCCCCCceecCCCCeEEc--ccccceecCCCCccccc
Q 037365 198 SLDFFLF------------------------------------NLKASNILLDKDMNPKIS--DFGMARICGGNELQANT 239 (398)
Q Consensus 198 ~L~~~~~------------------------------------dlkp~NILl~~~~~~kl~--DFGla~~~~~~~~~~~~ 239 (398)
+|..+++ .|.+..+++|++.+++|+ |--++-. .
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---------e 343 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------E 343 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---------c
Confidence 9965443 388899999999988775 3222211 1
Q ss_pred ccccccccccChhhhccCCC---CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 240 SRIVGTYGYMSPEYAIEGIF---SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
....-.+.||+||.++..+- -.++|+|||.+++|||.|...||.....-...+ +.+.+ -+.. .
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-kiale---------glrv----~ 409 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-KIALE---------GLRV----H 409 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-hhhhc---------cccc----c
Confidence 11234678999999987764 367999999999999999999986543321110 01110 0010 0
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
. ++.....+.+|+.-|...||.+||.++.++-.|++.
T Consensus 410 i-ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 I-PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred C-CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1 344556688999999999999999999999988875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-18 Score=161.91 Aligned_cols=225 Identities=27% Similarity=0.374 Sum_probs=166.1
Q ss_pred CCccceecccCceEEEEEEEcCCCEEEEEEccCCChh---hHHHHHHHHHHHHhcCCC-cccceeeEEEeCCeeEEEEec
Q 037365 118 FSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ---GLREMKNEASVIAKVQHK-NLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~e~ 193 (398)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|..++..+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 78899998655322 467889999999999988 799999999877778999999
Q ss_pred cCCCCh-----------------------------------hHHhhcCCCCCceecCCC-CeEEcccccceecCCCCccc
Q 037365 194 MPNKSL-----------------------------------DFFLFNLKASNILLDKDM-NPKISDFGMARICGGNELQA 237 (398)
Q Consensus 194 ~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 237 (398)
+.++++ +.+|||+||+||+++..+ .++++|||.++.........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 998866 246789999999999988 69999999998655433221
Q ss_pred ----ccccccccccccChhhhcc---CCCCcccccHHHHHHHHHHHcCCCCCCCCCCC--ccchhHHHHHhhhcCCcccc
Q 037365 238 ----NTSRIVGTYGYMSPEYAIE---GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD--TLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 238 ----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 308 (398)
......||..|+|||.+.+ ..++...|+||+|++++++++|..|+...... .............. ..
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 235 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP----SL 235 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc----cc
Confidence 2355689999999999988 57889999999999999999999995443321 11111111111110 00
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
........ .......+.+++..|+..+|..|.+..+....
T Consensus 236 -~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 -ASPLSPSN-PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccCccc-cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 01112457789999999999999999887764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-19 Score=161.35 Aligned_cols=148 Identities=15% Similarity=0.130 Sum_probs=115.4
Q ss_pred hhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHH---H------HHHHHHHHHhcCCCcccceeeEEEe
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLR---E------MKNEASVIAKVQHKNLVRLLGCCID 183 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~H~nIv~l~~~~~~ 183 (398)
...++|+..+.+|.|+||.||+... ++..+|+|.+......... . +.+|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3467899999999999999999766 5778999999755322222 2 5789999999999999999988664
Q ss_pred C--------CeeEEEEeccCCCCh------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 184 K--------DEKILIYEYMPNKSL------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 184 ~--------~~~~lV~e~~~~g~L------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
. +..+++|||++|.+| +.+|+|+||+|++++.++ ++|+|||..+...
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCccccc
Confidence 3 357899999999887 467889999999999888 9999999876543
Q ss_pred CCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHH
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIV 276 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 276 (398)
..... ..+.....|..++|+||||+++.-+.
T Consensus 186 e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 186 QRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred chhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 21110 11344556778999999999876544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.2e-20 Score=188.22 Aligned_cols=221 Identities=21% Similarity=0.249 Sum_probs=155.5
Q ss_pred CccceecccCceEEEEEEEcC-CCEEEEEEcc----C-CChhh-HHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 119 SDANKLGEGGFGPVYKGVLRK-GNEIAVKRLS----G-RSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~----~-~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.....+|.|++|.|+...... ....+.|.+. . ..... ...+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999888776543 3334444332 1 11111 122667888888899999998888777766666669
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc--c
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ--A 237 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 237 (398)
|||++ +| ++.|||+|++|+++..+|.+||+|||.+......... .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 66 4567899999999999999999999998765433222 3
Q ss_pred ccccccccccccChhhhccCCCCc-ccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSI-KFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.....+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||............. ...... ....+.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~~~~~-----~~~~~~ 550 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NYSDQR-----NIFEGP 550 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----cccccc-----ccccCh
Confidence 456688999999999999999965 5899999999999999999976543332221000 000000 000000
Q ss_pred c-ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 Y-SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~-~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. .....+.....++.++|+.||.+|.|+++|++
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 02334456788999999999999999999995
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-17 Score=160.45 Aligned_cols=229 Identities=22% Similarity=0.244 Sum_probs=161.6
Q ss_pred CCCccceecccCceEEEEEEEcCC--CEEEEEEccCCChhhHHHHHHHHHHHHhcCC----CcccceeeEE-EeCCeeEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRKG--NEIAVKRLSGRSGQGLREMKNEASVIAKVQH----KNLVRLLGCC-IDKDEKIL 189 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l 189 (398)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997663 4788887765432222367889999999873 6899999888 47778999
Q ss_pred EEeccCCCCh----------------------------------hHHhhcCCCCCceecCC-----CCeEEcccccce--
Q 037365 190 IYEYMPNKSL----------------------------------DFFLFNLKASNILLDKD-----MNPKISDFGMAR-- 228 (398)
Q Consensus 190 V~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~-----~~~kl~DFGla~-- 228 (398)
||+.+ |.+| +++||||||.|+++... ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99976 3333 57889999999999754 468999999998
Q ss_pred ecCCCCc----cc-c-cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc
Q 037365 229 ICGGNEL----QA-N-TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS 302 (398)
Q Consensus 229 ~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 302 (398)
.+..... .. . .....||..|.++.+..+...+.+.|+||++-++.|++.|..||........ .. .......
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~-~~~~~~~- 254 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KS-KFEKDPR- 254 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HH-HHHHHhh-
Confidence 3321111 11 1 2345699999999999999999999999999999999999999743322111 00 0000000
Q ss_pred CCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 303 NRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
...... . ....+..+.++...+-..+..++|....+...|+......
T Consensus 255 ---~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 ---KLLTDR-F-----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---hhcccc-c-----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000000 0 1111234555666666689999999999999988776554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.1e-19 Score=175.08 Aligned_cols=191 Identities=24% Similarity=0.331 Sum_probs=149.5
Q ss_pred ecccCceEEEEEEE----cCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEeccCC
Q 037365 124 LGEGGFGPVYKGVL----RKGNEIAVKRLSGRSG--QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 124 lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+|+|+||.|++++- ..|..+|.|..++... ........|..++..++ ||.+|+++..++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998752 2377788888765421 11124456888888887 99999999999999999999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
|.| ++++||+|++||+++.+|++++.|||+++..-.... .+|
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cg 155 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACG 155 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh------ccc
Confidence 876 577899999999999999999999999987643322 189
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc-ChHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY-SSKQVL 323 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 323 (398)
|..|||||+.. .....+|.||||++++||+||..||.. +....++.... .+....
T Consensus 156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------------------~~~~~Il~~~~~~p~~l~ 211 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------------------DTMKRILKAELEMPRELS 211 (612)
T ss_pred chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------------------HHHHHHhhhccCCchhhh
Confidence 99999999998 567899999999999999999999753 12222222111 144445
Q ss_pred HHHHHHHHHchhcCCCCCCCH
Q 037365 324 LRYVNIALLCVQESADDRPTT 344 (398)
Q Consensus 324 ~~~~~li~~cl~~dP~~RPt~ 344 (398)
....+++..++..+|.+|.-.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 567788889999999999755
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-17 Score=145.11 Aligned_cols=229 Identities=18% Similarity=0.252 Sum_probs=159.3
Q ss_pred cCCCCccceecccCceEEEEEEE-cCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC-CcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVL-RKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|..+++||+|+||.+|.|.. .+|..||+|.-+..... -++..|..+...++| ..|..+..+..+.+.-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 47899999999999999999985 45999999987544221 356778999999986 677788888888899999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecC---CCCeEEcccccceecCCCCc-
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDK---DMNPKISDFGMARICGGNEL- 235 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~---~~~~kl~DFGla~~~~~~~~- 235 (398)
.+ |.+| ..+||||||+|.|+.- ...+.++|||+|+.+.+..+
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 87 5555 4678999999999853 34688999999987754332
Q ss_pred ----ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 236 ----QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 236 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
+.......||.+|.+--...+...+...|+=|+|-+|...--|..||......... .-.+...+......++.
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~---QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK---QKYEKISEKKMSTPIEV 247 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH---HHHHHHHHhhcCCCHHH
Confidence 22344568999999988777777889999999999999999999997643322100 00000111111111111
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
. ....+.++.-.+.-|-..--++-|.-.-+-+.+.-+.
T Consensus 248 L------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 248 L------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred H------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1 1122345566667777777777777655554444433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.5e-17 Score=159.43 Aligned_cols=185 Identities=21% Similarity=0.284 Sum_probs=131.8
Q ss_pred HHhcCCCcccceeeEEEeCCeeEEEEeccCCCChhHH----------------------------------hhcCCCCCc
Q 037365 166 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF----------------------------------LFNLKASNI 211 (398)
Q Consensus 166 l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L~~~----------------------------------~~dlkp~NI 211 (398)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.++ |..+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3568899999999999999999999999999998433 346999999
Q ss_pred eecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCC-------CCcccccHHHHHHHHHHHcCCCCCCC
Q 037365 212 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI-------FSIKFDVFSFGVLLLEIVSGKKNTGF 284 (398)
Q Consensus 212 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlGvvl~elltg~~P~~~ 284 (398)
++|....+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.+.||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 99999999999999987764311111111122345799999997631 46789999999999999999999876
Q ss_pred CCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 285 YRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....... .+.+...... ......+.+.. ..+....+..++.+||..+|.+||+++++-..++....
T Consensus 161 ~~~~~~~-~eii~~~~~~--~~~~~rP~i~~---~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 161 RNLVEDP-DEIILRVKKG--GSNPFRPSIEL---LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccCCh-HHHHHHHHhc--CCCCcCcchhh---hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 4443321 1222222221 11111111111 11223368899999999999999999999988877643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-17 Score=160.37 Aligned_cols=76 Identities=36% Similarity=0.535 Sum_probs=65.4
Q ss_pred HhhcCCCCCceecCCCCeEEcccccceecCCCC----cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc
Q 037365 202 FLFNLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277 (398)
Q Consensus 202 ~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 277 (398)
+|+|+||.||....+..+||.|||+........ .....+...||..||+||.+.+..|+.|+||||||++|+|++.
T Consensus 378 ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 378 IHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 466899999999999999999999987665443 1223445689999999999999999999999999999999997
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.3e-16 Score=140.31 Aligned_cols=108 Identities=15% Similarity=0.147 Sum_probs=81.7
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChh--h------------------------HHHHHHHHHHHHhcCCCcc
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ--G------------------------LREMKNEASVIAKVQHKNL 174 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~nI 174 (398)
.+.||+|+||.||+|...+|+.||+|+++..... . ......|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999654211 0 0122459999999988877
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEE
Q 037365 175 VRLLGCCIDKDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKI 221 (398)
Q Consensus 175 v~l~~~~~~~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl 221 (398)
.....+.. ...++||||++++++ +++||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 44333322 234899999998653 467789999999998 478999
Q ss_pred cccccceecC
Q 037365 222 SDFGMARICG 231 (398)
Q Consensus 222 ~DFGla~~~~ 231 (398)
+|||+|....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05147 159 IDVSQSVEHD 168 (190)
T ss_pred EEccccccCC
Confidence 9999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-15 Score=139.39 Aligned_cols=168 Identities=20% Similarity=0.296 Sum_probs=134.6
Q ss_pred CCCCccceecccCceEEEEEE-EcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
-+|.+.++||+|.||..+.|. +-+++.||||.-...+ ..-++..|....+.|. .++|...+.+-..+-+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999998 3458999999754432 2245677888888885 68999988887777788899998
Q ss_pred cCCCChhH---------------------------------HhhcCCCCCceecCCC-----CeEEcccccceecCCCCc
Q 037365 194 MPNKSLDF---------------------------------FLFNLKASNILLDKDM-----NPKISDFGMARICGGNEL 235 (398)
Q Consensus 194 ~~~g~L~~---------------------------------~~~dlkp~NILl~~~~-----~~kl~DFGla~~~~~~~~ 235 (398)
+ |.+|++ +.|||||+|.||...+ .+.|.|||+|+.+.+..+
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 7 556632 2369999999996443 489999999998876543
Q ss_pred cc-----ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCC
Q 037365 236 QA-----NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYR 286 (398)
Q Consensus 236 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 286 (398)
.. ......||.+||+--...+...+..-|.=|||-++...+-|..||....
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 32 2345679999999998889999999999999999999999999976543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.2e-16 Score=136.49 Aligned_cols=109 Identities=18% Similarity=0.190 Sum_probs=85.5
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChh--------------------------hHHHHHHHHHHHHhcCCCcc
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ--------------------------GLREMKNEASVIAKVQHKNL 174 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~nI 174 (398)
.+.||+|++|.||+|...+|+.||||++...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754210 01223578999999999988
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEE
Q 037365 175 VRLLGCCIDKDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKI 221 (398)
Q Consensus 175 v~l~~~~~~~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl 221 (398)
.....+... ..++||||++++++ +++|+||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 555444333 34899999998742 367889999999998 789999
Q ss_pred cccccceecCC
Q 037365 222 SDFGMARICGG 232 (398)
Q Consensus 222 ~DFGla~~~~~ 232 (398)
+|||++.....
T Consensus 159 iDFG~a~~~~~ 169 (190)
T cd05145 159 IDVSQAVELDH 169 (190)
T ss_pred EEcccceecCC
Confidence 99999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=142.41 Aligned_cols=197 Identities=18% Similarity=0.210 Sum_probs=119.8
Q ss_pred CCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCC----------CcccceeeEEEe
Q 037365 118 FSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQH----------KNLVRLLGCCID 183 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~~~ 183 (398)
+...+.||.|+++.||.+.+.. ++++|+|.+... .....+++.+|.-....+.+ -.++.-++...-
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456789999999999999987 899999988432 22345666666655444322 122222222221
Q ss_pred ---------CC--------eeEEEEeccCCCCh---------------------------------------hHHhhcCC
Q 037365 184 ---------KD--------EKILIYEYMPNKSL---------------------------------------DFFLFNLK 207 (398)
Q Consensus 184 ---------~~--------~~~lV~e~~~~g~L---------------------------------------~~~~~dlk 207 (398)
.. ..+++|+-+. ++| +.+|.|||
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 2356777663 344 45667999
Q ss_pred CCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccC--------CCCcccccHHHHHHHHHHHcCC
Q 037365 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG--------IFSIKFDVFSFGVLLLEIVSGK 279 (398)
Q Consensus 208 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwSlGvvl~elltg~ 279 (398)
|+|++++.+|.++|+||+.....+.... . ...+..|.+||..... .++.+.|.|+||+++|.|++|+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYR---C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEE---G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceee---c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999999999999988765442211 1 2345779999977542 4789999999999999999999
Q ss_pred CCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCC
Q 037365 280 KNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDR 341 (398)
Q Consensus 280 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 341 (398)
.||+.......... .. ..+ . +.++.+..|+..+|++||.+|
T Consensus 248 lPf~~~~~~~~~~~------------------~f-~~C-~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW------------------DF-SRC-R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG------------------GG-TTS-S----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc------------------cc-hhc-C-CcCHHHHHHHHHHccCCcccC
Confidence 99875432211100 00 111 2 556778999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=133.25 Aligned_cols=158 Identities=18% Similarity=0.128 Sum_probs=118.3
Q ss_pred ccceecccCceEEEEEEEcCCCEEEEEEccCCChh----hHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEecc
Q 037365 120 DANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ----GLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
....|++|+||+||.+.. .+..++.+.+.....- ....+.+|+++|+++. |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 5788888877655321 1235789999999995 5889999886 4569999999
Q ss_pred CCCCh-------------------------hHHhhcC-CCCCceecCCCCeEEcccccceecCCCCcc----c-------
Q 037365 195 PNKSL-------------------------DFFLFNL-KASNILLDKDMNPKISDFGMARICGGNELQ----A------- 237 (398)
Q Consensus 195 ~~g~L-------------------------~~~~~dl-kp~NILl~~~~~~kl~DFGla~~~~~~~~~----~------- 237 (398)
.|.+| +++|+|| ||+|||++.++.++|+|||++........- .
T Consensus 81 ~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~l 160 (218)
T PRK12274 81 AGAAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHL 160 (218)
T ss_pred cCccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHH
Confidence 99877 4678899 799999999999999999999865432210 0
Q ss_pred ccccccccccccChhhhccC-CCC-cccccHHHHHHHHHHHcCCCCC
Q 037365 238 NTSRIVGTYGYMSPEYAIEG-IFS-IKFDVFSFGVLLLEIVSGKKNT 282 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvvl~elltg~~P~ 282 (398)
.......++.|++|+.-.-. ..+ ...+.++.|.-+|.++|++.+.
T Consensus 161 lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 161 LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 01112357778888754322 233 5678899999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-16 Score=165.03 Aligned_cols=197 Identities=18% Similarity=0.298 Sum_probs=135.9
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--------C
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--------D 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~ 185 (398)
.++|+.++.|..|+||.||..+++. .+..|+ ++.+.+ -+.+- ++.....|.+| |-|... .
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npfvv---gDc~tllk~~g~lPv 150 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPFVV---GDCATLLKNIGPLPV 150 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCccee---chhhhhcccCCCCcc
Confidence 3689999999999999999999876 566788 443322 11111 45555667665 333221 1
Q ss_pred eeEEEEeccCCCChhHHhhcCCCCCceecCCCCeEEcccccceecCCCCc-------------ccccccccccccccChh
Q 037365 186 EKILIYEYMPNKSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL-------------QANTSRIVGTYGYMSPE 252 (398)
Q Consensus 186 ~~~lV~e~~~~g~L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-------------~~~~~~~~gt~~y~aPE 252 (398)
...+-.||.. +-+++|||+||+|.++..-|++|+.|||+++....... .......+||+.|.|||
T Consensus 151 dmvla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 151 DMVLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhhHHhHhhc--cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 1234456653 45789999999999999999999999999875321100 01233568999999999
Q ss_pred hhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC----hHHHHHHHHH
Q 037365 253 YAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS----SKQVLLRYVN 328 (398)
Q Consensus 253 ~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 328 (398)
++..+.|++.+|+|++|+++||.+.|+.||+....+ +++...+..... ......+..+
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe------------------elfg~visd~i~wpE~dea~p~Ea~d 290 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------------------ELFGQVISDDIEWPEEDEALPPEAQD 290 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH------------------HHHhhhhhhhccccccCcCCCHHHHH
Confidence 999999999999999999999999999997543221 111111111100 1122345788
Q ss_pred HHHHchhcCCCCCC
Q 037365 329 IALLCVQESADDRP 342 (398)
Q Consensus 329 li~~cl~~dP~~RP 342 (398)
++.+.|+.+|..|-
T Consensus 291 li~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 291 LIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHHHHHhChHhhc
Confidence 99999999999996
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-16 Score=164.41 Aligned_cols=219 Identities=20% Similarity=0.264 Sum_probs=147.9
Q ss_pred CCCccceecccCceEEEEEEEcCCCEEEEEEccCCC-hhhHHHHH---HHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS-GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.+...+.||++.|=+|.+|++++|. |+||++-+.. .-..+.+. +|++ ...++|||++.+.-+-..+...|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4566688999999999999998777 9999986554 33334443 3444 555689999998877666666667766
Q ss_pred ccCCC-------------------------------ChhHHhhcCCCCCceecCCCCeEEcccccceec--CCCCccccc
Q 037365 193 YMPNK-------------------------------SLDFFLFNLKASNILLDKDMNPKISDFGMARIC--GGNELQANT 239 (398)
Q Consensus 193 ~~~~g-------------------------------~L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~--~~~~~~~~~ 239 (398)
|..+. .+++.|+|||.+|||++.=.-+.|+||..-+.. ..+.. ...
T Consensus 102 yvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP-adf 180 (1431)
T KOG1240|consen 102 YVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP-ADF 180 (1431)
T ss_pred HHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc-ccc
Confidence 66443 226788899999999998888999999765432 11111 111
Q ss_pred c----cccccccccChhhhccC----------C-CCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 240 S----RIVGTYGYMSPEYAIEG----------I-FSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 240 ~----~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
. +...-..|.|||.+... . .+++.||||+||++.||++ |++||... ++. .++.+
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~-----aYr~~ 250 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLL-----AYRSG 250 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHH-----hHhcc
Confidence 1 11223469999988641 1 5789999999999999998 56666421 111 12222
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
. ....+..+++-. ...+.+|+..|++.||++|.++++.++.-.+.
T Consensus 251 ~-~~~~e~~Le~Ie-----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 251 N-ADDPEQLLEKIE-----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred C-ccCHHHHHHhCc-----CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 2 222222222211 12478999999999999999999999875543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.1e-14 Score=130.96 Aligned_cols=107 Identities=21% Similarity=0.311 Sum_probs=82.8
Q ss_pred CccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-----CCCcccceeeEEEeCC---e-eEE
Q 037365 119 SDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV-----QHKNLVRLLGCCIDKD---E-KIL 189 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~-~~l 189 (398)
...+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 544333479998765444557789999999999 5799999999999874 3 337
Q ss_pred EEec--cCCCCh------------------------------hHHhhcCCCCCceecC----CCCeEEcccccc
Q 037365 190 IYEY--MPNKSL------------------------------DFFLFNLKASNILLDK----DMNPKISDFGMA 227 (398)
Q Consensus 190 V~e~--~~~g~L------------------------------~~~~~dlkp~NILl~~----~~~~kl~DFGla 227 (398)
|+|| +++|+| +++||||||+|||++. ++.++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 556776 3566899999999974 347999995433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.2e-15 Score=139.91 Aligned_cols=167 Identities=23% Similarity=0.251 Sum_probs=110.3
Q ss_pred CCCcccceeeEEEeC---------------------------CeeEEEEeccCCCCh-----------------------
Q 037365 170 QHKNLVRLLGCCIDK---------------------------DEKILIYEYMPNKSL----------------------- 199 (398)
Q Consensus 170 ~H~nIv~l~~~~~~~---------------------------~~~~lV~e~~~~g~L----------------------- 199 (398)
+|||||++.++|.+. ...|+||...+.. |
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~t-Lr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQT-LREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhh-HHHHHhcCCCchHHHHHHHHHHHH
Confidence 599999999988642 2468888766442 2
Q ss_pred --------hHHhhcCCCCCcee--cCCC--CeEEcccccceecCCCCcc----cccccccccccccChhhhccCC-----
Q 037365 200 --------DFFLFNLKASNILL--DKDM--NPKISDFGMARICGGNELQ----ANTSRIVGTYGYMSPEYAIEGI----- 258 (398)
Q Consensus 200 --------~~~~~dlkp~NILl--~~~~--~~kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----- 258 (398)
++.|||+|++|||+ |+|+ .+.|+|||++-..+..... ...-..-|....||||+....+
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 46789999999998 4444 4689999988654332111 1122235777899999987432
Q ss_pred -CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcC
Q 037365 259 -FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQES 337 (398)
Q Consensus 259 -~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 337 (398)
--.|+|.|+.|.+.||++....||.....-..+... +.+.+...+ +..++..+.+++...|++|
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qLPal----------p~~vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQLPAL----------PSRVPPVARQLVFDLLKRD 497 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhCCCC----------cccCChHHHHHHHHHhcCC
Confidence 136899999999999999999997542111111111 222222111 2223345778999999999
Q ss_pred CCCCCCHHHHHHHHh
Q 037365 338 ADDRPTTNDVVSMLT 352 (398)
Q Consensus 338 P~~RPt~~evl~~L~ 352 (398)
|++|++..-..+.|.
T Consensus 498 pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 498 PSKRVSPNIAANVLN 512 (598)
T ss_pred ccccCCccHHHhHHH
Confidence 999999876555543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-15 Score=156.64 Aligned_cols=168 Identities=17% Similarity=0.232 Sum_probs=129.0
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCcccceeeEEEeCCee
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~ 187 (398)
.+...+.|.+.+.||+|+||.||+|...+|+.||+|+=+..+... |.--.+++.+|+ -+.|..+..++.-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 344456788899999999999999999889999999887654321 111123344444 34566666666667888
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceec-------CCCCeEEcccccce
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLD-------KDMNPKISDFGMAR 228 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~-------~~~~~kl~DFGla~ 228 (398)
+||+||.+.|+| +++|.||||+|.||. ++..++|+|||.+-
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 999999999998 588899999999993 33468999999985
Q ss_pred ecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCC
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKN 281 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P 281 (398)
.+.--.........++|-.+-.+|...+.+++..+|-|.++.+++.|+.|+.-
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 54322222334556788999999999999999999999999999999999853
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.7e-14 Score=124.86 Aligned_cols=111 Identities=20% Similarity=0.203 Sum_probs=87.5
Q ss_pred CCCccceecccCceEEEEEEEcCCCEEEEEEccCCCh----------------------hhHHHHHHHHHHHHhcCCCc-
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSG----------------------QGLREMKNEASVIAKVQHKN- 173 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~n- 173 (398)
.|...+.||+|+||.||++...+|+.||||++..... ........|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4777899999999999999988899999998754320 01123567899999998874
Q ss_pred -ccceeeEEEeCCeeEEEEeccCCCCh--------------------------hHHhhcCCCCCceecCCCCeEEccccc
Q 037365 174 -LVRLLGCCIDKDEKILIYEYMPNKSL--------------------------DFFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 174 -Iv~l~~~~~~~~~~~lV~e~~~~g~L--------------------------~~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
+.+.++ .+..++||||+++++| +++|+||||+||++++++.++|+|||+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~ 171 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQ 171 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCc
Confidence 444444 2456899999999876 467889999999999999999999999
Q ss_pred ceecC
Q 037365 227 ARICG 231 (398)
Q Consensus 227 a~~~~ 231 (398)
+....
T Consensus 172 ~~~~~ 176 (198)
T cd05144 172 MVSTD 176 (198)
T ss_pred cccCC
Confidence 86544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.5e-13 Score=122.46 Aligned_cols=106 Identities=19% Similarity=0.316 Sum_probs=87.9
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChh--------hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ--------GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
+.||+|++|.||+|.+ .|..+++|+....... ....+.+|+.++..++|+|+.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 5778999986543211 123577899999999999998888888788889999999
Q ss_pred cCCCChh----------------------------HHhhcCCCCCceecCCCCeEEccccccee
Q 037365 194 MPNKSLD----------------------------FFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 194 ~~~g~L~----------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
++|++|. .+|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9998872 46789999999999 78899999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-13 Score=126.03 Aligned_cols=110 Identities=17% Similarity=0.158 Sum_probs=85.2
Q ss_pred CCCccceecccCceEEEEEE--EcCCCEEEEEEccCCChh------------------------hHHHHHHHHHHHHhcC
Q 037365 117 RFSDANKLGEGGFGPVYKGV--LRKGNEIAVKRLSGRSGQ------------------------GLREMKNEASVIAKVQ 170 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 170 (398)
.|++.+.||+|+||.||+|. ..+|+.||+|.+...... ....+.+|...+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 456999999998643210 1123568999999997
Q ss_pred CCc--ccceeeEEEeCCeeEEEEeccCCCCh--------------------------------h-HHhhcCCCCCceecC
Q 037365 171 HKN--LVRLLGCCIDKDEKILIYEYMPNKSL--------------------------------D-FFLFNLKASNILLDK 215 (398)
Q Consensus 171 H~n--Iv~l~~~~~~~~~~~lV~e~~~~g~L--------------------------------~-~~~~dlkp~NILl~~ 215 (398)
+.+ +.+++++ ...++||||+++++| + ++|+||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3444443 235899999999764 4 78899999999999
Q ss_pred CCCeEEcccccceecC
Q 037365 216 DMNPKISDFGMARICG 231 (398)
Q Consensus 216 ~~~~kl~DFGla~~~~ 231 (398)
++.++|+|||.+...+
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999987544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.7e-13 Score=139.48 Aligned_cols=113 Identities=19% Similarity=0.309 Sum_probs=89.5
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEc-cCC-C------hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRL-SGR-S------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
...|...+.||+|+||.||+|.+... .+++|+. ... . ....+.+.+|++++.+++|++++....++.+.+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556778999999999999998644 3444432 211 1 1123467899999999999999998888888888
Q ss_pred eEEEEeccCCCCh------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 187 KILIYEYMPNKSL------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 187 ~~lV~e~~~~g~L------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
.++||||+++++| +.+|+|+||+|||+ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8999999999988 35678999999999 577899999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-14 Score=150.37 Aligned_cols=223 Identities=19% Similarity=0.243 Sum_probs=163.9
Q ss_pred cCCCCccceecccCceEEEEEEEcC--CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK--GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 189 (398)
...|...+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3467777889999999998887644 4456777665432 233344556777777776 9999999999999999999
Q ss_pred EEeccCCCCh-----------------------------------hHHhhcCCCCCceecCCC-CeEEcccccceecCC-
Q 037365 190 IYEYMPNKSL-----------------------------------DFFLFNLKASNILLDKDM-NPKISDFGMARICGG- 232 (398)
Q Consensus 190 V~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~- 232 (398)
.++|..+|++ +..|+|+||+|.+++..+ ..|++|||+|..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 9999888866 245579999999999999 999999999987765
Q ss_pred CCcccccccccc-cccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 233 NELQANTSRIVG-TYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 233 ~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............|.. .....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~--- 250 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS-----NKGRF--- 250 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc-----ccccc---
Confidence 444444455678 9999999999885 4578899999999999999999997765544322222211 11000
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.............+++.+++..+|..|.+.+++..
T Consensus 251 ----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 ----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00001222334668888999999999999988764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.8e-13 Score=119.56 Aligned_cols=105 Identities=23% Similarity=0.362 Sum_probs=84.7
Q ss_pred eecccCceEEEEEEEcCCCEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSG--------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.||+|+||.||+|.+ ++..+++|....... .....+.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 478899998643211 11245678999999999988766666666777889999999
Q ss_pred CCCChh-------------------------HHhhcCCCCCceecCCCCeEEccccccee
Q 037365 195 PNKSLD-------------------------FFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 195 ~~g~L~-------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
+|++|. .+|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999873 45779999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.6e-12 Score=112.00 Aligned_cols=106 Identities=19% Similarity=0.249 Sum_probs=77.3
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChh--hHHH----------------------HHHHHHHHHhcCCCc--c
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ--GLRE----------------------MKNEASVIAKVQHKN--L 174 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--I 174 (398)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998654211 1111 134666666665443 4
Q ss_pred cceeeEEEeCCeeEEEEeccCCCC--------------------------------hhHHhhcCCCCCceecCCCCeEEc
Q 037365 175 VRLLGCCIDKDEKILIYEYMPNKS--------------------------------LDFFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 175 v~l~~~~~~~~~~~lV~e~~~~g~--------------------------------L~~~~~dlkp~NILl~~~~~~kl~ 222 (398)
.+.+++ ...++||||++++. .+++|+||||+||+++ ++.++|+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEE
Confidence 444443 34689999999842 2467889999999999 8999999
Q ss_pred ccccceecC
Q 037365 223 DFGMARICG 231 (398)
Q Consensus 223 DFGla~~~~ 231 (398)
|||.+....
T Consensus 157 Dfg~a~~~~ 165 (187)
T cd05119 157 DVPQAVEID 165 (187)
T ss_pred ECccccccc
Confidence 999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.30 E-value=8e-12 Score=105.29 Aligned_cols=107 Identities=18% Similarity=0.188 Sum_probs=90.9
Q ss_pred ccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC--CcccceeeEEEeCCeeEEEEeccCCC
Q 037365 120 DANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|...+..++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999999854 7899999866543 4578899999999987 58999999988888999999999887
Q ss_pred Ch----------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 198 SL----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 198 ~L----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
.+ ..+|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 156789999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.9e-11 Score=122.25 Aligned_cols=110 Identities=24% Similarity=0.330 Sum_probs=79.5
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhhHH----------------------------------------HHHH
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLR----------------------------------------EMKN 161 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 161 (398)
+.||+|++|.||+|++++|+.||||+..+....... .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 679999999999999999999999998654211100 1334
Q ss_pred HHHHHHhcC----CCcccceeeEEE-eCCeeEEEEeccCCCCh-------------------------------hHHhhc
Q 037365 162 EASVIAKVQ----HKNLVRLLGCCI-DKDEKILIYEYMPNKSL-------------------------------DFFLFN 205 (398)
Q Consensus 162 E~~~l~~l~----H~nIv~l~~~~~-~~~~~~lV~e~~~~g~L-------------------------------~~~~~d 205 (398)
|...+.+++ |.+-+.+-.++. ..+..+|||||++|++| +.+|+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~D 282 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHAD 282 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeCC
Confidence 555554442 322233322222 23467999999999866 466789
Q ss_pred CCCCCceecCCCCeEEcccccceecC
Q 037365 206 LKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 206 lkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
+||.||+++.++.++++|||++..++
T Consensus 283 ~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 283 LHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=8e-12 Score=126.70 Aligned_cols=117 Identities=20% Similarity=0.261 Sum_probs=82.2
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChh----------------------------------hHHHH
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ----------------------------------GLREM 159 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~~ 159 (398)
...|+. +.||+|++|.||+|++++ |+.||||+..+.-.. ..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999988 999999999754211 01112
Q ss_pred ------HHHHHHHHhcC----CCcccceeeEEEe-CCeeEEEEeccCCCCh-----------------------------
Q 037365 160 ------KNEASVIAKVQ----HKNLVRLLGCCID-KDEKILIYEYMPNKSL----------------------------- 199 (398)
Q Consensus 160 ------~~E~~~l~~l~----H~nIv~l~~~~~~-~~~~~lV~e~~~~g~L----------------------------- 199 (398)
.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 23333333332 3333333333322 3467899999999876
Q ss_pred --hHHhhcCCCCCceecCCC----CeEEcccccceecCC
Q 037365 200 --DFFLFNLKASNILLDKDM----NPKISDFGMARICGG 232 (398)
Q Consensus 200 --~~~~~dlkp~NILl~~~~----~~kl~DFGla~~~~~ 232 (398)
+.+|+|+||.||+++.++ .+++.|||+...++.
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 467789999999999888 999999999987754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.7e-11 Score=107.93 Aligned_cols=107 Identities=20% Similarity=0.271 Sum_probs=82.6
Q ss_pred ceec-ccCceEEEEEEEcCCCEEEEEEccCCC-------------hhhHHHHHHHHHHHHhcCCCcc--cceeeEEEeCC
Q 037365 122 NKLG-EGGFGPVYKGVLRKGNEIAVKRLSGRS-------------GQGLREMKNEASVIAKVQHKNL--VRLLGCCIDKD 185 (398)
Q Consensus 122 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~~ 185 (398)
..|| .|+.|+||..... +..+++|.+.... ......+.+|+.++.+++|+++ .+.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8899999998885 7789999885321 1223457889999999998875 67777654432
Q ss_pred ----eeEEEEeccCC-CCh---------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 186 ----EKILIYEYMPN-KSL---------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 186 ----~~~lV~e~~~~-g~L---------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
..++||||+++ .+| +++|+||||+|||++.++.++|+|||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 23599999997 455 467789999999999888999999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.8e-11 Score=117.15 Aligned_cols=218 Identities=20% Similarity=0.249 Sum_probs=151.8
Q ss_pred cCCCCccceecc--cCceEEEEEEE--c-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCe
Q 037365 115 TNRFSDANKLGE--GGFGPVYKGVL--R-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 186 (398)
...|.+.+.+|. |.+|.||.+.. . ++..+|+|+-+.. .+.....=.+|+...++++ |+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345677788999 99999999987 3 3788999984322 2222233356777777774 9999999999999999
Q ss_pred eEEEEeccCCCCh------------------------------------hHHhhcCCCCCceecCC-CCeEEccccccee
Q 037365 187 KILIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKD-MNPKISDFGMARI 229 (398)
Q Consensus 187 ~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~-~~~kl~DFGla~~ 229 (398)
.++-+|++.+-.+ .++|-|+||.||++..+ ..++++|||+...
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 9999999864322 24455899999999988 8899999999988
Q ss_pred cCCCCcccc---cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 230 CGGNELQAN---TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 230 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
+.+...... .....|...|++||.. .+.++.+.|+||+|.++.+..++...+....... |..++. .
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------W~~~r~---~ 341 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------WSQLRQ---G 341 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-------cccccc---c
Confidence 876543221 1223677889999966 5568899999999999999999876643211110 111111 1
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+.+....+ ....+...+.++++.+|..|++...+.+
T Consensus 342 ~ip~e~~~~------~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 YIPLEFCEG------GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cCchhhhcC------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111 1123444888999999999999988764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.8e-09 Score=91.53 Aligned_cols=103 Identities=20% Similarity=0.162 Sum_probs=79.0
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCccc-ceeeEEEeCCeeEEEEeccCCCCh
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
.+.++.|.++.||++... +..+++|....... ....+.+|..++..+.+.+++ +++++. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999875 78899998765432 123467899999998765554 455443 3346899999999866
Q ss_pred h-----------------------------HHhhcCCCCCceecCCCCeEEcccccce
Q 037365 200 D-----------------------------FFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 200 ~-----------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
. .+|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 2 28899999999998 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.8e-09 Score=104.53 Aligned_cols=218 Identities=18% Similarity=0.154 Sum_probs=149.1
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEc--CCCEEEEEEccCCChhhHH--HHHHHHHHHHhc-CCCcccceeeEEEeCC
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLR--KGNEIAVKRLSGRSGQGLR--EMKNEASVIAKV-QHKNLVRLLGCCIDKD 185 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 185 (398)
....+.+|..+..||.|.|+.|+....+ ++..+++|.+......... .-..|+.+...+ .|.+++.+...+...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445567888999999999999998755 3778999988655322222 224566666666 5999999998888888
Q ss_pred eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCC-CCeEEcccccceecCC
Q 037365 186 EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKD-MNPKISDFGMARICGG 232 (398)
Q Consensus 186 ~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~-~~~kl~DFGla~~~~~ 232 (398)
+.|+-.|||.++++ ..+|.|+||+||++..+ +..++.|||....+.-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 88999999999876 35667999999999876 7889999998864221
Q ss_pred CCcccccccccccccc-cChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 233 NELQANTSRIVGTYGY-MSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
.. .....++..| .+++......+..+.|++|||..+.|.+++..-... ......+...
T Consensus 420 ~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----------------~~~~~~i~~~ 478 (524)
T KOG0601|consen 420 SS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----------------GVQSLTIRSG 478 (524)
T ss_pred ec----ccccccccccccchhhccccccccccccccccccccccccCcccCcc-----------------cccceeeecc
Confidence 11 1111223334 356666677789999999999999999998754211 0011111111
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHh
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 352 (398)
.... .+.....+..+...+..+++..||.+.++....+
T Consensus 479 ~~p~---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 479 DTPN---LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccC---CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0100 1112245667888899999999999988775543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.1e-09 Score=112.75 Aligned_cols=215 Identities=16% Similarity=0.208 Sum_probs=143.1
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
...+.+.+.+-+-+|.++.++.+.-.. |...+.|..... .....+....+-.++-..+||.++....-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345677788888899999999876443 433333332211 1111223333444444445677776666655677889
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC----
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG---- 232 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~---- 232 (398)
|+++|+.+++| ...|+|++|.|.|...++..+++|||.....+.
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999977765 257889999999999999999999984322110
Q ss_pred --C-------------------Ccc----cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCC
Q 037365 233 --N-------------------ELQ----ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRT 287 (398)
Q Consensus 233 --~-------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 287 (398)
. ... .......||+.|.+||.+.+......+|+|+.|++++|.++|.+||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 000 012245799999999999999999999999999999999999999653322
Q ss_pred CccchhHHHHHhhhcCCccccchhhhhcccC----hHHHHHHHHHHHHHchhcCCCCCCCHH
Q 037365 288 DTLNLLGYAWDLWRSNRTLELTDAILEDEYS----SKQVLLRYVNIALLCVQESADDRPTTN 345 (398)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~ 345 (398)
..+++.++..... .........+++...+..+|.+|-.+.
T Consensus 1041 ------------------q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 ------------------QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ------------------hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1222222222111 122334567888899999999998776
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.2e-07 Score=91.99 Aligned_cols=139 Identities=14% Similarity=0.198 Sum_probs=100.6
Q ss_pred EcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCC------------------
Q 037365 137 LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS------------------ 198 (398)
Q Consensus 137 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~------------------ 198 (398)
..++.+|.|...+..+........+-++.|+.++||||++++..+...+..|||+|-+.--.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qI 113 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQI 113 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHHH
Confidence 33588888888877765555667788899999999999999999999999999999764321
Q ss_pred ----------hhHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHH
Q 037365 199 ----------LDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSF 268 (398)
Q Consensus 199 ----------L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 268 (398)
-..+|.+|.-..|+++..|.-||++|-++......... .....---.|..|+.+.... ...|.|-|
T Consensus 114 l~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s~D~~~L 189 (690)
T KOG1243|consen 114 LAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WSIDSWGL 189 (690)
T ss_pred HHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cchhhhhH
Confidence 03455678888899999999999999887654322210 01111122356666443222 45699999
Q ss_pred HHHHHHHHcCC
Q 037365 269 GVLLLEIVSGK 279 (398)
Q Consensus 269 Gvvl~elltg~ 279 (398)
||++||++.|.
T Consensus 190 g~li~el~ng~ 200 (690)
T KOG1243|consen 190 GCLIEELFNGS 200 (690)
T ss_pred HHHHHHHhCcc
Confidence 99999999994
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.3e-07 Score=88.06 Aligned_cols=167 Identities=21% Similarity=0.245 Sum_probs=103.9
Q ss_pred HHHHhcCCCcccceeeEEEeC-----CeeEEEEeccCCCChhHHh-----------------------------------
Q 037365 164 SVIAKVQHKNLVRLLGCCIDK-----DEKILIYEYMPNKSLDFFL----------------------------------- 203 (398)
Q Consensus 164 ~~l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~~~~g~L~~~~----------------------------------- 203 (398)
.-|-++-|.|||+++.|+.+. ....++.|||..|++..++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 345556799999999998764 3578999999999985444
Q ss_pred ---hcCCCCCceecCCCCeEEcccccceecC--CCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcC
Q 037365 204 ---FNLKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSG 278 (398)
Q Consensus 204 ---~dlkp~NILl~~~~~~kl~DFGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg 278 (398)
.++..+-|++..+|-+|+.--.-...-. ............+-++|.+||.-.....+.++|||+||....||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 3677778888888878775321111000 00001112223467889999988777788999999999999999887
Q ss_pred CCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 279 KKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 279 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..-..........-... ......+.+. .-.+++..|++.+|..||+|.+++.
T Consensus 279 Eiq~tnseS~~~~ee~i------a~~i~~len~-------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENI------ANVIIGLENG-------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceeehhhhh------hhheeeccCc-------------cccCcCcccccCCCCCCcchhhhhc
Confidence 64321111110000000 0000000000 0135788999999999999998764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.7e-06 Score=76.83 Aligned_cols=105 Identities=12% Similarity=0.114 Sum_probs=75.9
Q ss_pred ceecccCceEEEEEEEcC-------CCEEEEEEccCCC----------------------hhhHHHH----HHHHHHHHh
Q 037365 122 NKLGEGGFGPVYKGVLRK-------GNEIAVKRLSGRS----------------------GQGLREM----KNEASVIAK 168 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~ 168 (398)
..||.|--+.||.|...+ +..+|||..+... ....+.+ .+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998653 4789999764220 0112223 379999999
Q ss_pred cCC--CcccceeeEEEeCCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCcee
Q 037365 169 VQH--KNLVRLLGCCIDKDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILL 213 (398)
Q Consensus 169 l~H--~nIv~l~~~~~~~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl 213 (398)
+.. -++.+.+++ ..-++||||+.++.+ +++|+||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 853 456666654 467899999976421 35678999999999
Q ss_pred cCCCCeEEcccccceecC
Q 037365 214 DKDMNPKISDFGMARICG 231 (398)
Q Consensus 214 ~~~~~~kl~DFGla~~~~ 231 (398)
+ ++.+.|+|||.+-...
T Consensus 159 ~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 159 H-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred E-CCcEEEEECCCceeCC
Confidence 7 4679999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.2e-06 Score=79.14 Aligned_cols=78 Identities=15% Similarity=0.244 Sum_probs=59.9
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCC--CcccceeeEEEeCC---eeEEEEeccC
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSG-QGLREMKNEASVIAKVQH--KNLVRLLGCCIDKD---EKILIYEYMP 195 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~---~~~lV~e~~~ 195 (398)
+.|+.|..+.||++...+|..+++|....... .....+..|.+++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987678999999765432 134577899999999976 34677787776542 5689999998
Q ss_pred CCCh
Q 037365 196 NKSL 199 (398)
Q Consensus 196 ~g~L 199 (398)
|+++
T Consensus 84 G~~l 87 (223)
T cd05154 84 GRVL 87 (223)
T ss_pred CEec
Confidence 7744
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.5e-06 Score=73.96 Aligned_cols=106 Identities=21% Similarity=0.305 Sum_probs=78.8
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCC---hh-----hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS---GQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..+++|+-+.+|.+.+. |..+.+|.-.++. +. ....-.+|..++.+++--.|..-.=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999774 5556666543321 11 123456799999998765665555566678888999999
Q ss_pred cCCCCh-------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 194 MPNKSL-------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 194 ~~~g~L-------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
.+|..| +++|.||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998876 467789999999997654 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.4e-06 Score=70.91 Aligned_cols=109 Identities=24% Similarity=0.317 Sum_probs=79.8
Q ss_pred ccceecccCceEEEEEEEcCCCEEEEEEccCCC--------hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 120 DANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
....+-+|+-+.|+++.+. |+...||.-..+. .-..+...+|..+|.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578899999999999995 7777777542221 112345678999999987555554444566777778999
Q ss_pred eccCCCCh-----------------------------------hHHhhcCCCCCceecCCC---CeEEccccccee
Q 037365 192 EYMPNKSL-----------------------------------DFFLFNLKASNILLDKDM---NPKISDFGMARI 229 (398)
Q Consensus 192 e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~---~~kl~DFGla~~ 229 (398)
||.++-+. +++|.||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988422 577889999999996554 358999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.5e-06 Score=71.72 Aligned_cols=96 Identities=23% Similarity=0.257 Sum_probs=64.2
Q ss_pred EEEEEEEcCCCEEEEEEccCCC-------------h-------------hhHHHHHHHHHHHHhcCCC--cccceeeEEE
Q 037365 131 PVYKGVLRKGNEIAVKRLSGRS-------------G-------------QGLREMKNEASVIAKVQHK--NLVRLLGCCI 182 (398)
Q Consensus 131 ~Vy~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~ 182 (398)
.||.|...+|..+|+|..+... . .......+|...|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999889999999864321 0 0122456899999999865 456666542
Q ss_pred eCCeeEEEEeccC--CCCh-------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 183 DKDEKILIYEYMP--NKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 183 ~~~~~~lV~e~~~--~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
.-+|||||++ |..+ +++|.||.+.|||++++ .+.++|||.+..
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 4579999998 4322 46678999999999887 899999998865
Q ss_pred cC
Q 037365 230 CG 231 (398)
Q Consensus 230 ~~ 231 (398)
..
T Consensus 156 ~~ 157 (188)
T PF01163_consen 156 SS 157 (188)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.4e-06 Score=83.52 Aligned_cols=110 Identities=19% Similarity=0.314 Sum_probs=77.7
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhhH------------------------------H----------HHHH
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGL------------------------------R----------EMKN 161 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 161 (398)
+.|+.++-|.||+|++++|+.||||+..+.-.... + .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67899999999999999999999999876421100 0 1123
Q ss_pred HHHHHHhcC-----CCcccceeeEE-EeCCeeEEEEeccCCCCh-------------------------------hHHhh
Q 037365 162 EASVIAKVQ-----HKNLVRLLGCC-IDKDEKILIYEYMPNKSL-------------------------------DFFLF 204 (398)
Q Consensus 162 E~~~l~~l~-----H~nIv~l~~~~-~~~~~~~lV~e~~~~g~L-------------------------------~~~~~ 204 (398)
|...+.+++ .+++ ++=.++ .-.+...|+|||++|-.+ +.+|.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHa 289 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHA 289 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCcccc
Confidence 444444432 2222 222222 224577899999988644 57888
Q ss_pred cCCCCCceecCCCCeEEcccccceecCC
Q 037365 205 NLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 205 dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
|..|.||+++.+|.+-+.|||+...+..
T Consensus 290 DpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 290 DPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999876653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.5e-05 Score=71.72 Aligned_cols=107 Identities=20% Similarity=0.224 Sum_probs=83.0
Q ss_pred CCccceecccCceEEEEEEEcCCCEEEEEEccCCC----------------------hhhHHHHHHHHHHHHhcCCC--c
Q 037365 118 FSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS----------------------GQGLREMKNEASVIAKVQHK--N 173 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~--n 173 (398)
..+...||-|--+.||.|..++|.++|||.=+... .-.....++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45668899999999999999999999999422110 01123456899999998754 6
Q ss_pred ccceeeEEEeCCeeEEEEeccCCCCh---------------------------hHHhhcCCCCCceecCCCCeEEccccc
Q 037365 174 LVRLLGCCIDKDEKILIYEYMPNKSL---------------------------DFFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 174 Iv~l~~~~~~~~~~~lV~e~~~~g~L---------------------------~~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
+.+-+++ +..++||||.+|-.| +++|.|+.+=||+++++|.+.++||--
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ 248 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQ 248 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcc
Confidence 6666655 456899999988654 578899999999999999999999965
Q ss_pred ce
Q 037365 227 AR 228 (398)
Q Consensus 227 a~ 228 (398)
+.
T Consensus 249 ~v 250 (304)
T COG0478 249 AV 250 (304)
T ss_pred cc
Confidence 43
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.5e-06 Score=87.67 Aligned_cols=162 Identities=17% Similarity=0.090 Sum_probs=119.0
Q ss_pred hhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc-ccceeeEEEeCCeeEEEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~ 191 (398)
..+..+...+-+++|++++++|.+....+....+.+... ....-++++|.+++||| .+..++-+..++..++++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 334445556678999999999988655555556655433 33456889999999999 777888888888999999
Q ss_pred eccCCC-C-h--------------------------hHHhhc--CCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 192 EYMPNK-S-L--------------------------DFFLFN--LKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 192 e~~~~g-~-L--------------------------~~~~~d--lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+++.+| + . ...|.. ..+.||+..+ +..|..||+....+.... ....
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t 389 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSE-EEVKLLDFAVPPQLTRTM---KPRT 389 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcccccccc-cccccccccCCcccCccc---cccc
Confidence 999888 2 1 111111 2234777654 678999999887665432 3445
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCC
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTG 283 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~ 283 (398)
..+|+.|+|||+...+.+..+.|.|++|+--.++--|.+|-.
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 688999999999999999999999999987777887877643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00016 Score=71.68 Aligned_cols=134 Identities=25% Similarity=0.384 Sum_probs=94.7
Q ss_pred ceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEE----eCCeeEEEEeccCCC-ChhHH
Q 037365 129 FGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI----DKDEKILIYEYMPNK-SLDFF 202 (398)
Q Consensus 129 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----~~~~~~lV~e~~~~g-~L~~~ 202 (398)
-.+.|++... +|..|++|++.............-++.++++.|+|+|++..++. .+..+++|++|.|+. +|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3567888754 59999999994433222223344578899999999999999887 355789999999874 55444
Q ss_pred hh-----------------------------------------------cCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 203 LF-----------------------------------------------NLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 203 ~~-----------------------------------------------dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
|. -|.+.+||++.+.+++|+..|....+..+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~ 448 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT 448 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC
Confidence 42 3778899999888899988887655443220
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCC
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKN 281 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P 281 (398)
|.+.+ -.+-|.=.||.+++.|.||...
T Consensus 449 ----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 449 ----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 11111 1245888999999999999644
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=4e-05 Score=77.62 Aligned_cols=109 Identities=17% Similarity=0.291 Sum_probs=75.8
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhh-------------------------------HH------HHHHHHH
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQG-------------------------------LR------EMKNEAS 164 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~ 164 (398)
+.||.-+.|.||+|+.++|+.||||+-.+.-... .+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999876542110 01 1223333
Q ss_pred HHHh----cCCCc------ccceeeEEEeCCeeEEEEeccCCCCh-------------------------------hHHh
Q 037365 165 VIAK----VQHKN------LVRLLGCCIDKDEKILIYEYMPNKSL-------------------------------DFFL 203 (398)
Q Consensus 165 ~l~~----l~H~n------Iv~l~~~~~~~~~~~lV~e~~~~g~L-------------------------------~~~~ 203 (398)
-..+ +.|-+ |.+++-.+ .....|+||||+|..+ +.+|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~GffH 324 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFFH 324 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCcc
Confidence 3222 23444 22222222 3468999999999865 5788
Q ss_pred hcCCCCCceecC----CCCeEEcccccceecCC
Q 037365 204 FNLKASNILLDK----DMNPKISDFGMARICGG 232 (398)
Q Consensus 204 ~dlkp~NILl~~----~~~~kl~DFGla~~~~~ 232 (398)
.|-.|.||+++. ++.+.+-|||+...+..
T Consensus 325 aDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 325 ADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 899999999983 67899999999876653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=9.2e-06 Score=82.79 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=90.4
Q ss_pred CChhHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc------c-cccccccccccChhhhccCCCCcccccHHHH
Q 037365 197 KSLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA------N-TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFG 269 (398)
Q Consensus 197 g~L~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 269 (398)
++-..+|++|.|++|.++.++..||+.|+.+........+. . ..-..-...|.|||++.+...+.++|+||+|
T Consensus 117 ~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG 196 (700)
T KOG2137|consen 117 RSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLG 196 (700)
T ss_pred cCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccccccccceeee
Confidence 34567888999999999999999999999876544311110 0 0111234579999999998889999999999
Q ss_pred HHHHHHHcCCCC-CCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 037365 270 VLLLEIVSGKKN-TGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVV 348 (398)
Q Consensus 270 vvl~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 348 (398)
|++|.+..|..+ +...... +. .... .. ..+.... .+ ....+.++.+=+.+++..++.-||++.++.
T Consensus 197 ~li~~i~~~gk~i~~a~~~~---~~-~~~~----~~---~~~~~~~-~~-s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 197 VLIYTIYNGGKSIIAANGGL---LS-YSFS----RN---LLNAGAF-GY-SNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred eEEEEEecCCcchhhccCCc---ch-hhhh----hc---ccccccc-cc-cccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 999999955544 2211110 00 0000 00 0000000 00 234455678888899999999999887766
Q ss_pred H
Q 037365 349 S 349 (398)
Q Consensus 349 ~ 349 (398)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00046 Score=67.04 Aligned_cols=154 Identities=16% Similarity=0.091 Sum_probs=89.1
Q ss_pred hcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcC
Q 037365 204 FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSG 278 (398)
Q Consensus 204 ~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg 278 (398)
.|+.++|+|+++++.+.|.|-..-....++. .....+|...|.+||.-. +..-+...|-|.||+++++++.|
T Consensus 141 GDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 141 GDVNQNSFLVSDDSKVVLVDSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred cccCccceeeecCceEEEEcccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 4999999999999999998743222211111 122347889999999665 23346789999999999999986
Q ss_pred -CCCCCCCCC--C-ccchh-HHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhc--CCCCCCCHHHHHHHH
Q 037365 279 -KKNTGFYRT--D-TLNLL-GYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQE--SADDRPTTNDVVSML 351 (398)
Q Consensus 279 -~~P~~~~~~--~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~--dP~~RPt~~evl~~L 351 (398)
+.||..-.. + ..-.. +.....|........-...-.......-....+..|..+|+.. ++.-|||++.-+..|
T Consensus 218 grHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred CCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 888753211 1 00000 1111111100000000000001111222334567788888864 366899999988888
Q ss_pred hhcccccCC
Q 037365 352 TNEAAALLP 360 (398)
Q Consensus 352 ~~~~~~~~~ 360 (398)
..+.+.+.+
T Consensus 298 ~al~~~L~~ 306 (637)
T COG4248 298 DALRQQLKK 306 (637)
T ss_pred HHHHHhhhh
Confidence 777665544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00031 Score=64.09 Aligned_cols=72 Identities=25% Similarity=0.243 Sum_probs=54.7
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--ccceeeEEEeCCeeEEEEeccCCCC
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGCCIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~e~~~~g~ 198 (398)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999983 25567788876533 2345688999999986443 4677888877778889999999963
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00075 Score=63.17 Aligned_cols=106 Identities=16% Similarity=0.097 Sum_probs=70.6
Q ss_pred eecccCceEEEEEEEcCCCEEEEEEccCCChh-hHH----------HHHHHHHHHHhcCCCc--ccceeeEEEe-----C
Q 037365 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ-GLR----------EMKNEASVIAKVQHKN--LVRLLGCCID-----K 184 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~H~n--Iv~l~~~~~~-----~ 184 (398)
.+-.-....|++..+ +|+.+.||+....... ..+ .+.+|...+.++..-+ ..+.+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344333445667766 4788999987544311 111 3678999888885433 3344555543 2
Q ss_pred CeeEEEEeccCCC-Ch----------------------------------hHHhhcCCCCCceecC-------CCCeEEc
Q 037365 185 DEKILIYEYMPNK-SL----------------------------------DFFLFNLKASNILLDK-------DMNPKIS 222 (398)
Q Consensus 185 ~~~~lV~e~~~~g-~L----------------------------------~~~~~dlkp~NILl~~-------~~~~kl~ 222 (398)
...++|+|++++. +| +++|+|++++|||++. +..+.++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3578999999875 44 3566799999999975 4678999
Q ss_pred cccccee
Q 037365 223 DFGMARI 229 (398)
Q Consensus 223 DFGla~~ 229 (398)
||+.+..
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9997753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0005 Score=59.42 Aligned_cols=104 Identities=24% Similarity=0.307 Sum_probs=73.5
Q ss_pred CccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccc-eeeEEEeCCeeEEEEeccCCC
Q 037365 119 SDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR-LLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lV~e~~~~g 197 (398)
...+.||+|.+|.||+|.+. |..+|+|+-...++ ...+..|.++|..++-.++.. ++.|- .-++.|||..|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34577999999999999996 66899998766543 467889999999998776644 44443 234559999997
Q ss_pred ChhHHh-------------------------hcC-CCCCceecCCCCeEEccccccee
Q 037365 198 SLDFFL-------------------------FNL-KASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 198 ~L~~~~-------------------------~dl-kp~NILl~~~~~~kl~DFGla~~ 229 (398)
.|...- ..| .|...++-+++.+.|+||.-|+.
T Consensus 98 ~L~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 773222 122 24444444555899999988764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0015 Score=59.64 Aligned_cols=121 Identities=18% Similarity=0.196 Sum_probs=81.4
Q ss_pred cchhhhhhhcCCCCccce---ecccCceEEEEEEEcCCCEEEEEEccCCChhh-------------------HH-----H
Q 037365 106 FSFSSVSTATNRFSDANK---LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQG-------------------LR-----E 158 (398)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~---lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~ 158 (398)
.....+....++..+... |++|.-+.||+|...++..+|+|++....... .+ .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 334444455555555444 55677789999998889999999986442110 01 1
Q ss_pred HHHHHHHHHhcC--CCcccceeeEEEeCCeeEEEEeccCCCCh---------------------------------hHHh
Q 037365 159 MKNEASVIAKVQ--HKNLVRLLGCCIDKDEKILIYEYMPNKSL---------------------------------DFFL 203 (398)
Q Consensus 159 ~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~e~~~~g~L---------------------------------~~~~ 203 (398)
..+|+.-|+++. +-.+.+-+++. .-.|||||+..... +.+|
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVH 190 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVH 190 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCccc
Confidence 235777777763 34444555543 34699999876522 4678
Q ss_pred hcCCCCCceecCCCCeEEcccccceecC
Q 037365 204 FNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 204 ~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
.||..=|||+. ++.+.|+|||-|....
T Consensus 191 gDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 191 GDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ccchhhheEEE-CCeEEEEECccccccC
Confidence 89999999999 8899999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0039 Score=56.16 Aligned_cols=114 Identities=15% Similarity=0.153 Sum_probs=74.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHH---------HHHHHHHhcCC---CcccceeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMK---------NEASVIAKVQH---KNLVRLLGCC 181 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~H---~nIv~l~~~~ 181 (398)
..++|...+.+-......|.+-.. +|..+.+|.........++.|. +++..+.+++. ...+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346777778887777777777766 4788999988766433333322 33344444432 3333433333
Q ss_pred Ee-----CCeeEEEEeccCCCCh------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 182 ID-----KDEKILIYEYMPNKSL------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 182 ~~-----~~~~~lV~e~~~~g~L------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
.. ....+++|||++|-.| +.+|.|..|.|+++++++ +++.||+..+.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 32 2355799999999755 356789999999998654 99999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0031 Score=56.21 Aligned_cols=103 Identities=16% Similarity=0.281 Sum_probs=73.9
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCC----------------hhhHHHHHHHHHHHHhcC------CCccccee
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS----------------GQGLREMKNEASVIAKVQ------HKNLVRLL 178 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~l~ 178 (398)
...||+|+.-.||. +++.....||+..... ....++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999999986 4456677888886554 122455666777666665 88999999
Q ss_pred eEEEeCCeeEEEEeccCCC--C----h---------------------------hHHhhcCCCCCceecCC--C--CeEE
Q 037365 179 GCCIDKDEKILIYEYMPNK--S----L---------------------------DFFLFNLKASNILLDKD--M--NPKI 221 (398)
Q Consensus 179 ~~~~~~~~~~lV~e~~~~g--~----L---------------------------~~~~~dlkp~NILl~~~--~--~~kl 221 (398)
|+..++-..-+|+|...+. + | .++.+|++|.||++... + .+.|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvl 163 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVL 163 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEE
Confidence 9999999999999986543 2 2 23335899999999532 2 4677
Q ss_pred cc-cc
Q 037365 222 SD-FG 225 (398)
Q Consensus 222 ~D-FG 225 (398)
+| ||
T Consensus 164 IDG~G 168 (199)
T PF10707_consen 164 IDGLG 168 (199)
T ss_pred EeCCC
Confidence 76 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0012 Score=59.73 Aligned_cols=76 Identities=20% Similarity=0.310 Sum_probs=55.3
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC--cccceeeEEEe---CCeeEEEEeccC
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLVRLLGCCID---KDEKILIYEYMP 195 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~---~~~~~lV~e~~~ 195 (398)
++.++.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++..+.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999876 69999997654 4456778899998888533 35566765533 335689999998
Q ss_pred CCCh
Q 037365 196 NKSL 199 (398)
Q Consensus 196 ~g~L 199 (398)
+..+
T Consensus 79 g~~~ 82 (239)
T PF01636_consen 79 GRPL 82 (239)
T ss_dssp SEEH
T ss_pred cccc
Confidence 8754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0027 Score=58.42 Aligned_cols=73 Identities=15% Similarity=0.173 Sum_probs=51.8
Q ss_pred eecccCc-eEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 123 KLGEGGF-GPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 123 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
.|-.|.. +.||+.... +..+.+|...... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3444554 788998764 4678888875543 245677898888884 44456778877766778999999988654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.005 Score=54.77 Aligned_cols=106 Identities=18% Similarity=0.291 Sum_probs=75.7
Q ss_pred CCCCccceecccCc-eEEEEEEEcCCCEEEEEEccCC---Ch------------------hhHHHHHHHHHHHHhcC---
Q 037365 116 NRFSDANKLGEGGF-GPVYKGVLRKGNEIAVKRLSGR---SG------------------QGLREMKNEASVIAKVQ--- 170 (398)
Q Consensus 116 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~---~~------------------~~~~~~~~E~~~l~~l~--- 170 (398)
.+++..+.||.|.- |.||+++.. |+.+|+|.+... .. ....-|..|+....+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888999999999 999999995 889999993211 00 11234678888888875
Q ss_pred CCcc--cceeeEEEeC------------------CeeEEEEeccCCCC------h-------------hHHhhcCCCCCc
Q 037365 171 HKNL--VRLLGCCIDK------------------DEKILIYEYMPNKS------L-------------DFFLFNLKASNI 211 (398)
Q Consensus 171 H~nI--v~l~~~~~~~------------------~~~~lV~e~~~~g~------L-------------~~~~~dlkp~NI 211 (398)
+.++ |+.+||..-. ....||.||.+... + +++.+|+|+.|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny 195 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLGIVPRDVKPRNY 195 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCCeeeccCccccc
Confidence 4566 9999998432 13468999988764 1 223347888876
Q ss_pred eecCCCCeEEcccccc
Q 037365 212 LLDKDMNPKISDFGMA 227 (398)
Q Consensus 212 Ll~~~~~~kl~DFGla 227 (398)
. .-||+|||.+
T Consensus 196 ~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 196 R-----GGKLVDFSSS 206 (207)
T ss_pred c-----CCEEEecccC
Confidence 5 3589999854
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0069 Score=59.86 Aligned_cols=74 Identities=16% Similarity=0.262 Sum_probs=53.9
Q ss_pred ceecccCceEEEEEEEcCC-CEEEEEEccCC------C-hhhHHHHHHHHHHHHhcC---CCcccceeeEEEeCCeeEEE
Q 037365 122 NKLGEGGFGPVYKGVLRKG-NEIAVKRLSGR------S-GQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV 190 (398)
+.||.|.++.||+....+| +.+.||.-.+. . +...+....|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999999776 48999985321 1 123456677888888763 2456777776 44667899
Q ss_pred EeccCCC
Q 037365 191 YEYMPNK 197 (398)
Q Consensus 191 ~e~~~~g 197 (398)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999874
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0017 Score=43.55 Aligned_cols=43 Identities=51% Similarity=0.744 Sum_probs=37.3
Q ss_pred cccCCCCCCccccccccccccCCCCCC--CCCcccceeeeecccC
Q 037365 356 AALLPPKQPAFSYVRNTVTSTSSTGKT--EDCSINQVTISLLEAR 398 (398)
Q Consensus 356 ~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~s~~~~~~~~~~~~ 398 (398)
..++.|++|+|...+......+++... +.+|.|+++++.++||
T Consensus 4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 467889999999998877777777666 8999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0049 Score=57.20 Aligned_cols=72 Identities=11% Similarity=0.063 Sum_probs=45.9
Q ss_pred eecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcc-cceeeEEEeCCeeEEEEeccCCCCh
Q 037365 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
.+..|-.+.+|+... ++..+++|..........-...+|..+++.+....+ .++++.+. -++||||++|..+
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence 355677889998874 467788887654322211235778899988864433 34444432 3689999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.0084 Score=56.77 Aligned_cols=75 Identities=8% Similarity=0.080 Sum_probs=49.4
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--ccceeeE------EEeCCeeEEEEe
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGC------CIDKDEKILIYE 192 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~------~~~~~~~~lV~e 192 (398)
.+.+..|....+|+.... +..+++|..... ....+..|+.++..+.+.+ +.+.+.. ...++..+.+++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777888899998764 456888987642 2345667888888875332 4444331 123456789999
Q ss_pred ccCCCCh
Q 037365 193 YMPNKSL 199 (398)
Q Consensus 193 ~~~~g~L 199 (398)
|++|..+
T Consensus 95 ~i~G~~~ 101 (296)
T cd05153 95 FLAGEHL 101 (296)
T ss_pred eCCCCCC
Confidence 9988653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.021 Score=54.70 Aligned_cols=73 Identities=8% Similarity=0.064 Sum_probs=43.7
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--ccceee------EEEeCCeeEEEEec
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLG------CCIDKDEKILIYEY 193 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~------~~~~~~~~~lV~e~ 193 (398)
+.++.|....+|+....+| .+++|++.... .+.+..|...+..+...+ +.+.+. +....+..+++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4567777789999887545 68889875222 233444555555553211 233332 12235567899999
Q ss_pred cCCCC
Q 037365 194 MPNKS 198 (398)
Q Consensus 194 ~~~g~ 198 (398)
++|..
T Consensus 104 l~G~~ 108 (319)
T PRK05231 104 LEGKW 108 (319)
T ss_pred cCCCC
Confidence 98864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.012 Score=64.07 Aligned_cols=77 Identities=17% Similarity=0.371 Sum_probs=57.2
Q ss_pred cceecccCceEEEEEEEcCC---CEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCcc--cceeeEEEeC---CeeEEE
Q 037365 121 ANKLGEGGFGPVYKGVLRKG---NEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNL--VRLLGCCIDK---DEKILI 190 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~~~~~~~---~~~~lV 190 (398)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|..+++.+. |.++ .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887653 467788765432 122356789999999995 6665 7888888764 467899
Q ss_pred EeccCCC
Q 037365 191 YEYMPNK 197 (398)
Q Consensus 191 ~e~~~~g 197 (398)
|||++|.
T Consensus 123 ME~v~G~ 129 (822)
T PLN02876 123 MEYLEGR 129 (822)
T ss_pred EEecCCc
Confidence 9999875
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.012 Score=53.60 Aligned_cols=73 Identities=15% Similarity=0.268 Sum_probs=47.8
Q ss_pred ceecccCceEEEEEEEcC--CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc-ccceeeEEEeCCeeEEEEeccCCCC
Q 037365 122 NKLGEGGFGPVYKGVLRK--GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~e~~~~g~ 198 (398)
+.|..|-...+|+....+ +..+++|....... ......+|..++..+...+ ..++++.+. -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999998764 67888997754322 1123357888888885433 344444332 237999988764
Q ss_pred h
Q 037365 199 L 199 (398)
Q Consensus 199 L 199 (398)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.013 Score=53.58 Aligned_cols=72 Identities=13% Similarity=0.248 Sum_probs=44.3
Q ss_pred ceecccCce-EEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC---cccceeeEEEeC---CeeEEEEecc
Q 037365 122 NKLGEGGFG-PVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCIDK---DEKILIYEYM 194 (398)
Q Consensus 122 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~---~~~~lV~e~~ 194 (398)
+.++.|+.. .||+. +..+++|...... ....+.+|.+.+..+... -+.+.++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777766 58875 3356777655422 235788899999887532 234444433322 2347889998
Q ss_pred CCCCh
Q 037365 195 PNKSL 199 (398)
Q Consensus 195 ~~g~L 199 (398)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 88644
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.016 Score=52.05 Aligned_cols=73 Identities=22% Similarity=0.271 Sum_probs=54.3
Q ss_pred HHHHHHHHHHHhcCCC--cccceeeEEEeCC----eeEEEEeccCCC-Ch------------------------------
Q 037365 157 REMKNEASVIAKVQHK--NLVRLLGCCIDKD----EKILIYEYMPNK-SL------------------------------ 199 (398)
Q Consensus 157 ~~~~~E~~~l~~l~H~--nIv~l~~~~~~~~----~~~lV~e~~~~g-~L------------------------------ 199 (398)
....+|...+..+..- .+.+.+++..... ..++|+|++++. +|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 3567788888887533 3456666665532 458999999874 44
Q ss_pred --hHHhhcCCCCCceecCCC---CeEEccccccee
Q 037365 200 --DFFLFNLKASNILLDKDM---NPKISDFGMARI 229 (398)
Q Consensus 200 --~~~~~dlkp~NILl~~~~---~~kl~DFGla~~ 229 (398)
+++|+|+++.|||++.+. .+.++||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 466779999999998877 799999997765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.021 Score=57.26 Aligned_cols=155 Identities=21% Similarity=0.245 Sum_probs=84.1
Q ss_pred HHHHHHHHHHHhcCCCcccceeeEEEeCC-eeEEEEeccCCCChhHHhhcCCCCCceecCCCC---------eEEccccc
Q 037365 157 REMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILIYEYMPNKSLDFFLFNLKASNILLDKDMN---------PKISDFGM 226 (398)
Q Consensus 157 ~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e~~~~g~L~~~~~dlkp~NILl~~~~~---------~kl~DFGl 226 (398)
.++....+.++.+.|+|...++++..... ...+|+|++ +-+|.++.+ ..| +.+.++. .+.+|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~---~~~-l~~~s~~~~~~~~~~~~~~td--- 98 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK---TGN-LKDESLLAHGVLHLNIIYITD--- 98 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH---hcc-cchhhhcccccceehhhhccc---
Confidence 45666788899999999999999887654 456788887 446655442 222 2222221 12222
Q ss_pred ceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 227 ARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
. .-| .| | .+..+|+||||+|.++.|+.-|..-+... ...+........+......
T Consensus 99 --~-------------~~t-~~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~--~~s~~l~~i~k~~~~d~~~ 153 (725)
T KOG1093|consen 99 --H-------------FLT-KY--P-----SPIGPKSDVWSLGFIILELYLGISLEAEL--TESEYLEILLKYYTDDQEL 153 (725)
T ss_pred --c-------------ccc-cC--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHH--HHHHHHHHHHHhccCchhH
Confidence 0 000 00 1 11225999999999999999887542110 0011111111111111100
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHH
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDV 347 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ev 347 (398)
.. -.... ....++...+.++...|+-..|..||...++
T Consensus 154 ~~--~a~e~-~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 154 LS--TAMEH-LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HH--HHHHH-HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 00 00000 1134455678889999999999988865443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.028 Score=53.69 Aligned_cols=75 Identities=11% Similarity=0.084 Sum_probs=45.8
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--ccceeeEE------EeCCeeEEEEe
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGCC------IDKDEKILIYE 192 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~------~~~~~~~lV~e 192 (398)
.+.++.|....+|+....+| .+++|....... ...+..|.+++..+.... +.+.+... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876544 577887754321 234556677777764222 34443321 12456789999
Q ss_pred ccCCCC
Q 037365 193 YMPNKS 198 (398)
Q Consensus 193 ~~~~g~ 198 (398)
|++|..
T Consensus 104 ~i~G~~ 109 (307)
T TIGR00938 104 FLQGLS 109 (307)
T ss_pred eCCCCC
Confidence 998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.00068 Score=75.06 Aligned_cols=123 Identities=14% Similarity=-0.010 Sum_probs=92.2
Q ss_pred HHHHHHHHHHhcCCCcccceeeEEEe--CCeeEEEEeccCCCChh-----------------------------------
Q 037365 158 EMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMPNKSLD----------------------------------- 200 (398)
Q Consensus 158 ~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~~~g~L~----------------------------------- 200 (398)
....|.+.++...|+++.....-... ....+.+++|+.+|.+-
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34445556666789988776554432 33567888888888662
Q ss_pred ------HHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHH
Q 037365 201 ------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLE 274 (398)
Q Consensus 201 ------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 274 (398)
-+++++|+-|.++..+..+|++++|+.+..... ........+++.|+.|+....-.++.++|+|..|+-+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 233479999999999999999999999843221 122334578889999999988889999999999999999
Q ss_pred HHcCCCCC
Q 037365 275 IVSGKKNT 282 (398)
Q Consensus 275 lltg~~P~ 282 (398)
...|..++
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 99887764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.16 Score=45.68 Aligned_cols=104 Identities=17% Similarity=0.135 Sum_probs=70.4
Q ss_pred ecccCceEEEEEEEcCCCEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCC--cccceeeEEEeC----CeeEEEE
Q 037365 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRS------GQGLREMKNEASVIAKVQHK--NLVRLLGCCIDK----DEKILIY 191 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~----~~~~lV~ 191 (398)
-|+||.+-|++-.+. |..+-+|+-...- +-....|.+|...+.++..- .+.+...+.... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 477888889997774 5578889875321 23456789999999998532 244444222221 2467999
Q ss_pred eccCCC-Ch----------------------------------hHHhhcCCCCCceecCCCC--eEEcccccce
Q 037365 192 EYMPNK-SL----------------------------------DFFLFNLKASNILLDKDMN--PKISDFGMAR 228 (398)
Q Consensus 192 e~~~~g-~L----------------------------------~~~~~dlkp~NILl~~~~~--~kl~DFGla~ 228 (398)
|-+++- +| +..|+|+-+.||+++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 966532 22 3456799999999986677 9999997654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.061 Score=50.88 Aligned_cols=73 Identities=16% Similarity=0.233 Sum_probs=48.5
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
.+.++.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+.+++....+..+|+|||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999977 5688899998762 23356788998888884 345778899888888889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.17 Score=55.46 Aligned_cols=166 Identities=17% Similarity=0.192 Sum_probs=103.9
Q ss_pred HHHHHHHHHHhcCCCcccceeeEEEeCCeeE----EEEeccCCCChh--------------------------HHhhcCC
Q 037365 158 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKI----LIYEYMPNKSLD--------------------------FFLFNLK 207 (398)
Q Consensus 158 ~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~----lV~e~~~~g~L~--------------------------~~~~dlk 207 (398)
....|...+.++.|+|++.+++|....-..- +..+++..-++. .+| +.+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h-~~~ 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH-SLS 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH-Hhc
Confidence 3445777888899999999999877543322 334566555442 222 234
Q ss_pred CCCcee----------cCCCCeEEc--ccccceecCCCCcccccccccccccccChhhhccCCCCcc--cccHHHHHHHH
Q 037365 208 ASNILL----------DKDMNPKIS--DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK--FDVFSFGVLLL 273 (398)
Q Consensus 208 p~NILl----------~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDvwSlGvvl~ 273 (398)
-.|+.+ +..+...++ ||+.++.+....... ....+..|.+||......+..+ .|+|.+|....
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 455544 334556666 888877665443221 1234556888888876665544 79999999999
Q ss_pred HHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 274 EIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 274 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.+..|..+.... ......+.... .....+....|+..++++|+++.+++...-.
T Consensus 384 ~~~~~~~i~~~~---------------------~~~~~~l~~~~-----~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 384 QLSQGEDISEKS---------------------AVPVSLLDVLS-----TSELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred hhhhcCcccccc---------------------cchhhhhcccc-----chhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 999987662211 00111111100 0135678889999999999999999976443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.11 Score=50.43 Aligned_cols=73 Identities=16% Similarity=0.245 Sum_probs=47.8
Q ss_pred eecccCceEEEEEEEcCC-CEEEEEEccC-------CChhhHHHHHHHHHHHHhcC--CC-cccceeeEEEeCCeeEEEE
Q 037365 123 KLGEGGFGPVYKGVLRKG-NEIAVKRLSG-------RSGQGLREMKNEASVIAKVQ--HK-NLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--H~-nIv~l~~~~~~~~~~~lV~ 191 (398)
.||.|....||++..++| +.|+||.-.. .-+-..+...-|...|.... -| .+.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998654 6899996421 11223344556777776653 24 34445544 455667999
Q ss_pred eccCCC
Q 037365 192 EYMPNK 197 (398)
Q Consensus 192 e~~~~g 197 (398)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998664
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.11 Score=49.25 Aligned_cols=71 Identities=24% Similarity=0.353 Sum_probs=43.2
Q ss_pred ceecccCceEEEEEEEcC-------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcc-cceeeEEEeCCeeEEEEec
Q 037365 122 NKLGEGGFGPVYKGVLRK-------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e~ 193 (398)
+.+..|-...+|+....+ ++.+++|...... .......+|..++..+...++ .++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899988654 4788899875543 222445678888888753333 344554421 245666
Q ss_pred cCCC
Q 037365 194 MPNK 197 (398)
Q Consensus 194 ~~~g 197 (398)
++|.
T Consensus 79 i~G~ 82 (302)
T cd05156 79 IPSR 82 (302)
T ss_pred eCCC
Confidence 5554
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.18 Score=49.03 Aligned_cols=73 Identities=15% Similarity=0.140 Sum_probs=46.0
Q ss_pred ceecccCceEEEEEEEcC-----CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCccc-ceeeEEEeCCeeEEEEeccC
Q 037365 122 NKLGEGGFGPVYKGVLRK-----GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~e~~~ 195 (398)
..+-.|-...+|+....+ ++.+++|......... -.-.+|..++..+..-++. ++++.+..+ .|++|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 445557788999987542 3678889876543222 2236788888888654443 455655322 5788887
Q ss_pred CCCh
Q 037365 196 NKSL 199 (398)
Q Consensus 196 ~g~L 199 (398)
+.++
T Consensus 117 g~~l 120 (344)
T PLN02236 117 ARTL 120 (344)
T ss_pred CCCC
Confidence 6554
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.26 Score=48.87 Aligned_cols=73 Identities=12% Similarity=0.136 Sum_probs=50.3
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCC----Ch---hhHHHHHHHHHHHHhcC---CCcccceeeEEEeCCeeEEE
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR----SG---QGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV 190 (398)
.+.||.|....||+.... ++.++||.-... .. .....-..|...|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998864 567899976521 10 12333344666666653 357888888876 456889
Q ss_pred EeccCC
Q 037365 191 YEYMPN 196 (398)
Q Consensus 191 ~e~~~~ 196 (398)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.62 E-value=0.3 Score=46.47 Aligned_cols=76 Identities=11% Similarity=0.106 Sum_probs=57.1
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC---CcccceeeEEEe---CCeeEEEEecc
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQH---KNLVRLLGCCID---KDEKILIYEYM 194 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~---~~~~~lV~e~~ 194 (398)
.+.||.|..+.||+....++ .+.+|..+.. .....+..|...|+.+.- -.+.+++++|.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 46799999999999877655 4666765331 122578899999999853 367888888764 36689999999
Q ss_pred CCCCh
Q 037365 195 PNKSL 199 (398)
Q Consensus 195 ~~g~L 199 (398)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.1 Score=46.09 Aligned_cols=66 Identities=26% Similarity=0.446 Sum_probs=51.4
Q ss_pred HHHHHHHHhcCC-CcccceeeEEEeCCeeEEEEeccCCCChh--------------------------------------
Q 037365 160 KNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYEYMPNKSLD-------------------------------------- 200 (398)
Q Consensus 160 ~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e~~~~g~L~-------------------------------------- 200 (398)
..|.-+++.+++ +++.+++|+|- .+++.||...+++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 69999999993 46788998865331
Q ss_pred HHhhcCCCCCceecCCCCeEEccccccee
Q 037365 201 FFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 201 ~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
.++.|++++|+-+++++++|+.|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 11138999999999999999999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=93.28 E-value=0.15 Score=41.37 Aligned_cols=31 Identities=10% Similarity=0.220 Sum_probs=17.5
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHhhhhcCcc
Q 037365 36 FFVLLSLSITLAAVATLGLNFYCFLHTSGED 66 (398)
Q Consensus 36 ~~~~i~~~~~~~~~~~~~~~~~~~~r~~~~~ 66 (398)
-+++|++++++++++++++++||++|++++.
T Consensus 65 ~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~ 95 (122)
T PF01102_consen 65 AIIGIIFGVMAGVIGIILLISYCIRRLRKKS 95 (122)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred ceeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence 3444555555556666667777777666654
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=93.08 E-value=0.042 Score=44.75 Aligned_cols=44 Identities=18% Similarity=0.348 Sum_probs=33.7
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHh
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAK 168 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~ 168 (398)
+.||.|+.|.||+|++++|+.||||+..+.-. +.+...+.+++.
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~---~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPGIE---EQIEADLRILRR 60 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchHHH---HHHHHHHHHHHH
Confidence 67999999999999999999999999876533 344444444443
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=92.95 E-value=0.018 Score=36.67 Aligned_cols=32 Identities=9% Similarity=0.183 Sum_probs=16.7
Q ss_pred CCCccchhhHHHHHHHHHHHHHHHHHHHhhhh
Q 037365 31 VDSASFFVLLSLSITLAAVATLGLNFYCFLHT 62 (398)
Q Consensus 31 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~r~ 62 (398)
.++.+-.+.+++++.+++++++..+++++++|
T Consensus 6 ~~~~~vaIa~~VvVPV~vI~~vl~~~l~~~~r 37 (40)
T PF08693_consen 6 SNSNTVAIAVGVVVPVGVIIIVLGAFLFFWYR 37 (40)
T ss_pred CCCceEEEEEEEEechHHHHHHHHHHhheEEe
Confidence 33444555666666666555544444444333
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.24 Score=48.87 Aligned_cols=75 Identities=12% Similarity=0.178 Sum_probs=48.9
Q ss_pred cceecccCceEEEEEEEcC-CCEEEEEEccCC------ChhhHHHHHHHHHHHHhcC--CC-cccceeeEEEeCCeeEEE
Q 037365 121 ANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR------SGQGLREMKNEASVIAKVQ--HK-NLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~--H~-nIv~l~~~~~~~~~~~lV 190 (398)
.+.||.|.-..||++...+ ++.|+||.-... -+-..++..-|.+.|+... -| ++.+++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999853 567999864211 1223455566778877663 34 45556554 44556678
Q ss_pred EeccCCC
Q 037365 191 YEYMPNK 197 (398)
Q Consensus 191 ~e~~~~g 197 (398)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 8877653
|
|
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=91.79 E-value=0.37 Score=30.19 Aligned_cols=25 Identities=8% Similarity=0.275 Sum_probs=10.6
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhhcC
Q 037365 40 LSLSITLAAVATLGLNFYCFLHTSG 64 (398)
Q Consensus 40 i~~~~~~~~~~~~~~~~~~~~r~~~ 64 (398)
.+|.++++++++..+.+.|.+||.+
T Consensus 10 v~V~vg~~iiii~~~~YaCcykk~~ 34 (38)
T PF02439_consen 10 VAVVVGMAIIIICMFYYACCYKKHR 34 (38)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcccc
Confidence 3333333333333334445555443
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=91.67 E-value=0.1 Score=49.82 Aligned_cols=107 Identities=15% Similarity=0.176 Sum_probs=77.0
Q ss_pred CCCccceecccCceEEEEEEEcCCCEEEEEEccC----------C-------ChhhH-----HHHHHHHHHHHhcC-CCc
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSG----------R-------SGQGL-----REMKNEASVIAKVQ-HKN 173 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------~-------~~~~~-----~~~~~E~~~l~~l~-H~n 173 (398)
-+..++.||-|.-+.+|.+-..+|++.++|.=.. + ....| -...+|...|+.+. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3677899999999999999998899998883211 0 01111 12357888888874 322
Q ss_pred -ccceeeEEEeCCeeEEEEeccCCCCh--------------------------hHHhhcCCCCCceecCCCCeEEccccc
Q 037365 174 -LVRLLGCCIDKDEKILIYEYMPNKSL--------------------------DFFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 174 -Iv~l~~~~~~~~~~~lV~e~~~~g~L--------------------------~~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
+.+.+++ +..++|||+..+-.| +.+|+|..-=||++++++.++++||--
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechH
Confidence 3334443 456789998888765 567789999999999999999999964
Q ss_pred c
Q 037365 227 A 227 (398)
Q Consensus 227 a 227 (398)
.
T Consensus 249 m 249 (465)
T KOG2268|consen 249 M 249 (465)
T ss_pred h
Confidence 4
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=90.75 E-value=1.3 Score=40.34 Aligned_cols=72 Identities=17% Similarity=0.266 Sum_probs=49.0
Q ss_pred ecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
+.-|.--.-|...+ ...++-||.-. ......|..|+.-|..+. .-++.+++.+-.+.++.|+||||++-|.+
T Consensus 24 v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 24 VSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred cCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 33333334444333 36678888653 234567888888777774 35577788888888999999999998765
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.45 E-value=1 Score=42.77 Aligned_cols=63 Identities=13% Similarity=0.211 Sum_probs=37.6
Q ss_pred EEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC--cccceeeE------EEeCCeeEEEEeccCCCC
Q 037365 131 PVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLVRLLGC------CIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 131 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~------~~~~~~~~lV~e~~~~g~ 198 (398)
.||+....+| .+++|++... ...+..|...+..+... .+.+++.. ...++..+.++||++|..
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~ 81 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRE 81 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcC
Confidence 4888876545 6889988532 13344566666666432 33333322 223567889999998854
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.14 E-value=1.1 Score=43.39 Aligned_cols=72 Identities=15% Similarity=0.183 Sum_probs=43.2
Q ss_pred ecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCcccc---eee----EEEeCCeeEEEEec
Q 037365 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVR---LLG----CCIDKDEKILIYEY 193 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~---l~~----~~~~~~~~~lV~e~ 193 (398)
|.+ .-..+|+....+|+. ++|..... ....++..|...+..+. .+-.+. +=| ....+...+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789988877776 88888765 33456667777777763 222222 111 11111367788899
Q ss_pred cCCCCh
Q 037365 194 MPNKSL 199 (398)
Q Consensus 194 ~~~g~L 199 (398)
++|..+
T Consensus 110 l~G~~~ 115 (331)
T COG2334 110 LPGRPL 115 (331)
T ss_pred cCCcCc
Confidence 888644
|
|
| >KOG3021 consensus Predicted kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.65 E-value=1.8 Score=39.01 Aligned_cols=80 Identities=18% Similarity=0.150 Sum_probs=54.9
Q ss_pred CCCccceecccCceEEEEEEE--cCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccc---eeeEEEe-CCeeEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVL--RKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR---LLGCCID-KDEKILI 190 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~---l~~~~~~-~~~~~lV 190 (398)
+...++.+|+-+-|.+-.++. .+...|-||.=.. ...+.|.-|+.-|..++..+.|. -+.+..- .+..++|
T Consensus 10 ~~~~vr~~gs~gggcI~~~r~ydtDaG~~FvK~nr~---~~~~mfeGE~~sLeAi~sT~tv~vprpikvid~p~Ggs~li 86 (313)
T KOG3021|consen 10 GLNNVRALGSVGGGCISDGRHYDTDAGKVFVKVNRS---IARDMFEGELASLEAIQSTETVLVPRPIKVIDLPGGGSSLI 86 (313)
T ss_pred CcceeeeecCCCCceeccccccccCCccEEEEeccc---cchHHHhhHHHHHHHHHhcCceecCCceeeEecCCCceeee
Confidence 334456788766677777763 3355678886543 44577888999999887766554 3555554 5678999
Q ss_pred EeccCCCCh
Q 037365 191 YEYMPNKSL 199 (398)
Q Consensus 191 ~e~~~~g~L 199 (398)
|||++-+.|
T Consensus 87 me~idf~~l 95 (313)
T KOG3021|consen 87 MEHIDFQGL 95 (313)
T ss_pred eehhhcccc
Confidence 999987755
|
|
| >PF15050 SCIMP: SCIMP protein | Back alignment and domain information |
|---|
Probab=89.47 E-value=0.36 Score=38.40 Aligned_cols=30 Identities=27% Similarity=0.614 Sum_probs=17.6
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHhhhhcCcc
Q 037365 36 FFVLLSLSITLAAVATLGLNFYCFLHTSGED 66 (398)
Q Consensus 36 ~~~~i~~~~~~~~~~~~~~~~~~~~r~~~~~ 66 (398)
++|++++.| +.+-+.+++++||.+|+..++
T Consensus 8 FWiiLAVaI-I~vS~~lglIlyCvcR~~lRq 37 (133)
T PF15050_consen 8 FWIILAVAI-ILVSVVLGLILYCVCRWQLRQ 37 (133)
T ss_pred hHHHHHHHH-HHHHHHHHHHHHHHHHHHHHc
Confidence 456666653 334445677778776654443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=88.57 E-value=2.8 Score=39.37 Aligned_cols=45 Identities=16% Similarity=-0.057 Sum_probs=31.4
Q ss_pred ecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC
Q 037365 124 LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ 170 (398)
Q Consensus 124 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 170 (398)
.++|-...|+.....+|..+++|.-... .....+.+|..+|..+.
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVR 63 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHH
Confidence 4556566777776666888888877432 23456788999998885
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=88.50 E-value=0.9 Score=41.20 Aligned_cols=95 Identities=18% Similarity=0.114 Sum_probs=59.3
Q ss_pred cCceEEEEEEEcCCCEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCC--------
Q 037365 127 GGFGPVYKGVLRKGNEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK-------- 197 (398)
Q Consensus 127 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g-------- 197 (398)
|+.++.-.+...- .+..+|++....-. ...-+.++..++.++. .|+++..- +....-++.|+|-.-
T Consensus 73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~~~N~i 147 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKINFSNFI 147 (308)
T ss_pred CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccchhHHH
Confidence 3444444444332 33456666543222 3455677888888764 45665521 233556788877432
Q ss_pred -----Ch--------hHHhhcCCCCCceecCCCCeEEccccc
Q 037365 198 -----SL--------DFFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 198 -----~L--------~~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
+| ..+|.|..|+||+-|..|.+||.|-+.
T Consensus 148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 23 345579999999999999999999874
|
The function of this family is unknown. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=88.39 E-value=1.7 Score=42.48 Aligned_cols=105 Identities=15% Similarity=0.209 Sum_probs=69.3
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCC------------------------ChhhH--HHHHHHHHHHHhcCCCccc
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGR------------------------SGQGL--REMKNEASVIAKVQHKNLV 175 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~------------------------~~~~~--~~~~~E~~~l~~l~H~nIv 175 (398)
.-|..|--+.||.+.-.+|..+|||+++.. ++... -....|+.-|.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 457788889999999989999999987532 11111 1234677788887654432
Q ss_pred ceeeEEEeCCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEc
Q 037365 176 RLLGCCIDKDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 176 ~l~~~~~~~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~ 222 (398)
.---... ....|||+|+..... ..+|.||.-=|+|+- +|.+.|+
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiI 306 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYII 306 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEE
Confidence 2111111 134699999864321 356679998999984 5789999
Q ss_pred cccccee
Q 037365 223 DFGMARI 229 (398)
Q Consensus 223 DFGla~~ 229 (398)
|-+-+-.
T Consensus 307 DVSQSVE 313 (520)
T KOG2270|consen 307 DVSQSVE 313 (520)
T ss_pred Ecccccc
Confidence 9887654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=87.92 E-value=3.5 Score=39.30 Aligned_cols=27 Identities=22% Similarity=0.180 Sum_probs=22.8
Q ss_pred HhhcCCCCCceecCCCCeEEcccccce
Q 037365 202 FLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 202 ~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
+|+|+.+.|+|+++++.+.++||..+.
T Consensus 199 cHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 199 VHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 556899999999988889999998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.77 E-value=2.3 Score=40.77 Aligned_cols=69 Identities=17% Similarity=0.262 Sum_probs=42.4
Q ss_pred cCceEEEEEEEcCCCEEEEEEcc--CCChhhHHHHHHHHHHHHhcCC--CcccceeeEEEeCC--eeEEEEeccCCC
Q 037365 127 GGFGPVYKGVLRKGNEIAVKRLS--GRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKD--EKILIYEYMPNK 197 (398)
Q Consensus 127 G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~--~~~lV~e~~~~g 197 (398)
|....+|..... ++.+++. .. ...........+|..+++.+.- .-+...+++|.++. ..+.||+|.+|.
T Consensus 36 G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 36 GWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred CcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 333344554443 6677777 32 1223344566778888887753 23445577777665 679999999884
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 398 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-28 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-113
Identities = 100/302 (33%), Positives = 141/302 (46%), Gaps = 51/302 (16%)
Query: 102 QFPLFSFSSVSTATNRFSD------ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR---- 151
+F FSF + TN F + NK+GEGGFG VYKG + +AVK+L+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 152 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------ 205
+ + ++ E V+AK QH+NLV LLG D D+ L+Y YMPN SL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 206 -----------------------------LKASNILLDKDMNPKISDFGMARICGGNELQ 236
+K++NILLD+ KISDFG+AR
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA 296
TSRIVGT YM+PE + G + K D++SFGV+LLEI++G +R LL
Sbjct: 190 VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIK 247
Query: 297 WDLWRSNRTLE-LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355
++ +T+E D + D S V ++A C+ E + RP V +L
Sbjct: 248 EEIEDEEKTIEDYIDKKMND-ADSTSV-EAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 356 AA 357
A+
Sbjct: 306 AS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-111
Identities = 95/295 (32%), Positives = 145/295 (49%), Gaps = 45/295 (15%)
Query: 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGL-REMKNEAS 164
FS + A++ FS+ N LG GGFG VYKG L G +AVKRL QG + + E
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 165 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------- 205
+I+ H+NL+RL G C+ E++L+Y YM N S+ L
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 206 --------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245
+KA+NILLD++ + DFG+A++ + T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRT---DTLNLLGYAWDLWRS 302
G+++PEY G S K DVF +GV+LLE+++G++ R D + LL + L +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 303 NRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357
+ L D L+ Y ++V + + +ALLC Q S +RP ++VV ML + A
Sbjct: 259 KKLEALVDVDLQGNYKDEEV-EQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 3e-97
Identities = 86/283 (30%), Positives = 144/283 (50%), Gaps = 38/283 (13%)
Query: 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASV 165
+ ATN F +G G FG VYKGVLR G ++A+KR + S QG+ E + E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 166 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------- 205
++ +H +LV L+G C +++E ILIY+YM N +L L+
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 206 ----------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 249
+K+ NILLD++ PKI+DFG+++ + ++ + GT GY+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 250 SPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYR-TDTLNLLGYAWDLWRSNRTLEL 308
PEY I+G + K DV+SFGV+L E++ + + +NL +A + + + ++
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
D L D+ + L ++ + A+ C+ S++DRP+ DV+ L
Sbjct: 269 VDPNLADKIRPES-LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-69
Identities = 51/306 (16%), Positives = 102/306 (33%), Gaps = 62/306 (20%)
Query: 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASV 165
++ + G FG V+K L +AVK + Q + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 166 IAKVQHKNLVRLLGCCI----DKDEKILIYEYMPNKSLDFFLFN---------------- 205
+ ++H+N+++ +G + LI + SL FL
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMA 131
Query: 206 -------------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTS 240
+K+ N+LL ++ I+DFG+A + +T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 241 RIVGTYGYMSPEYAIEGI-----FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGY 295
VGT YM+PE I ++ D+++ G++L E+ S + +L +
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--YMLPF 249
Query: 296 AWDLWRSNRTLELTDAI--------LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDV 347
++ + ++ + + L D + + C A+ R + V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 348 VSMLTN 353
+T
Sbjct: 310 GERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-59
Identities = 58/329 (17%), Positives = 105/329 (31%), Gaps = 73/329 (22%)
Query: 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASV 165
+ S S + +G G +G VYKG L +AVK S + Q NE ++
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNI 58
Query: 166 --IAKVQHKNLVRLLGCCI-----DKDEKILIYEYMPNKSLDFFLFN------------- 205
+ ++H N+ R + + E +L+ EY PN SL +L
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH 118
Query: 206 ---------------------------LKASNILLDKDMNPKISDFGMARICGGN----- 233
L + N+L+ D ISDFG++ GN
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 234 -ELQANTSRIVGTYGYMSPEYAIEGI-------FSIKFDVFSFGVLLLEIVSGKKNTGFY 285
E VGT YM+PE + + D+++ G++ EI +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 286 RTDTLNLLGYAWDLWRSNRTLELTDAILE--------DEYSSKQVLLR-YVNIALLCVQE 336
+ + + ++ ++ + + + + +R C +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 337 SADDRPTTNDVVSMLTNEAAALLPPKQPA 365
A+ R T + K +
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 59/281 (20%), Positives = 110/281 (39%), Gaps = 57/281 (20%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 179
K+G G FG V++ G+++AVK L + + + E E +++ +++H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------- 205
++ EY+ SL L
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
LK+ N+L+DK K+ DFG++R+ L + ++ GT +M+PE + + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEK 219
Query: 263 FDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322
DV+SFGV+L E+ + ++ + LN + + LE+ +
Sbjct: 220 SDVYSFGVILWELATLQQ---PW--GNLNPAQVVAAVGFKCKRLEIPRNLNPQ------- 267
Query: 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQ 363
I C RP+ ++ +L + +PP
Sbjct: 268 ---VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-42
Identities = 55/278 (19%), Positives = 96/278 (34%), Gaps = 64/278 (23%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
LG+G FG K R+ G + +K L + R E V+ ++H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFN---------------------------------LK 207
I EY+ +L + + L
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSR------------IVGTYGYMSPEYAI 255
+ N L+ ++ N ++DFG+AR+ + Q R +VG +M+PE
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315
+ K DVFSFG++L EI+ A + RT++ +
Sbjct: 196 GRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLP-RTMDFGLNVRGF 239
Query: 316 E--YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
Y + I + C + RP+ + L
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 7e-40
Identities = 52/274 (18%), Positives = 94/274 (34%), Gaps = 68/274 (24%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 179
KL E G ++KG + GN+I VK L R S + R+ E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 180 CCIDKDEKIL--IYEYMPNKSLDFFL---------------------------------- 203
C I +MP SL L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 204 --FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG---- 257
L + ++++D+DM +IS + + + +++PE A++
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPE-ALQKKPED 186
Query: 258 IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317
D++SF VLL E+V+ + + L+ + + + I
Sbjct: 187 TNRRSADMWSFAVLLWELVTREV---PF--ADLSNMEIGMKVALEGLRPTIPPGISP--- 238
Query: 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
+ +C+ E RP + +V +L
Sbjct: 239 -------HVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 41/196 (20%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 179
++G G FG VYKG ++AVK L + + Q L+ KNE V+ K +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 180 CCIDKDEKILIYEYMPNKSLDFFL---------------------------------FNL 206
+ ++ ++ SL L +L
Sbjct: 88 YST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YAIEGIFSIKF 263
K++NI L +D KI DFG+A ++ G+ +M+PE +S +
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 264 DVFSFGVLLLEIVSGK 279
DV++FG++L E+++G+
Sbjct: 207 DVYAFGIVLYELMTGQ 222
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 66/278 (23%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRL----SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
+G GGFG VY+ G+E+AVK Q + ++ EA + A ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
G C+ + L+ E+ L+ L
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 206 --LKASNILLDKDMNP--------KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 255
LK+SNIL+ + + KI+DFG+AR + G Y +M+PE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAPEVIR 187
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315
+FS DV+S+GVLL E+++G+ + ++ L A+ + + L + E
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEV---PF--RGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
+ + C RP+ +++ LT
Sbjct: 243 ----------FAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 59/295 (20%), Positives = 108/295 (36%), Gaps = 63/295 (21%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+G G FG V K R ++A+K++ S + E +++V H N+V+L G C
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 182 IDKDEKILIYEYMPNKSLDFFLFN------------------------------------ 205
++ L+ EY SL L
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 206 --LKASNILLDKDMN-PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
LK N+LL KI DFG A ++Q + + G+ +M+PE +S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 263 FDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322
DVFS+G++L E+++ +K + W + R L + +
Sbjct: 184 CDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR-PPLIKNLPKP------- 232
Query: 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTS 377
++ C + RP+ ++V ++T+ +P ++++
Sbjct: 233 ---IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGE 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 55/282 (19%), Positives = 111/282 (39%), Gaps = 70/282 (24%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQG-------LREMKNEASVIAKVQHKN 173
++G+GGFG V+KG L K + +A+K L +G +E + E +++ + H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN---------------------------- 205
+V+L G + ++ E++P L L +
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 206 -------LKASNILLDK-----DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE- 252
L++ NI L + K++DFG+++ + + S ++G + +M+PE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPET 197
Query: 253 -YAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311
A E ++ K D +SF ++L I++G+ + + + + + + +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
R N+ LC RP + +V L+
Sbjct: 255 CPP----------RLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 50/290 (17%), Positives = 98/290 (33%), Gaps = 65/290 (22%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 179
+G+G FG VY G E+A++ + + L+ K E + +H+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------L 206
C+ +I ++L + + L
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRI---VGTYGYMSPE---------YA 254
K+ N+ D + I+DFG+ I G + ++ G +++PE
Sbjct: 157 KSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE 215
Query: 255 IEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314
+ FS DVF+ G + E+ + + ++ T W + + + +
Sbjct: 216 DKLPFSKHSDVFALGTIWYELHAREWP---FK--TQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQP 364
+ +I L C ++RPT ++ ML P
Sbjct: 271 E----------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 61/286 (21%), Positives = 107/286 (37%), Gaps = 67/286 (23%)
Query: 122 NKLGEGGFGPVYKGVL-----RKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
+LG+G FG V G +AVK+L + + LR+ + E ++ +QH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 177 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFN----------------------------- 205
G C + LI EY+P SL +L
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAI 255
L NIL++ + KI DFG+ ++ L + + +PE
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA-WDLWRSNRTLELTDAILE 314
E FS+ DV+SFGV+L E+ + + + + + ++G +EL L+
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL----LK 277
Query: 315 DEY-------SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
+ ++ Y I C + + RP+ D+ +
Sbjct: 278 NNGRLPRPDGCPDEI---Y-MIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-35
Identities = 61/286 (21%), Positives = 107/286 (37%), Gaps = 67/286 (23%)
Query: 122 NKLGEGGFGPVYKGVLR-----KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
+LG+G FG V G +AVK+L + + LR+ + E ++ +QH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 177 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFN----------------------------- 205
G C + LI EY+P SL +L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAI 255
L NIL++ + KI DFG+ ++ L + + +PE
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA-WDLWRSNRTLELTDAILE 314
E FS+ DV+SFGV+L E+ + + + + + ++G +EL L+
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL----LK 246
Query: 315 DEY-------SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
+ ++ Y I C + + RP+ D+ +
Sbjct: 247 NNGRLPRPDGCPDEI---Y-MIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 51/190 (26%), Positives = 74/190 (38%), Gaps = 35/190 (18%)
Query: 123 KLGEGGFGPVYKGVLRKGN-EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
++G G FG V+ G LR N +AVK + EA ++ + H N+VRL+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFN---------------------------------LK 207
C K ++ E + FL L
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFS 267
A N L+ + KISDFGM+R A+ + +PE G +S + DV+S
Sbjct: 241 ARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 268 FGVLLLEIVS 277
FG+LL E S
Sbjct: 301 FGILLWETFS 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 53/284 (18%), Positives = 101/284 (35%), Gaps = 67/284 (23%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 175
LGEG FG V + +AVK L G + ++K E ++ + H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 176 RLLGCCIDKDEK--ILIYEYMPNKSLDFFLFN---------------------------- 205
+ G C + LI E++P+ SL +L
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 206 -----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 254
L A N+L++ + KI DFG+ + ++ + + +PE
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 255 IEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313
++ F I DV+SFGV L E+++ ++ + + + L + +
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM--TVT--RLVNTLK 257
Query: 314 ED------EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
E +V Y + C + +R + +++
Sbjct: 258 EGKRLPCPPNCPDEV---Y-QLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 68/312 (21%), Positives = 119/312 (38%), Gaps = 68/312 (21%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE-----IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
++LG+G FG V + +AVK+L R+ + E ++ + +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 177 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFN----------------------------- 205
G + L+ EY+P+ L FL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAI 255
L A NIL++ + + KI+DFG+A++ L + V + +PE
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKL-----LPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 256 EGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314
+ IFS + DV+SFGV+L E+ + K+ + L ++G D+ +R LEL LE
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPS-AEFLRMMGCERDVPALSRLLEL----LE 258
Query: 315 DEY-------SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFS 367
+ +V + + LC S DRP+ + + L + + AF+
Sbjct: 259 EGQRLPAPPACPAEV---H-ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
Query: 368 YVRNTVTSTSST 379
+ S
Sbjct: 315 AHPEGKHHSLSF 326
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 72/283 (25%), Positives = 107/283 (37%), Gaps = 63/283 (22%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 175
LGEG FG V N+ +AVK L + Q K E ++ + H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 176 RLLGCCIDKDEK--ILIYEYMPNKSLDFFLFN---------------------------- 205
+ GCC D L+ EY+P SL +L
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYI 156
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIEG 257
L A N+LLD D KI DFG+A+ V G + +PE E
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPECLKEY 212
Query: 258 IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED-- 315
F DV+SFGV L E+++ ++ T L L+G A R EL LE
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL----LERGE 268
Query: 316 -----EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
+ +V Y ++ C + A RPT +++ +L
Sbjct: 269 RLPRPDKCPAEV---Y-HLMKNCWETEASFRPTFENLIPILKT 307
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 55/296 (18%), Positives = 99/296 (33%), Gaps = 74/296 (25%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 179
+G+G +G V++G + G +AVK S R + E + ++H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69
Query: 180 CCIDKDEKI----LIYEYMPNKSLDFFLFN------------------------------ 205
+ LI Y SL +L
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 206 ---------LKASNILLDKDMNPKISDFGMARI---CGGNELQANTSRIVGTYGYMSPE- 252
LK+ NIL+ K+ I+D G+A + N R VGT YM+PE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMAPEV 188
Query: 253 -----YAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW-DLWRSNRTL 306
+ D+++FG++L E+ + G + D+ ++ +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-----PFYDVVPNDPSF 243
Query: 307 E-LTDAILED--------EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
E + + D + S L + C ++ R T + LT
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 65/285 (22%), Positives = 109/285 (38%), Gaps = 83/285 (29%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 175
LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------ 205
RLLG C+ LI + MP L ++
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIEG 257
L A N+L+ + KI+DFG+A++ G E + + G +M+ E +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHR 194
Query: 258 IFSIKFDVFSFGVLLLEIVS-------GKKNTGFYRTDTLNLL--GYAWDLWRSNRTLEL 308
I++ + DV+S+GV + E+++ G ++ ++L G R L
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGE-----R----LPQ 240
Query: 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
D Y I C AD RP +++ +
Sbjct: 241 PPICTIDVY----------MIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 47/193 (24%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+G+G FG V G +GN++AVK + ++ + EASV+ +++H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 182 IDKDEKI-LIYEYMPNKSLDFFLFN----------------------------------L 206
+++ + ++ EYM SL +L + L
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYAIEGIFSIKFD 264
A N+L+ +D K+SDFG+ + +A++++ G +PE E FS K D
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 265 VFSFGVLLLEIVS 277
V+SFG+LL EI S
Sbjct: 369 VWSFGILLWEIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 47/193 (24%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+G+G FG V G +GN++AVK + ++ + EASV+ +++H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 182 IDKDEKILI-YEYMPNKSLDFFLFN----------------------------------L 206
+++ + I EYM SL +L + L
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYAIEGIFSIKFD 264
A N+L+ +D K+SDFG+ + +A++++ G +PE E FS K D
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 265 VFSFGVLLLEIVS 277
V+SFG+LL EI S
Sbjct: 197 VWSFGILLWEIYS 209
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 43/193 (22%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
++G G FG V+ G +++A+K + G + + EA V+ K+ H LV+L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFN---------------------------------LK 207
C+++ L+ E+M + L +L L
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIKFD 264
A N L+ ++ K+SDFGM R ++ ++T GT + SPE +S K D
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSKSD 187
Query: 265 VFSFGVLLLEIVS 277
V+SFGVL+ E+ S
Sbjct: 188 VWSFGVLMWEVFS 200
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 49/201 (24%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
+G G FG VY G L + AVK L + + E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 177 LLGCCIDKDEKIL-IYEYMPNKSLDFFLFN------------------------------ 205
LLG C+ + L + YM + L F+ N
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIE 256
L A N +LD+ K++DFG+AR + + G +M+ E
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 257 GIFSIKFDVFSFGVLLLEIVS 277
F+ K DV+SFGVLL E+++
Sbjct: 207 QKFTTKSDVWSFGVLLWELMT 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 71/312 (22%), Positives = 124/312 (39%), Gaps = 83/312 (26%)
Query: 123 KLGEGGFGPVYKGVLRKGNE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
+G G FG VYKG+L+ + +A+K L +G + + + EA ++ + H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------- 205
L G ++I EYM N +LD FL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 170
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIEG 257
L A NIL++ ++ K+SDFG++R+ + T+ G + +PE
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPEAISYR 225
Query: 258 IFSIKFDVFSFGVLLLEIVS-------GKKNTGFYRTDTLNLL--GYAWDLWRSNRTLEL 308
F+ DV+SFG+++ E+++ N + + + G+ R ++
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDGF-----RLPTPMDC 275
Query: 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSY 368
AI Y + + C Q+ RP D+VS+L A K A
Sbjct: 276 PSAI----Y----------QLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFD 321
Query: 369 VRNTVTSTSSTG 380
R ++ S++G
Sbjct: 322 PRVSIRLPSTSG 333
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 49/200 (24%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
+G G G V G LR + +A+K L +G + + R+ +EAS++ + H N++R
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------- 205
L G +++ EYM N SLD FL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIEG 257
L A N+L+D ++ K+SDFG++R+ + A T+ G + +PE
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPEAIAFR 229
Query: 258 IFSIKFDVFSFGVLLLEIVS 277
FS DV+SFGV++ E+++
Sbjct: 230 TFSSASDVWSFGVVMWEVLA 249
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 53/193 (27%), Positives = 81/193 (41%), Gaps = 43/193 (22%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
+LG G FG V G R ++A+K + G + E EA V+ + H+ LV+L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFN---------------------------------LK 207
C + +I EYM N L +L L
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIKFD 264
A N L++ K+SDFG++R +E ++ G+ + PE + FS K D
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 265 VFSFGVLLLEIVS 277
+++FGVL+ EI S
Sbjct: 204 IWAFGVLMWEIYS 216
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 58/294 (19%), Positives = 100/294 (34%), Gaps = 70/294 (23%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 179
++G+G +G V+ G R G ++AVK E + ++H+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 180 CCIDKDEKI----LIYEYMPNKSLDFFL-------------------------------- 203
I LI +Y N SL +L
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 204 -------FNLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEYA 254
+LK+ NIL+ K+ I+D G+A NE+ + VGT YM PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-V 217
Query: 255 IEGI-------FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE 307
++ I D++SFG++L E+ + G L Y + +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE---YQLPYHDLVPSDPSYED 274
Query: 308 LTDAILED--------EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
+ + + +SS + L + + C + R T V L
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-32
Identities = 55/281 (19%), Positives = 92/281 (32%), Gaps = 76/281 (27%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
+G+G FG VY G + A+K L Q + E ++ + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 177 LLGCCIDKDEKIL-IYEYMPNKSLDFFLFN------------------------------ 205
L+G + + + YM + L F+ +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIEG 257
L A N +LD+ K++DFG+AR E S + + + E
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREY---YSVQQHRHARLPVKWTALESLQTY 203
Query: 258 IFSIKFDVFSFGVLLLEIVS-------GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310
F+ K DV+SFGVLL E+++ D + L R L +
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-----FDLTHFL-------AQGRRLPQPE 251
Query: 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
+ Y + C + RPT +V +
Sbjct: 252 YCPDSLY----------QVMQQCWEADPAVRPTFRVLVGEV 282
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 37/191 (19%)
Query: 122 NKLGEGGFGPVYKGVLRKGN-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
+KLG G +G VY+GV +K + +AVK L + + + E EA+V+ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFN----------------------------------L 206
C + +I E+M +L +L L
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
A N L+ ++ K++DFG++R+ G+ A+ + +PE FSIK DV+
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVW 403
Query: 267 SFGVLLLEIVS 277
+FGVLL EI +
Sbjct: 404 AFGVLLWEIAT 414
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 59/193 (30%), Positives = 86/193 (44%), Gaps = 43/193 (22%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
KLG G FG V+ K ++AVK + + EA+V+ +QH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 182 IDKDEKILIYEYMPNKSLDFFLFN----------------------------------LK 207
K+ +I E+M SL FL + L+
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIKFD 264
A+NIL+ + KI+DFG+AR+ NE A G + +PE G F+IK D
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSD 367
Query: 265 VFSFGVLLLEIVS 277
V+SFG+LL+EIV+
Sbjct: 368 VWSFGILLMEIVT 380
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 63/194 (32%), Positives = 90/194 (46%), Gaps = 45/194 (23%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 180
+LG G FG V+ G ++AVK L + G + EA+++ ++QH+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 181 CIDKDEKILI-YEYMPNKSLDFFLFN---------------------------------- 205
E I I EYM N SL FL
Sbjct: 77 VT--QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYAIEGIFSIKF 263
L+A+NIL+ ++ KI+DFG+AR+ NE T+R + +PE G F+IK
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 264 DVFSFGVLLLEIVS 277
DV+SFG+LL EIV+
Sbjct: 192 DVWSFGILLTEIVT 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 50/192 (26%), Positives = 82/192 (42%), Gaps = 43/192 (22%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 181
+LG G FG V G + ++AVK + + G + EA + K+ H LV+ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMI--KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 182 IDKDEKILIYEYMPNKSLDFFLFN---------------------------------LKA 208
+ ++ EY+ N L +L + L A
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIKFDV 265
N L+D+D+ K+SDFGM R ++ ++ GT + +PE +S K DV
Sbjct: 133 RNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 266 FSFGVLLLEIVS 277
++FG+L+ E+ S
Sbjct: 189 WAFGILMWEVFS 200
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 50/200 (25%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 175
LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------ 205
RLLG C+ LI + MP L ++
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIEG 257
L A N+L+ + KI+DFG+A++ G E + + G +M+ E +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHR 194
Query: 258 IFSIKFDVFSFGVLLLEIVS 277
I++ + DV+S+GV + E+++
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 51/200 (25%), Positives = 79/200 (39%), Gaps = 47/200 (23%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
+G G FG VY G L + AVK L + + E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 177 LLGCCIDKDEKIL-IYEYMPNKSLDFFLFN------------------------------ 205
LLG C+ + L + YM + L F+ N
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIEG 257
L A N +LD+ K++DFG+AR E + ++ T +M+ E
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALESLQTQ 271
Query: 258 IFSIKFDVFSFGVLLLEIVS 277
F+ K DV+SFGVLL E+++
Sbjct: 272 KFTTKSDVWSFGVLLWELMT 291
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 43/197 (21%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 176
+G G FG V G L+ ++ +A+K L G + + R+ EAS++ + H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------- 205
L G +++ EYM N SLD FL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFS 260
L A NIL++ ++ K+SDFG+ R+ + A T+R G + SPE F+
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFT 228
Query: 261 IKFDVFSFGVLLLEIVS 277
DV+S+G++L E++S
Sbjct: 229 SASDVWSYGIVLWEVMS 245
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 45/195 (23%)
Query: 122 NKLGEGGFGPVYKGVLRKGN-EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 179
+KLG G +G VY+GV +K + +AVK L E EA+V+ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 76
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------- 205
C + +I E+M +L +L
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIK 262
L A N L+ ++ K++DFG++R+ G+ A+ G + +PE FSIK
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPESLAYNKFSIK 192
Query: 263 FDVFSFGVLLLEIVS 277
DV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 50/199 (25%), Positives = 79/199 (39%), Gaps = 51/199 (25%)
Query: 123 KLGEGGFGPVYKGVLRKGNE---IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+LG G FG V +GV R + +A+K L G EM EA ++ ++ + +VRL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 179 GCCIDKDEKILI-YEYMPNKSLDFFLFN-------------------------------- 205
G C + E +++ E L FL
Sbjct: 77 GVC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIEGI 258
L A N+LL KISDFG+++ G ++ + +PE
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECINFRK 189
Query: 259 FSIKFDVFSFGVLLLEIVS 277
FS + DV+S+GV + E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 56/214 (26%), Positives = 83/214 (38%), Gaps = 66/214 (30%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE---IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLVR 176
+ +GEG FG V K ++K A+KR+ S R+ E V+ K+ H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------- 205
LLG C + L EY P+ +L FL
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 206 -----------------LKASNILLDKDMNPKISDFGMARICGGNELQANTS-----RIV 243
L A NIL+ ++ KI+DFG++R G T R
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR-- 206
Query: 244 GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+M+ E +++ DV+S+GVLL EIVS
Sbjct: 207 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 50/200 (25%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE-----IAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLV 175
LG G FG V+KGV E + +K + +SG Q + + + I + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------ 205
RLLG C L+ +Y+P SL +
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIEG 257
L A N+LL +++DFG+A + ++ Q S +M+ E G
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALESIHFG 192
Query: 258 IFSIKFDVFSFGVLLLEIVS 277
++ + DV+S+GV + E+++
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 64/215 (29%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
+LGEG FG V+ + +AVK L + ++ + EA ++ +QH+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------ 205
+ G C D D I+++EYM + L+ FL
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 206 ------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247
L N L+ ++ KI DFGM+R ++ + VG +
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGGHT 195
Query: 248 -----YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+M PE + F+ + DV+SFGV+L EI +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 70/291 (24%), Positives = 99/291 (34%), Gaps = 88/291 (30%)
Query: 122 NKLGEGGFGPVYKGVLRKGN------EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 174
LG G FG VY+G + ++AVK L S Q + EA +I+K H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFN----------------------------- 205
VR +G + + ++ E M L FL
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 206 ----------LKASNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGY---- 248
+ A N LL KI DFGMAR ++ + G
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPVK 210
Query: 249 -MSPEYAIEGIFSIKFDVFSFGVLLLEIVS-------GKKNTGFYRTDTLNLLGYAWDLW 300
M PE +EGIF+ K D +SFGVLL EI S K N + L +
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEFV------- 258
Query: 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
S ++ Y I C Q +DRP ++ +
Sbjct: 259 TSGGRMDPPKNCPGPVY----------RIMTQCWQHQPEDRPNFAIILERI 299
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 63/214 (29%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
+LGEG FG V+ +AVK L S ++ + EA ++ +QH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------ 205
R G C + ++++EYM + L+ FL +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 206 -----------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG- 247
L N L+ + + KI DFGM+R + + R VG
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGGRTM 221
Query: 248 ----YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+M PE + F+ + DV+SFGV+L EI +
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 61/292 (20%), Positives = 99/292 (33%), Gaps = 76/292 (26%)
Query: 123 KLGEGGFGPVYKGVLRKGNE---IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+LG G FG V +GV R + +A+K L G EM EA ++ ++ + +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLFN--------------------------------- 205
G C + +L+ E L FL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIFSIK 262
L A N+LL KISDFG+++ G ++ + +PE FS +
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSR 519
Query: 263 FDVFSFGVLLLEIVS-------GKKNTGFYRTDTLNLL--GYAWDLWRSNRTLELTDAIL 313
DV+S+GV + E +S K + + + G R +E
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGK-----R----MECPPECP 565
Query: 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPA 365
+ Y + C +DRP V + +L +
Sbjct: 566 PELY----------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 51/212 (24%), Positives = 80/212 (37%), Gaps = 70/212 (33%)
Query: 123 KLGEGGFGPVYKGVLRKGN--------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 174
LG+G F ++KGV R+ E+ +K L AS+++K+ HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFL------------------------------F 204
V G C+ DE IL+ E++ SLD +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL 134
Query: 205 ---NLKASNILLDKDMNP--------KISDFGMARICGGNELQANTSRIVGTYGY----- 248
N+ A NILL ++ + K+SD G++ ++
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDILQERIP 182
Query: 249 -MSPEYAIE--GIFSIKFDVFSFGVLLLEIVS 277
+ PE IE ++ D +SFG L EI S
Sbjct: 183 WVPPE-CIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 56/320 (17%), Positives = 107/320 (33%), Gaps = 89/320 (27%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE----IAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLV 175
LG+G FG V + L++ + +AVK L + + E EA+ + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 176 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFN------------------------ 205
+L+G + K +I +M + L FL
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 206 --------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG---- 247
L A N +L +DM ++DFG++R ++ + G
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKLPV 203
Query: 248 -YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-------GKKNTGFYRTDTLNLLGYAWDL 299
+++ E + ++++ DV++FGV + EI++ G +N + N L
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AEIYNYL------ 252
Query: 300 WRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359
L+ +E+ Y ++ C RP+ + L N L
Sbjct: 253 -IGGNRLKQPPECMEEVY----------DLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 360 PPKQPAFSYVRNTVTSTSST 379
N +
Sbjct: 302 VLSTSQDPLYINIERAHHHH 321
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 56/216 (25%), Positives = 82/216 (37%), Gaps = 65/216 (30%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 174
+LGE FG VYKG L +A+K L G E ++EA + A++QH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFN----------------------------- 205
V LLG +I+ Y + L FL
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 206 -------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 246
L N+L+ +N KISD G+ R E+ A +
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKLLGN 189
Query: 247 G-----YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+M+PE + G FSI D++S+GV+L E+ S
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 59/296 (19%), Positives = 106/296 (35%), Gaps = 74/296 (25%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 179
+G+G FG V++G R G E+AVK S + R EA + ++H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 180 CCIDKDEKI----LIYEYMPNKSLDFFL-------------------------------- 203
+ L+ +Y + SL +L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 204 -------FNLKASNILLDKDMNPKISDFGMARI---CGGNELQANTSRIVGTYGYMSPEY 253
+LK+ NIL+ K+ I+D G+A A R VGT YM+PE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYMAPE- 221
Query: 254 AIEGI-------FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306
++ + D+++ G++ EI G + L +DL S+ ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY----YDLVPSDPSV 277
Query: 307 E-LTDAI--------LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
E + + + + + S + L I C + R T + L+
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 56/210 (26%), Positives = 84/210 (40%), Gaps = 59/210 (28%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 174
+LG+G FG VY+GV + + +A+K + S + E NEASV+ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFN----------------------------- 205
VRLLG ++I E M L +L +
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 206 -------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY---- 248
L A N ++ +D KI DFGM R ++ G G
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPVR 205
Query: 249 -MSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
MSPE +G+F+ DV+SFGV+L EI +
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 60/293 (20%), Positives = 109/293 (37%), Gaps = 88/293 (30%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE----IAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLV 175
LGEG FG V +G L++ + +AVK + S + + E +EA+ + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 176 RLLGCCIDKD-----EKILIYEYMPNKSLDFFLFN------------------------- 205
RLLG CI+ + ++I +M L +L
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 206 -------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG----- 247
L A N +L DM ++DFG+++ ++ + G
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMPVK 214
Query: 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-------GKKNTGFYRTDTLNLLGYAWDLW 300
+++ E + +++ K DV++FGV + EI + G +N + + L
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----HEMYDYL------- 262
Query: 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
L+ + L++ Y I C + DRPT + + L
Sbjct: 263 LHGHRLKQPEDCLDELY----------EIMYSCWRTDPLDRPTFSVLRLQLEK 305
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 49/202 (24%), Positives = 74/202 (36%), Gaps = 47/202 (23%)
Query: 123 KLGEGGFGPVYKGVLR--KGNEI--AVKRL---SGRSGQGLREMKNEASVIAKVQHKNLV 175
KLG+G FG V +G G + AVK L + + + E + + + H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------ 205
RL G + K+ + E P SL L
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI 143
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIEGIF 259
L A N+LL KI DFG+ R N+ + + +PE F
Sbjct: 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTF 201
Query: 260 SIKFDVFSFGVLLLEIVS-GKK 280
S D + FGV L E+ + G++
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQE 223
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 70/269 (26%), Positives = 115/269 (42%), Gaps = 62/269 (23%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 180
KLG+G FG V+ G +A+K L + G E EA V+ K++H+ LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFN----------------------------------L 206
++ I + EYM SL FL L
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
+A+NIL+ +++ K++DFG+AR+ NE A + +PE A+ G F+IK DV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVW 448
Query: 267 SFGVLLLEIVS-GKK-NTGFYRTDTLNLL--GYAWDLWRSNRTLELTDAILEDEYSSKQV 322
SFG+LL E+ + G+ G + L+ + GY R + E +
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----R----MPCPPECPESLH----- 494
Query: 323 LLRYVNIALLCVQESADDRPTTNDVVSML 351
++ C ++ ++RPT + + L
Sbjct: 495 -----DLMCQCWRKEPEERPTFEYLQAFL 518
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 70/291 (24%), Positives = 98/291 (33%), Gaps = 88/291 (30%)
Query: 122 NKLGEGGFGPVYKGVLRKGN------EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 174
LG G FG VY+G + ++AVK L S Q + EA +I+K H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFN----------------------------- 205
VR +G + + ++ E M L FL
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 206 ----------LKASNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGY---- 248
+ A N LL KI DFGMAR ++ G
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPVK 251
Query: 249 -MSPEYAIEGIFSIKFDVFSFGVLLLEIVS-------GKKNTGFYRTDTLNLLGYAWDLW 300
M PE +EGIF+ K D +SFGVLL EI S K N + L +
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEFV------- 299
Query: 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
S ++ Y I C Q +DRP ++ +
Sbjct: 300 TSGGRMDPPKNCPGPVY----------RIMTQCWQHQPEDRPNFAIILERI 340
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 41/206 (19%), Positives = 70/206 (33%), Gaps = 66/206 (32%)
Query: 123 KLGEGGFGPVYKGVLRKGNE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
+GEG FG V++G+ +A+K + S + EA + + H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 178 LGCCIDKDEKILI-YEYMPNKSLDFFLFN------------------------------- 205
+G + + I E L FL
Sbjct: 82 IGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 139
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY------------MSP 251
+ A N+L+ + K+ DFG++R + Y M+P
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------------YYKASKGKLPIKWMAP 186
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVS 277
E F+ DV+ FGV + EI+
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 45/205 (21%), Positives = 72/205 (35%), Gaps = 64/205 (31%)
Query: 123 KLGEGGFGPVYKGVLRKGNE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
LGEG FG VY+GV +AVK + + +EA ++ + H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
+G +++ +I E P L +L
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY------------MSPE 252
+ NIL+ K+ DFG++R + Y MSPE
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDED-------------YYKASVTRLPIKWMSPE 184
Query: 253 YAIEGIFSIKFDVFSFGVLLLEIVS 277
F+ DV+ F V + EI+S
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILS 209
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 58/191 (30%), Positives = 89/191 (46%), Gaps = 39/191 (20%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 180
KLG+G FG V+ G +A+K L + G E EA V+ K++H+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFN----------------------------------L 206
++ I + EYM SL FL L
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
+A+NIL+ +++ K++DFG+AR+ NE A + +PE A+ G F+IK DV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVW 365
Query: 267 SFGVLLLEIVS 277
SFG+LL E+ +
Sbjct: 366 SFGILLTELTT 376
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 49/198 (24%)
Query: 123 KLGEGGFGPVYKGVLRKGN---EIAVKRL-SGRSGQGLR-EMKNEASVIAKVQHKNLVRL 177
+LG G FG V KG + +AVK L + + L+ E+ EA+V+ ++ + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
+G C + + +L+ E L+ +L
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 142
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIEGIF 259
L A N+LL KISDFG+++ +E + +PE F
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKF 197
Query: 260 SIKFDVFSFGVLLLEIVS 277
S K DV+SFGVL+ E S
Sbjct: 198 SSKSDVWSFGVLMWEAFS 215
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 52/218 (23%), Positives = 83/218 (38%), Gaps = 67/218 (30%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE------IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 173
LG G FG V + ++ +AVK L G + R + +E ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 174 LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFN--------------------------- 205
+V LLG C + +I E+ +L +L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 206 ---------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 244
L A NILL + KI DFG+AR ++ + +
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRK 207
Query: 245 TYG-----YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+M+PE + +++I+ DV+SFGVLL EI S
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 51/215 (23%), Positives = 76/215 (35%), Gaps = 60/215 (27%)
Query: 122 NKLGEGGFGPVYKGV---LRKGNE---IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 173
LG G FG V + L K + +AVK L + +E V++ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN---------------------------- 205
+V LLG C ++I EY L FL
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 206 ----------------------LKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRI 242
L A NILL KI DFG+AR I + +
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+ +M+PE +++ + DV+S+G+ L E+ S
Sbjct: 209 L-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 52/211 (24%), Positives = 82/211 (38%), Gaps = 56/211 (26%)
Query: 122 NKLGEGGFGPVYKGV---LRKGNE---IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 173
LG G FG V + L K + +AVK L S + +E +++ + QH+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN---------------------------- 205
+V LLG C ++I EY L FL
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 206 ------------------LKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTY 246
+ A N+LL KI DFG+AR I + + +
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PV 230
Query: 247 GYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
+M+PE + +++++ DV+S+G+LL EI S
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 50/219 (22%), Positives = 85/219 (38%), Gaps = 68/219 (31%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE--------IAVKRL-SGRSGQGLREMKNEASVIAKV-QH 171
LGEG FG V ++ +AVK L + + L ++ +E ++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------- 205
KN++ LLG C +I EY +L +L
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 206 ----------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243
L A N+L+ ++ KI+DFG+AR ++
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKK 215
Query: 244 GTYG-----YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
T G +M+PE + +++ + DV+SFGVL+ EI +
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 68/219 (31%)
Query: 122 NKLGEGGFGPVYKGVLRKGN--------EIAVKRL-SGRSGQGLREMKNEASVIAKV-QH 171
LGEG FG V + ++AVK L S + + L ++ +E ++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------- 205
KN++ LLG C +I EY +L +L
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 206 ----------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243
L A N+L+ +D KI+DFG+AR ++
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKK 249
Query: 244 GTYG-----YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS 277
T G +M+PE + I++ + DV+SFGVLL EI +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 60/302 (19%), Positives = 102/302 (33%), Gaps = 97/302 (32%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE--------IAVKRL-SGRSGQGLREMKNEASVIAKV-QH 171
LGEG FG V ++ +AVK L + + L ++ +E ++ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------- 205
KN++ LLG C +I EY +L +L
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 206 ----------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 243
L A N+L+ ++ KI+DFG+AR ++
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKK 261
Query: 244 GTYG-----YMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-------GKKNTGFYRTDTLN 291
T G +M+PE + +++ + DV+SFGVL+ EI + G +
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----EELFK 316
Query: 292 LLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
LL + ++ + Y + C RPT +V L
Sbjct: 317 LL-------KEGHRMDKPANCTNELY----------MMMRDCWHAVPSQRPTFKQLVEDL 359
Query: 352 TN 353
Sbjct: 360 DR 361
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 40/193 (20%), Positives = 73/193 (37%), Gaps = 40/193 (20%)
Query: 123 KLGEGGFGPVYKGVLRKGNE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 177
+GEG FG V++G+ +A+K + S + EA + + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
+G ++ +I E L FL
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+ A N+L+ + K+ DFG++R + + + +M+PE F+ D
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASD 574
Query: 265 VFSFGVLLLEIVS 277
V+ FGV + EI+
Sbjct: 575 VWMFGVCMWEILM 587
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 61/297 (20%)
Query: 123 KLGEGGFGPVYKGVLRK--GNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
K+GEG FG V G + +K +S S + E + E +V+A ++H N+V+
Sbjct: 31 KIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLFN--------------------------------- 205
+ ++ +Y L +
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI-FSIKF 263
+K+ NI L KD ++ DFG+AR+ A +GT Y+SPE E ++ K
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPE-ICENKPYNNKS 206
Query: 264 DVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVL 323
D+++ G +L E+ + K F NL+ + + + + YS
Sbjct: 207 DIWALGCVLYELCTLKH--AFEAGSMKNLV---------LKIISGSFPPVSLHYSYD--- 252
Query: 324 LRYVNIALLCVQESADDRPTTNDVVSM--LTNEAAALLPPKQPAFSYVRNTVTSTSS 378
LR ++ + + DRP+ N ++ + L P+ A + T + S
Sbjct: 253 LR--SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGS 307
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 53/274 (19%), Positives = 99/274 (36%), Gaps = 59/274 (21%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK--GNEIAVK--RLSGRSGQGLREM-KNEASVIAKVQ 170
F K+G G F VY+ G +A+K ++ R E ++ ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYR-AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 171 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------- 205
H N+++ I+ +E ++ E L + +
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 206 -----------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 254
+K +N+ + K+ D G+ R A++ +VGT YMSPE
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE-R 207
Query: 255 IEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313
I ++ K D++S G LL E+ + + + D +NL + + + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCD-----YPPLP 259
Query: 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDV 347
D YS + LR + +C+ + RP V
Sbjct: 260 SDHYSEE---LR--QLVNMCINPDPEKRPDVTYV 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 49/230 (21%)
Query: 93 KRNKKKEVDQFPLFSFSSVSTATNRFSDANK-LGEGGFGPVYKGV-LRKGNEIAVK--RL 148
+RN++++ + +S RF + +G G F VYKG+ E+A +
Sbjct: 3 ERNQQQDDIEELETKAVGMSN-DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 149 SGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK----ILIYEYMPNKSLDFFLF 204
+ + K EA ++ +QH N+VR + +L+ E M + +L +L
Sbjct: 62 RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121
Query: 205 ----------------------------------NLKASNILLD-KDMNPKISDFGMARI 229
+LK NI + + KI D G+A +
Sbjct: 122 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181
Query: 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ ++GT +M+PE E + DV++FG+ +LE+ + +
Sbjct: 182 KRAS----FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 57/289 (19%), Positives = 97/289 (33%), Gaps = 83/289 (28%)
Query: 112 STATNRFSDANKLGEGGFGPVYKGVLRK--GNEIAVKRLSGRSGQGLREMKNEASVIAKV 169
F + +G GGFG V+K + G +KR+ + + E +AK+
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFK-AKHRIDGKTYVIKRVK----YNNEKAEREVKALAKL 61
Query: 170 QHKNLVRLLGCCIDKDEKI----------------LIYEYMPNKSLDFFLFN-------- 205
H N+V GC D + E+ +L+ ++
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 206 --------------------------LKASNILLDKDMNPKISDFGMARICGGNELQANT 239
LK SNI L KI DFG+ N+ +
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTR 180
Query: 240 SRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD 298
GT YMSPE I + + D+++ G++L E++ T F +
Sbjct: 181 --SKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCD-TAFETSKFFTD------ 230
Query: 299 LWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDV 347
L D I+ D + K + + + + +DRP T+++
Sbjct: 231 ---------LRDGIISDIFDKK---EK--TLLQKLLSKKPEDRPNTSEI 265
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 50/231 (21%), Positives = 77/231 (33%), Gaps = 43/231 (18%)
Query: 88 NSKLTKRNKKKEVDQFPLFSFSSVSTAT-NRFSDANKLGEGGFGPVYKGVLRKGNEI-AV 145
+++ R + E Q P + S + F ++LG G +G V+K ++ + AV
Sbjct: 28 PRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87
Query: 146 K--RLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF 202
K R + E KV QH VRL + L E SL
Sbjct: 88 KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQH 146
Query: 203 L------FN---------------------------LKASNILLDKDMNPKISDFGMARI 229
+K +NI L K+ DFG+
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKK 280
G G YM+PE ++G + DVFS G+ +LE+ +
Sbjct: 207 LGTAGA-GEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 56/292 (19%), Positives = 95/292 (32%), Gaps = 79/292 (27%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK--GNEIAVKRLS-GRSGQGLREMKNEASVIAKVQHK 172
F LG GGFG V++ K A+KR+ ++ E +AK++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 173 NLVRLLGCCIDKDE---------KILIY---EYMPNKSLDFFLFN--------------- 205
+VR ++K+ K+ +Y + ++L ++
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 206 --------------------LKASNILLDKDMNPKISDFGMARICGGNELQANT------ 239
LK SNI D K+ DFG+ +E +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 240 ----SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGY 295
+ VGT YMSPE +S K D+FS G++L E+ Y T
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--------LYPFSTQMERVR 235
Query: 296 AWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDV 347
R+ + L + + + + S +RP ++
Sbjct: 236 TLTDVRNLKF-----PPLFTQKYPCE-----YVMVQDMLSPSPMERPEAINI 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 58/281 (20%), Positives = 97/281 (34%), Gaps = 78/281 (27%)
Query: 123 KLGEGGFGPVYKGVLRK--GNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+G G +G K + RK G + K + + + +E +++ +++H N+VR
Sbjct: 13 TIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 179 GCCIDKDEKIL--IYEYMPNKSLDFFLFN------------------------------- 205
ID+ L + EY L +
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 206 ----------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 255
LK +N+ LD N K+ DFG+ARI + A T VGT YMSPE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMN 189
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315
++ K D++S G LL E+ + + + EL I E
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMP------------------PFTAFSQKELAGKIREG 231
Query: 316 EYS------SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350
++ S + L I + RP+ +++
Sbjct: 232 KFRRIPYRYSDE--LN--EIITRMLNLKDYHRPSVEEILEN 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 52/220 (23%), Positives = 81/220 (36%), Gaps = 49/220 (22%)
Query: 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKR--LSGRSGQGLREMKNEAS 164
F S+S +S ++G GG V++ + K A+K L Q L +NE +
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 165 VIAKVQHKNL--VRLLGCCIDKDEKILIYEY---------MPNKSLD-----FFLF---- 204
+ K+Q + +RL I ++ E KS+D +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 138
Query: 205 -------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 251
+LK +N L+ K+ DFG+A + VGT YM P
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 252 EYAIEGI------------FSIKFDVFSFGVLLLEIVSGK 279
E AI+ + S K DV+S G +L + GK
Sbjct: 198 E-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 45/197 (22%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182
LG+G +G VY G L IA+K + R + + + E ++ ++HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 183 DKDEKILIY-EYMPNKSLDFFLFN-----------------------------------L 206
+ + I I+ E +P SL L + +
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 207 KASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI---FSIK 262
K N+L++ KISDFG ++ G T GT YM+PE I+ +
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE-IIDKGPRGYGKA 205
Query: 263 FDVFSFGVLLLEIVSGK 279
D++S G ++E+ +GK
Sbjct: 206 ADIWSLGCTIIEMATGK 222
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 49/205 (23%), Positives = 75/205 (36%), Gaps = 49/205 (23%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNL--VRL 177
++G GG V++ + K A+K L Q L +NE + + K+Q + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 178 LGCCIDKDEKILIYEY---------MPNKSLD-----FFLFN-----------------L 206
I ++ E KS+D + N L
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 134
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI-------- 258
K +N L+ K+ DFG+A + VGT YM PE AI+ +
Sbjct: 135 KPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGK 192
Query: 259 ----FSIKFDVFSFGVLLLEIVSGK 279
S K DV+S G +L + GK
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 48/206 (23%), Positives = 75/206 (36%), Gaps = 51/206 (24%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNL--VRL 177
++G GG V++ + K A+K L Q L +NE + + K+Q + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFL-----FN--------------------------- 205
I ++ E N L+ +L +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI------- 258
LK +N L+ D K+ DFG+A + VG YM PE AI+ +
Sbjct: 181 LKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMSSSRENG 238
Query: 259 -----FSIKFDVFSFGVLLLEIVSGK 279
S K DV+S G +L + GK
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 45/225 (20%)
Query: 93 KRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGR 151
++K ++ F + F ++LG G G V+K + + A K +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69
Query: 152 SGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF------ 204
++ E V+ + +V G E + E+M SLD L
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 129
Query: 205 ---------------------------NLKASNILLDKDMNPKISDFGMARICGGNEL-- 235
++K SNIL++ K+ DFG++ +L
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLID 184
Query: 236 -QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
AN+ VGT YMSPE +S++ D++S G+ L+E+ G+
Sbjct: 185 SMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 43/224 (19%), Positives = 80/224 (35%), Gaps = 61/224 (27%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 173
+ F + LG+G FG V K A+K++ + L + +E ++A + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFF---------LFN------------------- 205
+VR +++ + + KS F L++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 206 ------------------LKASNILLDKDMNPKISDFGMARIC------------GGNEL 235
LK NI +D+ N KI DFG+A+
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 236 QANTSRIVGTYGYMSPE-YAIEGIFSIKFDVFSFGVLLLEIVSG 278
N + +GT Y++ E G ++ K D++S G++ E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-21
Identities = 44/210 (20%), Positives = 73/210 (34%), Gaps = 55/210 (26%)
Query: 123 KLGEGGFGPVYKGVLRK--GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
KLGEGGF V V G+ A+KR+ Q E + EA + H N++RL+
Sbjct: 36 KLGEGGFSYVDL-VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 181 CIDKDEK----ILIYEYMPNKSLDFFLFN------------------------------- 205
C+ + L+ + +L +
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 206 -----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV-------GTYGYMSPE- 252
LK +NILL + P + D G + + + + T Y +PE
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 253 ---YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ I + DV+S G +L ++ G+
Sbjct: 215 FSVQSHCVI-DERTDVWSLGCVLYAMMFGE 243
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 45/197 (22%), Positives = 89/197 (45%), Gaps = 34/197 (17%)
Query: 115 TNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 173
+++ K+G+G G VY + + G E+A+++++ + + NE V+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFN--------------------------- 205
+V L + DE ++ EY+ SL D
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 206 ---LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+K+ NILL D + K++DFG + + +T +VGT +M+PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 196
Query: 263 FDVFSFGVLLLEIVSGK 279
D++S G++ +E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 41/210 (19%), Positives = 75/210 (35%), Gaps = 46/210 (21%)
Query: 109 SSVSTATNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIA 167
+ + ++G G FG V++ + G + AVK++ + E A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 168 KVQHKNLVRLLGCCIDKDEKILIY-EYMPNKSLDFFL-----FN---------------- 205
+ +V L G + + I+ E + SL +
Sbjct: 106 GLSSPRIVPLYGAVR-EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164
Query: 206 -----------LKASNILLDKDMNP-KISDFGMARICGGNELQANTSR---IVGTYGYMS 250
+KA N+LL D + + DFG A + L + I GT +M+
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 251 PEYAIEGI-FSIKFDVFSFGVLLLEIVSGK 279
PE + G K D++S ++L +++G
Sbjct: 225 PE-VVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-20
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 36/226 (15%)
Query: 88 NSKLTKRNKKKEVDQFP--LFSFSSVSTATNRFSDANKLGEGGFGPVYKGV-LRKGNEIA 144
L ++ +QF L K+GEG G V G ++A
Sbjct: 15 TENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVA 74
Query: 145 VKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFL 203
VK + R Q + NE ++ QH N+V + + +E ++ E++ +L D
Sbjct: 75 VKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS 134
Query: 204 FN------------------------------LKASNILLDKDMNPKISDFGMARICGGN 233
+K+ +ILL D K+SDFG +
Sbjct: 135 QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194
Query: 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ + +VGT +M+PE +++ + D++S G++++E+V G+
Sbjct: 195 VPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 64/321 (19%), Positives = 102/321 (31%), Gaps = 87/321 (27%)
Query: 123 KLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 180
L EGGF VY+ + G E A+KRL + R + E + K+ H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 181 CIDKDEK-------ILIYEYMPNKSLDFFLFN---------------------------- 205
E+ L+ + L FL
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 206 ---------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRI----------VGTY 246
LK N+LL K+ DFG A + +++ T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 247 GYMSPE----YAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS 302
Y +PE Y+ I K D+++ G +L + + F L
Sbjct: 215 MYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQ--HPFEDGAKL------------ 259
Query: 303 NRTLELTDAILEDEYSSKQVLLRYVNIALL---CVQESADDRPTTNDVVSMLTNEAAAL- 358
I+ +YS +Y L +Q + ++R + +VV L AAA
Sbjct: 260 --------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311
Query: 359 LPPKQPAFSYVRNTVTSTSST 379
+ PK P + S+T
Sbjct: 312 VNPKSPITELLEQNGGYGSAT 332
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 49/220 (22%), Positives = 81/220 (36%), Gaps = 56/220 (25%)
Query: 112 STATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLRE-MKNEASVIAKV 169
ST+ + + ++ LG+G V++G +K G+ A+K + S + E V+ K+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 170 QHKNLVRLLGC--CIDKDEKILIYEYMPNKSLDFFLFN---------------------- 205
HKN+V+L K+LI E+ P SL L
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 206 -------------LKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
+K NI+ D K++DFG AR +E + + GT Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEY 181
Query: 249 MSPEYAIEGI---------FSIKFDVFSFGVLLLEIVSGK 279
+ P+ E + D++S GV +G
Sbjct: 182 LHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 44/195 (22%)
Query: 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 179
LG+GGF ++ A K + RE M E S+ + H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 180 CCIDKDEKILIYEYMPNKSL----------------DFF--LFN--------------LK 207
D D ++ E +SL + + LK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIEGIFSIKFD 264
N+ L++D+ KI DFG+A +++ + R + GT Y++PE + S + D
Sbjct: 169 LGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVD 223
Query: 265 VFSFGVLLLEIVSGK 279
V+S G ++ ++ GK
Sbjct: 224 VWSIGCIMYTLLVGK 238
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 48/229 (20%), Positives = 83/229 (36%), Gaps = 46/229 (20%)
Query: 93 KRNKKKEVDQFPLFSFSSVSTATNRFSDA----NKLGEGGFGPVYKGVLRK-GNEIAVKR 147
R +++ S+ KLG G +G V + E A+K
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 148 LSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL------ 199
+ S ++ E +V+ + H N+++L DK L+ E L
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 200 -DFF-----------LFN--------------LKASNILL---DKDMNPKISDFGMARIC 230
F + + LK N+LL +KD KI DFG++ +
Sbjct: 130 RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189
Query: 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ +GT Y++PE + + K DV+S GV+L +++G
Sbjct: 190 ENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 49/220 (22%), Positives = 81/220 (36%), Gaps = 56/220 (25%)
Query: 112 STATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLRE-MKNEASVIAKV 169
ST+ + + ++ LG+G V++G +K G+ A+K + S + E V+ K+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 170 QHKNLVRLLGC--CIDKDEKILIYEYMPNKSLDFFLFN---------------------- 205
HKN+V+L K+LI E+ P SL L
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 206 -------------LKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
+K NI+ D K++DFG AR +E + + GT Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEY 181
Query: 249 MSPEYAIEGI---------FSIKFDVFSFGVLLLEIVSGK 279
+ P+ E + D++S GV +G
Sbjct: 182 LHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 48/203 (23%), Positives = 74/203 (36%), Gaps = 49/203 (24%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL-- 178
+LG GGFG V + + + G ++A+K+ RE E ++ K+ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 179 ----GCCIDKDEKILIYEYMPNKSL-------------------DFF---------LFN- 205
D +L EY L L
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 206 ------LKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE 256
LK NI+L + + KI D G A+ EL VGT Y++PE +
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF--VGTLQYLAPELLEQ 197
Query: 257 GIFSIKFDVFSFGVLLLEIVSGK 279
+++ D +SFG L E ++G
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGF 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 44/195 (22%)
Query: 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 179
LG+GGF ++ A K + RE M E S+ + H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 180 CCIDKDEKILIYEYMPNKSL----------------DFF--LFN--------------LK 207
D D ++ E +SL + + LK
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIEGIFSIKFD 264
N+ L++D+ KI DFG+A +++ + R + GT Y++PE + S + D
Sbjct: 143 LGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVD 197
Query: 265 VFSFGVLLLEIVSGK 279
V+S G ++ ++ GK
Sbjct: 198 VWSIGCIMYTLLVGK 212
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 45/196 (22%), Positives = 89/196 (45%), Gaps = 35/196 (17%)
Query: 117 RFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNL 174
F+ K+G+G FG V+KG+ R +A+K + + + +++ E +V+++ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 175 VRLLGCCIDKDEKILIYEYMPNKS-------------------------LDFFLFN---- 205
+ G + + +I EY+ S LD+
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 142
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
+KA+N+LL + K++DFG+A +++ NT VGT +M+PE + + K
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKA 200
Query: 264 DVFSFGVLLLEIVSGK 279
D++S G+ +E+ G+
Sbjct: 201 DIWSLGITAIELARGE 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 42/195 (21%), Positives = 77/195 (39%), Gaps = 47/195 (24%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
+G+G F V + + R+ G + AVK + + G ++K EAS+ ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 177 LLGCCIDKDEKILIYEYMP---------NKSLDFFLFN---------------------- 205
LL +++E+M ++ F+++
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 206 -----LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
+K +LL + K+ FG+A G + L A VGT +M+PE
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKRE 208
Query: 258 IFSIKFDVFSFGVLL 272
+ DV+ GV+L
Sbjct: 209 PYGKPVDVWGCGVIL 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 56/229 (24%), Positives = 88/229 (38%), Gaps = 45/229 (19%)
Query: 86 PVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSD------ANKLGEGGFGPVYKGVLRK 139
PV SK T F V+ + LG G FG V+K
Sbjct: 53 PVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112
Query: 140 -GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP--- 195
G ++A K + R + E+KNE SV+ ++ H NL++L K++ +L+ EY+
Sbjct: 113 TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172
Query: 196 ------NKSLDF-----------------FL-------FNLKASNILL-DKDMNP-KISD 223
++S + + +LK NIL ++D KI D
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID 232
Query: 224 FGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLL 272
FG+AR E GT +++PE S D++S GV+
Sbjct: 233 FGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-18
Identities = 42/204 (20%), Positives = 75/204 (36%), Gaps = 52/204 (25%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSG-QGLREMKNEASVIAK-VQHKNLVRLL 178
+LG G +G V K +I AVKR+ Q + + + + + V V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLFNL-------------------------------- 206
G + + + E M + SLD F +
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 207 -----KASNILLDKDMNPKISDFGMARICG--GNELQANTSRIVGTYGYMSPE----YAI 255
K SN+L++ K+ DFG I G +++ + G YM+PE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFG---ISGYLVDDVAKDID--AGCKPYMAPERINPELN 186
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGK 279
+ +S+K D++S G+ ++E+ +
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILR 210
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 1e-17
Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 45/196 (22%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 179
LG+G F VY+ + G E+A+K + ++ G+ + ++NE + +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------L 206
D + L+ E N ++ +L N L
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDL 138
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIEGIFSIKF 263
SN+LL ++MN KI+DFG+A +L+ + + GT Y+SPE A ++
Sbjct: 139 TLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLES 193
Query: 264 DVFSFGVLLLEIVSGK 279
DV+S G + ++ G+
Sbjct: 194 DVWSLGCMFYTLLIGR 209
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 40/221 (18%)
Query: 93 KRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGR 151
+ ++++ + L S F KLGEG +G VYK + G +A+K++
Sbjct: 8 RNPPRRQLKK--LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-- 63
Query: 152 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFN----- 205
L+E+ E S++ + ++V+ G + ++ EY S+ D
Sbjct: 64 VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT 123
Query: 206 ---------------------------LKASNILLDKDMNPKISDFGMARICGGNELQAN 238
+KA NILL+ + + K++DFG+A + N
Sbjct: 124 EDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183
Query: 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
T ++GT +M+PE E ++ D++S G+ +E+ GK
Sbjct: 184 T--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 46/225 (20%), Positives = 76/225 (33%), Gaps = 43/225 (19%)
Query: 88 NSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSD----ANKLGEGGFGPVYKGVLRK-GNE 142
++ D + + V + D +LG G FG V++ R GN
Sbjct: 125 KGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNN 184
Query: 143 IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--- 199
A K + ++ E ++ ++H LV L D +E ++IYE+M L
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244
Query: 200 ----DFFL--------------------------FNLKASNILL-DKDMNP-KISDFGMA 227
+ +LK NI+ K N K+ DFG+
Sbjct: 245 VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 228 RICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLL 272
+ + GT + +PE A D++S GVL
Sbjct: 305 AHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 36/152 (23%), Positives = 59/152 (38%), Gaps = 28/152 (18%)
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTS----------RIVGTYGYMSPEYAI 255
LK SNI D K+ DFG+ +E + VGT YMSPE
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315
+S K D+FS G++L E++ T R + + R L+ +
Sbjct: 250 GNNYSHKVDIFSLGLILFELLYSFS-TQMERVRIITDV----------RNLKFPL-LFTQ 297
Query: 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDV 347
+Y + ++++ + S +RP D+
Sbjct: 298 KYPQEHMMVQ------DMLSPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 20/97 (20%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK--GNEIAVKRLS-GRSGQGLREMKNEASVIAKVQHK 172
F +G GGFG V++ K A+KR+ ++ E +AK++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFNLKAS 209
+VR ++ + E D +S
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSS 101
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 43/204 (21%), Positives = 87/204 (42%), Gaps = 41/204 (20%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKN 173
+ +LG+G FG VYK ++ + A K + +S + L + E ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLD--------------------------FFLFN-- 205
+V+LLG + ++ E+ P ++D FL +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 206 -----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE-----YAI 255
LKA N+L+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMK 195
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGK 279
+ + K D++S G+ L+E+ +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIE 219
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 44/226 (19%), Positives = 76/226 (33%), Gaps = 44/226 (19%)
Query: 88 NSKLTKRNKKKEV-DQFPLFSFSSVSTATNRFSD----ANKLGEGGFGPVYKGVLRK-GN 141
+ K D + + V D +LG G FG V++ V + G
Sbjct: 18 YDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGR 77
Query: 142 EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP------ 195
K ++ +KNE S++ ++ H L+ L DK E +LI E++
Sbjct: 78 VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 137
Query: 196 ---NKSLDF-----------------FL-------FNLKASNILL-DKDMNP-KISDFGM 226
+ + ++K NI+ K + KI DFG+
Sbjct: 138 RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 227 ARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLL 272
A +E+ T + +PE D+++ GVL
Sbjct: 198 ATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-17
Identities = 41/232 (17%), Positives = 70/232 (30%), Gaps = 68/232 (29%)
Query: 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKR--LSGRSGQGLREMKNEASV 165
S T F + K+G G FG V+K V R I A+KR + E
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 166 IAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------- 205
A + QH ++VR + D ++ EY SL +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 206 -----------------LKASNILLDKDMNP-------------------KISDFGMARI 229
+K SNI + + P KI D G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFS--IKFDVFSFGVLLLEIVSGK 279
+ G +++ E ++ ++ K D+F+ + ++ +
Sbjct: 184 IS------SPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 47/217 (21%), Positives = 75/217 (34%), Gaps = 65/217 (29%)
Query: 123 KLGEGGFGPVY---------------KGVLRKGNEIAVKRLSGRSGQGLRE-MKNEASVI 166
L +G F + K +L K + S + + KNE +I
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 167 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN--------------------- 205
++++ + G + DE +IYEYM N S+ F
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 206 --------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 245
+K SNIL+DK+ K+SDFG + +++ S GT
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS--RGT 213
Query: 246 YGYMSPEYAIEGIFSI---KFDVFSFGVLLLEIVSGK 279
Y +M PE S K D++S G+ L +
Sbjct: 214 YEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 51/195 (26%), Positives = 79/195 (40%), Gaps = 42/195 (21%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLL 178
LG+G FG V K R E AVK ++ + + E ++ K+ H N+++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 179 GCCIDKDEKILIYEYMPNKSL-------DFF-----------LFN--------------L 206
D ++ E L F +F+ L
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 207 KASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
K NILL +KD + KI DFG++ N +GT Y++PE + G + K
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPE-VLRGTYDEKC 203
Query: 264 DVFSFGVLLLEIVSG 278
DV+S GV+L ++SG
Sbjct: 204 DVWSAGVILYILLSG 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 53/204 (25%)
Query: 123 KLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSG-QGLREMKNEASVIAK-VQHKNLVRLLG 179
++G G +G V K V + +I AVKR+ + +++ + V+ + +V+ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------- 205
+ + + E M + S D F
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPE----YAI 255
+K SNILLD+ N K+ DFG I G +L + ++ G YM+PE A
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFG---ISG--QLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGK 279
+ ++ DV+S G+ L E+ +G+
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGR 226
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 50/196 (25%), Positives = 79/196 (40%), Gaps = 43/196 (21%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRL 177
LG+G FG V + G E AVK +S R + E ++ ++ H N+++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 178 LGCCIDKDEKILIYEYMPNKSL-------DFF-----------LFN-------------- 205
DK L+ E L F + +
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 206 LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
LK N+LL KD N +I DFG++ ++ +GT Y++PE + G + K
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEK 207
Query: 263 FDVFSFGVLLLEIVSG 278
DV+S GV+L ++SG
Sbjct: 208 CDVWSTGVILYILLSG 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 45/226 (19%)
Query: 93 KRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLS-- 149
+ + + FSD ++G G FG VY +R +A+K++S
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90
Query: 150 -GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN--- 205
+S + +++ E + K++H N ++ GC + + L+ EY + D +
Sbjct: 91 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP 150
Query: 206 -----------------------------LKASNILLDKDMNPKISDFGMARICGGNELQ 236
+KA NILL + K+ DFG A
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAP 206
Query: 237 ANTSRIVGTYGYMSPE---YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
AN+ VGT +M+PE EG + K DV+S G+ +E+ K
Sbjct: 207 ANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 38/204 (18%), Positives = 69/204 (33%), Gaps = 45/204 (22%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLV 175
F + LG G G + + ++AVKR+ E ++ + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 176 RLLGCCIDKDEKILIYEYMP--------NKSLDFFLF----------------------- 204
R D+ + + E K
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141
Query: 205 -NLKASNILL-----DKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEY---A 254
+LK NIL+ + ISDFG+ + G + S + GT G+++PE
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 255 IEGIFSIKFDVFSFGVLLLEIVSG 278
+ + D+FS G + ++S
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISE 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 57/209 (27%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLS------GRSGQGLREMKNEASVIAKV 169
++ K+GEG +G VYK +G +A+KR+ G +RE+ S++ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKEL 76
Query: 170 QHKNLVRLLGCCIDKDEKILIYEYMPN------------------KSLDFFLFN------ 205
H N+V L+ + L++E+M K + L
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 206 --------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE----- 252
LK N+L++ D K++DFG+AR G +++ T +V T Y +P+
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGS 194
Query: 253 --YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
Y S D++S G + E+++GK
Sbjct: 195 KKY------STSVDIWSIGCIFAEMITGK 217
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 48/195 (24%), Positives = 78/195 (40%), Gaps = 42/195 (21%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVR 176
LG+G FG VY ++ +A+K L ++G +++ E + + ++H N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILR 73
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FN-------------------------- 205
L G D LI EY P ++ L F+
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHR 133
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
+K N+LL KI+DFG + + + GT Y+ PE + K D
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPEMIEGRMHDEKVD 189
Query: 265 VFSFGVLLLEIVSGK 279
++S GVL E + GK
Sbjct: 190 LWSLGVLCYEFLVGK 204
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 40/186 (21%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+G G +G V V + A K++ + + K E ++ + H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 182 IDKDEKILIYEYMPNKSL----------------DFF--LFN--------------LKAS 209
D + L+ E L + + LK
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE 135
Query: 210 NILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
N L D K+ DFG+A ++ VGT Y+SP+ +EG++ + D +
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-VLEGLYGPECDEW 191
Query: 267 SFGVLL 272
S GV++
Sbjct: 192 SAGVMM 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 42/188 (22%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 179
LG+G FG V K R E AVK ++ + + E ++ K+ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 180 CCIDKDEKILIYEYMPNKSL-------DFF-----------LFN--------------LK 207
D ++ E L F +F+ LK
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 208 ASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
NILL +KD + KI DFG++ N +GT Y++PE + G + K D
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCD 204
Query: 265 VFSFGVLL 272
V+S GV+L
Sbjct: 205 VWSAGVIL 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 43/191 (22%), Positives = 68/191 (35%), Gaps = 45/191 (23%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREM-KNEASVIAKVQHKNLVRLLGC 180
KLG G FG V+ R G E +K ++ Q E + E V+ + H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 181 CIDKDEKILIYEYMP---------NKSLDFFLFN-------------------------- 205
D ++ E + +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 206 -LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSI 261
LK NIL KI DFG+A + +E N GT YM+PE + +
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYMAPE-VFKRDVTF 204
Query: 262 KFDVFSFGVLL 272
K D++S GV++
Sbjct: 205 KCDIWSAGVVM 215
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 122 NKLGEGGFGPVYKGVLRKGNE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 174
+GEG FG V++ +AVK L S + + EA+++A+ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFL 203
V+LLG C L++EYM L+ FL
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 21/77 (27%), Positives = 36/77 (46%), Gaps = 10/77 (12%)
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY-----MSPEYAIEGIFS 260
L N L+ ++M KI+DFG++R + + M PE ++
Sbjct: 200 LATRNCLVGENMVVKIADFGLSR-----NIYSADYYKADGNDAIPIRWMPPESIFYNRYT 254
Query: 261 IKFDVFSFGVLLLEIVS 277
+ DV+++GV+L EI S
Sbjct: 255 TESDVWAYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 122 NKLGEGGFGPVYKGV---LRKGNE---IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 174
LGEG FG V K L+ +AVK L S LR++ +E +V+ +V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFL 203
++L G C +LI EY SL FL
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFL 117
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 12/78 (15%)
Query: 206 LKASNILLDKDMNPKISDFGMAR-ICGGNELQANTS-----RIVGTYGYMSPEYAIEGIF 259
L A NIL+ + KISDFG++R + + + + +M+ E + I+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIY 229
Query: 260 SIKFDVFSFGVLLLEIVS 277
+ + DV+SFGVLL EIV+
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 48/207 (23%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRL-SGRSGQGLREMKNEASVIAK-VQHK 172
N + ++G G G V+K RK + AVK++ + + + + + V+ K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN--------------------------- 205
+V+ G I + + E M +
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 206 ------LKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIVGTYGYMSPE----- 252
+K SNILLD+ K+ DFG I G ++ + S G YM+PE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRS--AGCAAYMAPERIDPP 199
Query: 253 YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ + I+ DV+S G+ L+E+ +G+
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 46/244 (18%), Positives = 88/244 (36%), Gaps = 57/244 (23%)
Query: 88 NSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDA----NKLGEGGFGPVYKGVLRK-GNE 142
+ + + + V + ++ KLG G +G V + +E
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 143 IAVKRLS-------------GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189
A+K + + E+ NE S++ + H N+++L DK L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 190 IYEYMPNKSL-------DFF-----------LFN--------------LKASNILL---D 214
+ E+ L F + + +K NILL +
Sbjct: 124 VTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
Query: 215 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLE 274
+N KI DFG++ + +GT Y++PE ++ ++ K DV+S GV++
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYI 239
Query: 275 IVSG 278
++ G
Sbjct: 240 LLCG 243
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 7e-16
Identities = 47/192 (24%), Positives = 78/192 (40%), Gaps = 36/192 (18%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 179
LGEG F V + A+K L R + + E V++++ H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 180 CCIDKDEKILIYEYMPNKSLDFFL-----FN---------------------------LK 207
D ++ Y N L ++ F+ LK
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFS 267
NILL++DM+ +I+DFG A++ QA + VGT Y+SPE E D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 268 FGVLLLEIVSGK 279
G ++ ++V+G
Sbjct: 218 LGCIIYQLVAGL 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 8e-16
Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 45/176 (25%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLS------GRSGQGLREMKNEASVIAK 168
++ K+GEG +G V+K R+ +EI A+KR+ G LRE+ ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKE 57
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEYMPN------------------KSLDFFLFN----- 205
++HKN+VRL + L++E+ KS F L
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 206 ---------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 252
LK N+L++++ K+++FG+AR G ++ ++ +V T Y P+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPD 171
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-16
Identities = 46/200 (23%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 116 NRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLS---GRSGQGLREMKNEASVIAKVQH 171
R+ +KLG GG VY ++A+K + + L+ + E +++ H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------- 205
+N+V ++ + D L+ EY+ +L ++ +
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 206 ------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
+K NIL+D + KI DFG+A+ L T+ ++GT Y SPE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEAT 189
Query: 260 SIKFDVFSFGVLLLEIVSGK 279
D++S G++L E++ G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 58/212 (27%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 174
+++ +G G FG V++ L + +E+A+K++ RE++ ++ V+H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 175 VRLLGC----CIDKDEKI--LIYEYMP-------------NKSLD-----FFLF------ 204
V L KDE L+ EY+P +++ +++
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 205 -----------NLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPE 252
++K N+LLD K+ DFG A+I + N S I Y Y +PE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPE 211
Query: 253 YAIEGIF-----SIKFDVFSFGVLLLEIVSGK 279
IF + D++S G ++ E++ G+
Sbjct: 212 L----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 1e-15
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 57/209 (27%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLS------GRSGQGLREMKNEASVIAKV 169
++ K+GEG +G VYK G A+K++ G +RE+ S++ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI----SILKEL 57
Query: 170 QHKNLVRLLGCCIDKDEKILIYEYMPN------------------KSLDFFLFN------ 205
+H N+V+L K +L++E++ KS L N
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 206 --------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE----- 252
LK N+L++++ KI+DFG+AR G ++ T IV T Y +P+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLMGS 175
Query: 253 --YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
Y S D++S G + E+V+G
Sbjct: 176 KKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 54/207 (26%), Positives = 82/207 (39%), Gaps = 59/207 (28%)
Query: 115 TNRFSDA----NKLGEGGFGPVYKGVLRK-GNEIAVK-----RLSGRSGQGLREMKNEAS 164
+ +FSD +LG+G F V + V + G E A K +LS R Q L EA
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REAR 57
Query: 165 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------- 205
+ K+QH N+VRL ++ L+++ + LF
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQ 113
Query: 206 -----------------LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT 245
LK N+LL K K++DFG+A +E GT
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
Query: 246 YGYMSPEYAIEGIFSIKFDVFSFGVLL 272
GY+SPE + +S D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 62/217 (28%)
Query: 113 TATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQG-----LREMKNEASVI 166
+++++F KLG G + VYKG+ + A+K + S +G +RE+ S++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREI----SLM 57
Query: 167 AKVQHKNLVRLLGCCIDKDEKILIYEYMPN-----------------------KSLDFFL 203
+++H+N+VRL +++ L++E+M N K + L
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 204 FN--------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 249
LK N+L++K K+ DFG+AR G + +S +V T Y
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYR 175
Query: 250 SPE-------YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+P+ Y S D++S G +L E+++GK
Sbjct: 176 APDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 43/193 (22%), Positives = 71/193 (36%), Gaps = 46/193 (23%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVK-----RLSGRSGQGLRE-MKNEASVIAKVQHKNLV 175
+LG G F V K + G E A K + RE ++ E S++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 176 RLLGCCIDKDEKILIYEYMPNKSL------DFFL-------------------------- 203
L ++ + +LI E + L L
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 204 FNLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
F+LK NI+L + K+ DFG+A I GT +++PE
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPL 195
Query: 260 SIKFDVFSFGVLL 272
++ D++S GV+
Sbjct: 196 GLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 45/193 (23%), Positives = 74/193 (38%), Gaps = 46/193 (23%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVK-----RLSGRSGQGLRE-MKNEASVIAKVQHKNLV 175
+LG G F V K + G E A K + RE ++ E S++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 176 RLLGCCIDKDEKILIYEYMPNKSL------DFFL-------------------------- 203
L ++ + +LI E + L L
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 204 FNLKASNILL-DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
F+LK NI+L DK++ K+ DFG+A I GT +++PE
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPL 195
Query: 260 SIKFDVFSFGVLL 272
++ D++S GV+
Sbjct: 196 GLEADMWSIGVIT 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 47/199 (23%), Positives = 70/199 (35%), Gaps = 52/199 (26%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVK--------RLSGRSGQGLREM-KNEASVIAKV-QH 171
LG G V + + + E AVK S Q LRE E ++ KV H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSL----------------DFF--LFN-------- 205
N+++L L+++ M L L
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 206 ------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE------Y 253
LK NILLD DMN K++DFG + E + GT Y++PE
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMN 200
Query: 254 AIEGIFSIKFDVFSFGVLL 272
+ + D++S GV++
Sbjct: 201 DNHPGYGKEVDMWSTGVIM 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 35/195 (17%), Positives = 64/195 (32%), Gaps = 46/195 (23%)
Query: 123 KLGEGGFGPVYKGV-LR-KGNEIAVKRLSGRSGQGLREM-KNEASVIAKVQHKNLVRLL- 178
+ GG G +Y + G + +K L + M E +A+V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 179 -GCCIDKDEKILIY---EYMPNKSLDFFLFN----------------------------- 205
D+ + Y EY+ +SL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYN 206
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
LK NI+L ++ K+ D G + GT G+ +PE ++ D
Sbjct: 207 DLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV-RTGPTVATD 258
Query: 265 VFSFGVLLLEIVSGK 279
+++ G L +
Sbjct: 259 IYTVGRTLAALTLDL 273
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 50/239 (20%), Positives = 82/239 (34%), Gaps = 55/239 (23%)
Query: 86 PVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDA----NKLGEGGFGPVYKGVLRK-G 140
+N K + A F + +G G V + V R G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 141 NEIAVK-------RLSGRSGQGLREM-KNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 191
+E AVK RLS + +RE + E ++ +V H +++ L+ L++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 192 EYMPNKSL----------------DFF--LFN--------------LKASNILLDKDMNP 219
+ M L L LK NILLD +M
Sbjct: 180 DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI 239
Query: 220 KISDFGMARICGGNELQANTSRIVGTYGYMSPE------YAIEGIFSIKFDVFSFGVLL 272
++SDFG + E + GT GY++PE + + D+++ GV+L
Sbjct: 240 RLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 43/193 (22%), Positives = 72/193 (37%), Gaps = 42/193 (21%)
Query: 124 LGEGGFGPVYKGVLRK-GNEIAVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLL 178
LG+G FG VY ++ +A+K L + G +++ E + + ++H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRMY 80
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFL-----FN---------------------------L 206
D+ L+ E+ P L L F+ +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDI 140
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
K N+L+ KI+DFG + T GT Y+ PE K D++
Sbjct: 141 KPENLLMGYKGELKIADFGWSVHAPSLRR--RTM--CGTLDYLPPEMIEGKTHDEKVDLW 196
Query: 267 SFGVLLLEIVSGK 279
GVL E + G
Sbjct: 197 CAGVLCYEFLVGM 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 48/244 (19%), Positives = 89/244 (36%), Gaps = 55/244 (22%)
Query: 80 NVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSD----ANKLGEGGFGPVYKG 135
L NS++ + +V F + S D + LG G G V
Sbjct: 95 GKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA 154
Query: 136 VLRK-GNEIAVK-----RLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLGCCIDKDE 186
RK ++A++ + + S + ++ E ++ K+ H ++++ D ++
Sbjct: 155 FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FFDAED 213
Query: 187 KILIYEYMPNKSL----------------DFF--LFN--------------LKASNILL- 213
++ E M L +F + LK N+LL
Sbjct: 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273
Query: 214 --DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YAIEGIFSIKFDVFSF 268
++D KI+DFG ++I G L + GT Y++PE ++ D +S
Sbjct: 274 SQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 269 GVLL 272
GV+L
Sbjct: 331 GVIL 334
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 46/214 (21%)
Query: 112 STATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQ-GLREMKNEASVIAKV 169
S + + +G G V E A+KR++ Q + E+ E +++
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 170 QHKNLVRLLGCCIDKDEKILIYEYM-------------PNKSLDFFLFN----------- 205
H N+V + KDE L+ + + + +
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 206 ----------------LKASNILLDKDMNPKISDFGM-ARICGGNELQANTSR--IVGTY 246
+KA NILL +D + +I+DFG+ A + G ++ N R VGT
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 247 GYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGK 279
+M+PE + + K D++SFG+ +E+ +G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 57/209 (27%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQG-----LREMKNEASVIAKV 169
+ +KLGEG + VYKG + + + A+K + +G +RE+ S++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREV----SLLKDL 57
Query: 170 QHKNLVRLLGCCIDKDEKILIYEYMPN------------------KSLDFFLFN------ 205
+H N+V L + L++EY+ K F L
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 206 --------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE----- 252
LK N+L+++ K++DFG+AR + + +V T Y P+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDILLGS 175
Query: 253 --YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
Y S + D++ G + E+ +G+
Sbjct: 176 TDY------STQIDMWGVGCIFYEMATGR 198
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 25/90 (27%), Positives = 37/90 (41%), Gaps = 8/90 (8%)
Query: 122 NKLGEGGFGPVYKGV---LRKGNE---IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 173
LG G FG V + K +AVK L + +E ++ ++ H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL 203
+V LLG C LI+EY L +L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 12/78 (15%)
Query: 206 LKASNILLDKDMNPKISDFGMAR-ICGGNELQANTS-----RIVGTYGYMSPEYAIEGIF 259
L A N+L+ KI DFG+AR I + + + +M+PE EGI+
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIY 251
Query: 260 SIKFDVFSFGVLLLEIVS 277
+IK DV+S+G+LL EI S
Sbjct: 252 TIKSDVWSYGILLWEIFS 269
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 25/219 (11%), Positives = 53/219 (24%), Gaps = 54/219 (24%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNE------IAVKRLSGRSGQGLREMKNEASVIAK 168
+ + LGEG F VY+ N+ +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD--------------------FFLF---- 204
++ + ++ +L+ E +L F
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 205 -------------NLKASNILL-----------DKDMNPKISDFGMARICGGNELQANTS 240
++K N +L D + D G + +
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
T G+ E ++ + D F + ++ G
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 48/184 (26%)
Query: 111 VSTATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVK--RLSGRSGQ-------GLREMK 160
V + R+ + LGEG F VYK + N+I A+K +L RS LRE+K
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 161 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN------------------KSLDFF 202
++ ++ H N++ LL K L++++M K+
Sbjct: 65 ----LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 203 LFN--------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
LK +N+LLD++ K++DFG+A+ G+ +A T ++V T Y
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWY 178
Query: 249 MSPE 252
+PE
Sbjct: 179 RAPE 182
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 49/235 (20%), Positives = 94/235 (40%), Gaps = 69/235 (29%)
Query: 102 QFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRL---SGRSG---Q 154
Q+ +++ K+G+G FG V+K RK + A+K++ + + G
Sbjct: 4 QYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62
Query: 155 GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI--------LIYEYMPN---------- 196
LRE+K ++ ++H+N+V L+ C K L++++ +
Sbjct: 63 ALREIK----ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118
Query: 197 --------KSLDFFLFN--------------LKASNILLDKDMNPKISDFGMARICG--- 231
K + L N +KA+N+L+ +D K++DFG+AR
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 232 GNELQANTSRIVGTYGYMSPE-------YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
++ T+R+V T Y PE Y D++ G ++ E+ +
Sbjct: 179 NSQPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-15
Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 46/193 (23%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVK-----RLSGRSGQGLREM-KNEASVIAKVQHKNLV 175
+LG G F V K + G E A K RLS RE + E +++ +++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 176 RLLGCCIDKDEKILIYEYMP----------------NKSLDFFL---------------- 203
L +K + +LI E + +++ F
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 131
Query: 204 FNLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
F+LK NI+L + K+ DFG+A I GT +++PE
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPL 188
Query: 260 SIKFDVFSFGVLL 272
++ D++S GV+
Sbjct: 189 GLEADMWSIGVIT 201
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 38/217 (17%), Positives = 69/217 (31%), Gaps = 46/217 (21%)
Query: 109 SSVSTATNRFSDANKLGEG--GFGPVYKGV-LRKGNEIAVKR--LSGRSGQGLREMKNEA 163
SS + +G+G V G + V+R L S + + ++ E
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 164 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS------------------------- 198
V H N+V I +E ++ +M S
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 199 ---LDFFLFN------LKASNILLDKDMNPKISDFGMARICGGNELQANT-----SRIVG 244
LD+ +KAS+IL+ D +S + + V
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 245 TYGYMSPEYAIEGI--FSIKFDVFSFGVLLLEIVSGK 279
++SPE + + + K D++S G+ E+ +G
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 51/195 (26%), Positives = 77/195 (39%), Gaps = 55/195 (28%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
+LG+G F V + V + G E A K +LS R Q L EA + K+QH N+VR
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 92
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------- 205
L ++ L+++ + LF
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 206 -----LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
LK N+LL K K++DFG+A +E GT GY+SPE +
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD 205
Query: 258 IFSIKFDVFSFGVLL 272
+S D+++ GV+L
Sbjct: 206 PYSKPVDIWACGVIL 220
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 37/186 (19%), Positives = 69/186 (37%), Gaps = 40/186 (21%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
LG G FG V++ V K + + G +K E S++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 182 IDKDEKILIYEYMP---------NKSLDF-----------------FL-------FNLKA 208
+E ++I+E++ + + FL F+++
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 209 SNILL--DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
NI+ + KI +FG AR + + Y +PE + S D++
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMW 187
Query: 267 SFGVLL 272
S G L+
Sbjct: 188 SLGTLV 193
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 51/233 (21%), Positives = 86/233 (36%), Gaps = 56/233 (24%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLG 179
LG GGFG V+ ++ ++ A K+L+ + +G + E ++AKV + +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------- 205
K + L+ M + + ++N
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
LK N+LLD D N +ISD G+A + + GT G+M+PE + +
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEEYDFSV 370
Query: 264 DVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316
D F+ GV L E+++ + F EL +LE
Sbjct: 371 DYFALGVTLYEMIAAR--GPFRARG------------EKVENKELKQRVLEQA 409
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 45/193 (23%), Positives = 73/193 (37%), Gaps = 46/193 (23%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVK-----RLSGRSGQGLRE-MKNEASVIAKVQHKNLV 175
+LG G F V K + G + A K R RE ++ E S++ ++QH N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 176 RLLGCCIDKDEKILIYEYMP----------------NKSLDFFL---------------- 203
L +K + ILI E + ++ +F
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 204 FNLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
F+LK NI+L KI DFG+A I GT +++PE
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPL 194
Query: 260 SIKFDVFSFGVLL 272
++ D++S GV+
Sbjct: 195 GLEADMWSIGVIT 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 58/218 (26%), Positives = 87/218 (39%), Gaps = 62/218 (28%)
Query: 112 STATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLS------GRSGQGLREMKNEAS 164
+T+ +R+ KLGEG +G VYK + NE A+KR+ G G +RE+ S
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV----S 85
Query: 165 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN-----------------KSLDFFLFN-- 205
++ ++QH+N++ L LI+EY N KS + L N
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 206 ------------LKASNILLDKDMNP-----KISDFGMARICGGNELQANTSRIVGTYGY 248
LK N+LL KI DFG+AR G ++ T I+ T Y
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWY 203
Query: 249 MSPE-------YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
PE Y S D++S + E++
Sbjct: 204 RPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 3e-14
Identities = 39/190 (20%), Positives = 70/190 (36%), Gaps = 48/190 (25%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
LG G F V+ R G A+K + ++NE +V+ K++H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 182 IDKDEKILIYEYMPNKSLDFFLFN------------------------------------ 205
L+ + + LF+
Sbjct: 76 ESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 206 LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
LK N+L +++ I+DFG++++ + GT GY++PE + +S
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYVAPEVLAQKPYSKA 187
Query: 263 FDVFSFGVLL 272
D +S GV+
Sbjct: 188 VDCWSIGVIT 197
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 58/210 (27%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRL------SGRSGQGLREMKNEASVIAK 168
++ + +GEG +G V K + I A+K+ +RE+K ++ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK----LLKQ 80
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEYMPN------------------KSLDFFLFN----- 205
++H+NLV LL C K L++E++ + + F + N
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 206 ---------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 252
+K NIL+ + K+ DFG AR + + T Y +PE
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPELLVG 198
Query: 253 ---YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
Y DV++ G L+ E+ G+
Sbjct: 199 DVKY------GKAVDVWAIGCLVTEMFMGE 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 53/231 (22%), Positives = 86/231 (37%), Gaps = 55/231 (23%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLG 179
LG+GGFG V +R ++ A K+L + +G NE ++ KV + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------- 205
KD L+ M L F +++
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
LK NILLD + +ISD G+A + VGT GYM+PE ++ D
Sbjct: 312 LKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDW 368
Query: 266 FSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316
++ G LL E+++G+ + F + + E+ + E
Sbjct: 369 WALGCLLYEMIAGQ--SPFQQRKK------------KIKREEVERLVKEVP 405
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 59/213 (27%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKN 173
++D +G G FG VY+ L E+ A+K++ RE++ ++ K+ H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 174 LVRLLGCCIDKDEKI------LIYEYMP-------------NKSLD-----FFLF----- 204
+VRL EK L+ +Y+P ++L +++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 205 ------------NLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 251
++K N+LLD D K+ DFG A+ E N S I Y Y +P
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 225
Query: 252 EYAIEGIF-----SIKFDVFSFGVLLLEIVSGK 279
E IF + DV+S G +L E++ G+
Sbjct: 226 EL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 42/197 (21%), Positives = 76/197 (38%), Gaps = 51/197 (25%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVK-----RLSGRSGQGLRE---MKNEASVIAKVQHKN 173
LG G G V RK ++A+K + + S + ++ E ++ K+ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSL----------------DFF--LFN---------- 205
++++ D ++ ++ E M L +F +
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGI 135
Query: 206 ----LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YAI 255
LK N+LL ++D KI+DFG ++I G L + GT Y++PE
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVG 192
Query: 256 EGIFSIKFDVFSFGVLL 272
++ D +S GV+L
Sbjct: 193 TAGYNRAVDCWSLGVIL 209
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 7e-14
Identities = 46/205 (22%), Positives = 77/205 (37%), Gaps = 41/205 (20%)
Query: 116 NRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLS---GRSGQGLREMKNEASVIAKVQH 171
+R+ LG GG V+ LR ++AVK L R + EA A + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 172 KNLVRLLGCCIDKDEKILIY----EYMPNKSLDFFLFN---------------------- 205
+V + + + EY+ +L +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 206 ----------LKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYA 254
+K +NI++ K+ DFG+AR I T+ ++GT Y+SPE A
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 255 IEGIFSIKFDVFSFGVLLLEIVSGK 279
+ DV+S G +L E+++G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 45/208 (21%), Positives = 76/208 (36%), Gaps = 52/208 (25%)
Query: 111 VSTATNRFSDA----NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREM--KNEA 163
+ RF++ +LG+G F V + V G E A ++ + + EA
Sbjct: 2 ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61
Query: 164 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------ 205
+ ++H N+VRL ++ LI++ + LF
Sbjct: 62 RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQ 117
Query: 206 ------------------LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVG 244
LK N+LL K K++DFG+A G + G
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175
Query: 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLL 272
T GY+SPE + + D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 50/212 (23%), Positives = 81/212 (38%), Gaps = 62/212 (29%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRL------SGRSGQGLREMKNEASVIAK 168
++ K+GEG +G V+K R +I A+K+ LRE++ ++ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR----MLKQ 58
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEYMPN------------------KSLDFFLFN----- 205
++H NLV LL K L++EY + KS+ +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 206 ---------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 252
+K NIL+ K K+ DFG AR+ G + T Y SPE
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPELLVG 176
Query: 253 ---Y--AIEGIFSIKFDVFSFGVLLLEIVSGK 279
Y + DV++ G + E++SG
Sbjct: 177 DTQYGPPV--------DVWAIGCVFAELLSGV 200
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 50/212 (23%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLREMKNEASVIAKV-QHK 172
F +G G +G VYKG K ++ A+K + +G E+K E +++ K H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81
Query: 173 NLVRLLGCCIDKDEKI------LIYEYM------------PNKSLD-------------- 200
N+ G I K+ L+ E+ +L
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 201 -FFLFN-------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 252
L +K N+LL ++ K+ DFG++ + NT +GT +M+PE
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPE 199
Query: 253 -----YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ + K D++S G+ +E+ G
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 46/219 (21%), Positives = 86/219 (39%), Gaps = 75/219 (34%)
Query: 123 KLGEGGFGPVYKGVLRK---GNEIAVKRLS--GRSGQGLREMKNEASVIAKVQHKNLVRL 177
K+G G +G VYK + + A+K++ G S RE+ ++ +++H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA----LLRELKHPNVISL 83
Query: 178 LGCCIDK-DEKI-LIYEYMPN--------------------------KSLDFFLFN---- 205
+ D K+ L+++Y + KSL + + +
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 206 ----------LKASNILLDKDMNP----KISDFGMARICG--GNELQANTSRIVGTYGYM 249
LK +NIL+ + KI+D G AR+ L +V T+ Y
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 202
Query: 250 SPE-------Y--AIEGIFSIKFDVFSFGVLLLEIVSGK 279
+PE Y AI D+++ G + E+++ +
Sbjct: 203 APELLLGARHYTKAI--------DIWAIGCIFAELLTSE 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 43/191 (22%), Positives = 69/191 (36%), Gaps = 44/191 (23%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQH-KNLVRLL 178
+LG G F V + + + G E A K L R E+ +E +V+ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 179 GCCIDKDEKILIYEYMP---------NKSLDFF-----------LFN------------- 205
+ E ILI EY + + +
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 206 -LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSI 261
LK NILL + KI DFGM+R G I+GT Y++PE +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITT 212
Query: 262 KFDVFSFGVLL 272
D+++ G++
Sbjct: 213 ATDMWNIGIIA 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 48/230 (20%), Positives = 83/230 (36%), Gaps = 71/230 (30%)
Query: 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNE-IAVK------RLSGRSGQGLREM 159
+ +RF G+G FG V G + +A+K R R L+ M
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIM 70
Query: 160 KNEASVIAKVQHKNLVRLLGCCIDKDEK-------ILIYEYMP-------------NKSL 199
+ +A + H N+V+L E+ ++ EY+P +
Sbjct: 71 Q----DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAP 126
Query: 200 D-----FFLF-------------------NLKASNILLDKDMNP-KISDFGMARICGGNE 234
FLF ++K N+L+++ K+ DFG A+ +E
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 235 LQANTSRIVGTYGYMSPEYAIEGIF-----SIKFDVFSFGVLLLEIVSGK 279
N + I Y Y +PE IF + D++S G + E++ G+
Sbjct: 187 --PNVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 45/205 (21%), Positives = 74/205 (36%), Gaps = 58/205 (28%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASV---IA-------KVQHK 172
LG+GGFG V+ G L ++A+K + G + + + +A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN--------------------------- 205
++RLL ++ +L+ E P + D LF+
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 206 ---------LKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 255
+K NIL+D K+ DFG + GT Y PE+ I
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT--DF--DGTRVYSPPEW-I 210
Query: 256 EGI--FSIKFDVFSFGVLLLEIVSG 278
++ V+S G+LL ++V G
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCG 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 41/224 (18%), Positives = 64/224 (28%), Gaps = 64/224 (28%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNL 174
N LG G G V +G +AVKR+ E ++ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 175 VRLLGCCIDKDEKILIYEYMP---------NKSLDFFLFN-------------------- 205
+R + E D L
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 206 ---------LKASNILLD-------------KDMNPKISDFGMARICGGNE--LQANTSR 241
LK NIL+ +++ ISDFG+ + + + N +
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 242 IVGTYGYMSPEYAIEGIFSIKF-------DVFSFGVLLLEIVSG 278
GT G+ +PE E D+FS G + I+S
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 49/202 (24%), Positives = 71/202 (35%), Gaps = 52/202 (25%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKN------EASVIAKVQHK--NL 174
LG GGFG VY G+ + +A+K + E+ N E ++ KV +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFF----------------LF-------------- 204
+RLL D +LI E P D F F
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 169
Query: 205 ----NLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI- 258
++K NIL+D + K+ DFG + GT Y PE+ I
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DF--DGTRVYSPPEW-IRYHR 224
Query: 259 -FSIKFDVFSFGVLLLEIVSGK 279
V+S G+LL ++V G
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGD 246
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 63/235 (26%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKN---LVR 176
+G GGFG VY ++ A+K L + QG NE +++ V + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------- 205
+ D+ I + M L + L
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI---FSI 261
LK +NILLD+ + +ISD G+A C ++ + + S VGT+GYM+PE +G+ S
Sbjct: 317 DLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSA 372
Query: 262 KFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316
D FS G +L +++ G + F + T + E+ L
Sbjct: 373 --DWFSLGCMLFKLLRGH--SPFRQHKTKD-------------KHEIDRMTLTMA 410
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 47/215 (21%), Positives = 79/215 (36%), Gaps = 52/215 (24%)
Query: 110 SVSTATNRFSD-----ANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEA 163
S + + RF D + LGEG V + E AVK + + G + E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 164 SVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSL-------DFF-----------LF 204
++ + Q H+N++ L+ ++D L++E M S+ F +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVA 121
Query: 205 N--------------LKASNILL---DKDMNPKISDFGMARICGGNELQANTSR-----I 242
+ LK NIL ++ KI DF + N + S
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 243 VGTYGYMSPE-----YAIEGIFSIKFDVFSFGVLL 272
G+ YM+PE I+ + D++S GV+L
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 45/195 (23%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGC 180
+G+G F V + G E+A+K + + L+++ E ++ + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 181 CIDKDEKI-LIYEYMPNKSL-DF-------------FLF------------------NLK 207
I+ ++ + LI EY + D+ F +LK
Sbjct: 83 -IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141
Query: 208 ASNILLDKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYAIEGIFSI--KFD 264
A N+LLD DMN KI+DFG + G +L + G Y +PE +G + D
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKL--DAF--CGAPPYAAPE-LFQGKKYDGPEVD 196
Query: 265 VFSFGVLLLEIVSGK 279
V+S GV+L +VSG
Sbjct: 197 VWSLGVILYTLVSGS 211
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 27/236 (11%), Positives = 58/236 (24%), Gaps = 86/236 (36%)
Query: 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQ--------- 170
LG+ + ++ G V +++MK E + ++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 171 ----------------HKNLVRLLGCCIDKDEK--ILIYEYMPNKSLDFF--LFN----- 205
K ++R+ D +Y M + F L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 206 -------------------------------LKASNILLDKDMNPKISDFGMARICGGNE 234
L+ +I+LD+ ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--- 257
Query: 235 LQANTSRIVGTYGYMSPEYAI-----------EGIFSIKFDVFSFGVLLLEIVSGK 279
+ G+ PE + + FD ++ G+++ I
Sbjct: 258 ---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 47/204 (23%), Positives = 78/204 (38%), Gaps = 54/204 (26%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLL 178
LGEG +G V + + AVK L R G +K E ++ +++HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 179 GCCIDKDEKILIY---EYMPNKSLDFF---------------LF---------------- 204
+ +EK +Y EY + F
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 205 --NLKASNILLDKDMNPKISDFGMARI----CGGNELQANTSRIVGTYGYMSPEYAIEGI 258
++K N+LL KIS G+A + + TS+ G+ + PE G+
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR--TSQ--GSPAFQPPE-IANGL 186
Query: 259 FS---IKFDVFSFGVLLLEIVSGK 279
+ K D++S GV L I +G
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 29/73 (39%), Positives = 41/73 (56%), Gaps = 2/73 (2%)
Query: 206 LKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
L A NILL + KI DFG+AR I + + +M+PE + +++I+ D
Sbjct: 219 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSD 277
Query: 265 VFSFGVLLLEIVS 277
V+SFGVLL EI S
Sbjct: 278 VWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 9/93 (9%)
Query: 122 NKLGEGGFGPVYKGVL------RKGNEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 173
LG G FG V + +AVK L G + R + +E ++ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 174 LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFN 205
+V LLG C + +I E+ +L +L +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 58/219 (26%)
Query: 112 STATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRL------SGRSG---QGLRE--- 158
S AT+R+ ++G G +G VYK A+K + G G +RE
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 159 MKNEASVIAKVQHKNLVRLL----GCCIDKDEKI-LIYEYMPN----------------- 196
++ + +H N+VRL+ D++ K+ L++E++
Sbjct: 65 LRR----LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 197 --KSLDFFLFN--------------LKASNILLDKDMNPKISDFGMARICGGNELQANTS 240
K L LK NIL+ K++DFG+ARI A T
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTP 178
Query: 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+V T Y +PE ++ ++ D++S G + E+ K
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 50/197 (25%), Positives = 78/197 (39%), Gaps = 49/197 (24%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 181
LGEG +G V V +AVK + + E +K E + + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 182 IDKDEKILIYEYMPNKSL----------------DFF--LFN--------------LKAS 209
+ + + L EY L FF L +K
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 210 NILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF---- 263
N+LLD+ N KISDFG+A + E N GT Y++PE + +
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE-----LLKRREFHAE 187
Query: 264 --DVFSFGVLLLEIVSG 278
DV+S G++L +++G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 56/213 (26%)
Query: 116 NRFSDANKLGEGGFGPVYKGV-LRKGNEI-AVKRL---SGRSG---QGLRE---MKNEAS 164
++ ++GEG +G V+K L+ G A+KR+ +G G +RE +++
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--- 67
Query: 165 VIAKVQHKNLVRLL----GCCIDKDEKI-LIYEYMPN-------------------KSLD 200
+ +H N+VRL D++ K+ L++E++ K +
Sbjct: 68 -LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 201 FFLFN--------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 246
F L LK NIL+ K++DFG+ARI A TS +V T
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVV-TL 183
Query: 247 GYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
Y +PE ++ ++ D++S G + E+ K
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 50/197 (25%), Positives = 78/197 (39%), Gaps = 49/197 (24%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 181
LGEG +G V V +AVK + + E +K E + + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 182 IDKDEKILIYEYMPNKSL----------------DFF--LFN--------------LKAS 209
+ + + L EY L FF L +K
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 210 NILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF---- 263
N+LLD+ N KISDFG+A + E N GT Y++PE + +
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE-----LLKRREFHAE 187
Query: 264 --DVFSFGVLLLEIVSG 278
DV+S G++L +++G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 69/221 (31%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLS----------------------GRSGQGLREM- 159
+G+G +G V A+K LS R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 160 ---KNEASVIAKVQHKNLVRLLGCCIDKDEKILIY---EYMPNKSL-------------- 199
E +++ K+ H N+V+L+ +D + +Y E + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 200 -DFF--LFN--------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242
+F L +K SN+L+ +D + KI+DFG++ G++ + +
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT-- 197
Query: 243 VGTYGYMSPEYAIEGIFSI----KFDVFSFGVLLLEIVSGK 279
VGT +M+PE ++ I DV++ GV L V G+
Sbjct: 198 VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 44/205 (21%), Positives = 76/205 (37%), Gaps = 60/205 (29%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVK--------RLSGRSGQGLREMKNEASVIAKVQHKNL 174
LG G FG V+ V K E+ VK L ++ E +++++V+H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFF----------------LF-------------- 204
+++L ++ L+ E + LD F +F
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150
Query: 205 ----NLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
++K NI++ +D K+ DFG A + G T GT Y +PE +
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTF--CGTIEYCAPE-----VL 201
Query: 260 SIKF------DVFSFGVLLLEIVSG 278
+++S GV L +V
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 22/74 (29%), Positives = 36/74 (48%), Gaps = 1/74 (1%)
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
+K NIL+ D + DFG+A +L VGT YM+PE E + + D+
Sbjct: 160 VKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADI 218
Query: 266 FSFGVLLLEIVSGK 279
++ +L E ++G
Sbjct: 219 YALTCVLYECLTGS 232
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 9/76 (11%), Positives = 19/76 (25%), Gaps = 7/76 (9%)
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY--AIEGIFSIKF 263
N+ + D + D G Y E+ A F+
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHAL 274
Query: 264 DVFSFGVLLLEIVSGK 279
+ + G+ + +
Sbjct: 275 NAWQLGLSIYRVWCLF 290
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 10/82 (12%), Positives = 22/82 (26%), Gaps = 4/82 (4%)
Query: 104 PLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREM 159
S +S + L G V+ + + A+K + S L +
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 160 KNEASVIAKVQHKNLVRLLGCC 181
A++ ++
Sbjct: 110 HEATFAAARLLGESPEEARDRR 131
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 11/79 (13%), Positives = 25/79 (31%), Gaps = 6/79 (7%)
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----EGIFS 260
L+ +I+LD+ ++ F G + R + + +
Sbjct: 237 LRPVDIVLDQRGGVFLTGFEHLVR-DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMT 295
Query: 261 IKFDVFSFGVLLLEIVSGK 279
FD ++ G+ + I
Sbjct: 296 FAFDTWTLGLAIYWIWCAD 314
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 38/193 (19%), Positives = 65/193 (33%), Gaps = 52/193 (26%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 180
LG G G V + R+ G + A+K L + + E + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 181 CIDKDEKI----LIYEYMP---------NKSLDFF-----------LFN----------- 205
+ +I E M + F +
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIA 150
Query: 206 ---LKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
+K N+L +KD K++DFG A+ N LQ T Y++PE +
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKY 206
Query: 260 SIKFDVFSFGVLL 272
D++S GV++
Sbjct: 207 DKSCDMWSLGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 41/203 (20%), Positives = 66/203 (32%), Gaps = 54/203 (26%)
Query: 115 TNRFSDA----NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV 169
+ +F+D +G G + + + + E AVK + E ++
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYG 73
Query: 170 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------ 205
QH N++ L D ++ E M L +
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTV 129
Query: 206 ------------LKASNILL-DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYM 249
LK SNIL D+ NP +I DFG A+ T T ++
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFV 187
Query: 250 SPEYAIEGIFSIKFDVFSFGVLL 272
+PE + D++S GVLL
Sbjct: 188 APEVLERQGYDAACDIWSLGVLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 43/238 (18%), Positives = 83/238 (34%), Gaps = 49/238 (20%)
Query: 75 NLKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYK 134
+L N+ + + + + S+ ++ F ++LG G VY+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71
Query: 135 GVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193
+ A+K L + + ++ E V+ ++ H N+++L E L+ E
Sbjct: 72 CKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129
Query: 194 MPNKSLDFFLFN------------------------------------LKASNILL---D 214
+ L F+ LK N+L
Sbjct: 130 VTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA 185
Query: 215 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLL 272
D KI+DFG+++I L + GT GY +PE + + D++S G++
Sbjct: 186 PDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 45/187 (24%), Positives = 69/187 (36%), Gaps = 42/187 (22%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 180
LGEG F K V +K AVK +S R + E + + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 181 CIDKDEKILIYEYMPNKSL-------DFF-----------LFN--------------LKA 208
D+ L+ E + L F L + LK
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 209 SNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
N+L + ++ KI DFG AR+ + T T Y +PE + + D+
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDL 192
Query: 266 FSFGVLL 272
+S GV+L
Sbjct: 193 WSLGVIL 199
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 56/243 (23%), Positives = 97/243 (39%), Gaps = 56/243 (23%)
Query: 83 IELPVNSKLTKRNKKKEVDQFPLFS-FSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-G 140
+++ +K +K K +QF S T R+ + +G G G V
Sbjct: 28 VDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLD 87
Query: 141 NEIAVKRLSG---------RSGQGLREMKNEASVIAKVQHKNLVRLL-----GCCIDKDE 186
+A+K+LS R+ RE+ ++ V HKN++ LL +++ +
Sbjct: 88 RNVAIKKLSRPFQNQTHAKRA---YRELV----LMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 187 KI-LIYEYMP-------NKSLD-----FFLF-----------------NLKASNILLDKD 216
+ L+ E M LD + L+ +LK SNI++ D
Sbjct: 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
Query: 217 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIV 276
KI DFG+AR G + + + V T Y +PE + + D++S G ++ E+V
Sbjct: 201 CTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257
Query: 277 SGK 279
K
Sbjct: 258 RHK 260
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 38/211 (18%), Positives = 79/211 (37%), Gaps = 61/211 (28%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNE-IAVKRLSGRSGQG-LREMKNEASVIAK--VQ 170
+ + KLG G + V++ + NE + VK L + RE+K I +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK-----ILENLRG 89
Query: 171 HKNLVRLLGCCIDKDEK--ILIYEYMPNKSLD------------FFLF------------ 204
N++ L D + L++E++ N F+++
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 205 -----NLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE------ 252
++K N+++D + ++ D+G+A + Q R+ Y + PE
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGPELLVDYQ 206
Query: 253 ---YAIEGIFSIKFDVFSFGVLLLEIVSGKK 280
Y++ D++S G +L ++ K+
Sbjct: 207 MYDYSL--------DMWSLGCMLASMIFRKE 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 50/224 (22%), Positives = 85/224 (37%), Gaps = 57/224 (25%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNE-IAVKRLSG---------RSGQGLREMKNEAS 164
R+ + +G G G V +A+K+LS R+ RE+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELV---- 76
Query: 165 VIAKVQHKNLVRLL------GCCIDKDEKILIYEYMP-------NKSLD-----FFLF-- 204
++ V HKN++ LL + + ++ E M LD + L+
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 205 ---------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 249
+LK SNI++ D KI DFG+AR G + + V T Y
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYR 193
Query: 250 SPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL 293
+PE + + D++S G ++ E++ G F TD ++
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG--VLFPGTDHIDQW 235
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 43/205 (20%), Positives = 78/205 (38%), Gaps = 43/205 (20%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 179
LG G FG V ++ A+K L + L++ NE ++ V LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 180 CCIDKDEKILIYEYMPNKSLDFFL-----FN---------------------------LK 207
D ++ EY+ + L F+ LK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFS 267
N+L+D+ +++DFG A+ G T + GT ++PE + ++ D ++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWA 223
Query: 268 FGVLLLEIVSGKKNTGFYRTDTLNL 292
GVL+ E+ +G F+ + +
Sbjct: 224 LGVLIYEMAAGY--PPFFADQPIQI 246
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 41/214 (19%), Positives = 76/214 (35%), Gaps = 52/214 (24%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAK------ 168
+ ++ + G +G V GV +G +A+KR+ G S + K
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 169 -----VQHKNLVRLLGCCI----DKDEKI-LIYEYM----------PNKSLD-----FFL 203
H N++ L + K+ L+ E M + +F+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 204 F-----------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 246
+ +L NILL + + I DF +AR + N + V
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHR 197
Query: 247 GYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGK 279
Y +PE ++ F+ D++S G ++ E+ + K
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 179
LG G FG V G G+++AVK L+ + + +K E + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 180 CCIDKDEKILIYEYMPNKSL----------------DFF--LFN--------------LK 207
+ ++ EY+ L F + + LK
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF--SIKFDV 265
N+LLD MN KI+DFG++ + E TS G+ Y +PE I G + D+
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE-VISGRLYAGPEVDI 194
Query: 266 FSFGVLLLEIVSGK 279
+S GV+L ++ G
Sbjct: 195 WSCGVILYALLCGT 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 45/193 (23%), Positives = 83/193 (43%), Gaps = 41/193 (21%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGR--SGQGLRE-MKNEASVIAKVQHKNLVRLLG 179
LGEG FG V + ++A+K +S + + ++ E S + ++H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 180 CCIDKDEKILIYEYM---------------PNKSLDFF--LFN--------------LKA 208
+ +++ EY ++ FF + LK
Sbjct: 77 VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF--SIKFDVF 266
N+LLD ++N KI+DFG++ I TS G+ Y +PE I G + DV+
Sbjct: 137 ENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNYAAPE-VINGKLYAGPEVDVW 192
Query: 267 SFGVLLLEIVSGK 279
S G++L ++ G+
Sbjct: 193 SCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 50/198 (25%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVK---RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 179
LG G FG V G G+++AVK R RS + +++ E + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 180 CCIDKDEKILIYEYMPNKSL----------------DFF--LFN--------------LK 207
+ ++ EY+ L F + + LK
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF---- 263
N+LLD MN KI+DFG++ + E TS G+ Y +PE + S +
Sbjct: 144 PENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE-----VISGRLYAGP 195
Query: 264 --DVFSFGVLLLEIVSGK 279
D++S GV+L ++ G
Sbjct: 196 EVDIWSSGVILYALLCGT 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 39/237 (16%), Positives = 75/237 (31%), Gaps = 59/237 (24%)
Query: 86 PVNSKLTKRNKKKEVDQFPLFSF-SSVSTATNRFSD-----ANKLGEGGFGPVYKGVLRK 139
P + QFP F S + N D + LG G G V + ++
Sbjct: 26 PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKR 85
Query: 140 -GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKI----LIYEY 193
+ A+K L + + E + + ++VR++ + ++ E
Sbjct: 86 TQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140
Query: 194 MP---------NKSLDFF-----------LFN--------------LKASNILL---DKD 216
+ ++ F + +K N+L +
Sbjct: 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 200
Query: 217 MNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLL 272
K++DFG A+ N L T Y++PE + D++S GV++
Sbjct: 201 AILKLTDFGFAKETTSHNSLT----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 36/225 (16%), Positives = 76/225 (33%), Gaps = 54/225 (24%)
Query: 86 PVNSKLTKRNKKKEVDQFPLFS-FSSVSTATNRFSDANKLGEGGFGPVYKGV-LRKGNEI 143
+ +R + S +R+ + +G G +G V + + +
Sbjct: 22 GSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 144 AVKRLSG---------RSGQGLREMKNEASVIAKVQHKNLVRLLGCCI----DKDEKI-L 189
A+K++ R LRE+ ++ ++ H ++V++L I +K +++ +
Sbjct: 82 AIKKILRVFEDLIDCKRI---LREIA----ILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 190 IYEYMP---------NKSLD-----FFLFN-----------------LKASNILLDKDMN 218
+ E L L+N LK +N L+++D +
Sbjct: 135 VLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS 194
Query: 219 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
K+ DFG+AR E + I M+ +
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 40/247 (16%), Positives = 86/247 (34%), Gaps = 91/247 (36%)
Query: 113 TATNRFSDANKLGEGGFGPVYKGVLRKGNE-IAVKRLSGRSGQGLREMKNEASVIAKVQH 171
T++ ++S LG G FG V + + + A+K++ RE+ ++ + H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 172 KNLVRLLGCCIDKDEKI--------------------------------------LIYEY 193
N+++L+ ++ +I EY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 194 MP-------------NKSLD-----FFLF-----------------NLKASNILLD-KDM 217
+P +S+ +++ ++K N+L++ KD
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 218 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF-----SIKFDVFSFGVLL 272
K+ DFG A+ + + + I + Y +PE + + D++S G +
Sbjct: 180 TLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPEL----MLGATEYTPSIDLWSIGCVF 232
Query: 273 LEIVSGK 279
E++ GK
Sbjct: 233 GELILGK 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 49/210 (23%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 179
+G G FG V L+ +++ A+K L+ E + E V+ K + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------- 205
D + L+ +Y L L +
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 206 LKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE-----YAIEGIF 259
+K NIL+D + + +++DFG ++ +Q++ VGT Y+SPE +G +
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPEILQAMEGGKGRY 258
Query: 260 SIKFDVFSFGVLLLEIVSGKKNTGFYRTDT 289
+ D +S GV + E++ G+ T FY
Sbjct: 259 GPECDWWSLGVCMYEMLYGE--TPFYAESL 286
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 42/211 (19%), Positives = 85/211 (40%), Gaps = 58/211 (27%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNE-IAVKRLSG---------RSGQGLREMKNEAS 164
+ +G G +G V + ++ E +A+K+LS R+ RE+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELL---- 75
Query: 165 VIAKVQHKNLVRLL-----GCCIDKDEKI-LIYEYMP------------NKSLDFFLF-- 204
++ +QH+N++ LL + L+ +M + + + ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 205 ---------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 249
+LK N+ +++D KI DFG+AR A + V T Y
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYR 190
Query: 250 SPEYAIE-GIFSIKFDVFSFGVLLLEIVSGK 279
+PE + ++ D++S G ++ E+++GK
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 46/217 (21%), Positives = 92/217 (42%), Gaps = 65/217 (29%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSG--------RSGQGLREMKNEASV 165
R+++ + +GEG +G V +A+K++S R+ LRE+K +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIK----I 78
Query: 166 IAKVQHKNLVRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLF--- 204
+ + +H+N++ + I++ + + ++ + M + L +FL+
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 205 --------------NLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYM 249
+LK SN+LL+ + KI DFG+AR+ + + V T Y
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 250 SPE-------YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
+PE Y + D++S G +L E++S +
Sbjct: 199 APEIMLNSKGY------TKSIDIWSVGCILAEMLSNR 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 8e-09
Identities = 51/196 (26%), Positives = 81/196 (41%), Gaps = 51/196 (26%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 179
LG G FG V+ R A+K L L++ +E +++ V H ++R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 180 CCIDKDEKILIYEYMPNKSLDFFL-----FN---------------------------LK 207
D + +I +Y+ L L F LK
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK----- 262
NILLDK+ + KI+DFG A+ + T + GT Y++PE + S K
Sbjct: 134 PENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE-----VVSTKPYNKS 183
Query: 263 FDVFSFGVLLLEIVSG 278
D +SFG+L+ E+++G
Sbjct: 184 IDWWSFGILIYEMLAG 199
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 46/207 (22%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 179
+G G FG V + ++ A+K LS + E ++A +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN--------------------------------LK 207
D ++ EYMP L L + +K
Sbjct: 137 AFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195
Query: 208 ASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE----YAIEGIFSIK 262
N+LLDK + K++DFG ++ ++ +T+ VGT Y+SPE +G + +
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRE 253
Query: 263 FDVFSFGVLLLEIVSGKKNTGFYRTDT 289
D +S GV L E++ G T FY
Sbjct: 254 CDWWSVGVFLYEMLVGD--TPFYADSL 278
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 41/201 (20%), Positives = 78/201 (38%), Gaps = 54/201 (26%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+G+G FG V ++ A+K ++ + +R + E ++ ++H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHPFLVNLW 81
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFL-----FN---------------------------L 206
D+++ ++ + + L + L F +
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF--- 263
K NILLD+ + I+DF +A + + + GT YM+PE +FS +
Sbjct: 142 KPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPE-----MFSSRKGAG 193
Query: 264 -----DVFSFGVLLLEIVSGK 279
D +S GV E++ G+
Sbjct: 194 YSFAVDWWSLGVTAYELLRGR 214
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 44/196 (22%), Positives = 67/196 (34%), Gaps = 50/196 (25%)
Query: 124 LGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182
+G G FG +AVK + R ++ E ++H N+VR +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 183 DKDEKILIYEYMPNKSL----------------DFF--LFN--------------LKASN 210
+I EY L FF L + LK N
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLEN 146
Query: 211 ILLDKD--MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF----- 263
LLD KI DFG ++ + ++ VGT Y++PE + +
Sbjct: 147 TLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST--VGTPAYIAPE-----VLLRQEYDGKI 198
Query: 264 -DVFSFGVLLLEIVSG 278
DV+S GV L ++ G
Sbjct: 199 ADVWSCGVTLYVMLVG 214
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 48/221 (21%), Positives = 91/221 (41%), Gaps = 66/221 (29%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSG--------RSGQGLREMKNEASV 165
++ F + LGEG +G V + G +A+K++ R+ LRE+K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIK----I 62
Query: 166 IAKVQHKNLVRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLF--- 204
+ +H+N++ + + ++ +I E M + L +F++
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 205 --------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 250
+LK SN+L++ + + K+ DFG+ARI +E A+ S G M
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSGMV 180
Query: 251 PEY-------AIEGIFSIK-----FDVFSFGVLLLEIVSGK 279
E+ A E + + DV+S G +L E+ +
Sbjct: 181 -EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 31/189 (16%), Positives = 65/189 (34%), Gaps = 53/189 (28%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNE-IAVKRLSG---------RSGQGLREMKNEAS 164
+ + + +G G +G VY + + +A+K+++ R LRE+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREIT---- 77
Query: 165 VIAKVQHKNLVRLLGCCIDKDEKI-----LIYEYMP---------NKSLD-----FFLFN 205
++ +++ ++RL I D ++ E L L+N
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 206 -----------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
LK +N LL++D + K+ DFG+AR + + +
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 249 MSPEYAIEG 257
++
Sbjct: 198 GPHNKNLKK 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 20/80 (25%), Positives = 34/80 (42%), Gaps = 6/80 (7%)
Query: 206 LKASNILL--DKDMNPKISDFGMARICGGNELQANT--SRIVGTYGYMSPE--YAIEGIF 259
+K N L +K K+ DFG+++ + GT +++PE +
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253
Query: 260 SIKFDVFSFGVLLLEIVSGK 279
K D +S GVLL ++ G
Sbjct: 254 GPKCDAWSAGVLLHLLLMGA 273
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 17/83 (20%), Positives = 35/83 (42%), Gaps = 6/83 (7%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVR 176
+G+G +G V + + A+K ++ + + + +K E ++ K+ H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 177 LLGCCIDKDEKILIYEYMPNKSL 199
L D+ L+ E L
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHL 115
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 45/212 (21%), Positives = 89/212 (41%), Gaps = 59/212 (27%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSG---------RSGQGLREMKNEAS 164
R+ + + +G G +G V K G +AVK+LS R+ RE++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELR---- 80
Query: 165 VIAKVQHKNLVRLL-----GCCIDKDEKI-LIYEYMP--------NKSLD-----FFLF- 204
++ ++H+N++ LL +++ + L+ M + L F ++
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 205 ----------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
+LK SN+ +++D KI DFG+AR + V T Y
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWY 195
Query: 249 MSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGK 279
+PE + ++ D++S G ++ E+++G+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 42/212 (19%), Positives = 78/212 (36%), Gaps = 51/212 (24%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 179
+G G F V +++ ++ A+K ++ E + E V+ + + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------------- 205
D++ L+ EY L L +
Sbjct: 129 AFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 206 LKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE-------YAIEG 257
+K NILLD+ + +++DFG ++ +++ VGT Y+SPE G
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGGPGTG 245
Query: 258 IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT 289
+ + D ++ GV E+ G+ T FY T
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQ--TPFYADST 275
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 43/212 (20%), Positives = 86/212 (40%), Gaps = 59/212 (27%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNE-IAVKRLSG---------RSGQGLREMKNEAS 164
+ D +G G +G V V + +A+K+L R+ RE++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELR---- 76
Query: 165 VIAKVQHKNLVRLL------GCCIDKDEKILIYEYMP--------NKSLD-----FFLF- 204
++ ++H+N++ LL D + L+ +M ++ L F ++
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 205 ----------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 248
+LK N+ +++D KI DFG+AR + + V T Y
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----ADSEMTGYVVTRWY 191
Query: 249 MSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGK 279
+PE + ++ D++S G ++ E+++GK
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 45/193 (23%), Positives = 69/193 (35%), Gaps = 39/193 (20%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 179
LG+G FG V + A+K L E E V+ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 180 CCIDKDEKILIYEYMPNKSLDFFL-----FN----------------------------L 206
D + EY L F L F+ L
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
K N++LDKD + KI+DFG+ + + T GT Y++PE + + D +
Sbjct: 276 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWW 333
Query: 267 SFGVLLLEIVSGK 279
GV++ E++ G+
Sbjct: 334 GLGVVMYEMMCGR 346
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 68/223 (30%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRKGNE-IAVKRLSGRSGQG----LREMKNEASVIAKV 169
+R+ D LG GG G V+ V ++ +A+K++ Q LRE+K +I ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRL 65
Query: 170 QHKNLVRLL--------------GCCIDKDEKILIYEYMP--------NKSLD-----FF 202
H N+V++ G + + ++ EYM L F
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 203 LF-----------------NLKASNILLD-KDMNPKISDFGMARICGGNELQANT-SRIV 243
++ +LK +N+ ++ +D+ KI DFG+ARI + S +
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 244 GTYGYMSPE-------YAIEGIFSIKFDVFSFGVLLLEIVSGK 279
T Y SP Y + D+++ G + E+++GK
Sbjct: 186 VTKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 3e-07
Identities = 54/236 (22%), Positives = 97/236 (41%), Gaps = 59/236 (25%)
Query: 84 ELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVY---KGVLRKG 140
E+ + + + ++K + QF V LG+G FG V+ K
Sbjct: 7 EIAITHHVKEGHEKADPSQF---ELLKV------------LGQGSFGKVFLVKKISGSDA 51
Query: 141 NEI-AVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI-LIYEYMPN 196
++ A+K L + + K E ++ +V H +V+L + K+ LI +++
Sbjct: 52 RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRG 110
Query: 197 KSLDFF------LFN---------------------------LKASNILLDKDMNPKISD 223
L F +F LK NILLD++ + K++D
Sbjct: 111 GDL-FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTD 169
Query: 224 FGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
FG+++ +E +A + GT YM+PE + D +SFGVL+ E+++G
Sbjct: 170 FGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 5e-07
Identities = 47/198 (23%), Positives = 82/198 (41%), Gaps = 46/198 (23%)
Query: 124 LGEGGFGPVY---KGVLRKGNEI-AVKRLS----GRSGQGLREMKNEASVIAKVQHKNLV 175
LG+GG+G V+ K +I A+K L R+ + K E +++ +V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 176 RLLGCCIDKDEKI-LIYEYMPNKSLDFF------LFN----------------------- 205
L+ K+ LI EY+ L F +F
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 206 ----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSI 261
LK NI+L+ + K++DFG+ + + +T GT YM+PE + +
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRSGHNR 200
Query: 262 KFDVFSFGVLLLEIVSGK 279
D +S G L+ ++++G
Sbjct: 201 AVDWWSLGALMYDMLTGA 218
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 72/229 (31%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSG---------RSGQGLREMKNEAS 164
++ KLG+G +G V+K + R+ G +AVK++ R+ RE+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIM---- 60
Query: 165 VIAK--VQHKNLVRLLGCCI-DKDEKI-LIYEYMP--------NKSLD-----FFLFN-- 205
I H+N+V LL D D + L+++YM L+ + ++
Sbjct: 61 -ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI 119
Query: 206 ---------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 250
+K SNILL+ + + K++DFG++R N + +
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 251 P--------EY-------AIEGIFSIK-----FDVFSFGVLLLEIVSGK 279
+Y A E + D++S G +L EI+ GK
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 40/193 (20%)
Query: 124 LGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 179
LG+G FG V + A+K L E E+ V+ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 180 CCIDKDEKILIYEYMPNKSLDFF------LFN---------------------------L 206
D + EY L FF +F +
Sbjct: 73 AFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
K N++LDKD + KI+DFG+ + + T GT Y++PE + + D +
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 267 SFGVLLLEIVSGK 279
GV++ E++ G+
Sbjct: 190 GLGVVMYEMMCGR 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 15/114 (13%)
Query: 205 NLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+LK N+LLD + + K++D+GM + + G+ TS GT Y++PE +
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGEDYGFS 233
Query: 263 FDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316
D ++ GVL+ E+++G+ + F + D N L ILE +
Sbjct: 234 VDWWALGVLMFEMMAGR--SPFDIVGS-------SDNPDQNTEDYLFQVILEKQ 278
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 15/114 (13%)
Query: 205 NLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+LK N+LLD + + K++D+GM + + G+ TS GT Y++PE +
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGEDYGFS 190
Query: 263 FDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316
D ++ GVL+ E+++G+ + F + D N L ILE +
Sbjct: 191 VDWWALGVLMFEMMAGR--SPFDIVGS-------SDNPDQNTEDYLFQVILEKQ 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 206 LKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
LK N++LD + + KI+DFGM + I G T GT Y++PE +
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSV 523
Query: 264 DVFSFGVLLLEIVSGK 279
D ++FGVLL E+++G+
Sbjct: 524 DWWAFGVLLYEMLAGQ 539
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 18/183 (9%), Positives = 49/183 (26%), Gaps = 47/183 (25%)
Query: 123 KLGEGGFGPVYKGV-LRKGNEIAVKRL---SGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
G ++ + ++A+ + L+E + ++++ + R+L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLFNLKASNILLDKDMNPKISDFGMARICG------- 231
+ +++ E++ SL + D +P G R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ----------EVADTSPSPV----GAIRAMQSLAAAAD 143
Query: 232 --------------GNELQANTSRIV-GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIV 276
+ +V M + + D+ G L ++
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA-------NPQDDIRGIGASLYALL 196
Query: 277 SGK 279
+
Sbjct: 197 VNR 199
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 6e-06
Identities = 72/437 (16%), Positives = 126/437 (28%), Gaps = 151/437 (34%)
Query: 14 VSAVFLILAFISGLSKGVDSASFFVLLSLSITLAAVATLGLNFYCFLHTSGEDLMMFDLD 73
VS + F + LSK + FV L +N Y FL +
Sbjct: 61 VSGTLRL--FWTLLSKQEEMVQKFV----------EEVLRIN-YKFLMSP---------- 97
Query: 74 LNLKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVY 133
+K + + +R++ +Q +F+ +VS R KL + +
Sbjct: 98 --IKTEQRQPSMMTRMYIEQRDRLYNDNQ--VFAKYNVS----RLQPYLKLRQA----LL 145
Query: 134 KGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIA-------KVQHKNLVRL----LGCCI 182
+ LR + + G G G K + +A KVQ K ++ L C
Sbjct: 146 E--LRPAKNVLID---GVLGSG----K---TWVALDVCLSYKVQCKMDFKIFWLNLKNC- 192
Query: 183 DKDEKILIYEYMPNKSLDFFLFNLKAS-NILLDKDMNPKISDFGMARICGGNELQANTSR 241
+ E +L + L L+ + + D N K+ RI + +QA R
Sbjct: 193 NSPETVL-------EMLQKLLYQIDPNWTSRSDHSSNIKL------RI---HSIQAELRR 236
Query: 242 IVGTYGYMSPEYA-----IEGIFSIK-FDVFSFG--VLLL----------------EIVS 277
++ S Y + + + K ++ F+ +LL I
Sbjct: 237 LL-----KSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291
Query: 278 GKKNTGFYRTDTLNLLGYA---------------------------------WDLWRS-- 302
+ + +LL WD W+
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351
Query: 303 ----NRTLE-----LTDAILEDEYSSKQVLLRYVNI--ALLCVQESADDRPTTNDVVSML 351
+E L A + V +I LL + + VV+ L
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL 411
Query: 352 TNEAAALLPPKQPAFSY 368
+ PK+ S
Sbjct: 412 HKYSLVEKQPKESTISI 428
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 2e-04
Identities = 50/384 (13%), Positives = 112/384 (29%), Gaps = 123/384 (32%)
Query: 65 EDLMMFDLDLNLKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKL 124
ED + + D +++ S L+K +E+D + + T R
Sbjct: 26 EDAFVDNFDCK------DVQDMPKSILSK----EEIDH--IIMSKDAVSGTLRLFWT--- 70
Query: 125 GEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 184
+L K E+ V++ + LR N +++ ++ +
Sbjct: 71 -----------LLSKQEEM-VQKFVE---EVLR--INYKFLMSPIKTE--------QRQP 105
Query: 185 DEKILIYEYMPNKSLDFFLFN----------------LKASNILLDKDMNPKISDFGMAR 228
+Y ++ L+N LK LL+ + G+
Sbjct: 106 SMMTRMYIEQRDR-----LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160
Query: 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF--SFG-----VLLLEIV----- 276
G + + Y ++ F +F + +LE++
Sbjct: 161 -SGKTWVALDVCL----------SYKVQCKMD--FKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 277 -------SGKKNTGFYRTDTLNLLGYAWDLWRS---NRTLELTDAILEDEYSSK------ 320
S ++ + ++ L +S L L +L + ++K
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL-L---VLLNVQNAKAWNAFN 263
Query: 321 ---QVLL--RYVNIALLCVQESADDRPTTNDVVSMLT-NEAAALLPPKQPAFSYVRNTVT 374
++LL R+ + + + + + LT +E +LL Y+
Sbjct: 264 LSCKILLTTRFKQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLL------KYLDCRPQ 316
Query: 375 STSSTGKTEDCSINQVTISLLEAR 398
E + N +S++
Sbjct: 317 DLPR----EVLTTNPRRLSIIAES 336
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 6e-06
Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 206 LKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
LK N+LLD + + K++DFGM IC G T+ GT Y++PE E ++
Sbjct: 150 LKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYIAPEILQEMLYGPAV 205
Query: 264 DVFSFGVLLLEIVSGK 279
D ++ GVLL E++ G
Sbjct: 206 DWWAMGVLLYEMLCGH 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 29/115 (25%), Positives = 49/115 (42%), Gaps = 21/115 (18%)
Query: 206 LKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
+K NILLD + + ++DFG+++ + E GT YM+P+ G
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDFCGTIEYMAPDIVRGGDSGHDK 241
Query: 264 DV--FSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316
V +S GVL+ E+++G + F N E++ IL+ E
Sbjct: 242 AVDWWSLGVLMYELLTGA--SPFTVDG------------EKNSQAEISRRILKSE 282
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 206 LKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKF 263
LK N++LD + + KI+DFGM + I G T GT Y++PE +
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSV 202
Query: 264 DVFSFGVLLLEIVSGK 279
D ++FGVLL E+++G+
Sbjct: 203 DWWAFGVLLYEMLAGQ 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 31/73 (42%), Positives = 44/73 (60%), Gaps = 2/73 (2%)
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
LK NILLDKD + KI+DFGM + + + NT GT Y++PE + ++ D
Sbjct: 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDW 201
Query: 266 FSFGVLLLEIVSG 278
+SFGVLL E++ G
Sbjct: 202 WSFGVLLYEMLIG 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 2e-05
Identities = 20/116 (17%), Positives = 38/116 (32%), Gaps = 21/116 (18%)
Query: 98 KEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRL--------S 149
E Q FS T + K+GEG FG V++ + +A+K + +
Sbjct: 3 GECSQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVN 60
Query: 150 GRSGQGLREMKNEASV---------IAKVQHKNLVRLLG--CCIDKDEKILIYEYM 194
G + E+ E + + + + L C +L+ +
Sbjct: 61 GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 21/74 (28%), Positives = 36/74 (48%), Gaps = 2/74 (2%)
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
LK NILLD + ++DFG+ + + +T GT Y++PE + + D
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 266 FSFGVLLLEIVSGK 279
+ G +L E++ G
Sbjct: 223 WCLGAVLYEMLYGL 236
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 22/148 (14%), Positives = 47/148 (31%), Gaps = 48/148 (32%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGC 180
LG G G V + ++ + A+K L + + E + + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 181 CIDKDEKI----LIYEYMP---------NKSLDFF-----------LFN----------- 205
+ ++ E + ++ F +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 206 ---LKASNILL---DKDMNPKISDFGMA 227
+K N+L + K++DFG A
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 42/214 (19%), Positives = 78/214 (36%), Gaps = 64/214 (29%)
Query: 123 KLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSG-----QGLREMK-----NEASVIAKVQ- 170
KLG G F V+ + +A+K + R E+K N+A +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 171 -HKNLVRLLGC-----------CI-----DKDEKILIYEY----MPNK-----------S 198
++++LL + ++ LI +Y +P
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 199 LDFFLFN-------LKASNILLDKDMNP------KISDFGMARICGGNELQANTSRIVGT 245
LD+ +K N+L++ +P KI+D G A C +E + + + T
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE---HYTNSIQT 198
Query: 246 YGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
Y SPE + + D++S L+ E+++G
Sbjct: 199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 398 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.88 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.77 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.02 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.68 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.55 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.1 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.62 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.16 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.07 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.85 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.7 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 93.36 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 92.94 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.77 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 90.64 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.59 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 87.48 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.08 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 84.51 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 83.26 | |
| 4ev6_A | 339 | Magnesium transport protein CORA; membrane protein | 83.13 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 81.8 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=394.84 Aligned_cols=226 Identities=27% Similarity=0.430 Sum_probs=183.5
Q ss_pred CCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999874 367899999988777777889999999999999999999999999999999
Q ss_pred EEeccCCCCh---------------------------------------------hHHhhcCCCCCceecCCCCeEEccc
Q 037365 190 IYEYMPNKSL---------------------------------------------DFFLFNLKASNILLDKDMNPKISDF 224 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------------------~~~~~dlkp~NILl~~~~~~kl~DF 224 (398)
|||||++|+| +++||||||+|||+++++.+||+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCc
Confidence 9999999987 2567899999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 225 GMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 225 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
|+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||..... .++... ... +
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~---i~~-~ 246 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIEC---ITQ-G 246 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH---HHH-T
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH---HHc-C
Confidence 99987655444334445679999999999999999999999999999999999 8999754221 112111 111 1
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
..... +..++..+.+|+.+||+.||++|||++||++.|+++...
T Consensus 247 ~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 RVLQR----------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11111 222345688999999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=395.80 Aligned_cols=226 Identities=28% Similarity=0.411 Sum_probs=176.1
Q ss_pred CCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|.+.+.||+|+||+||+|+++ +++.||||+++..+....+.|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999975 367899999988777777889999999999999999999999999999999
Q ss_pred EEeccCCCChh-----------------------------------------------HHhhcCCCCCceecCCCCeEEc
Q 037365 190 IYEYMPNKSLD-----------------------------------------------FFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 190 V~e~~~~g~L~-----------------------------------------------~~~~dlkp~NILl~~~~~~kl~ 222 (398)
|||||++|+|. ++||||||+|||+++++.+||+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEc
Confidence 99999999873 4678999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhh
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWR 301 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 301 (398)
|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.... ...+...+ ..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--~~~~~~~i---~~ 275 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--NTEAIDCI---TQ 275 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--HHHHHHHH---HH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--HHHHHHHH---Hc
Confidence 9999997765444444455689999999999999999999999999999999999 899975322 11121111 11
Q ss_pred cCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 302 SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
+..... +..++..+.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 276 -g~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 -GRELER----------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -TCCCCC----------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCC----------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111 222345688999999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=389.96 Aligned_cols=223 Identities=28% Similarity=0.416 Sum_probs=179.5
Q ss_pred CCCCccceecccCceEEEEEEEc------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
++++..+.||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999973 3678999999754 3344678999999999999999999999999999999
Q ss_pred EEEeccCCCChh------------------------------------------------HHhhcCCCCCceecCCCCeE
Q 037365 189 LIYEYMPNKSLD------------------------------------------------FFLFNLKASNILLDKDMNPK 220 (398)
Q Consensus 189 lV~e~~~~g~L~------------------------------------------------~~~~dlkp~NILl~~~~~~k 220 (398)
+|||||++|+|. ++||||||+|||+++++.+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 999999999883 45679999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHh
Q 037365 221 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDL 299 (398)
Q Consensus 221 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 299 (398)
|+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.... ..++...
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--~~~~~~~---- 259 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQDVVEM---- 259 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--HHHHHHH----
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--HHHHHHH----
Confidence 999999987755444444556789999999999999999999999999999999998 888975432 1122211
Q ss_pred hhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 300 WRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
...+..... +..++..+.+|+.+||+.||++|||++||++.|+..
T Consensus 260 i~~~~~~~~----------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRNRQVLPC----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHcCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122211111 223345688999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=385.04 Aligned_cols=234 Identities=23% Similarity=0.372 Sum_probs=176.1
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
++...+++++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.++++++|||||+++|+|. ++..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEE
Confidence 3445578888999999999999999875 36999998644 4455678999999999999999999999885 46789
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||||||++|+| +++||||||+|||+++++.+||+|||+|+.......
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999998 467789999999999999999999999987654433
Q ss_pred ccccccccccccccChhhhcc---CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIE---GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||...... . ........+........
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~----~~~~~~~~~~~~p~~~~- 261 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-D----QIIFMVGRGYASPDLSK- 261 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-H----HHHHHHHTTCCCCCSTT-
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-H----HHHHHHhcCCCCCCccc-
Confidence 334455789999999999964 46899999999999999999999998543211 1 11111111111000000
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
. ...++..+.+|+.+||+.||++|||+.||++.|+.+...+
T Consensus 262 ~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 262 L-----YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp S-----CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred c-----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 0 1223456889999999999999999999999998775443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=389.60 Aligned_cols=216 Identities=21% Similarity=0.360 Sum_probs=171.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|++.+.||+|+||+||+|++.. |+.||||++... .....+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999999865 899999999654 34556789999999999999999999999999999999999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
||+||+| +++||||||+|||++.++.+||+|||+|+.+.... ..
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~ 181 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--EL 181 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--cc
Confidence 9999998 46778999999999999999999999998764321 12
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+......... ....
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~-~~~~---------- 245 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIISGS-FPPV---------- 245 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTC-CCCC----------
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCC-CCCC----------
Confidence 334689999999999999999999999999999999999999985321 111122222211 1110
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223456889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=385.76 Aligned_cols=219 Identities=24% Similarity=0.351 Sum_probs=178.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.+.|+..+.||+|+||.||+|++.. |+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4579999999999999999999875 899999999765444556788999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
|++|+| +++||||||+|||++.++.+||+|||+|+.+.... ......
T Consensus 153 ~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~ 230 (346)
T 4fih_A 153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 230 (346)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCC
T ss_pred CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cccccc
Confidence 999988 46789999999999999999999999999875433 223457
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
+||+.|||||++.+..|+.++|||||||++|||++|+.||... +.......+ ......... .....
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i----~~~~~~~~~--------~~~~~ 296 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMI----RDNLPPRLK--------NLHKV 296 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHH----HHSSCCCCS--------CGGGS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHH----HcCCCCCCC--------ccccC
Confidence 8999999999999999999999999999999999999998532 111111111 111110000 01223
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+..+.+|+.+||+.||++|||++|+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 456889999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=381.42 Aligned_cols=216 Identities=23% Similarity=0.324 Sum_probs=177.8
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||+||+|++.. ++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999865 899999999643 2234577899999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|||+||+| +++||||||+|||++.++.+||+|||+|+.+.........
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 99999998 4778999999999999999999999999987654444445
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||... +...+. ...... .. .+ +
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~---~~i~~~-~~-~~----------p 254 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEGLIF---AKIIKL-EY-DF----------P 254 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHH---HHHHHT-CC-CC----------C
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHH---HHHHcC-CC-CC----------C
Confidence 5679999999999999999999999999999999999999998532 111111 111111 10 01 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVV 348 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl 348 (398)
...+..+.+|+.+||+.||++|||++|++
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12234578999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=379.83 Aligned_cols=226 Identities=19% Similarity=0.187 Sum_probs=177.2
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.+.|+..++||+|+||.||+|++.. |+.||||+++.... ..+|+.++++++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 4568888999999999999999865 89999999975432 24699999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCC-CeEEcccccceecCCCCccc---
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDM-NPKISDFGMARICGGNELQA--- 237 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~--- 237 (398)
|+||+| +++||||||+|||++.++ .+||+|||+|+.+.......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 999998 477899999999999987 69999999999875432211
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+...+ ........ .
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i---~~~~~~~~----~----- 277 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCLKI---ASEPPPIR----E----- 277 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHHHH---HHSCCGGG----G-----
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHH---HcCCCCch----h-----
Confidence 233468999999999999999999999999999999999999998643222 111111 11110000 0
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
.++..+..+.+++.+||+.||++|||+.|+++.|........
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 022334568899999999999999999999999887655443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=387.05 Aligned_cols=219 Identities=24% Similarity=0.353 Sum_probs=179.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.+.|+..+.||+|+||.||+|++.. |+.||||++........+.+.+|+.+|++++|||||+++++|.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4579999999999999999999875 899999999766555566789999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
|+||+| +++||||||+|||++.+|.+||+|||+|+.+.... ......
T Consensus 230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~ 307 (423)
T 4fie_A 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 307 (423)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCC
T ss_pred CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cccccc
Confidence 999988 46789999999999999999999999999875433 223457
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
+||+.|||||++.+..|+.++|||||||++|||++|+.||... +.......+ ........ . .....
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i----~~~~~~~~-----~---~~~~~ 373 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMI----RDNLPPRL-----K---NLHKV 373 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHH----HHSCCCCC-----S---CTTSS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHH----HcCCCCCC-----c---ccccC
Confidence 8999999999999999999999999999999999999998532 111111111 11110000 0 01123
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+..+.+|+.+||+.||++|||++|+++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 356889999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=379.39 Aligned_cols=235 Identities=26% Similarity=0.342 Sum_probs=187.5
Q ss_pred chhhhhhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCC-Cccccee
Q 037365 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQH-KNLVRLL 178 (398)
Q Consensus 107 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~nIv~l~ 178 (398)
..+.++...++|++.+.||+|+||+||+|.+.. ++.||||++.... ....+.+.+|+.+|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345567778899999999999999999999753 3579999997653 3445779999999999975 8999999
Q ss_pred eEEEeC-CeeEEEEeccCCCChh------------------------------------------------HHhhcCCCC
Q 037365 179 GCCIDK-DEKILIYEYMPNKSLD------------------------------------------------FFLFNLKAS 209 (398)
Q Consensus 179 ~~~~~~-~~~~lV~e~~~~g~L~------------------------------------------------~~~~dlkp~ 209 (398)
|+|.+. +..++|||||++|+|. ++||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 999765 5689999999999872 467899999
Q ss_pred CceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCC
Q 037365 210 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTD 288 (398)
Q Consensus 210 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~ 288 (398)
|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998765544444556789999999999999999999999999999999998 89997543222
Q ss_pred ccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 289 TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
. .+......+..... +..++..+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 295 -~----~~~~~i~~g~~~~~----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 295 -E----EFCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp -H----HHHHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -H----HHHHHHHcCCCCCC----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 1 11112222211111 11233458899999999999999999999999988654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=363.54 Aligned_cols=213 Identities=23% Similarity=0.351 Sum_probs=159.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||+||+|++.. |+.||+|++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999764 899999999654 2334567899999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||| +|+| +++||||||+|||+++++.+||+|||+|+...... ..
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~ 168 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FL 168 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC---cc
Confidence 999 5666 57789999999999999999999999998765432 23
Q ss_pred ccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 240 SRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
...+||+.|||||++.+..| +.++||||+||++|||++|+.||.... ...+. ..... ... .+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~---~~i~~-~~~-~~---------- 231 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLF---KNISN-GVY-TL---------- 231 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH---HHHHH-TCC-CC----------
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHH---HHHHc-CCC-CC----------
Confidence 34689999999999998886 589999999999999999999985321 11111 11111 110 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+...+..+.+++.+||+.||++|||++|+++
T Consensus 232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122345789999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=367.82 Aligned_cols=235 Identities=21% Similarity=0.283 Sum_probs=171.0
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----eeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~ 191 (398)
.+|.+.+.||+|+||+||+|++ +|+.||||++...... ......|+..+.+++|||||+++|+|.+++ ..||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3567778999999999999998 4899999999654321 122345666667889999999999998764 579999
Q ss_pred eccCCCCh---------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 192 EYMPNKSL---------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 192 e~~~~g~L---------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
|||++|+| +++||||||+|||++.++++||+|||+|+....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 99999998 146899999999999999999999999987754
Q ss_pred CCcc--cccccccccccccChhhhccC------CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccc---------hhHH
Q 037365 233 NELQ--ANTSRIVGTYGYMSPEYAIEG------IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLN---------LLGY 295 (398)
Q Consensus 233 ~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~---------~~~~ 295 (398)
.... ......+||+.|||||++.+. .++.++|||||||++|||+||++|+......... ....
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 3322 123346899999999999764 4788999999999999999998876533221100 0111
Q ss_pred HHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 296 AWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
......... .++.+.......+.+..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 241 ~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 241 MRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111111 111111111133456678899999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=364.30 Aligned_cols=212 Identities=25% Similarity=0.388 Sum_probs=165.9
Q ss_pred CccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe----CCeeEEEE
Q 037365 119 SDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIY 191 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 191 (398)
+..+.||+|+||+||+|.+.. +..||+|++... .....+.+.+|+.++++++|||||+++++|.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 556789999999999999875 889999999643 44456789999999999999999999999875 34689999
Q ss_pred eccCCCCh--------------------------------h--HHhhcCCCCCceecC-CCCeEEcccccceecCCCCcc
Q 037365 192 EYMPNKSL--------------------------------D--FFLFNLKASNILLDK-DMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 192 e~~~~g~L--------------------------------~--~~~~dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 236 (398)
|||++|+| + ++||||||+|||++. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~--- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---
Confidence 99999998 3 789999999999974 799999999999864332
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ..+ ............ .
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~----~~~i~~~~~~~~----~--- 251 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQI----YRRVTSGVKPAS----F--- 251 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHH----HHHHTTTCCCGG----G---
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HHH----HHHHHcCCCCCC----C---
Confidence 2345689999999998864 6999999999999999999999998532211 111 111111111110 1
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+...+..+.+|+.+||+.||++|||++|+++
T Consensus 252 --~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 --DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111235789999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=369.39 Aligned_cols=215 Identities=21% Similarity=0.308 Sum_probs=165.0
Q ss_pred CCCCccceecccCceEEEEEEEc----CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|++.+.||+|+||+||+|+.. .++.||+|++.... ......+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 36889999996542 2233467889999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||||+||+| +++||||||+|||++.++.+||+|||+|+...... .
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 181 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 181 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------C
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC--c
Confidence 9999999998 47789999999999999999999999998754332 2
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...+. ....... . ..
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~---~~i~~~~-~-~~--------- 245 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--RKETM---TMILKAK-L-GM--------- 245 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH---HHHHHCC-C-CC---------
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--HHHHH---HHHHcCC-C-CC---------
Confidence 2345689999999999999999999999999999999999999985321 11111 1111111 0 00
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCH-----HHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTT-----NDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~ 349 (398)
+...+..+.+|+.+||+.||++|||+ +|+++
T Consensus 246 -p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 -PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11233457899999999999999984 67764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=355.78 Aligned_cols=216 Identities=24% Similarity=0.346 Sum_probs=158.8
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC--------
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-------- 185 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-------- 185 (398)
++|++.+.||+|+||+||+|++.. |+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 458889999999999999999865 899999999654 3345567899999999999999999999997654
Q ss_pred ----eeEEEEeccCCCCh-----------------------------------hHHhhcCCCCCceecCCCCeEEccccc
Q 037365 186 ----EKILIYEYMPNKSL-----------------------------------DFFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 186 ----~~~lV~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
..|+|||||++|+| +++||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 36999999999988 467889999999999999999999999
Q ss_pred ceecCCCCccc----------ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH
Q 037365 227 ARICGGNELQA----------NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA 296 (398)
Q Consensus 227 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 296 (398)
|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||... .+.....
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----MERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----cHHHHHH
Confidence 98775432211 1234579999999999999999999999999999999996 54311 0111111
Q ss_pred HHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 297 WDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.. ........ . .........+|+.+||+.||++|||+.|+++
T Consensus 238 ~~-~~~~~~p~----~------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TD-VRNLKFPP----L------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHTTCCCH----H------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HhcCCCCC----C------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11111100 0 1222345678999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=347.56 Aligned_cols=172 Identities=23% Similarity=0.371 Sum_probs=144.3
Q ss_pred hhcCCCCccceecccCceEEEEEEEc----CCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCee
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 187 (398)
...++|++.+.||+|+||+||+|+.+ .++.||+|++.... ....+.+|+++|+.+ +||||+++++++.++++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999864 36789999986543 335678999999998 699999999999999999
Q ss_pred EEEEeccCCCCh-----------------------------hHHhhcCCCCCceecCC-CCeEEcccccceecCCCCcc-
Q 037365 188 ILIYEYMPNKSL-----------------------------DFFLFNLKASNILLDKD-MNPKISDFGMARICGGNELQ- 236 (398)
Q Consensus 188 ~lV~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~- 236 (398)
|+|||||++|+| +++||||||+|||++.+ +.+||+|||+|+...+....
T Consensus 96 ~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp EEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred EEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 999999999988 57889999999999876 79999999999876433211
Q ss_pred -------------------------cccccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCC
Q 037365 237 -------------------------ANTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYR 286 (398)
Q Consensus 237 -------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~ 286 (398)
......+||+.|||||++.+.. |+.++||||+||++|||++|+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1123457999999999998764 8999999999999999999999986443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=336.13 Aligned_cols=251 Identities=34% Similarity=0.576 Sum_probs=205.9
Q ss_pred ccchhhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC
Q 037365 105 LFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 184 (398)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 184 (398)
.+++.++...+++|+..+.||+|+||.||+|++++++.||+|++........+.+.+|+.++++++||||+++++++.++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 35566777889999999999999999999999888999999999877666678899999999999999999999999999
Q ss_pred CeeEEEEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 185 DEKILIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
+..++||||+++|+| +++|+||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999877 35578999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCC-ccchhHHHHHhhhcCCccc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD-TLNLLGYAWDLWRSNRTLE 307 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~ 307 (398)
...............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......|............
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 765433333334457899999999999999999999999999999999999998654333 3334444444444444444
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 308 LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
..++...... ....+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 268 ~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 268 IVDPNLADKI-RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSSCTTCS-CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcChhhcccc-CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 4444333322 45677889999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=352.20 Aligned_cols=232 Identities=17% Similarity=0.245 Sum_probs=170.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC------C
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------D 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 185 (398)
.++|++.+.||+|+||+||+|++.. |+.||||++... .....+.+.+|+++|++++|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4689999999999999999999865 899999999654 334456788999999999999999999998643 5
Q ss_pred eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 186 EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 186 ~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
..|||||||+ |+| +++||||||+|||++.++.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7899999996 455 5788999999999999999999999999876433
Q ss_pred C--cccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc--
Q 037365 234 E--LQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL-- 308 (398)
Q Consensus 234 ~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 308 (398)
. ........+||+.|||||++.+. .|+.++||||+||++|||++|++||.... ..+....+............
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCCCCGGGTC-
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhcCCCChHHhhh
Confidence 2 12234457899999999998875 46999999999999999999999985322 11111111111110000000
Q ss_pred -----chhhhh----c-ccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 309 -----TDAILE----D-EYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 309 -----~~~~~~----~-~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...... . ... .+.....+.+|+.+||+.||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0 000 0112356789999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=360.88 Aligned_cols=219 Identities=22% Similarity=0.315 Sum_probs=178.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|++.+.||+|+||.||+|+++. |+.||+|++........+.+.+|+.+|+.++|||||++++++.+++..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4689999999999999999999865 899999999877666677889999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCC--CCeEEcccccceecCCCCcccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKD--MNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~--~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+||+| +++||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~--- 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--- 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---
Confidence 999988 35678999999999854 8999999999998764432
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .... ....... . ...+..
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~---~~i~~~~-~-~~~~~~------ 379 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETL---RNVKSCD-W-NMDDSA------ 379 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHH---HHHHTTC-C-CCCSGG------
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH---HHHHhCC-C-CCCccc------
Confidence 3346899999999999999999999999999999999999999853221 1111 1111110 0 000000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123455789999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=331.59 Aligned_cols=253 Identities=36% Similarity=0.640 Sum_probs=207.6
Q ss_pred CCCCccchhhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCcccceee
Q 037365 101 DQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLG 179 (398)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~ 179 (398)
.....+++.++....++|+..+.||+|+||.||+|+..+++.||+|++..... .....+.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34566888999999999999999999999999999987899999999975532 22336889999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCh---------------------------------------hHHhhcCCCCCceecCCCCeE
Q 037365 180 CCIDKDEKILIYEYMPNKSL---------------------------------------DFFLFNLKASNILLDKDMNPK 220 (398)
Q Consensus 180 ~~~~~~~~~lV~e~~~~g~L---------------------------------------~~~~~dlkp~NILl~~~~~~k 220 (398)
++.+++..++||||+++|+| +++|+||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999876 356789999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCC---CCCCccchhHHHH
Q 037365 221 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGF---YRTDTLNLLGYAW 297 (398)
Q Consensus 221 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~---~~~~~~~~~~~~~ 297 (398)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.. ..........|..
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999987654332 223345699999999999999999999999999999999999999853 1223344555655
Q ss_pred HhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 298 DLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
............+....... .......+.+++.+||+.||.+|||++|+++.|++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNY-KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSC-CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHhhchhhhhhcChhhcccc-CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 55555555555555554444 5666788999999999999999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.20 Aligned_cols=217 Identities=25% Similarity=0.284 Sum_probs=168.9
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHH---HHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
.++|++.+.||+|+||.||+|+... |+.||+|++.+.. ........ .++.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4679999999999999999999876 8999999996431 11222333 346667778999999999999999999
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
|+|||||+||+| +++||||||+|||++.+|.+||+|||+|+.+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 999999999998 57789999999999999999999999999875433
Q ss_pred ccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
....+||+.|||||++.+ ..|+.++|||||||++|||++|++||....... ............ . ..
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~~~~-~-~~------ 413 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMA-V-EL------ 413 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHHHCC-C-CC------
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcCCC-C-CC------
Confidence 344689999999999975 579999999999999999999999985322211 111111111110 0 00
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
+...+..+.+|+.+||+.||.+|++ ++||++
T Consensus 414 ----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 414 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1223456789999999999999998 688875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=317.85 Aligned_cols=231 Identities=23% Similarity=0.371 Sum_probs=183.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|...+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3678889999999999999999865 899999999877777788899999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc---
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA--- 237 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--- 237 (398)
+++|+| +++|+||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 999988 35678999999999999999999999998765432211
Q ss_pred ---------ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 238 ---------NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 238 ---------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
......||+.|+|||++.+..++.++||||||+++|||++|..|+..................
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-------- 240 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-------- 240 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--------
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--------
Confidence 111457999999999999999999999999999999999999987654332211110000000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
+... +...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 241 -~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 241 -DRYC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp -HHTC-----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -cccC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0000 11223457899999999999999999999999998766543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=321.11 Aligned_cols=235 Identities=24% Similarity=0.409 Sum_probs=174.9
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
..+....++|++.+.||+|+||.||+|++ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34445567899999999999999999988 58899999986553 4455678999999999999999999999999999
Q ss_pred eEEEEeccCCCCh-----------------------------------h--HHhhcCCCCCceecCCCCeEEccccccee
Q 037365 187 KILIYEYMPNKSL-----------------------------------D--FFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 187 ~~lV~e~~~~g~L-----------------------------------~--~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
.++||||+++|+| + ++|+||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999987 3 78899999999999999999999999976
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. .............
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~---~~~~~~~~~~~~~- 260 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QV---VAAVGFKCKRLEI- 260 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HH---HHHHHHSCCCCCC-
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH---HHHHHhcCCCCCC-
Confidence 54322 1233457999999999999999999999999999999999999997543211 11 1111001111111
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCC
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPP 361 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 361 (398)
+...+..+.+++.+||+.||++|||++++++.|+.......||
T Consensus 261 ---------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 261 ---------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 1122345789999999999999999999999999987655443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.94 Aligned_cols=220 Identities=21% Similarity=0.374 Sum_probs=177.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|+..+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 35689999999999999999999754 89999999976555556778999999999999999999999999999999999
Q ss_pred ccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 193 YMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 193 ~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
|+++|+| +++|+||||+|||++.++.+||+|||++........ ....
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 175 (297)
T 3fxz_A 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRST 175 (297)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCC
T ss_pred CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCC
Confidence 9999998 356789999999999999999999999987654332 2334
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............. .. .+..
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~-~~--------~~~~ 241 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGTPE-LQ--------NPEK 241 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHCSCC-CS--------CGGG
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCCC-CC--------Cccc
Confidence 67999999999999999999999999999999999999997532211 1111111111100 00 0122
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+..+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 3345789999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=310.92 Aligned_cols=248 Identities=38% Similarity=0.579 Sum_probs=194.0
Q ss_pred CCccchhhhhhhcCCCCcc------ceecccCceEEEEEEEcCCCEEEEEEccCC----ChhhHHHHHHHHHHHHhcCCC
Q 037365 103 FPLFSFSSVSTATNRFSDA------NKLGEGGFGPVYKGVLRKGNEIAVKRLSGR----SGQGLREMKNEASVIAKVQHK 172 (398)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~ 172 (398)
...+++.++..++++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567888999999988876 8999999999999987 5889999998643 234467789999999999999
Q ss_pred cccceeeEEEeCCeeEEEEeccCCCCh-----------------------------------hHHhhcCCCCCceecCCC
Q 037365 173 NLVRLLGCCIDKDEKILIYEYMPNKSL-----------------------------------DFFLFNLKASNILLDKDM 217 (398)
Q Consensus 173 nIv~l~~~~~~~~~~~lV~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~ 217 (398)
||+++++++.+.+..++||||+++|+| +++|+||||+||+++.++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF 170 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC
Confidence 999999999999999999999999987 345679999999999999
Q ss_pred CeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHH
Q 037365 218 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW 297 (398)
Q Consensus 218 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 297 (398)
.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ....+..
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 248 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKE 248 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTHHHH
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHHHHH
Confidence 999999999987654433333444679999999998864 58999999999999999999999986543322 1222211
Q ss_pred HhhhcC-CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 298 DLWRSN-RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 298 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
...... ......+..+.. ........+.+++.+||+.||.+|||++++++.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 249 EIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred Hhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111 111111211111 14556678999999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=322.90 Aligned_cols=235 Identities=20% Similarity=0.256 Sum_probs=180.4
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----eeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV 190 (398)
.++|++.+.||+|+||.||+|++. ++.||||++.... .......+|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999986 8899999996543 23345567999999999999999999998754 46999
Q ss_pred EeccCCCCh-----------------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 191 YEYMPNKSL-----------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 191 ~e~~~~g~L-----------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
|||+++|+| +++|+||||+|||++.++.+||+|||+++.
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 999999987 456889999999999999999999999988
Q ss_pred cCCCCcccccccccccccccChhhhcc-----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchh-----------
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIE-----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL----------- 293 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~----------- 293 (398)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 765544334445689999999999986 3567889999999999999999999865433211110
Q ss_pred HHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 294 GYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.+...... .... +...........+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 261 ~~~~~~~~-~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 261 DMQEVVVH-KKKR----PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHTT-SCCC----CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhc-ccCC----CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01110111 1111 1111111123445678999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.33 Aligned_cols=218 Identities=23% Similarity=0.306 Sum_probs=175.7
Q ss_pred hhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
...++|++.+.||+|+||.||+|++. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 34578999999999999999999985 5899999998654 44556778899999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--- 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--- 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence 9999999987 45678999999999999999999999998665332
Q ss_pred ccccccccccccChhhhccCCCC-cccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFS-IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.....+||+.|+|||++.+..++ .++|||||||++|||++|+.||..... ............. .
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~--~-------- 233 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRERVLRGKYR--I-------- 233 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCC--C--------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC--C--------
Confidence 23446899999999999988874 899999999999999999999753211 1111111111100 0
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 234 --p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 --PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11123457899999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=323.72 Aligned_cols=228 Identities=25% Similarity=0.378 Sum_probs=182.1
Q ss_pred hhcCCCCccceecccCceEEEEEEEc--------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR--------KGNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCI 182 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 182 (398)
...++|++.+.||+|+||.||+|++. ++..||+|++.... ....+.+.+|+.+++++ +||||++++++|.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34578999999999999999999863 24579999997653 34567789999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChh------------------------------------------------HHhhcCCCCCceec
Q 037365 183 DKDEKILIYEYMPNKSLD------------------------------------------------FFLFNLKASNILLD 214 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L~------------------------------------------------~~~~dlkp~NILl~ 214 (398)
+.+..|+||||+++|+|. ++||||||+|||++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 999999999999998762 35679999999999
Q ss_pred CCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchh
Q 037365 215 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLL 293 (398)
Q Consensus 215 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 293 (398)
.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--~~~~ 315 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELF 315 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence 999999999999997765444334445577889999999999999999999999999999999 9988754321 1111
Q ss_pred HHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 294 GYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.. ......... +..++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 316 ~~----~~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 316 KL----LKEGHRMDK----------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HH----HHTTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HhcCCCCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 111111111 12233468899999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=326.16 Aligned_cols=229 Identities=24% Similarity=0.316 Sum_probs=181.1
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
+....++|...+.||+|+||.||+|.+. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3445578889999999999999999987 5899999999754 3334457889999999999999999999999999999
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+||||+++|+| +++||||||+|||++.++.+||+|||+++.......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999987 356789999999999999999999999987654332
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
........+++.|+|||.+.++.++.++|||||||++|||++ |..||...... .. ............
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~----~~~~~~~~~~~~------ 336 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QT----REFVEKGGRLPC------ 336 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HH----HHHHHTTCCCCC------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCCCCCC------
Confidence 222222346778999999999999999999999999999998 88887543211 11 111111111111
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
+..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus 337 ----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 337 ----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1122345789999999999999999999999998864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=315.47 Aligned_cols=234 Identities=22% Similarity=0.396 Sum_probs=166.6
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcCC----CEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRKG----NEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID 183 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 183 (398)
+.....++|++.+.||+|+||.||+|.+... ..||+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 4445567899999999999999999997653 27999999754 34456789999999999999999999999988
Q ss_pred CCee------EEEEeccCCCCh--------------------------------------hHHhhcCCCCCceecCCCCe
Q 037365 184 KDEK------ILIYEYMPNKSL--------------------------------------DFFLFNLKASNILLDKDMNP 219 (398)
Q Consensus 184 ~~~~------~lV~e~~~~g~L--------------------------------------~~~~~dlkp~NILl~~~~~~ 219 (398)
.+.. ++||||+++|+| +++|+||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7655 999999999987 35667999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHH
Q 037365 220 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWD 298 (398)
Q Consensus 220 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 298 (398)
||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~--- 251 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNY--- 251 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH---
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHH---
Confidence 9999999987655443333344567889999999999999999999999999999999 88887543221 11111
Q ss_pred hhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 299 LWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
... ...... ....+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 252 ~~~-~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 252 LIG-GNRLKQ----------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHT-TCCCCC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred Hhc-CCCCCC----------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 111 111000 12233468899999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=312.69 Aligned_cols=231 Identities=22% Similarity=0.331 Sum_probs=181.1
Q ss_pred CccchhhhhhhcCC----------CCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC
Q 037365 104 PLFSFSSVSTATNR----------FSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHK 172 (398)
Q Consensus 104 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 172 (398)
+.+++.++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34555555555543 666789999999999999987 5999999999876666677889999999999999
Q ss_pred cccceeeEEEeCCeeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEE
Q 037365 173 NLVRLLGCCIDKDEKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKI 221 (398)
Q Consensus 173 nIv~l~~~~~~~~~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl 221 (398)
||+++++++...+..++||||+++|+| +++|+||||+|||++.++.+||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 182 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEE
Confidence 999999999999999999999999987 3567899999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh
Q 037365 222 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR 301 (398)
Q Consensus 222 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 301 (398)
+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .... .. ..
T Consensus 183 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~---~~-~~ 254 (321)
T 2c30_A 183 SDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAM---KR-LR 254 (321)
T ss_dssp CCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH---HH-HH
T ss_pred eeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HH-Hh
Confidence 99999987654321 23345799999999999999999999999999999999999999753211 1111 11 11
Q ss_pred cCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 302 SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
......... ....+..+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 255 DSPPPKLKN--------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HSSCCCCTT--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCCcCc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111000 11223457899999999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.64 Aligned_cols=222 Identities=24% Similarity=0.337 Sum_probs=174.2
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999987 48999999986543 2334568899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|+++|+| +++|+||||+|||++.++.+||+|||+++.+..........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 9999887 35678999999999999999999999998765433333344
Q ss_pred cccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+. ..... ... .
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-----~~~~~--~~~-------~ 231 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKTY--LNP-------W 231 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH-----TTCTT--STT-------G
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-----ccccc--CCc-------c
Confidence 5689999999999988776 7899999999999999999999865433222211111 11000 000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
......+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1223457799999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=315.64 Aligned_cols=229 Identities=26% Similarity=0.384 Sum_probs=178.4
Q ss_pred hcCCCCccceecccCceEEEEEEEcC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
..++|++.+.||+|+||.||+|.+.. +..||||++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 34678999999999999999999853 456999999765 4445678899999999999999999999999999999
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+||||+++|+| +++|+||||+|||++.++.+||+|||+++.......
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 99999999988 355679999999999999999999999987754322
Q ss_pred cc-ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 236 QA-NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.. ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..... ........
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~----~~~~~~~~------ 274 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISS----VEEGYRLP------ 274 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHH----HHTTCCCC------
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH----HHcCCCCC------
Confidence 11 2233456788999999999999999999999999999999 99997432211 11111 11110000
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
.....+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 275 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 275 ----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 01223456889999999999999999999999999986543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=320.73 Aligned_cols=235 Identities=26% Similarity=0.371 Sum_probs=186.0
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC--------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceee
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK--------GNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLG 179 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~ 179 (398)
.++...++|.+.+.||+|+||.||+|++.. +..||+|++... .......+.+|+++++++ +||||+++++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 344556789999999999999999998632 357999999765 344557789999999999 8999999999
Q ss_pred EEEeCCeeEEEEeccCCCChh------------------------------------------------HHhhcCCCCCc
Q 037365 180 CCIDKDEKILIYEYMPNKSLD------------------------------------------------FFLFNLKASNI 211 (398)
Q Consensus 180 ~~~~~~~~~lV~e~~~~g~L~------------------------------------------------~~~~dlkp~NI 211 (398)
++.+++..++||||+++|+|. ++|+||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 999999999999999998762 45679999999
Q ss_pred eecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 037365 212 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTL 290 (398)
Q Consensus 212 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~ 290 (398)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~ 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--E 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 999999999999999987765443344445578899999999999999999999999999999999 9988753221 1
Q ss_pred chhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCC
Q 037365 291 NLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLP 360 (398)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 360 (398)
.+ ............ +......+.+++.+||+.||++|||++|+++.|+++......
T Consensus 301 ~~----~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 301 EL----FKLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HH----HHHHHTTCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HH----HHHHHcCCCCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11 111111111111 112234588999999999999999999999999998765543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=305.52 Aligned_cols=232 Identities=22% Similarity=0.287 Sum_probs=175.2
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCcccceeeEEEeC----Cee
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCIDK----DEK 187 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~ 187 (398)
..++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999998 5899999998653 33556677777777 7899999999997653 458
Q ss_pred EEEEeccCCCChh---------------------------------------HHhhcCCCCCceecCCCCeEEcccccce
Q 037365 188 ILIYEYMPNKSLD---------------------------------------FFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 188 ~lV~e~~~~g~L~---------------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
++||||+++|+|. ++||||||+|||++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 9999999999872 2568999999999999999999999998
Q ss_pred ecCCCCccc--ccccccccccccChhhhccC------CCCcccccHHHHHHHHHHHcC----------CCCCCCCCCCcc
Q 037365 229 ICGGNELQA--NTSRIVGTYGYMSPEYAIEG------IFSIKFDVFSFGVLLLEIVSG----------KKNTGFYRTDTL 290 (398)
Q Consensus 229 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg----------~~P~~~~~~~~~ 290 (398)
......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 765433221 12335799999999999876 566899999999999999999 777654433332
Q ss_pred chhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 291 NLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
...................... .....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 SFEDMRKVVCVDQQRPNIPNRW-----FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGG-----GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhhhHHHhccCCCCCCChhh-----ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2222211111111111111111 1234567789999999999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.92 Aligned_cols=217 Identities=22% Similarity=0.298 Sum_probs=174.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|+..+.||+|+||.||+|+... |+.||+|++... .......+.+|..++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3678999999999999999999865 899999999643 223456788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++|+| +++||||||+|||++.++.+||+|||+++...... ..
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--Cc
Confidence 999999988 46678999999999999999999999998643222 22
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ...... .. ..
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~---~~i~~~-~~-~~---------- 224 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLF---ELILME-EI-RF---------- 224 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHC-CC-CC----------
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHH---HHHHcC-CC-CC----------
Confidence 3456899999999999999999999999999999999999999753211 1111 111111 00 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRP-----TTNDVVSM 350 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 350 (398)
+...+..+.+++.+||+.||++|| +++|+++.
T Consensus 225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112234578999999999999999 89999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=309.00 Aligned_cols=233 Identities=24% Similarity=0.372 Sum_probs=176.5
Q ss_pred cCCCCccceecccCceEEEEEEEc-----CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--Cee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-----KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 187 (398)
.++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 467899999999999999999852 4789999999887777778899999999999999999999998653 568
Q ss_pred EEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 188 ILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 188 ~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
++||||+++|+| +++|+||||+|||++.++.+||+|||+++......
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 999999999988 35678999999999999999999999998765432
Q ss_pred cc-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc----------cchhHHHHHhhhcC
Q 037365 235 LQ-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT----------LNLLGYAWDLWRSN 303 (398)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~----------~~~~~~~~~~~~~~ 303 (398)
.. .......+|..|+|||.+.+..++.++||||||+++|||++|..|+....... ..............
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 21 12233457788999999999999999999999999999999998865321110 00000001111111
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
... ..+..++..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 249 ~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 249 GRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcC----------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000 00223345688999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=302.36 Aligned_cols=225 Identities=27% Similarity=0.387 Sum_probs=180.2
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
..++|++.+.||+|+||.||+|.+.++..||+|++.... ...+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 456889999999999999999999888899999997654 2346789999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++++| +++|+||||+||+++.++.+||+|||+++........ ...
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 163 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSV 163 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECC
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-ccc
Confidence 999987 3456799999999999999999999999876544322 223
Q ss_pred cccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ......... ..... +
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~----------~ 227 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKVSQG-HRLYR----------P 227 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHTT-CCCCC----------C
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHHHHcC-CCCCC----------C
Confidence 3456788999999999999999999999999999999 99997533221 111111111 10000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
...+..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1123457899999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=304.98 Aligned_cols=224 Identities=26% Similarity=0.399 Sum_probs=179.2
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.++|+..+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46788899999999999999999888999999997653 23467899999999999999999999999999999999999
Q ss_pred CCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 195 PNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 195 ~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
++|+| +++|+||||+||+++.++.+||+|||+++....... .....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 166 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTG 166 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTS
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc-ccccC
Confidence 99987 356779999999999999999999999986643321 22334
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (398)
..+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .. ........ .+.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~---~~-~~~~~~~~----------~~~ 230 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVV---ED-ISTGFRLY----------KPR 230 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HH-HHTTCCCC----------CCT
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHH---HH-HhcCccCC----------CCC
Confidence 467888999999999999999999999999999999 88887532211 111 11 11110000 011
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 321 QVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 321 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
..+..+.+++.+||+.||++|||++++++.|+++.+
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 123457899999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=303.99 Aligned_cols=231 Identities=23% Similarity=0.342 Sum_probs=176.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|++.+.||+|+||.||+|++.. ++.||+|.+... .....+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 35789999999999999999999764 889999998543 34455778999999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+++|+| +++|+||||+|||++.++.+||+|||+++....... .
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 167 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-T 167 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-c
Confidence 9999999988 356789999999999999999999999976543321 2
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........... ... ....
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~-~~~-~~~~---- 236 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHIQDSV-PNV-TTDV---- 236 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHHSSCC-CCH-HHHS----
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhhccC-CCc-chhc----
Confidence 233457999999999999999999999999999999999999997532211 11111111111 110 0000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHhhcccc
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRP-TTNDVVSMLTNEAAA 357 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~ 357 (398)
....+..+.+++.+||+.||++|| +++++.+.|+.....
T Consensus 237 -~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 237 -RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 112345688999999999999998 999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=310.72 Aligned_cols=219 Identities=18% Similarity=0.288 Sum_probs=174.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|++.+.||+|+||.||+|.+.. ++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 35789999999999999999999875 7889999987553 345678899999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecC--CCCeEEcccccceecCCCCccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDK--DMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|+++|+| +++||||||+|||++. ++.+||+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~-- 159 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc--
Confidence 9999987 3567899999999987 78999999999988754332
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... ... ......... . .....
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~---~~~i~~~~~-~-~~~~~----- 226 (321)
T 1tki_A 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQI---IENIMNAEY-T-FDEEA----- 226 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHH---HHHHHHTCC-C-CCHHH-----
T ss_pred -cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HHH---HHHHHcCCC-C-CChhh-----
Confidence 2345789999999999998899999999999999999999999753221 111 111111110 0 00000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 -~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 -FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122456889999999999999999999997
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=313.20 Aligned_cols=220 Identities=22% Similarity=0.282 Sum_probs=174.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh------hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
..++|++.+.||+|+||.||+|+... |+.||+|.+..... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 35689999999999999999999875 89999999965432 135778999999999999999999999999999
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCC----CeEEcccccceec
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDM----NPKISDFGMARIC 230 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~----~~kl~DFGla~~~ 230 (398)
.++||||+++|+| +++|+||||+|||++.++ .+||+|||+++..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999988 356789999999998777 7999999999887
Q ss_pred CCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .... ..... ... .. +
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~~~---~~i~~-~~~-~~-~ 238 (361)
T 2yab_A 170 EDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETL---ANITA-VSY-DF-D 238 (361)
T ss_dssp CTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHH---HHHHT-TCC-CC-C
T ss_pred CCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHh-cCC-CC-C
Confidence 5432 23345799999999999999999999999999999999999999753211 1111 11111 100 00 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
... ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 239 EEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chh-----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 1122356789999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.29 Aligned_cols=231 Identities=29% Similarity=0.433 Sum_probs=184.1
Q ss_pred hhhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 108 FSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 108 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
...++...++|+..+.||+|+||.||+|.++++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 345566778899999999999999999999888899999997654 34678999999999999999999999986 6678
Q ss_pred EEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 188 ILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 188 ~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
++||||+++|+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999988 3567899999999999999999999999876533
Q ss_pred CcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.. .......+|..|+|||++....++.++|||||||++|||++ |+.||..... ......+ ..... ..
T Consensus 338 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i---~~~~~-~~----- 405 (454)
T 1qcf_A 338 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRAL---ERGYR-MP----- 405 (454)
T ss_dssp HH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH---HHTCC-CC-----
T ss_pred ce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---HcCCC-CC-----
Confidence 21 12233456789999999999999999999999999999999 9999753221 1111111 11110 00
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
.+..++..+.+++.+||+.||++|||+++|++.|+.....
T Consensus 406 -----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 406 -----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0122345688999999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.35 Aligned_cols=233 Identities=26% Similarity=0.384 Sum_probs=183.2
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEE
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCC 181 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 181 (398)
..+....++|++.+.||+|+||.||+|++.. ++.||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455667899999999999999999999853 478999999765 344467789999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChh--------------------------------------------------------HHhhc
Q 037365 182 IDKDEKILIYEYMPNKSLD--------------------------------------------------------FFLFN 205 (398)
Q Consensus 182 ~~~~~~~lV~e~~~~g~L~--------------------------------------------------------~~~~d 205 (398)
.+++..++||||+++|+|. ++|+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999998763 35679
Q ss_pred CCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCC
Q 037365 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGF 284 (398)
Q Consensus 206 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~ 284 (398)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987654333233344578999999999999999999999999999999999 9988753
Q ss_pred CCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 285 YRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
... ... . ........... +...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 280 ~~~--~~~---~-~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAH--EEV---I-YYVRDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCH--HHH---H-HHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCh--HHH---H-HHHhCCCcCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 221 111 1 11111111111 112234688999999999999999999999999997643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.69 Aligned_cols=216 Identities=23% Similarity=0.357 Sum_probs=168.6
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 189 (398)
.++|+..+.||+|+||.||+|++.. ++.||+|++... .....+.+.+|..++..+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4789999999999999999999875 899999999653 223456678899999998 69999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++...... .
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~ 179 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--V 179 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC--c
Confidence 9999999988 46778999999999999999999999998643222 2
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ........ .. +
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~---~~~i~~~~-~~----------~ 243 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DDL---FEAILNDE-VV----------Y 243 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHCC-CC----------C
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HHH---HHHHHcCC-CC----------C
Confidence 23456899999999999999999999999999999999999999753221 111 11111110 00 0
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCH------HHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTT------NDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~ 349 (398)
+......+.+++.+||+.||.+||++ +|+++
T Consensus 244 -p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 -PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11123457899999999999999998 77775
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=320.03 Aligned_cols=228 Identities=29% Similarity=0.391 Sum_probs=178.2
Q ss_pred hcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
..++|++.+.||+|+||.||+|++. .++.||||++... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3467899999999999999999954 2568999999654 34455678899999999999999999999999999
Q ss_pred eEEEEeccCCCCh---------------------------------------hHHhhcCCCCCceecCCC---CeEEccc
Q 037365 187 KILIYEYMPNKSL---------------------------------------DFFLFNLKASNILLDKDM---NPKISDF 224 (398)
Q Consensus 187 ~~lV~e~~~~g~L---------------------------------------~~~~~dlkp~NILl~~~~---~~kl~DF 224 (398)
.++||||+++|+| +++||||||+|||++.++ .+||+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 9999999999887 356789999999998555 5999999
Q ss_pred ccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 225 GMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 225 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
|+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||..... ...... ....
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~----i~~~ 302 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEF----VTSG 302 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHH----HHTT
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcC
Confidence 99986543322233344578999999999999999999999999999999998 8888753221 111111 1111
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
..... ....+..+.+++.+||+.||++|||+.++++.|+.....
T Consensus 303 ~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRMDP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCC----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11110 112234578999999999999999999999999886553
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=307.95 Aligned_cols=231 Identities=29% Similarity=0.403 Sum_probs=183.7
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 182 (398)
+++...++|.+.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 34445678999999999999999999863 2578999999754 3455678899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChh--------------------------------------------------------HHhhcC
Q 037365 183 DKDEKILIYEYMPNKSLD--------------------------------------------------------FFLFNL 206 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L~--------------------------------------------------------~~~~dl 206 (398)
+.+..++||||+++|+|. ++|+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 999999999999988762 356799
Q ss_pred CCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCC
Q 037365 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFY 285 (398)
Q Consensus 207 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~ 285 (398)
||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987765443333444567889999999999999999999999999999999 99997543
Q ss_pred CCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 286 RTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
... .+.. .......... ....+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 257 ~~~--~~~~----~~~~~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 257 PPE--RLFN----LLKTGHRMER----------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CGG--GHHH----HHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH--HHHH----HhhcCCcCCC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221 1111 1111111111 11233568899999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=324.23 Aligned_cols=235 Identities=26% Similarity=0.406 Sum_probs=179.8
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
..++...++|+..+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34555667899999999999999999999888889999997654 335678999999999999999999999876 7789
Q ss_pred EEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 189 LIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 189 lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
+||||+++|+| +++||||||+|||++.++.+||+|||+++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999988 35678999999999999999999999998765432
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. .......+|..|+|||++.++.++.++|||||||++|||++ |+.||..... ...... ...+.....
T Consensus 335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~----i~~~~~~~~----- 402 (452)
T 1fmk_A 335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----VERGYRMPC----- 402 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTCCCCC-----
T ss_pred e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCCCCC-----
Confidence 2 12233457889999999999999999999999999999999 8988753221 111111 111111000
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCC
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPK 362 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 362 (398)
+..++..+.+++.+||+.||++|||++++++.|+.......+..
T Consensus 403 -----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 403 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 12234568899999999999999999999999999876554443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=311.94 Aligned_cols=224 Identities=28% Similarity=0.444 Sum_probs=170.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CC----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GN----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|+..+.||+|+||.||+|++.. ++ .||+|.+... .....+.+.+|+.++++++||||++++++|.+++ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 578889999999999999999754 43 3688888544 3345678999999999999999999999998754 789
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
|+||+++|+| +++||||||+|||++.++.+||+|||+++........
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence 9999999987 3567899999999999999999999999877654433
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+... .........
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~----~~~~~~~~~------- 240 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI----LEKGERLPQ------- 240 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTCCCCC-------
T ss_pred ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHH----HHcCCCCCC-------
Confidence 33444567889999999999999999999999999999999 99997543221 11111 111110000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.......+.+++.+||+.||++|||+.|+++.|+....
T Consensus 241 ---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 241 ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11223457899999999999999999999999987654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=314.96 Aligned_cols=236 Identities=23% Similarity=0.329 Sum_probs=179.2
Q ss_pred CCCCccceecccCceEEEEEEE-----cCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--CCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVL-----RKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 188 (398)
++|++.+.||+|+||.||+|++ ..++.||+|++........+.+.+|++++++++||||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999985 2478899999988777777889999999999999999999999874 56789
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+||||+++|+| +++|+||||+|||++.++.+||+|||+++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence 99999999988 346679999999999999999999999987754332
Q ss_pred c-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc----cccch
Q 037365 236 Q-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT----LELTD 310 (398)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 310 (398)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......... ....+
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-------LRMMGCERDVPALSRLLE 255 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-------HHHCC----CCHHHHHHH
T ss_pred cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-------hhhcccccccccHHHHHH
Confidence 1 12334568889999999999999999999999999999999999864321110 000000000 00000
Q ss_pred hhhhcc--cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 311 AILEDE--YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 311 ~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
....+. ......+..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 000000 002233456889999999999999999999999999876544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=314.00 Aligned_cols=245 Identities=27% Similarity=0.353 Sum_probs=179.7
Q ss_pred cCCC-CccceecccCceEEEEEEEc-----CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--C
Q 037365 115 TNRF-SDANKLGEGGFGPVYKGVLR-----KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--D 185 (398)
Q Consensus 115 ~~~~-~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~ 185 (398)
.++| ++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. .
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3455 88999999999999998753 47889999997653 34567789999999999999999999999984 5
Q ss_pred eeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 186 EKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 186 ~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
..++||||+++|+| +++|+||||+|||++.++.+||+|||+++......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred eEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 78999999999988 35667999999999999999999999998876443
Q ss_pred cc-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 235 LQ-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.. .......||..|+|||++.+..++.++||||||+++|||++|+.||............+..................
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 21 22334568889999999999999999999999999999999999965321110000000000000000000000000
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCC
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLP 360 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 360 (398)
.. ......+..+.+++.+||+.||++|||++|+++.|+++......
T Consensus 269 ~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 269 RL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred CC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 00 00222345688999999999999999999999999987665543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.86 Aligned_cols=236 Identities=26% Similarity=0.357 Sum_probs=184.2
Q ss_pred cchhhhhhhcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccce
Q 037365 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRL 177 (398)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l 177 (398)
+....++...++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445566677889999999999999999999853 2578999999765 334456789999999999 79999999
Q ss_pred eeEEEeCCe-eEEEEeccCCCChh--------------------------------------------------------
Q 037365 178 LGCCIDKDE-KILIYEYMPNKSLD-------------------------------------------------------- 200 (398)
Q Consensus 178 ~~~~~~~~~-~~lV~e~~~~g~L~-------------------------------------------------------- 200 (398)
++++.+.+. .++||||+++|+|.
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 89999999987652
Q ss_pred ------------------------------------------HHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 201 ------------------------------------------FFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 201 ------------------------------------------~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
++|+||||+|||++.++.+||+|||+++..........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 45789999999999999999999999987654433333
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ..............
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~~~~~~~~--------- 317 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTRMRA--------- 317 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----HHHHHHHHTCCCCC---------
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-----HHHHHHHcCCCCCC---------
Confidence 445678999999999999999999999999999999998 999975432221 11111111111111
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+......+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 318 -~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 318 -PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11123457899999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=322.19 Aligned_cols=222 Identities=22% Similarity=0.301 Sum_probs=173.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
..++|++.+.||+|+||.||+|.... |+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45689999999999999999999764 8899999997553 33456788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceec---CCCCeEEcccccceecCCCCc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLD---KDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~---~~~~~kl~DFGla~~~~~~~~ 235 (398)
|||+++|+| +++||||||+|||++ .++.+||+|||+++.......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 999999988 467789999999998 567899999999987654321
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..... . ...+... ...+.
T Consensus 169 --~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~---~-i~~~~~~-~~~~~--- 236 (444)
T 3soa_A 169 --AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQ---Q-IKAGAYD-FPSPE--- 236 (444)
T ss_dssp --BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH---H-HHHTCCC-CCTTT---
T ss_pred --eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHH---H-HHhCCCC-CCccc---
Confidence 22346899999999999999999999999999999999999999753211 11111 1 1111100 00000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ---~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 237 ---WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11223558899999999999999999999973
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.12 Aligned_cols=242 Identities=16% Similarity=0.157 Sum_probs=182.6
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|++.+.||+|+||.||+|+.. +++.||||.+..... .+.+.+|+.+++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 468999999999999999999975 488999999865432 24578999999999 99999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCC-----eEEcccccceecCCCC
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMN-----PKISDFGMARICGGNE 234 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~-----~kl~DFGla~~~~~~~ 234 (398)
|+ +++| +++||||||+|||++.++. +||+|||+++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 8877 3567899999999998887 9999999998765433
Q ss_pred ccc-----ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 235 LQA-----NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 235 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... ... ..
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~~-~~~-~~ 240 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQKIGDT-KRA-TP 240 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHHHHHH-HHH-SC
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHHHHhh-hcc-CC
Confidence 211 1245689999999999999999999999999999999999999986543221 11111110000 000 00
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCCCCccccc
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYV 369 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~~~~ 369 (398)
..... ...+ .+.+++..||+.||.+||+++++.+.|++............+.|.
T Consensus 241 ~~~~~-----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 241 IEVLC-----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHT-----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHHHh-----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 00000 0112 688999999999999999999999999887665543333344443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=303.36 Aligned_cols=229 Identities=29% Similarity=0.395 Sum_probs=178.7
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.+....++|+..+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 33445678999999999999999999998888999999976532 34678999999999999999999999999999999
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++|+| +++|+||||+|||++.++.+||+|||+++.......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 9999999987 356789999999999999999999999986643321
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ........ ...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~---~~~~~~~~-~~~------- 242 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETA---EHIAQGLR-LYR------- 242 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH---HHHHTTCC-CCC-------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHH---HHHhcccC-CCC-------
Confidence 12233457888999999999999999999999999999998 99997543211 111 11111100 000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+......+.+++.+||+.||++|||++++++.|+++..
T Consensus 243 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 243 ---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11123457899999999999999999999999988653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=310.88 Aligned_cols=235 Identities=27% Similarity=0.404 Sum_probs=185.4
Q ss_pred cchhhhhhhcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCccccee
Q 037365 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLL 178 (398)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~ 178 (398)
+...+++...++|++.+.||+|+||.||+|.+. .++.||+|.+... .......+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 445566777889999999999999999999865 2678999999754 334456788999999999999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCh------------------------------------------hHHhhcCCCCCceecCC
Q 037365 179 GCCIDKDEKILIYEYMPNKSL------------------------------------------DFFLFNLKASNILLDKD 216 (398)
Q Consensus 179 ~~~~~~~~~~lV~e~~~~g~L------------------------------------------~~~~~dlkp~NILl~~~ 216 (398)
+++.+++..++||||+++|+| +++|+||||+|||++.+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 999999999999999999877 24567999999999999
Q ss_pred CCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHH
Q 037365 217 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGY 295 (398)
Q Consensus 217 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 295 (398)
+.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~-- 250 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVL-- 250 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHH--
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HHHH--
Confidence 9999999999986654333233334567889999999999999999999999999999999 7888653211 1111
Q ss_pred HHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 296 AWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
........... ....+..+.+++.+||+.||++|||+.|+++.|++...
T Consensus 251 --~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 --RFVMEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111111 11223457899999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=307.40 Aligned_cols=218 Identities=23% Similarity=0.335 Sum_probs=168.2
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC------
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 185 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 185 (398)
..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467899999999999999999987 58999999997543 345578899999999999999999999986643
Q ss_pred ---------------------------------------------------eeEEEEeccCCCCh---------------
Q 037365 186 ---------------------------------------------------EKILIYEYMPNKSL--------------- 199 (398)
Q Consensus 186 ---------------------------------------------------~~~lV~e~~~~g~L--------------- 199 (398)
..++||||+++|+|
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999987
Q ss_pred --------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc----------ccccccccccccc
Q 037365 200 --------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ----------ANTSRIVGTYGYM 249 (398)
Q Consensus 200 --------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~ 249 (398)
+++||||||+|||++.++.+||+|||+++........ .......||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 3567899999999999999999999999887654211 1223457999999
Q ss_pred ChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHH
Q 037365 250 SPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNI 329 (398)
Q Consensus 250 aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 329 (398)
|||++.+..++.++|||||||++|||++|..|+. ..... .......... .........+.++
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~~~-~~~~~~~~~~----------~~~~~~~~~~~~l 305 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-------ERVRI-ITDVRNLKFP----------LLFTQKYPQEHMM 305 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHHHH-HHHHHTTCCC----------HHHHHHCHHHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-------HHHHH-HHHhhccCCC----------cccccCChhHHHH
Confidence 9999999999999999999999999999876621 00000 0001111000 0022334567899
Q ss_pred HHHchhcCCCCCCCHHHHHH
Q 037365 330 ALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 330 i~~cl~~dP~~RPt~~evl~ 349 (398)
+.+||+.||++|||++|+++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCcCCCHHHHhh
Confidence 99999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=306.25 Aligned_cols=233 Identities=21% Similarity=0.321 Sum_probs=173.2
Q ss_pred hhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
...++|++.+.||+|+||.||+|++.+++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3457899999999999999999999889999999996542 23346788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||++++.+ +++||||||+|||++.++.+||+|||+++...... ..
T Consensus 98 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~ 175 (311)
T 3niz_A 98 FEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RS 175 (311)
T ss_dssp EECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C-
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--cc
Confidence 999986321 46678999999999999999999999998765332 12
Q ss_pred cccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch---h---
Q 037365 239 TSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD---A--- 311 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--- 311 (398)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ................... .
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHHCCCChHHhhhhhccchh
Confidence 334578999999999976 568999999999999999999999986433321 1222222111111100000 0
Q ss_pred ------hhhccc---ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ------ILEDEY---SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ------~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...... ..+.....+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 01112346789999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=312.97 Aligned_cols=222 Identities=23% Similarity=0.334 Sum_probs=175.0
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
...++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 345789999999999999999999865 899999999654 34455778899999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCC---CCeEEcccccceecCCCC
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKD---MNPKISDFGMARICGGNE 234 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 234 (398)
||||+++|+| +++||||||+|||++.+ +.+||+|||+++......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 9999999987 35678999999999765 459999999998765432
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+... ....... .....
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~----i~~~~~~-~~~~~-- 253 (362)
T 2bdw_A 186 ---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQ----IKAGAYD-YPSPE-- 253 (362)
T ss_dssp ---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHTCCC-CCTTG--
T ss_pred ---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH----HHhCCCC-CCccc--
Confidence 22346799999999999999999999999999999999999999753211 111111 1111100 00000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 254 ----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 ----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223457899999999999999999998853
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=316.66 Aligned_cols=226 Identities=27% Similarity=0.411 Sum_probs=167.0
Q ss_pred cCCCCccceecccCceEEEEEEEc----CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.++|++.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999875 4678999999765 34456789999999999999999999999999999999
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 9999999988 3567899999999999999999999999876543211
Q ss_pred c-ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 237 A-NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
. ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ...... ........
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~----i~~~~~~~------- 270 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKA----VDEGYRLP------- 270 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHH----HHTTEECC-------
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCCCC-------
Confidence 1 1222345778999999999999999999999999999998 9999753221 111111 11110000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.....+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 271 ---~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 271 ---PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ---CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 011233568899999999999999999999999988754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=310.54 Aligned_cols=219 Identities=21% Similarity=0.318 Sum_probs=172.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
.++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999865 899999998532 1224577899999999999999999999999999999
Q ss_pred EEEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCC---eEEccccccee
Q 037365 189 LIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMN---PKISDFGMARI 229 (398)
Q Consensus 189 lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~---~kl~DFGla~~ 229 (398)
+||||+++|+| +++||||||+|||++.++. +||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999987 3567899999999986654 99999999988
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+. ..... .... .
T Consensus 183 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~---~~i~~-~~~~-~- 251 (351)
T 3c0i_A 183 LGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLF---EGIIK-GKYK-M- 251 (351)
T ss_dssp CCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHH---HHHHH-TCCC-C-
T ss_pred ecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHH---HHHHc-CCCC-C-
Confidence 764332 2334579999999999999999999999999999999999999975321 1111 11111 1100 0
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 0122356889999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=301.47 Aligned_cols=231 Identities=19% Similarity=0.262 Sum_probs=173.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|+..+.||+|+||.||+|++.. ++.||+|++... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 578999999999999999999865 889999999654 23345678899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|++++.+ +++|+||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--cccc
Confidence 9986533 46678999999999999999999999998765332 2233
Q ss_pred cccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch--h------
Q 037365 241 RIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD--A------ 311 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~------ 311 (398)
...||+.|+|||++.+.. ++.++|||||||++|||++|..|+....... .................... .
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 457899999999998766 7999999999999999999988864332221 11122211111110000000 0
Q ss_pred ------hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ------ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
........+.....+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000001223456789999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=299.18 Aligned_cols=242 Identities=15% Similarity=0.214 Sum_probs=185.9
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
..++|++.+.||+|+||.||+|... +++.||+|++..... .+.+.+|+.++.++ +|+|++++++++.++...++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 3468999999999999999999974 488999999865432 24578899999999 7999999999999999999999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCceecCCCC-----eEEcccccceecCCC
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILLDKDMN-----PKISDFGMARICGGN 233 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~-----~kl~DFGla~~~~~~ 233 (398)
||+ +++| +++|+||||+|||++.++. +||+|||+++.....
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999 8877 3567899999999987776 999999999877644
Q ss_pred Ccc-----cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCcc-chhHHHHHhhhcCCccc
Q 037365 234 ELQ-----ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTL-NLLGYAWDLWRSNRTLE 307 (398)
Q Consensus 234 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~ 307 (398)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..............
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 241 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP--- 241 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC---
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc---
Confidence 321 123456799999999999999999999999999999999999999865432211 11111100000000
Q ss_pred cchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCCCCcccc
Q 037365 308 LTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSY 368 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~~~ 368 (398)
.... ....+..+.+++.+||+.||++|||++++++.|+++...........+.|
T Consensus 242 --~~~~-----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 242 --LREL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp --HHHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred --HHHH-----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 0000 11224568899999999999999999999999999887666555445555
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=301.75 Aligned_cols=237 Identities=20% Similarity=0.269 Sum_probs=181.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC--eeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV 190 (398)
.++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999999876 8999999997543 234567889999999999999999999998765 78999
Q ss_pred EeccCCCCh-----------------------------------hHHhhcCCCCCcee----cCCCCeEEcccccceecC
Q 037365 191 YEYMPNKSL-----------------------------------DFFLFNLKASNILL----DKDMNPKISDFGMARICG 231 (398)
Q Consensus 191 ~e~~~~g~L-----------------------------------~~~~~dlkp~NILl----~~~~~~kl~DFGla~~~~ 231 (398)
|||+++|+| +++|+||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999987 34578999999999 788889999999998775
Q ss_pred CCCcccccccccccccccChhhhc--------cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAI--------EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ ............
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-NKEVMYKIITGK 243 (319)
T ss_dssp TTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG-CHHHHHHHHHHC
T ss_pred CCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch-hHHHHHHHhcCC
Confidence 4432 23457999999999987 56789999999999999999999999864333221 111122222111
Q ss_pred C---ccccc----------hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 304 R---TLELT----------DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 304 ~---~~~~~----------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
. ..... ................+.+++.+||+.||++|||++|+++...+..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1 00000 0000000113566678899999999999999999999999988764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=303.92 Aligned_cols=218 Identities=22% Similarity=0.323 Sum_probs=166.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--------------------------hhHHHHHHHHHHHH
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--------------------------QGLREMKNEASVIA 167 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 167 (398)
.++|++.+.||+|+||.||+|+... ++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4789999999999999999999865 88899999865421 12356889999999
Q ss_pred hcCCCcccceeeEEEe--CCeeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceec
Q 037365 168 KVQHKNLVRLLGCCID--KDEKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLD 214 (398)
Q Consensus 168 ~l~H~nIv~l~~~~~~--~~~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~ 214 (398)
+++||||+++++++.+ .+..++||||+++|+| +++|+||||+|||++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 9999999999999987 5689999999999876 467789999999999
Q ss_pred CCCCeEEcccccceecCCCCcccccccccccccccChhhhccCC---CCcccccHHHHHHHHHHHcCCCCCCCCCCCccc
Q 037365 215 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI---FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLN 291 (398)
Q Consensus 215 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~ 291 (398)
.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---- 245 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---- 245 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred CCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH----
Confidence 999999999999987654322 223457999999999998765 47889999999999999999999753211
Q ss_pred hhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 292 LLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...... ....... ... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 246 -~~~~~~-~~~~~~~-~~~--------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 -MCLHSK-IKSQALE-FPD--------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -HHHHHH-HHHCCCC-CCS--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -HHHHHH-HhcccCC-CCC--------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111111 1111000 000 1122345789999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=306.41 Aligned_cols=219 Identities=23% Similarity=0.301 Sum_probs=173.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh------hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
.++|+..+.||+|+||.||+|.... ++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4578899999999999999999865 89999999865422 1357789999999999999999999999999999
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCC----CeEEcccccceecC
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDM----NPKISDFGMARICG 231 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~----~~kl~DFGla~~~~ 231 (398)
++||||+++|+| +++|+||||+|||++.++ .+||+|||+++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 999999999988 356789999999998887 79999999998775
Q ss_pred CCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... .. .....
T Consensus 170 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~---~~~~~~-~~-~~~~~ 239 (326)
T 2y0a_A 170 FGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL---ANVSAV-NY-EFEDE 239 (326)
T ss_dssp TTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH---HHHHHT-CC-CCCHH
T ss_pred CCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHH---HHHHhc-CC-CcCcc
Confidence 432 223457999999999999999999999999999999999999997532111 111 111110 00 00000
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 240 Y------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp H------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 1112345789999999999999999999997
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=314.77 Aligned_cols=222 Identities=20% Similarity=0.356 Sum_probs=171.0
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 189 (398)
.++|++.+.||+|+||.||+|++.. ++.||+|+++.. .....+.+.+|..++.++ +||||+++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4679999999999999999999876 788999999654 222334578899999887 89999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++...... .
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~ 208 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 208 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--C
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC--C
Confidence 9999999988 46678999999999999999999999998633222 2
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc---cchhHHHHHhhhcCCccccchhhhh
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT---LNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................ ..
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~------ 281 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI------ 281 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-CC------
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-CC------
Confidence 2445689999999999999999999999999999999999999985432211 1111111111111110 00
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCH------HHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTT------NDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~ 349 (398)
+......+.+++.+||+.||.+||++ +|+++
T Consensus 282 ----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 282 ----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 12234557899999999999999995 56664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=311.28 Aligned_cols=213 Identities=21% Similarity=0.313 Sum_probs=169.9
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|.+.+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4789999999999999999999854 8999999986431 12235788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+ +|+| +++||||||+|||+++++.+||+|||++....... .
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~ 163 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---F 163 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---T
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc---c
Confidence 9999 5655 45678999999999999999999999998765432 2
Q ss_pred cccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... +........+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------------~~~~i~~~~~ 225 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------------LFKKVNSCVY 225 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------------CBCCCCSSCC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------------HHHHHHcCCC
Confidence 234579999999999988876 789999999999999999999975432211 0000000000
Q ss_pred -ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 -SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 -~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+...+..+.+++.+||+.||.+|||++|+++
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01122345789999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=301.09 Aligned_cols=225 Identities=24% Similarity=0.413 Sum_probs=171.5
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.++|++.+.||+|+||.||+|++. ++.||+|++... ...+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357888899999999999999985 788999999654 34577899999999999999999999886 4589999999
Q ss_pred CCCCh--------------------------------------hHHhhcCCCCCceecCCCC-eEEcccccceecCCCCc
Q 037365 195 PNKSL--------------------------------------DFFLFNLKASNILLDKDMN-PKISDFGMARICGGNEL 235 (398)
Q Consensus 195 ~~g~L--------------------------------------~~~~~dlkp~NILl~~~~~-~kl~DFGla~~~~~~~~ 235 (398)
++|+| +++|+||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99877 2567899999999998887 799999999765422
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+..... .....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~-~~~~~------- 225 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAVHNG-TRPPL------- 225 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH---HHHHHHTT-CCCCC-------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH---HHHHHhcC-CCCCc-------
Confidence 22346899999999999999999999999999999999999998643332211 11111111 11111
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCCC
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQ 363 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 363 (398)
....+..+.+++.+||+.||++|||++++++.|+.+....+....
T Consensus 226 ---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 226 ---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp ---BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred ---ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 112234578999999999999999999999999988766554433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=310.65 Aligned_cols=224 Identities=25% Similarity=0.388 Sum_probs=172.1
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCE----EEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNE----IAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|+..+.||+|+||.||+|.+.. ++. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 578899999999999999999754 443 7888875432 233356778999999999999999999886 567899
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++........
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 9999999987 4567899999999999999999999999887654433
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......||..|+|||++.+..++.++|||||||++|||++ |+.||...... ..... .........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~~~~~~------- 238 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDL----LEKGERLAQ------- 238 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHH----HHTTCBCCC-------
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHH----HHcCCCCCC-------
Confidence 33445678889999999999999999999999999999999 99997643222 11111 111111110
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+......+.+++.+||+.||.+|||+.++++.|+....
T Consensus 239 ---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 ---PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01112246789999999999999999999999988754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=326.04 Aligned_cols=229 Identities=28% Similarity=0.427 Sum_probs=183.6
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
.++...++|+..+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.++++++||||++++++|.+.+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 444556778889999999999999999876 8889999997653 34578999999999999999999999999999999
Q ss_pred EEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 189 LIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 189 lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
+||||+++|+| +++||||||+|||++.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999987 35678999999999999999999999998765433
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...... .........
T Consensus 373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~~~----- 440 (495)
T 1opk_A 373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYEL----LEKDYRMER----- 440 (495)
T ss_dssp E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHH----HHTTCCCCC-----
T ss_pred e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCCCCC-----
Confidence 2 22233456789999999999999999999999999999999 8888754321 111111 111111100
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+..++..+.+|+.+||+.||++|||+.++++.|+....
T Consensus 441 -----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 441 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 12234568899999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=307.40 Aligned_cols=229 Identities=21% Similarity=0.294 Sum_probs=166.9
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe---
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--- 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--- 186 (398)
..++|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999975 4889999999764 33445678899999999999999999999887553
Q ss_pred -eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 187 -KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 187 -~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
.|+||||+++|+| +++|+||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 4999999999988 3567899999999999999999999999876543
Q ss_pred Ccc-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 234 ELQ-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 234 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............. ...
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~---~~~ 241 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIP---PSA 241 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCC---HHH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCCCC---ccc
Confidence 221 223345789999999999999999999999999999999999999753221 11111111111110 000
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHH-HHHhhcc
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVV-SMLTNEA 355 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl-~~L~~~~ 355 (398)
. ....+..+.+++.+||+.||++||++.+++ +.+....
T Consensus 242 ~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 242 R-----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp H-----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c-----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0 111335688999999999999999766655 5565543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=298.92 Aligned_cols=220 Identities=27% Similarity=0.454 Sum_probs=164.6
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCC----hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|+..+.||+|+||.||+|.+. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468899999999999999999985 8899999986542 23356788999999999999999999999999999999
Q ss_pred EeccCCCCh-------------------------------h---HHhhcCCCCCceecC--------CCCeEEcccccce
Q 037365 191 YEYMPNKSL-------------------------------D---FFLFNLKASNILLDK--------DMNPKISDFGMAR 228 (398)
Q Consensus 191 ~e~~~~g~L-------------------------------~---~~~~dlkp~NILl~~--------~~~~kl~DFGla~ 228 (398)
|||+++++| + ++|+||||+|||++. ++.+||+|||+++
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 999999987 2 558999999999986 7789999999998
Q ss_pred ecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----AVAYGVAMNKLALPI 235 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHHHHHHTSCCCCCC
T ss_pred cccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHhhhcCCCCCCC
Confidence 654332 22357899999999999999999999999999999999999997532211 111111111111110
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 236 ----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 236 ----------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 112234588999999999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=306.50 Aligned_cols=213 Identities=25% Similarity=0.352 Sum_probs=172.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|++.+.||+|+||.||+|+... |+.||+|++.... ....+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 3678899999999999999999864 8999999986431 23456778899999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++|+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-----
Confidence 999999988 3567899999999999999999999999876432
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... . ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~-~-~~---------- 222 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILNAE-L-RF---------- 222 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHCC-C-CC----------
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC-C-CC----------
Confidence 2345899999999999999999999999999999999999999753211 11111111111 0 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
+......+.+++.+||+.||++|| +++|+++
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 112234578999999999999999 8999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=310.52 Aligned_cols=225 Identities=28% Similarity=0.436 Sum_probs=168.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CC----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GN----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
.++|++.+.||+|+||.||+|.+.. ++ .||+|.+... .....+.+.+|+.++++++||||+++++++..++ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3679999999999999999999754 44 3588877543 3345678899999999999999999999998754 88
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+++||+++|+| +++|+||||+|||++.++.+||+|||+++.......
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 99999999987 456789999999999999999999999987754443
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... ..... .........
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~----~~~~~~~~~------ 240 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI----LEKGERLPQ------ 240 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTCCCCC------
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCCCCC------
Confidence 333344567889999999999999999999999999999999 99997543222 11111 111111000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....+..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 241 ----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 241 ----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11223457899999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=303.49 Aligned_cols=231 Identities=25% Similarity=0.367 Sum_probs=182.4
Q ss_pred hhhcCCCCccceecccCceEEEEEEE------cCCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEEe
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVL------RKGNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID 183 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 183 (398)
+...++|+..+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34457899999999999999999985 236789999997653 34457789999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChh--------------------------------------------------HHhhcCCCCCcee
Q 037365 184 KDEKILIYEYMPNKSLD--------------------------------------------------FFLFNLKASNILL 213 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L~--------------------------------------------------~~~~dlkp~NILl 213 (398)
++..++||||+++|+|. ++|+||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 99999999999997662 3567999999999
Q ss_pred cCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccch
Q 037365 214 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNL 292 (398)
Q Consensus 214 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 292 (398)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-HH
Confidence 9999999999999987765443333344567889999999999999999999999999999999 998875433221 11
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
. .......... .....+..+.+++.+||+.||.+|||+.|+++.|++....
T Consensus 258 ~----~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 258 Y----KMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp H----HHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHhccCCCCC----------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 1111110000 0112234578999999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.37 Aligned_cols=222 Identities=28% Similarity=0.402 Sum_probs=176.8
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-eeEE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKIL 189 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~l 189 (398)
++...++|+..+.||+|+||.||+|.+. ++.||||.++... ..+.+.+|+.++++++||||+++++++.+.+ ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3445578889999999999999999985 7899999997653 4467899999999999999999999988765 7899
Q ss_pred EEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 190 IYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 190 V~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999987 3567899999999999999999999999864322
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..... ...+.....
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~----i~~~~~~~~------ 407 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR----VEKGYKMDA------ 407 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHH----HHTTCCCCC------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCCCCCC------
Confidence 122367889999999999999999999999999999998 99997543221 11111 111111110
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 408 ----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 408 ----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 12234568899999999999999999999999998653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=301.69 Aligned_cols=231 Identities=23% Similarity=0.411 Sum_probs=167.9
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
+...++|++.+.||+|+||.||+|++. ..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 344678999999999999999999874 46999998654 345567889999999999999999999965 5667899
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++++| +++|+||||+|||++.++.+||+|||+++........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999999887 3567899999999999999999999999865533322
Q ss_pred cccccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 237 ANTSRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.......||+.|+|||.+. +..++.++||||||+++|||++|+.||....... .. ................
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~----~~~~~~~~~~~~~~~~- 250 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QI----IEMVGRGSLSPDLSKV- 250 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HH----HHHHHHTSCCCCTTSS-
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HH----HHHhcccccCcchhhc-
Confidence 3334467999999999997 5678999999999999999999999985432211 11 1111111111100000
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
...++..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 251 -----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 251 -----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11234568899999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=300.44 Aligned_cols=227 Identities=22% Similarity=0.324 Sum_probs=166.8
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
+...++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++ .++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence 3445789999999999999999999753 456999998754 344556789999999999999999999998 4567
Q ss_pred eEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 187 KILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 187 ~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
.++||||+++|+| +++|+||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 8999999999877 3567899999999999999999999999876543
Q ss_pred CcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ........
T Consensus 170 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i----~~~~~~~~---- 238 (281)
T 1mp8_A 170 TYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI----ENGERLPM---- 238 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH----HTTCCCCC----
T ss_pred ccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHH----HcCCCCCC----
Confidence 221 2233457789999999999999999999999999999997 88887543221 111111 11111110
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 239 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 239 ------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 12234567899999999999999999999999988653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=307.08 Aligned_cols=179 Identities=30% Similarity=0.379 Sum_probs=153.8
Q ss_pred ccCCCCccchhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----CC
Q 037365 99 EVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----HK 172 (398)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~ 172 (398)
+.++...+++.+.....++|++.+.||+|+||.||+|++.. ++.||||++... ......+..|..+++.++ ||
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 33445667778888888999999999999999999999854 889999999753 344566788999999997 99
Q ss_pred cccceeeEEEeCCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecC---
Q 037365 173 NLVRLLGCCIDKDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDK--- 215 (398)
Q Consensus 173 nIv~l~~~~~~~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~--- 215 (398)
||+++++++...+..++||||+ +++| +++||||||+|||++.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999999 7776 3567899999999975
Q ss_pred ----------------------CCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHH
Q 037365 216 ----------------------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLL 273 (398)
Q Consensus 216 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ 273 (398)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999875432 23457899999999999999999999999999999
Q ss_pred HHHcCCCCCCC
Q 037365 274 EIVSGKKNTGF 284 (398)
Q Consensus 274 elltg~~P~~~ 284 (398)
||++|+.||..
T Consensus 251 ell~g~~pf~~ 261 (360)
T 3llt_A 251 ELYTGSLLFRT 261 (360)
T ss_dssp HHHHSSCSCCC
T ss_pred HHHHCCCCCCC
Confidence 99999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=299.71 Aligned_cols=241 Identities=22% Similarity=0.297 Sum_probs=176.0
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhc--CCCcccceeeEEEeC--
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV--QHKNLVRLLGCCIDK-- 184 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~-- 184 (398)
.......++|++.+.||+|+||.||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334455678999999999999999999986 8999999986432 23445566666554 899999999999987
Q ss_pred --CeeEEEEeccCCCCh---------------------------------------hHHhhcCCCCCceecCCCCeEEcc
Q 037365 185 --DEKILIYEYMPNKSL---------------------------------------DFFLFNLKASNILLDKDMNPKISD 223 (398)
Q Consensus 185 --~~~~lV~e~~~~g~L---------------------------------------~~~~~dlkp~NILl~~~~~~kl~D 223 (398)
...++||||+++|+| +++||||||+|||++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 789999999999987 246889999999999999999999
Q ss_pred cccceecCCCCccc--ccccccccccccChhhhccCCCCcc------cccHHHHHHHHHHHcC----------CCCCCCC
Q 037365 224 FGMARICGGNELQA--NTSRIVGTYGYMSPEYAIEGIFSIK------FDVFSFGVLLLEIVSG----------KKNTGFY 285 (398)
Q Consensus 224 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~elltg----------~~P~~~~ 285 (398)
||+++......... ......||+.|+|||++.+..++.+ +|||||||++|||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998765432211 1234579999999999987766554 9999999999999999 4454332
Q ss_pred CCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 286 RTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
.......... .......... +..........++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 266 ~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 266 VPSDPSYEDM-REIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SCSSCCHHHH-HHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCCCCchhhh-HHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 2222111111 1111111111 111111113356778999999999999999999999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.71 Aligned_cols=231 Identities=25% Similarity=0.380 Sum_probs=182.3
Q ss_pred hhhcCCCCccceecccCceEEEEEEEc--------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEE
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLR--------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCC 181 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 181 (398)
....++|++.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 334578999999999999999999874 3678999999765 344567789999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCChh------------------------------------------------HHhhcCCCCCcee
Q 037365 182 IDKDEKILIYEYMPNKSLD------------------------------------------------FFLFNLKASNILL 213 (398)
Q Consensus 182 ~~~~~~~lV~e~~~~g~L~------------------------------------------------~~~~dlkp~NILl 213 (398)
.+.+..++||||+++|+|. ++|+||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 9999999999999998762 3467999999999
Q ss_pred cCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccch
Q 037365 214 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNL 292 (398)
Q Consensus 214 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 292 (398)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EEL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--HHH
Confidence 9999999999999988765443333444567889999999999999999999999999999999 9988753221 111
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
.. .......... ....+..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 269 ~~----~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 269 FK----LLKEGHRMDK----------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HH----HHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH----HHhcCCCCCC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 1111111110 1122345789999999999999999999999999886543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.34 Aligned_cols=231 Identities=29% Similarity=0.428 Sum_probs=181.5
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
+++...++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+.+|++++++++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3445567899999999999999999999888899999997543 34577899999999999999999999986 456899
Q ss_pred EEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 190 IYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 190 V~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||||+++++| +++|+||||+||++++++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999988 356679999999999999999999999987754332
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... .........
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~----~~~~~~~~~------ 231 (279)
T 1qpc_A 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQN----LERGYRMVR------ 231 (279)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTCCCCC------
T ss_pred c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHHHHH----HhcccCCCC------
Confidence 2 2233467889999999998999999999999999999999 8888753221 111111 111100000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
....+..+.+++.+||+.||++|||++++++.|++......
T Consensus 232 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 11223468899999999999999999999999998766544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.80 Aligned_cols=216 Identities=22% Similarity=0.328 Sum_probs=163.0
Q ss_pred cCCCCccceecccCceEEEEEEE----cCCCEEEEEEccCCC----hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVL----RKGNEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
.++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999997 358999999997542 2334567889999999999999999999999999
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
.|+||||+++|+| +++||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 9999999999987 35678999999999999999999999997643222
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ......... . ..
T Consensus 176 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~---~~~~i~~~~-~-~~------ 240 (327)
T 3a62_A 176 --TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KK---TIDKILKCK-L-NL------ 240 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH---HHHHHHHTC-C-CC------
T ss_pred --ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--HH---HHHHHHhCC-C-CC------
Confidence 123345799999999999999999999999999999999999999753221 11 111111110 0 00
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
+......+.+++.+||+.||++|| ++.|+++
T Consensus 241 ----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 ----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 112234578999999999999999 7888876
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=312.21 Aligned_cols=221 Identities=23% Similarity=0.312 Sum_probs=176.4
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|++.+.||+|+||.||+|.... ++.||+|.+..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 34689999999999999999999865 88999999987766666788999999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecC--CCCeEEcccccceecCCCCccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDK--DMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|+++|+| +++||||||+|||++. ++.+||+|||+++.......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 206 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 206 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc--
Confidence 9999987 3567899999999974 57799999999988754322
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ........ ......
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~---~~i~~~~~--~~~~~~----- 273 (387)
T 1kob_A 207 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETL---QNVKRCDW--EFDEDA----- 273 (387)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHH---HHHHHCCC--CCCSST-----
T ss_pred -eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHH---HHHHhCCC--CCCccc-----
Confidence 2234799999999999999999999999999999999999999754221 1111 11111100 000000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 274 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 -FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11223467899999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=311.94 Aligned_cols=216 Identities=25% Similarity=0.353 Sum_probs=171.7
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 188 (398)
..++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 45789999999999999999999875 8889999996531 23456678899999887 8999999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
+||||+++|+| +++||||||+|||++.++.+||+|||+++......
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 172 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-- 172 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--
Confidence 99999999988 35678999999999999999999999998643222
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ..... ... ..
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~---~~i~~-~~~-~~-------- 237 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELF---HSIRM-DNP-FY-------- 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHH-CCC-CC--------
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHH---HHHHh-CCC-CC--------
Confidence 223456899999999999999999999999999999999999999753221 1111 11111 110 00
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTN-DVV 348 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~-evl 348 (398)
+...+..+.+++.+||+.||++||++. +++
T Consensus 238 --p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 --PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111234578999999999999999997 665
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=312.22 Aligned_cols=249 Identities=15% Similarity=0.166 Sum_probs=181.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCChhhHH-----------HHHHHHHHHHhcCCCcccc
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRSGQGLR-----------EMKNEASVIAKVQHKNLVR 176 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~H~nIv~ 176 (398)
..++|++.+.||+|+||.||+|.+.. ++.||+|++......... .+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999865 367999998765432111 2234556677778999999
Q ss_pred eeeEEEeC----CeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceec--CCC
Q 037365 177 LLGCCIDK----DEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLD--KDM 217 (398)
Q Consensus 177 l~~~~~~~----~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~--~~~ 217 (398)
+++++... ...++||||+ +++| +++||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99999875 4589999999 8877 356789999999999 889
Q ss_pred CeEEcccccceecCCCCccc-----ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccch
Q 037365 218 NPKISDFGMARICGGNELQA-----NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNL 292 (398)
Q Consensus 218 ~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~ 292 (398)
.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+. ..
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP-KY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH-HH
Confidence 99999999998765332111 1133469999999999999999999999999999999999999986422221 11
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCCCCccccc
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYV 369 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~~~~ 369 (398)
.......+. .....+.+..+. ....+..+.+++..||+.||.+|||++++++.|++.......+....+.|.
T Consensus 271 ~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 271 VRDSKIRYR-ENIASLMDKCFP----AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS 342 (364)
T ss_dssp HHHHHHHHH-HCHHHHHHHHSC----TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred HHHHHHHhh-hhHHHHHHHhcc----cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence 111111111 111222222211 112245688999999999999999999999999998877666555555554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=309.62 Aligned_cols=213 Identities=22% Similarity=0.330 Sum_probs=173.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|+..+.||+|+||.||+|++.. |+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4679999999999999999999864 8999999986432 23456788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++|+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-----
Confidence 999999988 3567899999999999999999999999876532
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ........ .. ..
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~---~~~~i~~~-~~-~~---------- 257 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQ---IYEKIVSG-KV-RF---------- 257 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHHC-CC-CC----------
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HH---HHHHHHcC-CC-CC----------
Confidence 2345899999999999999999999999999999999999999753211 11 11111111 10 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
+...+..+.+++.+||+.||.+||+ ++|+++
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1122345789999999999999998 888875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=309.01 Aligned_cols=233 Identities=27% Similarity=0.361 Sum_probs=180.0
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 182 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 182 (398)
++...++|+..+.||+|+||.||+|.+. .+..||+|.+... .....+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4455688999999999999999999962 2567999999754 233456789999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChh-------------------------------------------------------HHhhcCC
Q 037365 183 DKDEKILIYEYMPNKSLD-------------------------------------------------------FFLFNLK 207 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L~-------------------------------------------------------~~~~dlk 207 (398)
..+..++||||+++|+|. ++|+|||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 999999999999998762 3567999
Q ss_pred CCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCC
Q 037365 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYR 286 (398)
Q Consensus 208 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~ 286 (398)
|+|||++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433333444567889999999999999999999999999999998 999975433
Q ss_pred CCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 287 TDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
... .. ............ +...+..+.+++.+||+.||.+|||+.++++.|+......
T Consensus 280 ~~~-~~----~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDA-NF----YKLIQNGFKMDQ----------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSH-HH----HHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHH-HH----HHHHhcCCCCCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 221 11 111111111100 1112345889999999999999999999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=306.13 Aligned_cols=222 Identities=20% Similarity=0.357 Sum_probs=172.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 189 (398)
.++|+..+.||+|+||.||+|++.. ++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3578889999999999999999875 888999999654 334456788999999988 89999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++...... .
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~ 165 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 165 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--C
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC--C
Confidence 9999999988 35678999999999999999999999998643222 2
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc---cchhHHHHHhhhcCCccccchhhhh
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT---LNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................ .+
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~------ 238 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI------ 238 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CC------
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CC------
Confidence 2345689999999999999999999999999999999999999985422111 0111111111111110 00
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCH------HHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTT------NDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~ 349 (398)
+...+..+.+++.+||+.||.+||++ +|+++
T Consensus 239 ----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 239 ----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11233457899999999999999996 66664
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=300.02 Aligned_cols=230 Identities=27% Similarity=0.427 Sum_probs=183.6
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
..++...++|+..+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.++++++||||+++++++.+++..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 3445567889999999999999999999876 7889999997653 3457789999999999999999999999999999
Q ss_pred EEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 188 ILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 188 ~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
++||||+++++| +++|+||||+||+++.++.+||+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999877 3567899999999999999999999999876543
Q ss_pred CcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... .........
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~----~~~~~~~~~---- 233 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL----LEKDYRMER---- 233 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH----HHTTCCCCC----
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HhccCCCCC----
Confidence 32 22334567889999999999999999999999999999999 88887543221 11111 111100000
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+...+..+.+++.+||+.||.+|||++++++.|+....
T Consensus 234 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 234 ------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 11223568899999999999999999999999988654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=302.82 Aligned_cols=219 Identities=26% Similarity=0.364 Sum_probs=172.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-C-------CEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-G-------NEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
.++|+..+.||+|+||.||+|++.. + ..||+|.+........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678889999999999999998764 3 4699999977666667889999999999999999999999999999
Q ss_pred eEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCC--------eEEcccc
Q 037365 187 KILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMN--------PKISDFG 225 (398)
Q Consensus 187 ~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~--------~kl~DFG 225 (398)
.++||||+++|+| +++|+||||+|||++.++. +||+|||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 9999999999988 3567899999999998887 9999999
Q ss_pred cceecCCCCcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC
Q 037365 226 MARICGGNELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR 304 (398)
Q Consensus 226 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+....... .. ........
T Consensus 167 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~----~~~~~~~~ 235 (289)
T 4fvq_A 167 ISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RK----LQFYEDRH 235 (289)
T ss_dssp SCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HH----HHHHHTTC
T ss_pred ccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HH----HHHhhccC
Confidence 9865432 223467899999999987 678999999999999999999765543221111 00 01111100
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 305 TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.. +...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 236 --~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 --QL----------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp --CC----------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred --CC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 00012346789999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=305.81 Aligned_cols=231 Identities=22% Similarity=0.345 Sum_probs=174.7
Q ss_pred cCCCCccceecccCceEEEEEEE-----cCCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--Ce
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVL-----RKGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~ 186 (398)
..+|+..+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688899999999999999984 24889999999754 334457789999999999999999999999876 67
Q ss_pred eEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 187 KILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 187 ~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
.++||||+++|+| +++|+||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 8999999999988 3556799999999999999999999999887644
Q ss_pred Ccc-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCC---------ccchhHHHHHhhhcC
Q 037365 234 ELQ-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD---------TLNLLGYAWDLWRSN 303 (398)
Q Consensus 234 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~---------~~~~~~~~~~~~~~~ 303 (398)
... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...............
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 321 2233457888999999999999999999999999999999999884321100 000000000001100
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
.... .+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 260 ~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 260 KRLP----------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000 02223456889999999999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=302.41 Aligned_cols=234 Identities=26% Similarity=0.405 Sum_probs=170.4
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcC----CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEE
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 182 (398)
.+.....++|.+.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444556789999999999999999998653 447999999754 3445677899999999999999999999998
Q ss_pred eCC-----eeEEEEeccCCCCh--------------------------------------hHHhhcCCCCCceecCCCCe
Q 037365 183 DKD-----EKILIYEYMPNKSL--------------------------------------DFFLFNLKASNILLDKDMNP 219 (398)
Q Consensus 183 ~~~-----~~~lV~e~~~~g~L--------------------------------------~~~~~dlkp~NILl~~~~~~ 219 (398)
+.+ ..++||||+++|+| +++|+||||+|||++.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 765 35999999999887 34567999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHH
Q 037365 220 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWD 298 (398)
Q Consensus 220 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 298 (398)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ......
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~-- 262 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYL-- 262 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH--
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHH--
Confidence 9999999987654433333344567889999999999999999999999999999999 88886533221 111111
Q ss_pred hhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 299 LWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
.. ...... ....+..+.+++.+||+.||.+|||+.++++.|+++...+
T Consensus 263 -~~-~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 -LH-GHRLKQ----------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -HT-TCCCCC----------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -Hc-CCCCCC----------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 111110 1122345889999999999999999999999999886544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=309.90 Aligned_cols=236 Identities=18% Similarity=0.229 Sum_probs=173.7
Q ss_pred hcCCCCccceeccc--CceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 114 ATNRFSDANKLGEG--GFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G--~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
..++|++.+.||+| +||.||+|++.. ++.||||++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35789999999999 999999999874 899999999654 3445567889999999999999999999999999999
Q ss_pred EEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 189 LIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 189 lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
+||||+++|+| +++||||||+|||++.++.+||+|||.+.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 99999999987 35678999999999999999999999986543221
Q ss_pred c-----ccccccccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhh----cC
Q 037365 235 L-----QANTSRIVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWR----SN 303 (398)
Q Consensus 235 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~----~~ 303 (398)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .......... ..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTS 261 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-HHHC------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhcCCCCcccccc
Confidence 1 111233478999999999987 5799999999999999999999999865333211 1000000000 00
Q ss_pred C-----c----------cccchhh-----------hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 304 R-----T----------LELTDAI-----------LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 304 ~-----~----------~~~~~~~-----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. . ....+.. .............+.+|+.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0 0000000 00000012234568899999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=295.48 Aligned_cols=220 Identities=25% Similarity=0.449 Sum_probs=171.8
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhh-------HHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQG-------LREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
.++|+..+.||+|+||.||+|++. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999986 48999999986543211 167889999999999999999999986554
Q ss_pred eEEEEeccCCCCh---------------------------------h--HHhhcCCCCCceecCCCC-----eEEccccc
Q 037365 187 KILIYEYMPNKSL---------------------------------D--FFLFNLKASNILLDKDMN-----PKISDFGM 226 (398)
Q Consensus 187 ~~lV~e~~~~g~L---------------------------------~--~~~~dlkp~NILl~~~~~-----~kl~DFGl 226 (398)
++||||+++|+| + ++|+||||+|||++.++. +||+|||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 799999999987 4 788999999999988776 99999999
Q ss_pred ceecCCCCcccccccccccccccChhhhc--cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC
Q 037365 227 ARICGGNELQANTSRIVGTYGYMSPEYAI--EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR 304 (398)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.............. .....
T Consensus 176 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~ 247 (287)
T 4f0f_A 176 SQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI---REEGL 247 (287)
T ss_dssp CBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH---HHSCC
T ss_pred cccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH---hccCC
Confidence 975432 233457899999999984 45678999999999999999999999865433322111111 11111
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 305 TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
.... ....+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 248 ~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 RPTI----------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCC----------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 112234688999999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.28 Aligned_cols=232 Identities=25% Similarity=0.358 Sum_probs=182.0
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCC 181 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 181 (398)
.++...++|+..+.||+|+||.||+|.+.. ...||+|.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345556889999999999999999999754 247999999765 334557789999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCChh----------------------------------------------HHhhcCCCCCceecC
Q 037365 182 IDKDEKILIYEYMPNKSLD----------------------------------------------FFLFNLKASNILLDK 215 (398)
Q Consensus 182 ~~~~~~~lV~e~~~~g~L~----------------------------------------------~~~~dlkp~NILl~~ 215 (398)
.+++..++||||+++|+|. ++|+||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 9999999999999998772 356799999999999
Q ss_pred CCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhH
Q 037365 216 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLG 294 (398)
Q Consensus 216 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 294 (398)
++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~-- 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KF-- 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HH--
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HH--
Confidence 99999999999987654433233344567889999999999999999999999999999998 888875432221 11
Q ss_pred HHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 295 YAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
............ +...+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 277 --~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 277 --YKLVKDGYQMAQ----------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp --HHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHhcCCCCCC----------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 111111110000 11123457899999999999999999999999988654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=309.41 Aligned_cols=213 Identities=25% Similarity=0.305 Sum_probs=165.9
Q ss_pred cceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 121 ANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
.+.||+|+||.||+|.... |+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5679999999999999864 899999999877666677899999999999999999999999999999999999999987
Q ss_pred ---------------------------------hHHhhcCCCCCcee--cCCCCeEEcccccceecCCCCcccccccccc
Q 037365 200 ---------------------------------DFFLFNLKASNILL--DKDMNPKISDFGMARICGGNELQANTSRIVG 244 (398)
Q Consensus 200 ---------------------------------~~~~~dlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 244 (398)
+++|+||||+|||+ +.++.+||+|||+++....... .....|
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~g 250 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFG 250 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCS
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccC
Confidence 35678999999999 5678899999999988754332 233479
Q ss_pred cccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHH
Q 037365 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324 (398)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (398)
|+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ ..... ......
T Consensus 251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i~~~~~~--~~~~~------~~~~~~ 317 (373)
T 2x4f_A 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-----ETLNNILACRWD--LEDEE------FQDISE 317 (373)
T ss_dssp SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCCC--SCSGG------GTTSCH
T ss_pred CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhccCC--CChhh------hccCCH
Confidence 99999999999999999999999999999999999997543211 111111111100 00000 112235
Q ss_pred HHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 325 RYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 325 ~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+.+++.+||+.||.+|||+.|+++
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 6889999999999999999999997
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=308.66 Aligned_cols=216 Identities=24% Similarity=0.300 Sum_probs=171.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 189 (398)
.++|+..+.||+|+||.||+|+... ++.||+|++... .....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4689999999999999999999876 788999999653 123456778899999988 79999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++...... .
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~ 176 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--V 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--C
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--c
Confidence 9999999988 45678999999999999999999999998643222 2
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ....... .. ..
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~---~~~i~~~-~~-~~--------- 240 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DEL---FQSIMEH-NV-AY--------- 240 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHC-CC-CC---------
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHH---HHHHHhC-CC-CC---------
Confidence 23456899999999999999999999999999999999999999753211 111 1111111 10 00
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 241 -p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 -PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1123346789999999999999995 577764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.25 Aligned_cols=213 Identities=23% Similarity=0.295 Sum_probs=162.4
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|+..+.||+|+||+||+|++. +++.||||++... ..........|+..+.++ +||||++++++|.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999987 4899999998654 233344555666666655 89999999999999999999
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+ +++| +++|+||||+|||++.++.+||+|||+++......
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-- 211 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-- 211 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--
Confidence 99999 4555 35678999999999999999999999998765432
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..+........ ....
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---------~~~~~~~~~~~----~~~~--- 273 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---------EGWQQLRQGYL----PPEF--- 273 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---------HHHHHHTTTCC----CHHH---
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---------cHHHHHhccCC----Cccc---
Confidence 2234569999999998875 7999999999999999999997764321 01111111111 0011
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||++|||++|+++
T Consensus 274 --~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 --TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1122356889999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=297.61 Aligned_cols=229 Identities=21% Similarity=0.329 Sum_probs=168.1
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|+..+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999997799999999965432 2346788999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++ +| +++|+||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccc
Confidence 985 43 46678999999999999999999999998764322 1223
Q ss_pred cccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc--------chh
Q 037365 241 RIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL--------TDA 311 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 311 (398)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .................. .++
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhchhhhccccccc
Confidence 35789999999999764 5899999999999999999999998643211 111111111111000000 000
Q ss_pred hhhc------ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ILED------EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~~~~------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.... .......+..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0001123456789999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=318.18 Aligned_cols=228 Identities=21% Similarity=0.281 Sum_probs=176.6
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 184 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 184 (398)
.++....++|++.+.||+|+||.||+|++.. ++.||+|++.... ......+.+|..++..++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3455667899999999999999999999876 8899999986421 11223577899999999999999999999999
Q ss_pred CeeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 185 DEKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
+..|+||||+++|+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 999999999999988 3567899999999999999999999999876543
Q ss_pred CcccccccccccccccChhhhccCC----CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGI----FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
.. ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .... .............
T Consensus 222 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~---~~i~~~~~~~~~p 295 (410)
T 3v8s_A 222 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTY---SKIMNHKNSLTFP 295 (410)
T ss_dssp SE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH---HHHHTHHHHCCCC
T ss_pred Cc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--hhHH---HHHHhccccccCC
Confidence 32 1233568999999999998765 88999999999999999999999753211 1111 1111100000000
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADD--RPTTNDVVSM 350 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~ 350 (398)
. ....+..+.+|+.+||+.+|.+ ||+++|+++.
T Consensus 296 ~--------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 296 D--------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp T--------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred C--------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 1122345789999999999988 9999999964
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=295.75 Aligned_cols=224 Identities=26% Similarity=0.378 Sum_probs=178.6
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
.++|+..+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467888999999999999999998888999999976542 3467899999999999999999999999999999999999
Q ss_pred CCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 195 PNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 195 ~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
++++| +++|+||||+||+++.++.+||+|||+++....... .....
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 164 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTG 164 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTS
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc-ccccc
Confidence 99987 356679999999999999999999999986543221 12233
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (398)
..+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .... .. ......... +.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~---~~-i~~~~~~~~----------~~ 228 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVV---ED-ISTGFRLYK----------PR 228 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH---HH-HHTTCCCCC----------CT
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHH---HH-HhcCCcCCC----------Cc
Confidence 467889999999999999999999999999999999 8888753211 1111 11 111100000 11
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 321 QVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 321 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
..+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 123457899999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=307.71 Aligned_cols=218 Identities=20% Similarity=0.315 Sum_probs=172.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|++.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4679999999999999999999876 889999998643 123456788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++|+| +++||||||+|||++.++.+||+|||+++...... .
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~ 170 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---Q 170 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---C
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC---c
Confidence 999999988 35678999999999999999999999998765432 2
Q ss_pred cccccccccccChhhhcc---CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 239 TSRIVGTYGYMSPEYAIE---GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...... ...... ..
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~-~~~~~~-~~------- 239 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHT-FETTVV-TY------- 239 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHH-HHHCCC-CC-------
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHH-Hhhccc-CC-------
Confidence 345689999999999974 4589999999999999999999999864333211 111111 110000 00
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCC-HHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPT-TNDVVS 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~ 349 (398)
+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 240 ---p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 ---PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1122356889999999999999998 777764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=294.25 Aligned_cols=220 Identities=23% Similarity=0.342 Sum_probs=174.1
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
..++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 45789999999999999999999865 889999998644 344567788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCC---eEEcccccceecCCCCc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMN---PKISDFGMARICGGNEL 235 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~---~kl~DFGla~~~~~~~~ 235 (398)
|||+++|+| +++|+||||+||+++.++. +||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999987 3567899999999976655 99999999987654322
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .... . ....... ...+.
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~---~-~~~~~~~-~~~~~--- 230 (284)
T 3kk8_A 164 ---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYA---Q-IKAGAYD-YPSPE--- 230 (284)
T ss_dssp ---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---H-HHHTCCC-CCTTT---
T ss_pred ---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHH---H-HHhcccc-CCchh---
Confidence 23457899999999999999999999999999999999999997532211 1111 1 1111100 00000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 231 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 ---WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122345789999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=307.49 Aligned_cols=222 Identities=21% Similarity=0.286 Sum_probs=160.5
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.....++|++.+.||+|+||.||+|++.. ++.||+|++.... ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 34556789999999999999999999875 7899999997543 33567889999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecC---CCCeEEcccccceecCCCC
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDK---DMNPKISDFGMARICGGNE 234 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~---~~~~kl~DFGla~~~~~~~ 234 (398)
||||+++|+| +++|+||||+|||++. ++.+||+|||+++......
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999987 3567899999999975 8899999999998764332
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . .......... ...+.
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~----~~~i~~~~~~-~~~~~-- 274 (349)
T 2w4o_A 206 ---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-M----FRRILNCEYY-FISPW-- 274 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-H----HHHHHTTCCC-CCTTT--
T ss_pred ---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-H----HHHHHhCCCc-cCCch--
Confidence 12345789999999999999999999999999999999999999754322110 1 1111111110 00000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 275 ----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 275 ----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123346789999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=293.61 Aligned_cols=219 Identities=20% Similarity=0.248 Sum_probs=173.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|++.+.||+|+||.||+|.+.. +..+|+|++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999999876 77899999976655566789999999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCcee---cCCCCeEEcccccceecCCCCccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILL---DKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl---~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|+++++| +++|+||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--- 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--- 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---
Confidence 9999988 35678999999999 788999999999998765433
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...... . ....... .... .....
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~~~~-~~~~-~~~~~----- 230 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--E---VMLKIRE-GTFT-FPEKD----- 230 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--H---HHHHHHH-CCCC-CCHHH-----
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--H---HHHHHHh-CCCC-CCchh-----
Confidence 22345789999999988654 999999999999999999999997542211 1 1111111 1100 00000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 231 -~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 -WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0122356889999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=304.40 Aligned_cols=227 Identities=18% Similarity=0.217 Sum_probs=172.9
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCID 183 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 183 (398)
++....++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 455667889999999999999999999865 888999998543 33456788999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChh---------------------------------------------------------------
Q 037365 184 KDEKILIYEYMPNKSLD--------------------------------------------------------------- 200 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L~--------------------------------------------------------------- 200 (398)
.+..++||||+++|+|.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999998762
Q ss_pred ---------HHhhcCCCCCceecCCC--CeEEcccccceecCCCCc--ccccccccccccccChhhhcc--CCCCccccc
Q 037365 201 ---------FFLFNLKASNILLDKDM--NPKISDFGMARICGGNEL--QANTSRIVGTYGYMSPEYAIE--GIFSIKFDV 265 (398)
Q Consensus 201 ---------~~~~dlkp~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv 265 (398)
++|+||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 34679999999998776 899999999987643221 112334579999999999975 678999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHH
Q 037365 266 FSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTN 345 (398)
Q Consensus 266 wSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ 345 (398)
|||||++|||++|+.||...... .............. .+. .......+.+++.+||+.||.+|||+.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~--~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDA-----DTISQVLNKKLCFE--NPN------YNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCTT--SGG------GGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhcccccC--Ccc------cccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 99999999999999997533211 11111121111100 000 111234578999999999999999999
Q ss_pred HHHH
Q 037365 346 DVVS 349 (398)
Q Consensus 346 evl~ 349 (398)
|+++
T Consensus 327 ~~l~ 330 (345)
T 3hko_A 327 RALQ 330 (345)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=304.92 Aligned_cols=221 Identities=23% Similarity=0.308 Sum_probs=165.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCC--CcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~l 189 (398)
..++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++.+++| |||+++++++.+++..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35679999999999999999999988999999998644 34455778999999999987 999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||| +.+|+| +++||||||+|||++ ++.+||+|||+++.........
T Consensus 87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 999 456666 467789999999997 5789999999998765443333
Q ss_pred ccccccccccccChhhhcc-----------CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 238 NTSRIVGTYGYMSPEYAIE-----------GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHAIIDPNHEI 240 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHHCTTSCC
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----HHHHHHhcCCccc
Confidence 3345689999999999975 678999999999999999999999985322211 1111111111111
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.. +......+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~----------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 EF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC----------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 10 11112357899999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=296.84 Aligned_cols=233 Identities=20% Similarity=0.320 Sum_probs=170.6
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++..++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467999999999999999999975 4899999999753 34456778899999999999999999999999999999
Q ss_pred EEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 190 IYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 190 V~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
||||+++|+| +++|+||||+||+++.++.+||+|||+++.....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999987 3456799999999999999999999999866433
Q ss_pred CcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........+. .. ..........
T Consensus 190 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~-~~~~~~~~~~---- 259 (310)
T 2wqm_A 190 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC---KK-IEQCDYPPLP---- 259 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH---HH-HHTTCSCCCC----
T ss_pred Cc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH---HH-hhcccCCCCc----
Confidence 21 22335789999999999999999999999999999999999999754322211111 11 1111111100
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCC
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPP 361 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 361 (398)
....+..+.+++.+||+.||++|||++++++.|+++.+....|
T Consensus 260 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 260 -----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 1122345889999999999999999999999999987665543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=318.18 Aligned_cols=230 Identities=19% Similarity=0.262 Sum_probs=176.5
Q ss_pred chhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEE
Q 037365 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCI 182 (398)
Q Consensus 107 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 182 (398)
.+.++....++|++.+.||+|+||.||+|++.. ++.||+|++.... ......+.+|..++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345566677899999999999999999999876 7889999986421 112234788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 183 DKDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
+++..|+||||+++|+| +++||||||+|||++.++.+||+|||+++.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999988 356789999999999999999999999987
Q ss_pred cCCCCcccccccccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR 304 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
....... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...... ......
T Consensus 225 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--~~~~~~---i~~~~~ 298 (437)
T 4aw2_A 225 LMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGK---IMNHKE 298 (437)
T ss_dssp CCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHH---HHTHHH
T ss_pred cccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--hHHHHh---hhhccc
Confidence 6543322 233468999999999997 46789999999999999999999999853221 111111 111000
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCC--CCCHHHHHH
Q 037365 305 TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADD--RPTTNDVVS 349 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~ 349 (398)
....... ....+..+.+|+.+||..+|++ ||+++|+++
T Consensus 299 ~~~~p~~-------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 RFQFPTQ-------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HCCCCSS-------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccCCcc-------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000000 0112345789999999888888 999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=296.49 Aligned_cols=229 Identities=26% Similarity=0.388 Sum_probs=178.9
Q ss_pred cCCCCccc-eecccCceEEEEEEEc---CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 115 TNRFSDAN-KLGEGGFGPVYKGVLR---KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.++|.+.+ .||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 8999999999999864 4778999999765 344567889999999999999999999999 5567999
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++++| +++|+||||+||+++.++.+||+|||+++........
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999877 3556799999999999999999999999877543322
Q ss_pred -cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 237 -ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.......||+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..... .........
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~----i~~~~~~~~------ 234 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF----IEQGKRMEC------ 234 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHH----HHTTCCCCC------
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH----HhcCCcCCC------
Confidence 12233457899999999998899999999999999999998 99997543221 11111 111111111
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCC
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLP 360 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 360 (398)
+...+..+.+++.+||+.||++|||+.++++.|++.......
T Consensus 235 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 235 ----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 122345688999999999999999999999999987665443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.25 Aligned_cols=232 Identities=26% Similarity=0.414 Sum_probs=182.3
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
.++...++|++.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+.+|++++||||+++++++.+ +..++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3445566788889999999999999999888889999997654 335678999999999999999999999876 67899
Q ss_pred EEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 190 IYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 190 V~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999987 356789999999999999999999999986643221
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...... ...+.....
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~----i~~~~~~~~------ 485 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----VERGYRMPC------ 485 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHH----HHTTCCCCC------
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCCCCC------
Confidence 12233457789999999999999999999999999999999 8988753221 111111 111111100
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCC
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLP 360 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 360 (398)
...++..+.+|+.+||+.||++|||+++|++.|+.......+
T Consensus 486 ----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 486 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 122345688999999999999999999999999998655443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=304.44 Aligned_cols=222 Identities=20% Similarity=0.243 Sum_probs=163.7
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|+..+.||+|+||.||+++... ++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 35789999999999999999999874 89999999976432 23568899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCC--eEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMN--PKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~--~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++|+| +++||||||+|||++.++. +||+|||+++...... .
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~ 173 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 173 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---C
Confidence 9999988 3567899999999987765 9999999997543221 2
Q ss_pred cccccccccccChhhhccCCCCcc-cccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIK-FDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....||+.|+|||++.+..++.+ +|||||||++|||++|+.||....... .............. ....
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~--~~~~------- 243 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKY--SIPD------- 243 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCC--CCCT-------
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCC--CCCC-------
Confidence 234579999999999998887655 999999999999999999986432221 11111111111110 0000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 244 -~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 -DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 01123457899999999999999999999963
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=296.93 Aligned_cols=239 Identities=22% Similarity=0.275 Sum_probs=181.1
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCcccceeeEEEeCC--
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCIDKD-- 185 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~-- 185 (398)
......++|++.+.||+|+||.||+|++. ++.||+|.+... ....+.+|.+++.. ++||||+++++++...+
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 33455678999999999999999999984 899999999643 34567889999988 78999999999999876
Q ss_pred --eeEEEEeccCCCChh---------------------------------------HHhhcCCCCCceecCCCCeEEccc
Q 037365 186 --EKILIYEYMPNKSLD---------------------------------------FFLFNLKASNILLDKDMNPKISDF 224 (398)
Q Consensus 186 --~~~lV~e~~~~g~L~---------------------------------------~~~~dlkp~NILl~~~~~~kl~DF 224 (398)
..++||||+++|+|. ++|+||||+|||++.++.+||+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred cceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 789999999999872 356799999999999999999999
Q ss_pred ccceecCCCCccc--ccccccccccccChhhhccC------CCCcccccHHHHHHHHHHHcC----------CCCCCCCC
Q 037365 225 GMARICGGNELQA--NTSRIVGTYGYMSPEYAIEG------IFSIKFDVFSFGVLLLEIVSG----------KKNTGFYR 286 (398)
Q Consensus 225 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg----------~~P~~~~~ 286 (398)
|+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998765433211 23445799999999999865 345789999999999999999 56665433
Q ss_pred CCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 287 TDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
........+............+. ..+........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIP-----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCC-----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCcccHHHHHHHHHHHHhCCCCc-----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 32222222222111111111111 1111335567789999999999999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=316.75 Aligned_cols=233 Identities=21% Similarity=0.256 Sum_probs=169.9
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-----
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK----- 184 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 184 (398)
...++|++.+.||+|+||.||+|.+.. ++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 345889999999999999999999765 888999999754 444567788999999999999999999999765
Q ss_pred -CeeEEEEeccCCCCh-----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 185 -DEKILIYEYMPNKSL-----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 185 -~~~~lV~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
...|+||||++++.+ +++||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 357999999987633 46788999999999999999999999998765432
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcC-----------
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSN----------- 303 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------- 303 (398)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .+....+.......
T Consensus 219 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~--~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 219 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp ---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred ---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHHHHHcchh
Confidence 23446899999999999999999999999999999999999999854321 11111111100000
Q ss_pred -------C--cc-----ccchhh-hhccc-ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 304 -------R--TL-----ELTDAI-LEDEY-SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 304 -------~--~~-----~~~~~~-~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. .. ...... ..... ........+.+|+.+||+.||++|||++|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 000000 00000 012235678999999999999999999999963
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=301.79 Aligned_cols=229 Identities=24% Similarity=0.380 Sum_probs=158.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|+..+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4689999999999999999999765 8999999996543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 193 YMPNKSL--------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 193 ~~~~g~L--------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
|+++ +| +++|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 9985 44 35678999999999999999999999998765332
Q ss_pred cccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc-------
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL------- 306 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 306 (398)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ................
T Consensus 163 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 163 --NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp --CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCTTTCGGGGG
T ss_pred --ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhHhhhhhh
Confidence 122345789999999999864 6899999999999999999999998643221 1111111111100000
Q ss_pred -------------ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 -------------ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 -------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......+... ........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPH-TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGG-CSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhccc-ccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000000 01122346889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.85 Aligned_cols=221 Identities=24% Similarity=0.347 Sum_probs=175.0
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|++.+.||+|+||.||+|.... ++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 4678899999999999999999864 899999998644 23445778999999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|+++++| +++|+||||+||+++.++.+||+|||++.............
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 9999877 35678999999999999999999999998764333222334
Q ss_pred cccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...||+.|+|||.+.+..+ +.++||||||+++|||++|+.||............+ ...... ... .
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~--~~~-------~ 231 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTY--LNP-------W 231 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH-----HTTCTT--STT-------G
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh-----hhcccc--cCc-------h
Confidence 5678999999999988775 789999999999999999999986543322221111 111100 000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 122345789999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=294.42 Aligned_cols=228 Identities=25% Similarity=0.321 Sum_probs=175.1
Q ss_pred CCCccceecccCceEEEEEEEcC-C---CEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee-EEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-G---NEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK-ILI 190 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lV 190 (398)
.|...+.||+|+||.||+|.+.+ + ..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999998643 2 269999997543 34567889999999999999999999999876655 999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc-
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ- 236 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 236 (398)
|||+.+|+| +++|+||||+|||++.++.+||+|||+++........
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 999999988 3567899999999999999999999999866443211
Q ss_pred -cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 -ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......+|+.|+|||.+.+..++.++||||||+++|||++|..|+..... ........ ........
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~----~~~~~~~~------- 249 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFL----AQGRRLPQ------- 249 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHH----HTTCCCCC-------
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHh----hcCCCCCC-------
Confidence 123345688999999999999999999999999999999997666432211 11111111 11110000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
....+..+.+++.+||+.||.+|||++++++.|+++.....
T Consensus 250 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 250 ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11123458899999999999999999999999999876554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=315.86 Aligned_cols=220 Identities=21% Similarity=0.340 Sum_probs=175.5
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999986 48999999996432 12346788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++|+| +++||||||+|||++.++.+||+|||+++...... .
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---F 171 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---C
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc---c
Confidence 999999987 35678999999999999999999999998765432 2
Q ss_pred cccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..+. ..... ... ..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~---~~i~~-~~~-~~--------- 235 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLF---KKICD-GIF-YT--------- 235 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHH---HHHHT-TCC-CC---------
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHH---HHHhc-CCc-CC---------
Confidence 234579999999999998776 7899999999999999999999753221 1111 11111 100 00
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhhc
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTNE 354 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~~ 354 (398)
+......+.+++.+||+.||.+|||++|+++ .+.+.
T Consensus 236 -p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 236 -PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1112345789999999999999999999996 45543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=300.60 Aligned_cols=235 Identities=26% Similarity=0.356 Sum_probs=182.9
Q ss_pred chhhhhhhcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCccccee
Q 037365 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLL 178 (398)
Q Consensus 107 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~ 178 (398)
....+....++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 33455566789999999999999999999852 36789999997653 34456789999999999 799999999
Q ss_pred eEEEeCC-eeEEEEeccCCCCh------------------------------------------------hHHhhcCCCC
Q 037365 179 GCCIDKD-EKILIYEYMPNKSL------------------------------------------------DFFLFNLKAS 209 (398)
Q Consensus 179 ~~~~~~~-~~~lV~e~~~~g~L------------------------------------------------~~~~~dlkp~ 209 (398)
+++...+ ..++||||+++|+| +++|+||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9998755 58999999998876 2456799999
Q ss_pred CceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCC
Q 037365 210 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTD 288 (398)
Q Consensus 210 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~ 288 (398)
||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999999987654433333445578899999999999999999999999999999998 99887543222
Q ss_pred ccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 289 TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
. . ............. .......+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 258 ~-~----~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 258 E-E----FCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp H-H----HHHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-H----HHHHhccCccCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 1 1111111111111 11123457899999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=310.22 Aligned_cols=235 Identities=23% Similarity=0.352 Sum_probs=163.5
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCC--e
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD--E 186 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~ 186 (398)
...++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345789999999999999999999865 899999998643 3455667889999999997 999999999998654 6
Q ss_pred eEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 187 KILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 187 ~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.|+|||||++ +| +++||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 8999999984 55 467789999999999999999999999987643110
Q ss_pred -------------------ccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHH
Q 037365 236 -------------------QANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGY 295 (398)
Q Consensus 236 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 295 (398)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|++||..... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~ 242 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST--MNQLER 242 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 111234589999999999987 6789999999999999999999999864321 111111
Q ss_pred HHHhhhcCCc-----------------------------cccchhh---hhcccChHHHHHHHHHHHHHchhcCCCCCCC
Q 037365 296 AWDLWRSNRT-----------------------------LELTDAI---LEDEYSSKQVLLRYVNIALLCVQESADDRPT 343 (398)
Q Consensus 296 ~~~~~~~~~~-----------------------------~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt 343 (398)
.......... ....... .............+.+|+.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 1111110000 0000000 0000000022346889999999999999999
Q ss_pred HHHHHHH
Q 037365 344 TNDVVSM 350 (398)
Q Consensus 344 ~~evl~~ 350 (398)
++|+++.
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.57 Aligned_cols=216 Identities=22% Similarity=0.284 Sum_probs=161.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHH-HHhcCCCcccceeeEEEeCCeeE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASV-IAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
..++|+..+.||+|+||.||+|+... ++.||+|++.... ......+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 34679999999999999999999875 8889999996542 2233456667776 56789999999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
+||||+++|+| +++||||||+|||++.++.+||+|||+++......
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-- 193 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 193 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC--
Confidence 99999999988 45678999999999999999999999998643222
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... .. ..
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~---~~~i~~~-~~-~~-------- 258 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEM---YDNILNK-PL-QL-------- 258 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HHH---HHHHHHS-CC-CC--------
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHH---HHHHHhc-cc-CC--------
Confidence 223456899999999999999999999999999999999999999753211 111 1111111 00 00
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVV 348 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 348 (398)
.......+.+++.+||+.||.+||++.+.+
T Consensus 259 --~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 259 --KPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp --CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred --CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 112234578999999999999999985433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.98 Aligned_cols=230 Identities=22% Similarity=0.236 Sum_probs=162.7
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEe----
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCID---- 183 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~---- 183 (398)
.++....+|++.+.||+|+||.||+|++.. ++.||+|++........+.+.+|+.++.++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 334445689999999999999999999864 8999999997776666778899999999996 9999999999953
Q ss_pred ----CCeeEEEEeccCCCCh-----------------------------------h--HHhhcCCCCCceecCCCCeEEc
Q 037365 184 ----KDEKILIYEYMPNKSL-----------------------------------D--FFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 184 ----~~~~~lV~e~~~~g~L-----------------------------------~--~~~~dlkp~NILl~~~~~~kl~ 222 (398)
....+++|||+. |+| + ++|+||||+|||++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 345799999996 443 4 7889999999999999999999
Q ss_pred ccccceecCCCCccc----------ccccccccccccChhhh---ccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc
Q 037365 223 DFGMARICGGNELQA----------NTSRIVGTYGYMSPEYA---IEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT 289 (398)
Q Consensus 223 DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~ 289 (398)
|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765432211 11134689999999998 56678999999999999999999999975321110
Q ss_pred cchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 290 LNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
. ......... .......+.+++.+||+.||++|||+.|+++.|+.......
T Consensus 261 --~-------~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 --I-------VNGKYSIPP----------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------CCCCT----------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --h-------hcCcccCCc----------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0 000000000 00111236789999999999999999999999998876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.85 Aligned_cols=217 Identities=21% Similarity=0.290 Sum_probs=164.0
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|++.+.||+|+||.||+|+... ++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 34679999999999999999999865 899999998643 23344567889999999999999999999999999999
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++......
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 303 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-- 303 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC--
Confidence 9999999987 26678999999999999999999999997643222
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ....... . ..
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~---~~i~~~~-~-~~-------- 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLF---ELILMEE-I-RF-------- 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHCC-C-CC--------
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHH---HHHHhCC-C-CC--------
Confidence 223446899999999999999999999999999999999999999753221 1111 1111110 0 00
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
+......+.+++.+||+.||.+|| |++|+++
T Consensus 369 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 --PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 112234578999999999999999 9999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=292.68 Aligned_cols=218 Identities=22% Similarity=0.326 Sum_probs=173.6
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC--CeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 190 (398)
.++|+..+.||+|+||.||+|++. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467889999999999999999985 889999999754 344566789999999999999999999999887 788999
Q ss_pred EeccCCCCh----------------------------------h--HHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 191 YEYMPNKSL----------------------------------D--FFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 191 ~e~~~~g~L----------------------------------~--~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
|||+++|+| + ++|+||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 999999987 3 7788999999999999999999998865422
Q ss_pred cccccccccccccccChhhhccCCCCc---ccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSI---KFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
.....||+.|+|||.+.+..++. ++|||||||++|||++|+.||...... ...............
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~--- 232 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-----EIGMKVALEGLRPTI--- 232 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----HHHHHHHHSCCCCCC---
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----HHHHHHHhcCCCCCC---
Confidence 22347899999999998766544 899999999999999999997532211 111111111111111
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 233 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 233 -------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1122345889999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=298.10 Aligned_cols=228 Identities=21% Similarity=0.259 Sum_probs=168.0
Q ss_pred cCCCCcc-ceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEE
Q 037365 115 TNRFSDA-NKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 115 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.++|++. +.||+|+||.||+|... +++.||||++..........+.+|++++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678774 78999999999999975 4899999999776555667889999999995 7999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCC---eEEcccccceecCCCCc-
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMN---PKISDFGMARICGGNEL- 235 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~---~kl~DFGla~~~~~~~~- 235 (398)
||+++|+| +++|+||||+|||++.++. +||+|||+++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99999988 3567899999999988776 99999999876542211
Q ss_pred ----ccccccccccccccChhhhcc-----CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccch---------hHHHH
Q 037365 236 ----QANTSRIVGTYGYMSPEYAIE-----GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNL---------LGYAW 297 (398)
Q Consensus 236 ----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~---------~~~~~ 297 (398)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 111223469999999999975 568999999999999999999999986543321100 00001
Q ss_pred HhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 298 DLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
........ ...... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~i~~~~~-~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 251 ESIQEGKY-EFPDKD------WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHCCC-CCCHHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhccCc-ccCchh------cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11111100 000000 0112356889999999999999999999997
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=294.84 Aligned_cols=216 Identities=24% Similarity=0.340 Sum_probs=169.1
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|++.+.||+|+||.||+|.+.. +..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 35689999999999999999999876 7789999985432 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+++|+| +++|+||||+|||++.++.+||+|||++.......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc---
Confidence 9999999887 35678999999999999999999999986543322
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... .. ...... ..
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~---~~-~~~~~~-~~--------- 226 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETY---KR-ISRVEF-TF--------- 226 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH---HH-HHHTCC-CC---------
T ss_pred -ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHH---HH-HHhCCC-CC---------
Confidence 23457899999999999999999999999999999999999997532111 111 00 110000 00
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+......+.+++.+||+.||++|||++|+++.
T Consensus 227 -~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 -PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11123457899999999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=303.32 Aligned_cols=235 Identities=17% Similarity=0.182 Sum_probs=169.9
Q ss_pred cCCCCccceecccCceEEEEEEEc----CCCEEEEEEccCCChhh-----------HHHHHHHHHHHHhcCCCcccceee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGRSGQG-----------LREMKNEASVIAKVQHKNLVRLLG 179 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~ 179 (398)
.++|++.+.||+|+||.||+|.+. .+..+|+|++....... ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999986 46789999987653221 123567888999999999999999
Q ss_pred EEEe----CCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCC--CeEE
Q 037365 180 CCID----KDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDM--NPKI 221 (398)
Q Consensus 180 ~~~~----~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~--~~kl 221 (398)
++.. ....++||||+ +++| +++|+||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 67899999999 8887 356789999999998877 9999
Q ss_pred cccccceecCCCCcc-----cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH
Q 037365 222 SDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA 296 (398)
Q Consensus 222 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 296 (398)
+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~- 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA- 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH-
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH-
Confidence 999999876432211 11234579999999999999999999999999999999999999985322221111111
Q ss_pred HHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 297 WDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....... +.. ...........+..+.+++.+||+.||++|||++++++.|++...
T Consensus 274 ~~~~~~~----~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 274 KTNLLDE----LPQ-SVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHT----TTH-HHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHhhccc----ccH-HHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111110 000 000000001234568899999999999999999999999998653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=290.07 Aligned_cols=243 Identities=21% Similarity=0.252 Sum_probs=182.9
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEE-EeCCeeEEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC-IDKDEKILIY 191 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~ 191 (398)
..++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+|+.+++.++|++++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 3578999999999999999999974 4889999998654322 4588999999999998877666655 5677889999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCcee---cCCCCeEEcccccceecCCCCc
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILL---DKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||+ +++| +++|+||||+|||+ +.++.+||+|||+++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999 8877 35678999999999 5888999999999987765432
Q ss_pred cc-----ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc-cchhHHHHHhhhcCCccccc
Q 037365 236 QA-----NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-LNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 236 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 309 (398)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .............. .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~ 238 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----P 238 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----C
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-----c
Confidence 11 1244679999999999999999999999999999999999999986533221 11111111000000 0
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCCCCccccc
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYV 369 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~~~~ 369 (398)
.... ....+..+.+++.+||+.||++|||++++++.|+++......+....+.|.
T Consensus 239 ~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 239 IEVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHHH-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred hHHH-----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 0000 112235688999999999999999999999999998777665554445554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.10 Aligned_cols=216 Identities=23% Similarity=0.328 Sum_probs=173.9
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|.+.+.||+|+||.||++.+.+ ++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4679999999999999999999876 788999998643 334567788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++++| +++|+||||+|||++.++.+||+|||+++....... .
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--R 197 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--c
Confidence 999999987 356789999999999999999999999987653321 2
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ ... ..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~-~~---------- 260 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKK-NEY-SI---------- 260 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHH-TCC-CC----------
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHHHhc-CCC-CC----------
Confidence 23457899999999999999999999999999999999999997542211 11111111 100 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+......+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112345788999999999999999999996
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=294.75 Aligned_cols=228 Identities=26% Similarity=0.370 Sum_probs=172.2
Q ss_pred CCCCccceecccCceEEEEEEEcC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe-CCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~l 189 (398)
.+|+..+.||+|+||.||+|.+.+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999999653 235899998754 34456778999999999999999999998654 567899
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||||+++|+| +++|+||||+|||++.++.+||+|||+++........
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 9999999988 3567899999999999999999999999876543321
Q ss_pred --cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 237 --ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 237 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.......||+.|+|||.+.+..++.++||||||+++|||++|..|+...... ....... ..... ...
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~~~---~~~~~-~~~------ 253 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYL---LQGRR-LLQ------ 253 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHHHH---HTTCC-CCC------
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHHHH---hcCCC-CCC------
Confidence 1233456788999999999999999999999999999999955543222111 1111111 11110 000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
+...+..+.+++.+||+.||++|||++|+++.|+++....
T Consensus 254 ----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 254 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1112345889999999999999999999999999876544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=296.77 Aligned_cols=231 Identities=23% Similarity=0.332 Sum_probs=168.0
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.++|+..+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3679999999999999999999875 8999999986543 333567889999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++++| +++|+||||+|||++.++.+||+|||+++....... ..
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 159 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YY 159 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--cc
Confidence 99998866 356789999999999999999999999987653321 22
Q ss_pred ccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHh-----------hhcCCcc-
Q 037365 240 SRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL-----------WRSNRTL- 306 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-----------~~~~~~~- 306 (398)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ......... +......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhcccccccccccccccccc
Confidence 34578999999999986 56899999999999999999999998543221 111111111 0000000
Q ss_pred --ccchhhhhcc--cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 --ELTDAILEDE--YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 --~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+...... ...+..+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 001123455889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.45 Aligned_cols=220 Identities=22% Similarity=0.282 Sum_probs=174.1
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh------hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
..++|++.+.||+|+||.||+|+... ++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34679999999999999999999875 89999999865422 135778999999999999999999999999999
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCC----CeEEcccccceec
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDM----NPKISDFGMARIC 230 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~----~~kl~DFGla~~~ 230 (398)
.++||||+++++| +++|+||||+|||++.++ .+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999988 356789999999999888 7999999999876
Q ss_pred CCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ... ...... .. +
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~---~~~-i~~~~~-~~-~ 238 (321)
T 2a2a_A 170 EDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ET---LAN-ITSVSY-DF-D 238 (321)
T ss_dssp CTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HH---HHH-HHTTCC-CC-C
T ss_pred Cccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HH---HHH-HHhccc-cc-C
Confidence 5432 223457899999999999999999999999999999999999997532211 11 111 111100 00 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 239 EEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHH-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hhh-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0112345789999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=299.26 Aligned_cols=230 Identities=21% Similarity=0.248 Sum_probs=174.9
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe----CCeeE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 188 (398)
..++|++.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 4568999999999999999999984 489999999977666677889999999999999999999999973 34789
Q ss_pred EEEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 189 LIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 189 lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
+||||+++|+| +++|+||||+|||++.++.+||+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999987 355679999999999999999999999876532
Q ss_pred CCccc-------ccccccccccccChhhhccCC---CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc
Q 037365 233 NELQA-------NTSRIVGTYGYMSPEYAIEGI---FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS 302 (398)
Q Consensus 233 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 302 (398)
..... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.............. ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~ 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV----QN 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH----HC
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh----hc
Confidence 11100 012345799999999987554 68999999999999999999999742111111111100 00
Q ss_pred CCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 303 NRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
.. .. ......+..+.+++.+||+.||.+|||++++++.|+.+.+.
T Consensus 263 ~~--~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 263 QL--SI--------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp C----C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred cC--CC--------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00 00 00112234688999999999999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.34 Aligned_cols=219 Identities=22% Similarity=0.313 Sum_probs=165.9
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcC--CCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.+|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999998654 3455678899999999997 599999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
| +.+++| +++||||||+|||++ ++.+||+|||+++.+.........
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccC
Confidence 9 566666 467789999999995 588999999999876544332233
Q ss_pred ccccccccccChhhhcc-----------CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 240 SRIVGTYGYMSPEYAIE-----------GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ................
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHAIIDPNHEIEF 289 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHHHHCTTSCCCC
T ss_pred CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----HHHHHHHhCccccCCC
Confidence 45689999999999875 46899999999999999999999998543211 1111111111111110
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+......+.+++.+||+.||.+|||+.|+++.
T Consensus 290 ----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 290 ----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 00112357899999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=313.85 Aligned_cols=230 Identities=20% Similarity=0.269 Sum_probs=175.9
Q ss_pred chhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEE
Q 037365 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCI 182 (398)
Q Consensus 107 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 182 (398)
.+.+.....++|+..+.||+|+||.||+++... ++.||+|++.+.. ....+.+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 344556667899999999999999999999864 8999999996431 122345788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 183 DKDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
+.+..|+||||+++|+| +++||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 99999999999999988 356789999999999999999999999987
Q ss_pred cCCCCcccccccccccccccChhhhc-------cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAI-------EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS 302 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 302 (398)
....... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||..... ......+ ...
T Consensus 212 ~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i---~~~ 285 (412)
T 2vd5_A 212 LRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--AETYGKI---VHY 285 (412)
T ss_dssp CCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHH---HTH
T ss_pred ccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--HHHHHHH---Hhc
Confidence 6543321 223468999999999997 35689999999999999999999999754221 1111111 110
Q ss_pred CCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCC---CCHHHHHHH
Q 037365 303 NRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDR---PTTNDVVSM 350 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Pt~~evl~~ 350 (398)
...... +.. ....+..+.+++.+||. +|.+| |+++|+++.
T Consensus 286 ~~~~~~--p~~-----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 286 KEHLSL--PLV-----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHCCC--C---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccCcCC--Ccc-----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000000 000 11234568899999999 99998 599999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=290.55 Aligned_cols=242 Identities=21% Similarity=0.256 Sum_probs=177.7
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEE-EeCCeeEEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC-IDKDEKILIY 191 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~ 191 (398)
..++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+|+.+++.++|+|++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999999999999975 4889999987544322 3578899999999988877776665 5677889999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCcee---cCCCCeEEcccccceecCCCCc
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILL---DKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||+ +++| +++|+||||+|||+ +.++.+||+|||+++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999 8877 35678999999999 7889999999999987754432
Q ss_pred c-----cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc-cchhHHHHHhhhcCCccccc
Q 037365 236 Q-----ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-LNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 236 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 309 (398)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .............. .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~ 238 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----P 238 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----C
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----h
Confidence 1 12234679999999999999999999999999999999999999986533221 11111100000000 0
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCCCCcccc
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSY 368 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~~~ 368 (398)
.... ....+..+.+++.+||+.||++|||++++++.|+++......+..-.+.|
T Consensus 239 ~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 4hgt_A 239 IEVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp HHHH-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGG
T ss_pred hhhh-----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccch
Confidence 0000 01123568899999999999999999999999999877665544434444
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.57 Aligned_cols=239 Identities=20% Similarity=0.281 Sum_probs=181.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC--eeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~l 189 (398)
..++|.+.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 34679999999999999999999876 8999999997542 234567789999999999999999999998765 7799
Q ss_pred EEeccCCCCh-----------------------------------hHHhhcCCCCCcee----cCCCCeEEcccccceec
Q 037365 190 IYEYMPNKSL-----------------------------------DFFLFNLKASNILL----DKDMNPKISDFGMARIC 230 (398)
Q Consensus 190 V~e~~~~g~L-----------------------------------~~~~~dlkp~NILl----~~~~~~kl~DFGla~~~ 230 (398)
||||+++|+| +++|+||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999999877 35678999999999 77788999999999876
Q ss_pred CCCCcccccccccccccccChhhhcc--------CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIE--------GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS 302 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 302 (398)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..........
T Consensus 167 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~ 242 (396)
T 4eut_A 167 EDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKIITG 242 (396)
T ss_dssp CCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHHHHHS
T ss_pred cCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHHHhcC
Confidence 5432 2234579999999999875 56889999999999999999999998644332211 1122222221
Q ss_pred CCccc---c----------chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 303 NRTLE---L----------TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 303 ~~~~~---~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
..... . .................+.+++.+||+.||++|||++|+++.++.+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11100 0 000000001135567788999999999999999999999998877644
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=300.24 Aligned_cols=226 Identities=25% Similarity=0.406 Sum_probs=170.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
.++|+..+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678888999999999999998754 235999999765 3345567899999999999999999999999999999
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+||||+++|+| +++|+||||+|||++.++.+||+|||+++.......
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 99999999887 356679999999999999999999999987654321
Q ss_pred c-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 236 Q-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..... ..........
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~----~~~~~~~~~~----- 271 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMK----AINDGFRLPT----- 271 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH----HHHTTCCCCC-----
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHH----HHHCCCcCCC-----
Confidence 1 11223456789999999999999999999999999999999 9999753221 11111 1111110000
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 272 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 272 -----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp -----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11223457899999999999999999999999988754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=302.30 Aligned_cols=216 Identities=22% Similarity=0.260 Sum_probs=148.6
Q ss_pred cceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEeccCCCC
Q 037365 121 ANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~g~ 198 (398)
.+.||+|+||.||+|.+.. ++.||||++... ....+.+|+.+++.+. ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 3789999999999999865 899999999643 3466788999999997 9999999999999999999999999998
Q ss_pred h--------------------------------hHHhhcCCCCCceecCCC---CeEEcccccceecCCCCccccccccc
Q 037365 199 L--------------------------------DFFLFNLKASNILLDKDM---NPKISDFGMARICGGNELQANTSRIV 243 (398)
Q Consensus 199 L--------------------------------~~~~~dlkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~~~~~~ 243 (398)
| +++|+||||+|||++.++ .+||+|||+++....... ......
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~ 170 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPC 170 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccC
Confidence 8 356789999999997665 799999999987654321 223457
Q ss_pred ccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc--cchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 244 GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT--LNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 244 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ......... ..... ...
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~~~-~~~~~------~~~ 242 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFS-FEGEA------WKN 242 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTCCC-CCSHH------HHT
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCCCC-CCccc------ccC
Confidence 8999999999999999999999999999999999999986533221 1111111 111111110 00000 122
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+..+.+++.+||+.||.+|||++|+++
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 3456889999999999999999999885
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=300.45 Aligned_cols=238 Identities=23% Similarity=0.298 Sum_probs=170.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHH--HHhcCCCcccceeeEEEe-----CCe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLGCCID-----KDE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~-----~~~ 186 (398)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 357899999999999999999987 58999999996543 2334444444 445899999999986653 235
Q ss_pred eEEEEeccCCCCh----------------------------------------hHHhhcCCCCCceecCCCCeEEccccc
Q 037365 187 KILIYEYMPNKSL----------------------------------------DFFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 187 ~~lV~e~~~~g~L----------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
.++||||+++|+| +++||||||+|||++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 7899999999987 357889999999999999999999999
Q ss_pred ceecCCCCc------ccccccccccccccChhhhcc-------CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchh
Q 037365 227 ARICGGNEL------QANTSRIVGTYGYMSPEYAIE-------GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL 293 (398)
Q Consensus 227 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~ 293 (398)
++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+...........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 987654321 112234579999999999986 4577899999999999999999877644322211100
Q ss_pred HHH------------HHhhh-cCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 294 GYA------------WDLWR-SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 294 ~~~------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
.+. ..... ......+.+.. ......+..+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW----KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC----CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCccc----ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 000 00000 00001111100 0122355679999999999999999999999999999875543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=303.82 Aligned_cols=214 Identities=27% Similarity=0.437 Sum_probs=169.1
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 456888999999999999999975 48899999996542 33456788999999999999999999999999999999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+.+ +| +++|+||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 999985 43 456789999999999999999999999976542
Q ss_pred ccccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 238 NTSRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.....||+.|+|||++. ++.++.++|||||||++|||++|+.||..... ............. ...
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~~-~~~----- 274 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNESP-ALQ----- 274 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCCC-CCC-----
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcCCC-CCC-----
Confidence 22357999999999985 56789999999999999999999999753211 1111121211111 000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
....+..+.+++.+||+.||++|||++++++.
T Consensus 275 ----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11123457899999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=306.74 Aligned_cols=227 Identities=27% Similarity=0.399 Sum_probs=164.7
Q ss_pred CCCccceecccCceEEEEEEEcC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe-CCeeEEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILI 190 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV 190 (398)
.|+..+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999998643 235899998654 33556789999999999999999999999765 4578999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+++|+| +++||||||+|||++.++.+||+|||+++.........
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 999999988 35678999999999999999999999998764332211
Q ss_pred --ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 238 --NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 238 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||...... +..... ... .....
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~---~~~-~~~~~------ 317 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---LQG-RRLLQ------ 317 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHH---HTT-CCCCC------
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHH---HcC-CCCCC------
Confidence 1233467889999999999999999999999999999999 56665432221 111111 111 10000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
+...+..+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus 318 ----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 318 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11223458899999999999999999999999999865443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.04 Aligned_cols=225 Identities=24% Similarity=0.355 Sum_probs=173.1
Q ss_pred hcCCCCccceecccCceEEEEEEEcC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
..++|+..+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998654 235999999765 34456788999999999999999999999764 5678
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+||||+++++| +++|+||||+|||++.++.+||+|||+++.......
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 99999999987 356779999999999999999999999987654322
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ........
T Consensus 169 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~----~~~~~~~~------ 235 (281)
T 3cc6_A 169 Y-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVL----EKGDRLPK------ 235 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHH----HHTCCCCC------
T ss_pred c-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHH----hcCCCCCC------
Confidence 1 2233467889999999999999999999999999999998 99997543221 111111 11110000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 236 ----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 236 ----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 11123457899999999999999999999999987643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=294.87 Aligned_cols=228 Identities=26% Similarity=0.347 Sum_probs=174.6
Q ss_pred hhcCCCCccc-eecccCceEEEEEEEc---CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 113 TATNRFSDAN-KLGEGGFGPVYKGVLR---KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 113 ~~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
...++|.+.+ .||+|+||.||+|.+. .++.||+|++.... ....+.+.+|+.++++++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456788877 9999999999999653 26789999997542 23457789999999999999999999999 5678
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
.++||||+++++| +++|+||||+|||++.++.+||+|||+++......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 8999999999987 35667999999999999999999999998775433
Q ss_pred cc-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 235 LQ-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ...........
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~~~~~~~~~~---- 241 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT----AMLEKGERMGC---- 241 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTTCCCCC----
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHHcCCCCCC----
Confidence 22 12223456789999999999899999999999999999999 99997543221 111 11111111111
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
+...+..+.+++.+||+.||++|||+.++++.|++....
T Consensus 242 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 242 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 112345688999999999999999999999999987654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=304.78 Aligned_cols=231 Identities=23% Similarity=0.320 Sum_probs=173.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4679999999999999999999874 889999999765 34456778999999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+++|+| +++|+||||+|||++.++.+||+|||++...... ..
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~ 187 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 187 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C-
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cc
Confidence 9999987 2567899999999999999999999998754321 12
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhH----------HH-------------
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLG----------YA------------- 296 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~----------~~------------- 296 (398)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ..
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 3457899999999999999999999999999999999999998643321110000 00
Q ss_pred -HHhhhcCCccccchhhhhcc---cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 297 -WDLWRSNRTLELTDAILEDE---YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 297 -~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..........+..+...... ......+..+.+++.+||+.||++|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000001111111110 001123456889999999999999999999996
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=300.20 Aligned_cols=227 Identities=30% Similarity=0.398 Sum_probs=173.1
Q ss_pred hcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
..++|++.+.||+|+||.||+|++. ++..||+|.+... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3468999999999999999999842 3778999999754 34455678899999999999999999999999999
Q ss_pred eEEEEeccCCCCh---------------------------------------hHHhhcCCCCCceecC---CCCeEEccc
Q 037365 187 KILIYEYMPNKSL---------------------------------------DFFLFNLKASNILLDK---DMNPKISDF 224 (398)
Q Consensus 187 ~~lV~e~~~~g~L---------------------------------------~~~~~dlkp~NILl~~---~~~~kl~DF 224 (398)
.++||||+++|+| +++|+||||+|||++. +..+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 9999999999877 2456799999999984 446999999
Q ss_pred ccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 225 GMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 225 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
|+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... ....
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~----~~~~ 261 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEF----VTSG 261 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHH----HHTT
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHH----HhcC
Confidence 99976544333333344578899999999999999999999999999999998 8888753221 111111 1111
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
..... ....+..+.+++.+||+.||.+|||+.++++.|+....
T Consensus 262 ~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 262 GRMDP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11110 11223457899999999999999999999999987654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=300.86 Aligned_cols=242 Identities=12% Similarity=0.106 Sum_probs=181.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC---------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccc---------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK---------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR--------- 176 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~--------- 176 (398)
.++|++.+.||+|+||.||+|++.. ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999864 788999999754 35788999999999999998
Q ss_pred ------eeeEEEe-CCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecC
Q 037365 177 ------LLGCCID-KDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDK 215 (398)
Q Consensus 177 ------l~~~~~~-~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~ 215 (398)
+++++.. ++..++||||+ +++| +++|+||||+|||++.
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 6777776 77899999999 8877 3567899999999999
Q ss_pred CC--CeEEcccccceecCCCCcc-----cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCC
Q 037365 216 DM--NPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTD 288 (398)
Q Consensus 216 ~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~ 288 (398)
++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999876532211 1123457999999999999999999999999999999999999998654323
Q ss_pred ccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCCCCcccc
Q 037365 289 TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSY 368 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~~~ 368 (398)
............. ......+.... ....+..+.+++.+||+.||++|||++++++.|+++...........+.|
T Consensus 275 ~~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw 348 (352)
T 2jii_A 275 TEDIMKQKQKFVD--KPGPFVGPCGH----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGL 348 (352)
T ss_dssp HHHHHHHHHHHHH--SCCCEECTTSC----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCC
T ss_pred HHHHHHHHHhccC--Chhhhhhhccc----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccC
Confidence 2222222111111 11111111110 01123458899999999999999999999999999877665444334444
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.06 Aligned_cols=221 Identities=19% Similarity=0.267 Sum_probs=174.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|++.+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 3678899999999999999999875 7789999985431 22346788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++|+| +++|+||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---- 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc----
Confidence 999999887 35677999999999999999999999997654322
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ ... ..
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~-~~---------- 231 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRIVN-VDL-KF---------- 231 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHT-TCC-CC----------
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHHhc-ccc-CC----------
Confidence 23457899999999999999999999999999999999999997542211 11111111 000 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhhccc
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTNEAA 356 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 356 (398)
+...+..+.+++.+||+.||.+|||++++++ .+.....
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 1122345789999999999999999999996 4554433
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=292.45 Aligned_cols=222 Identities=23% Similarity=0.320 Sum_probs=173.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--CCeeEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKIL 189 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 189 (398)
.++|++.+.||+|+||.||+|.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4688999999999999999999864 899999999654 34456778999999999999999999998864 568999
Q ss_pred EEeccCCCCh------------------------------------h-----HHhhcCCCCCceecCCCCeEEcccccce
Q 037365 190 IYEYMPNKSL------------------------------------D-----FFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 190 V~e~~~~g~L------------------------------------~-----~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
||||+++|+| + ++|+||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999877 2 7889999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... .........+
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~----~i~~~~~~~~ 236 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAG----KIREGKFRRI 236 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHTCCCCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHH----HHhhcccccC
Confidence 7643321 12235789999999999999999999999999999999999999764321 11111 1111111111
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
+...+..+.+++.+||+.||++|||++|+++.+...
T Consensus 237 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 237 ----------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ----------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 112234588999999999999999999999877654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.75 Aligned_cols=219 Identities=21% Similarity=0.306 Sum_probs=170.6
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|...+.||+|+||.||+++.. +|+.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467889999999999999999986 489999999986654455678899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCcee---cCCCCeEEcccccceecCCCCccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILL---DKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl---~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|+++++| +++|+||||+||++ +.++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----
Confidence 9999988 35677999999999 78899999999998764322
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..... . ...... ..... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~---~-i~~~~~-~~~~~-~---- 230 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFE---K-IKEGYY-EFESP-F---- 230 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH---H-HHHCCC-CCCTT-T----
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH---H-HHcCCC-CCCcc-c----
Confidence 12335689999999999999999999999999999999999999753221 11111 1 111110 00000 0
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||++|||++|+++
T Consensus 231 -~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 -WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122356889999999999999999999996
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.29 Aligned_cols=226 Identities=27% Similarity=0.395 Sum_probs=171.3
Q ss_pred CCCCccc-eecccCceEEEEEEEc---CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDAN-KLGEGGFGPVYKGVLR---KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||++++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999875 35679999997653 3456789999999999999999999999976 569999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc-
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ- 236 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 236 (398)
|||+++|+| +++||||||+|||++.++.+||+|||+++........
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999999988 3567899999999999999999999999876433211
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..... ...+.....
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~----i~~~~~~~~------- 560 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF----IEQGKRMEC------- 560 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHH----HHTTCCCCC-------
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCCCCC-------
Confidence 11223346789999999999999999999999999999998 99997643221 11111 111111111
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
+..++..+.+++.+||+.||++|||+.++++.|+......
T Consensus 561 ---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 561 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1223456889999999999999999999999999875544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.33 Aligned_cols=230 Identities=18% Similarity=0.202 Sum_probs=168.9
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4789999999999999999999864 888999999654 233356788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++++| +++|+||||+|||++.++.+||+|||++........ ..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQ 191 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-cc
Confidence 999999887 356779999999999999999999999976654321 12
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........... .. ...
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~-~~--~~~----- 257 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAIP-RP--STV----- 257 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCCC-CG--GGT-----
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCCC-Cc--ccc-----
Confidence 23457899999999999999999999999999999999999997532211 11111111100 00 000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHhhcccccC
Q 037365 319 SKQVLLRYVNIALLCVQESADDRP-TTNDVVSMLTNEAAALL 359 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~ 359 (398)
....+..+.+++.+||+.||++|| |++++++.|++......
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 122234578999999999999999 99999999998765443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=295.98 Aligned_cols=228 Identities=16% Similarity=0.275 Sum_probs=172.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEe--CCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCID--KDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV 190 (398)
.++|++.+.||+|+||.||+|++.. ++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 3679999999999999999999754 8999999997543 367889999999997 9999999999998 6678999
Q ss_pred EeccCCCCh-----------------------------hHHhhcCCCCCceecCCC-CeEEcccccceecCCCCcccccc
Q 037365 191 YEYMPNKSL-----------------------------DFFLFNLKASNILLDKDM-NPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 191 ~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
|||+++++| +++|+||||+|||++.++ .+||+|||+++....... ..
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~ 188 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YN 188 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CC
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cc
Confidence 999999987 356789999999999776 899999999987654332 23
Q ss_pred cccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHH--------HhhhcCCc--c---
Q 037365 241 RIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW--------DLWRSNRT--L--- 306 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~--------~~~~~~~~--~--- 306 (398)
...||..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+..... ........ .
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 3578999999999987 66899999999999999999999998544332221111110 00000000 0
Q ss_pred ---------ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ---------ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ---------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......... .........+.+++.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHS-ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHCCCCCCCGGGGCCT-TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhccccchhhhccc-cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 001123456899999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=299.88 Aligned_cols=235 Identities=21% Similarity=0.331 Sum_probs=166.7
Q ss_pred CCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhh-HHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|+..+.||+|+||.||+|+.. +++.||+|++....... ...+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999987 48899999996543221 12345799999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
+++ +| +++|+||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccc
Confidence 985 43 45678999999999999999999999998654322 1223
Q ss_pred cccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc----
Q 037365 241 RIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED---- 315 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 315 (398)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ................... ......
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~ 235 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EEQLHFIFRILGTPTEETW-PGILSNEEFK 235 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTS-TTGGGCHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHhc-hhhhcchhhc
Confidence 4578999999999986 5689999999999999999999999864322 1222222221111110000 000000
Q ss_pred ---------c---cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhhccc
Q 037365 316 ---------E---YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTNEAA 356 (398)
Q Consensus 316 ---------~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 356 (398)
. ...+.....+.+++.+||+.||++|||++|+++ .+.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0 001122356789999999999999999999997 4555443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=292.55 Aligned_cols=216 Identities=23% Similarity=0.367 Sum_probs=150.9
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 357899999999999999999985 48999999986432 12346788999999999999999999999999999999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
|||+++++| +++|+||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 999999877 356679999999999999999999999987653321
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . ..... . .. ..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~~-~---~~---~~---- 231 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L---NKVVL-A---DY---EM---- 231 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCS-S---CC---CC----
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H---HHHhh-c---cc---CC----
Confidence 12235789999999999998999999999999999999999999764322110 0 00000 0 00 00
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+...+..+.+++.+||+.||++|||++++++
T Consensus 232 -~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 -PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1112345789999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=290.64 Aligned_cols=217 Identities=23% Similarity=0.320 Sum_probs=174.0
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|...+.||+|+||.||++.+.+ ++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4678899999999999999999875 788999998643 334556788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||+++++| +++|+||||+|||++.++.+||+|||+++....... .
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 171 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--R 171 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--c
Confidence 999999987 356679999999999999999999999987653321 2
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...... ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~-~~---------- 234 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLR-IKKNEY-SI---------- 234 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH-HHTTCC-CC----------
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HhhccC-CC----------
Confidence 23457899999999999989999999999999999999999997543211 11111 111110 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+......+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11123457899999999999999999999963
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.22 Aligned_cols=232 Identities=25% Similarity=0.381 Sum_probs=178.0
Q ss_pred cCCCCccceecccCceEEEEEEE-----cCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC--ee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVL-----RKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~ 187 (398)
.++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999985 248899999998777677788999999999999999999999987654 78
Q ss_pred EEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 188 ILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 188 ~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
++||||+++++| +++|+||||+|||++.++.+||+|||+++......
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 999999999988 35567999999999999999999999998775443
Q ss_pred cc-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc----------cchhHHHHHhhhcC
Q 037365 235 LQ-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT----------LNLLGYAWDLWRSN 303 (398)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~----------~~~~~~~~~~~~~~ 303 (398)
.. .......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ..............
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 21 11233457788999999999999999999999999999999998864221000 00000000111110
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.... .+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 280 ~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 280 GRLP----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp CCCC----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC----------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000 012234568899999999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=292.44 Aligned_cols=218 Identities=24% Similarity=0.361 Sum_probs=172.9
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe---------
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--------- 183 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------- 183 (398)
..++|+..+.||+|+||.||+|.+. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467889999999999999999987 58999999997654 346789999999999999999999865
Q ss_pred -------CCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEc
Q 037365 184 -------KDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 184 -------~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~ 222 (398)
....++||||+++|+| +++|+||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 3458999999999988 34567999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS 302 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 302 (398)
|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.. ... .......
T Consensus 165 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-------~~~-~~~~~~~ 233 (284)
T 2a19_B 165 DFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------TSK-FFTDLRD 233 (284)
T ss_dssp CCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-------HHH-HHHHHHT
T ss_pred cchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-------HHH-HHHHhhc
Confidence 9999987754321 2335789999999999999999999999999999999999988421 000 1111111
Q ss_pred CCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 303 NRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
.. . ....+..+.+++.+||+.||++|||+.|+++.|+.......
T Consensus 234 ~~--------~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 234 GI--------I-----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp TC--------C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred cc--------c-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 1 11123457799999999999999999999999998765443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.59 Aligned_cols=217 Identities=22% Similarity=0.325 Sum_probs=165.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|...+.||+|+||.||++.... +..+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 4678999999999999999999865 889999998654 23346788999999999999999999999999999999999
Q ss_pred ccCCCCh------------------------------------hHHhhcCCCCCcee---cCCCCeEEcccccceecCCC
Q 037365 193 YMPNKSL------------------------------------DFFLFNLKASNILL---DKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 193 ~~~~g~L------------------------------------~~~~~dlkp~NILl---~~~~~~kl~DFGla~~~~~~ 233 (398)
|+++|+| +++|+||||+|||+ +.++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 9999987 35667999999999 45678999999999866543
Q ss_pred CcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...... ............... .
T Consensus 181 ~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~-~--- 247 (285)
T 3is5_A 181 E---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----EVQQKATYKEPNYAV-E--- 247 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCCCC-----
T ss_pred c---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----HHHhhhccCCccccc-c---
Confidence 2 223457899999999875 56899999999999999999999997543211 111111111000000 0
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.+++.+||+.||++|||+.|+++
T Consensus 248 -----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 -----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0012345789999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=301.97 Aligned_cols=220 Identities=21% Similarity=0.240 Sum_probs=169.1
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
..++|+..+.||+|+||.||+|.+.. ++.||+|.+..... ...+|++++.++ +||||+++++++.+++..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 35679999999999999999999875 88999999976532 235688888888 7999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCC----CCeEEcccccceecCCCCc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKD----MNPKISDFGMARICGGNEL 235 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~----~~~kl~DFGla~~~~~~~~ 235 (398)
||+++|+| +++||||||+|||+.++ +.+||+|||+++.......
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99999987 45678999999998433 3599999999987654322
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....... ...+... ....
T Consensus 176 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~-i~~~~~~-~~~~---- 245 (342)
T 2qr7_A 176 --LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILAR-IGSGKFS-LSGG---- 245 (342)
T ss_dssp --CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHH-HHHCCCC-CCST----
T ss_pred --ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHH-HccCCcc-cCcc----
Confidence 2334578999999999998889999999999999999999999986432221 1111111 1111110 0000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 246 -~-~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 246 -Y-WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -T-TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -c-cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 1223456789999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=299.17 Aligned_cols=231 Identities=23% Similarity=0.359 Sum_probs=168.6
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.++|+..+.||+|+||.||+|++.. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4679999999999999999999876 899999998654 3334566789999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+++++| +++|+||||+|||++.++.+||+|||+++....... ..
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 181 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VY 181 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--cc
Confidence 99998866 356789999999999999999999999986643321 22
Q ss_pred ccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH----------HHhhhcC-----
Q 037365 240 SRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA----------WDLWRSN----- 303 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~----------~~~~~~~----- 303 (398)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.... ...+...
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 345789999999999875 68999999999999999999999976433211 111000 0001000
Q ss_pred -CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 304 -RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 304 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
............. ..+..+..+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 261 VRLPEIKEREPLER-RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCCSSCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCccccccchhhh-cccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000000 01123456889999999999999999999885
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=299.08 Aligned_cols=225 Identities=12% Similarity=0.136 Sum_probs=176.2
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEE------EcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCcccceee
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGV------LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLG 179 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~ 179 (398)
.++....++|.+.+.||+|+||.||+|. ...++.||+|++.... ...+..|..++.+++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3445566889999999999999999994 3348899999997654 356778888888887 999999999
Q ss_pred EEEeCCeeEEEEeccCCCCh-------------------------------------hHHhhcCCCCCceecC-------
Q 037365 180 CCIDKDEKILIYEYMPNKSL-------------------------------------DFFLFNLKASNILLDK------- 215 (398)
Q Consensus 180 ~~~~~~~~~lV~e~~~~g~L-------------------------------------~~~~~dlkp~NILl~~------- 215 (398)
++..++..++||||+++|+| +++||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999987 3567899999999988
Q ss_pred ----CCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccc
Q 037365 216 ----DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLN 291 (398)
Q Consensus 216 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~ 291 (398)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 899999999999876433222334456899999999999999999999999999999999999999642211100
Q ss_pred hhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCC-CCHHHHHHHHhhcccc
Q 037365 292 LLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDR-PTTNDVVSMLTNEAAA 357 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-Pt~~evl~~L~~~~~~ 357 (398)
.......... ....+.+++..|++.+|.+| |+++++.+.|++....
T Consensus 294 ----------------~~~~~~~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 ----------------KPEGLFRRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ----------------EECSCCTTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------------eechhccccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0011111101 13346789999999999999 6888888888876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=297.31 Aligned_cols=229 Identities=23% Similarity=0.314 Sum_probs=174.5
Q ss_pred cchhhhhhhcCCCCcc-ceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcC-CCcccceeeE
Q 037365 106 FSFSSVSTATNRFSDA-NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQ-HKNLVRLLGC 180 (398)
Q Consensus 106 ~~~~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~ 180 (398)
..+...+...++|.+. +.||+|+||.||+|.... ++.||+|++... .......+.+|+.++.++. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4445556667788887 889999999999999875 899999998654 2334678899999999995 6999999999
Q ss_pred EEeCCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecC---CCCeEEcc
Q 037365 181 CIDKDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDK---DMNPKISD 223 (398)
Q Consensus 181 ~~~~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~---~~~~kl~D 223 (398)
+.+.+..++||||+++|+| +++|+||||+|||++. ++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 9999999999999999876 3567899999999987 78999999
Q ss_pred cccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 224 FGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 224 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .......
T Consensus 178 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~---~~i~~~~ 249 (327)
T 3lm5_A 178 FGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--ETY---LNISQVN 249 (327)
T ss_dssp GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHHTC
T ss_pred CccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHH---HHHHhcc
Confidence 99998765332 123457999999999999999999999999999999999999997542211 111 1111100
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. ...... .......+.+++.+||+.||++|||++|+++.
T Consensus 250 -~-~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 -V-DYSEET------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -C-CCCTTT------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -c-ccCchh------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 000000 11223457899999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=292.72 Aligned_cols=231 Identities=22% Similarity=0.324 Sum_probs=166.5
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-----hhhHHHHHHHHHHHHhcC---CCcccceeeEEEe
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-----GQGLREMKNEASVIAKVQ---HKNLVRLLGCCID 183 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~ 183 (398)
...++|++.+.||+|+||.||+|++.. ++.||+|++.... ......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 346799999999999999999999754 8999999986322 112245667777777664 9999999999987
Q ss_pred CC-----eeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEccc
Q 037365 184 KD-----EKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDF 224 (398)
Q Consensus 184 ~~-----~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DF 224 (398)
.. ..++||||+.+ +| +++|+||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 57999999975 55 3567899999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC
Q 037365 225 GMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR 304 (398)
Q Consensus 225 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 165 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 165 GLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPP 239 (308)
T ss_dssp SCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred ccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence 9998654332 234467899999999999999999999999999999999999997543221 11111111111100
Q ss_pred cccc------chhhhhcc--cC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 305 TLEL------TDAILEDE--YS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 305 ~~~~------~~~~~~~~--~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.... ........ .. .+.....+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 00000000 00 1123356889999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=315.30 Aligned_cols=220 Identities=23% Similarity=0.356 Sum_probs=174.0
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|+..+.||+|+||.||+|++.. |+.||+|++.... ......+.+|..++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 4678999999999999999999865 8999999996432 23346788999999999999999999999999999999
Q ss_pred EeccCCCCh------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 191 YEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 191 ~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
|||+++|+| +++||||||+|||++.++.+||+|||+++......
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 999999987 35678999999999999999999999998765433
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............. . ..
T Consensus 344 ~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~-~-~~------ 412 (543)
T 3c4z_A 344 T--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQA-V-TY------ 412 (543)
T ss_dssp C--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCC-C-CC------
T ss_pred c--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhcc-c-CC------
Confidence 2 2334589999999999999999999999999999999999999986532211 1111111111110 0 00
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCH-----HHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTT-----NDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~ 349 (398)
+...+..+.+++.+||+.||++||++ +++++
T Consensus 413 ----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 413 ----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 12234567899999999999999975 66764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=310.05 Aligned_cols=225 Identities=22% Similarity=0.289 Sum_probs=172.3
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh-------------hhHHHHHHHHHHHHhcCCCccccee
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG-------------QGLREMKNEASVIAKVQHKNLVRLL 178 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~ 178 (398)
...++|++.+.||+|+||.||+|.... ++.||+|++..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 346789999999999999999999875 78999999865421 2356788999999999999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCC---CeEEcc
Q 037365 179 GCCIDKDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDM---NPKISD 223 (398)
Q Consensus 179 ~~~~~~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~---~~kl~D 223 (398)
+++.+++..++|||||++|+| +++||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999987 356789999999998776 699999
Q ss_pred cccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcC
Q 037365 224 FGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSN 303 (398)
Q Consensus 224 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 303 (398)
||+++...... ......||+.|+|||++. +.++.++|||||||++|+|++|..||..... .... ..... .
T Consensus 193 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~---~~i~~-~ 262 (504)
T 3q5i_A 193 FGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDII---KKVEK-G 262 (504)
T ss_dssp CTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHH-C
T ss_pred CCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHc-C
Confidence 99998775432 233457999999999886 5699999999999999999999999753221 1111 11111 1
Q ss_pred CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhhc
Q 037365 304 RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTNE 354 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~~ 354 (398)
..... ... ....+..+.+++.+||+.||.+|||++|+++ .+++.
T Consensus 263 ~~~~~-~~~------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 263 KYYFD-FND------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCCCC-HHH------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCCCC-ccc------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 10000 000 1122356889999999999999999999995 34443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=287.00 Aligned_cols=218 Identities=25% Similarity=0.400 Sum_probs=167.6
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
+.|.....||+|+||.||+|.+.. ++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 456666799999999999999754 8899999998766666678999999999999999999999999999999999999
Q ss_pred CCCCh-----------------------------------hHHhhcCCCCCceecC-CCCeEEcccccceecCCCCcccc
Q 037365 195 PNKSL-----------------------------------DFFLFNLKASNILLDK-DMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 195 ~~g~L-----------------------------------~~~~~dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
++++| +++|+||||+||+++. ++.+||+|||+++...... ..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Cc
Confidence 98877 3456799999999987 8999999999998765332 12
Q ss_pred cccccccccccChhhhccCC--CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 239 TSRIVGTYGYMSPEYAIEGI--FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.....||+.|+|||++.+.. ++.++||||||+++|||++|+.||............ .... .....+
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~--~~~~~~-------- 247 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK--VGMF--KVHPEI-------- 247 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH--HHHH--CCCCCC--------
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh--hccc--cccccc--------
Confidence 23457899999999998654 889999999999999999999997532211110000 0000 000000
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+...+..+.+++.+||+.||++|||++++++
T Consensus 248 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 --PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122345789999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=309.15 Aligned_cols=209 Identities=14% Similarity=0.205 Sum_probs=161.0
Q ss_pred hhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC---ChhhHHHHHHHH---HHHHhcCCCccccee-------
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR---SGQGLREMKNEA---SVIAKVQHKNLVRLL------- 178 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~------- 178 (398)
...++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+ .++++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 34578999999999999999999974 4899999999632 344567889999 555666899999998
Q ss_pred eEEEeCCe-----------------eEEEEeccCCCCh---------------------------------------hHH
Q 037365 179 GCCIDKDE-----------------KILIYEYMPNKSL---------------------------------------DFF 202 (398)
Q Consensus 179 ~~~~~~~~-----------------~~lV~e~~~~g~L---------------------------------------~~~ 202 (398)
+++.+++. .++||||+ +|+| +++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 66665532 78999999 5676 356
Q ss_pred hhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccC-----------CCCcccccHHHHHH
Q 037365 203 LFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG-----------IFSIKFDVFSFGVL 271 (398)
Q Consensus 203 ~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvv 271 (398)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 789999999999999999999999986432 2234567 999999999987 89999999999999
Q ss_pred HHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 272 LLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 272 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+|||++|+.||....... ........ ....+..+.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~------------------~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG------------------GSEWIFRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C------------------CSGGGGSS---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc------------------chhhhhhh---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999975322111 01111110 0112345789999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=291.05 Aligned_cols=218 Identities=21% Similarity=0.393 Sum_probs=174.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.+.|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 4578899999999999999999764 8899999996543 3456788999999999999999999999999999999999
Q ss_pred ccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 193 YMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 193 ~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
|+++++| +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 178 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNT 178 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCC
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCc
Confidence 9999887 356779999999999999999999999987654332 2234
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ... ........ . ...
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~~-~~~~~~~~-----~-----~~~ 242 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KV---LFL-IPKNNPPT-----L-----EGN 242 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HH---HHH-HHHSCCCC-----C-----CSS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HH---HHH-hhcCCCCC-----C-----ccc
Confidence 57899999999999999999999999999999999999997532211 11 111 11111111 1 111
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.+..+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 23457899999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=312.23 Aligned_cols=220 Identities=24% Similarity=0.307 Sum_probs=170.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
..++|++.+.||+|+||.||+|++.. ++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 45789999999999999999999864 899999998532 223457789999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceec---CCCCeEEcccccceecCCCCc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLD---KDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~---~~~~~kl~DFGla~~~~~~~~ 235 (398)
|||+++|+| +++||||||+|||++ .++.+||+|||+++......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 999999987 467789999999995 45679999999998664432
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .... ............ . .
T Consensus 179 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~---~~i~~~~~~~~~-~-~--- 245 (486)
T 3mwu_A 179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDIL---KRVETGKYAFDL-P-Q--- 245 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHTCCCSCS-G-G---
T ss_pred --ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHhCCCCCCC-c-c---
Confidence 2234579999999999875 599999999999999999999999753211 1111 111111100000 0 0
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 246 ---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 ---WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11233567899999999999999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=290.29 Aligned_cols=219 Identities=28% Similarity=0.404 Sum_probs=167.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-CeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~e 192 (398)
..++|+..+.||+|+||.||+|.+. ++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 3568999999999999999999985 8899999997543 446789999999999999999999997654 47899999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++|+| +++|+||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-----
Confidence 9999987 3566799999999999999999999998765432
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... .........
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~----~~~~~~~~~--------- 235 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR----VEKGYKMDA--------- 235 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHH----HTTTCCCCC---------
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HhcCCCCCC---------
Confidence 122367889999999999999999999999999999998 99987543221 11111 111110000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 236 -~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 236 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 11223468899999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=301.46 Aligned_cols=211 Identities=22% Similarity=0.344 Sum_probs=170.7
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCcccceeeEEEeC
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--------QGLREMKNEASVIAKVQHKNLVRLLGCCIDK 184 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 184 (398)
..++|++.+.||+|+||.||+|++.. ++.||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45689999999999999999999765 88899999975421 1234567899999999999999999999999
Q ss_pred CeeEEEEeccCCC-Ch--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 185 DEKILIYEYMPNK-SL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 185 ~~~~lV~e~~~~g-~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
+..++||||+.+| +| +++|+||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999877 65 45678999999999999999999999998775
Q ss_pred CCCcccccccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
.... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . .
T Consensus 182 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~---------~ 238 (335)
T 3dls_A 182 RGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------V---------E 238 (335)
T ss_dssp TTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------T---------T
T ss_pred CCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------H---------h
Confidence 4332 234579999999999998877 88999999999999999999997531110 0 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..... +...+..+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHP---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCC---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 11123457899999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=298.27 Aligned_cols=223 Identities=21% Similarity=0.325 Sum_probs=173.0
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCCh--------hhHHHHHHHHHHHHhc-CCCcccceeeE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSG--------QGLREMKNEASVIAKV-QHKNLVRLLGC 180 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~~~ 180 (398)
.....++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999986 599999999865431 1245678899999999 79999999999
Q ss_pred EEeCCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 181 CIDKDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 181 ~~~~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
+...+..++||||+++++| +++|+||||+|||++.++.+||+|||++.
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 9999999999999999987 35678999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccChhhhcc------CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIE------GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS 302 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 302 (398)
.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...... ...
T Consensus 249 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~----i~~ 319 (365)
T 2y7j_A 249 HLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRM----IME 319 (365)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHH
T ss_pred ccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHH----HHh
Confidence 775432 2234679999999999864 3588999999999999999999999753211 111111 111
Q ss_pred CCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 303 NRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.... ...+. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 320 ~~~~-~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 GQYQ-FSSPE------WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp TCCC-CCHHH------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-CCCcc------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1100 00000 0112345889999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.76 Aligned_cols=220 Identities=26% Similarity=0.348 Sum_probs=174.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|+..+.||+|+||.||+|+... |+.||+|++... .......+.+|+.+|++++||||+++++++.+.+..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 44679999999999999999999864 899999998643 12334667899999999999999999999999999999
Q ss_pred EEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 190 IYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 190 V~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||||+++|+| +++||||||+|||++.++.+||+|||+++.......
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 9999999988 356789999999999999999999999988754332
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .......... ...
T Consensus 342 ---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~-~i~~~i~~~~-~~~------- 408 (576)
T 2acx_A 342 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KRE-EVERLVKEVP-EEY------- 408 (576)
T ss_dssp ---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHH-HHHHHHHHCC-CCC-------
T ss_pred ---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHH-HHHHHhhccc-ccC-------
Confidence 233589999999999999999999999999999999999999986433211 111 1111111100 000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
+...+..+.+++.+||+.||.+|| +++|+++
T Consensus 409 ---p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 ---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 112234678999999999999999 7889885
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=307.09 Aligned_cols=164 Identities=23% Similarity=0.399 Sum_probs=125.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-----C
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----D 185 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~ 185 (398)
..++|++.+.||+|+||.||+|++.. ++.||||++... .....+.+.+|+.+|++++||||+++++++... +
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 34789999999999999999999764 899999999653 344567789999999999999999999999543 5
Q ss_pred eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 186 EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 186 ~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
..|+||||+. |+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 7899999985 444 4678899999999999999999999999876432
Q ss_pred Ccc-------------------------cccccccccccccChhhhc-cCCCCcccccHHHHHHHHHHHcC
Q 037365 234 ELQ-------------------------ANTSRIVGTYGYMSPEYAI-EGIFSIKFDVFSFGVLLLEIVSG 278 (398)
Q Consensus 234 ~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg 278 (398)
... ......+||+.|+|||++. +..++.++|||||||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 110 1233457899999999864 56799999999999999999994
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=296.55 Aligned_cols=233 Identities=21% Similarity=0.298 Sum_probs=166.3
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChh-----hHHHHHHHHHHHHhcCCCcccceeeEEEeCCe
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 186 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 186 (398)
...++|+..+.||+|+||.||+|.+.. |+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345789999999999999999999865 899999999653211 12467899999999999999999999999999
Q ss_pred eEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 187 KILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 187 ~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
.++||||+++ +| +++|+||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999986 43 4677899999999999999999999999876433
Q ss_pred CcccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc----
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL---- 308 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 308 (398)
. .......||+.|+|||++.+. .++.++|||||||++|||++|.+||..... ...................
T Consensus 166 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 166 N--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp C--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTTSSSTT
T ss_pred c--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHcCCCChhhhhhhc
Confidence 2 123345789999999999764 489999999999999999999988754321 1111111111111000000
Q ss_pred --chhhhhccc---C----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 309 --TDAILEDEY---S----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 309 --~~~~~~~~~---~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.+....... . .......+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000 0 01223568899999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=290.24 Aligned_cols=223 Identities=19% Similarity=0.216 Sum_probs=169.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC----hhhHHHHHHHHHHHHhcCCCcccceeeEEE--eCCee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCI--DKDEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 187 (398)
.++|++.+.||+|+||.||++.... ++.||+|.+.... ......+.+|+.++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4789999999999999999999864 8899999996532 234567899999999999999999999985 45578
Q ss_pred EEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 188 ILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 188 ~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
++||||++++.. +++|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999987721 35678999999999999999999999998765433
Q ss_pred cccccccccccccccChhhhccCC--CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGI--FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.........||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ...... ...... .
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~-i~~~~~-~----- 231 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFEN-IGKGSY-A----- 231 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH-HHHCCC-C-----
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHH-HhcCCC-C-----
Confidence 223334457899999999998644 47899999999999999999999753211 111111 111110 0
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--Hhhc
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM--LTNE 354 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~~ 354 (398)
. .......+.+++.+||+.||.+|||++|+++. +++.
T Consensus 232 ~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 232 I-----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp C-----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred C-----CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 0 11123457899999999999999999999963 4443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=286.90 Aligned_cols=218 Identities=22% Similarity=0.292 Sum_probs=169.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
++|++.+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 568889999999999999999874 8999999986542 123678899999999999999999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCC----CeEEcccccceecCC
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDM----NPKISDFGMARICGG 232 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~----~~kl~DFGla~~~~~ 232 (398)
+||||+++++| +++|+||||+||+++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 99999999988 356679999999998877 899999999987654
Q ss_pred CCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ......... .. ...
T Consensus 165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~~~~-~~-~~~ 233 (283)
T 3bhy_A 165 GNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ET----LTNISAVNY-DF-DEE 233 (283)
T ss_dssp ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HH----HHHHHTTCC-CC-CHH
T ss_pred CCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HH----HHHhHhccc-CC-cch
Confidence 321 23356899999999999999999999999999999999999997542211 11 111111100 00 000
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 234 Y-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp H-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 1112345789999999999999999999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=304.40 Aligned_cols=168 Identities=21% Similarity=0.386 Sum_probs=137.5
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-----Ce
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 186 (398)
.++|++.+.||+|+||.||+|++.. ++.||||++... .....+.+.+|+.+|++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4789999999999999999999865 788999999754 334557889999999999999999999999876 57
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
.|+||||+++ +| +++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 8999999874 55 46778999999999999999999999998765432
Q ss_pred cc--------------------cccccccccccccChhhh-ccCCCCcccccHHHHHHHHHHHcCCCCCC
Q 037365 235 LQ--------------------ANTSRIVGTYGYMSPEYA-IEGIFSIKFDVFSFGVLLLEIVSGKKNTG 283 (398)
Q Consensus 235 ~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~P~~ 283 (398)
.. ......+||+.|+|||++ .+..++.++|||||||++|||++|..|+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 11 112456899999999986 45669999999999999999998665543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=311.90 Aligned_cols=219 Identities=22% Similarity=0.314 Sum_probs=167.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
..++|+..+.||+|+||.||+|++.. +..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45679999999999999999999874 8899999986542 23356788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCC---CCeEEcccccceecCCCCc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKD---MNPKISDFGMARICGGNEL 235 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~---~~~kl~DFGla~~~~~~~~ 235 (398)
|||+++|+| +++||||||+|||++.. +.+||+|||+++......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 999999987 35678999999999764 459999999998775432
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
......||+.|+|||++. +.++.++|||||||++|+|++|..||..... ..+. ...... ... ...+.
T Consensus 194 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~---~~i~~~-~~~-~~~~~--- 260 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEIL---RKVEKG-KYT-FDSPE--- 260 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHT-CCC-CCSGG---
T ss_pred --cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHhC-CCC-CCchh---
Confidence 233457999999999886 5699999999999999999999999754221 1111 111111 100 00000
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||.+|||+.|+++
T Consensus 261 ---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 261 ---WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ---GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1122345789999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.45 Aligned_cols=217 Identities=17% Similarity=0.216 Sum_probs=160.8
Q ss_pred cCCCCcc-ceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHh-cCCCcccceeeEEEe----CCee
Q 037365 115 TNRFSDA-NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAK-VQHKNLVRLLGCCID----KDEK 187 (398)
Q Consensus 115 ~~~~~~~-~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~----~~~~ 187 (398)
.++|... +.||+|+||.||+|.+.. ++.||||++... ..+.+|+.++.+ .+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567665 689999999999999865 889999999643 456788888754 589999999999876 5678
Q ss_pred EEEEeccCCCCh----------------------------------hHHhhcCCCCCceecC---CCCeEEcccccceec
Q 037365 188 ILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDK---DMNPKISDFGMARIC 230 (398)
Q Consensus 188 ~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~---~~~~kl~DFGla~~~ 230 (398)
|+||||+++|+| +++||||||+|||++. ++.+||+|||+++..
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 999999999887 3567899999999987 789999999999876
Q ss_pred CCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCcc--chhHHHHHhhhcCCcccc
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTL--NLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 308 (398)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ...... ..
T Consensus 215 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~-~~ 286 (400)
T 1nxk_A 215 TSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQY-EF 286 (400)
T ss_dssp C--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCC-CC
T ss_pred CCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCcc-cC
Confidence 5332 23346789999999999999999999999999999999999999865432211 11111 110100 00
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 287 ~~~~------~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 PNPE------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CTTT------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcc------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 11234568899999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.19 Aligned_cols=220 Identities=26% Similarity=0.342 Sum_probs=173.8
Q ss_pred hhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
...++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34568999999999999999999987 48999999986442 345678899999999999999999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCcee---cCCCCeEEcccccceecCCC
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILL---DKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl---~~~~~~kl~DFGla~~~~~~ 233 (398)
+||||+.+|+| +++||||||+|||+ +.++.+||+|||+++.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999987 46778999999999 56789999999999876543
Q ss_pred CcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .... ............ +.
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~---~~i~~~~~~~~~--~~- 250 (484)
T 3nyv_A 183 K---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDIL---KKVEKGKYTFEL--PQ- 250 (484)
T ss_dssp C---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHCCCCCCS--GG-
T ss_pred c---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHH---HHHHcCCCCCCC--cc-
Confidence 2 2234579999999999865 699999999999999999999999754221 1111 111111100000 00
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||.+|||+.|+++
T Consensus 251 -----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 251 -----WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1223456889999999999999999999995
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=293.31 Aligned_cols=220 Identities=20% Similarity=0.384 Sum_probs=167.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|++.+.||+|+||.||+|.+.. ++.||+|.+........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45789999999999999999999875 88999999987666667889999999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+++++| +++|+||||+||+++.++.+||+|||++....... ...
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 174 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKR 174 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--ccc
Confidence 9999877 35667999999999999999999999875432111 112
Q ss_pred ccccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 240 SRIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
....||+.|+|||++. +..++.++||||||+++|||++|+.||...... ...............
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~------ 243 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSDPPTLL------ 243 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCCCCCS------
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHHHHhccCCcccC------
Confidence 2357899999999984 567899999999999999999999997543211 111111111111000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.....+..+.+++.+||+.||++|||+.++++
T Consensus 244 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 ---TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01222345789999999999999999999886
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=304.42 Aligned_cols=221 Identities=22% Similarity=0.325 Sum_probs=161.9
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--------hhhHHHHHHHHHHHHhcCCCcccceeeEEEe
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCID 183 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 183 (398)
...++|.+.+.||+|+||.||+|.... ++.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 456889999999999999999999865 7899999986431 112235789999999999999999999975
Q ss_pred CCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCC---CCeEEcccccce
Q 037365 184 KDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKD---MNPKISDFGMAR 228 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~---~~~kl~DFGla~ 228 (398)
.+..++||||+++|+| +++||||||+|||++.+ +.+||+|||+++
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 4568999999999988 35778999999999654 459999999998
Q ss_pred ecCCCCcccccccccccccccChhhhcc---CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIE---GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT 305 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 305 (398)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+... ......
T Consensus 291 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~----i~~~~~ 362 (419)
T 3i6u_A 291 ILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQ----ITSGKY 362 (419)
T ss_dssp SCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHH----HHTTCC
T ss_pred ecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHH----HhcCCC
Confidence 765332 2334679999999999863 668899999999999999999999986432221 11111 111111
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 306 LELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.. .... ....+..+.+++.+||+.||++|||++|+++
T Consensus 363 ~~-~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 NF-IPEV------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CC-CHHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-Cchh------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 0000 1112356889999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=298.30 Aligned_cols=232 Identities=20% Similarity=0.240 Sum_probs=164.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-----
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----- 185 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 185 (398)
..++|+..+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 35789999999999999999999765 888999999653 3445567889999999999999999999998765
Q ss_pred -eeEEEEeccCCCCh-----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 186 -EKILIYEYMPNKSL-----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 186 -~~~lV~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
..++||||++++.+ +++||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 181 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 181 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc-
Confidence 78999999986421 46778999999999999999999999998764322
Q ss_pred ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHh----------------
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDL---------------- 299 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~---------------- 299 (398)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 182 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 182 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred --ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 223457899999999999999999999999999999999999998643211 111000000
Q ss_pred ---hhcCCc------cccchhhhhcc--cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 300 ---WRSNRT------LELTDAILEDE--YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 300 ---~~~~~~------~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...... ........... .........+.+|+.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 00000000000 0012335678999999999999999999999963
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=298.33 Aligned_cols=232 Identities=21% Similarity=0.338 Sum_probs=166.9
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC-----
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----- 185 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 185 (398)
..++|+..+.||+|+||.||+|.+.. |+.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 35789999999999999999999864 899999999543 3344567889999999999999999999998753
Q ss_pred -eeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 186 -EKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 186 -~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
..|+||||+ +++| +++||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred ceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 469999999 6666 4567899999999999999999999999875432
Q ss_pred CcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+.......... ....+.....
T Consensus 182 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g-~~~~~~~~~~ 253 (367)
T 1cm8_A 182 -----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTG-TPPAEFVQRL 253 (367)
T ss_dssp -----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHC-CCCHHHHHTC
T ss_pred -----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcC-CCCHHHHHHh
Confidence 234578999999999987 6799999999999999999999999854321 111111111110 0000000000
Q ss_pred --------h-------hccc--ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--Hhhc
Q 037365 313 --------L-------EDEY--SSKQVLLRYVNIALLCVQESADDRPTTNDVVSM--LTNE 354 (398)
Q Consensus 313 --------~-------~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~~ 354 (398)
+ ...+ ........+.+|+.+||+.||++|||++|+++. +++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0 0000 011223568899999999999999999999973 4443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=286.26 Aligned_cols=217 Identities=23% Similarity=0.358 Sum_probs=164.7
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3578999999999999999999987 48999999986432 2335678899999999999999999999999999999
Q ss_pred EEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 190 IYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 190 V~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||+++++| +++|+||||+||+++.++.+||+|||++........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 166 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-- 166 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc--
Confidence 9999999988 356679999999999999999999999987654321
Q ss_pred ccccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... .... ........ ..
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~----~~~~~~~~-~~-------- 230 (276)
T 2h6d_A 167 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLF----KKIRGGVF-YI-------- 230 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHCCC-CC--------
T ss_pred -eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHH----HHhhcCcc-cC--------
Confidence 233478999999999988765 6899999999999999999999753211 1111 11111100 00
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
+......+.+++.+||+.||++|||++|+++.
T Consensus 231 --~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 --PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11123457899999999999999999999973
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=297.56 Aligned_cols=232 Identities=22% Similarity=0.289 Sum_probs=162.3
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
....++|++.+.||+|+||.||+|++.. ++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3445789999999999999999999764 88999999965432 23456789999999999999999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceec-----CCCCeEEcccccceecC
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLD-----KDMNPKISDFGMARICG 231 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~-----~~~~~kl~DFGla~~~~ 231 (398)
+||||+++ +| +++|+||||+|||++ .++.+||+|||+++...
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999985 55 467789999999994 45569999999998765
Q ss_pred CCCcccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc----
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL---- 306 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---- 306 (398)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ................
T Consensus 189 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 189 IPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSTT
T ss_pred Ccc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCchhhhhh
Confidence 332 123345789999999999875 4899999999999999999999998543221 1111111111000000
Q ss_pred ------------ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ------------ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......+.... .......+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVL-GALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHH-GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhc-ccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000000 0112356789999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=320.44 Aligned_cols=218 Identities=27% Similarity=0.354 Sum_probs=167.2
Q ss_pred ceecccCceEEEEEEEc---CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLR---KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||.||+|.+. .++.||||+++.. .....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 2578999999754 33446789999999999999999999999964 568999999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc-cccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIV 243 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~ 243 (398)
|+| +++||||||+|||++.++.+||+|||+++.+..... ........
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 987 467789999999999999999999999987654332 12223345
Q ss_pred ccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 244 GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 244 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .. ............ +..+
T Consensus 534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~----~~~i~~~~~~~~----------p~~~ 597 (635)
T 4fl3_A 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV----TAMLEKGERMGC----------PAGC 597 (635)
T ss_dssp -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHHHTTCCCCC----------CTTC
T ss_pred CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCCCCCC----------CCCC
Confidence 7889999999999999999999999999999998 99997543221 11 111111111111 1223
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+..+.+++.+||+.||++|||++++++.|++...
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4568899999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=294.95 Aligned_cols=234 Identities=19% Similarity=0.281 Sum_probs=169.9
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEe--------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID-------- 183 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------- 183 (398)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999985 48999999985542 2234567899999999999999999999987
Q ss_pred CCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 184 KDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
.+..++||||++++.+ +++|+||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 3468999999986322 46778999999999999999999999998765
Q ss_pred CCCc--ccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc---
Q 037365 232 GNEL--QANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT--- 305 (398)
Q Consensus 232 ~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 305 (398)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...............
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhhc
Confidence 3221 122344578999999999976 45899999999999999999999997643221 111111111110000
Q ss_pred ccc-----chh---hhhcccChHH------HHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 306 LEL-----TDA---ILEDEYSSKQ------VLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 306 ~~~-----~~~---~~~~~~~~~~------~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
... .+. .......... ....+.+|+.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000 000 0000000011 12457899999999999999999999973
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=294.13 Aligned_cols=225 Identities=28% Similarity=0.386 Sum_probs=171.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCE--EEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNE--IAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|+..+.||+|+||.||+|++.. +.. +|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 578889999999999999999764 554 499998653 333456788999999999 899999999999999999999
Q ss_pred EeccCCCChh------------------------------------------------HHhhcCCCCCceecCCCCeEEc
Q 037365 191 YEYMPNKSLD------------------------------------------------FFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 191 ~e~~~~g~L~------------------------------------------------~~~~dlkp~NILl~~~~~~kl~ 222 (398)
|||+++|+|. ++|+||||+|||++.++.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 9999998762 4567999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhh
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWR 301 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 301 (398)
|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .. . ....
T Consensus 185 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~---~-~~~~ 255 (327)
T 1fvr_A 185 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL---Y-EKLP 255 (327)
T ss_dssp CTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH---H-HHGG
T ss_pred ccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HH---H-HHhh
Confidence 99998743211 12223457889999999999899999999999999999998 99997532211 11 1 1111
Q ss_pred cCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccC
Q 037365 302 SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 359 (398)
....... ....+..+.+++.+||+.||.+|||++|+++.|+++.....
T Consensus 256 ~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 256 QGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp GTCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cCCCCCC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1100000 11223458899999999999999999999999998766543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=284.22 Aligned_cols=215 Identities=24% Similarity=0.360 Sum_probs=167.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe----CCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 188 (398)
..|...+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 457778899999999999999865 788999998643 44556788999999999999999999999876 35689
Q ss_pred EEEeccCCCCh--------------------------------h--HHhhcCCCCCceec-CCCCeEEcccccceecCCC
Q 037365 189 LIYEYMPNKSL--------------------------------D--FFLFNLKASNILLD-KDMNPKISDFGMARICGGN 233 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~--~~~~dlkp~NILl~-~~~~~kl~DFGla~~~~~~ 233 (398)
+||||+++|+| + ++|+||||+|||++ .++.+||+|||++......
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999999987 3 78899999999997 7899999999999754432
Q ss_pred CcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. .....||+.|+|||++. +.++.++|||||||++|+|++|+.||....... ..... ......... .
T Consensus 186 ~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~-~~~~~~~~~----~ 251 (290)
T 1t4h_A 186 F----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYRR-VTSGVKPAS----F 251 (290)
T ss_dssp S----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHHH-HTTTCCCGG----G
T ss_pred c----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----HHHHH-HhccCCccc----c
Confidence 2 23357899999999876 459999999999999999999999975432211 11111 111111100 0
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||.+|||+.|+++
T Consensus 252 -----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 -----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111235789999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=289.88 Aligned_cols=226 Identities=25% Similarity=0.364 Sum_probs=166.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC--CC--EEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK--GN--EIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
.++|++.+.||+|+||.||+|++.. ++ .||+|.+... .....+.+.+|+.++++++||||+++++++.+++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4679999999999999999998643 33 6899998654 2345678899999999999999999999998755 8
Q ss_pred EEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 188 ILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 188 ~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
++||||+++|+| +++|+||||+||+++.++.+||+|||+++......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 999999999987 35667999999999999999999999998775433
Q ss_pred cc-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 235 LQ-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.. .......+|..|+|||++.+..++.++||||||+++|||++ |+.||...... ...............
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~---- 246 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGERLPR---- 246 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCCCCCC----
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHHHHHccCCCCCC----
Confidence 21 12234567889999999999999999999999999999999 99997533211 111111111111100
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....+..+.+++.+||+.||++|||+.++++.|++..+
T Consensus 247 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 247 ------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11233568899999999999999999999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=292.97 Aligned_cols=228 Identities=22% Similarity=0.384 Sum_probs=168.4
Q ss_pred CccchhhhhhhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEE
Q 037365 104 PLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCC 181 (398)
Q Consensus 104 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 181 (398)
..+.+.++....++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34556667778899999999999999999999985 48999999986543 2346788999999999 799999999999
Q ss_pred Ee------CCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEE
Q 037365 182 ID------KDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKI 221 (398)
Q Consensus 182 ~~------~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl 221 (398)
.. .+..++||||+++|+| +++|+||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEE
Confidence 87 4688999999999877 3566799999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH
Q 037365 222 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA 296 (398)
Q Consensus 222 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 296 (398)
+|||++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||...... ...
T Consensus 171 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~ 243 (326)
T 2x7f_A 171 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RAL 243 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHH
T ss_pred eeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----HHH
Confidence 9999998654322 1223457899999999997 566899999999999999999999997532211 111
Q ss_pred HHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 297 WDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....... ..... ....+..+.+++.+||+.||.+|||++++++
T Consensus 244 ~~~~~~~-~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FLIPRNP-APRLK---------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHSC-CCCCS---------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhcCc-cccCC---------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111 11100 1112345789999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=286.25 Aligned_cols=211 Identities=22% Similarity=0.347 Sum_probs=166.9
Q ss_pred hcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999987 4899999998754 334456788999999999 89999999999999999999
Q ss_pred EEeccCCCCh------------------------------------hHHhhcCCCCCceecCC-----------------
Q 037365 190 IYEYMPNKSL------------------------------------DFFLFNLKASNILLDKD----------------- 216 (398)
Q Consensus 190 V~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~----------------- 216 (398)
||||+++|+| +++|+||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 9999999988 35667999999999844
Q ss_pred --CCeEEcccccceecCCCCcccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchh
Q 037365 217 --MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL 293 (398)
Q Consensus 217 --~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~ 293 (398)
..+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|.+|+... ..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~- 236 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----DQ- 236 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----HH-
T ss_pred CceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----hH-
Confidence 479999999998765432 23589999999999876 5678999999999999999998774321 00
Q ss_pred HHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 294 GYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+........... +...+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ---~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ---WHEIRQGRLPRI----------PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---HHHHHTTCCCCC----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHcCCCCCC----------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111111111111 1112345789999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=321.79 Aligned_cols=217 Identities=24% Similarity=0.297 Sum_probs=172.5
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 188 (398)
..++|++.+.||+|+||.||+|++.. ++.||||++... .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34679999999999999999999875 788999998643 123346678899999987 7999999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
+||||+++|+| +++||||||+|||++.++.+||+|||+++......
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-- 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-- 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC--
Confidence 99999999988 35678999999999999999999999998643322
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..+ ....... .. ..
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~---~~~i~~~-~~-~~-------- 561 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DEL---FQSIMEH-NV-AY-------- 561 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHSS-CC-CC--------
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHH---HHHHHhC-CC-CC--------
Confidence 224456899999999999999999999999999999999999999753211 111 1111111 10 00
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCH-----HHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTT-----NDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~ 349 (398)
+......+.+|+.+||+.||++||++ +||++
T Consensus 562 --p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 --PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 12234568899999999999999998 77764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=287.93 Aligned_cols=218 Identities=23% Similarity=0.394 Sum_probs=168.3
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|++.+.||+|+||.||+|.+.. |+.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 45789999999999999999999875 8999999997543 34678899999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+++|+| +++|+||||+||+++.++.+||+|||++........ ..
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 182 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KR 182 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CB
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--cc
Confidence 9999877 346679999999999999999999999987654321 22
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........ ........ .
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~~~--------~ 248 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFMIPT-NPPPTFRK--------P 248 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHH-SCCCCCSS--------G
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhc-CCCcccCC--------c
Confidence 3457899999999999999999999999999999999999997532211 11111111 11100000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+..+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 122345889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.28 Aligned_cols=244 Identities=20% Similarity=0.336 Sum_probs=171.6
Q ss_pred hhhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC
Q 037365 108 FSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 185 (398)
Q Consensus 108 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 185 (398)
..+.+...++|++.+.||+|+||.||+|.+.+ .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34555567899999999999999999999853 4999998644 2233456778999999999999999999999999
Q ss_pred eeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 186 EKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 186 ~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
..++||||+++++| +++|+||||+|||++ ++.+||+|||+++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999877 356789999999998 67999999999876532
Q ss_pred CC---cccccccccccccccChhhhcc---------CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhh
Q 037365 233 NE---LQANTSRIVGTYGYMSPEYAIE---------GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLW 300 (398)
Q Consensus 233 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 300 (398)
.. .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ...+...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~ 256 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQMG 256 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HHHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhc
Confidence 21 1112233468999999999974 45789999999999999999999997533211 1111111
Q ss_pred hcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCCCCccccc
Q 037365 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAFSYV 369 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~~~~ 369 (398)
.. ....... ...+..+.+++.+||+.||++|||+.++++.|+.+.........|...|.
T Consensus 257 ~~-~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 257 TG-MKPNLSQ---------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp TT-CCCCCCC---------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred cC-CCCCCCc---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 11 1111110 01123478999999999999999999999999998876665555555554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=299.07 Aligned_cols=223 Identities=20% Similarity=0.297 Sum_probs=171.2
Q ss_pred cCCCCccceecccCceEEEEEEEc----CCCEEEEEEccCCC----hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCC
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 185 (398)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999983 58999999986431 12335567899999999 6999999999999999
Q ss_pred eeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 186 EKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 186 ~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
..++||||+++|+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999988 3567899999999999999999999999876433
Q ss_pred CcccccccccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............. .
T Consensus 213 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~--~---- 284 (355)
T 1vzo_A 213 ET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSEP--P---- 284 (355)
T ss_dssp GG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCCC--C----
T ss_pred CC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhccCC--C----
Confidence 22 22334579999999999986 347899999999999999999999986433221 11111111111100 0
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHHH
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRP-----TTNDVVSML 351 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 351 (398)
.+......+.+++.+||+.||.+|| |++|+++..
T Consensus 285 ------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 ------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0122234578999999999999999 999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=297.10 Aligned_cols=238 Identities=18% Similarity=0.216 Sum_probs=167.9
Q ss_pred chhhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCC-----------hhhHHHHHHHHHHHHhcCCCccc
Q 037365 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS-----------GQGLREMKNEASVIAKVQHKNLV 175 (398)
Q Consensus 107 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~H~nIv 175 (398)
...++....++|++.+.||+|+||.||+|...+|+.||||++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4557778889999999999999999999998889999999985431 12247789999999999999999
Q ss_pred ceeeEEEeC-----CeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCC
Q 037365 176 RLLGCCIDK-----DEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMN 218 (398)
Q Consensus 176 ~l~~~~~~~-----~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~ 218 (398)
++++++... ...++||||++++.+ +++|+||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 999999653 367999999985322 4667899999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHH
Q 037365 219 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW 297 (398)
Q Consensus 219 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 297 (398)
+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 173 ~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~ 247 (362)
T 3pg1_A 173 ITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--NQLNKIV 247 (362)
T ss_dssp EEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH
T ss_pred EEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence 9999999997544322 2234578999999999987 67899999999999999999999998643211 1111111
Q ss_pred HhhhcCCccc-----------cchhhhhccc------ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 298 DLWRSNRTLE-----------LTDAILEDEY------SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 298 ~~~~~~~~~~-----------~~~~~~~~~~------~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......... .......... ..+.....+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111000000 0000000000 01122345889999999999999999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=296.21 Aligned_cols=231 Identities=18% Similarity=0.224 Sum_probs=173.3
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC--------CCcccceeeEEE-
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ--------HKNLVRLLGCCI- 182 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~- 182 (398)
...++|++.+.||+|+||.||+|++.. ++.||+|++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 345789999999999999999999765 788999999754 344567889999999985 788999999998
Q ss_pred ---eCCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCC--------
Q 037365 183 ---DKDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDM-------- 217 (398)
Q Consensus 183 ---~~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~-------- 217 (398)
+....++||||+.++.+ +++||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 45689999999955432 367889999999998775
Q ss_pred -----------------------------------------CeEEcccccceecCCCCcccccccccccccccChhhhcc
Q 037365 218 -----------------------------------------NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE 256 (398)
Q Consensus 218 -----------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 256 (398)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcC
Confidence 7999999999876532 233578999999999999
Q ss_pred CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccc----hhHHHHHhhhc---------CCcccc---------------
Q 037365 257 GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLN----LLGYAWDLWRS---------NRTLEL--------------- 308 (398)
Q Consensus 257 ~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~----~~~~~~~~~~~---------~~~~~~--------------- 308 (398)
..++.++|||||||++|||++|+.||......... ........... ......
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999998754433211 11111111100 000000
Q ss_pred ---chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 309 ---TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 309 ---~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+...............+.+|+.+||+.||++|||++|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000001113456678899999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=284.76 Aligned_cols=220 Identities=20% Similarity=0.285 Sum_probs=171.7
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---------hhhHHHHHHHHHHHHhcC-CCcccceeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---------GQGLREMKNEASVIAKVQ-HKNLVRLLGCCI 182 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~ 182 (398)
..++|++.+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35789999999999999999999865 8899999996543 123456789999999996 999999999999
Q ss_pred eCCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceec
Q 037365 183 DKDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARIC 230 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~ 230 (398)
+++..++||||+++++| +++|+||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999988 3566799999999999999999999999876
Q ss_pred CCCCcccccccccccccccChhhhc------cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAI------EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR 304 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..... .... ..... ..
T Consensus 175 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~---~~~~~-~~ 245 (298)
T 1phk_A 175 DPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLML---RMIMS-GN 245 (298)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHH-TC
T ss_pred CCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHH---HHHhc-CC
Confidence 5432 223457899999999986 45688999999999999999999999753221 1111 11111 11
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 305 TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.. ...+. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~-~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 YQ-FGSPE------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC-CCTTT------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cc-cCccc------ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00 00000 1223456889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=293.96 Aligned_cols=233 Identities=18% Similarity=0.277 Sum_probs=171.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-----Ce
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 186 (398)
..++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|+.++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 35789999999999999999999864 788999999754 334457788999999999999999999999765 36
Q ss_pred eEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 187 KILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 187 ~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.++||||+.+ +| +++|+||||+|||++.++.+||+|||+++.......
T Consensus 105 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 8999999985 55 456789999999999999999999999987653322
Q ss_pred cc-ccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc---ch
Q 037365 236 QA-NTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL---TD 310 (398)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 310 (398)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .................. .+
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--GHHHHHHHHHCSCCHHHHHTCCC
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhhh
Confidence 11 1244589999999998765 45899999999999999999999998543221 111111111111000000 00
Q ss_pred --------hhh-hcccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 --------AIL-EDEYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 --------~~~-~~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
... ..... .+.....+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00000 0112356889999999999999999999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=286.29 Aligned_cols=219 Identities=21% Similarity=0.318 Sum_probs=156.2
Q ss_pred hhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC-hhh-HHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS-GQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
...++|++.+.||+|+||.||+|++. +++.||+|++.... ... .+.+.++...++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34578999999999999999999985 48899999997552 222 2334455556788899999999999999999999
Q ss_pred EEeccCCCCh-------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 190 IYEYMPNKSL-------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 190 V~e~~~~g~L-------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
||||+++ +| +++|+||||+|||++.++.+||+|||+++....
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9999985 33 356789999999999999999999999987654
Q ss_pred CCcccccccccccccccChhhh----ccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 233 NELQANTSRIVGTYGYMSPEYA----IEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
.. ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......... .......... .
T Consensus 163 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~-~ 234 (290)
T 3fme_A 163 DV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL----KQVVEEPSPQ-L 234 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH----HHHHHSCCCC-C
T ss_pred cc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH----HHHhccCCCC-c
Confidence 32 12234789999999996 45678999999999999999999999986432221111 1111111111 0
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 P---------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c---------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 1122345789999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=299.59 Aligned_cols=166 Identities=21% Similarity=0.338 Sum_probs=142.5
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc------CCCcccceeeEEEeCC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV------QHKNLVRLLGCCIDKD 185 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~ 185 (398)
....+|++.+.||+|+||.||+|.+.. ++.||||++... ......+.+|+.++..+ +|+||+++++++...+
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 345789999999999999999999876 889999999754 33446778899988887 5779999999999999
Q ss_pred eeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCC--eEEccccccee
Q 037365 186 EKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMN--PKISDFGMARI 229 (398)
Q Consensus 186 ~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~--~kl~DFGla~~ 229 (398)
..++||||+.+ +| +++||||||+|||++.++. +||+|||+++.
T Consensus 173 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 99999999974 44 4667899999999999887 99999999976
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCC
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFY 285 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 285 (398)
.... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 252 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 252 EHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 5432 23357899999999999999999999999999999999999997643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.11 Aligned_cols=230 Identities=22% Similarity=0.358 Sum_probs=154.6
Q ss_pred hhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
...++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999975 48899999986542 33456788999999999999999999999999999999
Q ss_pred EeccCCCCh----------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceec
Q 037365 191 YEYMPNKSL----------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARIC 230 (398)
Q Consensus 191 ~e~~~~g~L----------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~ 230 (398)
|||+++|+| +++|+||||+||+++.++.+||+|||++...
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999876 2456799999999999999999999999765
Q ss_pred CCCCc---ccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 231 GGNEL---QANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 231 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .. ....... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~---~~~~~~~-~~ 245 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VL---MLTLQND-PP 245 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HH---HHHHTSS-CC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HH---HHHhccC-CC
Confidence 43221 111234578999999999876 568999999999999999999999986433221 11 1111111 11
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......... .........+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDK-EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccc-hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 100000000 001122345789999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=300.77 Aligned_cols=226 Identities=19% Similarity=0.296 Sum_probs=166.2
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe------eE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE------KI 188 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~ 188 (398)
..+|+..+.||+|+||.||+|++..+..+|+|++..... ...+|+++++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457999999999999999999998877899999865432 12469999999999999999999976443 78
Q ss_pred EEEeccCCCCh-----------------------------------hHHhhcCCCCCceec-CCCCeEEcccccceecCC
Q 037365 189 LIYEYMPNKSL-----------------------------------DFFLFNLKASNILLD-KDMNPKISDFGMARICGG 232 (398)
Q Consensus 189 lV~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~-~~~~~kl~DFGla~~~~~ 232 (398)
+||||++++.+ +++||||||+|||++ .++.+||+|||+++....
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 99999987632 356789999999999 799999999999987654
Q ss_pred CCcccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc---------
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS--------- 302 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------- 302 (398)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.. .......
T Consensus 195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~-i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 195 GEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVE-IIKVLGTPSREQIKTM 269 (394)
T ss_dssp TCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-HHHHHCCCCHHHHHHH
T ss_pred CCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHHhCCCCHHHHHhh
Confidence 332 2345789999999999765 5899999999999999999999998643221 11111 1111100
Q ss_pred ------CCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 303 ------NRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 303 ------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
..............+ ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVF-RPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHS-CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhc-cccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000000000 11233568899999999999999999999963
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=302.03 Aligned_cols=229 Identities=19% Similarity=0.280 Sum_probs=174.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCC-CcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|++.+.||+|+||.||+|++.. ++.||||++...... ..+.+|++++..++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4789999999999999999999754 899999988654322 357889999999987 556666777778889999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCcee---cCCCCeEEcccccceecCCCCcc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILL---DKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl---~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
|+ +++| +++||||||+|||+ +.++.+||+|||+++.+......
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99 8776 35678999999999 68899999999999887654321
Q ss_pred -----cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc-cchhHHHHHhhhcCCccccch
Q 037365 237 -----ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-LNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 237 -----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 310 (398)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... .......+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----~~~~~~~~ 238 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----KKVATSIE 238 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH----HHHHSCHH
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh----ccccccHH
Confidence 12235689999999999999999999999999999999999999986543321 111111000 00000001
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.. ...++..+.+++..||+.||++||++++|++.|+.+..
T Consensus 239 ~l------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 AL------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HH------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HH------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 00 01223568899999999999999999999999987643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=294.18 Aligned_cols=234 Identities=18% Similarity=0.241 Sum_probs=160.7
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe--
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-- 186 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-- 186 (398)
......++|++.+.||+|+||.||+|++.. ++.||||++.... .......+|+..+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 344567899999999999999999999864 8999999986543 223456778888999999999999999976443
Q ss_pred -----eEEEEeccCCCCh-------------------------------------hHHhhcCCCCCceecC-CCCeEEcc
Q 037365 187 -----KILIYEYMPNKSL-------------------------------------DFFLFNLKASNILLDK-DMNPKISD 223 (398)
Q Consensus 187 -----~~lV~e~~~~g~L-------------------------------------~~~~~dlkp~NILl~~-~~~~kl~D 223 (398)
.++||||++++.+ +++|+||||+|||++. ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 7899999987621 3567899999999996 89999999
Q ss_pred cccceecCCCCcccccccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc
Q 037365 224 FGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS 302 (398)
Q Consensus 224 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 302 (398)
||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ............
T Consensus 176 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~ 250 (360)
T 3e3p_A 176 FGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVRVLGC 250 (360)
T ss_dssp CTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCC
T ss_pred CCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHHHcCC
Confidence 999987654332 23457899999999997654 899999999999999999999998643221 111111111100
Q ss_pred CCccccchh----------hhhcccC--------hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 303 NRTLELTDA----------ILEDEYS--------SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 303 ~~~~~~~~~----------~~~~~~~--------~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
. ..+.... ....... .......+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 P-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp C-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred C-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000000 0000000 11134578999999999999999999999963
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=287.77 Aligned_cols=229 Identities=23% Similarity=0.309 Sum_probs=168.6
Q ss_pred cchhhhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcC--CCcccceeeEE
Q 037365 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQ--HKNLVRLLGCC 181 (398)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~ 181 (398)
+.+..+....++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4455555667789999999999999999999988999999998644 3445678899999999997 59999999999
Q ss_pred EeCCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEccccccee
Q 037365 182 IDKDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 182 ~~~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
.+++..++||| +.+++| +++|+||||+|||+++ +.+||+|||+++.
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999999999 556666 3567899999999964 8899999999987
Q ss_pred cCCCCcccccccccccccccChhhhcc-----------CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHH
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIE-----------GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD 298 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 298 (398)
..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .....
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~~ 251 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHA 251 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH----HHHHH
Confidence 654433222334578999999999875 468899999999999999999999975432211 11111
Q ss_pred hhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 299 LWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.......... +......+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 IIDPNHEIEF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHCTTSCCCC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcccccCC----------cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111110 01112457899999999999999999999963
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=299.35 Aligned_cols=227 Identities=19% Similarity=0.275 Sum_probs=163.9
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC------
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------ 184 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 184 (398)
+...++|+..+.||+|+||.||+|.+.. |+.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 4567899999999999999999999754 89999999865432 234799999999999999999998543
Q ss_pred --------------------------------CeeEEEEeccCCCCh---------------------------------
Q 037365 185 --------------------------------DEKILIYEYMPNKSL--------------------------------- 199 (398)
Q Consensus 185 --------------------------------~~~~lV~e~~~~g~L--------------------------------- 199 (398)
...++||||+++ +|
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 348899999985 43
Q ss_pred ---hHHhhcCCCCCceec-CCCCeEEcccccceecCCCCcccccccccccccccChhhhccCC-CCcccccHHHHHHHHH
Q 037365 200 ---DFFLFNLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLE 274 (398)
Q Consensus 200 ---~~~~~dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~e 274 (398)
+++||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+.. ++.++||||+||++||
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 456789999999998 688999999999987654332 23457899999999988754 8999999999999999
Q ss_pred HHcCCCCCCCCCCCccchhHHHHHhhhcCCcc---------------ccchhhhhcccChHHHHHHHHHHHHHchhcCCC
Q 037365 275 IVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL---------------ELTDAILEDEYSSKQVLLRYVNIALLCVQESAD 339 (398)
Q Consensus 275 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~ 339 (398)
|++|+.||...... +............... ........... +...+..+.+|+.+||+.||+
T Consensus 235 ll~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 235 LILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL-PEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHS-CTTCCHHHHHHHHHHCCSSGG
T ss_pred HHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhC-CCCCCHHHHHHHHHHccCChh
Confidence 99999998643221 1111111111100000 00000000000 112345688999999999999
Q ss_pred CCCCHHHHHH
Q 037365 340 DRPTTNDVVS 349 (398)
Q Consensus 340 ~RPt~~evl~ 349 (398)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.57 Aligned_cols=230 Identities=21% Similarity=0.309 Sum_probs=175.9
Q ss_pred hhhhhhcCCCCccceecccCceEEEEEEEcC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe
Q 037365 109 SSVSTATNRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID 183 (398)
Q Consensus 109 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 183 (398)
.+.+...++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3445556789999999999999999999753 457999998754 3444577899999999999999999999984
Q ss_pred CCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceec
Q 037365 184 KDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARIC 230 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~ 230 (398)
++..++||||+++|+| +++||||||+|||++.++.+||+|||+++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 5678999999999988 3567899999999999999999999999876
Q ss_pred CCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ...... ... ......
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~~~~---i~~-~~~~~~- 613 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGR---IEN-GERLPM- 613 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH---HHH-TCCCCC-
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHH---HHc-CCCCCC-
Confidence 543322 2233467889999999999999999999999999999997 8888753221 111111 111 111110
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 614 ---------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 614 ---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 12233568899999999999999999999999988643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=296.09 Aligned_cols=221 Identities=10% Similarity=0.071 Sum_probs=152.8
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCCh---hhHHHHHHHHHHHHhc--CCCccccee-------eEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSG---QGLREMKNEASVIAKV--QHKNLVRLL-------GCC 181 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~nIv~l~-------~~~ 181 (398)
...|+..+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888999999999999999986 488999999976532 3445677785544444 699988755 555
Q ss_pred EeC-----------------CeeEEEEeccCCCCh---------------------------------------hHHhhc
Q 037365 182 IDK-----------------DEKILIYEYMPNKSL---------------------------------------DFFLFN 205 (398)
Q Consensus 182 ~~~-----------------~~~~lV~e~~~~g~L---------------------------------------~~~~~d 205 (398)
..+ ...++||||++ |+| +++|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 443 33799999999 776 345689
Q ss_pred CCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCCC
Q 037365 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNTG 283 (398)
Q Consensus 206 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~ 283 (398)
|||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999876432 113467799999999987 679999999999999999999999986
Q ss_pred CCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 284 FYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......... +................ .....+..+.+++.+||+.||++|||+.|+++
T Consensus 295 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKGS-------WKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTTC-------CCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccccc-------hhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 543221110 00000000000000000 01123456889999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=289.41 Aligned_cols=220 Identities=23% Similarity=0.327 Sum_probs=165.5
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--------hhhHHHHHHHHHHHHhcCCCcccceeeEEEeC
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 184 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 184 (398)
..++|++.+.||+|+||.||+|.+.. ++.||||.+.... ......+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34679999999999999999999865 7899999986532 12234578999999999999999999998765
Q ss_pred CeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCC---eEEccccccee
Q 037365 185 DEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMN---PKISDFGMARI 229 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~---~kl~DFGla~~ 229 (398)
+ .++||||+++|+| +++|+||||+|||++.++. +||+|||+++.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 8999999999877 3567899999999987654 99999999987
Q ss_pred cCCCCcccccccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
..... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+.... ......
T Consensus 167 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~----~~~~~~ 238 (322)
T 2ycf_A 167 LGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQI----TSGKYN 238 (322)
T ss_dssp CCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHH----HHTCCC
T ss_pred ccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHH----HhCccc
Confidence 65432 123357899999999974 4668999999999999999999999986433221 111111 111100
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. .. .. ....+..+.+++.+||+.||++|||+.++++
T Consensus 239 ~-~~-~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 F-IP-EV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C-CH-HH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c-Cc-hh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 00 00 1112356889999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=293.17 Aligned_cols=228 Identities=21% Similarity=0.317 Sum_probs=167.5
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee---
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK--- 187 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~--- 187 (398)
..++|...+.||+|+||.||+|.+.. |+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 45789999999999999999999865 889999999754 334457788999999999999999999999877654
Q ss_pred ---EEEEeccCCCCh------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 188 ---ILIYEYMPNKSL------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 188 ---~lV~e~~~~g~L------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
++||||+.+ +| +++|+||||+|||++.++.+||+|||+++.....
T Consensus 120 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 120 YDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp CCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred eeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 999999984 44 4677899999999999999999999999865432
Q ss_pred cccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch---
Q 037365 235 LQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD--- 310 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 310 (398)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............. ..+...
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~-~~~~~~~~~ 270 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVP-GTEFVQKLN 270 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC-CHHHHTTCS
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCC-cHHHHHHhh
Confidence 234578999999999987 6789999999999999999999999854321 11111111100000 000000
Q ss_pred ---------hhhhcc-cC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 311 ---------AILEDE-YS----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 311 ---------~~~~~~-~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...... .. .+.....+.+++.+||+.||++|||++|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 00 11224568899999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=294.55 Aligned_cols=228 Identities=23% Similarity=0.329 Sum_probs=157.2
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC------
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------ 184 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 184 (398)
..++|+..+.||+|+||.||+|.+.. |+.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 35789999999999999999999765 889999999653 334556788999999999999999999999754
Q ss_pred CeeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCC
Q 037365 185 DEKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGN 233 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~ 233 (398)
...++|+||+ +++| +++||||||+|||++.++.+||+|||+++.....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred CeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 5679999998 4554 4677899999999999999999999999865432
Q ss_pred CcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh-
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA- 311 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 311 (398)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............. ..+....
T Consensus 186 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p-~~~~~~~~ 257 (367)
T 2fst_X 186 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTP-GAELLKKI 257 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSC-CHHHHTTC
T ss_pred -----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC-CHHHHHHh
Confidence 234578999999999987 6789999999999999999999999854321 11111111111100 0000000
Q ss_pred -------hh---h--cccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 312 -------IL---E--DEYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 312 -------~~---~--~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
.. . .... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 0 0000 01123457899999999999999999999963
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=286.95 Aligned_cols=232 Identities=21% Similarity=0.306 Sum_probs=164.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEE-----------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI----------- 182 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----------- 182 (398)
.++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4789999999999999999999876 8899999998777777788999999999999999999999874
Q ss_pred ---eCCeeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceec-CCCCeEEcccccc
Q 037365 183 ---DKDEKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLD-KDMNPKISDFGMA 227 (398)
Q Consensus 183 ---~~~~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~-~~~~~kl~DFGla 227 (398)
+.+..++||||++ |+| +++|+||||+|||++ +++.+||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence 3467899999998 465 356789999999997 5679999999999
Q ss_pred eecCCCCc-ccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC-
Q 037365 228 RICGGNEL-QANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR- 304 (398)
Q Consensus 228 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~- 304 (398)
+....... ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILESIPVVHE 246 (320)
T ss_dssp BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHSCCCCH
T ss_pred cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCch
Confidence 87643211 112234567999999998876 67899999999999999999999998643221 11111111000000
Q ss_pred ---------ccccchhhhhccc-C----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 305 ---------TLELTDAILEDEY-S----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 305 ---------~~~~~~~~~~~~~-~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
............. . .+..+..+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000000000 0 1123456889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=292.53 Aligned_cols=172 Identities=24% Similarity=0.357 Sum_probs=144.9
Q ss_pred cchhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CC-----ccccee
Q 037365 106 FSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HK-----NLVRLL 178 (398)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~ 178 (398)
+.........++|++.+.||+|+||.||+|.+.. ++.||||++... ......+..|+.++..++ |+ +|++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 3344556667899999999999999999999875 788999999754 334567788999998885 55 499999
Q ss_pred eEEEeCCeeEEEEeccCCCCh------------------------------------hHHhhcCCCCCceec--CCCCeE
Q 037365 179 GCCIDKDEKILIYEYMPNKSL------------------------------------DFFLFNLKASNILLD--KDMNPK 220 (398)
Q Consensus 179 ~~~~~~~~~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~--~~~~~k 220 (398)
+++...+..++||||+++ +| +++||||||+|||++ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 999999999999999975 44 357789999999994 578899
Q ss_pred EcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCC
Q 037365 221 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGF 284 (398)
Q Consensus 221 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~ 284 (398)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999876532 2345789999999999999999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=301.08 Aligned_cols=226 Identities=21% Similarity=0.283 Sum_probs=163.2
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC------ee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------EK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~ 187 (398)
..+|+..+.||+|+||.||+|++.. ++.||||++..... ...+|++++++++||||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 3468899999999999999999865 89999999865432 2347999999999999999999986421 36
Q ss_pred EEEEeccCCCCh-----------------------------------hHHhhcCCCCCceecCC-CCeEEcccccceecC
Q 037365 188 ILIYEYMPNKSL-----------------------------------DFFLFNLKASNILLDKD-MNPKISDFGMARICG 231 (398)
Q Consensus 188 ~lV~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~~-~~~kl~DFGla~~~~ 231 (398)
++||||++++.+ +++||||||+|||++.+ +.+||+|||+++.+.
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 799999986421 46778999999999965 568999999998765
Q ss_pred CCCcccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc--------
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS-------- 302 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-------- 302 (398)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..... ....
T Consensus 209 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~-~lg~p~~~~~~~ 283 (420)
T 1j1b_A 209 RGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIK-VLGTPTREQIRE 283 (420)
T ss_dssp TTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH-HHCSCCHHHHHH
T ss_pred cCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HhCCCCHHHHHh
Confidence 4321 2335789999999999765 7899999999999999999999998643211 11111111 1000
Q ss_pred --CCccccchhhhhcc-c---ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 303 --NRTLELTDAILEDE-Y---SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 303 --~~~~~~~~~~~~~~-~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+...+..... + ........+.+|+.+||+.||.+|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000000000000 0 01122356889999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=295.28 Aligned_cols=234 Identities=18% Similarity=0.303 Sum_probs=154.8
Q ss_pred cCCCCc-cceecccCceEEEEEEEc---CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--CCeeE
Q 037365 115 TNRFSD-ANKLGEGGFGPVYKGVLR---KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKI 188 (398)
Q Consensus 115 ~~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 188 (398)
.+.|++ .++||+|+||.||+|++. +++.||+|++..... ...+.+|+.+|++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345655 458999999999999976 378899999975432 2467899999999999999999999965 66899
Q ss_pred EEEeccCCCCh----------------------------------------hHHhhcCCCCCcee----cCCCCeEEccc
Q 037365 189 LIYEYMPNKSL----------------------------------------DFFLFNLKASNILL----DKDMNPKISDF 224 (398)
Q Consensus 189 lV~e~~~~g~L----------------------------------------~~~~~dlkp~NILl----~~~~~~kl~DF 224 (398)
+||||++++.+ +++||||||+|||+ +.++.+||+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 99999976421 35678999999999 77889999999
Q ss_pred ccceecCCCCc-ccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCc-------cchhHH
Q 037365 225 GMARICGGNEL-QANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-------LNLLGY 295 (398)
Q Consensus 225 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~-------~~~~~~ 295 (398)
|+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+. .+....
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99987653321 1223446899999999999874 58999999999999999999999986443321 011111
Q ss_pred HHHhhhcCCccccch------------hhhhcccC---hH--------HHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 296 AWDLWRSNRTLELTD------------AILEDEYS---SK--------QVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~------------~~~~~~~~---~~--------~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
....+.......+.+ ......+. .. .....+.+|+.+||+.||.+|||++|+++.
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111000000000 00000000 00 013457899999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=280.57 Aligned_cols=221 Identities=23% Similarity=0.296 Sum_probs=171.2
Q ss_pred hhhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999986 4899999998543 2345678899999999999999999999999999999
Q ss_pred EEEeccCCCCh--------------------------------hHHhhcCCCCCceecCC---CCeEEcccccceecCCC
Q 037365 189 LIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKD---MNPKISDFGMARICGGN 233 (398)
Q Consensus 189 lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~---~~~kl~DFGla~~~~~~ 233 (398)
+||||+++++| +++|+||||+||+++.+ +.+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999987 35667999999999754 46999999999766433
Q ss_pred CcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ... ............. . .
T Consensus 178 ~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~---~~~~~~~~~~~~~-~-~- 245 (287)
T 2wei_A 178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDI---LKRVETGKYAFDL-P-Q- 245 (287)
T ss_dssp S---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHCCCCCCS-G-G-
T ss_pred C---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHH---HHHHHcCCCCCCc-h-h-
Confidence 2 1223468999999998865 489999999999999999999999754221 111 1111111100000 0 0
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 246 -----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 246 -----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1122345789999999999999999999997
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=288.93 Aligned_cols=233 Identities=20% Similarity=0.289 Sum_probs=169.4
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-----Ce
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 186 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 186 (398)
..++|++.+.||+|+||.||+|.+.. |+.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 45789999999999999999999864 889999999654 334456788999999999999999999998764 67
Q ss_pred eEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 187 KILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 187 ~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.++||||+.+ +| +++|+||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 8999999974 55 456789999999999999999999999987653321
Q ss_pred cc--------ccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 236 QA--------NTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 236 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ................
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--HQLLLIFGIIGTPHSD 245 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCST
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCchh
Confidence 11 1223578999999998765 67899999999999999999999998643211 1111111111100000
Q ss_pred ----ccchh----hhhc----c-cC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ----ELTDA----ILED----E-YS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ----~~~~~----~~~~----~-~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
..... .... . .. .+..+..+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 0000 0 00 1123456789999999999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=290.18 Aligned_cols=226 Identities=22% Similarity=0.318 Sum_probs=172.5
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChh-----------------hHHHHHHHHHHHHhcCCCcccc
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQ-----------------GLREMKNEASVIAKVQHKNLVR 176 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~nIv~ 176 (398)
..++|++.+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999999 8999999998643211 1277899999999999999999
Q ss_pred eeeEEEeCCeeEEEEeccCCCCh-----------------------------------------hHHhhcCCCCCceecC
Q 037365 177 LLGCCIDKDEKILIYEYMPNKSL-----------------------------------------DFFLFNLKASNILLDK 215 (398)
Q Consensus 177 l~~~~~~~~~~~lV~e~~~~g~L-----------------------------------------~~~~~dlkp~NILl~~ 215 (398)
+++++.+.+..++||||+++|+| +++|+||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999765 2456799999999999
Q ss_pred CCCeEEcccccceecCCCCcccccccccccccccChhhhccC-CCCc-ccccHHHHHHHHHHHcCCCCCCCCCCCccchh
Q 037365 216 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG-IFSI-KFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLL 293 (398)
Q Consensus 216 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~ 293 (398)
++.+||+|||++...... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||...... ....
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~ 262 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VELF 262 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHHH
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHH
Confidence 999999999999876543 23345789999999999887 6766 999999999999999999998644331 1111
Q ss_pred HHHHHhhhcCCcccc------chhhhhc--ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 294 GYAWDLWRSNRTLEL------TDAILED--EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~------~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.. ......... ....... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 111110000 0000000 0001223456889999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=283.11 Aligned_cols=227 Identities=21% Similarity=0.271 Sum_probs=171.4
Q ss_pred hhcCCCCccceecccCceEEEEEEEc--CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc------ccceeeEEEeC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR--KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN------LVRLLGCCIDK 184 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~ 184 (398)
...++|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|+.++..++|+| ++++++++.+.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 34578999999999999999999973 4788999999754 344567889999999987654 99999999999
Q ss_pred CeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecC---------------
Q 037365 185 DEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDK--------------- 215 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~--------------- 215 (398)
+..++||||+ +++| +++|+||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999999 6665 4567899999999987
Q ss_pred ----CCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccc
Q 037365 216 ----DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLN 291 (398)
Q Consensus 216 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~ 291 (398)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~ 241 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK--E 241 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH--H
T ss_pred ccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH--H
Confidence 678999999999875432 23457899999999999999999999999999999999999998643221 1
Q ss_pred hhHHHHHhhhcCCcccc------------------------------chhhhhcccChHHHHHHHHHHHHHchhcCCCCC
Q 037365 292 LLGYAWDLWRSNRTLEL------------------------------TDAILEDEYSSKQVLLRYVNIALLCVQESADDR 341 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 341 (398)
.......... ...... .................+.+++.+||+.||.+|
T Consensus 242 ~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 242 HLAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 1111111110 000000 000000001123445678999999999999999
Q ss_pred CCHHHHHH
Q 037365 342 PTTNDVVS 349 (398)
Q Consensus 342 Pt~~evl~ 349 (398)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=284.79 Aligned_cols=221 Identities=22% Similarity=0.400 Sum_probs=148.1
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHH-HHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
..++|+..+.||+|+||.||+|.... ++.||+|++.... ......+..|.. +++.++||||+++++++.+++..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 35789999999999999999999864 8899999997653 334455666666 66778999999999999999999999
Q ss_pred EeccCCCCh--------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 191 YEYMPNKSL--------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
|||++++ | +++|+||||+|||++.++.+||+|||+++....
T Consensus 100 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 100 MELMSTS-FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp ECCCSEE-HHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred EeecCCC-hHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9999863 2 456789999999999999999999999987643
Q ss_pred CCcccccccccccccccChhhh----ccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 233 NELQANTSRIVGTYGYMSPEYA----IEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
.. ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.........+ ..... .....+
T Consensus 179 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~-~~~~~~ 250 (327)
T 3aln_A 179 SI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL----TQVVK-GDPPQL 250 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCC-SCCCCC
T ss_pred cc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----HHHhc-CCCCCC
Confidence 32 12234789999999998 45678999999999999999999999986432211000 00000 000011
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
... . .......+.+++.+||+.||++|||+.++++
T Consensus 251 ~~~-~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 251 SNS-E-----EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCC-S-----SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCc-c-----cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000 0 1122345889999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=285.39 Aligned_cols=231 Identities=23% Similarity=0.333 Sum_probs=167.6
Q ss_pred hhcCCCCccceecccCceEEEEEEEc--CCCEEEEEEccCCC--hhhHHHHHHHHHHHHhc---CCCcccceeeEEE---
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR--KGNEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCI--- 182 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~--- 182 (398)
...++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45678999999999999999999984 47889999985432 11223456777777766 8999999999997
Q ss_pred --eCCeeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEccccc
Q 037365 183 --DKDEKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGM 226 (398)
Q Consensus 183 --~~~~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGl 226 (398)
.....++||||++ |+| +++|+||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4567899999998 465 356789999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 227 ARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .................
T Consensus 167 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 167 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCGG
T ss_pred cccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCcc
Confidence 97654221 23345789999999999999999999999999999999999999764322 11111111111100000
Q ss_pred cc------chhhhh----c--ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 EL------TDAILE----D--EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ~~------~~~~~~----~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.. ...... . .......+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000000 0 0001123456789999999999999999999995
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=285.44 Aligned_cols=226 Identities=21% Similarity=0.338 Sum_probs=166.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe-----
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----- 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 186 (398)
.++|...+.||+|+||.||+|.+.. |+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4689999999999999999999865 889999999654 33445678899999999999999999999987654
Q ss_pred -eEEEEeccCCCCh------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 187 -KILIYEYMPNKSL------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 187 -~~lV~e~~~~g~L------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.++||||+++ +| +++|+||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 179 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 179 (353)
T ss_dssp CCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred eEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--
Confidence 4999999974 54 4667899999999999999999999999765422
Q ss_pred ccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccc----h
Q 037365 236 QANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT----D 310 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 310 (398)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+............ ..+.. +
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~-~~~~~~~~~~ 253 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVP-GTEFVQKLND 253 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHHHCBC-CHHHHTTCSC
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC-CHHHHHHHhh
Confidence 233578999999999987 6789999999999999999999999754321 11111111100000 00000 0
Q ss_pred h----hh-------hccc--ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 A----IL-------EDEY--SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~----~~-------~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. .. .... ........+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00 0000 01223456889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=279.57 Aligned_cols=219 Identities=23% Similarity=0.366 Sum_probs=159.9
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe----------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID---------- 183 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 183 (398)
.++|+..+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999986 4899999999643 3445778899999999999999999999865
Q ss_pred ---CCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccc
Q 037365 184 ---KDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMA 227 (398)
Q Consensus 184 ---~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla 227 (398)
.+..++||||+++|+| +++|+||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 3568999999999988 3566799999999999999999999999
Q ss_pred eecCCCCc------------ccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhH
Q 037365 228 RICGGNEL------------QANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLG 294 (398)
Q Consensus 228 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 294 (398)
+....... ........||+.|+|||++.+. .++.++|||||||++|||++ |+... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----~~~~~ 236 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----MERVN 236 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----hhHHH
Confidence 76543210 1122345789999999999864 68999999999999999998 43211 01111
Q ss_pred HHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 295 YAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.. ........ .. .... ....+..+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~-~~~~~~~~-~~-~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 237 IL-KKLRSVSI-EF-PPDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH-HHHHSTTC-CC-CTTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH-Hhcccccc-cc-Cccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 11111100 00 0000 1222345789999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=293.75 Aligned_cols=218 Identities=22% Similarity=0.265 Sum_probs=160.7
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEecc
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345556889999999998776667999999998653 235678899999986 8999999999999999999999999
Q ss_pred CCCCh---------------------------------------hHHhhcCCCCCceecCC-------------CCeEEc
Q 037365 195 PNKSL---------------------------------------DFFLFNLKASNILLDKD-------------MNPKIS 222 (398)
Q Consensus 195 ~~g~L---------------------------------------~~~~~dlkp~NILl~~~-------------~~~kl~ 222 (398)
. |+| +++||||||+|||++.+ +.+||+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 6 455 35678999999999754 489999
Q ss_pred ccccceecCCCCccc--ccccccccccccChhhhcc-------CCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccch
Q 037365 223 DFGMARICGGNELQA--NTSRIVGTYGYMSPEYAIE-------GIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNL 292 (398)
Q Consensus 223 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 292 (398)
|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--- 247 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--- 247 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---
Confidence 999999876433211 1234579999999999976 568999999999999999999 899975432211
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
... .......... ........+..+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~~i----~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNI----IRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH----HHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH----hcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 1111000000 01113445677899999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=283.26 Aligned_cols=228 Identities=19% Similarity=0.282 Sum_probs=167.2
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----------CCcccceeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----------HKNLVRLLGCCI 182 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~ 182 (398)
.++|++.+.||+|+||.||+|++.. ++.||+|++... ......+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 4689999999999999999999754 889999999753 334567889999999886 899999999998
Q ss_pred eCC----eeEEEEeccCCCCh-----------------------------------hHHhhcCCCCCceec------CCC
Q 037365 183 DKD----EKILIYEYMPNKSL-----------------------------------DFFLFNLKASNILLD------KDM 217 (398)
Q Consensus 183 ~~~----~~~lV~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~------~~~ 217 (398)
..+ ..++||||+ +++| +++|+||||+|||++ ..+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 654 789999999 6554 367789999999994 444
Q ss_pred CeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCcc----chh
Q 037365 218 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTL----NLL 293 (398)
Q Consensus 218 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~----~~~ 293 (398)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 176 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 7999999999876532 2334789999999999999999999999999999999999999865432211 011
Q ss_pred HHHHHhhhc------------------CCccc--------cchhhhhcc-cChHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 037365 294 GYAWDLWRS------------------NRTLE--------LTDAILEDE-YSSKQVLLRYVNIALLCVQESADDRPTTND 346 (398)
Q Consensus 294 ~~~~~~~~~------------------~~~~~--------~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~e 346 (398)
......... ..... .....+... .........+.+|+.+||+.||++|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 111110000 00000 000011111 113456778999999999999999999999
Q ss_pred HHH
Q 037365 347 VVS 349 (398)
Q Consensus 347 vl~ 349 (398)
+++
T Consensus 331 ll~ 333 (373)
T 1q8y_A 331 LVN 333 (373)
T ss_dssp HHT
T ss_pred Hhh
Confidence 997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=280.12 Aligned_cols=228 Identities=20% Similarity=0.253 Sum_probs=170.6
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-C-CEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc------ccceeeEEEeC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-G-NEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN------LVRLLGCCIDK 184 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~ 184 (398)
...++|++.+.||+|+||.||+|.... + +.||+|++... ....+.+.+|+.++++++|+| ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 345789999999999999999999864 4 68999999754 344567888999999997766 99999999999
Q ss_pred CeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCcee------------------
Q 037365 185 DEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILL------------------ 213 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl------------------ 213 (398)
+..++||||+.++.+ +++|+||||+|||+
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999999955432 46678999999999
Q ss_pred -cCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccch
Q 037365 214 -DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNL 292 (398)
Q Consensus 214 -~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~ 292 (398)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~ 247 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR--EH 247 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH
T ss_pred ccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HH
Confidence 66789999999999875432 23457899999999999999999999999999999999999998643221 11
Q ss_pred hHHHHHhhhcCCccccc------------------------------hhhhhcccChHHHHHHHHHHHHHchhcCCCCCC
Q 037365 293 LGYAWDLWRSNRTLELT------------------------------DAILEDEYSSKQVLLRYVNIALLCVQESADDRP 342 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 342 (398)
......... ....... ................+.+++.+||+.||++||
T Consensus 248 ~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 248 LVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 111111110 0000000 000000011223355788999999999999999
Q ss_pred CHHHHHH
Q 037365 343 TTNDVVS 349 (398)
Q Consensus 343 t~~evl~ 349 (398)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=280.85 Aligned_cols=213 Identities=22% Similarity=0.365 Sum_probs=159.4
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChh------hHHHHHHHHHHHHhc----CCCcccceee
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ------GLREMKNEASVIAKV----QHKNLVRLLG 179 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~~ 179 (398)
.+...++|++.+.||+|+||.||+|++.. ++.||+|++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34556889999999999999999998754 889999999655321 223456799999999 8999999999
Q ss_pred EEEeCCeeEEEEec-cCCCCh--------------------------------hHHhhcCCCCCceec-CCCCeEEcccc
Q 037365 180 CCIDKDEKILIYEY-MPNKSL--------------------------------DFFLFNLKASNILLD-KDMNPKISDFG 225 (398)
Q Consensus 180 ~~~~~~~~~lV~e~-~~~g~L--------------------------------~~~~~dlkp~NILl~-~~~~~kl~DFG 225 (398)
++.+.+..++|||| +.+++| +++|+||||+||+++ .++.+||+|||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999999 788877 356789999999999 88999999999
Q ss_pred cceecCCCCcccccccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC
Q 037365 226 MARICGGNELQANTSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR 304 (398)
Q Consensus 226 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
+++...... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||.... . .... .
T Consensus 186 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~----~~~~-~ 249 (312)
T 2iwi_A 186 SGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------E----ILEA-E 249 (312)
T ss_dssp SCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----HHHT-C
T ss_pred hhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------H----Hhhh-c
Confidence 998765432 234578999999999987776 458999999999999999999974210 0 0000 0
Q ss_pred ccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 305 TLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
... .......+.+++.+||+.||++|||++|+++.
T Consensus 250 -~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 -LHF----------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -CCC----------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -cCC----------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 11223457899999999999999999999973
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=276.20 Aligned_cols=220 Identities=23% Similarity=0.349 Sum_probs=151.1
Q ss_pred hhcCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCC-hhh-HHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS-GQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
...++|+..+.||+|+||.||+|.+. +++.||+|++.... ... .+.+.++..+++.++||||+++++++.+++..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34578899999999999999999986 48999999997553 222 2334455567888899999999999999999999
Q ss_pred EEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 190 IYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 190 V~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
||||+. +.+ +++|+||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 102 AMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp EECCCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEeccC-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 999993 322 36678999999999999999999999997664332
Q ss_pred ccccccccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 236 QANTSRIVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ........... .....
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~-~~~~~ 252 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF----EVLTKVLQEEP-PLLPG 252 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHHHSCC-CCCCS
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH----HHHHHHhccCC-CCCCc
Confidence 123357899999999995 4568899999999999999999999976432211 11111111111 10000
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||.+|||++++++
T Consensus 253 --------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 --------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112345789999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=280.21 Aligned_cols=224 Identities=19% Similarity=0.219 Sum_probs=144.0
Q ss_pred hcCCCCccc-eecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe----CCee
Q 037365 114 ATNRFSDAN-KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEK 187 (398)
Q Consensus 114 ~~~~~~~~~-~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 187 (398)
..++|.+.+ .||+|+||.||+|.+.. ++.||+|++.... ....+....+..++||||+++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357888855 69999999999999874 8999999996532 122223334567799999999999986 4458
Q ss_pred EEEEeccCCCCh----------------------------------hHHhhcCCCCCceecC---CCCeEEcccccceec
Q 037365 188 ILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDK---DMNPKISDFGMARIC 230 (398)
Q Consensus 188 ~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~---~~~~kl~DFGla~~~ 230 (398)
++||||+++|+| +++|+||||+|||++. ++.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999999887 3567899999999976 455999999999876
Q ss_pred CCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .......... .....
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~-~~~~~ 254 (336)
T 3fhr_A 182 TQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRLGQ-YGFPN 254 (336)
T ss_dssp --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------CCCT
T ss_pred cccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhccc-cccCc
Confidence 5332 234578999999999988899999999999999999999999985433221100 0000000000 00000
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhhc
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTNE 354 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~~ 354 (398)
. .....+..+.+++.+||+.||.+|||++|+++ .+.+.
T Consensus 255 ~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 255 P------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp T------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred h------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0 01123456889999999999999999999997 45443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=282.78 Aligned_cols=213 Identities=23% Similarity=0.362 Sum_probs=167.1
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh------hhHHHHHHHHHHHHhcC--CCcccceeeE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG------QGLREMKNEASVIAKVQ--HKNLVRLLGC 180 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~ 180 (398)
+.+...++|++.+.||+|+||.||+|.+.. ++.||||.+..... .....+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 444556889999999999999999999754 88899999865421 12245678999999996 5999999999
Q ss_pred EEeCCeeEEEEeccCC-CCh--------------------------------hHHhhcCCCCCceec-CCCCeEEccccc
Q 037365 181 CIDKDEKILIYEYMPN-KSL--------------------------------DFFLFNLKASNILLD-KDMNPKISDFGM 226 (398)
Q Consensus 181 ~~~~~~~~lV~e~~~~-g~L--------------------------------~~~~~dlkp~NILl~-~~~~~kl~DFGl 226 (398)
+.+++..++||||+.+ ++| +++|+||||+|||++ +++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999986 655 356789999999999 788999999999
Q ss_pred ceecCCCCcccccccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc
Q 037365 227 ARICGGNELQANTSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT 305 (398)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 305 (398)
++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ........
T Consensus 197 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~~~~~~~~ 261 (320)
T 3a99_A 197 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQVF 261 (320)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCCCC
T ss_pred cccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------hhhccccc
Confidence 98765432 233578999999999987776 788999999999999999999974310 00110000
Q ss_pred cccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 306 LELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ....+..+.+++.+||+.||++|||++|+++
T Consensus 262 -------~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 262 -------F-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------C-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------c-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 1112345789999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.79 Aligned_cols=218 Identities=21% Similarity=0.293 Sum_probs=158.0
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
...+|+..+.||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+.+..|+|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3456888899999999997655556799999999965432 2356799999999 79999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecC-----CCCeEEcccccceecCCCC
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDK-----DMNPKISDFGMARICGGNE 234 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~-----~~~~kl~DFGla~~~~~~~ 234 (398)
||.+ +| +++||||||+|||++. ...+||+|||+++......
T Consensus 99 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 9974 54 4678899999999943 3368899999998765432
Q ss_pred c-ccccccccccccccChhhhc---cCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 235 L-QANTSRIVGTYGYMSPEYAI---EGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 235 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
. ........||+.|+|||++. ...++.++|||||||++|||++ |..||....... ......... ....
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------~~~~~~~~~-~~~~ 250 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------ANILLGACS-LDCL 250 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH------HHHHTTCCC-CTTS
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH------HHHHhccCC-cccc
Confidence 1 12234467999999999997 4567889999999999999999 888874322111 001111100 0100
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ........+.+++.+||+.||.+|||++|+++
T Consensus 251 ~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 H-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 01223445789999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.76 Aligned_cols=211 Identities=20% Similarity=0.330 Sum_probs=168.4
Q ss_pred hhcCCCCccceecccCceEEEEEEEc--CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCe---
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLR--KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--- 186 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--- 186 (398)
...++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34589999999999999999999986 4889999998654 34455678899999999999999999999988665
Q ss_pred --eEEEEeccCCCCh------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 --KILIYEYMPNKSL------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 --~~lV~e~~~~g~L------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
.|+||||+++++| +++||||||+|||++.+ .+||+|||+++.....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred ceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 7999999999887 46788999999999875 8999999999876533
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
....||+.|+|||++.+.. +.++|||||||++|||++|.+|+...... .+..
T Consensus 235 -----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~~~---- 286 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GLPE---- 286 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SCCT----
T ss_pred -----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------cccc----
Confidence 3457999999999987654 89999999999999999998875421100 0000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCC-HHHHHHHHhhc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPT-TNDVVSMLTNE 354 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~~L~~~ 354 (398)
..........+.+++.+||+.||++||+ ++++.+.|...
T Consensus 287 -~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 287 -DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0001223356889999999999999995 56666666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.16 Aligned_cols=226 Identities=22% Similarity=0.297 Sum_probs=165.0
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe------CCe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID------KDE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 186 (398)
.++|++.+.||+|+||.||+|.+.. |+.||||++... .....+.+.+|+.++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 4789999999999999999999754 889999998764 44556778999999999999999999998765 667
Q ss_pred eEEEEeccCCCCh-----------------------------------hHHhhcCCCCCceecCCCC---eEEcccccce
Q 037365 187 KILIYEYMPNKSL-----------------------------------DFFLFNLKASNILLDKDMN---PKISDFGMAR 228 (398)
Q Consensus 187 ~~lV~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~~---~kl~DFGla~ 228 (398)
.++||||+++|+| +++|+||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 8999999999987 3567899999999997765 9999999998
Q ss_pred ecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcccc
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..|.............
T Consensus 173 ~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 173 ELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNEHIV 245 (676)
T ss_dssp BTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC------CC
T ss_pred ccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccchhhh
Confidence 7654332 23457999999999999999999999999999999999999998542111 0110000000000000
Q ss_pred c----------hhhhh-cccChHHHHHHHHHHHHHchhcCCCCCCCHHHH
Q 037365 309 T----------DAILE-DEYSSKQVLLRYVNIALLCVQESADDRPTTNDV 347 (398)
Q Consensus 309 ~----------~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ev 347 (398)
. ..... ........+..+.+++.+||+.||++|||+.|+
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0 00000 000123355678999999999999999999773
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=262.02 Aligned_cols=204 Identities=12% Similarity=0.100 Sum_probs=157.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
..++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+++..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34789999999999999999999876 8899999997653 3445778999999999999999999999999999999
Q ss_pred EEeccCCCCh------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 190 IYEYMPNKSL------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 190 V~e~~~~g~L------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||||+++++| +++||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred EEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 9999999987 45678999999999999999998543
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
|++ .++.++|||||||++|||++|+.||........... ....... ... ..... .
T Consensus 175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~~~~-~~~--~~~~~-----~ 229 (286)
T 3uqc_A 175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDTAG-QPI--EPADI-----D 229 (286)
T ss_dssp --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBCTTS-CBC--CHHHH-----C
T ss_pred --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHHhcc-CCC--Chhhc-----c
Confidence 333 368899999999999999999999865332210000 0000000 000 00000 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
...+..+.+++.+||+.||++| |+.|+++.|++....
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 1234568899999999999999 999999999987653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-33 Score=275.32 Aligned_cols=208 Identities=15% Similarity=0.183 Sum_probs=148.8
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCC-Ccccce---------e
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQH-KNLVRL---------L 178 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l---------~ 178 (398)
.....|...+.||+|+||.||+|.+.. |+.||||++.... ....+.+.+|+.++..++| +|.... .
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 344557788999999999999999764 8999999987432 2235778999999999987 322111 1
Q ss_pred eE------------EEe-----CCeeEEEEeccCCCCh---------------------------------------hHH
Q 037365 179 GC------------CID-----KDEKILIYEYMPNKSL---------------------------------------DFF 202 (398)
Q Consensus 179 ~~------------~~~-----~~~~~lV~e~~~~g~L---------------------------------------~~~ 202 (398)
.. +.. ....+++|+++ +++| +++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 11 111 12456777765 3443 356
Q ss_pred hhcCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhh----------ccCCCCcccccHHHHHHH
Q 037365 203 LFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA----------IEGIFSIKFDVFSFGVLL 272 (398)
Q Consensus 203 ~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvvl 272 (398)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 7899999999999999999999999875432 334577 999999999 555688999999999999
Q ss_pred HHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 037365 273 LEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVV 348 (398)
Q Consensus 273 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 348 (398)
|||++|+.||....... ..+...... ...+..+.+++.+||+.||++|||+.+++
T Consensus 308 ~elltg~~Pf~~~~~~~------------------~~~~~~~~~---~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALG------------------GSEWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGS------------------CSGGGGSSC---CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhh------------------hHHHHHhhc---ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999975432111 111111110 01234588999999999999999987765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=256.18 Aligned_cols=201 Identities=15% Similarity=0.206 Sum_probs=148.3
Q ss_pred cCCCCcc-ceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHH-HhcCCCcccceeeEEEe----CCee
Q 037365 115 TNRFSDA-NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVI-AKVQHKNLVRLLGCCID----KDEK 187 (398)
Q Consensus 115 ~~~~~~~-~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~ 187 (398)
.++|.+. +.||+|+||.||+|.... ++.||+|++... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567776 779999999999999854 889999999643 4567888888 55689999999999987 6788
Q ss_pred EEEEeccCCCCh----------------------------------hHHhhcCCCCCceecC---CCCeEEcccccceec
Q 037365 188 ILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDK---DMNPKISDFGMARIC 230 (398)
Q Consensus 188 ~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~---~~~~kl~DFGla~~~ 230 (398)
++||||+++|+| +++|+||||+|||++. ++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 999999999987 3567899999999998 788999999998753
Q ss_pred CCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
. +..++.++|||||||++|||++|+.||......... .........
T Consensus 171 ~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------~~~~~~~~~ 216 (299)
T 3m2w_A 171 T------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------PGMKTRIRM 216 (299)
T ss_dssp T------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCSSCT
T ss_pred c------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------HHHHHHHhh
Confidence 2 234678999999999999999999998543221100 000000000
Q ss_pred hhhhcc-cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhhc
Q 037365 311 AILEDE-YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTNE 354 (398)
Q Consensus 311 ~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~~ 354 (398)
...... ......+..+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 000000 000123456889999999999999999999996 35444
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=265.43 Aligned_cols=211 Identities=16% Similarity=0.165 Sum_probs=154.3
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCC--------hhhHHHHHHHHHHHHhcC---------CCcccce
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS--------GQGLREMKNEASVIAKVQ---------HKNLVRL 177 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l 177 (398)
.++|++.+.||+|+||.||+|++ +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 68999999996542 233477889999999986 7777776
Q ss_pred eeEEE-----------------e-------------CCeeEEEEeccCCCCh----------------------------
Q 037365 178 LGCCI-----------------D-------------KDEKILIYEYMPNKSL---------------------------- 199 (398)
Q Consensus 178 ~~~~~-----------------~-------------~~~~~lV~e~~~~g~L---------------------------- 199 (398)
.+++. + .+..|+||||+++|++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 66543 2 6789999999999853
Q ss_pred ----hHHhhcCCCCCceecCCC--------------------CeEEcccccceecCCCCcccccccccccccccChhhhc
Q 037365 200 ----DFFLFNLKASNILLDKDM--------------------NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 255 (398)
Q Consensus 200 ----~~~~~dlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 255 (398)
+++||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++.
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGC
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhc
Confidence 356789999999999887 8999999999876532 347999999999998
Q ss_pred cCCCCcccccHHHHHH-HHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHch
Q 037365 256 EGIFSIKFDVFSFGVL-LLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCV 334 (398)
Q Consensus 256 ~~~~~~~sDvwSlGvv-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 334 (398)
+.. +.++||||+|++ .+++++|..||..... ................... .......+..+.+|+.+||
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW----LHYLTDKMLKQMTFKTKCN-----TPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH----HHHHHHHHHHTCCCSSCCC-----SHHHHHHHHHHHHHHHHGG
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcchhh----hhHHHHhhhhhhccCcccc-----hhhhhhcCHHHHHHHHHHh
Confidence 766 899999998777 7788889888521000 0000001110000000000 0013456678999999999
Q ss_pred hcCCCCCCCHHHHH
Q 037365 335 QESADDRPTTNDVV 348 (398)
Q Consensus 335 ~~dP~~RPt~~evl 348 (398)
+.| |++|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=238.73 Aligned_cols=156 Identities=15% Similarity=0.097 Sum_probs=105.9
Q ss_pred eecccCceEEEEEEEc-CCCEEEEEEccCCC----------hhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEE
Q 037365 123 KLGEGGFGPVYKGVLR-KGNEIAVKRLSGRS----------GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 123 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 190 (398)
..+.|++|.+..++.. -|+.+|+|.+.... ....+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777766665432 38889999996541 23456799999999999 699999999999999999999
Q ss_pred EeccCCCCh-----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 191 YEYMPNKSL-----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 191 ~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
|||++|++| +++||||||+|||++++|.+||+|||+|+...... .....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t 398 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTN 398 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHH
T ss_pred EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccC
Confidence 999999998 57889999999999999999999999998765433 22345
Q ss_pred ccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCC
Q 037365 242 IVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKN 281 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P 281 (398)
.+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 399 ~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 399 LVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 689999999999875 467789999999998887766443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.7e-23 Score=210.42 Aligned_cols=161 Identities=19% Similarity=0.197 Sum_probs=124.1
Q ss_pred CccceecccCceEEEEEEEcCCCEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 119 SDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSG--------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
...+.||+|+||.||+|.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999955 478899998644321 1134578999999999999999777777788889999
Q ss_pred EeccCCCCh------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc-----cccc
Q 037365 191 YEYMPNKSL------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA-----NTSR 241 (398)
Q Consensus 191 ~e~~~~g~L------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-----~~~~ 241 (398)
|||+++++| +++||||||+|||++. .+||+|||+++......... ....
T Consensus 418 mE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~ 495 (540)
T 3en9_A 418 MSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKA 495 (540)
T ss_dssp EECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhh
Confidence 999999988 3567899999999998 99999999999876432211 1235
Q ss_pred ccccccccChhhhcc--CCCCcccccHHHHHHHHHHHcCCCCC
Q 037365 242 IVGTYGYMSPEYAIE--GIFSIKFDVFSFGVLLLEIVSGKKNT 282 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~ 282 (398)
..||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|
T Consensus 496 ~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 496 VLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 689999999999987 66888999999999988888877664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.5e-20 Score=172.56 Aligned_cols=137 Identities=18% Similarity=0.115 Sum_probs=106.2
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCCh------------------hhHHHHHHHHHHHHhcCCCc
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSG------------------QGLREMKNEASVIAKVQHKN 173 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~n 173 (398)
......|+..+.||+|+||.||+|.+.+|+.||+|.+..... .....+.+|+.++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 334455667799999999999999996699999999964321 13456889999999999 5
Q ss_pred ccceeeEEEeCCeeEEEEeccCCCCh-------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 174 LVRLLGCCIDKDEKILIYEYMPNKSL-------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 174 Iv~l~~~~~~~~~~~lV~e~~~~g~L-------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
+++.+++.. +..++||||+++|+| +++||||||+|||++ ++.+||+|||+++
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 667765544 567999999999887 467789999999999 9999999999986
Q ss_pred ecCCCCcccccccccccccccChhhhcc----------CCCCcccccHHH
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIE----------GIFSIKFDVFSF 268 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDvwSl 268 (398)
. +..|+|||++.. ..|+..+|+|.+
T Consensus 241 ~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 241 E---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp E---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred E---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 4 334789998864 345556666643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=4.6e-15 Score=137.06 Aligned_cols=107 Identities=15% Similarity=0.169 Sum_probs=82.0
Q ss_pred CCccceecccCceEEEEEEE-cCCCE--EEEEEccCCChh------------------------hHHHHHHHHHHHHhcC
Q 037365 118 FSDANKLGEGGFGPVYKGVL-RKGNE--IAVKRLSGRSGQ------------------------GLREMKNEASVIAKVQ 170 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 170 (398)
|++.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 66888 999987543111 1135788999999998
Q ss_pred CCcc--cceeeEEEeCCeeEEEEeccCC-C----Ch------------------------------hHHhhcCCCCCcee
Q 037365 171 HKNL--VRLLGCCIDKDEKILIYEYMPN-K----SL------------------------------DFFLFNLKASNILL 213 (398)
Q Consensus 171 H~nI--v~l~~~~~~~~~~~lV~e~~~~-g----~L------------------------------~~~~~dlkp~NILl 213 (398)
|+++ ...++. +..++||||+.+ | +| +++|+||||+|||+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl 204 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY 204 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 8864 344432 357899999942 3 32 34578999999999
Q ss_pred cCCCCeEEcccccceec
Q 037365 214 DKDMNPKISDFGMARIC 230 (398)
Q Consensus 214 ~~~~~~kl~DFGla~~~ 230 (398)
+. .++|+|||+|...
T Consensus 205 ~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 205 ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SS--SEEECCCTTCEET
T ss_pred cC--cEEEEECcccccC
Confidence 88 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-13 Score=133.55 Aligned_cols=111 Identities=12% Similarity=0.122 Sum_probs=78.9
Q ss_pred CCCccceecccCceEEEEEEEcCCCEEEEEEccCCC--------------hhhHH--------HHHHHHHHHHhcCCCcc
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS--------------GQGLR--------EMKNEASVIAKVQHKNL 174 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~--------~~~~E~~~l~~l~H~nI 174 (398)
-|++.+.||+|++|.||+|...+|+.||||+++... ..... ...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 389999999999999999999889999999875320 00011 12346666666654443
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCh--------------------------hHHhhcCCCCCceecCCC----------C
Q 037365 175 VRLLGCCIDKDEKILIYEYMPNKSL--------------------------DFFLFNLKASNILLDKDM----------N 218 (398)
Q Consensus 175 v~l~~~~~~~~~~~lV~e~~~~g~L--------------------------~~~~~dlkp~NILl~~~~----------~ 218 (398)
....-+.. ...+|||||++|+.| +++||||||.|||+++++ .
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccc
Confidence 22111111 234799999998876 578899999999998776 3
Q ss_pred eEEccccccee
Q 037365 219 PKISDFGMARI 229 (398)
Q Consensus 219 ~kl~DFGla~~ 229 (398)
+.|+||+-+-.
T Consensus 254 ~~iID~~Q~V~ 264 (397)
T 4gyi_A 254 PIIIXFPQMVS 264 (397)
T ss_dssp EEECCCTTCEE
T ss_pred eEEEEeCCccc
Confidence 89999997654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.88 E-value=1.6e-09 Score=98.80 Aligned_cols=82 Identities=15% Similarity=0.147 Sum_probs=60.5
Q ss_pred cCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--ccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~e 192 (398)
...+......+.|..+.||+....+|..+++|...... ...+.+|..+++.+.+.+ +.+++++...++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 34454433334566699999987668889999976542 245778999999986544 5568998888888999999
Q ss_pred ccCCCCh
Q 037365 193 YMPNKSL 199 (398)
Q Consensus 193 ~~~~g~L 199 (398)
|++|.++
T Consensus 96 ~i~G~~l 102 (264)
T 1nd4_A 96 EVPGQDL 102 (264)
T ss_dssp CCSSEET
T ss_pred ecCCccc
Confidence 9998655
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.1e-08 Score=93.86 Aligned_cols=86 Identities=10% Similarity=0.039 Sum_probs=68.3
Q ss_pred hhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 191 (398)
.....|+....++.|+.+.||+.... ++.+++|............+.+|..+++.+. |.++.++++++.+.+..|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34467877788888899999999864 7899999986422122245788999999985 677889999999999999999
Q ss_pred eccCCCCh
Q 037365 192 EYMPNKSL 199 (398)
Q Consensus 192 e~~~~g~L 199 (398)
||++|.+|
T Consensus 90 e~i~G~~l 97 (263)
T 3tm0_A 90 SEADGVLC 97 (263)
T ss_dssp ECCSSEEH
T ss_pred EecCCeeh
Confidence 99998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.2e-06 Score=84.17 Aligned_cols=79 Identities=15% Similarity=0.315 Sum_probs=56.9
Q ss_pred ccceecccCceEEEEEEEcCCCEEEEEEcc--CCC-hhhHHHHHHHHHHHHhcC--CCcccceeeEEEeC---CeeEEEE
Q 037365 120 DANKLGEGGFGPVYKGVLRKGNEIAVKRLS--GRS-GQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDK---DEKILIY 191 (398)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lV~ 191 (398)
..+.++.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999998875 5678888876 322 122356788999999997 45688899988776 4589999
Q ss_pred eccCCCCh
Q 037365 192 EYMPNKSL 199 (398)
Q Consensus 192 e~~~~g~L 199 (398)
||++|..+
T Consensus 121 e~v~G~~l 128 (359)
T 3dxp_A 121 EFVSGRVL 128 (359)
T ss_dssp ECCCCBCC
T ss_pred EecCCeec
Confidence 99998644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.02 E-value=1.3e-06 Score=81.80 Aligned_cols=73 Identities=12% Similarity=0.156 Sum_probs=49.8
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCc--ccceeeEEEeCC---eeEEEEecc
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKN--LVRLLGCCIDKD---EKILIYEYM 194 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lV~e~~ 194 (398)
.+.++.|..+.||+.. ..+++|..... .....+.+|..+++.+. +.. +.++++.....+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999853 56888886432 34567889999999884 333 344544433333 348899999
Q ss_pred CCCCh
Q 037365 195 PNKSL 199 (398)
Q Consensus 195 ~~g~L 199 (398)
+|..+
T Consensus 99 ~G~~l 103 (304)
T 3sg8_A 99 KGVPL 103 (304)
T ss_dssp CCEEC
T ss_pred CCeEC
Confidence 98644
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00014 Score=66.34 Aligned_cols=74 Identities=16% Similarity=0.195 Sum_probs=54.9
Q ss_pred eecccCce-EEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 123 KLGEGGFG-PVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 123 ~lG~G~~g-~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
.+..|..| .||+..... +..+.+|+-... ....+.+|...|+.+. +--+-++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445444 689877654 667889986532 3456788999999885 33467889999999999999999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00017 Score=66.79 Aligned_cols=77 Identities=17% Similarity=0.217 Sum_probs=57.2
Q ss_pred CCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC---cccceeeEEEeCCeeEEEEecc
Q 037365 118 FSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 118 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
....+.+|.|..+.||+....+|+.+.+|+...........+..|...|+.+.-. -+.+++++ +..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 3445778999999999999999999999987655444445678899999988522 34455554 2347899999
Q ss_pred CCCC
Q 037365 195 PNKS 198 (398)
Q Consensus 195 ~~g~ 198 (398)
+++.
T Consensus 93 ~~~~ 96 (288)
T 3f7w_A 93 DERP 96 (288)
T ss_dssp CCCC
T ss_pred cccC
Confidence 8764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0011 Score=62.00 Aligned_cols=73 Identities=16% Similarity=0.153 Sum_probs=53.3
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC---cccceeeEEE-eCCeeEEEEeccCC
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCI-DKDEKILIYEYMPN 196 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~e~~~~ 196 (398)
.+.++.|....||+. +..+++|... .......+.+|..+|..+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888999987 5678888753 233456788999999999753 3566677664 34567899999988
Q ss_pred CCh
Q 037365 197 KSL 199 (398)
Q Consensus 197 g~L 199 (398)
..+
T Consensus 98 ~~l 100 (306)
T 3tdw_A 98 QIL 100 (306)
T ss_dssp EEC
T ss_pred eEC
Confidence 543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0043 Score=58.17 Aligned_cols=75 Identities=16% Similarity=0.108 Sum_probs=60.4
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCcccceeeEEEeCCeeEEEEeccCCC
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNK 197 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~e~~~~g 197 (398)
.+.|+.|....+|+... ++..+++|..... ....+..|...|+.+. ...+.++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999876 4778889987543 3467888999998884 356888999988888999999999987
Q ss_pred Ch
Q 037365 198 SL 199 (398)
Q Consensus 198 ~L 199 (398)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.015 Score=54.44 Aligned_cols=71 Identities=10% Similarity=0.172 Sum_probs=40.7
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----CCccccee-e--EEEeCCeeEEEEec
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----HKNLVRLL-G--CCIDKDEKILIYEY 193 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~-~--~~~~~~~~~lV~e~ 193 (398)
+.|+.|..+.||+....+| .+++|+.... . ..+..|..++..+. .|.++... | +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987544 5899988752 2 23344555555443 34444311 1 12346678999999
Q ss_pred cCCC
Q 037365 194 MPNK 197 (398)
Q Consensus 194 ~~~g 197 (398)
++|.
T Consensus 113 i~G~ 116 (346)
T 2q83_A 113 IEGR 116 (346)
T ss_dssp CCCB
T ss_pred ecCc
Confidence 9874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.07 E-value=0.008 Score=56.02 Aligned_cols=74 Identities=8% Similarity=-0.005 Sum_probs=42.8
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--ccceee------EEEeCCeeEEEEec
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLG------CCIDKDEKILIYEY 193 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~------~~~~~~~~~lV~e~ 193 (398)
+.|+.|....+|+....+| .+++|...... ....+..|..++..+...+ +.+++. +....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788899999987655 67889886521 1134556777777664212 223331 11234567899999
Q ss_pred cCCCC
Q 037365 194 MPNKS 198 (398)
Q Consensus 194 ~~~g~ 198 (398)
++|..
T Consensus 105 l~G~~ 109 (322)
T 2ppq_A 105 LEGMW 109 (322)
T ss_dssp CCCBC
T ss_pred CCCcC
Confidence 98753
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.016 Score=36.96 Aligned_cols=30 Identities=13% Similarity=0.257 Sum_probs=17.8
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhhhcCcc
Q 037365 37 FVLLSLSITLAAVATLGLNFYCFLHTSGED 66 (398)
Q Consensus 37 ~~~i~~~~~~~~~~~~~~~~~~~~r~~~~~ 66 (398)
.|+..++.++++++++++.+++++|||+++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 355566666666666666666666655544
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.018 Score=36.80 Aligned_cols=30 Identities=10% Similarity=0.041 Sum_probs=18.1
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhhhcCcc
Q 037365 37 FVLLSLSITLAAVATLGLNFYCFLHTSGED 66 (398)
Q Consensus 37 ~~~i~~~~~~~~~~~~~~~~~~~~r~~~~~ 66 (398)
.|+..+++++++++++++.+++++||++.+
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 355666666666666666666666665544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.32 E-value=0.034 Score=51.77 Aligned_cols=74 Identities=8% Similarity=0.021 Sum_probs=48.0
Q ss_pred ceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC--cccceeeE-----EEeCCeeEEEEecc
Q 037365 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLVRLLGC-----CIDKDEKILIYEYM 194 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~-----~~~~~~~~lV~e~~ 194 (398)
..++ |....||+....+|+.+++|...... .....+..|..++..+... .+.+++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999877667789999986432 1234566788888777422 23444432 22345667899998
Q ss_pred CCC
Q 037365 195 PNK 197 (398)
Q Consensus 195 ~~g 197 (398)
+|.
T Consensus 110 ~G~ 112 (328)
T 1zyl_A 110 GGR 112 (328)
T ss_dssp CCE
T ss_pred CCC
Confidence 874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.82 E-value=0.029 Score=54.01 Aligned_cols=73 Identities=16% Similarity=0.225 Sum_probs=45.0
Q ss_pred ceecccCceEEEEEEEcC--------CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeEEEEe
Q 037365 122 NKLGEGGFGPVYKGVLRK--------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 192 (398)
+.+..|-...+|+....+ ++.+.+|+.... ......+.+|..+++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567778888999988742 478999986332 223456678999998885 3333566666543 29999
Q ss_pred ccCCCCh
Q 037365 193 YMPNKSL 199 (398)
Q Consensus 193 ~~~~g~L 199 (398)
|++|..|
T Consensus 131 ~i~G~~l 137 (379)
T 3feg_A 131 YIPSRPL 137 (379)
T ss_dssp CCSEEEC
T ss_pred EecCccC
Confidence 9987543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.70 E-value=0.051 Score=52.76 Aligned_cols=73 Identities=10% Similarity=0.162 Sum_probs=45.5
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCC----Ch-----hhHHHHHHHHHHHH-hcCCCcccceeeEEEeCCeeEEE
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR----SG-----QGLREMKNEASVIA-KVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~-----~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.+.+|.|..+.||+... +++.++||..... .. .....+..|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999965 4678999943211 00 12233334443332 22334566777665 5678999
Q ss_pred Eecc-CC
Q 037365 191 YEYM-PN 196 (398)
Q Consensus 191 ~e~~-~~ 196 (398)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 75
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.39 E-value=0.041 Score=53.81 Aligned_cols=70 Identities=14% Similarity=0.239 Sum_probs=47.8
Q ss_pred cceecccCceEEEEEEEcC--------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcc-cceeeEEEeCCeeEEEE
Q 037365 121 ANKLGEGGFGPVYKGVLRK--------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIY 191 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 191 (398)
.+.|+.|....+|+....+ ++.+++|+...... ...+.+|..++..+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4568888889999998753 47899998844211 1445579999888853333 56776553 2 2788
Q ss_pred eccCC
Q 037365 192 EYMPN 196 (398)
Q Consensus 192 e~~~~ 196 (398)
||++|
T Consensus 152 e~l~G 156 (429)
T 1nw1_A 152 EYIPS 156 (429)
T ss_dssp CCCCE
T ss_pred EEeCC
Confidence 88875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=93.36 E-value=0.051 Score=50.10 Aligned_cols=68 Identities=12% Similarity=0.182 Sum_probs=43.3
Q ss_pred cceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcc-cceeeEEEeCCeeEEEEecc-CC
Q 037365 121 ANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYM-PN 196 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e~~-~~ 196 (398)
.+.|+.|....+|+. ..+++|........ .....+|..+++.+...++ .++++. +.+.-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 578889999999998 55888887643211 1123568877777743233 455554 344467899999 54
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=92.94 E-value=0.14 Score=49.19 Aligned_cols=74 Identities=14% Similarity=0.265 Sum_probs=49.5
Q ss_pred cceecccCceEEEEEEEc-CCCEEEEEEccCCCh-------hhHHHHHHHHHHHHhcCC--Ccc-cceeeEEEeCCeeEE
Q 037365 121 ANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSG-------QGLREMKNEASVIAKVQH--KNL-VRLLGCCIDKDEKIL 189 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~nI-v~l~~~~~~~~~~~l 189 (398)
.+.+|.|..+.||++... +++.+++|....... .....+..|.++++.+.+ +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999764 368899998643211 122456778889888742 443 455543 4556789
Q ss_pred EEeccCC
Q 037365 190 IYEYMPN 196 (398)
Q Consensus 190 V~e~~~~ 196 (398)
||||+++
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999976
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.66 E-value=0.22 Score=31.61 Aligned_cols=27 Identities=15% Similarity=0.284 Sum_probs=13.1
Q ss_pred hhHHHHHHHHHHHHHHHHHHHhhhhcCc
Q 037365 38 VLLSLSITLAAVATLGLNFYCFLHTSGE 65 (398)
Q Consensus 38 ~~i~~~~~~~~~~~~~~~~~~~~r~~~~ 65 (398)
++.+++. +.+++++++.+++++|||+.
T Consensus 14 Ia~~vVG-vll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 14 IISAVVG-ILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHH-HHHHHHHHHHHHHHHHHHCS
T ss_pred hHHHHHH-HHHHHHHHHHHHhheehhhh
Confidence 4444433 44555555555555555444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.51 E-value=0.22 Score=46.83 Aligned_cols=67 Identities=16% Similarity=0.155 Sum_probs=41.9
Q ss_pred cccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCcccceeeE------EEeCCeeEEEEeccC
Q 037365 125 GEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGC------CIDKDEKILIYEYMP 195 (398)
Q Consensus 125 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~------~~~~~~~~lV~e~~~ 195 (398)
|.|....||+....+| .+++|+...... ..|...+..+. -|++.+.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3344689999987666 899998765431 34555555552 1224444432 234567899999998
Q ss_pred CCC
Q 037365 196 NKS 198 (398)
Q Consensus 196 ~g~ 198 (398)
|..
T Consensus 105 G~~ 107 (339)
T 3i1a_A 105 APN 107 (339)
T ss_dssp CCB
T ss_pred CCc
Confidence 763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.77 E-value=0.17 Score=47.97 Aligned_cols=71 Identities=13% Similarity=0.121 Sum_probs=43.1
Q ss_pred ceecccCceEEEEEEEcC---------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc-ccceeeEEEeCCeeEEEE
Q 037365 122 NKLGEGGFGPVYKGVLRK---------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~ 191 (398)
+.++.|....+|+....+ ++.+++|....... .......|..+++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567788888999998754 26888888754322 1122357888888775333 34666544 2 36889
Q ss_pred eccCCC
Q 037365 192 EYMPNK 197 (398)
Q Consensus 192 e~~~~g 197 (398)
||++|.
T Consensus 114 e~i~G~ 119 (369)
T 3c5i_A 114 EWLYGD 119 (369)
T ss_dssp ECCCSE
T ss_pred EEecCC
Confidence 998864
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=90.64 E-value=0.38 Score=29.61 Aligned_cols=20 Identities=15% Similarity=-0.272 Sum_probs=8.3
Q ss_pred HHHHHHHHHHHHHHHHhhhh
Q 037365 43 SITLAAVATLGLNFYCFLHT 62 (398)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~r~ 62 (398)
+..++.+++++.+.|+++||
T Consensus 18 vG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 18 FGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHCC
T ss_pred hHHHHHHHHHHHHHHHHeec
Confidence 33333333344444444544
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=87.48 E-value=0.29 Score=45.92 Aligned_cols=79 Identities=9% Similarity=0.013 Sum_probs=55.5
Q ss_pred cee-cccCceEEEEEEEc-------CCCEEEEEEccCCC---hhhHHHHHHHHHHHHhcC-C--CcccceeeEEEeC---
Q 037365 122 NKL-GEGGFGPVYKGVLR-------KGNEIAVKRLSGRS---GQGLREMKNEASVIAKVQ-H--KNLVRLLGCCIDK--- 184 (398)
Q Consensus 122 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~--- 184 (398)
+.| +.|..+.+|+.... +++.+++|...... ......+.+|..+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999998764 25678888765422 001245678888888885 2 3567788887665
Q ss_pred CeeEEEEeccCCCChh
Q 037365 185 DEKILIYEYMPNKSLD 200 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L~ 200 (398)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3578999999987764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.08 E-value=0.082 Score=52.19 Aligned_cols=61 Identities=10% Similarity=0.089 Sum_probs=18.4
Q ss_pred ccceecccCceEEEEEEEcC-CCEEEE------EEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe
Q 037365 120 DANKLGEGGFGPVYKGVLRK-GNEIAV------KRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID 183 (398)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 183 (398)
..+.|| ||.||+|.+.. ..+||+ |..... ..+....+.+|..+++..+|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999999864 467888 766543 22334567888999999999999999988654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=84.51 E-value=2.2 Score=37.35 Aligned_cols=58 Identities=10% Similarity=0.058 Sum_probs=33.1
Q ss_pred CCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCC
Q 037365 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKN 281 (398)
Q Consensus 208 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P 281 (398)
|..|++..+|.+...+ +.+. .....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 78 ~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 78 AAQIRVWRDGAVTLAP-AADD--------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp GGGEEEETTSCEEECC-C--------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CcceEEecCCceeccc-cccc--------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 4567777888776664 1110 1122466888653 3456788899999999999864444
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.26 E-value=1.2 Score=27.67 Aligned_cols=10 Identities=0% Similarity=0.149 Sum_probs=3.8
Q ss_pred hHHHHHHHHH
Q 037365 39 LLSLSITLAA 48 (398)
Q Consensus 39 ~i~~~~~~~~ 48 (398)
+++++.++++
T Consensus 16 ~~~vv~Gv~l 25 (41)
T 2k9y_A 16 IGGVAVGVVL 25 (41)
T ss_dssp HHHHHHHHHH
T ss_pred EeehhHHHHH
Confidence 3333333333
|
| >4ev6_A Magnesium transport protein CORA; membrane protein, ION transporter, metal TR; HET: UMQ; 3.20A {Methanocaldococcus jannaschii} | Back alignment and structure |
|---|
Probab=83.13 E-value=1.4 Score=41.25 Aligned_cols=20 Identities=20% Similarity=0.607 Sum_probs=17.0
Q ss_pred HHHHHHHHHHhhhhhhcccc
Q 037365 10 VVLLVSAVFLILAFISGLSK 29 (398)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~s~ 29 (398)
+.-+++++++||++++|+=.
T Consensus 281 ~LTiit~IflP~T~IaGiyG 300 (339)
T 4ev6_A 281 ILTMVTTIFAVPMWITGIYG 300 (339)
T ss_dssp HHHHHHHHSSHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhhcc
Confidence 45678999999999999873
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.80 E-value=2.7 Score=27.80 Aligned_cols=25 Identities=24% Similarity=0.255 Sum_probs=13.8
Q ss_pred CccchhhHHHHHHHHHHHHHHHHHH
Q 037365 33 SASFFVLLSLSITLAAVATLGLNFY 57 (398)
Q Consensus 33 ~~~~~~~i~~~~~~~~~~~~~~~~~ 57 (398)
.+-+++++++.+++.+++++.+++|
T Consensus 7 vp~WiIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 7 VPLWVILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp CCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CchHHHHHHHHHHHHHHHHHHHHHH
Confidence 3455666666666665554444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 398 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-23 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 5e-55
Identities = 53/283 (18%), Positives = 113/283 (39%), Gaps = 50/283 (17%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
+ + ++G G FG VYKG + + ++ + Q L+ KNE V+ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLF------------------------------- 204
+G + ++ ++ SL L
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSII 126
Query: 205 --NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA---IEGIF 259
+LK++NI L +D+ KI DFG+A + ++ G+ +M+PE + +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 260 SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319
S + DV++FG++L E+++G+ + + + + + + +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP--YSNINNRDQI---IFMVGRGYLSPDLSKVRSN---- 237
Query: 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPK 362
+ C+++ D+RP +++ + A +L PK
Sbjct: 238 --CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL--PK 276
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-53
Identities = 66/284 (23%), Positives = 112/284 (39%), Gaps = 52/284 (18%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
KLG+G FG V+ G +A+K L EA V+ K++H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLF------------------------------- 204
+L ++ ++ EYM SL FL
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 205 ---NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSI 261
+L+A+NIL+ +++ K++DFG+AR+ NE A + +PE A+ G F+I
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTI 193
Query: 262 KFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321
K DV+SFG+LL E+ + + + +L D + E
Sbjct: 194 KSDVWSFGILLTELTTKGRVP-YPGMVNREVL----DQVERGYRMPCPPECPES------ 242
Query: 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPA 365
++ C ++ ++RPT + + L + + P QP
Sbjct: 243 ----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-52
Identities = 59/271 (21%), Positives = 109/271 (40%), Gaps = 54/271 (19%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
+ + ++G G FG V+ G +++A+K + + EA V+ K+ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLF------------------------------- 204
+L G C+++ L++E+M + L +L
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 205 --NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIK 262
+L A N L+ ++ K+SDFGM R ++ +++ + SPE +S K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 263 FDVFSFGVLLLEIVSGKK--NTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320
DV+SFGVL+ E+ S K ++ + + + L++ +S
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-------------PRLAST 229
Query: 321 QVLLRYVNIALLCVQESADDRPTTNDVVSML 351
V I C +E +DRP + ++ L
Sbjct: 230 HV----YQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 8e-51
Identities = 73/270 (27%), Positives = 111/270 (41%), Gaps = 52/270 (19%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
+LG G FG V+ G ++AVK L + EA+++ ++QH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLF------------------------------- 204
RL + +I EYM N SL FL
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 205 ---NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSI 261
+L+A+NIL+ ++ KI+DFG+AR+ NE A + +PE G F+I
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTI 189
Query: 262 KFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321
K DV+SFG+LL EIV+ + Y T + + D E+ Y
Sbjct: 190 KSDVWSFGILLTEIVTHGRI--PYPGMTNPEV---IQNLERGYRMVRPDNCPEELY---- 240
Query: 322 VLLRYVNIALLCVQESADDRPTTNDVVSML 351
+ LC +E +DRPT + + S+L
Sbjct: 241 ------QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-49
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 54/267 (20%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+LG G FG V G R ++A+K + E EA V+ + H+ LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 182 IDKDEKILIYEYMPNKSLDFFLF---------------------------------NLKA 208
+ +I EYM N L +L +L A
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 128
Query: 209 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSF 268
N L++ K+SDFG++R +E ++ + PE + FS K D+++F
Sbjct: 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKSDIWAF 187
Query: 269 GVLLLEIVSGKKN--TGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326
GVL+ EI S K F ++T + L+R + E +
Sbjct: 188 GVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-----------------KV 230
Query: 327 VNIALLCVQESADDRPTTNDVVSMLTN 353
I C E AD+RPT ++S + +
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 2e-49
Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 52/271 (19%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNE-IAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 174
+ +KLG G +G VY+GV +K + +AVK L + E EA+V+ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFL------------------------------- 203
V+LLG C + +I E+M +L +L
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 204 ---FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
+L A N L+ ++ K++DFG++R+ G+ A+ + +PE FS
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFS 194
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320
IK DV++FGVLL EI + + Y L+ + ++L + +E + E
Sbjct: 195 IKSDVWAFGVLLWEIATYGMS--PYPGIDLSQV---YELLEKDYRMERPEGCPEK----- 244
Query: 321 QVLLRYVNIALLCVQESADDRPTTNDVVSML 351
+ C Q + DRP+ ++
Sbjct: 245 -----VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 3e-49
Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 69/298 (23%)
Query: 106 FSFSSVSTATNRFSDA---------NKLGEGGFGPVYKGVLRKGNE----IAVKRL-SGR 151
F+F + A F+ +G G FG V G L+ + +A+K L SG
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 152 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF------- 204
+ + R+ +EAS++ + H N++ L G ++I E+M N SLD FL
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 205 --------------------------NLKASNILLDKDMNPKISDFGMARICGGNELQAN 238
+L A NIL++ ++ K+SDFG++R +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186
Query: 239 TSRIVG---TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGY 295
+ +G + +PE F+ DV+S+G+++ E ++ Y
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE-----------------VMSY 229
Query: 296 AWDLWRSNRTLELTDAILEDEY--SSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
+ ++ +AI +D + L C Q+ + RP +V+ L
Sbjct: 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-48
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 56/272 (20%)
Query: 122 NKLGEGGFGPVYKGVLRKGN----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVR 176
+G G FG VY G L + AVK L+ + G + + E ++ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 177 LLGCCIDKDEKI-LIYEYMPNKSLDFFLF------------------------------- 204
LLG C+ + ++ YM + L F+
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 205 --NLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAIEGIFS 260
+L A N +LD+ K++DFG+AR E + ++ +M+ E F+
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320
K DV+SFGVLL E+++ + +T ++ Y R +L+ EY
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRR----------LLQPEYCPD 261
Query: 321 QVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352
+ + L C A+ RP+ +++VS ++
Sbjct: 262 PL----YEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-48
Identities = 54/287 (18%), Positives = 100/287 (34%), Gaps = 58/287 (20%)
Query: 123 KLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 182
+G+G FG V++G R G E+AVK S R + + E ++H+N++ +
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67
Query: 183 DKDEKI----LIYEYMPNKSLDFFL----------------------------------- 203
+ L+ +Y + SL +L
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 204 ----FNLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEYAIEG 257
+LK+ NIL+ K+ I+D G+A + + + VGT YM+PE +
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 258 I------FSIKFDVFSFGVLLLEIVSGKKNTGFYRTD-----TLNLLGYAWDLWRSNRTL 306
I + D+++ G++ EI G + L + + R
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
+ + + + S + L I C + R T + L+
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-47
Identities = 63/265 (23%), Positives = 105/265 (39%), Gaps = 58/265 (21%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+G+G FG V G R GN++AVK + ++ + EASV+ +++H NLV+LLG
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 182 IDKDEKI-LIYEYMPNKSLDFFLF----------------------------------NL 206
+++ + ++ EYM SL +L +L
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 129
Query: 207 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
A N+L+ +D K+SDFG+ + E + + +PE E FS K DV+
Sbjct: 130 AARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 184
Query: 267 SFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326
SFG+LL EI S + + R +++ ++ D
Sbjct: 185 SFGILLWEIYSFGRVP-YPRIPLKDVV----PRVEKGYKMDAPDGCPPA----------V 229
Query: 327 VNIALLCVQESADDRPTTNDVVSML 351
+ C A RP+ + L
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-46
Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 59/278 (21%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNE-----IAVKRLS-GRSGQGLREMKNEASVIAKV 169
+ + +G G FG VYKG+L+ + +A+K L G + + + EA ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 170 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF------------------------- 204
H N++RL G ++I EYM N +LD FL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 205 --------NLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAI 255
+L A NIL++ ++ K+SDFG++R+ + T S + +PE
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315
F+ DV+SFG+++ E+++ G SN E+ AI +
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTY---------------GERPYWELSNH--EVMKAINDG 229
Query: 316 EY--SSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
+ + + C Q+ RP D+VS+L
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 1e-45
Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 60/274 (21%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQG---LREMKNEASVIAKVQ 170
FSD ++G G FG VY + +A+K++S Q +++ E + K++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 171 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--------------------------- 203
H N ++ GC + + L+ EY + D
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 204 -----FNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI--- 255
++KA NILL + K+ DFG A I A + VGT +M+PE +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMD 187
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315
EG + K DV+S G+ +E+ K + + ++ L + L+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL---------YHIAQNESPALQS 236
Query: 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349
+ S+ N C+Q+ DRPT+ ++
Sbjct: 237 GHWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-45
Identities = 65/302 (21%), Positives = 114/302 (37%), Gaps = 66/302 (21%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLS-GRSGQGLREMKNEASVIAK 168
+ + + +LG+G FG VY+GV + +A+K ++ S + E NEASV+ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF------------------------ 204
++VRLLG ++I E M L +L
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 205 ------------------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 246
+L A N ++ +D KI DFGM R + + +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 247 GYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306
+MSPE +G+F+ DV+SFGV+L EI + + + +L L
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVL----RFVMEGGLL 254
Query: 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPAF 366
+ D + + +C Q + RP+ +++S + E ++ +F
Sbjct: 255 DKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEP--GFREVSF 302
Query: 367 SY 368
Y
Sbjct: 303 YY 304
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-45
Identities = 51/281 (18%), Positives = 92/281 (32%), Gaps = 41/281 (14%)
Query: 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLRE-MKNEASVIAKVQH 171
+ F ++LG G G V+K + + A K + +R + E V+ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------- 205
+V G E + E+M SLD L
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 206 -------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI 258
+K SNIL++ K+ DFG++ + + VGT YMSPE
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTH 179
Query: 259 FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318
+S++ D++S G+ L+E+ G+ D L +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYP--IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359
S + +A+ + + + P + + E +
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-44
Identities = 58/267 (21%), Positives = 100/267 (37%), Gaps = 54/267 (20%)
Query: 123 KLGEGGFGPVYKGVLR---KGNEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 178
+LG G FG V +GV R K ++A+K L + + EM EA ++ ++ + +VRL+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 179 GCCIDKDEKILIYEYMPNKSLDFFLF---------------------------------N 205
G C + +L+ E L FL +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYAIEGIFSIKFD 264
L A N+LL KISDFG+++ G ++ S + +PE FS + D
Sbjct: 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 194
Query: 265 VFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLL 324
V+S+GV + E +S + + + ++ + +E + Y
Sbjct: 195 VWSYGVTMWEALSYGQ-KPYKKMKGPEVM----AFIEQGKRMECPPECPPELY------- 242
Query: 325 RYVNIALLCVQESADDRPTTNDVVSML 351
+ C +DRP V +
Sbjct: 243 ---ALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-44
Identities = 57/272 (20%), Positives = 97/272 (35%), Gaps = 54/272 (19%)
Query: 120 DANKLGEGGFGPVYKGVLRK---GNEIAVKRLSGRSGQG--LREMKNEASVIAKVQHKNL 174
+ +LG G FG V KG + +AVK L + E+ EA+V+ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFLF------------------------------ 204
VR++G C + + +L+ E L+ +L
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 205 --NLKASNILLDKDMNPKISDFGMARICGGNELQANTS-RIVGTYGYMSPEYAIEGIFSI 261
+L A N+LL KISDFG+++ +E + +PE FS
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 262 KFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321
K DV+SFGVL+ E S + + + + + +
Sbjct: 190 KSDVWSFGVLMWEAFSYGQ-KPYRGMKGSEVT----AMLEKGERMGCPAGCPRE------ 238
Query: 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
++ LC ++RP V L N
Sbjct: 239 ----MYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-44
Identities = 61/273 (22%), Positives = 106/273 (38%), Gaps = 55/273 (20%)
Query: 118 FSDANKLGEGGFGPVYKGVLRKGNE-----IAVKRLS-GRSGQGLREMKNEASVIAKVQH 171
F LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF--------------------------- 204
++ RLLG C+ + LI + MP L ++
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 205 ------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGI 258
+L A N+L+ + KI+DFG+A++ G E + + +M+ E + I
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 259 FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318
++ + DV+S+GV + E+++ Y + + + L D
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEI---SSILEKGERLPQPPICTID--- 241
Query: 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
I + C AD RP +++
Sbjct: 242 -------VYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-43
Identities = 57/272 (20%), Positives = 94/272 (34%), Gaps = 56/272 (20%)
Query: 122 NKLGEGGFGPVYKGVLR----KGNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNL 174
KLG+G FG V +G K +AVK L + + + E + + + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFN----------------------------- 205
+RL G + K+ + E P SL L
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 206 ----LKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
L A N+LL KI DFG+ R + ++ + + +PE FS
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320
D + FGV L E+ + + + + +L + + L + +D
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEP-WIGLNGSQIL---HKIDKEGERLPRPEDCPQD----- 243
Query: 321 QVLLRYVNIALLCVQESADDRPTTNDVVSMLT 352
N+ + C +DRPT + L
Sbjct: 244 -----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-43
Identities = 54/270 (20%), Positives = 102/270 (37%), Gaps = 61/270 (22%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLL 178
++G G F VYKG+ + E+A L R + + K EA ++ +QH N+VR
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 179 GCCID----KDEKILIYEYMPNKSLDFFLF------------------------------ 204
K +L+ E M + +L +L
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 205 ----NLKASNILL-DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
+LK NI + + KI D G+A + + ++GT +M+PE E +
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YEEKY 189
Query: 260 SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319
DV++FG+ +LE+ + + + + R D+ +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYP--YSECQNAAQI--------YRRVTSGVKPASFDKVAI 239
Query: 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349
+V I C++++ D+R + D+++
Sbjct: 240 PEV----KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-42
Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 78/302 (25%)
Query: 103 FPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGN---EIAVKRLS-GRSGQGLRE 158
+P+ + N + +GEG FG V K ++K + A+KR+ S R+
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 159 MKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF------------- 204
E V+ K+ H N++ LLG C + L EY P+ +L FL
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 205 -----------------------------------NLKASNILLDKDMNPKISDFGMARI 229
+L A NIL+ ++ KI+DFG++R
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 176
Query: 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT 289
+ +M+ E +++ DV+S+GVLL EIVS T +
Sbjct: 177 QEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-TPYCGMTC 232
Query: 290 LNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349
L +R + L D + + + C +E +RP+ ++
Sbjct: 233 AELYEKLPQGYRLEKPLNCDDEVYD--------------LMRQCWREKPYERPSFAQILV 278
Query: 350 ML 351
L
Sbjct: 279 SL 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-41
Identities = 59/273 (21%), Positives = 111/273 (40%), Gaps = 48/273 (17%)
Query: 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASV 165
S SV +++ K+G+G G VY + G E+A+++++ + + NE V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 166 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------- 205
+ + ++ N+V L + DE ++ EY+ SL +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 206 -----------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 254
+K+ NILL D + K++DFG Q+ S +VGT +M+PE
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVV 188
Query: 255 IEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314
+ K D++S G++ +E++ G+ + + L L L +N T EL +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL----YLIATNGTPELQN---- 238
Query: 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDV 347
E S + C+ + R + ++
Sbjct: 239 PEKLSAIF----RDFLNRCLDMDVEKRGSAKEL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-41
Identities = 59/297 (19%), Positives = 95/297 (31%), Gaps = 72/297 (24%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRSGQGLRE-MKNEASVIAK 168
NR S LG G FG V + +AVK L + RE + +E V++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 169 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF----------------------- 204
+ H N+V LLG C ++I EY L FL
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 205 ---------------------------NLKASNILLDKDMNPKISDFGMARICGGNELQA 237
+L A NILL KI DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW 297
+M+PE +++ + DV+S+G+ L E+ S + +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF----Y 258
Query: 298 DLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354
+ + + + + +I C RPT +V ++ +
Sbjct: 259 KMIKEGFRMLSPEHAPAE----------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 8e-41
Identities = 52/269 (19%), Positives = 105/269 (39%), Gaps = 63/269 (23%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 180
+LG+G FG VYK ++ + + A K + +S + L + E ++A H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 181 CIDKDEKILIYEYMPNKSLDFFLFN---------------------------------LK 207
++ ++ E+ ++D + LK
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 137
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----EGIFSIK 262
A NIL D + K++DFG++ + ++ +GT +M+PE + + + K
Sbjct: 138 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYK 195
Query: 263 FDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322
DV+S G+ L+E+ + + + I + E +
Sbjct: 196 ADVWSLGITLIEMAEIEP------------------PHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 323 LLRY----VNIALLCVQESADDRPTTNDV 347
R+ + C++++ D R TT+ +
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-40
Identities = 55/263 (20%), Positives = 96/263 (36%), Gaps = 49/263 (18%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 179
LGEG +G V V R +AVK + R+ +K E + + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 180 CCIDKDEKILIYEYMPNKSLDFFLFN--------------------------------LK 207
+ + + L EY L + +K
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 130
Query: 208 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF-SIKFDVF 266
N+LLD+ N KISDFG+A + N + +++ GT Y++PE F + DV+
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190
Query: 267 SFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326
S G++L +++G+ + N ++ A +L +
Sbjct: 191 SCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP-------LALLHK- 242
Query: 327 VNIALLCVQESADDRPTTNDVVS 349
+ E+ R T D+
Sbjct: 243 ------ILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 7e-40
Identities = 48/276 (17%), Positives = 90/276 (32%), Gaps = 55/276 (19%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQ 170
R +GEG FG V++G+ +A+K + +RE EA + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 171 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-------------------------- 204
H ++V+L+G + + +I E L FL
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 205 -------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
++ A N+L+ + K+ DFG++R + S+ +M+PE
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR 184
Query: 258 IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317
F+ DV+ FGV + EI+ + + L +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLPMPPNCPPT-- 237
Query: 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
++ C RP ++ + L+
Sbjct: 238 --------LYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 8e-40
Identities = 54/268 (20%), Positives = 97/268 (36%), Gaps = 55/268 (20%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHK 172
F LGEG F V E A+K L R + + E V++++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF---------------------------- 204
V+L D ++ Y N L ++
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 205 ----NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
+LK NILL++DM+ +I+DFG A++ QA + VGT Y+SPE E
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS-S 319
D+++ G ++ ++V+G +R+ + I++ EY
Sbjct: 189 KSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQKIIKLEYDFP 230
Query: 320 KQVLLRYVNIALLCVQESADDRPTTNDV 347
++ + ++ + A R ++
Sbjct: 231 EKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-39
Identities = 54/275 (19%), Positives = 94/275 (34%), Gaps = 68/275 (24%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 178
+G G +G K + G + K L + + + +E +++ +++H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 179 GCCIDKDEKIL--IYEYMPNKSLDFFLF-------------------------------- 204
ID+ L + EY L +
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 205 ---------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 255
+LK +N+ LD N K+ DFG+ARI + A VGT YMSPE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMN 187
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315
++ K D++S G LL E+ + + + EL I E
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMP------------------PFTAFSQKELAGKIREG 229
Query: 316 EYSS--KQVLLRYVNIALLCVQESADDRPTTNDVV 348
++ + I + RP+ +++
Sbjct: 230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 4e-39
Identities = 55/265 (20%), Positives = 93/265 (35%), Gaps = 59/265 (22%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG+G FG VY ++ I A+K L +++ E + + ++H N++RL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------------------- 205
G D LI EY P ++ L
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRD 131
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
+K N+LL KI+DFG + + + + GT Y+ PE + K D+
Sbjct: 132 IKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDL 187
Query: 266 FSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS-SKQVLL 324
+S GVL E + GK + +N E I E++ V
Sbjct: 188 WSLGVLCYEFLVGKP------------------PFEANTYQETYKRISRVEFTFPDFVTE 229
Query: 325 RYVNIALLCVQESADDRPTTNDVVS 349
++ ++ + RP +V+
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 3e-37
Identities = 61/295 (20%), Positives = 97/295 (32%), Gaps = 71/295 (24%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRSGQG-LREMKNEASVIAK 168
+R LG G FG V + +AVK L + R + +E ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 169 -VQHKNLVRLLGCCIDKDEKILI-YEYMPNKSLDFFLF---------------------- 204
H N+V LLG C +++ E+ +L +L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 205 --------------------------NLKASNILLDKDMNPKISDFGMARICGGNELQAN 238
+L A NILL + KI DFG+AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD 298
+M+PE + +++I+ DV+SFGVLL EI S + + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEFCR 248
Query: 299 LWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
+ + D + Y L C RPT +++V L N
Sbjct: 249 RLKEGTRMRAPDYTTPEMY----------QTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 1e-36
Identities = 63/294 (21%), Positives = 106/294 (36%), Gaps = 73/294 (24%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLR--------KGNEIAVKRL-SGRSGQGLREMKNEASVI 166
+R LGEG FG V + ++AVK L S + + L ++ +E ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 167 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF--------------------- 204
+ +HKN++ LLG C +I EY +L +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 205 ---------------------------NLKASNILLDKDMNPKISDFGMARICGGNELQA 237
+L A N+L+ +D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAW 297
T+ +M+PE + I++ + DV+SFGVLL EI + + Y + L +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL---F 247
Query: 298 DLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSML 351
L + ++ + + C RPT +V L
Sbjct: 248 KLLKEGHRMDKPSNCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 130 bits (328), Expect = 3e-35
Identities = 46/273 (16%), Positives = 86/273 (31%), Gaps = 62/273 (22%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 174
+ + +LG G FG V++ R GN A K + ++ E ++ ++H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFN----------------------------- 205
V L D +E ++IYE+M L + +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 206 ----LKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
LK NI+ + K+ DFG+ + + GT + +PE A
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPV 202
Query: 260 SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319
D++S GVL ++SG + E + +++
Sbjct: 203 GYYTDMWSVGVLSYILLSGLS------------------PFGGENDDETLRNVKSCDWNM 244
Query: 320 KQVLLRYV-----NIALLCVQESADDRPTTNDV 347
+ + + + R T +
Sbjct: 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 128 bits (323), Expect = 2e-34
Identities = 49/266 (18%), Positives = 88/266 (33%), Gaps = 62/266 (23%)
Query: 123 KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 181
+LG G FG V++ V + G K ++ +KNE S++ ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 182 IDKDEKILIYEYMPNKSLDFFLF---------------------------------NLKA 208
DK E +LI E++ L + ++K
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 155
Query: 209 SNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVF 266
NI+ + KI DFG+A +E+ T + +PE D++
Sbjct: 156 ENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMW 212
Query: 267 SFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRY 326
+ GVL ++SG + LE + ++ +
Sbjct: 213 AIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 327 VNIALL-----CVQESADDRPTTNDV 347
V+ +Q+ R T +D
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 123 bits (309), Expect = 3e-33
Identities = 51/273 (18%), Positives = 102/273 (37%), Gaps = 58/273 (21%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLS---GRSGQGLREMKNEASVIAKVQ 170
++R+ LG GG V+ + ++AVK L R + EA A +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 171 HKNLVRLLGCCIDKDEKI----LIYEYMPNKSLDFFLF---------------------- 204
H +V + + ++ EY+ +L +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 205 ----------NLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 253
++K +NI++ K+ DFG+AR I T+ ++GT Y+SPE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 254 AIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313
A + DV+S G +L E+++G+ F +++ ++ R + +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSV------AYQHVREDPIPPSAR 237
Query: 314 EDEYSS--KQVLLRYVNIALLCVQESADDRPTT 344
+ S+ V+L+ + ++ ++R T
Sbjct: 238 HEGLSADLDAVVLK-------ALAKNPENRYQT 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (312), Expect = 4e-33
Identities = 48/195 (24%), Positives = 80/195 (41%), Gaps = 41/195 (21%)
Query: 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRL 177
LG G FG V+ R G A+K L + + +E +++ V H ++R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 178 LGCCIDKDEKILIYEYMPNKSLDFFLF--------------------------------N 205
G D + +I +Y+ L L +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 129
Query: 206 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDV 265
LK NILLDK+ + KI+DFG A+ + T + GT Y++PE ++ D
Sbjct: 130 LKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDW 184
Query: 266 FSFGVLLLEIVSGKK 280
+SFG+L+ E+++G
Sbjct: 185 WSFGILIYEMLAGYT 199
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 1e-32
Identities = 48/275 (17%), Positives = 93/275 (33%), Gaps = 63/275 (22%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK 172
+ + + LG G F V ++ +A+K ++ ++ +G M+NE +V+ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN--------------------------- 205
N+V L LI + + L +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 206 --------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
LD+D ISDFG++++ + S GT GY++PE +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQK 184
Query: 258 IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317
+S D +S GV+ ++ G + +L + IL+ EY
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYP------------------PFYDENDAKLFEQILKAEY 226
Query: 318 SSKQVLLRYV-----NIALLCVQESADDRPTTNDV 347
+ + +++ + R T
Sbjct: 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-32
Identities = 45/272 (16%), Positives = 97/272 (35%), Gaps = 63/272 (23%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
++ A LG G FG V++ V + K + G +K E S++ +H+N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNIL 64
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------------------------------- 203
L +E ++I+E++ + +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 204 -FNLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
F+++ NI+ + KI +FG AR + N + Y +PE + S
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVS 181
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320
D++S G L+ ++SG + + ++ + I+ EY+
Sbjct: 182 TATDMWSLGTLVYVLLSGIN------------------PFLAETNQQIIENIMNAEYTFD 223
Query: 321 QVLLRYVNIALL-----CVQESADDRPTTNDV 347
+ + ++I + + + R T ++
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-32
Identities = 51/286 (17%), Positives = 104/286 (36%), Gaps = 53/286 (18%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK 172
R+++ + +GEG +G V +A+K++S Q + E ++ + +H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF---------------------------- 204
N++ + + + Y+ + L+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 205 -------NLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIE 256
+LK SN+LL+ + KI DFG+AR+ + + V T Y +PE +
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 257 GI-FSIKFDVFSFGVLLLEIVSGKK-NTGFYRTDTLN-----LLGYAWDLWRSNRTLELT 309
++ D++S G +L E++S + G + D LN L + + L+
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 310 DAILEDEYSSKQVLLRYVN------IALL--CVQESADDRPTTNDV 347
+ +L + +K R + LL + + R
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 8e-32
Identities = 54/280 (19%), Positives = 92/280 (32%), Gaps = 69/280 (24%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRL------SGRSGQGLREMKNEASVIAK 168
+ + +LG G F V K + G + A K + S R G +++ E S++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF-------------------------- 202
+QH N++ L +K + ILI E + L F
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 203 ------LFNLKASNILLDKDMNP----KISDFGMARICGGNELQANTSRIVGTYGYMSPE 252
F+LK NI+L P KI DFG+A I GT +++PE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPE 186
Query: 253 YAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312
++ D++S GV+ ++SG + + E +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGA------------------SPFLGDTKQETLANV 228
Query: 313 LEDEYSSKQVLLRYVNIALL-----CVQESADDRPTTNDV 347
Y + + + + R T D
Sbjct: 229 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 1e-31
Identities = 49/301 (16%), Positives = 95/301 (31%), Gaps = 82/301 (27%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRSGQGLR-EMKNEASVIAK 168
N +GEG FG V++ +AVK L + ++ + + EA+++A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 169 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFNLKASNILLD-------------- 214
+ N+V+LLG C L++EYM L+ FL ++ +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 215 ----------------------------------KDMNPKISDFGMARIC--------GG 232
N + + + +I
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 233 NELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNL 292
+ +M PE ++ + DV+++GV+L EI S
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP---------- 242
Query: 293 LGYAWDLWRSNRTLELTDAILEDEYSS--KQVLLRYVNIALLCVQESADDRPTTNDVVSM 350
+ E+ + + + + L N+ LC + DRP+ + +
Sbjct: 243 -------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 351 L 351
L
Sbjct: 296 L 296
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-31
Identities = 53/297 (17%), Positives = 101/297 (34%), Gaps = 58/297 (19%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLV 175
+ LGEG F VYK + N+I A+K++ S R E ++ ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 176 RLLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------ 205
LL K L++++M N
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 206 --LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE-GIFSIK 262
LK +N+LLD++ K++DFG+A+ G + V T Y +PE ++ +
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 263 FDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322
D+++ G +L E++ L+ L ++ + + D +Y + +
Sbjct: 182 VDMWAVGCILAELLLRV--PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 323 LLRYVNIALL-------------CVQESADDRPTTNDVVSM--LTNEAAALLPPKQP 364
+ + R T + M +N + P
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 117 bits (295), Expect = 2e-30
Identities = 52/204 (25%), Positives = 78/204 (38%), Gaps = 44/204 (21%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLS---GRSGQGLREMKNEASVIAKVQ- 170
N FS +G GGFG VY G A+K L + QG NE +++ V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 171 --HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN----------------------- 205
+V + D+ I + M L + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 206 ---------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE 256
LK +NILLD+ + +ISD G+A + VGT+GYM+PE +
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQK 179
Query: 257 GI-FSIKFDVFSFGVLLLEIVSGK 279
G+ + D FS G +L +++ G
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (290), Expect = 3e-30
Identities = 48/280 (17%), Positives = 88/280 (31%), Gaps = 53/280 (18%)
Query: 116 NRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 174
NR+ K+G G FG +Y G + G E+A+K ++ ++ E+ + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 175 VRLLG-CCIDKDEKILIYEYMPNKSLDFFLFN---------------------------- 205
+ + C + D +++ E + D F F
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 206 ----LKASNIL---LDKDMNPKISDFGMARICGGNELQAN-----TSRIVGTYGYMSPEY 253
+K N L K I DFG+A+ + + GT Y S
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 254 AIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313
+ S + D+ S G +L+ G + T + + +E+
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
E + C DD+P + + + N
Sbjct: 245 PSE---------FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 5e-30
Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 39/195 (20%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEI-AVKRLS---GRSGQGLREMKNEASVIAKV-QHKNLVR 176
LG+G FG V+ +K N+ A+K L + E V++ +H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 177 LLGCCIDKDEKILIYEYMPNKSLDFFLFN------------------------------- 205
+ K+ + EY+ L + + +
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 127
Query: 206 -LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFD 264
LK NILLDKD + KI+DFGM + + + NT GT Y++PE + ++ D
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVD 185
Query: 265 VFSFGVLLLEIVSGK 279
+SFGVLL E++ G+
Sbjct: 186 WWSFGVLLYEMLIGQ 200
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-30
Identities = 60/342 (17%), Positives = 109/342 (31%), Gaps = 90/342 (26%)
Query: 76 LKANNVNIELPVNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKG 135
+ ++ N V+ + + + K E + LG G FG V
Sbjct: 10 VTGSSDNEYFYVDFREYEYDLKWEFPR-------------ENLEFGKVLGSGAFGKVMNA 56
Query: 136 VLRKGNE------IAVKRLSGRSGQGLRE-MKNEASVIAKV-QHKNLVRLLGCCIDKDEK 187
++ +AVK L ++ RE + +E ++ ++ H+N+V LLG C
Sbjct: 57 TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116
Query: 188 ILIYEYMPNKSLDFFLFNLK-----------------------------ASNILLD---- 214
LI+EY L +L + +
Sbjct: 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176
Query: 215 --------------KDMNPKISDFGMARIC--------GGNELQANTSRIVGTYGYMSPE 252
N ++ + +IC + +M+PE
Sbjct: 177 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236
Query: 253 YAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312
EGI++IK DV+S+G+LL EI S N + + L ++ ++
Sbjct: 237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANF---YKLIQNGFKMDQPFYA 292
Query: 313 LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354
E+ Y I C + RP+ ++ S L +
Sbjct: 293 TEEIY----------IIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 112 bits (281), Expect = 4e-29
Identities = 44/199 (22%), Positives = 80/199 (40%), Gaps = 37/199 (18%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKN 173
++ K+GEG +G VYK G A+K RL E S++ +++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLF----------------------------- 204
+V+L K +L++E++
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 205 ---NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-EGIFS 260
+LK N+L++++ KI+DFG+AR G + + T Y +P+ + +S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYS 179
Query: 261 IKFDVFSFGVLLLEIVSGK 279
D++S G + E+V+G
Sbjct: 180 TTIDIWSVGCIFAEMVNGT 198
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 111 bits (279), Expect = 6e-29
Identities = 52/285 (18%), Positives = 90/285 (31%), Gaps = 75/285 (26%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRL--------SGRSGQGLRE-MKNEASVI 166
+ LG G V + + + E AVK + S Q LRE E ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 167 AKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN-------------------- 205
KV H N+++L L+++ M L +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 206 ------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 253
LK NILLD DMN K++DFG + E + GT Y++PE
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEI 180
Query: 254 A------IEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE 307
+ + D++S GV++ +++G + + +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------PFWHRKQML 222
Query: 308 LTDAILEDEYSSKQVLLRYV-----NIALLCVQESADDRPTTNDV 347
+ I+ Y ++ + R T +
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 9e-29
Identities = 43/199 (21%), Positives = 81/199 (40%), Gaps = 37/199 (18%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKN 173
F K+GEG +G VYK + G +A+K RL + E S++ ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 174 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN---------------------------- 205
+V+LL +++ L++E++ F +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 206 -----LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
LK N+L++ + K++DFG+AR G ++ T +V + +S
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 261 IKFDVFSFGVLLLEIVSGK 279
D++S G + E+V+ +
Sbjct: 182 TAVDIWSLGCIFAEMVTRR 200
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 41/210 (19%), Positives = 82/210 (39%), Gaps = 46/210 (21%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRL--SGRSGQGLREMKNEASVIAKVQHK 172
+++ K+G+G FG V+K RK G ++A+K++ E ++ ++H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 173 NLVRLLGCCIDKDEKI--------LIYEYMPNKSLDFFL--------------------- 203
N+V L+ C K L++++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 204 -----------FNLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMS 250
++KA+N+L+ +D K++DFG+AR N + V T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 251 PEYAI-EGIFSIKFDVFSFGVLLLEIVSGK 279
PE + E + D++ G ++ E+ +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 2e-27
Identities = 46/208 (22%), Positives = 70/208 (33%), Gaps = 48/208 (23%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVKRLSGRSGQGLREMKN------EASVIAK 168
+++ LG GGFG VY G+ N A+K + E+ N E ++ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 169 VQ--HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF---------------------- 204
V ++RLL D +LI E F
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 205 -----------NLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 252
++K NIL+D + K+ DFG + + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 179
Query: 253 Y-AIEGIFSIKFDVFSFGVLLLEIVSGK 279
+ V+S G+LL ++V G
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 106 bits (265), Expect = 7e-27
Identities = 37/282 (13%), Positives = 85/282 (30%), Gaps = 55/282 (19%)
Query: 116 NRFSDANKLGEGGFGPVYKGV-LRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 174
+ ++GEG FG +++G L ++A+K RS ++++E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFL------------------------------- 203
+ + + ++ + SL+ L
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 204 --FNLKASNILLDKDMNP-----KISDFGMARICGGNELQAN-----TSRIVGTYGYMSP 251
++K N L+ + + + DFGM + + + + GT YMS
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 252 EYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311
+ S + D+ + G + + + G + T + + L A
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353
+E+ + D P + + + +
Sbjct: 243 GFPEEFY---------KYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 1e-26
Identities = 56/292 (19%), Positives = 106/292 (36%), Gaps = 64/292 (21%)
Query: 114 ATNRFSDANKLGEGGFGPVYKGVLRK--GNEIAVKRLSGRSGQG------LREMKNEASV 165
A ++ ++GEG +G V+K K G +A+KR+ ++G+ +RE+
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRH 63
Query: 166 IAKVQHKNLVRLLGCCIDKDEK-----ILIYEYMPNKSLDFFLFN--------------- 205
+ +H N+VRL C L++E++ +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 206 ------------------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 247
LK NIL+ K++DFG+ARI + +V T
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLW 180
Query: 248 YMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE 307
Y +PE ++ ++ D++S G + E+ K F + ++ LG D+ +
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK--PLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 308 LTDAILEDEYS----SKQVLLRYVN------IALL--CVQESADDRPTTNDV 347
+ + S Q + ++V LL C+ + R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 3e-26
Identities = 40/200 (20%), Positives = 83/200 (41%), Gaps = 36/200 (18%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRKGNEI-AVK--RLSGRSGQGLREMKNEASVIAKVQHK 172
++ K+GEG +G V+K R+ +EI A+K RL E ++ +++HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 173 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF---------------------------- 204
N+VRL + L++E+ +F
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 205 ----NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
+LK N+L++++ K+++FG+AR G ++ ++ +V + ++S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 261 IKFDVFSFGVLLLEIVSGKK 280
D++S G + E+ + +
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 5e-26
Identities = 45/200 (22%), Positives = 73/200 (36%), Gaps = 38/200 (19%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLS---GRSGQGLREMKNEASVIAKVQH 171
N F LG+G FG V + G A+K L + + E+ V+ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 172 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF--------------------------- 204
L L D + EY L F L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 205 -----NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIF 259
++K N++LDKD + KI+DFG+ + + A GT Y++PE + +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDY 182
Query: 260 SIKFDVFSFGVLLLEIVSGK 279
D + GV++ E++ G+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-25
Identities = 47/207 (22%), Positives = 78/207 (37%), Gaps = 51/207 (24%)
Query: 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 175
++D +G G FG VY+ L G +A+K++ Q R E ++ K+ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 176 RLLGCCIDKDEK------ILIYEYMPNKSLDFFLF------------------------- 204
RL EK L+ +Y+P
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 205 ----------NLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 253
++K N+LLD D K+ DFG A+ E + + + Y +PE
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPEL 193
Query: 254 AIEGI-FSIKFDVFSFGVLLLEIVSGK 279
++ DV+S G +L E++ G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 96.8 bits (240), Expect = 3e-23
Identities = 36/228 (15%), Positives = 80/228 (35%), Gaps = 48/228 (21%)
Query: 87 VNSKLTKRNKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEI-AV 145
VN+ + E + + + KLG G + V++ + NE V
Sbjct: 13 VNTHRPREYWDYESHVVEWGNQ-------DDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 146 KRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEK--ILIYEYMPNKSLDFF 202
K L +++K E ++ ++ N++ L D + L++E++ N
Sbjct: 66 KILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 203 LFNL-----------------------------KASNILLD-KDMNPKISDFGMARICGG 232
L K N+++D + ++ D+G+A
Sbjct: 123 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 233 NELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGK 279
+ + V + + PE ++ ++ D++S G +L ++ K
Sbjct: 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 4e-23
Identities = 40/204 (19%), Positives = 83/204 (40%), Gaps = 45/204 (22%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRL--SGRSGQGLREMKNEASVIAKVQHK 172
+ D +G G +G V V + G ++A+K+L +S + E ++ ++H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 173 NLVRLLGCCIDKD------EKILIYEYMPNK----------------------------- 197
N++ LL + + L+ +M
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 198 -SLDFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIE 256
+ +LK N+ +++D KI DFG+AR + + + V T Y +PE +
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILN 192
Query: 257 GI-FSIKFDVFSFGVLLLEIVSGK 279
+ ++ D++S G ++ E+++GK
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.8 bits (240), Expect = 5e-23
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 41/221 (18%)
Query: 95 NKKKEVDQFPLFSFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG 153
K KE + S + ++F LG G FG V ++ GN A+K L +
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 154 QGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFN----- 205
L++++ NE ++ V LV+L D ++ EY+ + L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 206 ---------------------------LKASNILLDKDMNPKISDFGMARICGGNELQAN 238
LK N+L+D+ +++DFG A+ G
Sbjct: 140 EPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----R 194
Query: 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK 279
T + GT ++PE + ++ D ++ GVL+ E+ +G
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (238), Expect = 8e-23
Identities = 44/202 (21%), Positives = 75/202 (37%), Gaps = 41/202 (20%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLS--GRSGQGLREMKNEASVIAKVQHK 172
R+ + +G G G V +A+K+LS ++ + E ++ V HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 173 NLVRLLGCCIDKD------EKILIYEYMPNKSLDFFLF---------------------- 204
N++ LL + + L+ E M
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 205 -------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEG 257
+LK SNI++ D KI DFG+AR G + + + V T Y +PE +
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM 193
Query: 258 IFSIKFDVFSFGVLLLEIVSGK 279
+ D++S G ++ E+V K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 9e-23
Identities = 40/267 (14%), Positives = 84/267 (31%), Gaps = 60/267 (22%)
Query: 124 LGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCC 181
LG G G V + ++ + A+K L + + E + + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 182 IDKDEK----ILIYEYMPNKSLDFFL---------------------------------- 203
+ +++ E + L +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 204 FNLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFS 260
++K N+L K++DFG A+ + T Y++PE +
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYD 191
Query: 261 IKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSK 320
D++S GV++ ++ G FY L + + R + E S+
Sbjct: 192 KSCDMWSLGVIMYILLCGY--PPFYSNHGLAIS---PGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 321 QVLLRYVNIALLCVQESADDRPTTNDV 347
+V + ++ R T +
Sbjct: 247 EV----KMLIRNLLKTEPTQRMTITEF 269
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 1e-20
Identities = 37/204 (18%), Positives = 76/204 (37%), Gaps = 43/204 (21%)
Query: 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLS--GRSGQGLREMKNEASVIAKVQH 171
R+ + + +G G +G V K G +AVK+LS +S + E ++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 172 KNLVRLLGCCIDKD-----EKILIYEYMPNKSLDFFLFN--------------------- 205
+N++ LL + + ++ L+ +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 206 ----------LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 255
LK SN+ +++D KI DFG+AR T + +
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLN 192
Query: 256 EGIFSIKFDVFSFGVLLLEIVSGK 279
++ D++S G ++ E+++G+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 1e-19
Identities = 43/207 (20%), Positives = 74/207 (35%), Gaps = 44/207 (21%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLS----GRSGQGLREMKNEASVIA 167
F LG G +G V+ G A+K L + + + E V+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 168 KVQHK-NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF---------------------- 204
++ LV L + + LI +Y+ L L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 205 ----------NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 254
++K NILLD + + ++DFG+++ +E + GT YM+P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIV 202
Query: 255 IEGI--FSIKFDVFSFGVLLLEIVSGK 279
G D +S GVL+ E+++G
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.9 bits (193), Expect = 8e-17
Identities = 42/299 (14%), Positives = 89/299 (29%), Gaps = 58/299 (19%)
Query: 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 174
R+ KLG G F V+ +A+K + G ++E ++ +V +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71
Query: 175 VRLLGCCIDKDEKILIYEYMPNKSLDFFLF------------------------------ 204
+ + K+L + + +
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 205 -------------------NLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVG 244
++K N+L++ D + +A + + + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 245 TYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK----KNTGFYRTDTLNLLGYAWDLW 300
T Y SPE + + D++S L+ E+++G + G T + + +L
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALL 359
+ L + + + + LLR NI+ L D E + L
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLR--NISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 8e-14
Identities = 24/146 (16%), Positives = 42/146 (28%), Gaps = 40/146 (27%)
Query: 122 NKLGEGGFGPVYKGVLRKGNEIAVK--RLSGRSGQ--------GLREMKNEASVIAKVQH 171
+GEG V+ K E VK ++ S + G A A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 172 KNLVRLLGCCI----DKDEKILIYEYMPNKSLDFFLFN---------------------- 205
+ L +L G + + ++ E + K L
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 125
Query: 206 ---LKASNILLDKDMNPKISDFGMAR 228
L N+L+ + I DF +
Sbjct: 126 HGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 398 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.78 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.6 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.57 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.16 | |
| d2iuba2 | 64 | Magnesium transport protein CorA {Thermotoga marit | 92.14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=368.67 Aligned_cols=233 Identities=23% Similarity=0.391 Sum_probs=175.9
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
+...++|++.+.||+|+||+||+|+++ ..||||+++.. +....+.+.+|+.++++++|||||+++|++. .+..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 445678999999999999999999874 46999998644 4456778999999999999999999999875 457899
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
|||||++|+| +++||||||+|||++.++.+||+|||+|+........
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999988 4677899999999999999999999999876544433
Q ss_pred cccccccccccccChhhhcc---CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 237 ANTSRIVGTYGYMSPEYAIE---GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.......||+.|||||++.+ ..|+.++|||||||++|||+||+.||...... ..+ ......+........ .
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-~~~----~~~~~~~~~~p~~~~-~ 234 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQI----IFMVGRGYLSPDLSK-V 234 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHH----HHHHHHTSCCCCGGG-S
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-HHH----HHHHhcCCCCCcchh-c
Confidence 34455689999999999964 35899999999999999999999997543221 111 111111111100000 0
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccccc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAAL 358 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 358 (398)
...++..+.+|+.+||+.||++|||++||++.|+.+...+
T Consensus 235 -----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 235 -----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 1223456889999999999999999999999999876543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=365.58 Aligned_cols=224 Identities=26% Similarity=0.373 Sum_probs=170.0
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
++|+..+.||+|+||.||+|++.+++.||||+++... ...+++.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5688889999999999999999888899999997643 345789999999999999999999999999999999999999
Q ss_pred CCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 196 NKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 196 ~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+|+| +++||||||+|||+++++.+||+|||+++........ .....
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~ 162 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGT 162 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce-eecce
Confidence 9998 4577899999999999999999999999876544322 23345
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.||+.|+|||++.+..|+.++|||||||++|||+|+..|+.... ....+...+. . +..... +..+
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i~---~-~~~~~~----------p~~~ 227 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDIS---T-GFRLYK----------PRLA 227 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHHH---H-TCCCCC----------CTTS
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHHH---h-cCCCCC----------cccc
Confidence 78999999999999999999999999999999999655543221 1111211111 1 111000 1122
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+..+.+++.+||+.||++|||++||++.|+++.+
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 3467899999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=363.17 Aligned_cols=221 Identities=24% Similarity=0.358 Sum_probs=175.1
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|++.+.||+|+||+||+|++.. |+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4679999999999999999999865 8999999996543 2344678899999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
||++|+| +++||||||+|||+++++.+||+|||+|+............
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 9999988 57789999999999999999999999999875444333445
Q ss_pred cccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 241 RIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
..+||+.|||||++.+..+ +.++|||||||++|||++|+.||............ ........ .. .
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-----~~~~~~~~--~~-------~ 229 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKTYL--NP-------W 229 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-----HHTTCTTS--TT-------G
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-----HhcCCCCC--Cc-------c
Confidence 5789999999999988876 67899999999999999999998643332211111 11111000 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+..+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122345779999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=363.47 Aligned_cols=227 Identities=30% Similarity=0.421 Sum_probs=180.0
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
++...++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|++++++++|||||+++|++. ++..++|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEE
Confidence 344557888999999999999999999888899999997543 34577999999999999999999999875 4567999
Q ss_pred EeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 191 YEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 191 ~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
|||+++|+| +++||||||+|||+++++.+||+|||+|+........
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999998 4567899999999999999999999999987654322
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
......||+.|+|||++.++.++.++|||||||++|||+||..|+..... ....... ...+.....
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~----i~~~~~~~~-------- 231 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQN----LERGYRMVR-------- 231 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHH----HHTTCCCCC--------
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHH----HHhcCCCCC--------
Confidence 23445789999999999999999999999999999999997666432221 1111111 111111111
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
+...+..+.+|+.+||+.||++|||++||++.|+...
T Consensus 232 --p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1223346889999999999999999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=364.27 Aligned_cols=219 Identities=22% Similarity=0.386 Sum_probs=178.9
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|+..+.||+|+||+||+|++.. |+.||||++........+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4589999999999999999999754 899999999765545567899999999999999999999999999999999999
Q ss_pred cCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 194 MPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 194 ~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
|++|+| +++||||||+|||++.++.+||+|||+|+.+..... .....
T Consensus 99 ~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~ 176 (293)
T d1yhwa1 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 176 (293)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCC
T ss_pred cCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--ccccc
Confidence 999998 477889999999999999999999999998754332 23456
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .............. .. .+...
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~~-~~--------~~~~~ 242 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTPE-LQ--------NPEKL 242 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSCC-CS--------SGGGS
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCCCCC-CC--------CcccC
Confidence 899999999999999999999999999999999999999753211 11111111111110 00 01223
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+..+.+++.+||+.||++|||++|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 456889999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-48 Score=367.40 Aligned_cols=233 Identities=27% Similarity=0.422 Sum_probs=186.3
Q ss_pred chhhhhhhcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC
Q 037365 107 SFSSVSTATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 185 (398)
Q Consensus 107 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 185 (398)
++.+++...++|+..+.||+|+||+||+|++.+ ++.||||+++... ...+++.+|+++|++++|||||+++|+|.+++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 334555566789999999999999999999875 8889999997553 34578999999999999999999999999999
Q ss_pred eeEEEEeccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 186 EKILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 186 ~~~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
..++|||||++|+| +++||||||+|||+++++.+||+|||+|+...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999987 46788999999999999999999999998765
Q ss_pred CCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
..... ......||+.|+|||++.++.|+.++|||||||++|||++|..|+..... ...+ ......+.....
T Consensus 167 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~----~~~i~~~~~~~~--- 237 (287)
T d1opja_ 167 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQV----YELLEKDYRMER--- 237 (287)
T ss_dssp SSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHH----HHHHHTTCCCCC---
T ss_pred CCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHH----HHHHhcCCCCCC---
Confidence 43322 23345689999999999999999999999999999999998777532211 1111 111221111111
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+...+..+.+|+.+||+.||++|||++|+++.|+.+..
T Consensus 238 -------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 238 -------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12234568899999999999999999999999988643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=360.51 Aligned_cols=213 Identities=24% Similarity=0.351 Sum_probs=174.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||+||+|+++. ++.||+|++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 568899999999999999999865 889999998643 2234567889999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|||++|+| +++||||||+|||++.++.+||+|||+|+...... .
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~ 161 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----R 161 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----C
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc----c
Confidence 99999998 46788999999999999999999999998765432 3
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..... ..... ... .. +
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~---~~i~~-~~~-~~----------p 224 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--YQETY---KRISR-VEF-TF----------P 224 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHH---HHHHT-TCC-CC----------C
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--HHHHH---HHHHc-CCC-CC----------C
Confidence 34589999999999999999999999999999999999999975321 11111 11111 110 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+..+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 123456789999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=360.27 Aligned_cols=236 Identities=26% Similarity=0.410 Sum_probs=181.1
Q ss_pred hhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 112 STATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 112 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
+...++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|+.++++++|||||+++|+|. .+..++||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 33456899999999999999999999888899999997553 34578999999999999999999999985 56689999
Q ss_pred eccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 192 EYMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 192 e~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||+++|+| +++||||||+|||+++++.+||+|||+++....... .
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 99999987 467789999999999999999999999987654332 2
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
......||+.|+|||++.++.++.++|||||||++|||++|..|+...... ......+ ..+.....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i----~~~~~~~~--------- 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQV----ERGYRMPC--------- 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHH----HTTCCCCC---------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHH----HhcCCCCC---------
Confidence 233457899999999999999999999999999999999987775433221 1111111 11111111
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCCCCCc
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPPKQPA 365 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~ 365 (398)
+..++..+.+++.+||+.||++|||+++|+++|+.......|+.+|+
T Consensus 236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282 (285)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCC
Confidence 12234568899999999999999999999999999877666655554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=360.06 Aligned_cols=216 Identities=23% Similarity=0.332 Sum_probs=164.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--CCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 190 (398)
++|++.+.||+|+||+||+|+... |+.||+|++... .....+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 679999999999999999999865 899999998654 34455678999999999999999999999975 4568999
Q ss_pred EeccCCCCh------------------------------------h-----HHhhcCCCCCceecCCCCeEEccccccee
Q 037365 191 YEYMPNKSL------------------------------------D-----FFLFNLKASNILLDKDMNPKISDFGMARI 229 (398)
Q Consensus 191 ~e~~~~g~L------------------------------------~-----~~~~dlkp~NILl~~~~~~kl~DFGla~~ 229 (398)
||||++|+| + ++||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999987 1 68999999999999999999999999987
Q ss_pred cCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccc
Q 037365 230 CGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELT 309 (398)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||..... .++. .. ........+
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~---~~-i~~~~~~~~- 234 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELA---GK-IREGKFRRI- 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH---HH-HHHTCCCCC-
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHH---HH-HHcCCCCCC-
Confidence 754322 23346899999999999999999999999999999999999999753211 1111 11 111111111
Q ss_pred hhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 310 DAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
+...+..+.+|+.+||+.||.+|||++|+++
T Consensus 235 ---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1123346889999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=362.65 Aligned_cols=218 Identities=23% Similarity=0.390 Sum_probs=175.7
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEecc
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 194 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 194 (398)
+.|++.+.||+|+||.||+|++.. ++.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 568889999999999999999865 8899999998776666778999999999999999999999999999999999999
Q ss_pred CCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 195 PNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 195 ~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
++|+| +++||||||+|||++.++.+||+|||+|+...... .....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccc
Confidence 99988 46778999999999999999999999998654221 12334
Q ss_pred ccccccccChhhhc-----cCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 242 IVGTYGYMSPEYAI-----EGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 242 ~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
..||+.|+|||++. +..|+.++|||||||++|||++|+.||..... .... ....... .....
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~---~~i~~~~-~~~~~------- 236 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVL---LKIAKSE-PPTLA------- 236 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHH---HHHHHSC-CCCCS-------
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HHHH---HHHHcCC-CCCCC-------
Confidence 68999999999984 45689999999999999999999999754321 1111 1111111 11110
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+...+..+.+|+.+||+.||++|||++|+++
T Consensus 237 -~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 -QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01223456889999999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=352.76 Aligned_cols=220 Identities=29% Similarity=0.411 Sum_probs=180.1
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccC
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 195 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 195 (398)
++|+..+.||+|+||+||+|++++++.||||+++... ...+++.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788999999999999999999888899999997654 345789999999999999999999999999999999999999
Q ss_pred CCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccccc
Q 037365 196 NKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 242 (398)
Q Consensus 196 ~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 242 (398)
+|+| +++||||||+|||+++++.+||+|||+++........ .....
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 161 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGS 161 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCS
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eeccc
Confidence 9987 4677899999999999999999999999876554332 23346
Q ss_pred cccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHH
Q 037365 243 VGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQ 321 (398)
Q Consensus 243 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
.||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... ++. .... ....... +..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~---~~i~-~~~~~~~----------p~~ 225 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETA---EHIA-QGLRLYR----------PHL 225 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHH---HHHH-TTCCCCC----------CTT
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHH---HHHH-hCCCCCC----------ccc
Confidence 78999999999999999999999999999999998 78887543221 111 1111 1111111 112
Q ss_pred HHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 322 VLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 322 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
.+..+.+++.+||+.||++|||++++++.|.+
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 23468899999999999999999999999865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=364.60 Aligned_cols=217 Identities=23% Similarity=0.327 Sum_probs=172.2
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||+||+|++.. ++.||||++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 569999999999999999999864 899999998643 2234567899999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|||++|+| +++||||||+|||+++++.+||+|||+|+.+.........
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 99999988 4678899999999999999999999999987654433344
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ...+. ..... ... .+ +
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~---~~i~~-~~~-~~----------p 230 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EYLIF---QKIIK-LEY-DF----------P 230 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH---HHHHT-TCC-CC----------C
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--HHHHH---HHHHc-CCC-CC----------C
Confidence 45689999999999999999999999999999999999999975321 11111 11111 110 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+..+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 123345789999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-48 Score=362.89 Aligned_cols=225 Identities=24% Similarity=0.380 Sum_probs=168.6
Q ss_pred CCCCccceecccCceEEEEEEEcC-C---CEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-G---NEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|++.+.||+|+||+||+|+++. + ..||||++... .....+.|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567788999999999999999864 2 25899998654 445567899999999999999999999999999999999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||||++|+| +++||||||+|||++.++.+||+|||+++.+.......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 999999988 46778999999999999999999999998775433221
Q ss_pred ---ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 238 ---NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 238 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
......||+.|||||.+.++.++.++|||||||++|||+| |+.||..... ..+...+ ..+.....
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i----~~~~~~~~----- 254 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAI----EQDYRLPP----- 254 (299)
T ss_dssp ----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTTCCCCC-----
T ss_pred eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCCCCCC-----
Confidence 1223467999999999999999999999999999999998 8888753321 1121111 11111100
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+..++..+.+|+.+||+.||++|||++||++.|+++.+
T Consensus 255 -----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 255 -----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 22234568899999999999999999999999988654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=358.74 Aligned_cols=227 Identities=25% Similarity=0.395 Sum_probs=172.0
Q ss_pred cCCCCccceecccCceEEEEEEEcCC-----CEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRKG-----NEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
.++|+..++||+|+||.||+|.++.+ ..||||++... .......+.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35788889999999999999997652 36999999654 3444567899999999999999999999999999999
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+|||||.+|++ +++||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 99999999976 467889999999999999999999999987754322
Q ss_pred c-cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 Q-ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
. .......||+.|||||++.++.++.++|||||||++|||++|..|+..... ...+... ...+.....
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~~----i~~~~~~~~------ 234 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKA----INDGFRLPT------ 234 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHH----HHTTCCCCC------
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHHH----HhccCCCCC------
Confidence 2 223345789999999999999999999999999999999997766543221 1112111 111111111
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+...+..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 235 ----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 235 ----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 12234568899999999999999999999999988654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=365.83 Aligned_cols=236 Identities=23% Similarity=0.314 Sum_probs=177.3
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
..++|++.+.||+|+||+||+|++.. |+.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.++++.|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35789999999999999999999865 889999999754 3344567899999999999999999999999999999999
Q ss_pred eccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 192 EYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 192 e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|||++|+| +++||||||+|||++.++.+||+|||+|+..... .
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~ 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 159 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----T
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----c
Confidence 99999988 3677899999999999999999999999865422 2
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHH--------------------
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWD-------------------- 298 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~-------------------- 298 (398)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||................
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 334689999999999999999999999999999999999999986543221111000000
Q ss_pred hhhcCC----ccccchhhhhcc---cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhh
Q 037365 299 LWRSNR----TLELTDAILEDE---YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTN 353 (398)
Q Consensus 299 ~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~ 353 (398)
...... ..+..+...... ......+..+.+++.+||+.||.+|||++|+++ .+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000 000000000000 000112346889999999999999999999986 3544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-47 Score=360.48 Aligned_cols=232 Identities=25% Similarity=0.382 Sum_probs=184.4
Q ss_pred hhhhhhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeE
Q 037365 108 FSSVSTATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGC 180 (398)
Q Consensus 108 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 180 (398)
+.+++...++|++.+.||+|+||+||+|+++. ++.||||++.... ....+++.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 44566778899999999999999999999752 5689999997653 3445679999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCh--------------------------------------------------------hHHhh
Q 037365 181 CIDKDEKILIYEYMPNKSL--------------------------------------------------------DFFLF 204 (398)
Q Consensus 181 ~~~~~~~~lV~e~~~~g~L--------------------------------------------------------~~~~~ 204 (398)
|.+.+..+++|||+++|+| +++||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 9999999999999999987 24578
Q ss_pred cCCCCCceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCC-CCC
Q 037365 205 NLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKK-NTG 283 (398)
Q Consensus 205 dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-P~~ 283 (398)
||||+|||+|.++.+||+|||+|+...............||+.|+|||.+.+..|+.++|||||||++|||++|.. ||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999987655444444455678999999999999999999999999999999999965 443
Q ss_pred CCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 284 FYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
.. +..++... ...+..... +...+..+.+|+.+||+.||++||||.||+++|+++.
T Consensus 245 ~~--~~~e~~~~----v~~~~~~~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GM--AHEEVIYY----VRDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TS--CHHHHHHH----HHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CC--CHHHHHHH----HHcCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22 11111111 122222111 1123345889999999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=354.10 Aligned_cols=224 Identities=26% Similarity=0.368 Sum_probs=176.8
Q ss_pred CCCCccce-ecccCceEEEEEEEcC---CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANK-LGEGGFGPVYKGVLRK---GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~-lG~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|...+. ||+|+||.||+|.++. +..||||+++.. .....+.+.+|+++|++++|||||+++|+|.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 9999999999998753 457999999755 44556789999999999999999999999865 568999
Q ss_pred EeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc-
Q 037365 191 YEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ- 236 (398)
Q Consensus 191 ~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 236 (398)
||||++|+| +++||||||+|||++.++.+||+|||+++.+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999999998 4567899999999999999999999999987654322
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......||+.|+|||++.++.++.++|||||||++|||+| |+.||..... .++.. ....+...+.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~----~i~~~~~~~~------- 233 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMA----FIEQGKRMEC------- 233 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHH----HHHTTCCCCC-------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHH----HHHcCCCCCC-------
Confidence 22334578999999999999999999999999999999998 8999764322 11211 1222211111
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
++.++..+.+|+.+||+.||++|||+.+|++.|+....
T Consensus 234 ---p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12234568899999999999999999999999987543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=361.65 Aligned_cols=226 Identities=27% Similarity=0.372 Sum_probs=177.9
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC-C-----CEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeC
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK-G-----NEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 184 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 184 (398)
...++|++.+.||+|+||+||+|++.. + ..||+|.+... .......+.+|+.++.++ +|||||+++++|.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345789999999999999999999754 2 26999998654 334456788999999998 899999999999999
Q ss_pred CeeEEEEeccCCCCh-------------------------------------------------------hHHhhcCCCC
Q 037365 185 DEKILIYEYMPNKSL-------------------------------------------------------DFFLFNLKAS 209 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L-------------------------------------------------------~~~~~dlkp~ 209 (398)
+..++|||||++|+| +++||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 999999999999987 2467899999
Q ss_pred CceecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCC
Q 037365 210 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTD 288 (398)
Q Consensus 210 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~ 288 (398)
|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987655443333445678999999999999999999999999999999998 89997543222
Q ss_pred ccchhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhh
Q 037365 289 TLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTN 353 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 353 (398)
..+. .....+...+. +...+..+.+|+.+||+.||++|||++||++.|..
T Consensus 274 -~~~~----~~~~~~~~~~~----------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 -ANFY----KLIQNGFKMDQ----------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp -HHHH----HHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHH----HHHhcCCCCCC----------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1111 11221111111 12234568899999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=351.47 Aligned_cols=216 Identities=27% Similarity=0.364 Sum_probs=168.2
Q ss_pred ceecccCceEEEEEEEcC---CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEeccCC
Q 037365 122 NKLGEGGFGPVYKGVLRK---GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 196 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 196 (398)
+.||+|+||+||+|.+++ ++.||||+++.. +....+.+.+|+.+|++++|||||+++|+|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998754 467999999654 33445689999999999999999999999965 567899999999
Q ss_pred CCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc-ccccccc
Q 037365 197 KSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIV 243 (398)
Q Consensus 197 g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~ 243 (398)
|+| +++||||||+|||++.++.+||+|||+++.+...... .......
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 998 4667899999999999999999999999987544322 2233457
Q ss_pred ccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccChHHH
Q 037365 244 GTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSSKQV 322 (398)
Q Consensus 244 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
||+.|||||.+.+..++.++|||||||++|||+| |+.||..... .++. .....+..... +..+
T Consensus 172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~----~~i~~~~~~~~----------p~~~ 235 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVT----AMLEKGERMGC----------PAGC 235 (277)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH----HHHHTTCCCCC----------CTTC
T ss_pred CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHH----HHHHcCCCCCC----------Cccc
Confidence 8999999999999999999999999999999998 8999754221 1111 11221111111 1223
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 323 LLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 323 ~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
+..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 45688999999999999999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-47 Score=357.27 Aligned_cols=220 Identities=20% Similarity=0.282 Sum_probs=159.8
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
..+.|++.+.||+|+||+||+|++.. ++.||||++.... ......+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45779999999999999999999865 8899999997543 233456789999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceec---CCCCeEEcccccceecCCCCcc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLD---KDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~---~~~~~kl~DFGla~~~~~~~~~ 236 (398)
|||++|+| +++||||||+|||+. +++.+||+|||+|+......
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 99999998 467789999999994 57899999999998765432
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+. ......... ...+ .
T Consensus 165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~---~~i~~~~~~--~~~~-~--- 232 (307)
T d1a06a_ 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLF---EQILKAEYE--FDSP-Y--- 232 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH---HHHHTTCCC--CCTT-T---
T ss_pred -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HHHH---HHHhccCCC--CCCc-c---
Confidence 23346899999999999999999999999999999999999999853211 1111 111111100 0000 0
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+++.+||+.||++|||++|+++
T Consensus 233 --~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 233 --WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1223456889999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-46 Score=358.75 Aligned_cols=220 Identities=22% Similarity=0.317 Sum_probs=178.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|++.+.||+|+||.||+|++.. |+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4689999999999999999999864 889999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceec--CCCCeEEcccccceecCCCCcccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLD--KDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~--~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|++|+| +++||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--- 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--- 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc---
Confidence 999998 467789999999995 467899999999998764432
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..... ......... .....
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~---~~i~~~~~~--~~~~~------ 248 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETL---RNVKSCDWN--MDDSA------ 248 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH---HHHHHTCCC--SCCGG------
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--HHHHH---HHHHhCCCC--CCccc------
Confidence 334689999999999999999999999999999999999999975321 11111 111111100 00000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
....+..+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223467899999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=345.51 Aligned_cols=212 Identities=25% Similarity=0.389 Sum_probs=165.3
Q ss_pred CccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe----CCeeEEEE
Q 037365 119 SDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIY 191 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 191 (398)
+..+.||+|+||+||+|++.. ++.||+|++... .....+.+.+|+++|++++|||||++++++.+ +...|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 455689999999999999865 889999998654 34456778999999999999999999999875 34679999
Q ss_pred eccCCCCh--------------------------------h--HHhhcCCCCCceec-CCCCeEEcccccceecCCCCcc
Q 037365 192 EYMPNKSL--------------------------------D--FFLFNLKASNILLD-KDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 192 e~~~~g~L--------------------------------~--~~~~dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~ 236 (398)
||+++|+| + ++||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---
Confidence 99999998 3 78899999999996 5789999999999864432
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
......||+.|||||++.+ .++.++|||||||++|||++|+.||...... ..+ ......+..... .
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~~----~~~i~~~~~~~~----~--- 234 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQI----YRRVTSGVKPAS----F--- 234 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHH----HHHHTTTCCCGG----G---
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HHH----HHHHHcCCCCcc----c---
Confidence 2334689999999998865 6999999999999999999999998532211 111 111111111110 1
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.......+.+++.+||+.||++|||++|+++
T Consensus 235 --~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 --DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112234789999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-46 Score=354.79 Aligned_cols=213 Identities=26% Similarity=0.432 Sum_probs=171.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
+.|+..+.||+|+||.||+|++.. ++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 458889999999999999999765 8889999986543 334567899999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|||++|+| +++||||||+|||++.++.+||+|||+|+.... .
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------B
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------C
Confidence 99999977 467899999999999999999999999986542 2
Q ss_pred ccccccccccChhhhcc---CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcc
Q 037365 240 SRIVGTYGYMSPEYAIE---GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDE 316 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||..... ............ ....
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~~~~i~~~~~-~~~~------- 235 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES-PALQ------- 235 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCC-CCCS-------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCCC-CCCC-------
Confidence 34579999999999864 4589999999999999999999999753211 111111121111 1111
Q ss_pred cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 317 YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 317 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....+..+.+|+.+||+.||++|||++|+++
T Consensus 236 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1122346889999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=347.75 Aligned_cols=226 Identities=22% Similarity=0.316 Sum_probs=168.1
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC----CCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK----GNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
...++|++.+.||+|+||.||+|++.. +..||||+++.. .....+.+.+|+.++++++|||||+++|++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345689999999999999999998754 346899998654 3444567999999999999999999999985 5678
Q ss_pred EEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 188 ILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 188 ~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
++||||+++|+| +++||||||+||++++++.+||+|||+|+......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999987 46778999999999999999999999998765433
Q ss_pred cccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. .......||+.|+|||++.+..++.++|||||||++|||++ |.+||..... ..+...+ ..+.....
T Consensus 163 ~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i----~~~~~~~~----- 230 (273)
T d1mp8a_ 163 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRI----ENGERLPM----- 230 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHH----HTTCCCCC-----
T ss_pred c-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHH----HcCCCCCC-----
Confidence 2 22334578999999999999999999999999999999998 7888654322 1222111 11111111
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
++..+..+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus 231 -----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 231 -----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22234568899999999999999999999999987643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8e-46 Score=357.04 Aligned_cols=223 Identities=23% Similarity=0.299 Sum_probs=179.8
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.++|++.+.||+|+||.||+|++.. |+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3679999999999999999999864 999999999877666667888999999999999999999999999999999999
Q ss_pred cCCCCh---------------------------------hHHhhcCCCCCceec--CCCCeEEcccccceecCCCCcccc
Q 037365 194 MPNKSL---------------------------------DFFLFNLKASNILLD--KDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 194 ~~~g~L---------------------------------~~~~~dlkp~NILl~--~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|++|+| +++||||||+|||++ .++.+||+|||+|+.+.... .
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---I 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---C
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC---c
Confidence 999988 467899999999997 67899999999999876543 2
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ... .......... .....
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~---~~~i~~~~~~--~~~~~------ 251 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LET---LQNVKRCDWE--FDEDA------ 251 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHH---HHHHHHCCCC--CCSST------
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHHhCCCC--CCccc------
Confidence 3345799999999999999999999999999999999999999753211 111 1111111100 00000
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--Hhh
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTNDVVSM--LTN 353 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~ 353 (398)
....+..+.+|+.+||+.||.+|||++|+++. +++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 12234567899999999999999999999873 544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=345.95 Aligned_cols=219 Identities=24% Similarity=0.307 Sum_probs=174.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
.++|++.+.||+|+||+||+|++.. |+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4689999999999999999999864 8999999986431 22457899999999999999999999999999999
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCC----CeEEcccccceecC
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDM----NPKISDFGMARICG 231 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~----~~kl~DFGla~~~~ 231 (398)
|+|||||++|+| +++||||||+|||++.++ .+||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999998 466789999999998776 49999999998875
Q ss_pred CCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA 311 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.. ..... ... .....
T Consensus 169 ~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~---~~i~~-~~~-~~~~~ 238 (293)
T d1jksa_ 169 FGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETL---ANVSA-VNY-EFEDE 238 (293)
T ss_dssp TSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHT-TCC-CCCHH
T ss_pred CCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--HHHH---HHHHh-cCC-CCCch
Confidence 433 23345789999999999999999999999999999999999999753211 1111 11111 110 00000
Q ss_pred hhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 312 ILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ....+..+.+|+.+||+.||++|||++|+++
T Consensus 239 ~------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 239 Y------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp H------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h------cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1122356789999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-45 Score=351.19 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=174.0
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++.+.||+|+||+||+|+++. |+.||||++... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 568999999999999999999865 899999998643 2234577899999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|||++|+| +++||||||+|||++.++.+||+|||+|+..... .
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----T 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----B
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-----c
Confidence 99999987 5778999999999999999999999999987543 2
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ............ .. +
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~~~~--~~----------p 221 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILNAEL--RF----------P 221 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHCCC--CC----------C
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHHHHHcCCC--CC----------C
Confidence 346899999999999999999999999999999999999999753211 111111111110 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
...+..+.+++.+||+.||.+|+ |++++++
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 22334578999999999999996 8999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=352.76 Aligned_cols=216 Identities=22% Similarity=0.301 Sum_probs=175.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
.++|++.+.||+|+||.||+|+... |+.||+|++.+. .....+.+.+|+.+|++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 4679999999999999999999864 899999999643 223457788999999999999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
||||++|+| +++||||||+|||++.+|.+||+|||+|+...... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC--cc
Confidence 999999998 57789999999999999999999999998764332 22
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..+. ..... ... ..
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~---~~i~~-~~~-~~---------- 224 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLF---ELILM-EEI-RF---------- 224 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHH-CCC-CC----------
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHH---HHHhc-CCC-CC----------
Confidence 3456899999999999999999999999999999999999999754221 1111 11111 110 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
+...+..+.+|+.+||+.||.+||+ ++|+++
T Consensus 225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1223345789999999999999995 888876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=350.51 Aligned_cols=224 Identities=28% Similarity=0.439 Sum_probs=171.8
Q ss_pred CCCCccceecccCceEEEEEEEcC-CC----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GN----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 189 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 189 (398)
++|+..+.||+|+||+||+|.+.. |+ .||+|++... .....+.+.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999764 43 5899998654 344567899999999999999999999999864 5678
Q ss_pred EEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 190 IYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 190 V~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
++||+.+|+| +++||||||+|||++.++.+||+|||+|+........
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 8999999987 4678999999999999999999999999987655444
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhc
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILED 315 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.......||+.|+|||++.++.|+.++|||||||++|||+| |.+||..... ..+...+ ..+.....
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i----~~~~~~~~------- 234 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSIL----EKGERLPQ------- 234 (317)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHH----HHTCCCCC-------
T ss_pred ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCCCCCC-------
Confidence 44455678999999999999999999999999999999999 6777653221 1222111 11111110
Q ss_pred ccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 316 EYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 316 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+..++..+.+|+.+||+.||++|||+.|+++.|+....
T Consensus 235 ---p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 235 ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 12234568899999999999999999999999887643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=349.36 Aligned_cols=229 Identities=27% Similarity=0.379 Sum_probs=182.7
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID 183 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 183 (398)
++...++|+..+.||+|+||.||+|.++ +++.||||+++.. .......+.+|++++++++||||++++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4445578889999999999999999874 2578999999754 34445678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCCh------------------------------------------hHHhhcCCCCCceecCCCCeEE
Q 037365 184 KDEKILIYEYMPNKSL------------------------------------------DFFLFNLKASNILLDKDMNPKI 221 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L------------------------------------------~~~~~dlkp~NILl~~~~~~kl 221 (398)
++..++||||+++|+| +++||||||+|||+++++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 9999999999999987 3567899999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCC-CCCCCCCCCccchhHHHHHhh
Q 037365 222 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGK-KNTGFYRTDTLNLLGYAWDLW 300 (398)
Q Consensus 222 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~ 300 (398)
+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+||. .|+... .. ...... .
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--~~---~~~~~~-i 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SN---EQVLRF-V 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CH---HHHHHH-H
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--CH---HHHHHH-H
Confidence 9999998776544444445567899999999999999999999999999999999986 454321 11 111111 1
Q ss_pred hcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 301 RSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
..+..... +..++..+.+++.+||+.||++|||+++|++.|++..
T Consensus 249 ~~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 MEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HhCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111111 1223356889999999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=343.25 Aligned_cols=232 Identities=25% Similarity=0.337 Sum_probs=172.3
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcC------CCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRK------GNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCC 181 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 181 (398)
.++...++|++.+.||+|+||.||+|++.. ++.||||+++.. .....+.+.+|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 344455789999999999999999999643 467999999754 344456788888888887 689999999998
Q ss_pred EeCC-eeEEEEeccCCCCh------------------------------------------------hHHhhcCCCCCce
Q 037365 182 IDKD-EKILIYEYMPNKSL------------------------------------------------DFFLFNLKASNIL 212 (398)
Q Consensus 182 ~~~~-~~~lV~e~~~~g~L------------------------------------------------~~~~~dlkp~NIL 212 (398)
...+ ..++|||||++|+| +++||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 7654 68999999999987 2457899999999
Q ss_pred ecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCC-CCCCCCCCccc
Q 037365 213 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKK-NTGFYRTDTLN 291 (398)
Q Consensus 213 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-P~~~~~~~~~~ 291 (398)
+++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++|.. ||..... ...
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~~~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEE 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-HHH
Confidence 99999999999999987765544444556789999999999999999999999999999999999765 5432211 111
Q ss_pred hhHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 292 LLGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
+ ......+..... +...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 246 ~----~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 F----CRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp H----HHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----HHHHhcCCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 111222211111 11223457899999999999999999999999998653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=339.11 Aligned_cols=218 Identities=28% Similarity=0.408 Sum_probs=166.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEe-CCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e 192 (398)
..++|+..+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|++++++++||||++++|+|.+ ++..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 3456788899999999999999995 7899999997543 34779999999999999999999999965 466899999
Q ss_pred ccCCCCh----------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 193 YMPNKSL----------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 193 ~~~~g~L----------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
|+++|+| +++||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-----
Confidence 9999998 3566799999999999999999999999865432
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.|+... +..++...+ ..+...++
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i----~~~~~~~~--------- 221 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRV----EKGYKMDA--------- 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHH----TTTCCCCC---------
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHH----HcCCCCCC---------
Confidence 223467899999999999999999999999999999998 56665432 222222222 11111111
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcc
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEA 355 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 355 (398)
+...+..+.+|+.+||+.||.+|||+.+++++|+++.
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1122346789999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=341.75 Aligned_cols=222 Identities=27% Similarity=0.404 Sum_probs=173.9
Q ss_pred cceecccCceEEEEEEEcCC----CEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe-CCeeEEEEecc
Q 037365 121 ANKLGEGGFGPVYKGVLRKG----NEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEYM 194 (398)
Q Consensus 121 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~~ 194 (398)
.++||+|+||+||+|++.++ ..||||+++.. +....+.+.+|+++|++++||||++++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36799999999999997652 25899999753 55566889999999999999999999999876 46899999999
Q ss_pred CCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccc--cc
Q 037365 195 PNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQA--NT 239 (398)
Q Consensus 195 ~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~ 239 (398)
++|+| +++||||||+|||+++++.+||+|||+++......... ..
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 99988 45778999999999999999999999998775443222 23
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .+....+ ..+.. ... +
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i---~~g~~-~~~----------p 256 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYL---LQGRR-LLQ----------P 256 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH---HTTCC-CCC----------C
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHH---HcCCC-CCC----------c
Confidence 3457899999999999999999999999999999999988886543221 1222221 11111 111 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 320 KQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
...+..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12234588999999999999999999999999988653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=342.66 Aligned_cols=232 Identities=24% Similarity=0.318 Sum_probs=183.7
Q ss_pred hhhhcCCCCccceecccCceEEEEEEEc------CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEE
Q 037365 111 VSTATNRFSDANKLGEGGFGPVYKGVLR------KGNEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 182 (398)
Q Consensus 111 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 182 (398)
++...++|++.+.||+|+||.||+|++. .++.||||+++.. .......+.+|+.+++++ +|||||+++|+|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3445578999999999999999999863 2568999999764 344556789999999999 6999999999999
Q ss_pred eCCeeEEEEeccCCCCh--------------------------------------------------hHHhhcCCCCCce
Q 037365 183 DKDEKILIYEYMPNKSL--------------------------------------------------DFFLFNLKASNIL 212 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L--------------------------------------------------~~~~~dlkp~NIL 212 (398)
+++..++|||||++|+| +++||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 99999999999999976 3567899999999
Q ss_pred ecCCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccch
Q 037365 213 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNL 292 (398)
Q Consensus 213 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~ 292 (398)
++.++.+|++|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|+..|+.........+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999998765554445556789999999999999999999999999999999999555543322222222
Q ss_pred hHHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 293 LGYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
... ...+..... +...+..+.+|+.+||+.||++|||++||+++|++...
T Consensus 258 ~~~----i~~~~~~~~----------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 258 YKM----IKEGFRMLS----------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHH----HHHTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HhcCCCCCC----------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 221 111111110 11223458899999999999999999999999987644
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-44 Score=347.56 Aligned_cols=212 Identities=22% Similarity=0.336 Sum_probs=173.7
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 191 (398)
++|++++.||+|+||.||+|+++. |+.||||++... .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 679999999999999999999864 899999998643 2234567889999999999999999999999999999999
Q ss_pred eccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 192 EYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 192 e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
||+.+|+| +++||||||+|||++.++.+||+|||+|+.+... .
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----T 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----B
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----c
Confidence 99999987 5678999999999999999999999999987533 2
Q ss_pred ccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccCh
Q 037365 240 SRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYSS 319 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (398)
....||+.|||||++.+..++.++|||||||++|||++|+.||... +...+ ........ . .. +
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~---~~~i~~~~-~-~~----------p 258 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQI---YEKIVSGK-V-RF----------P 258 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHH---HHHHHHCC-C-CC----------C
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--CHHHH---HHHHhcCC-C-CC----------C
Confidence 3468999999999999999999999999999999999999997532 11111 11111111 0 00 1
Q ss_pred HHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 320 KQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 320 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
...+..+.+++.+||+.||.+|+ |++|+++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12334578999999999999994 9999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=344.63 Aligned_cols=235 Identities=21% Similarity=0.279 Sum_probs=170.3
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----eeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~ 191 (398)
.+|...+.||+|+||.||+|++ +|+.||||++..... .......|+..+.+++||||++++|+|.+.+ ..|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3566778999999999999998 588999999965432 1122234555556789999999999998754 579999
Q ss_pred eccCCCCh---------------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 192 EYMPNKSL---------------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 192 e~~~~g~L---------------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
|||++|+| +++||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 99999988 245889999999999999999999999988754
Q ss_pred CCcc--cccccccccccccChhhhccC------CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccc---------hhHH
Q 037365 233 NELQ--ANTSRIVGTYGYMSPEYAIEG------IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLN---------LLGY 295 (398)
Q Consensus 233 ~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~---------~~~~ 295 (398)
.... .......||+.|+|||++.+. .++.++|||||||++|||+||..|+......... ....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 3322 123456899999999998754 3678999999999999999998876543222110 0111
Q ss_pred HHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 296 AWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.......... ++.+............+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 241 ~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 241 MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1111111111 11111122233455678999999999999999999999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=340.51 Aligned_cols=223 Identities=25% Similarity=0.357 Sum_probs=166.2
Q ss_pred CCCCccceecccCceEEEEEEEcC--C--CEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK--G--NEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 188 (398)
++|++.+.||+|+||.||+|++.. + ..||||++... .....+.+.+|+.+|++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568889999999999999998643 2 36899998654 33445789999999999999999999999965 5678
Q ss_pred EEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 189 LIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 189 lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
+||||+++|++ +++||||||+|||++.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999999987 467789999999999999999999999998755432
Q ss_pred cc-ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 236 QA-NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.. ......||..|+|||++.+..++.++|||||||++|||+| |+.||..... .+........+...+.
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~----- 236 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGERLPR----- 236 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSCCCCCC-----
T ss_pred cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----HHHHHHHHhCCCCCCC-----
Confidence 22 2334567889999999999999999999999999999998 8988753211 1111222222211111
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNE 354 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 354 (398)
+...+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus 237 -----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 -----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122234588999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-44 Score=337.93 Aligned_cols=227 Identities=21% Similarity=0.303 Sum_probs=172.0
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----e
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----E 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 186 (398)
.++|++.+.||+|+||.||+|++.. |+.||||+++.. +......+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 5789999999999999999999864 889999999754 3344567899999999999999999999998754 3
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
.|+||||+++|+| +++||||||+|||++.++..+++|||.++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 7999999999988 47788999999999999999999999987664332
Q ss_pred c-ccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 235 L-QANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 235 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. ........||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+............. ...
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~~~~~~~~~~---~~~ 237 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIPP---SAR 237 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCCG---GGT
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----HHHHHHHHhcCCCCC---chh
Confidence 1 2234456899999999999999999999999999999999999999853211 111222222211110 000
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHhhc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRP-TTNDVVSMLTNE 354 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~ 354 (398)
....+..+.+++.+||+.||++|| |++++++.|.++
T Consensus 238 -----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 238 -----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 112335688999999999999999 899999988765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-45 Score=343.76 Aligned_cols=223 Identities=28% Similarity=0.380 Sum_probs=171.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CC--EEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GN--EIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|++.+.||+|+||.||+|++++ +. .||||++... .....+.+.+|+++|.++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 577888999999999999999865 33 4788988644 334556799999999998 799999999999999999999
Q ss_pred EeccCCCCh------------------------------------------------hHHhhcCCCCCceecCCCCeEEc
Q 037365 191 YEYMPNKSL------------------------------------------------DFFLFNLKASNILLDKDMNPKIS 222 (398)
Q Consensus 191 ~e~~~~g~L------------------------------------------------~~~~~dlkp~NILl~~~~~~kl~ 222 (398)
|||+++|+| +++||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 999999987 24567999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCC-CCCCCCCccchhHHHHHhhh
Q 037365 223 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKN-TGFYRTDTLNLLGYAWDLWR 301 (398)
Q Consensus 223 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P-~~~~~~~~~~~~~~~~~~~~ 301 (398)
|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|..| |... +...+...+ ..
T Consensus 170 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~~~~~~~~i---~~ 241 (309)
T d1fvra_ 170 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKL---PQ 241 (309)
T ss_dssp CTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHG---GG
T ss_pred cccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--CHHHHHHHH---Hh
Confidence 999998654221 22345789999999999999999999999999999999997654 4321 111121111 11
Q ss_pred cCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccc
Q 037365 302 SNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAA 357 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 357 (398)
+...+. +...+..+.+|+.+||+.||++||||+||++.|+++...
T Consensus 242 -~~~~~~----------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 242 -GYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -TCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -cCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111111 122345688999999999999999999999999987653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=341.05 Aligned_cols=228 Identities=27% Similarity=0.382 Sum_probs=177.6
Q ss_pred hhcCCCCccceecccCceEEEEEEEcC--------CCEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCcccceeeEEE
Q 037365 113 TATNRFSDANKLGEGGFGPVYKGVLRK--------GNEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCI 182 (398)
Q Consensus 113 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 182 (398)
...++|++.+.||+|+||.||+|+... +..||||++.... ......+.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345789999999999999999998643 2469999997653 34557888999999888 7999999999999
Q ss_pred eCCeeEEEEeccCCCCh------------------------------------------------hHHhhcCCCCCceec
Q 037365 183 DKDEKILIYEYMPNKSL------------------------------------------------DFFLFNLKASNILLD 214 (398)
Q Consensus 183 ~~~~~~lV~e~~~~g~L------------------------------------------------~~~~~dlkp~NILl~ 214 (398)
+++..++|||||++|+| +++||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 99999999999999977 356789999999999
Q ss_pred CCCCeEEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHc-CCCCCCCCCCCccchh
Q 037365 215 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVS-GKKNTGFYRTDTLNLL 293 (398)
Q Consensus 215 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 293 (398)
.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||..... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~--- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--E--- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H---
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--H---
Confidence 999999999999998765544444555689999999999999999999999999999999998 5777543221 1
Q ss_pred HHHHHhhhcCCccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 294 GYAWDLWRSNRTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
.+...+..+..... +...+..+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus 245 -~~~~~i~~~~~~~~----------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 -ELFKLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHHHTTCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCCCC----------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 12222222221111 11123458899999999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=340.11 Aligned_cols=219 Identities=18% Similarity=0.283 Sum_probs=174.6
Q ss_pred hcCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
..++|++.+.||+|+||+||+|.+.. ++.||||.++.... ....+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 35789999999999999999999865 88899999976643 34568899999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecC--CCCeEEcccccceecCCCCccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDK--DMNPKISDFGMARICGGNELQA 237 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 237 (398)
||++|+| +++||||||+|||++. ...+||+|||+++.......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-- 159 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc--
Confidence 9999988 4678899999999975 45899999999987654332
Q ss_pred ccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhccc
Q 037365 238 NTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEY 317 (398)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
.....||+.|+|||.+.+..|+.++|||||||++|||++|+.||..... .. .......... ......
T Consensus 160 -~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--~~---~~~~i~~~~~--~~~~~~----- 226 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQ---IIENIMNAEY--TFDEEA----- 226 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HH---HHHHHHHTCC--CCCHHH-----
T ss_pred -ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--HH---HHHHHHhCCC--CCChhh-----
Confidence 2345789999999999999999999999999999999999999754221 11 1111111110 000000
Q ss_pred ChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 318 SSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 318 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.+..+..+.+|+.+||+.||++|||++|+++
T Consensus 227 -~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 -FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122356789999999999999999999997
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=335.78 Aligned_cols=226 Identities=20% Similarity=0.260 Sum_probs=166.1
Q ss_pred ccceecccCceEEEEEEEcC-CCEEEEEEccCCChh-----hHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 120 DANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 120 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
.+++||+|+||+||+|++.. |+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 35789999999999999865 899999999654221 124688999999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+.++++ +++||||||+|||++.++.+||+|||+|+....... ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc--cccc
Confidence 998865 577899999999999999999999999987654322 2334
Q ss_pred ccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh------hhh
Q 037365 242 IVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA------ILE 314 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 314 (398)
..||+.|+|||++.+. .|+.++|||||||++|||++|++||..... .+....+.............+. ...
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 5799999999998754 579999999999999999999988753321 1111111111110000000000 000
Q ss_pred c---ccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 315 D---EYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 315 ~---~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ... .......+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 000 0122356889999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-43 Score=330.74 Aligned_cols=218 Identities=21% Similarity=0.297 Sum_probs=172.4
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh---------hhHHHHHHHHHHHHhcC-CCcccceeeEEEeC
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG---------QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDK 184 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 184 (398)
++|++.+.||+|+||+||+|++.. |+.||||++..... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 689999999999999999999854 88999999865421 12346789999999997 99999999999999
Q ss_pred CeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCC
Q 037365 185 DEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGG 232 (398)
Q Consensus 185 ~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~ 232 (398)
+..|+|||||++|+| +++||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 999999999999998 467789999999999999999999999998764
Q ss_pred CCcccccccccccccccChhhhcc------CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc
Q 037365 233 NELQANTSRIVGTYGYMSPEYAIE------GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL 306 (398)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
.. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ... ....... ...
T Consensus 163 ~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~~---~~~i~~~-~~~ 233 (277)
T d1phka_ 163 GE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLM---LRMIMSG-NYQ 233 (277)
T ss_dssp TC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHT-CCC
T ss_pred CC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HHH---HHHHHhC-CCC
Confidence 32 2334689999999999863 3478899999999999999999999864321 111 1111111 111
Q ss_pred ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...+ .....+..+.+++.+||+.||++|||++|+++
T Consensus 234 -~~~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 234 -FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -CCCc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000 01223456889999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=342.21 Aligned_cols=215 Identities=25% Similarity=0.355 Sum_probs=170.8
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC---ChhhHHHHHHHHHHHH-hcCCCcccceeeEEEeCCeeEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR---SGQGLREMKNEASVIA-KVQHKNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV 190 (398)
++|++.+.||+|+||+||+|++.. ++.||||++... .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578999999999999999999875 889999999643 1233456677777765 68999999999999999999999
Q ss_pred EeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccc
Q 037365 191 YEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQAN 238 (398)
Q Consensus 191 ~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 238 (398)
||||++|+| +++||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc--cc
Confidence 999999998 46778999999999999999999999998765432 22
Q ss_pred cccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhhcccC
Q 037365 239 TSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILEDEYS 318 (398)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (398)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..+. ........ ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~----~~i~~~~~-~~---------- 222 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELF----HSIRMDNP-FY---------- 222 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHCCC-CC----------
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHH----HHHHcCCC-CC----------
Confidence 3446899999999999999999999999999999999999999853211 1111 11111111 00
Q ss_pred hHHHHHHHHHHHHHchhcCCCCCCCHH-HHHH
Q 037365 319 SKQVLLRYVNIALLCVQESADDRPTTN-DVVS 349 (398)
Q Consensus 319 ~~~~~~~~~~li~~cl~~dP~~RPt~~-evl~ 349 (398)
+...+..+.+|+.+||+.||++|||+. |+++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 112234588999999999999999995 6764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.1e-44 Score=344.59 Aligned_cols=217 Identities=25% Similarity=0.298 Sum_probs=168.3
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC---hhhHHHHHH---HHHHHHhcCCCcccceeeEEEeCCee
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS---GQGLREMKN---EASVIAKVQHKNLVRLLGCCIDKDEK 187 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~nIv~l~~~~~~~~~~ 187 (398)
.++|++.+.||+|+||.||+|++.. |+.||||++.... ......+.+ |+.+++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 3679999999999999999999865 8999999985431 112233334 46677778899999999999999999
Q ss_pred EEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 188 ILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 188 ~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
|+|||||++|+| +++||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 999999999998 46778999999999999999999999999775432
Q ss_pred ccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhhh
Q 037365 236 QANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAILE 314 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... .......... .....
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~--~~~~~------ 228 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLT--MAVEL------ 228 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSSS--CCCCC------
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccc--CCCCC------
Confidence 334589999999999975 568999999999999999999999986433221 1111111000 00000
Q ss_pred cccChHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 037365 315 DEYSSKQVLLRYVNIALLCVQESADDRPT-----TNDVVS 349 (398)
Q Consensus 315 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 349 (398)
+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 229 ----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 229 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1122345789999999999999999 688875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=329.71 Aligned_cols=235 Identities=20% Similarity=0.320 Sum_probs=174.0
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|++.+.||+|+||+||+|++.. |+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 589999999999999999999854 8999999996542 2235678999999999999999999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccc
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANT 239 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 239 (398)
|+.++.+ +++||||||+|||++.++.+||+|||+|+...... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--ccc
Confidence 9987644 57889999999999999999999999998765433 223
Q ss_pred ccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc------ccch--
Q 037365 240 SRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL------ELTD-- 310 (398)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~-- 310 (398)
....||+.|+|||.+.... ++.++|||||||++|||++|+.||..... ................. ...+
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH--HHHHHHHHHhcCCCchhhccccccccccc
Confidence 3458999999999988766 47899999999999999999999864321 11111111111000000 0000
Q ss_pred ----hhhhcccC--hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--Hhhc
Q 037365 311 ----AILEDEYS--SKQVLLRYVNIALLCVQESADDRPTTNDVVSM--LTNE 354 (398)
Q Consensus 311 ----~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~~ 354 (398)
........ .......+.+|+.+||+.||++|||++|+++. ++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00000000 11223568899999999999999999999974 5544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=333.05 Aligned_cols=218 Identities=17% Similarity=0.195 Sum_probs=166.6
Q ss_pred cCCCCccc-eecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCcccceeeEEEe----CCee
Q 037365 115 TNRFSDAN-KLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID----KDEK 187 (398)
Q Consensus 115 ~~~~~~~~-~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~ 187 (398)
.++|++.+ .||+|+||.||+|++.. ++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788775 59999999999999854 899999999643 4567899987655 89999999999876 4578
Q ss_pred EEEEeccCCCCh----------------------------------hHHhhcCCCCCceecC---CCCeEEcccccceec
Q 037365 188 ILIYEYMPNKSL----------------------------------DFFLFNLKASNILLDK---DMNPKISDFGMARIC 230 (398)
Q Consensus 188 ~lV~e~~~~g~L----------------------------------~~~~~dlkp~NILl~~---~~~~kl~DFGla~~~ 230 (398)
|+|||||+||+| +++||||||+|||+++ ++.+||+|||+|+..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 999999999988 4677899999999975 567999999999877
Q ss_pred CCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 231 GGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
..... .....||+.|||||++.+..|+.++|||||||++|||+||+.||....... .............. ....
T Consensus 165 ~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~~~~-~~~~ 238 (335)
T d2ozaa1 165 TSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRMGQY-EFPN 238 (335)
T ss_dssp CCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSS-SCCT
T ss_pred cCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHHHhcCCC-CCCC
Confidence 54432 334689999999999999999999999999999999999999985322211 00000000000000 0000
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
......+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 239 ------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 002234567899999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-42 Score=323.54 Aligned_cols=230 Identities=20% Similarity=0.308 Sum_probs=171.3
Q ss_pred CCCCccceecccCceEEEEEEEcCCCEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 193 (398)
++|++.+.||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999996543 23357889999999999999999999999999999999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCccccccc
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
+.++.+ +++||||||+|||++.++.+||+|||.+........ ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~ 159 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTH 159 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccce
Confidence 988765 577899999999999999999999999987654322 2334
Q ss_pred ccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchh--------h
Q 037365 242 IVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDA--------I 312 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 312 (398)
..|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... .+..................+. .
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 4689999999999764 569999999999999999999999854321 1111111111110000000000 0
Q ss_pred hh------cccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 313 LE------DEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 313 ~~------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.. ...........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00001122356789999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=326.55 Aligned_cols=208 Identities=24% Similarity=0.362 Sum_probs=165.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCCh------hhHHHHHHHHHHHHhcC--CCcccceeeEEEeCC
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSG------QGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKD 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~ 185 (398)
.++|++.+.||+|+||+||+|++.. |+.||||++..... .....+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 3689999999999999999999864 89999999864311 11234678999999997 899999999999999
Q ss_pred eeEEEEeccCCC-Ch--------------------------------hHHhhcCCCCCceecC-CCCeEEcccccceecC
Q 037365 186 EKILIYEYMPNK-SL--------------------------------DFFLFNLKASNILLDK-DMNPKISDFGMARICG 231 (398)
Q Consensus 186 ~~~lV~e~~~~g-~L--------------------------------~~~~~dlkp~NILl~~-~~~~kl~DFGla~~~~ 231 (398)
..++||||+.++ ++ +++||||||+|||++. ++.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 999999999864 43 5778999999999985 4789999999998764
Q ss_pred CCCcccccccccccccccChhhhccCCC-CcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccch
Q 037365 232 GNELQANTSRIVGTYGYMSPEYAIEGIF-SIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTD 310 (398)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ....... .
T Consensus 163 ~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~i~~~~~--~--- 222 (273)
T d1xwsa_ 163 DTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQV--F--- 222 (273)
T ss_dssp SSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCCC--C---
T ss_pred ccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------HHhhccc--C---
Confidence 332 334689999999999987765 677999999999999999999975310 0011100 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
. ....+..+.+++.+||+.||++|||++|+++
T Consensus 223 --~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 --F-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --C-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --C-----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 1112345789999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=324.55 Aligned_cols=231 Identities=22% Similarity=0.321 Sum_probs=167.7
Q ss_pred hcCCCCccceecccCceEEEEEEEc-C-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhc---CCCcccceeeEEEe---
Q 037365 114 ATNRFSDANKLGEGGFGPVYKGVLR-K-GNEIAVKRLSGR--SGQGLREMKNEASVIAKV---QHKNLVRLLGCCID--- 183 (398)
Q Consensus 114 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~--- 183 (398)
..++|++.+.||+|+||+||+|++. + ++.||||++... .......+.+|+.+++.+ +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999985 3 567999998543 222223456777777665 79999999999864
Q ss_pred --CCeeEEEEeccCCCCh---------------------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 184 --KDEKILIYEYMPNKSL---------------------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 184 --~~~~~lV~e~~~~g~L---------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
....+++|||+.++++ +++||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3468999999998865 57789999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccc-
Q 037365 229 ICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLE- 307 (398)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 307 (398)
..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ..................
T Consensus 165 ~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 165 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCGGGS
T ss_pred hhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCCchhcc
Confidence 65432 233456899999999999999999999999999999999999999854321 111111111111000000
Q ss_pred -----cchhhhh----cc--cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 308 -----LTDAILE----DE--YSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 308 -----~~~~~~~----~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
....... .. .........+.+|+.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 00 001122345789999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=319.94 Aligned_cols=234 Identities=19% Similarity=0.269 Sum_probs=169.0
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe--------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-------- 183 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------- 183 (398)
.++|++.+.||+|+||+||+|++. +|+.||||++... .......+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999986 4899999998544 33345678899999999999999999999865
Q ss_pred CCeeEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecC
Q 037365 184 KDEKILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICG 231 (398)
Q Consensus 184 ~~~~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~ 231 (398)
++..++||||+.++.+ +++||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 3468999999988755 57889999999999999999999999998765
Q ss_pred CCCcc--cccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCC---c
Q 037365 232 GNELQ--ANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNR---T 305 (398)
Q Consensus 232 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~ 305 (398)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ............... .
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSITPEVW 246 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHHHHHHhcCCCChhhc
Confidence 43321 123345799999999999865 689999999999999999999999853221 111111111111000 0
Q ss_pred ccc--------chhhhhcccChH------HHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 306 LEL--------TDAILEDEYSSK------QVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 306 ~~~--------~~~~~~~~~~~~------~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
... ............ .....+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 000000000011 112456789999999999999999999963
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-41 Score=321.27 Aligned_cols=231 Identities=21% Similarity=0.305 Sum_probs=166.6
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC------
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 185 (398)
.++|++++.||+|+||+||+|.+.. |+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 5789999999999999999999865 899999999754 3344567889999999999999999999998654
Q ss_pred eeEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 186 EKILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 186 ~~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
..|+||||+ +++| +++||||||+|||++.++.+|++|||+|+.....
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred eEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence 579999999 4444 5778999999999999999999999999876533
Q ss_pred cccccccccccccccChhhhccC-CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhc--------CCc
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEG-IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRS--------NRT 305 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------~~~ 305 (398)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ............ ...
T Consensus 175 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 175 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--HHHHHHHhccCCCcHHHHhhhcc
Confidence 2345799999999999864 5689999999999999999999998543211 111100000000 000
Q ss_pred ----------cccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--Hhhcc
Q 037365 306 ----------LELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM--LTNEA 355 (398)
Q Consensus 306 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 355 (398)
.+......... .......+.+|+.+||+.||++|||++|+++. ++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASI--LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGT--CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhhccCCcccccchHHh--ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000000 11123457899999999999999999999974 65543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-40 Score=312.02 Aligned_cols=230 Identities=20% Similarity=0.255 Sum_probs=169.7
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccc-eeeEEEeCCeeEEEEec
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR-LLGCCIDKDEKILIYEY 193 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lV~e~ 193 (398)
++|++.+.||+|+||.||+|++.. |+.||||.+...... .++..|++++++++|+|++. +.+++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 679999999999999999999854 889999988654322 45788999999998776555 55566778889999999
Q ss_pred cCCCCh--------------------------------hHHhhcCCCCCceec---CCCCeEEcccccceecCCCCcc--
Q 037365 194 MPNKSL--------------------------------DFFLFNLKASNILLD---KDMNPKISDFGMARICGGNELQ-- 236 (398)
Q Consensus 194 ~~~g~L--------------------------------~~~~~dlkp~NILl~---~~~~~kl~DFGla~~~~~~~~~-- 236 (398)
+.++.+ +++||||||+|||++ .+..+||+|||+|+.+......
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 965532 578899999999875 4567999999999987643321
Q ss_pred ---cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhhh
Q 037365 237 ---ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAIL 313 (398)
Q Consensus 237 ---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.......||+.|||||.+.+..++.++|||||||++|||++|+.||........... ...... .. .....+..
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~--~~~~~~-~~-~~~~~~~~ 240 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YERISE-KK-MSTPIEVL 240 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHHH-HH-HHSCHHHH
T ss_pred eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH--HHHhhc-cc-CCCChhHh
Confidence 123456899999999999999999999999999999999999999865433321110 000000 00 00000001
Q ss_pred hcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhccc
Q 037365 314 EDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAA 356 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 356 (398)
....+..+.+++..||+.||++||+++++.+.|+....
T Consensus 241 -----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 241 -----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11233568899999999999999999999988887644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=312.29 Aligned_cols=231 Identities=19% Similarity=0.255 Sum_probs=174.9
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCCeeEEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 192 (398)
++|++++.||+|+||+||+|++.. ++.||||+++.. .......+.+|+.+|+.++||||+++++++.+.+..++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 589999999999999999999864 889999998644 33456788999999999999999999999999999999999
Q ss_pred ccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcccccc
Q 037365 193 YMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQANTS 240 (398)
Q Consensus 193 ~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 240 (398)
++.+++| +++||||||+|||++.++.+||+|||.++....... ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--cce
Confidence 9998876 467889999999999999999999999988754332 223
Q ss_pred cccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc-------------
Q 037365 241 RIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL------------- 306 (398)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------------- 306 (398)
...+++.|+|||.+.+.. ++.++|||||||++|||++|+.||...... .+....+..........
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-HHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 346788999999988765 689999999999999999999997543222 22222111111110000
Q ss_pred -ccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 307 -ELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 307 -~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
...................+.+|+.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000001223356789999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-40 Score=310.25 Aligned_cols=234 Identities=15% Similarity=0.195 Sum_probs=177.7
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCC-CcccceeeEEEeCCeeEEEEe
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 192 (398)
.++|++.+.||+|+||+||+|++.. |+.||||++..... ...+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4689999999999999999999865 88999998865432 2356789999999976 899999999999999999999
Q ss_pred ccCCCCh---------------------------------hHHhhcCCCCCceecC-----CCCeEEcccccceecCCCC
Q 037365 193 YMPNKSL---------------------------------DFFLFNLKASNILLDK-----DMNPKISDFGMARICGGNE 234 (398)
Q Consensus 193 ~~~~g~L---------------------------------~~~~~dlkp~NILl~~-----~~~~kl~DFGla~~~~~~~ 234 (398)
|+ +|+| +++||||||+|||++. ++.+||+|||+|+......
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99 5665 5788999999999964 5789999999999875432
Q ss_pred cc-----cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccc-hhHHHHHhhhcCCcccc
Q 037365 235 LQ-----ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLN-LLGYAWDLWRSNRTLEL 308 (398)
Q Consensus 235 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 308 (398)
.. .......||+.|||||++.+..++.++|||||||++|||++|+.||......... .............
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~---- 236 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP---- 236 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC----
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC----
Confidence 11 1234568999999999999999999999999999999999999998643332111 1111100000000
Q ss_pred chhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHhhcccccCCC
Q 037365 309 TDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVSMLTNEAAALLPP 361 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 361 (398)
...+ ....+..+.+++..||..+|++||+++.+.+.|+++.......
T Consensus 237 -~~~l-----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 237 -LREL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp -HHHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -hHHh-----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 0001 1112356889999999999999999999999888876544433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-41 Score=321.70 Aligned_cols=229 Identities=21% Similarity=0.270 Sum_probs=166.6
Q ss_pred CCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC------CeeEE
Q 037365 117 RFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DEKIL 189 (398)
Q Consensus 117 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 189 (398)
+|+..++||+|+||+||+|++.. |+.||||++..... ...+|+++|++++||||++++++|... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 57788999999999999999865 89999999976532 234799999999999999999999653 35789
Q ss_pred EEeccCCCCh-----------------------------------hHHhhcCCCCCceecCCC-CeEEcccccceecCCC
Q 037365 190 IYEYMPNKSL-----------------------------------DFFLFNLKASNILLDKDM-NPKISDFGMARICGGN 233 (398)
Q Consensus 190 V~e~~~~g~L-----------------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~~ 233 (398)
|||||++|.+ +++||||||+|||++.++ .+||+|||+++.....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 9999987632 577899999999999775 8999999999887544
Q ss_pred CcccccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH----------HHhhhc
Q 037365 234 ELQANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA----------WDLWRS 302 (398)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~----------~~~~~~ 302 (398)
.. .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+.... +.....
T Consensus 177 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 177 EP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp SC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCC
T ss_pred cc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhhhhcc
Confidence 32 233579999999998875 46899999999999999999999998643221 1111110 000000
Q ss_pred C----CccccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhhc
Q 037365 303 N----RTLELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTNE 354 (398)
Q Consensus 303 ~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~~ 354 (398)
. ............ .........+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0 000000000000 001223446889999999999999999999996 35444
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-40 Score=312.40 Aligned_cols=228 Identities=16% Similarity=0.274 Sum_probs=170.3
Q ss_pred CCCCccceecccCceEEEEEEEcC-CCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeC--CeeEEEE
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDK--DEKILIY 191 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~ 191 (398)
++|++.+.||+|+||+||+|++.. |+.||||+++... .+.+.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 579999999999999999999854 8899999997543 467889999999996 99999999999854 5689999
Q ss_pred eccCCCCh-----------------------------hHHhhcCCCCCceecCCC-CeEEcccccceecCCCCccccccc
Q 037365 192 EYMPNKSL-----------------------------DFFLFNLKASNILLDKDM-NPKISDFGMARICGGNELQANTSR 241 (398)
Q Consensus 192 e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~ 241 (398)
|||.+|+| +++||||||+|||++.++ .+||+|||+|+....... ...
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~ 188 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNV 188 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCS
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCc---ccc
Confidence 99999987 567899999999998655 589999999987754432 334
Q ss_pred ccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH--------HHhhhcCCc--cccch
Q 037365 242 IVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA--------WDLWRSNRT--LELTD 310 (398)
Q Consensus 242 ~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~~~ 310 (398)
..||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.............. ......... .....
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 268 (328)
T d3bqca1 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268 (328)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence 57899999999988754 79999999999999999999999865443211111100 000000000 00000
Q ss_pred hh-----------hhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 037365 311 AI-----------LEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS 349 (398)
Q Consensus 311 ~~-----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 349 (398)
.. .............+.+|+.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000011223456889999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-40 Score=314.82 Aligned_cols=234 Identities=18% Similarity=0.262 Sum_probs=167.2
Q ss_pred cCCCCccceecccCceEEEEEEEc-CCCEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeCC----eeE
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKI 188 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~ 188 (398)
+++|++++.||+|+||+||+|++. +|+.||||++... .....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 468999999999999999999975 4999999999754 3445567889999999999999999999997653 235
Q ss_pred EEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc-
Q 037365 189 LIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ- 236 (398)
Q Consensus 189 lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 236 (398)
++++|+.+|+| +++||||||+|||+++++.+||+|||+++........
T Consensus 87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 55566778887 5778999999999999999999999999876543222
Q ss_pred cccccccccccccChhhhcc-CCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCcc--------c
Q 037365 237 ANTSRIVGTYGYMSPEYAIE-GIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTL--------E 307 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 307 (398)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... +............... .
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH--HHHHHHhhhccCCChhhhhhhhhhh
Confidence 22345679999999999854 56789999999999999999999998543221 1111111101000000 0
Q ss_pred cchhhh---h-cccC----hHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 308 LTDAIL---E-DEYS----SKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 308 ~~~~~~---~-~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
...... . .... .+.....+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0 0000 01122457899999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=316.50 Aligned_cols=220 Identities=20% Similarity=0.309 Sum_probs=170.5
Q ss_pred CCCCccceecccCceEEEEEEEc----CCCEEEEEEccCC----ChhhHHHHHHHHHHHHhcCC-CcccceeeEEEeCCe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR----KGNEIAVKRLSGR----SGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDE 186 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~ 186 (398)
++|++.+.||+|+||+||+|+.. +|+.||||.++.. +....+.+.+|++++++++| |||+++++++.+++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999863 3789999998643 12234567899999999976 899999999999999
Q ss_pred eEEEEeccCCCCh--------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCC
Q 037365 187 KILIYEYMPNKSL--------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNE 234 (398)
Q Consensus 187 ~~lV~e~~~~g~L--------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 234 (398)
.+++|||+.+|+| +++||||||+|||++.++.+||+|||+++.+....
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 9999999999998 46788999999999999999999999998765433
Q ss_pred cccccccccccccccChhhhccC--CCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCccccchhh
Q 037365 235 LQANTSRIVGTYGYMSPEYAIEG--IFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRTLELTDAI 312 (398)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
.. ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....... ............ .. .
T Consensus 184 ~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~i~~~~~~~-~~-~----- 254 (322)
T d1vzoa_ 184 TE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS-EP-P----- 254 (322)
T ss_dssp GG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC-CC-C-----
T ss_pred cc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcccC-CC-C-----
Confidence 22 23346799999999999765 46889999999999999999999986443221 111111111111 00 0
Q ss_pred hhcccChHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 037365 313 LEDEYSSKQVLLRYVNIALLCVQESADDRP-----TTNDVVS 349 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 349 (398)
.+...+..+.+++.+||++||++|| |++|+++
T Consensus 255 -----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 255 -----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0122345688999999999999999 5888886
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=314.69 Aligned_cols=231 Identities=21% Similarity=0.248 Sum_probs=165.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEe------CC
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID------KD 185 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~ 185 (398)
.++|++.+.||+|+||+||+|++.. |+.||||++... +......+.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 4789999999999999999999875 899999999754 34445678899999999999999999999964 36
Q ss_pred eeEEEEeccCCCCh-----------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCcc
Q 037365 186 EKILIYEYMPNKSL-----------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNELQ 236 (398)
Q Consensus 186 ~~~lV~e~~~~g~L-----------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 236 (398)
..|+|||||.++.+ +++||||||+|||++.++.+|++|||+++......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~-- 173 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 173 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc--
Confidence 88999999988755 57789999999999999999999999988665432
Q ss_pred cccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHH-------------------H
Q 037365 237 ANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYA-------------------W 297 (398)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~-------------------~ 297 (398)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... .
T Consensus 174 -~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 174 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred -ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH--HHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 234457899999999999999999999999999999999999997533211 000000 0
Q ss_pred HhhhcCCc------cccc-hhhhhcc-cChHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 037365 298 DLWRSNRT------LELT-DAILEDE-YSSKQVLLRYVNIALLCVQESADDRPTTNDVVSM 350 (398)
Q Consensus 298 ~~~~~~~~------~~~~-~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 350 (398)
........ .... +...... .........+.+|+.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 0000 0000000 0123455678999999999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-39 Score=309.31 Aligned_cols=231 Identities=21% Similarity=0.298 Sum_probs=167.4
Q ss_pred cCCCCccceecccCceEEEEEEEcC-CCEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCcccceeeEEEeC-----Ce
Q 037365 115 TNRFSDANKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 186 (398)
Q Consensus 115 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 186 (398)
.++|++.+.||+|+||+||+|++.. |+.||||++... +....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5789999999999999999999764 899999999754 334456788999999999999999999999743 34
Q ss_pred eEEEEeccCCCCh-------------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 187 KILIYEYMPNKSL-------------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 187 ~~lV~e~~~~g~L-------------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
.+++++|+.+|+| +++||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc---
Confidence 5677788889988 467789999999999999999999999876432
Q ss_pred ccccccccccccccChhhhccCC-CCcccccHHHHHHHHHHHcCCCCCCCCCCCccchhHHHHHhhhcCCc---------
Q 037365 236 QANTSRIVGTYGYMSPEYAIEGI-FSIKFDVFSFGVLLLEIVSGKKNTGFYRTDTLNLLGYAWDLWRSNRT--------- 305 (398)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------- 305 (398)
......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...... ...............
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChHHhhhccch
Confidence 233457899999999887754 689999999999999999999998533211 111111111000000
Q ss_pred ---------cccchhhhhcccChHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHhhc
Q 037365 306 ---------LELTDAILEDEYSSKQVLLRYVNIALLCVQESADDRPTTNDVVS--MLTNE 354 (398)
Q Consensus 306 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~--~L~~~ 354 (398)
........... .......+.+|+.+||+.||.+|||++|+++ .+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANV--FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHH--STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccCCCcchhhh--cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000000000 0112345789999999999999999999997 45554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-34 Score=278.85 Aligned_cols=228 Identities=17% Similarity=0.210 Sum_probs=163.3
Q ss_pred CCCCccceecccCceEEEEEEEc-CCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-----------CCcccceeeEEEe
Q 037365 116 NRFSDANKLGEGGFGPVYKGVLR-KGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----------HKNLVRLLGCCID 183 (398)
Q Consensus 116 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~ 183 (398)
++|++++.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999985 48999999997543 33467788999988875 5789999998865
Q ss_pred --CCeeEEEEeccCCCCh------------------------------------hHHhhcCCCCCceecCCCC------e
Q 037365 184 --KDEKILIYEYMPNKSL------------------------------------DFFLFNLKASNILLDKDMN------P 219 (398)
Q Consensus 184 --~~~~~lV~e~~~~g~L------------------------------------~~~~~dlkp~NILl~~~~~------~ 219 (398)
....+++++++..+.. +++||||||+|||++.++. +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 4566777777655432 4788999999999976653 8
Q ss_pred EEcccccceecCCCCcccccccccccccccChhhhccCCCCcccccHHHHHHHHHHHcCCCCCCCCCCCc-cc----hhH
Q 037365 220 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIEGIFSIKFDVFSFGVLLLEIVSGKKNTGFYRTDT-LN----LLG 294 (398)
Q Consensus 220 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~-~~----~~~ 294 (398)
|++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||....... .. +..
T Consensus 172 kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999865422 234579999999999999999999999999999999999999986443221 00 111
Q ss_pred HHHHhhhc------------------C----Cccc----cchhhhhcc-cChHHHHHHHHHHHHHchhcCCCCCCCHHHH
Q 037365 295 YAWDLWRS------------------N----RTLE----LTDAILEDE-YSSKQVLLRYVNIALLCVQESADDRPTTNDV 347 (398)
Q Consensus 295 ~~~~~~~~------------------~----~~~~----~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~ev 347 (398)
... .+.. . .... ......... .........+.+|+.+||+.||.+|||++|+
T Consensus 247 ~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 247 IIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 100 0000 0 0000 000000001 1134566789999999999999999999999
Q ss_pred HHH
Q 037365 348 VSM 350 (398)
Q Consensus 348 l~~ 350 (398)
++.
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.78 E-value=4.4e-20 Score=160.95 Aligned_cols=138 Identities=19% Similarity=0.188 Sum_probs=101.0
Q ss_pred CccceecccCceEEEEEEEcCCCEEEEEEccCCCh------------------hhHHHHHHHHHHHHhcCCCcccceeeE
Q 037365 119 SDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSG------------------QGLREMKNEASVIAKVQHKNLVRLLGC 180 (398)
Q Consensus 119 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 180 (398)
.+.++||+|+||.||+|+..+|+.||||+++.... .......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999998899999998753210 112334568899999999999998866
Q ss_pred EEeCCeeEEEEeccCCCCh-------------------------hHHhhcCCCCCceecCCCCeEEcccccceecCCCCc
Q 037365 181 CIDKDEKILIYEYMPNKSL-------------------------DFFLFNLKASNILLDKDMNPKISDFGMARICGGNEL 235 (398)
Q Consensus 181 ~~~~~~~~lV~e~~~~g~L-------------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 235 (398)
. ..+++|||++++.+ +++||||||+|||+++++ ++|+|||+|.....+..
T Consensus 83 ~----~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~ 157 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGW 157 (191)
T ss_dssp E----TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTH
T ss_pred c----CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCc
Confidence 3 24799999998754 578899999999998654 89999999987543221
Q ss_pred ccccccccccccccC------hhhhccCCCCcccccHHHHHHH
Q 037365 236 QANTSRIVGTYGYMS------PEYAIEGIFSIKFDVFSFGVLL 272 (398)
Q Consensus 236 ~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwSlGvvl 272 (398)
. .|.. .+. ....|+.++|+||..--+
T Consensus 158 ~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 158 R----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp H----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred H----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 1 1111 111 245688999999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.93 E-value=7e-06 Score=72.55 Aligned_cols=89 Identities=10% Similarity=0.048 Sum_probs=62.4
Q ss_pred hhhhhcCCCCccceecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCcccceeeEEEeCCeeE
Q 037365 110 SVSTATNRFSDANKLGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKI 188 (398)
Q Consensus 110 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 188 (398)
++....+.|+..+..+-++.+.||+... +++.+.+|+...........+.+|...+..+. +--+.++++++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444556666665544455678998865 46778888886543333345678888888774 434677888888889999
Q ss_pred EEEeccCCCCh
Q 037365 189 LIYEYMPNKSL 199 (398)
Q Consensus 189 lV~e~~~~g~L 199 (398)
+||++++|..+
T Consensus 87 lv~~~l~G~~~ 97 (263)
T d1j7la_ 87 LLMSEADGVLC 97 (263)
T ss_dssp EEEECCSSEEH
T ss_pred EEEEecccccc
Confidence 99999988654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.60 E-value=4.5e-05 Score=66.76 Aligned_cols=74 Identities=15% Similarity=0.153 Sum_probs=53.7
Q ss_pred eecccC-ceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCC--CcccceeeEEEeCCeeEEEEeccCCCCh
Q 037365 123 KLGEGG-FGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKILIYEYMPNKSL 199 (398)
Q Consensus 123 ~lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~g~L 199 (398)
.+..|. .+.||+....++..+.+|....... ..+..|...++.+.. -.+.++++++.+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344454 3679999887777888998765432 346678888877743 3366788888888899999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.57 E-value=0.0019 Score=60.28 Aligned_cols=74 Identities=14% Similarity=0.235 Sum_probs=47.8
Q ss_pred ceecccCceEEEEEEEcC-CCEEEEEEccCC-------ChhhHHHHHHHHHHHHhcC-C--CcccceeeEEEeCCeeEEE
Q 037365 122 NKLGEGGFGPVYKGVLRK-GNEIAVKRLSGR-------SGQGLREMKNEASVIAKVQ-H--KNLVRLLGCCIDKDEKILI 190 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lV 190 (398)
+.||.|....||+....+ ++.++||.-... -+........|.+.|..+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 568999999999998765 678999964321 1112234556888887663 2 345556554 45667899
Q ss_pred EeccCCC
Q 037365 191 YEYMPNK 197 (398)
Q Consensus 191 ~e~~~~g 197 (398)
||++++.
T Consensus 110 mE~L~~~ 116 (392)
T d2pula1 110 MEDLSHL 116 (392)
T ss_dssp ECCCTTS
T ss_pred EeccCCc
Confidence 9999764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.02 E-value=0.0036 Score=56.66 Aligned_cols=68 Identities=9% Similarity=0.057 Sum_probs=46.6
Q ss_pred eEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcc-----cce--eeEEEeCCeeEEEEeccCCCC
Q 037365 130 GPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-----VRL--LGCCIDKDEKILIYEYMPNKS 198 (398)
Q Consensus 130 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-----v~l--~~~~~~~~~~~lV~e~~~~g~ 198 (398)
..||+....+|+.+++|...... ...+++..|...+..|...++ +.. -..+...+..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 58999999889999999986542 234667788888888742221 111 122344667889999998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.12 E-value=0.019 Score=51.11 Aligned_cols=119 Identities=10% Similarity=0.032 Sum_probs=72.4
Q ss_pred chhhhhhhcCCCCccce-----ecccCceEEEEEEEcCCCEEEEEEccCCChhhHHHHHHHHHHHHhcCCC-----cccc
Q 037365 107 SFSSVSTATNRFSDANK-----LGEGGFGPVYKGVLRKGNEIAVKRLSGRSGQGLREMKNEASVIAKVQHK-----NLVR 176 (398)
Q Consensus 107 ~~~~~~~~~~~~~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~-----nIv~ 176 (398)
+-+++.....+|.+.+. |..|--.+.|+....+|+ +++|++..... ..++..|.+++..+.+. ..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 34556666677766443 445666788998886554 88998865321 23445566666666422 2221
Q ss_pred ee---eEEEeCCeeEEEEeccCCCCh------------------------------------------------------
Q 037365 177 LL---GCCIDKDEKILIYEYMPNKSL------------------------------------------------------ 199 (398)
Q Consensus 177 l~---~~~~~~~~~~lV~e~~~~g~L------------------------------------------------------ 199 (398)
.. .+.........++.+..+...
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 112234556677777766532
Q ss_pred -----------------------hHHhhcCCCCCceecCCCCeEEcccccce
Q 037365 200 -----------------------DFFLFNLKASNILLDKDMNPKISDFGMAR 228 (398)
Q Consensus 200 -----------------------~~~~~dlkp~NILl~~~~~~kl~DFGla~ 228 (398)
+.+|.|+.+.||+++++...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 35677999999999988777899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.16 E-value=0.058 Score=49.62 Aligned_cols=72 Identities=15% Similarity=0.282 Sum_probs=48.6
Q ss_pred ceecccCceEEEEEEEcC--------CCEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcc-cceeeEEEeCCeeEEEEe
Q 037365 122 NKLGEGGFGPVYKGVLRK--------GNEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYE 192 (398)
Q Consensus 122 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e 192 (398)
+.|+.|-.-.+|+....+ .+.|.++... .. .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 578888899999998754 2456666654 22 223456689999888853344 577777642 68999
Q ss_pred ccCCCCh
Q 037365 193 YMPNKSL 199 (398)
Q Consensus 193 ~~~~g~L 199 (398)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2iuba2 f.17.3.1 (A:286-349) Magnesium transport protein CorA {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Transmembrane helix hairpin superfamily: Magnesium transport protein CorA, transmembrane region family: Magnesium transport protein CorA, transmembrane region domain: Magnesium transport protein CorA species: Thermotoga maritima [TaxId: 2336]
Probab=92.14 E-value=0.086 Score=35.00 Aligned_cols=20 Identities=30% Similarity=0.748 Sum_probs=16.6
Q ss_pred HHHHHHHHHHhhhhhhcccc
Q 037365 10 VVLLVSAVFLILAFISGLSK 29 (398)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~s~ 29 (398)
+.-+++++++||++++|+=.
T Consensus 8 ~lT~it~iflP~t~i~gifG 27 (64)
T d2iuba2 8 VLTIIATIFMPLTFIAGIYG 27 (64)
T ss_dssp HHHHHHHHHHHHHHHTTSCC
T ss_pred HHHHHHHHHHHHHHHHhhhc
Confidence 35578999999999999863
|